PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Smith, C				Smith, C			Drug target validation: Hitting the target	NATURE			English	Article																			0	59	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					341	+		10.1038/422341a	http://dx.doi.org/10.1038/422341a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646929	Bronze			2022-12-24	WOS:000181637300045
J	Plath, K; Fang, J; Mlynarczyk-Evans, SK; Cao, R; Worringer, KA; Wang, HB; de la Cruz, CC; Otte, AP; Panning, B; Zhang, Y				Plath, K; Fang, J; Mlynarczyk-Evans, SK; Cao, R; Worringer, KA; Wang, HB; de la Cruz, CC; Otte, AP; Panning, B; Zhang, Y			Role of histone H3 lysine 27 methylation in X inactivation	SCIENCE			English	Article							METHYLTRANSFERASE ACTIVITY; CHROMOSOME INACTIVATION; PROTEINS; ENHANCER; COMPLEX	The Polycomb group (PcG) protein Eed is implicated in regulation of imprinted X-chromosome inactivation in extraembryonic cells but not of random X inactivation in embryonic cells. The Drosophila homolog of the Eed-Ezh2 PcG protein complex achieves gene silencing through methylation of histone H3 on lysine 27 (H3-K27), which suggests a role for H3-K27 methylation in imprinted X inactivation. Here we demonstrate that transient recruitment of the Eed-Ezh2 complex to the inactive X chromosome (Xi) occurs during initiation of X inactivation in both extraembryonic and embryonic cells and is accompanied by H3-K27 methylation. Recruitment of the complex and methylation on the Xi depend on Xist RNA but are independent of its silencing function. Together, our results suggest a role for Eed-Ezh2-mediated H3-K27 methylation during initiation of both imprinted and random X inactivation and demonstrate that H3-K27 methylation is not sufficient for silencing of the Xi.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ Amsterdam, Bioctr Amsterdam, Swammerdam Inst Life Sci, NL-1018 TV Amsterdam, Netherlands	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam	Panning, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	bpanning@biochem.ucsf.edu; yi_zhang@med.unc.edu		Wang, Hengbin/0000-0003-2414-0609; Plath, Kathrin/0000-0001-7796-3372; Fang, Jia/0000-0001-8583-1652; Zhang, Yi/0000-0002-2789-0811; Worringer, Kathleen/0000-0001-7807-2344	NIGMS NIH HHS [R01 GM063671] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063671] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Brockdorff N, 2002, TRENDS GENET, V18, P352, DOI 10.1016/S0168-9525(02)02717-8; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CAO R, UNPUB; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; PANNING B, UNPUB; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; PLATH K, UNPUB; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; WORRINGER KA, UNPUB; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	21	909	964	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					131	135		10.1126/science.1084274	http://dx.doi.org/10.1126/science.1084274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12649488				2022-12-24	WOS:000181988900049
J	Vermeer, SE; Prins, ND; den Heijer, T; Hofman, A; Koudstaal, PJ; Breteler, MMB				Vermeer, SE; Prins, ND; den Heijer, T; Hofman, A; Koudstaal, PJ; Breteler, MMB			Silent brain infarcts and the risk of dementia and cognitive decline	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHITE-MATTER LESIONS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; NEUROFIBRILLARY TANGLES; CLINICAL DETERMINANTS; VASCULAR DEMENTIA; ELDERLY-PEOPLE; PREVALENCE; EXPRESSION	BACKGROUND: Silent brain infarcts are frequently seen on magnetic resonance imaging (MRI) in healthy elderly people and may be associated with dementia and cognitive decline. METHODS: We studied the association between silent brain infarcts and the risk of dementia and cognitive decline in 1015 participants of the prospective, population-based Rotterdam Scan Study, who were 60 to 90 years of age and free of dementia and stroke at base line. Participants underwent neuropsychological testing and cerebral MRI at base line in 1995 to 1996 and again in 1999 to 2000 and were monitored for dementia throughout the study period. We performed Cox proportional-hazards and multiple linear-regression analyses, adjusted for age, sex, and level of education and for the presence or absence of subcortical atrophy and white-matter lesions. RESULTS: During 3697 person-years of follow-up (mean per person, 3.6 years), dementia developed in 30 of the 1015 participants. The presence of silent brain infarcts at base line more than doubled the risk of dementia (hazard ratio, 2.26; 95 percent confidence interval, 1.09 to 4.70). The presence of silent brain infarcts on the base-line MRI was associated with worse performance on neuropsychological tests and a steeper decline in global cognitive function. Silent thalamic infarcts were associated with a decline in memory performance, and nonthalamic infarcts with a decline in psychomotor speed. When participants with silent brain infarcts at base line were subdivided into those with and those without additional infarcts at follow-up, the decline in cognitive function was restricted to those with additional silent infarcts. CONCLUSIONS: Elderly people with silent brain infarcts have an increased risk of dementia and a steeper decline in cognitive function than those without such lesions.	Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Neurol, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Breteler, MMB (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	m.breteler@erasmusmc.nl	Zito, Giancarlo/F-9008-2010; Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305; Prins, Niels/0000-0002-6297-7592				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Barber R, 1999, J NEUROL NEUROSUR PS, V67, P66, DOI 10.1136/jnnp.67.1.66; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P837, DOI 10.1212/WNL.38.6.837; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P1335; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; de Groot JC, 2000, ANN NEUROL, V47, P145; de Groot JC, 2002, ANN NEUROL, V52, P335, DOI 10.1002/ana.10294; de la Monte SM, 2000, NEUROBIOL AGING, V21, P309, DOI 10.1016/S0197-4580(99)00108-6; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Desmond DW, 2000, NEUROLOGY, V54, P1124, DOI 10.1212/WNL.54.5.1124; Esiri MM, 2001, LANCET, V357, P169; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Heyman A, 1998, NEUROLOGY, V51, P159, DOI 10.1212/WNL.51.1.159; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; HOFMAN A, 1983, NEW ENGL J MED, V309, P1248; Howard G, 1998, STROKE, V29, P913, DOI 10.1161/01.STR.29.5.913; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Petrovitch H, 2000, NEUROBIOL AGING, V21, P57, DOI 10.1016/S0197-4580(00)82479-3; Pohjasvaara T, 1998, STROKE, V29, P75, DOI 10.1161/01.STR.29.1.75; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; Small SA, 1999, NEUROLOGY, V52, P1392, DOI 10.1212/WNL.52.7.1392; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; SPARKS DL, 1995, J NEUROL SCI, V131, P162, DOI 10.1016/0022-510X(95)00105-B; TATEMICHI TK, 1992, ANN NEUROL, V32, P162, DOI 10.1002/ana.410320207; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111	33	1618	1693	4	105	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2003	348	13					1215	1222		10.1056/NEJMoa022066	http://dx.doi.org/10.1056/NEJMoa022066			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659RG	12660385	Bronze, Green Published			2022-12-24	WOS:000181790800003
J	Nagar, B; Hantschel, O; Young, MA; Scheffzek, K; Veach, D; Bornmann, V; Clarkson, B; Superti-Furga, G; Kuriyan, J				Nagar, B; Hantschel, O; Young, MA; Scheffzek, K; Veach, D; Bornmann, V; Clarkson, B; Superti-Furga, G; Kuriyan, J			Structural basis for the autoinhibition of c-Abl tyrosine kinase	CELL			English	Article							CRYSTAL-STRUCTURE; SRC FAMILY; BCR-ABL; CELLULAR FUNCTIONS; DIFFRACTION DATA; DOMAIN; INHIBITORS; MECHANISM; PHOSPHORYLATION; ACTIVATION	c-Abl is normally regulated by an autoinhibitory mechanism, the disruption of which leads to chronic myelogenous leukemia. The details of this mechanism have been elusive because c-Abl lacks a phosphotyrosine residue that triggers the assembly of the autoinhibited form of the closely related Src kinases by internally engaging the SH2 domain. Crystal structures of c-Abl show that the N-terminal myristoyl modification of c-Abl 1b binds to the kinase domain and induces conformational changes that allow the SH2 and SH3 domains to dock onto it. Autoinhibited c-Abl forms an assembly that is strikingly similar to that of inactive Src kinases but with specific differences that explain the differential ability of the drug STI-571/Gleevec/imatinib (STI-571) to inhibit the catalytic activity of Abl, but not that of c-Src.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany; Cellzome AG, D-69117 Heidelberg, Germany; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Cellzome GmbH; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Memorial Sloan Kettering Cancer Center	Kuriyan, J (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	superti@embl-heidelberg.de; kudyan@uclink.berkeley.edu	Nagar, Bhushan/C-1297-2010; Superti-Furga, Giulio/F-4755-2015; Hantschel, Oliver D/H-4705-2013; Hantschel, Oliver/M-7016-2019; Young, Matthew/D-2033-2011; Superti-Furga, Giulio/AAE-5681-2019; Young, Matthew/AAE-2632-2020	Superti-Furga, Giulio/0000-0002-0570-1768; Hantschel, Oliver D/0000-0001-8569-8169; Hantschel, Oliver/0000-0001-8569-8169; Young, Matthew/0000-0003-2921-3432; Young, Matthew/0000-0003-2921-3432; Veach, Darren/0000-0002-8201-622X	NATIONAL CANCER INSTITUTE [P01CA064593, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, P01 CA064593] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Brasher BB, 2001, ONCOGENE, V20, P7744, DOI 10.1038/sj.onc.1204978; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DeLano WL, 2002, PYMOL USERS MANUAL; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Gangal M, 1999, P NATL ACAD SCI USA, V96, P12394, DOI 10.1073/pnas.96.22.12394; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koegl M, 1995, ONCOGENE, V11, P2317; Kraker AJ, 2000, BIOCHEM PHARMACOL, V60, P885, DOI 10.1016/S0006-2952(00)00405-6; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; MULLER AJ, 1993, P NATL ACAD SCI USA, V90, P3457, DOI 10.1073/pnas.90.8.3457; Nagar B, 2002, CANCER RES, V62, P4236; Nam HJ, 1996, STRUCTURE, V4, P1105, DOI 10.1016/S0969-2126(96)00116-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sawyers CL, 2002, CANCER CELL, V1, P13, DOI 10.1016/S1535-6108(02)00022-3; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Wisniewski D, 2002, CANCER RES, V62, P4244; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zimmermann J, 1997, BIOORG MED CHEM LETT, V7, P187, DOI 10.1016/S0960-894X(96)00601-4	38	628	664	2	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2003	112	6					859	871		10.1016/S0092-8674(03)00194-6	http://dx.doi.org/10.1016/S0092-8674(03)00194-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654251	Bronze			2022-12-24	WOS:000181818500012
J	Sniderman, AD; Furberg, CD; Keech, A; van Lennep, JER; Frohlich, J; Jungner, I; Walldius, G				Sniderman, AD; Furberg, CD; Keech, A; van Lennep, JER; Frohlich, J; Jungner, I; Walldius, G			Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment	LANCET			English	Editorial Material							HEART-DISEASE; A-I; LIPOPROTEIN CHOLESTEROL; B REPLACE; FOLLOW-UP; PREVENTION; PREDICTION; PROFILE; EVENTS		McGill Univ, McGill Univ Hlth Ctr, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ, Canada; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; Leiden Univ, Med Ctr, Leiden, Netherlands; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; St Gorans Univ Hosp, CALAB Res, Stockholm, Sweden; Karolinska Inst, Karolinska Hosp, Clin Epidemiol Unit, S-10401 Stockholm, Sweden; AstraZeneca, Molndal, Sweden; Karolinska Inst, King Gustaf V Res Inst, Stockholm, Sweden	McGill University; Wake Forest University; Wake Forest Baptist Medical Center; University of Sydney; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Saint Goran's Hospital; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; Karolinska Institutet	Sniderman, AD (corresponding author), Royal Victoria Hosp, Mike Rosenbloom Lab Cardiovasc Res, Room H7-22,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	allan.sniderman@muhc.mcgill.ca						Ballantyne CM, 2001, AM J CARDIOL, V88, P265, DOI 10.1016/S0002-9149(01)01638-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Durrington PN, 2002, CLIN CHEM, V48, P401; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Miremadi S, 2002, CLIN CHEM, V48, P484; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Otvos JD, 2002, AM J CARDIOL, V90, p22I; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; Simes RJ, 2002, CIRCULATION, V105, P1162, DOI 10.1161/hc1002.105136; Sniderman AD, 2001, ANN INTERN MED, V135, P447, DOI 10.7326/0003-4819-135-6-200109180-00014; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2	17	357	370	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					777	780		10.1016/S0140-6736(03)12663-3	http://dx.doi.org/10.1016/S0140-6736(03)12663-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620753				2022-12-24	WOS:000181232000023
J	Fowler, KB; Stagno, S; Pass, RF				Fowler, KB; Stagno, S; Pass, RF			Maternal immunity and prevention of congenital cytomegalovirus infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DAY-CARE; VIRUS INFECTION; INFANTS BORN; MOTHERS; TRANSMISSION; POPULATION; PREGNANCY; WORKERS; WOMEN	Context Vaccine development to prevent congenital cytomegalovinus (CMV) infection has been impeded by the uncertainty over whether maternal immunity protects the fetus. Objective To determine whether the presence of maternal antibodies to CMV significantly reduces the risk of congenital CMV infection in future pregnancies. Design, Setting, and Participants Cohort study of 3461 multiparous women from a population with a high rate of congenital CMV infection who delivered newborns screened for congenital CMV infection between 1993 and 1998, and whose cord serum specimen from a previous delivery could be retrieved and tested for antibody to CMV. Main Outcome Measure Congenital CMV infection according to maternal immune status, age, race, parity, and socioeconomic status. Results Of 604 newborns born to initially seronegative mothers, congenital CMV infection occurred in 18 (3.0%). In contrast, of 2857 newborns born to immune mothers, congenital CMV infection occurred in 29 (1.0%) Two factors, preconception maternal immunity (adjusted risk ratio, 0.31; 95% confidence interval, 0.17-0.58) and maternal age of 25 years or older (adjusted risk ratio, 0.19; 95% confidence interval, 0.07-0.49), were highly protective against congenital CMV infection. No other factors were associated with a reduction in the risk of congenital CMV infection. Conclusion Naturally acquired immunity results in a 69% reduction in the risk of congenital CMV infection in future pregnancies.	Univ Alabama, Dept Pediat, Birmingham, AL 35233 USA; Univ Alabama, Dept Epidemiol, Birmingham, AL 35233 USA; Univ Alabama, Dept Maternal & Child Hlth, Birmingham, AL 35233 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fowler, KB (corresponding author), Univ Alabama, Dept Pediat, 1600 7th Ave S,CHB 306, Birmingham, AL 35233 USA.			Pass, Robert/0000-0003-2029-0247	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043681] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000032] Funding Source: Medline; NIAID NIH HHS [P01 AI43681, P01 AI043681] Funding Source: Medline; PHS HHS [M01 R00032] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADLER SP, 1989, NEW ENGL J MED, V321, P1290, DOI 10.1056/NEJM198911093211903; Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969; BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; CHANDLER SH, 1985, J INFECT DIS, V152, P249, DOI 10.1093/infdis/152.2.249; FOWLER KB, 1993, J INFECT DIS, V168, P552, DOI 10.1093/infdis/168.3.552; Fowler KB, 1999, J PEDIATR-US, V135, P60, DOI 10.1016/S0022-3476(99)70328-8; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; HICKS T, 1993, J PEDIATR-US, V123, P779, DOI 10.1016/S0022-3476(05)80859-5; MURPH JR, 1991, JAMA-J AM MED ASSOC, V265, P603, DOI 10.1001/jama.265.5.603; Mussi-Pinhata MM, 1998, J PEDIATR-US, V132, P285, DOI 10.1016/S0022-3476(98)70446-9; PASS RF, 1990, PEDIATR INFECT DIS J, V9, P465, DOI 10.1097/00006454-199007000-00003; Pass RF, 1996, INFECT AGENT DIS, V5, P240; PREECE PM, 1986, J EPIDEMIOL COMMUN H, V40, P205, DOI 10.1136/jech.40.3.205; SCHOPFER K, 1978, ARCH DIS CHILD, V53, P536, DOI 10.1136/adc.53.7.536; SOHN Y M, 1992, Journal of Korean Medical Science, V7, P47; SOHN YM, 1991, J INFECT DIS, V163, P460, DOI 10.1093/infdis/163.3.460; STAGNO C, 1995, INFECT DIS FETUS NEW, P312; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STAGNO S, 1977, NEW ENGL J MED, V296, P1254, DOI 10.1056/NEJM197706022962203; STRATTON K, 2001, VACCINES 21 CENTURY, P476	22	296	308	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1008	1011		10.1001/jama.289.8.1008	http://dx.doi.org/10.1001/jama.289.8.1008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597753	Bronze			2022-12-24	WOS:000181129800027
J	Lokkegaard, E; Pedersen, AT; Heitmann, BL; Jovanovic, Z; Keiding, N; Hundrup, YA; Obel, EB; Ottesen, B				Lokkegaard, E; Pedersen, AT; Heitmann, BL; Jovanovic, Z; Keiding, N; Hundrup, YA; Obel, EB; Ottesen, B			Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTMENOPAUSAL WOMEN; ESTROGEN REPLACEMENT; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; PLASMA-LIPIDS; RISK FACTOR; PREVENTION; NONUSERS; COHORT; NIDDM	Objective To investigate the risk of ischaemic heart disease and myocardial infarction among women using hormone replacement therapy, especially the potential modifying effect of cardiovascular risk factors. Design Prospective observational study. Setting Denmark. Participants 19 898 nurses aged 45 and over completing a questionnaire on lifestyle and use of hormone replacement therapy in 1993. Main outcome measures All cases of death and incident cases of ischaemic heart disease and myocardial infarction until the end of 1998. Results Current users of hormone replacement therapy smoked more, consumed more alcohol, had lower self rated health, but were slimmer and had a lower prevalence of diabetes than never users. In current users compared with never users, hormone replacement therapy had no protective effect on ischaemic heart disease (hazard ratio 1.2, 0.9 to 1.7) or myocardial infarction (1.0, 0.6 to 1.7), whereas current users with diabetes had an increased risk of death (3.2, 1.4 to 7.5), ischaemic heart disease (4.2, 1.4 to 12.5), and myocardial infarction (9.2, 2.0 to 41.4) compared with never users with diabetes. Conclusion Hormone replacement therapy showed no protective effect on ischaemic heart disease, but there was a significantly increased risk of death from all causes and ischaemic heart disease among women with diabetes.	Hvidovre Univ Hosp, Dept Obstet & Gynaecol, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Rigshosp, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Panum Inst, Dept Biostat, DK-2100 Copenhagen, Denmark; Natl Inst Publ Hlth, Danish Nurse Study, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-1399 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Lokkegaard, E (corresponding author), Hvidovre Univ Hosp, Dept Obstet & Gynaecol, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	loekkegaard@dadlnet.dk	Andersen, Zorana Jovanovic/P-4983-2014	Andersen, Zorana Jovanovic/0000-0003-4138-9828; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Lokkegaard, Ellen/0000-0003-4149-5663				Andersson B, 1997, J CLIN ENDOCR METAB, V82, P638, DOI 10.1210/jc.82.2.638; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Brussaard HE, 1997, DIABETOLOGIA, V40, P843, DOI 10.1007/s001250050758; Cornu C, 2000, MATURITAS, V37, P95, DOI 10.1016/S0378-5122(00)00164-X; FALKEBORN M, 1992, BRIT J OBSTET GYNAEC, V99, P821, DOI 10.1111/j.1471-0528.1992.tb14414.x; Friday KE, 2001, J CLIN ENDOCR METAB, V86, P48, DOI 10.1210/jc.86.1.48; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRADY J, 2002, JAMA-J AM MED ASSOC, V288, P49; Grodstein F, 1999, EPIDEMIOLOGY, V10, P476, DOI 10.1097/00001648-199909000-00003; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hu FB, 2000, NEW ENGL J MED, V343, P530, DOI 10.1056/NEJM200008243430802; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hundrup YA, 2000, ACTA OBSTET GYN SCAN, V79, P194, DOI 10.1080/j.1600-0412.2000.079003194.x; Hundrup YA, 2002, SCAND J PUBLIC HEALT, V30, P47, DOI 10.1080/140349401753481583; Koh KK, 2001, J AM COLL CARDIOL, V38, P1409, DOI 10.1016/S0735-1097(01)01566-2; Manwaring P, 2000, MATURITAS, V34, P239, DOI 10.1016/S0378-5122(99)00112-7; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Rodstrom K, 1999, BMJ-BRIT MED J, V319, P890, DOI 10.1136/bmj.319.7214.890; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Troisi RJ, 2000, OBSTET GYNECOL, V96, P665, DOI 10.1097/00006250-200011000-00005	25	32	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					426	428A		10.1136/bmj.326.7386.426	http://dx.doi.org/10.1136/bmj.326.7386.426			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595383	Bronze, Green Published			2022-12-24	WOS:000181318000020
J	Ikeda, H; Heinke, B; Ruscheweyh, R; Sandkuhler, J				Ikeda, H; Heinke, B; Ruscheweyh, R; Sandkuhler, J			Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia	SCIENCE			English	Article							LONG-TERM POTENTIATION; SUBSTANCE-P RECEPTOR; DORSAL HORN; T-TYPE; NEUROPATHIC PAIN; CALCIUM CHANNELS; RAT; INVOLVEMENT; EXPRESSION; MEMORY	Inflammation, trauma, or nerve injury may cause enduring hyperalgesia, an enhanced sensitivity to painful stimuli. Neurons in lamina I of the spinal dorsal horn that express the neurokinin 1 receptor for substance P mediate this abnormal pain sensitivity by an unknown cellular mechanism. We report that in these, but not in other nociceptive lamina I cells, neurokinin 1 receptor-activated signal transduction pathways and activation of low-threshold (T-type) voltage-gated calcium channels synergistically facilitate activity- and calcium-dependent long-term potentiation at synapses from nociceptive nerve fibers. Thereby, memory traces of painful events are retained.	Univ Heidelberg, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; Univ Vienna, Sch Med, Brain Res Inst, A-1090 Vienna, Austria	Ruprecht Karls University Heidelberg; University of Vienna	Sandkuhler, J (corresponding author), Univ Heidelberg, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany.		Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X				Bester H, 2000, J NEUROPHYSIOL, V83, P2239, DOI 10.1152/jn.2000.83.4.2239; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; DUGGAN AW, 1988, BRAIN RES, V451, P261, DOI 10.1016/0006-8993(88)90771-8; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Honore P, 1999, J NEUROSCI, V19, P7670, DOI 10.1523/JNEUROSCI.19-17-07670.1999; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Kawamata M, 1996, PAIN, V68, P85, DOI 10.1016/S0304-3959(96)03222-8; Khasabov SG, 2002, J NEUROSCI, V22, P9086; KLEIN T, 2003, IN PRESS PROGR PAIN, V24; LITTLEWOOD NK, 1995, NEUROSCIENCE, V66, P597, DOI 10.1016/0306-4522(95)00039-L; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Matthews EA, 2001, EUR J PHARMACOL, V415, P141, DOI 10.1016/S0014-2999(01)00812-3; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Talley EM, 1999, J NEUROSCI, V19, P1895; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Tolle TR, 1996, PROG BRAIN RES, V110, P193; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	24	419	442	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1237	1240		10.1126/science.1080659	http://dx.doi.org/10.1126/science.1080659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595694				2022-12-24	WOS:000181065500042
J	Janssen, EM; Lemmens, EE; Wolfe, T; Christen, U; von Herrath, MG; Schoenberger, SP				Janssen, EM; Lemmens, EE; Wolfe, T; Christen, U; von Herrath, MG; Schoenberger, SP			CD4(+) T cells are required for secondary expansion and memory in CD8(+) T lymphocytes	NATURE			English	Article							HELPER; DIFFERENTIATION; RESPONSES; GENERATION; INDUCTION; INVIVO; MICE; CTL	A long-standing paradox in cellular immunology concerns the conditional requirement for CD4(+) T-helper (T-H) cells in the priming of cytotoxic CD8(+) T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4(+) T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T-H cells(1-4). A clearer understanding of the contribution of T-H cells to CTL development has been hampered by the fact that most T-H-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T-H-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T-H-dependent and T-H-independent CTLs and find in both cases that CD4(+) T cells are dispensable for primary expansion of CD8(+) T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T-H cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8(+) T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Christen, Urs/A-7338-2009	Christen, Urs/0000-0003-4165-7976; janssen, edith/0000-0001-7881-6307				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; DI RF, 1996, J EXP MED, V183, P2153; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; Oehen S, 1998, J IMMUNOL, V161, P5338; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Suresh M, 2001, J IMMUNOL, V167, P5565, DOI 10.4049/jimmunol.167.10.5565; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730	27	1254	1304	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					852	856		10.1038/nature01441	http://dx.doi.org/10.1038/nature01441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594515				2022-12-24	WOS:000181044700050
J	Larkin, RM; Alonso, JM; Ecker, JR; Chory, J				Larkin, RM; Alonso, JM; Ecker, JR; Chory, J			GUN4, a regulator of chlorophyll synthesis and intracellular signaling	SCIENCE			English	Article							CHELATASE H-SUBUNIT; MAGNESIUM-CHELATASE; NUCLEUS; CHLOROPLAST; BIOSYNTHESIS; ACCUMULATION; PROTEIN; IX	Nuclear genes control plastid differentiation in response to developmental signals, environmental signals, and retrograde signals from plastids themselves. In return, plastids emit signals that are essential for proper expression of many nuclear photosynthetic genes. Accumulation of magnesium-protoporphyrin IX (Mg-Proto), an intermediate in chlorophyll biosynthesis, is a plastid signal that represses nuclear transcription through a signaling pathway that, in Arabidopsis, requires the GUN4 gene. GUN4 binds the product and substrate of Mg-chelatase, an enzyme that produces Mg-Proto, and activates Mg-chelatase. Thus, GUN4 participates in plastid-to-nucleus signaling by regulating Mg-Proto synthesis or trafficking.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Alonso, Jose M/K-6826-2014; Ecker, Joseph R/B-9144-2008	Alonso, Jose M/0000-0001-7087-1571; Ecker, Joseph R/0000-0001-5799-5895; , Robert/0000-0002-4665-3731				[Anonymous], METHODS CHLOROPLAST; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; FALBEL TG, 1994, PLANT PHYSIOL, V104, P639, DOI 10.1104/pp.104.2.639; FIDAI S, 1995, FEBS LETT, V372, P264, DOI 10.1016/0014-5793(95)00995-L; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; JACOBS JM, 1993, PLANT PHYSIOL, V101, P1181, DOI 10.1104/pp.101.4.1181; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; LARKIN RM, UNPUB; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Popperl G, 1998, J PLANT PHYSIOL, V153, P40, DOI 10.1016/S0176-1617(98)80042-4; Reid JD, 2002, BIOCHEM SOC T, V30, P643, DOI 10.1042/bst0300643; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; Takamiya K, 2000, TRENDS PLANT SCI, V5, P426, DOI 10.1016/S1360-1385(00)01735-0; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; THOMAS J, 1990, PLANT PHYSIOL, V94, P1414, DOI 10.1104/pp.94.3.1414; Walker CJ, 1997, BIOCHEM J, V327, P321	24	373	427	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					902	906		10.1126/science.1079978	http://dx.doi.org/10.1126/science.1079978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574634				2022-12-24	WOS:000180830900056
J	Ruban, AV; Wentworth, M; Yakushevska, AE; Andersson, J; Lee, PJ; Keegstra, W; Dekker, JP; Boekema, EJ; Jansson, S; Horton, P				Ruban, AV; Wentworth, M; Yakushevska, AE; Andersson, J; Lee, PJ; Keegstra, W; Dekker, JP; Boekema, EJ; Jansson, S; Horton, P			Plants lacking the main light-harvesting complex retain photosystem II macro-organization	NATURE			English	Article							A/B-BINDING PROTEIN; ANTENNA; MEMBRANE; MECHANISM; SPINACH	Photosystem II (PSII) is a key component of photosynthesis, the process of converting sunlight into the chemical energy of life. In plant cells, it forms a unique oligomeric macrostructure in membranes of the chloroplasts(1). Several light-harvesting antenna complexes are organized precisely in the PSII macrostructure-the major trimeric complexes (LHCII)(2) that bind 70% of PSII chlorophyll and three minor monomeric complexes(3)-which together form PSII supercomplexes(4-6). The antenna complexes are essential for collecting sunlight and regulating photosynthesis(7-9), but the relationship between these functions and their molecular architecture is unresolved. Here we report that antisense Arabidopsis plants lacking the proteins that form LHCII trimers(10) have PSII supercomplexes with almost identical abundance and structure to those found in wild-type plants. The place of LHCII is taken by a normally minor and monomeric complex, CP26, which is synthesized in large amounts and organized into trimers. Trimerization is clearly not a specific attribute of LHCII. Our results highlight the importance of the PSII macrostructure: in the absence of one of its main components, another protein is recruited to allow it to assemble and function.	Univ Sheffield, Robert Hill Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; Vrije Univ Amsterdam, Fac Sci, Div Phys & Astron, NL-1081 HV Amsterdam, Netherlands	University of Sheffield; University of Groningen; Umea University; Vrije Universiteit Amsterdam	Horton, P (corresponding author), Univ Sheffield, Robert Hill Inst, Dept Mol Biol & Biotechnol, Firth Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.horton@sheffield.ac.uk	Jansson, Stefan/A-1119-2009; Horton, Peter/A-3958-2012	Jansson, Stefan/0000-0002-7906-6891; Horton, Peter/0000-0002-6095-1460				Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; ANDERSSON J, IN PRESS PLANT J; Barber J, 2002, CURR OPIN STRUC BIOL, V12, P523, DOI 10.1016/S0959-440X(02)00357-3; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; CAFFARRI S, 2001, PS2001 P 12 INT C PH, pS31; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Garab G, 1999, AUST J PLANT PHYSIOL, V26, P649, DOI 10.1071/PP99069; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; HOBE S, 1995, BIOCHEMISTRY-US, V34, P10224, DOI 10.1021/bi00032a016; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; KUHLBRANDT W, 1991, NATURE, V350, P130, DOI 10.1038/350130a0; Kuttkat A, 1996, EUR J BIOCHEM, V242, P288, DOI 10.1111/j.1432-1033.1996.0288r.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nield J, 2000, NAT STRUCT BIOL, V7, P44; PAULSEN H, 1995, PHOTOCHEM PHOTOBIOL, V62, P367, DOI 10.1111/j.1751-1097.1995.tb02357.x; PETER GF, 1991, J BIOL CHEM, V266, P16745; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Walters RG, 1999, PLANTA, V209, P517, DOI 10.1007/s004250050756; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	131	136	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					648	652		10.1038/nature01344	http://dx.doi.org/10.1038/nature01344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571599	Green Accepted, Green Published			2022-12-24	WOS:000180803200046
J	Wong, KK; Maser, RS; Bachoo, RM; Menon, J; Carrasco, DR; Gu, YS; Alt, FW; DePinho, RA				Wong, KK; Maser, RS; Bachoo, RM; Menon, J; Carrasco, DR; Gu, YS; Alt, FW; DePinho, RA			Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing	NATURE			English	Article							ATAXIA-TELANGIECTASIA; STEM-CELL; MICE; DNA; CANCER; MOUSE; STABILITY; DEFECTS; LEADS	Ataxia-telangiectasia (A-T) results from the loss of ataxia-telangiectasia mutated (Atm) function and is characterized by accelerated telomere loss, genomic instability, progressive neurological degeneration, premature ageing and increased neoplasia incidence(1). Here we evaluate the functional interaction of Atm and telomeres in vivo. We examined the impact of Atm deficiency as a function of progressive telomere attrition at both the cellular and whole-organism level in mice doubly null for Atm and the telomerase RNA component (Terc)(2-4). These compound mutants showed increased telomere erosion and genomic instability, yet they experienced a substantial elimination of T-cell lymphomas associated with Atm deficiency. A generalized proliferation defect was evident in all cell types and tissues examined, and this defect extended to tissue stem/progenitor cell compartments, thereby providing a basis for progressive multi-organ system compromise, accelerated ageing and premature death. We show that Atm deficiency and telomere dysfunction act together to impair cellular and whole-organism viability, thus supporting the view that aspects of A-T pathophysiology are linked to the functional state of telomeres and its adverse effects on stem/progenitor cell reserves.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA 92507 USA; Univ Washington, Sch Med, Dept Radiat Oncol & Immunol, Seattle, WA 98195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.		Maser, Richard/B-2970-2012	wong, kwok kin/0000-0001-6323-235X; DePinho, Ronald/0000-0002-5625-577X				AHMED S, 1995, J NEUROSCI, V15, P5765; ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P727; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Eilam R, 1998, P NATL ACAD SCI USA, V95, P12653, DOI 10.1073/pnas.95.21.12653; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hande MP, 2001, HUM MOL GENET, V10, P519, DOI 10.1093/hmg/10.5.519; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Spector BD, 1982, ATAXIA TELANGIECTASI, P103; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	30	312	323	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					643	648		10.1038/nature01385	http://dx.doi.org/10.1038/nature01385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12540856				2022-12-24	WOS:000180803200045
J	Yen, HCS; Gordon, C; Chang, EC				Yen, HCS; Gordon, C; Chang, EC			Schizosaccharomyces pombe Int6 and Ras homologs regulate cell division and mitotic fidelity via the proteasome	CELL			English	Article							MAMMARY-TUMOR VIRUS; FISSION YEAST INT6; COP9 SIGNALOSOME; 26S PROTEASOME; TRANSLATION INITIATION; GENE; PROTEIN; SUBUNIT; LOCALIZATION; COMPLEXES	Yin6 is a yeast homolog of Int6, which is implicated in tumorigenesis. We show that Yin6 binds to and regulates proteasome activity. Overexpression of Yin6 strengthens proteasome function while inactivation weakens and causes the accumulation of polyubiquitinated proteins including securin/Cut2 and cyclin/Cdc13. Yin6 regulates the proteasome by preferentially interacting with Rpn5, a conserved proteasome subunit, and affecting its localization/assembly. We showed previously that Yin6 cooperates with Ras1 to mediate chromosome segregation; here, we demonstrate that Ras1 similarly regulates the proteasome via Rpn5. In yeast, human Int6 binds Rpn5 and regulates its localization. We propose that human Int6, either alone or cooperatively with Ras, influences proteasome activities via Rpn5. Inactivating Int6 can lead to accumulation of mitotic regulators affecting cell division and mitotic fidelity.	Baylor Coll Med, Dept Mol & Cellular Biol, Breast Canc Ctr, Houston, TX 77030 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Baylor College of Medicine; University of Edinburgh	Chang, EC (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Breast Canc Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	echang@breastcenter.tmc.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	NCI NIH HHS [R01-CA90464] Funding Source: Medline; OAPP OPHS HHS [RPG-97-137-01-MGO] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OAPP OPHS HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams J, 2002, TRENDS MOL MED, V8, pS49, DOI 10.1016/S1471-4914(02)02315-8; Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Alves KH, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; AMSTERDAM A, 1993, P NATL ACAD SCI USA, V90, P99, DOI 10.1073/pnas.90.1.99; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; AYSCOUGH K, 1994, YEAST, V10, P1, DOI 10.1002/yea.320100102; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; BASELGA J, 2000, CANCER CELL, V1, P31; Berry LD, 1999, MOL CELL BIOL, V19, P2535; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Chen CR, 1999, P NATL ACAD SCI USA, V96, P517, DOI 10.1073/pnas.96.2.517; Chen CR, 2000, MOL BIOL CELL, V11, P4067, DOI 10.1091/mbc.11.12.4067; Criekinge W. V., 1999, BIOL P ONLINE, V2, P1; Desbois C, 1996, SCIENCE, V273, P951, DOI 10.1126/science.273.5277.951; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; FUKUI Y, 1988, MOL GEN GENET, V215, P26, DOI 10.1007/BF00331298; FUKUI Y, 1986, CELL, V44, P329, DOI 10.1016/0092-8674(86)90767-1; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gohring UJ, 1999, TUMOR BIOL, V20, P173, DOI 10.1159/000030061; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Grishchuk EL, 1998, GENETICS, V149, P1251; Guo JJ, 2000, J VIROL, V74, P1892, DOI 10.1128/JVI.74.4.1892-1899.2000; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hemelaar J, 2001, J VIROL, V75, P11106, DOI 10.1128/JVI.75.22.11106-11115.2001; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; KIARIS H, 1995, INT J ONCOL, V7, P413; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Lafarga M, 2002, GLIA, V38, P313, DOI 10.1002/glia.10075; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Leclercq G, 2002, J STEROID BIOCHEM, V80, P259, DOI 10.1016/S0960-0760(02)00026-2; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu SQ, 2002, P NATL ACAD SCI USA, V99, P3770, DOI 10.1073/pnas.052710299; Lonning Per Eystein, 2002, Int J Clin Oncol, V7, P265, DOI 10.1007/s101470200038; LUCA FC, 1989, J CELL BIOL, V109, P1895, DOI 10.1083/jcb.109.5.1895; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Miyazaki S, 1997, GENOMICS, V46, P155, DOI 10.1006/geno.1997.4996; NADINDAVIS SA, 1986, EMBO J, V5, P2963, DOI 10.1002/j.1460-2075.1986.tb04593.x; Pajonk F, 2001, RADIAT RES, V156, P447, DOI 10.1667/0033-7587(2001)156[0447:TPICBA]2.0.CO;2; PALMER A, 1994, EUR J CELL BIOL, V64, P163; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Saito A, 1997, GENE, V203, P241, DOI 10.1016/S0378-1119(97)00524-6; Schondorf T, 1999, ONCOL REP, V6, P1029; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Tekmal R.R., 1997, FRONT BIOSCI, V2, P519; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Wilkinson CRM, 1997, J BIOL CHEM, V272, P25768, DOI 10.1074/jbc.272.41.25768; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yahalom A, 2001, J BIOL CHEM, V276, P334, DOI 10.1074/jbc.M006721200; Yen HCS, 2000, P NATL ACAD SCI USA, V97, P14370, DOI 10.1073/pnas.97.26.14370; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	66	72	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					207	217		10.1016/S0092-8674(03)00043-6	http://dx.doi.org/10.1016/S0092-8674(03)00043-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553909	Bronze			2022-12-24	WOS:000181191600010
J	Evans, JP; Zane, L; Francescato, S; Pilastro, A				Evans, JP; Zane, L; Francescato, S; Pilastro, A			Directional postcopulatory sexual selection revealed by artificial insemination	NATURE			English	Article							SPERM PRECEDENCE; POECILIA-RETICULATA; TRINIDADIAN GUPPY; FEMALE CHOICE; FLOUR BEETLES; PATTERNS; PATERNITY; BENEFITS; MALES	Postcopulatory sexual selection comprises both sperm competition, where the sperm from different males compete for fertilization(1), and cryptic female choice, where females bias sperm use in favour of particular males(2). Despite intense current interest in both processes as potential agents of directional sexual selection(3), few studies have attributed the success of attractive males to events that occur exclusively after insemination. This is because the interactions between pre- and post-insemination episodes of sexual selection can be important sources of variation in paternity(4). The use of artificial insemination overcomes this difficulty because it controls for variation in male fertilization success attributable to the female's perception of male quality, as well as effects due to mating order and the relative contribution of sperm from competing males(5). Here, we adopt this technique and show that in guppies, when equal numbers of sperm from two males compete for fertilization, relatively colourful individuals achieve greater parentage than their less ornamented counterparts. This finding indicates that precopulatory female mating preferences can be reinforced exclusively through postcopulatory processes occurring at a physiological level. Our analysis also revealed that relatively small individuals were advantaged in sperm competition, suggesting a possible trade-off between sperm competitive ability and body growth.	Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Evans, JP (corresponding author), Univ Padua, Dept Biol, Via U Bassi 58-B, I-35131 Padua, Italy.		Pilastro, Andrea/G-3868-2011; Zane, Lorenzo/G-6249-2010; Evans, Jonathan/A-1992-2011	Pilastro, Andrea/0000-0001-9803-6308; Zane, Lorenzo/0000-0002-6963-2132; 				Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, 2000, EVOLUTION, V54, P1057; Birkhead TR, 1998, SPERM COMPETITION SE; Blount JD, 2001, ECOL LETT, V4, P393, DOI 10.1046/j.1461-0248.2001.00255.x; Constantz G.D., 1989, P33; Dziuk PJ, 1996, ANIM REPROD SCI, V43, P65, DOI 10.1016/0378-4320(95)01463-2; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Harvey IF, 2000, P ROY SOC B-BIOL SCI, V267, P2537, DOI 10.1098/rspb.2000.1317; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; HOUDE AE, 1997, SEX COLOR MALE CHOIC; JAMES WH, 1975, GENET RES, V26, P45, DOI 10.1017/S0016672300015834; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Krackow S, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P112, DOI 10.1017/CBO9780511542053.006; LEWIS SM, 1994, BEHAV ECOL, V5, P219; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Neems RM, 1998, BEHAV ECOL, V9, P279, DOI 10.1093/beheco/9.3.279; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Simmons L.W., 2001, SPERM COMPETITION IT; WILLIAMS DA, 1982, J R STAT SOC C-APPL, V31, P144; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	30	214	221	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					360	363		10.1038/nature01367	http://dx.doi.org/10.1038/nature01367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540898				2022-12-24	WOS:000180533000039
J	Heiling, AM; Herberstein, ME; Chittka, L				Heiling, AM; Herberstein, ME; Chittka, L			Pollinator attraction - Crab-spiders manipulate flower signals	NATURE			English	Article							COLOR-PERCEPTION; ULTRAVIOLET; CAMOUFLAGE; BEES		Univ Vienna, Inst Zool, A-1090 Vienna, Austria; Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; Univ London, Queen Mary Coll, Sch Biol Sci, London E1 4NS, England	University of Vienna; Macquarie University; University of London; Queen Mary University London	Heiling, AM (corresponding author), Univ Vienna, Inst Zool, A-1090 Vienna, Austria.	astrid.heiling@univie.ac.at	Chittka, Lars/C-3110-2012; Herberstein, Marie/D-2042-2011	Chittka, Lars/0000-0001-8153-1732; Herberstein, Marie/0000-0001-5071-2952				Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 2001, ENTOMOL GEN, V25, P181; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Lunau K, 1996, J COMP PHYSIOL A, V178, P477, DOI 10.1007/BF00190178; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a	8	145	154	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					334	334		10.1038/421334a	http://dx.doi.org/10.1038/421334a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540891	Bronze			2022-12-24	WOS:000180533000031
J	Kemper, C; Chan, AC; Green, JM; Brett, KA; Murphy, KM; Atkinson, JP				Kemper, C; Chan, AC; Green, JM; Brett, KA; Murphy, KM; Atkinson, JP			Activation of human CD4(+) cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype	NATURE			English	Article							COFACTOR PROTEIN CD46; SELF-TOLERANCE; MEASLES-VIRUS; RECEPTOR; COMPLEMENT; ELIMINATION; MOLECULE; IMMUNITY; THYMUS; MCP	The immune system must distinguish not only between self and non-self, but also between innocuous and pathological foreign antigens to prevent unnecessary or self-destructive immune responses. Unresponsiveness to harmless antigens is established through central and peripheral processes(1). Whereas clonal deletion and anergy are mechanisms of peripheral tolerance(2,3), active suppression by T-regulatory 1 (Tr1) cells has emerged as an essential factor in the control of autoreactive cells(4). Tr1 cells are CD4(+) T lymphocytes that are defined by their production of interleukin 10 (IL-10)(5) and suppression of T-helper cells(6); however, the physiological conditions underlying Tr1 differentiation are unknown. Here we show that co-engagement of CD3 and the complement regulator CD46 in the presence of IL-2 induces a Tr1-specific cytokine phenotype in human CD4(+) T cells. These CD3/CD46-stimulated IL-10-producing CD4(+) cells proliferate strongly, suppress activation of bystander T cells and acquire a memory phenotype. Our findings identify an endogenous receptor-mediated event that drives Tr1 differentiation and suggest that the complement system has a previously unappreciated role in T-cell-mediated immunity and tolerance.	Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA; Genentech Inc, San Francisco, CA 94080 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Grad Program Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Pathol & Immunol, St Louis, MO 63110 USA; Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Roche Holding; Genentech; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Atkinson, JP (corresponding author), Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA.		Kemper, Claudia/A-3673-2008; Kemper, Claudia/B-1502-2015	Green, Jonathan/0000-0002-7449-4387; Atkinson, John/0000-0002-2514-3441; Kemper, Claudia/0000-0003-4196-1417				Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; COLE JL, 1985, P NATL ACAD SCI USA, V82, P859, DOI 10.1073/pnas.82.3.859; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; LeDouarin N, 1996, IMMUNOL REV, V149, P35; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Van Parijs L, 1998, SCIENCE, V280, P243; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839	30	453	480	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					388	392		10.1038/nature01315	http://dx.doi.org/10.1038/nature01315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540904				2022-12-24	WOS:000180533000046
J	Morris, DG; Huang, XZ; Kaminski, N; Wang, YN; Shapiro, SD; Dolganov, G; Glick, A; Sheppard, D				Morris, DG; Huang, XZ; Kaminski, N; Wang, YN; Shapiro, SD; Dolganov, G; Glick, A; Sheppard, D			Loss of integrin alpha v beta 6-mediated TGF-beta activation causes Mmp12-dependent emphysema	NATURE			English	Article							MACROPHAGE METALLOELASTASE; CYTOPLASMIC DOMAIN; LUNG INFLAMMATION; FOCAL CONTACTS; EXPRESSION; MICE; SUBUNIT; REVEALS; LOCALIZATION; INHIBITION	Integrins are heterodimeric cell-surface proteins that regulate cell growth, migration and survival. We have shown previously that the epithelial-restricted integrin alphavbeta6 has another critical function; that is, it binds and activates latent transforming growth factor-beta (TGF-beta)(1,2). Through a global analysis of pulmonary gene expression in the lungs of mice lacking this integrin (Itgb6 null mice) we have identified a marked induction of macrophage metalloelastase (Mmp12)-a metalloproteinase that preferentially degrades elastin and has been implicated in the chronic lung disease emphysema(3). Here we report that Itgb6-null mice develop age-related emphysema that is completely abrogated either by transgenic expression of versions of the beta6 integrin subunit that support TGF-beta activation, or by the loss of Mmp12. Furthermore, we show that the effects of Itgb6 deletion are overcome by simultaneous transgenic expression of active TGF-beta1. We have uncovered a pathway in which the loss of integrin-mediated activation of latent TGF-beta causes age-dependent pulmonary emphysema through alterations of macrophage Mmp12 expression. Furthermore, we show that a functional alteration in the TGF-beta activation pathway affects susceptibility to this disease.	Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; Univ Pittsburgh, Dept Med, Div Pulm & Crit Care Med, Pittsburgh, PA 15261 USA; Brigham & Womens Hosp, Dept Med, Pulm & Crit Care Med Sect, Boston, MA 02115 USA; NCI, Cellular Carcinogenesis & Tumor Promot Lab, Bethesda, MD 20892 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sheppard, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, Dept Med, San Francisco, CA 94143 USA.			Kaminski, Naftali/0000-0001-5917-4601				AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Clark JC, 2001, AM J PHYSIOL-LUNG C, V280, pL705, DOI 10.1152/ajplung.2001.280.4.L705; CONE RI, 1994, CELL ADHES COMMUN, V2, P101, DOI 10.3109/15419069409004430; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Feinberg MW, 2000, J BIOL CHEM, V275, P25766, DOI 10.1074/jbc.M002664200; Fujita M, 2001, AM J PHYSIOL-LUNG C, V280, pL39, DOI 10.1152/ajplung.2001.280.1.L39; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HUANG XZ, 1995, AM J RESP CELL MOL, V13, P245, DOI 10.1165/ajrcmb.13.2.7626292; Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921; Huang XZ, 1998, AM J RESP CELL MOL, V19, P636, DOI 10.1165/ajrcmb.19.4.3293; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; WERB Z, 1975, J EXP MED, V142, P361, DOI 10.1084/jem.142.2.361; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; WIKENHEISER KA, 1992, CANCER RES, V52, P5342; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	27	373	393	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					169	173		10.1038/nature01413	http://dx.doi.org/10.1038/nature01413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634787				2022-12-24	WOS:000181488900046
J	Conway, G; Toenniessen, G				Conway, G; Toenniessen, G			Science for African food security	SCIENCE			English	Editorial Material							SOIL		Rockefeller Fdn, Food Secur Theme, New York, NY 10018 USA		Conway, G (corresponding author), Rockefeller Fdn, Food Secur Theme, New York, NY 10018 USA.							Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; [Anonymous], 2001, STAT FOOD INS WORLD; Banziger M, 2001, EUPHYTICA, V122, P503, DOI 10.1023/A:1017510928038; Conway G, 1999, DOUBLY GREEN REVOLUT; CONWAY G, 1997, FEEDING WORLD POPULA, P249; Delgado C.L., 1998, 107 IFPRI; DeVries J, 2001, SECURING HARVEST BIO; HENNO J, 1999, ESTIMATING RATES NUT; Herren Hans R., 1996, V15, P136; ININDA J, 2000, COORDINATED ECOSYSTE; Kanampiu F, 2002, PLANT CELL TISS ORG, V69, P105, DOI 10.1023/A:1015241509808; LANGAT M, 2000, MBILI UPDATE TESTING; Legg JP, 1999, CROP PROT, V18, P627, DOI 10.1016/S0261-2194(99)00062-9; Mwangi WM, 1997, NUTR CYCL AGROECOSYS, V47, P135; Nziguheba G, 1998, PLANT SOIL, V198, P159, DOI 10.1023/A:1004389704235; Palm CA, 2001, AGR ECOSYST ENVIRON, V83, P27, DOI 10.1016/S0167-8809(00)00267-X; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; SEWARD PD, 1998, METHODS DEV INFRASTR; Wambugu F, 2001, BENEFITS BIOTECHNOLO; World Bank, 1986, POVERTY HUNGER ISSUE; *WORLD FOOD PROGR, 2002, WFP GLOB FOOD AID SH	21	44	46	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1187	1188		10.1126/science.1081978	http://dx.doi.org/10.1126/science.1081978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595678				2022-12-24	WOS:000181065500024
J	Rohde, JU; In, JH; Lim, MH; Brennessel, WW; Bukowski, MR; Stubna, A; Munck, E; Nam, W; Que, L				Rohde, JU; In, JH; Lim, MH; Brennessel, WW; Bukowski, MR; Stubna, A; Munck, E; Nam, W; Que, L			Crystallographic and spectroscopic characterization of a nonheme Fe(IV)=O complex	SCIENCE			English	Article							FE-2(MU-O)(2) DIAMOND CORE; PEROXIDASE COMPOUND-I; METHANE MONOOXYGENASE; CRYSTAL-STRUCTURE; MECHANISM; HYDROXYLATION; INTERMEDIATE; LIGAND; METALLOPORPHYRINS; ACTIVATION	Following the heme paradigm, it is often proposed that dioxygen activation by nonheme monoiron enzymes involves an iron(IV)=oxo intermediate that is responsible for the substrate oxidation step. Such a transient species has now been obtained from a synthetic complex with a nonheme macrocyclic ligand and characterized spectroscopically. Its high-resolution crystal structure reveals an iron-oxygen bond length of 1.646(3) angstroms, demonstrating that a terminal iron(IV)=oxo unit can exist in a nonporphyrin ligand environment and [ending credence to proposed mechanisms of nonheme iron catalysis.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA; Ewha Womans Univ, Dept Chem, Seoul 120750, South Korea; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Ewha Womans University; Ewha Womans University; Carnegie Mellon University	Munck, E (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.		Lim, Mi Hee/D-1913-2018	Nam, Wonwoo/0000-0001-8592-4867; Bukowski, Michael/0000-0001-8381-4429	NIGMS NIH HHS [GM-22701, GM-33162, GM-38767] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038767, R01GM033162, R01GM022701, R37GM033162] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basch H, 1999, J AM CHEM SOC, V121, P7249, DOI 10.1021/ja9906296; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1266, DOI 10.1021/bi00354a011; CHE CM, 1985, J CHEM SOC CHEM COMM, P546, DOI 10.1039/c39850000546; CHIN DH, 1980, J AM CHEM SOC, V102, P5945, DOI 10.1021/ja00538a059; Costas M, 2001, J AM CHEM SOC, V123, P12931, DOI 10.1021/ja017204f; DEBRUNNER PG, 1989, IRON PORPHYRINS, V3, P199; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; FULOP V, 1994, STRUCTURE, V2, P210; Grapperhaus CA, 2000, INORG CHEM, V39, P5306, DOI 10.1021/ic0005238; Groves John T., 1995, P3; Hata M, 2001, J AM CHEM SOC, V123, P6410, DOI 10.1021/ja000908p; HOPPE R, 1982, ACTA CRYSTALLOGR B, V38, P2237; Hsu HF, 1999, J AM CHEM SOC, V121, P5230, DOI 10.1021/ja983666q; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; KITAGAWA T, 1994, COORDIN CHEM REV, V135, P685, DOI 10.1016/0010-8545(94)80081-2; KOSTKA KL, 1993, J AM CHEM SOC, V115, P6746, DOI 10.1021/ja00068a035; Lange SJ, 1999, J AM CHEM SOC, V121, P6330, DOI 10.1021/ja990233u; Lee D, 2002, J AM CHEM SOC, V124, P3993, DOI 10.1021/ja012251t; MacBeth CE, 2000, SCIENCE, V289, P938, DOI 10.1126/science.289.5481.938; Miyake H, 2001, INORG CHEM, V40, P3534, DOI 10.1021/ic000935g; NAM WW, 1991, J AM CHEM SOC, V113, P7052, DOI 10.1021/ja00018a062; Ogliaro F, 2000, J AM CHEM SOC, V122, P8977, DOI 10.1021/ja991878x; OOSTERHUIS WT, 1973, J CHEM PHYS, V58, P4757, DOI 10.1063/1.1679055; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; SCHAPPACHER M, 1985, J AM CHEM SOC, V107, P3736, DOI 10.1021/ja00298a065; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Siegbahn PEM, 2001, J BIOL INORG CHEM, V6, P27, DOI 10.1007/s007750000184; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Watanabe Y, 2000, STRUCT BOND, V97, P61; Wolter T, 2000, J INORG BIOCHEM, V78, P117, DOI 10.1016/S0162-0134(99)00217-2; Zheng H, 2000, J AM CHEM SOC, V122, P3789, DOI 10.1021/ja9936722	34	737	741	10	299	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1037	1039		10.1126/science.299.5609.1037	http://dx.doi.org/10.1126/science.299.5609.1037			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586936				2022-12-24	WOS:000180960000038
J	Garner, D; Weston, V				Garner, D; Weston, V			Effectiveness of vaccination for Haemophilus influenzae type b	LANCET			English	Article							CONJUGATE	Several cases of invasive Haemophilus influenzae type b (Hib) infection have been identified in children previously vaccinated against this disease. We have reviewed all cases of Hib in Nottingham, UK, since the conjugated vaccine was introduced into the primary course of childhood immunisations in 1992. Our results show a worrying increase in the frequency of Hib in Nottingham, which is much the same as the national trends. We believe that the medical profession should be aware of the return of Hib, and that we now need to review the need for a booster vaccination for what was thought to be a disease of the past.	Univ Nottingham Hosp, Queens Med Ctr, Dept Microbiol, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Publ Hlth Lab, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Garner, D (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Dept Microbiol, Nottingham NG7 2UH, England.							Eskola J, 1999, LANCET, V354, P2063, DOI 10.1016/S0140-6736(99)04377-9; Heath PT, 2000, CLIN INFECT DIS, V31, P973, DOI 10.1086/318132; MCVERNON J, 2000, 15 BRIT PAED SURV UN, P23; *PUBL HLTH LAB SER, 2002, CDR WEEKLY      0124, P3	4	29	31	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					395	396		10.1016/S0140-6736(03)12385-9	http://dx.doi.org/10.1016/S0140-6736(03)12385-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573380				2022-12-24	WOS:000180787000016
J	Festenstein, R; Pagakis, SN; Hiragami, K; Lyon, D; Verreault, A; Sekkali, B; Kioussis, D				Festenstein, R; Pagakis, SN; Hiragami, K; Lyon, D; Verreault, A; Sekkali, B; Kioussis, D			Modulation of heterochromatin protein 1 dynamics in primary mammalian cells	SCIENCE			English	Article							POSITION-EFFECT VARIEGATION; LIVING HUMAN-CELLS; RAPID EXCHANGE; HISTONE H3; CHROMATIN STRUCTURE; TRANSGENIC MICE; HP1 PROTEINS; LYSINE 9; DROSOPHILA; EXPRESSION	Heterochromatin protein 1 (HP1beta), a key component of condensed DNA, is strongly implicated in gene silencing and centromeric cohesion. Heterochromatin has been considered a static structure, stabilizing crucial aspects of nuclear organization and prohibiting access to transcription factors. We demonstrate here, by fluorescence recovery after photobleaching, that a green fluorescent protein-HP1beta fusion protein is highly mobile within both the euchromatin and heterochromatin of ex vivo resting murine T cells. Moreover, T cell activation greatly increased this mobility, indicating that such a process may facilitate (hetero)chromatin remodeling and permit access of epigenetic modifiers and transcription factors to the many genes that are consequently derepressed.	Imperial Coll Sch Med, Div Med, CSC Gene Control Mech & Dis Grp, London W12 0NN, England; Natl Inst Med Res, Confocal & Image Anal Lab, London NW7 1AA, England; London Res Inst, Canc Res UK, Chromosome Dynam Lab, Potters Bar EN6 3LD, Herts, England; Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	Imperial College London; MRC National Institute for Medical Research; Cancer Research UK; MRC National Institute for Medical Research	Festenstein, R (corresponding author), Imperial Coll Sch Med, Div Med, CSC Gene Control Mech & Dis Grp, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.							Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Briggs SD, 2002, NAT GENET, V30, P241, DOI 10.1038/ng0302-241; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; EISSENBERG JC, 1992, GENETICS, V131, P345; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; McMorrow T, 2000, EMBO J, V19, P4986, DOI 10.1093/emboj/19.18.4986; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Paro R, 2000, NATURE, V406, P579, DOI 10.1038/35020675; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	30	234	239	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					719	721		10.1126/science.1078694	http://dx.doi.org/10.1126/science.1078694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560554				2022-12-24	WOS:000180687700051
J	Ciesla, FJ; Lauretta, DS; Cohen, BA; Hood, LL				Ciesla, FJ; Lauretta, DS; Cohen, BA; Hood, LL			A nebular origin for chondritic fine-grained phyllosilicates	SCIENCE			English	Article							SOLAR NEBULA; CHONDRULE FORMATION; WATER; PARTICLES; EVOLUTION; MODEL	Hydrated minerals occur in accretionary rims around chondrules in CM chondrites. Previous models suggested that these phyllosilicates did not form by gas-solid reactions in the canonical solar nebula. We propose that chondrule-forming shock waves in icy regions of the nebula produced conditions that allowed rapid mineral hydration. The time scales for phyllosilicate formation are similar to the time it takes for a shocked system to cool from the temperature of phyllosilicate stability to that of water ice condensation. This scenario allows for simultaneous formation of chondrules and their fine-grained accretionary rims.	Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Arizona; University of Hawaii System	Ciesla, FJ (corresponding author), Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	fciesla@lpl.arizona.edu	COHEN, BARBARA/AAV-8199-2021	Cohen, Barbara/0000-0001-5896-5903				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Bischoff A, 1998, METEORIT PLANET SCI, V33, P1113, DOI 10.1111/j.1945-5100.1998.tb01716.x; Ciesla FJ, 2002, ICARUS, V158, P281, DOI 10.1006/icar.2002.6895; Cohen BA, 2000, ICARUS, V145, P369, DOI 10.1006/icar.2000.6329; Connolly HC, 1998, GEOCHIM COSMOCHIM AC, V62, P2725, DOI 10.1016/S0016-7037(98)00176-8; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; CONNOLLY HC, 1994, NATURE, V371, P136, DOI 10.1038/371136a0; Cuzzi JN, 2001, ASTROPHYS J, V546, P496, DOI 10.1086/318233; Cyr KE, 1998, ICARUS, V135, P537, DOI 10.1006/icar.1998.5959; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Fegley B.J., 1989, FORMATION EVOLUTION, P171; GRIMM RE, 1989, ICARUS, V82, P244, DOI 10.1016/0019-1035(89)90038-9; Hewins R. H., 1996, CHONDRULES PROTOPLAN, P197; Iida A, 2001, ICARUS, V153, P430, DOI 10.1006/icar.2001.6682; Lauretta DS, 2000, GEOCHIM COSMOCHIM AC, V64, P3263, DOI 10.1016/S0016-7037(00)00425-7; Lauretta DS, 2001, GEOCHIM COSMOCHIM AC, V65, P1337, DOI 10.1016/S0016-7037(00)00615-3; LEE MR, 1993, METEORITICS, V28, P53, DOI 10.1111/j.1945-5100.1993.tb00248.x; LODDERS K, 1998, PLANETARY SCI COMPAN, V80, P80; METZLER K, 1992, GEOCHIM COSMOCHIM AC, V56, P2873, DOI 10.1016/0016-7037(92)90365-P; PRINN RG, 1987, ANNU REV EARTH PL SC, V15, P171; Rasmussen MG, 1998, CAN MINERAL, V36, P147; Sears DWG, 1998, METEORIT PLANET SCI, V33, P1157, DOI 10.1111/j.1945-5100.1998.tb01720.x; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; Supulver KD, 2000, ICARUS, V146, P525, DOI 10.1006/icar.2000.6418; Wagner W.W, 1983, AM J SCI, V283, P151; WEIDENSCHILLING SJ, 1988, METEORITES EARLY SOL, P348	26	113	113	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					549	552		10.1126/science.1079427	http://dx.doi.org/10.1126/science.1079427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543970				2022-12-24	WOS:000180559800044
J	Hutson, MS; Tokutake, Y; Chang, MS; Bloor, JW; Venakides, S; Kiehart, DP; Edwards, GS				Hutson, MS; Tokutake, Y; Chang, MS; Bloor, JW; Venakides, S; Kiehart, DP; Edwards, GS			Forces for morphogenesis investigated with laser microsurgery and quantitative modeling	SCIENCE			English	Article							DROSOPHILA DORSAL CLOSURE; DYNAMIC ANALYSIS; AMNIOSEROSA; ADHESION; BIOLOGY; REVEAL; EMBRYO; CELLS	We investigated the forces that connect the genetic program of development to morphogenesis in Drosophila. We focused on dorsal closure, a powerful model system for development and wound healing. We found that the bulk of progress toward closure is driven by contractility in supracellular "purse strings" and in the amnioserosa, whereas adhesion-mediated zipping coordinates the forces produced by the purse strings and is essential only for the end stages. We applied quantitative modeling to show that these forces, generated in distinct cells, are coordinated in space and synchronized in time. Modeling of wild-type and mutant phenotypes is predictive; although closure in myospheroid mutants ultimately fails when the cell sheets rip themselves apart, our analysis indicates that beta(PS) integrin has an earlier, important role in zipping.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Dept Math, Durham, NC 27708 USA; Duke Univ, Dept Phys, Durham, NC 27708 USA; Duke Univ, Free Electron Laser Lab, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Kiehart, DP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	dkiehart@duke.edu; edwards@fel.duke.edu	Chang, Ming-Shien/F-7922-2012	Chang, Ming-Shien/0000-0002-6385-0374	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033830, R01GM061240] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33830, GM61240] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnes F, 1999, CR ACAD SCI III-VIE, V322, P5, DOI 10.1016/S0764-4469(99)80012-2; Bloor JW, 2002, DEVELOPMENT, V129, P3173; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; Davidson LA, 1999, DEV BIOL, V209, P221, DOI 10.1006/dbio.1999.9249; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FOE VE, 1989, DEVELOPMENT, V107, P1; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Harden N, 2002, J CELL SCI, V115, P2119; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Kiehart DP, 1999, CURR BIOL, V9, pR602, DOI 10.1016/S0960-9822(99)80384-4; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; MACKRELL AJ, 1988, P NATL ACAD SCI USA, V85, P2633, DOI 10.1073/pnas.85.8.2633; Magie CR, 1999, DEVELOPMENT, V126, P5353; Martinez Arias Alfonso, 1993, P517; Meinhardt H, 2002, NATURE, V419, P261, DOI 10.1038/419261a; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Reed BH, 2001, CURR BIOL, V11, P1098, DOI 10.1016/S0960-9822(01)00318-9; Stronach BE, 2001, DEVELOPMENT, V128, P2905; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	22	373	374	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					145	149		10.1126/science.1079552	http://dx.doi.org/10.1126/science.1079552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12574496				2022-12-24	WOS:000181988900053
J	Chapman, S; Reeve, E; Rajaratnam, G; Neary, R				Chapman, S; Reeve, E; Rajaratnam, G; Neary, R			Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care	BRITISH MEDICAL JOURNAL			English	Article							MS		Univ Keele, Dept Med Management, Keele ST5 5BG, Staffs, England; N Stoke Primary Care Trust, Stoke On Trent ST4 4LX, Staffs, England; S Stoke Primary Care Trust, Stoke On Trent ST4 4LX, Staffs, England; N Staffordshire Hosp NHS Trust, Cent Pathol Lab, Stoke On Trent ST4 7PA, Staffs, England	Keele University; University Hospital of North Staffordshire NHS Trust	Chapman, S (corresponding author), Univ Keele, Dept Med Management, Keele ST5 5BG, Staffs, England.	s.r.chapman@keele.ac.uk						BELLINGHAM C, 2001, PHARM J, V267, P672; *DEP HLTH, 2001, NAT SERV FRAM COR HE; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; Little R, 2002, BRIT MED J, V324, P316; Mayor S, 2001, BRIT MED J, V323, P1087, DOI 10.1136/bmj.323.7321.1087; *N STAFF HLTH AUTH, 2001, HLTH WELL BEING IMPR; *N STAFF HLTH AUTH, 2000, CLOS GAP HLTH IN N S; RICHARDS RG, GUARANTEED OUTCOMES; *STAND MED ADV COM, 1997, USE STAT; Taylor D, 2001, BRIT MED J, V323, P1379, DOI 10.1136/bmj.323.7326.1379; Wood D, 1998, HEART, V80, pS1	11	29	31	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 29	2003	326	7391					707	709		10.1136/bmj.326.7391.707	http://dx.doi.org/10.1136/bmj.326.7391.707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663WL	12663411	Green Published			2022-12-24	WOS:000182029500029
J	Spies, M; Herndon, DN; Rosenblatt, J; Sanford, AP; Wolf, SE				Spies, M; Herndon, DN; Rosenblatt, J; Sanford, AP; Wolf, SE			Prediction of mortality from catastrophic burns in children	LANCET			English	Article; Proceedings Paper	33rd Annual Meeting of the American-Burn-Association	APR 18-21, 2001	BOSTON, MASSACHUSETTS	Amer Burn Assoc			80-PERCENT; OUTCOMES; TBSA	Background We previously developed a model to predict survival in massive paediatric burns (>80% total body surface area [TBSA]). This model included not only demographic variables, but also variables obtained throughout the hospital course. We aimed to prospectively validate our model for accuracy of outcome prediction. Methods We admitted 33 paediatric burn patients with burns greater than 80% TBSA. We recorded age, burn size, inhalation injury, resuscitation, packed-cell volume at admission, base deficit, serum osmolarity, sepsis, inotropic support, platelet count, creatinine, and ventilator dependency. We entered these data into our previous models. Results 20 male and 13 female children with mean age 7.6 (SD 1) years with TBSA burns of 88% (SD 1; full thickness 86% [SD 1]) were admitted. Mortality was 39.4% (13 of 30). When all variables were integrated into our final model, we predicted outcome with 97% accuracy. When we used a model based only on demographic characteristics of age, burn size, and presence of inhalation injury, outcome was correctly predicted in only 51% of patients. Conclusions We show prospectively that mortality in severely burned children can be reliably estimated at a burn centre, and that outcome cannot be reliably predicted on the basis of demographic and injury characteristics alone. These data suggest that all severely burned children should be given a course of treatment before consideration of treatment futility.	Shriners Hosp Children, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Surg, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Wolf, SE (corresponding author), Shriners Hosp Children, 815 Market St, Galveston, TX 77550 USA.		Herndon, David/AAC-3354-2020	Wolf, Steven/0000-0003-2972-3440				BAUX S, 1989, BURNS, V15, P239, DOI 10.1016/0305-4179(89)90039-9; Blakeney P, 1998, J TRAUMA, V44, P625, DOI 10.1097/00005373-199804000-00011; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Meyers-Paal R, 2000, J BURN CARE REHABIL, V21, P43, DOI 10.1097/00004630-200021010-00009; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Saffle Jeffrey R., 1995, Journal of Burn Care and Rehabilitation, V16, P219, DOI 10.1097/00004630-199505000-00002; SMITH DL, 1994, J TRAUMA, V37, P655, DOI 10.1097/00005373-199410000-00021; TOBIASEN J, 1982, SURG GYNECOL OBSTET, V154, P711; Wolf SE, 1997, ANN SURG, V225, P554, DOI 10.1097/00000658-199705000-00012	10	44	46	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 22	2003	361	9362					989	994		10.1016/S0140-6736(03)12824-3	http://dx.doi.org/10.1016/S0140-6736(03)12824-3			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658AP	12660055				2022-12-24	WOS:000181699700008
J	Nong, Y; Huang, YQ; Ju, W; Kalia, LV; Ahmadian, G; Wang, YT; Salter, MW				Nong, Y; Huang, YQ; Ju, W; Kalia, LV; Ahmadian, G; Wang, YT; Salter, MW			Glycine binding primes NMDA receptor internalization	NATURE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC VESICLE ENDOCYTOSIS; D-ASPARTATE RECEPTOR; ACID; SITE; AMPA; TRANSMISSION; HIPPOCAMPUS; ANTAGONISTS; ACTIVATION	NMDA (N-methyl-D-aspartate) receptors (NMDARs) are a principal subtype of excitatory ligand-gated ion channel with prominent roles in physiological and disease processes in the central nervous system(1). Recognition that glycine potentiates NMDAR-mediated currents(2) as well as being a requisite co-agonist of the NMDAR subtype of 'glutamate' receptor(3) profoundly changed our understanding of chemical synaptic communication in the central nervous system. The binding of both glycine and glutamate is necessary to cause opening of the NMDAR conductance pore(1). Although binding of either agonist alone is insufficient to cause current flow through the channel, we report here that stimulation of the glycine site initiates signalling through the NMDAR complex, priming the receptors for clathrin-dependent endocytosis. Glycine binding alone does not cause the receptor to be endocytosed; this requires both glycine and glutamate site activation of NMDARs. The priming effect of glycine is mimicked by the NMDAR glycine site agonist D-serine, and is blocked by competitive glycine site antagonists. Synaptic as well as extrasynaptic NMDARs are primed for internalization by glycine site stimulation. Our results demonstrate transmembrane signal transduction through activating the glycine site of NMDARs, and elucidate a model for modulating cell-cell communication in the central nervous system.	Univ Toronto, Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pathobiol & Lab Med, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Dept Med, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of British Columbia	Salter, MW (corresponding author), Univ Toronto, Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada.		Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	Kalia, Lorraine/0000-0002-9384-1305				BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Danysz W, 1998, PHARMACOL REV, V50, P597; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FOSTER AC, 1992, MOL PHARMACOL, V41, P914; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; HANSFORD C. G., 1961, SYDOWIA ANN MYCOLOGICI SER II SUPPL, V2, P1; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kittler JT, 2000, J NEUROSCI, V20, P7972; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mugnaini M, 1998, J RECEPT SIGNAL TR R, V18, P91, DOI 10.3109/10799899809047739; Mugnaini M, 2000, EUR J PHARMACOL, V391, P233, DOI 10.1016/S0014-2999(00)00101-1; Popik P, 1995, EUR J PHARM-MOLEC PH, V291, P221, DOI 10.1016/0922-4106(95)90061-6; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; SALITURO FG, 1992, J MED CHEM, V35, P1791, DOI 10.1021/jm00088a014; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8	29	327	339	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					302	307		10.1038/nature01497	http://dx.doi.org/10.1038/nature01497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646920				2022-12-24	WOS:000181637300038
J	Hari, P; Raivonen, M; Vesala, T; Munger, JW; Pilegaard, K; Kulmala, M				Hari, P; Raivonen, M; Vesala, T; Munger, JW; Pilegaard, K; Kulmala, M			Atmospheric science - Ultraviolet light and leaf emission of NOx	NATURE			English	Article							FLUX; CHEMISTRY		Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Riso Natl Lab, Plant Res Dept, DK-4000 Roskilde, Denmark	University of Helsinki; University of Helsinki; Harvard University; Technical University of Denmark	Hari, P (corresponding author), Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland.		Pilegaard, Kim/H-9026-2019; Pilegaard, Kim/I-7137-2013; Munger, J William/H-4502-2013; Vesala, Timo/C-3795-2017; Kulmala, Markku T/I-7671-2016	Pilegaard, Kim/0000-0002-5169-5717; Pilegaard, Kim/0000-0002-5169-5717; Munger, J William/0000-0002-1042-8452; Vesala, Timo/0000-0002-4852-7464; Kulmala, Markku T/0000-0003-3464-7825; Raivonen, Maarit/0000-0002-8987-4972				Altimir N, 2002, ATMOS ENVIRON, V36, P19, DOI 10.1016/S1352-2310(01)00478-2; CONRAD R, 1994, BIOGEOCHEMISTRY, V27, P155, DOI 10.1007/BF00000582; ESALA T, 1998, TRENDS HEAT MASS MOM, V4, P17; Hari P, 1999, PLANT CELL ENVIRON, V22, P1297, DOI 10.1046/j.1365-3040.1999.00478.x; Hereid DP, 2001, ATMOS ENVIRON, V35, P975, DOI 10.1016/S1352-2310(00)00342-3; Honrath RE, 2000, J GEOPHYS RES-ATMOS, V105, P24183, DOI 10.1029/2000JD900361; Lerdau MT, 2000, SCIENCE, V289, P2291, DOI 10.1126/science.289.5488.2291; RONDON A, 1994, TELLUS B, V46, P339, DOI 10.1034/j.1600-0889.1994.t01-4-00001.x; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Sparks JP, 2001, OECOLOGIA, V127, P214, DOI 10.1007/s004420000594; Wildt J, 1997, J GEOPHYS RES-ATMOS, V102, P5919, DOI 10.1029/96JD02968	11	42	46	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					134	134		10.1038/422134a	http://dx.doi.org/10.1038/422134a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634774	Bronze			2022-12-24	WOS:000181488900033
J	Knight, J				Knight, J			NASA seeks inspiration from microscopic views of life	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					878	878		10.1038/421878b	http://dx.doi.org/10.1038/421878b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606959	Bronze			2022-12-24	WOS:000181186900005
J	Sugita, Y; Suzuki, Y				Sugita, Y; Suzuki, Y			Audiovisual perception - Implicit estimation of sound-arrival time	NATURE			English	Editorial Material									Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3004201, Japan; Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; Tohoku University	Sugita, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Teragu Hakusan 1497-1, Tsukuba, Ibaraki 3004201, Japan.							McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669	3	141	142	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					911	911		10.1038/421911a	http://dx.doi.org/10.1038/421911a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606990	Bronze			2022-12-24	WOS:000181186900037
J	Hinrichs, KU; Hmelo, LR; Sylva, SP				Hinrichs, KU; Hmelo, LR; Sylva, SP			Molecular fossil record of elevated methane levels in late pleistocene coastal waters	SCIENCE			English	Article							SANTA-BARBARA BASIN; MARINE-SEDIMENTS; SUBDUCTION ZONE; GAS HYDRATE; OXIDATION; DISSOCIATION; PALEOCENE; LIPIDS; OCEAN; SEEPS	Accumulating evidence suggests that methane has been released episodically from hydrates trapped in sea floor sediments during many intervals of rapid climate warming. Here we show that sediments from the Santa Barbara Basin deposited during warm intervals in the last glacial period contain molecular fossils that are diagnostic of aerobic and anaerobic methanotrophs. Sediment intervals with high abundances of these compounds indicate episodes of vigorous methanotrophic activity in methane-laden water masses. Signals for anaerobic methanotrophy in 44, 100-year-old sediment are evidence for particularly intense methane emissions and suggest that the basin's methane cycle can profoundly affect oxygen budgets in the water column.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Hinrichs, KU (corresponding author), Univ Bremen, DFG Res Ctr Ocean Margins, POB 330 440, D-28334 Bremen, Germany.	khinrichs@uni-bremen.de	Sylva, Sean/D-4400-2014; Hinrichs, Kai-Uwe/C-7675-2009	Sylva, Sean/0000-0002-4727-440X; Hinrichs, Kai-Uwe/0000-0002-0739-9291				Behl R. J., 1995, P OCEAN DRILL PROGRA, V146, P295; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Bohrmann G, 1998, GEOLOGY, V26, P647, DOI 10.1130/0091-7613(1998)026<0647:ACFTCS>2.3.CO;2; Clark JF, 2000, J GEOPHYS RES-OCEANS, V105, P11509, DOI 10.1029/2000JC000259; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dickens GR, 2001, ORG GEOCHEM, V32, P1179, DOI 10.1016/S0146-6380(01)00086-9; Dickens GR, 2000, B SOC GEOL FR, V171, P37; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HEESCHEN K, 2002, GEOL SOC AM ABSTR, V34, P35231; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hinrichs KU, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000286; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; Hinrichs KU, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; HINRICHS KU, UNPUB; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Kennett JP, 2003, METHANE HYDRATES QUA; Kuwabara JS, 1999, GEOCHIM COSMOCHIM AC, V63, P2199, DOI 10.1016/S0016-7037(99)00084-8; LANGWORTHY TA, 1986, SYST APPL MICROBIOL, V7, P253; Pancost RD, 2001, ORG GEOCHEM, V32, P695, DOI 10.1016/S0146-6380(01)00015-8; REEBURGH WS, 1991, DEEP-SEA RES, V38, pS1189; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Schimmelmann A, 1991, GLOBAL BIOGEOCHEM CY, V5, P173, DOI 10.1029/91GB00382; Stott LD, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000196; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; VANGEEN A, 1995, PALEOCEANOGRAPHY, V10, P159, DOI 10.1029/94PA03352; WAKEHAM SG, IN PRESS GEOCHIM COS; WARD BB, 1987, NATURE, V327, P226, DOI 10.1038/327226a0; WEFER G, 1994, NATURE, V369, P282, DOI 10.1038/369282a0	30	83	95	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1214	1217		10.1126/science.1079601	http://dx.doi.org/10.1126/science.1079601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595688				2022-12-24	WOS:000181065500035
J	Krasilnikov, AS; Yang, XJ; Pan, T; Mondragon, A				Krasilnikov, AS; Yang, XJ; Pan, T; Mondragon, A			Crystal structure of the specificity domain of ribonuclease P	NATURE			English	Article							SUBTILIS RNASE-P; IN-VITRO SELECTION; PRE-TRANSFER-RNA; MACROMOLECULAR STRUCTURES; TERTIARY INTERACTIONS; RIBOZYME; RECOGNITION; EVOLUTION; SUBSTRATE; SUBUNIT	RNase P is the only endonuclease responsible for processing the 5' end of transfer RNA by cleaving a precursor and leading to tRNA maturation(1,2). It contains an RNA component and a protein component and has been identified in all organisms. It was one of the first catalytic RNAs identified(3) nd the first that acts as a multiple-turnover enzyme in vivo. RNase P and the ribosome are so far the only two ribozymes known to be conserved in all kingdoms of life. The RNA component of bacterial RNase P can catalyse pre-tRNA cleavage in the absence of the RNase P protein in vitro and consists of two domains: a specificity domain and a catalytic domain(4,5). Here we report a 3.15-Angstrom resolution crystal structure of the 154-nucleotide specificity domain of Bacillus subtilis RNase P. The structure reveals the architecture of this domain, the interactions that maintain the overall fold of the molecule, a large non-helical but well-structured module that is conserved in all RNase P RNA, and the regions that are involved in interactions with the substrate.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu						Altman S., 1999, RNA WORLD, P351; Barrera A, 2002, BIOCHEMISTRY-US, V41, P12986, DOI 10.1021/bi020416k; Brown JW, 1999, NUCLEIC ACIDS RES, V27, P314, DOI 10.1093/nar/27.1.314; Brown JW, 1996, P NATL ACAD SCI USA, V93, P3001, DOI 10.1073/pnas.93.7.3001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen JL, 1997, RNA, V3, P557; Chen JL, 1998, EMBO J, V17, P1515, DOI 10.1093/emboj/17.5.1515; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 1997, EMBO J, V16, P3289, DOI 10.1093/emboj/16.11.3289; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Frank DN, 2000, RNA, V6, P1895, DOI 10.1017/S1355838200001461; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Loria A, 1997, BIOCHEMISTRY-US, V36, P6317, DOI 10.1021/bi970115o; Loria A, 1996, RNA, V2, P551; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; NOLAN JM, 1993, SCIENCE, V261, P762, DOI 10.1126/science.7688143; Odell L, 1998, NUCLEIC ACIDS RES, V26, P3717, DOI 10.1093/nar/26.16.3717; PAN T, 1995, BIOCHEMISTRY-US, V34, P8458, DOI 10.1021/bi00026a029; Pan T, 1995, P NATL ACAD SCI USA, V92, P12510, DOI 10.1073/pnas.92.26.12510; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; Qin H, 2001, BIOCHEMISTRY-US, V40, P11202, DOI 10.1021/bi010076n; TANNER MA, 1995, RNA, V1, P349	29	188	201	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					760	764		10.1038/nature01386	http://dx.doi.org/10.1038/nature01386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610630				2022-12-24	WOS:000180938000048
J	Mitchell, CE; Power, AG				Mitchell, CE; Power, AG			Release of invasive plants from fungal and viral pathogens	NATURE			English	Article							DISEASES	Invasive plant species both threaten native biodiversity and are economically costly(1-5), but only a few naturalized species become pests(2,4). Here we report broad, quantitative support for two long-standing hypotheses that explain why only some naturalized species have large impacts. The enemy release hypothesis argues that invaders' impacts result from reduced natural enemy attack(2,4,6-10). The biotic resistance hypothesis argues that interactions with native species, including natural enemies, limit invaders' impacts(6-8). We tested these hypotheses for viruses and for rust, smut and powdery mildew fungi that infect 473 plant species naturalized to the United States from Europe. On average, 84% fewer fungi and 24% fewer virus species infect each plant species in its naturalized range than in its native range. In addition, invasive plant species that are more completely released from pathogens are more widely reported as harmful invaders of both agricultural and natural ecosystems. Together, these results strongly support the enemy release hypothesis. Among noxious agricultural weeds, species accumulating more pathogens in their naturalized range are less widely noxious, supporting the biotic resistance hypothesis. Our results indicate that invasive plants' impacts may be a function of both release from and accumulation of natural enemies, including pathogens.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Mitchell, CE (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.		Mitchell, Charles E/I-3709-2014	Mitchell, Charles E/0000-0002-1633-1993				Agrios GN., 1997, PLANT PATHOL; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Braun U., 1995, POWDERY MILDEWS ERYS; Charudattan R, 2001, BIOCONTROL, V46, P229, DOI 10.1023/A:1011477531101; CLAY K, 1995, CAN J BOT, V73, pS42, DOI 10.1139/b95-223; Darwin C., 1859, ORIGIN SPECIES MEANS; Elton C. S., 1958, ECOLOGY INVASIONS; Farr D. F., 1989, Fungi on plants and plant products in the United States.; Gaumann E, 1959, ROSTPILZE MITTELEURO; HOKKANEN H, 1985, AGR ECOSYST ENVIRON, V14, P63, DOI 10.1016/0167-8809(85)90085-4; Holm L. G., 1977, WORLDS WORST WEEDS D; Julien M.H., 1998, BIOL CONTROL WEEDS W; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Liebman M., 2001, ECOLOGICAL MANAGEMEN, P375; Mabberly DJ., 1997, PLANT BOOK PORTABLE; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Naylor R. L., 1997, Nature's services: societal dependence on natural ecosystems., P151; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pimentel D., 2002, BIOL INVASIONS EC EN; TORCHIN ME, IN PRESS NATURE; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; *US C OFF TECHN AS, 1993, OTAF565 US C; Van der Putten WH, 2002, NATURE, V417, P32, DOI 10.1038/417032a; VuYnky K., 1994, EUROPEAN SMUT FUNGI; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williamson M, 1996, BIOL INVASIONS; Wilson M., 1966, BRIT RUST FUNGI	30	841	894	8	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					625	627		10.1038/nature01317	http://dx.doi.org/10.1038/nature01317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571594				2022-12-24	WOS:000180803200040
J	Palmer, K; Backman, L; Winblad, B; Fratiglioni, L				Palmer, K; Backman, L; Winblad, B; Fratiglioni, L			Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; OLD ADULTS; SAMPLE; PREDICT; WILL; AD	Objectives To evaluate a simple three step procedure to identify people in the general population who are in the preclinical phase of Alzheimer's disease and dementia. Design Three year population based cohort study. Setting Kunasholmen cohort, Stockholm, Sweden. Participants 1435 people aged 75-95 years without dementia. Assessments Single question asking about memory complaints, assessment by mini-mental state examination, and neuropsychological testing. Main outcome measure Alzheimer's disease and dementia at three year follow up. Results None of the three instruments was sufficiently predictive of Alzheimer's disease and dementia when administered separately. After participants had been screened for memory complaints and global cognitive impairment, specific tests of word recall and verbal fluency had positive predictive values for dementia of 85-100% (95% confidence interval range from 62% to 100%). However, only 18% of future dementia cases were identified in the preclinical phase by this three step procedure. Memory complaints were the most sensitive indicator of Alzheimer's disease and dementia in the whole population, but only half the future dementia cases reported memory problems three years before diagnosis. Conclusion This three step procedure, which simulates what might occur in clinical practice, has a high positive predictive value for dementia, although only a small number of future cases can be identified.	Karolinska Inst, Aging Res Ctr, Div Geriatr Epidemiol & Med, S-11382 Stockholm, Sweden; Stockholm Gerontol Res Ctr, S-11382 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Palmer, K (corresponding author), Karolinska Inst, Aging Res Ctr, Div Geriatr Epidemiol & Med, Box 6401, S-11382 Stockholm, Sweden.		Palmer, Katie/A-1430-2016	Palmer, Katie/0000-0001-8783-016X				Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373; BACKMAN L, 1994, J ABNORM PSYCHOL, V103, P361; BACKMAN L, IN PRESS NEW FRONTIE; BACKMAN L, NEW FRONTIERS COGNIT; Berger AK, 1999, NEUROLOGY, V53, P1998, DOI 10.1212/WNL.53.9.1998; Bozoki A, 2001, ARCH NEUROL-CHICAGO, V58, P411, DOI 10.1001/archneur.58.3.411; Chen P, 2000, NEUROLOGY, V55, P1847, DOI 10.1212/WNL.55.12.1847; CHRISTENSEN AL, 1984, LURIAS NEUROPSYCHOLO; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Hogan DB, 2000, CAN J NEUROL SCI, V27, P18, DOI 10.1017/S0317167100051921; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Levy R, 1994, Int Psychogeriatr, V6, P63, DOI 10.1017/S1041610294001626; Neri M, 1998, DEMENT GERIATR COGN, V9, P56, DOI 10.1159/000017023; Palmer K, 2002, AM J PSYCHIAT, V159, P436, DOI 10.1176/appi.ajp.159.3.436; Petersen R C, 2000, Neurologia, V15, P93; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Ritchie K, 2000, COMPR PSYCHIAT, V41, P61, DOI 10.1016/S0010-440X(00)80010-3; Small BJ, 1997, PSYCHOL AGING, V12, P309, DOI 10.1037/0882-7974.12.2.309; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Wechsler D., 2002, WECHSLER ADULT INTEL, DOI DOI 10.1037/T15169-000	25	117	123	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					245	247		10.1136/bmj.326.7383.245	http://dx.doi.org/10.1136/bmj.326.7383.245			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	644FY	12560271	Bronze, Green Published			2022-12-24	WOS:000180908300014
J	Smith, O				Smith, O			Weathering the big chill	SCIENCE			English	Editorial Material																		Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; HOFFMEISTER KM, 2002, BLOOD, V100	2	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					530	530		10.1126/science.299.5606.530	http://dx.doi.org/10.1126/science.299.5606.530			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543964				2022-12-24	WOS:000180559800037
J	Woywodt, A; Streiber, F; de Groot, K; Regelsberger, H; Haller, H; Haubitz, M				Woywodt, A; Streiber, F; de Groot, K; Regelsberger, H; Haller, H; Haubitz, M			Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis	LANCET			English	Article							TISSUE FACTOR; WEGENERS-GRANULOMATOSIS; ANTIBODY; PROTEINASE-3; EXPRESSION; INDUCTION	Background Histological findings in small-vessel vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs) suggest that damaged endothelial cells undergo necrosis and detachment from the basement membrane. We postulated that isolation of these cells from peripheral blood might provide a novel marker of the disease and elucidate pathogenetic events. Methods 18 patients with active ANCA-associated vasculitis, 20 patients in remission, 20 healthy controls, 12 patients with infection, and 12 patients with glomerular disease not associated with ANCA were studied. Endothelial cells were isolated from peripheral blood by use of Dynabeads coated with antibodies against CD146, and were stained for von Willebrand factor (vWF), CD31, and Ulex Europaeus lectin 1 (UEA-1). Tissue-factor immunocytochemistry and assays for markers of apoptosis and necrosis were also done. Findings Few circulating endothelial cells were seen in healthy controls (0-20 cells/mL, median 5 cells/mL), patients with infection (0-16 cells/mL, median 8 cells/mL), and patients with non-ANCA glomerulonephritis (0-21 cells/mL, median 4 cells/mL). By contrast, large numbers of circulating endothelial cells were detected in patients with active vasculitis (20-5700 cells/mL, median 136 cells/mL, p<0.0001 when compared with healthy controls). Cell numbers fell substantially during 6 months of successful immunosuppressive treatment among those with active disease. Patients in remission had moderately raised cell numbers (0.60 cells/mL, median 16 cells/mL). 84% of cells obtained from patients with active disease stained positive for annexin/propidium iodide and 86% stained tissue factor positive, indicating a necrotic and procoagulant phenotype. Interpretation Circulating endothelial cells are a novel marker of active ANCA-associated small-vessel vasculitis. The clinical use of this tool and the pathogenic mechanisms leading to these findings require further investigation.	Hannover Med Sch, Dept Med, Div Nephrol, D-30625 Hannover, Germany	Hannover Medical School	Woywodt, A (corresponding author), Hannover Med Sch, Dept Med, Div Nephrol, D-30625 Hannover, Germany.	Woywodt.Alexander@MH-Hannover.de	Woywodt, Alexander/ABD-2711-2020	Woywodt, Alexander/0000-0002-3825-6955				Bardin N, 1996, TISSUE ANTIGENS, V48, P531, DOI 10.1111/j.1399-0039.1996.tb02666.x; Barker RN, 2002, CLIN EXP IMMUNOL, V127, P220, DOI 10.1046/j.1365-2249.2002.01774.x; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; BOUVIER CA, 1970, THROMB DIATH HAEMOST, P163; Contrino J, 1997, CIRCULATION, V96, P605; DAGATI V, 1986, AM J KIDNEY DIS, V7, P95, DOI 10.1016/S0272-6386(86)80062-2; DAVIES DJ, 1982, BMJ-BRIT MED J, V285, P606, DOI 10.1136/bmj.285.6342.606; Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x; Girard T, 2001, RHEUMATOLOGY, V40, P147, DOI 10.1093/rheumatology/40.2.147; Gobel U, 1996, AM J KIDNEY DIS, V28, P186, DOI 10.1016/S0272-6386(96)90300-5; Haubitz M, 2001, CLIN EXP IMMUNOL, V126, P584, DOI 10.1046/j.1365-2249.2001.01587.x; Hergesell O, 1996, THROMB HAEMOSTASIS, V75, P892; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; Jennette JC, 1998, HEPTINSTALLSPATHOLOG, P1059; KERR GS, 1993, ARTHRITIS RHEUM, V36, P365, DOI 10.1002/art.1780360312; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; LUQMANI RA, 1994, Q J MED, V87, P671; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Mutin M, 1999, BLOOD, V93, P2951; Pendergraft WF, 2000, KIDNEY INT, V57, P1981, DOI 10.1046/j.1523-1755.2000.00048.x; Preston GA, 2001, KIDNEY INT, V59, P1981, DOI 10.1046/j.1523-1755.2001.0590051981.x; SBARBATI R, 1991, BLOOD, V77, P764; Semeraro N, 1997, THROMB HAEMOSTASIS, V78, P759; Sibelius U, 1998, J EXP MED, V187, P497, DOI 10.1084/jem.187.4.497; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203	25	244	264	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					206	210		10.1016/S0140-6736(03)12269-6	http://dx.doi.org/10.1016/S0140-6736(03)12269-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547543				2022-12-24	WOS:000180535400009
J	Messenger, S; Keller, LP; Stadermann, FJ; Walker, RM; Zinner, E				Messenger, S; Keller, LP; Stadermann, FJ; Walker, RM; Zinner, E			Samples of stars beyond the solar system: Silicate grains in interplanetary dust	SCIENCE			English	Article							ISOTOPIC COMPOSITION; OXYGEN ISOTOPES; PRESOLAR; CORUNDUM; NUCLEOSYNTHESIS; IDENTIFICATION; ORIGINS; AL2O3	We have identified six circumstellar silicate grains within interplanetary dust particles (IDPs). Their extrasolar origins are demonstrated by their extremely anomalous oxygen isotopic compositions. Three O-17-rich grains appear to originate from red giant or asymptotic giant branch stars. One O-16-rich grain may be from a metal-poor star. Two O-16-poor grains have unknown stellar sources. One of the grains is forsterite, and two are amorphous silicate "GEMS" (glass with embedded metal and sulfides), which is consistent with astronomical identifications of crystalline and amorphous silicates in the outflows of evolved stars. These observations suggest cometary origins of these IDPs and underscore the perplexing absence of silicates among circumstellar dust grains from meteorites.	Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; Washington Univ, Dept Phys, St Louis, MO 63130 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Washington University (WUSTL); Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Messenger, S (corresponding author), Washington Univ, Space Sci Lab, St Louis, MO 63130 USA.							ALEXANDER CMO, 2001, LUNAR PLANET SCI, V32, P2191; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bradley J, 1996, ASTR SOC P, V104, P275; Bradley J. P., 1988, METEORITES EARLY SOL, P861; Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; BRADLEY JP, 1983, NATURE, V301, P473, DOI 10.1038/301473a0; Choi BG, 1998, SCIENCE, V282, P1284, DOI 10.1126/science.282.5392.1284; Choi BG, 1999, ASTROPHYS J, V522, pL133, DOI 10.1086/312239; ENGRAND C, 1999, LUNAR PLANET SCI, V30, pA1690; ESAT TM, 1979, SCIENCE, V206, P190, DOI 10.1126/science.206.4415.190; Harker DE, 2002, ASTROPHYS J, V565, pL109, DOI 10.1086/339363; HUSS GR, 1994, ASTROPHYS J, V430, pL81, DOI 10.1086/187443; HUTCHEON ID, 1994, ASTROPHYS J, V425, pL97, DOI 10.1086/187319; Keller LP, 2000, J GEOPHYS RES-SPACE, V105, P10397, DOI 10.1029/1999JA900395; Kemper F, 2001, ASTRON ASTROPHYS, V369, P132, DOI 10.1051/0004-6361:20010086; KRESTINA N, 2002, LUNAR PLANET SCI, V33, pA1425; Li A, 2001, ASTROPHYS J, V550, pL213, DOI 10.1086/319640; MCKEEGAN KD, 1987, SCIENCE, V237, P1468, DOI 10.1126/science.237.4821.1468; MCKEEGAN KD, 1987, THESIS WASHINGTON U; Messenger S, 2000, METEORIT PLANET SCI, V35, pA109; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2002, METEORIT PLANET SCI, V37, P1491, DOI 10.1111/j.1945-5100.2002.tb00806.x; Messenger S, 1997, AIP CONF PROC, P545, DOI 10.1063/1.53336; MOLSTER FJ, 2002, LUNAR PLANET SCI, V33, pA1471; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; NITTLER LR, 2003, LUNAR PLANET SCI, V34; Sandford S. A., 1987, Fundamentals of Cosmic Physics, V12, P1; STADERMANN FJ, 1991, THESIS U HEIDELBERG; WASSERBURG GJ, 1995, ASTROPHYS J, V447, pL37, DOI 10.1086/309555; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361; Waters LBFM, 2000, ASTR SOC P, V196, P3; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147; ZINNER E, UNPUB	34	321	327	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					105	108		10.1126/science.1080576	http://dx.doi.org/10.1126/science.1080576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12610229				2022-12-24	WOS:000181988900041
J	Green, MJ; Botkin, JR				Green, MJ; Botkin, JR			"Genetic exceptionalism" in medicine: Clarifying the differences between genetic and nongenetic tests	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CANCER SUSCEPTIBILITY GENE; BREAST-CANCER; HEALTH-INSURANCE; FAMILY-HISTORY; PRIVACY ACT; DISEASE; DISCRIMINATION; INFORMATION; DIAGNOSIS; POLICY	Predictive genetic tests are now available for assessing susceptibility to a variety of conditions, including breast and colon cancer, hemochromatosis, and Alzheimer and Huntington disease. Much controversy surrounds the application of these tests, stemming from their similarities to and differences from other tests commonly used in asymptomatic persons. Some have argued that genetic tests are unique and therefore justify special consideration with regard to informed consent and privacy. This paper examines the arguments for such "genetic exceptionalism" and concludes that no clear, significant distinctions between genetic and non-genetic tests justify a different approach to testing by clinicians. Nevertheless, with many genetic tests, the results may cause stigmatization, family discord, and psychological distress. Regardless of whether a test is genetic, when this combination of characteristics is present and when health care providers are not specifically trained to interpret results, testing should be performed with particular caution and the highest standards of informed consent and privacy protection should be applied.	Penn State Coll Med, Dept Humanities, Hershey, PA 17033 USA; Univ Utah, Sch Med, Salt Lake City, UT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Utah System of Higher Education; University of Utah	Green, MJ (corresponding author), Penn State Coll Med, Dept Humanities, H134,Rm 1743,500 Univ Dr, Hershey, PA 17033 USA.		Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749	NATIONAL CANCER INSTITUTE [R03CA070838, R01CA084770] Funding Source: NIH RePORTER; NCI NIH HHS [5R03 CA70838, R01CA84770] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen GE, 1997, GENETICA, V99, P77, DOI 10.1023/A:1018396529332; ALONZO AA, 1995, SOC SCI MED, V41, P303, DOI 10.1016/0277-9536(94)00384-6; Annas GJ, 1995, J LAW MED ETHICS, V23, P360, DOI 10.1111/j.1748-720X.1995.tb01378.x; Beckwith J, 1998, J LAW MED ETHICS, V26, P205, DOI 10.1111/j.1748-720X.1998.tb01421.x; Bernhardt Barbara A, 1997, J Genet Couns, V6, P207, DOI 10.1023/A:1025668320403; Bernstein T, 1994, RADON RENTAL HOUSING; Biesecker B B, 1997, Semin Oncol Nurs, V13, P129, DOI 10.1016/S0749-2081(97)80010-1; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BLOOM JR, 1981, AM J PUBLIC HEALTH, V71, P1228, DOI 10.2105/AJPH.71.11.1228; BOLGER A, 2000, FINANCIAL TIMES 1013; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; Capron Alexander Morgan, 1990, Emory Law J, V39, P665; CHESNEY MA, 1994, PSYCHIAT CLIN N AM, V17, P163; CODORI AM, 1994, AM J MED GENET, V54, P167, DOI 10.1002/ajmg.1320540303; COHEN MM, 1994, AM J HUM GENET, V55, pR1; Collins FS, 1996, NEW ENGL J MED, V334, P186, DOI 10.1056/NEJM199601183340311; COLLINS FS, 1994, JAMA-J AM MED ASSOC, V271, P785, DOI 10.1001/jama.1994.03510340075038; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Vries BBA, 1998, J MED GENET, V35, P579, DOI 10.1136/jmg.35.7.579; de Vries BBA, 1999, J MED GENET, V36, P467; Dodek DY, 1997, CAN MED ASSOC J, V156, P847; Elsas LJ, 2000, POSTGRAD MED, V107, P191, DOI 10.3810/pgm.2000.04.1000; Flinter FA, 2001, BRIT MED J, V322, P1008, DOI 10.1136/bmj.322.7293.1008; FOST N, 1993, AM J DIS CHILD, V147, P1190, DOI 10.1001/archpedi.1993.02160350064009; FOST N, 1992, FASEB J, V6, P2813, DOI 10.1096/fasebj.6.10.1634044; Geller G, 1997, JAMA-J AM MED ASSOC, V277, P1467, DOI 10.1001/jama.277.18.1467; GELLER G, 1995, NAT GENET, V11, P364, DOI 10.1038/ng1295-364; Geller G, 1993, Arch Fam Med, V2, P1119, DOI 10.1001/archfami.2.11.1119; Geller Lisa N, 1996, Sci Eng Ethics, V2, P71, DOI 10.1007/BF02639319; GOSTIN L, 1991, AM J LAW MED, V17, P109; Gould S.J., 1981, MISMEASURE MAN; Guazzo E, 1997, GERIATRICS, V52, P25; Hall MA, 2000, AM J HUM GENET, V66, P293, DOI 10.1086/302714; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; HOFMAN KJ, 1993, ACAD MED, V68, P625, DOI 10.1097/00001888-199308000-00013; HOLM S, 1999, GENETIC INFORMATION; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; JOHNSTON ME, 1984, J CHRON DIS, V37, P417, DOI 10.1016/0021-9681(84)90025-0; Juengst Eric T, 1995, Genome Sci Technol, V1, P21, DOI 10.1089/gst.1995.1.21; KASH KM, 1992, J NATL CANCER I, V84, P24, DOI 10.1093/jnci/84.1.24; Keller EF., 1992, SCI SOCIAL ISSUES HU, P281; Kevles D., 1985, NAME EUGENICS; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; Lerman C, 1994, J Natl Cancer Inst Monogr, P171; Lifton Robert J, 1986, NAZI DOCTORS MED KIL; LO B, 1989, ANN INTERN MED, V110, P727; MACDONALD LA, 1984, J CHRON DIS, V37, P933, DOI 10.1016/0021-9681(84)90070-5; Markel H, 1997, Health Matrix Clevel, V7, P49; MARKEL H, 1992, AM J MED, V93, P209, DOI 10.1016/0002-9343(92)90052-D; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; MCEWEN JE, 1992, AM J HUM GENET, V51, P785; MCGINISS MJ, 1997, EMORY RIMOINS PRINCI, P537; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MOSSEY JM, 1981, CLIN INVEST MED, V4, P201; MURRAY TH, 1997, GENETIC SECRETS PROT, P60; NATOWICZ MR, 1992, AM J HUM GENET, V50, P465; Nelkin D, 1995, DNS MYSTIQUE GENE CU; *NIH, 2000, ENH OV GEN TESTS REC, P20; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; OSTRER H, 1993, AM J HUM GENET, V52, P565; POKORSKI RJ, 1989, PRINCIPLES INSURANCE, P45; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; Rothenberg K, 1997, SCIENCE, V275, P1755, DOI 10.1126/science.275.5307.1755; Rothenberg KH, 1995, J LAW MED ETHICS, V23, P312, DOI 10.1111/j.1748-720X.1995.tb01373.x; Rothstein Mark A, 1992, Houst Law Rev, V29, P23; Schulman J D, 1996, Cancer J Sci Am, V2, P244; SCRIVER CR, 1995, METABOLIC MOL BASES, P1052; Secretary's Advisory Committee on Genetic Testing, 2000, ENH OV GEN TESTS REC, P15; SIEGLER M, 1982, NEW ENGL J MED, V307, P1518, DOI 10.1056/NEJM198212093072411; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Troy ESF, 1997, J LAW MED ETHICS, V25, P256, DOI 10.1111/j.1748-720X.1997.tb01408.x; UBEL PA, 1995, AM J MED, V99, P190, DOI 10.1016/S0002-9343(99)80139-9; WALDHOLZ M, 1997, CURING CANC STORY ME; Wertz D C, 1997, J Contemp Health Law Policy, V13, P299; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; Wilfond BS, 1997, J LAW MED ETHICS, V25, P243, DOI 10.1111/j.1748-720X.1997.tb01406.x; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	82	147	148	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2003	138	7					571	575		10.7326/0003-4819-138-7-200304010-00013	http://dx.doi.org/10.7326/0003-4819-138-7-200304010-00013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661BV	12667027				2022-12-24	WOS:000181872100006
J	Floto, RA; Smith, KGC				Floto, RA; Smith, KGC			The vagus nerve, macrophages, and nicotine	LANCET			English	Editorial Material							STIMULATION; SMOKING; LUNG		Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Floto, RA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	arf27@cam.ac.uk		Smith, Kenneth/0000-0003-3829-4326				Baughman RP, 2001, SARCOIDOSIS VASC DIF, V18, P70; BAUR X, 1992, RESPIRATION, V59, P211; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Camarena A, 2001, AM J RESP CRIT CARE, V163, P1528, DOI 10.1164/ajrccm.163.7.2004023; CORMIER Y, 1988, AM REV RESPIR DIS, V137, P1104, DOI 10.1164/ajrccm/137.5.1104; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Grutters JC, 2002, AM J RESP CRIT CARE, V165, P1119, DOI 10.1164/ajrccm.165.8.200110-0320; HANCE AJ, 1986, ANN NY ACAD SCI, V465, P643, DOI 10.1111/j.1749-6632.1986.tb18541.x; Kolappan C, 2002, THORAX, V57, P964, DOI 10.1136/thorax.57.11.964; Mori H, 2002, NEUROSCI LETT, V320, P21, DOI 10.1016/S0304-3940(02)00012-5; Son YS, 2002, NEUROSCI LETT, V319, P45, DOI 10.1016/S0304-3940(01)02538-1; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Vassallo R, 2000, NEW ENGL J MED, V342, P1969, DOI 10.1056/NEJM200006293422607; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x	15	31	33	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2003	361	9363					1069	1070		10.1016/S0140-6736(03)12902-9	http://dx.doi.org/10.1016/S0140-6736(03)12902-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672307				2022-12-24	WOS:000181865200005
J	Lum, L; Yao, SQ; Mozer, B; Rovescalli, A; Von Kessler, D; Nirenberg, M; Beachy, PA				Lum, L; Yao, SQ; Mozer, B; Rovescalli, A; Von Kessler, D; Nirenberg, M; Beachy, PA			Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells	SCIENCE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; DOUBLE-STRANDED-RNA; CUBITUS INTERRUPTUS; TRANSCRIPTIONAL REGULATION; TOUT-VELU; WINGLESS; GENE; PROTEIN; INTERFERENCE; SUPPRESSOR	Classical genetic screens can be limited by the selectivity of mutational targeting, the complexities of anatomically based phenotypic analysis, or difficulties in subsequent gene identification. Focusing on signaling response to the secreted morphogen Hedgehog (Hh), we used RNA interference (RNAi) and a quantitative cultured cell assay to systematically screen functional roles of all kinases and phosphatases, and subsequently 43% of predicted Drosophila genes. Two gene products reported to function in Wingless (Wg) signaling were identified as Hh pathway components: a cell surface protein (Daily-like protein) required for Hh signal reception, and casein kinase 1alpha, a candidate tumor suppressor that regulates basal activities of both Hh and Wg pathways. This type of cultured cell-based functional genomics approach may be useful in the systematic analysis of other biological processes.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; NHLBI, Lab Biochem Genet, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000009, ZIAHL000009] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baeg GH, 2001, DEVELOPMENT, V128, P87; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BROWN S, 1995, AM J HUM GENET, V57, P859; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Campbell GL, 2000, DEVELOPMENT, V127, P4095; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FORBES AJ, 1993, DEVELOPMENT, P115; GomezSkarmeta JL, 1996, GENE DEV, V10, P2935, DOI 10.1101/gad.10.22.2935; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Paine-Saunders S, 1999, GENOMICS, V57, P455, DOI 10.1006/geno.1999.5793; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; PREAT T, 1992, GENETICS, V132, P725; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; VEEMON MT, IN PRESS CURR BIOL; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733	37	424	444	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2039	2045		10.1126/science.1081403	http://dx.doi.org/10.1126/science.1081403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663920				2022-12-24	WOS:000181834200046
J	Tamas, G; Lorincz, A; Simon, A; Szabadics, J				Tamas, G; Lorincz, A; Simon, A; Szabadics, J			Identified sources and targets of slow inhibition in the neocortex	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; POSTSYNAPTIC POTENTIALS; INTERNATIONAL-UNION; PHYSIOLOGICAL-ROLE; GABA(B) RECEPTORS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; RAT NEOCORTEX; INTERNEURONS; HIPPOCAMPUS	There are two types of inhibitory postsynaptic potentials in the cerebral cortex. Fast inhibition is mediated by ionotropic gamma-aminobutyric acid type A (GABA(A)) receptors, and slow inhibition is due to metabotropic GABA(B) receptors. Several neuron classes elicit inhibitory postsynaptic potentials through GABA(A) receptors, but possible distinct sources of slow inhibition remain unknown. We identified a class of GABAergic interneurons, the neurogliaform cells, that, in contrast to other GABA-releasing cells, elicited combined GABA(A) and GABA(B) receptor-mediated responses with single action potentials and that predominantly targeted the dendritic spines of pyramidal neurons. Slow inhibition evoked by a distinct interneuron in spatially restricted postsynaptic compartments could locally and selectively modulate cortical excitability.	Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary	Szeged University	Tamas, G (corresponding author), Univ Szeged, Dept Comparat Physiol, Kozep Fasor 52, H-6726 Szeged, Hungary.		Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001; Szabadics, Janos/0000-0002-4968-2562				Banks MI, 1998, J NEUROSCI, V18, P1305; Barnard EA, 1998, PHARMACOL REV, V50, P291; BENARDO LS, 1994, J PHYSIOL-LONDON, V476, P203, DOI 10.1113/jphysiol.1994.sp020124; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Cajal S. R., 1904, TEXTURA SYSTEMA NERV, V2; DESTEXHE A, 1995, P NATL ACAD SCI USA, V92, P9515, DOI 10.1073/pnas.92.21.9515; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hestrin S, 1996, J NEUROSCI, V16, P5290; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JONES EG, 1975, J COMP NEUROL, V160, P205, DOI 10.1002/cne.901600204; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; KISVARDAY ZF, 1990, BRAIN, V113, P793, DOI 10.1093/brain/113.3.793; KRNJEVIC K, 1967, EXP BRAIN RES, V3, P320, DOI 10.1007/BF00237558; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Li JL, 2001, NEUROSCI LETT, V315, P93, DOI 10.1016/S0304-3940(01)02321-7; Lopez-Bendito G, 2002, EUR J NEUROSCI, V15, P1766, DOI 10.1046/j.1460-9568.2002.02032.x; MILES R, 1996, NEURON, V16, P816; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Overstreet LS, 2000, J NEUROSCI, V20, P7914; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; QIAN N, 1990, P NATL ACAD SCI USA, V87, P8145, DOI 10.1073/pnas.87.20.8145; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Thomson AM, 1999, NEUROSCIENCE, V92, P1193, DOI 10.1016/S0306-4522(99)00021-4; VALVERDE F, 1971, International Journal of Neuroscience, V1, P181, DOI 10.3109/00207457109146970	35	252	257	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1902	1905		10.1126/science.1082053	http://dx.doi.org/10.1126/science.1082053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649485				2022-12-24	WOS:000181669700049
J	Walden, H; Podgorski, MS; Schulman, BA				Walden, H; Podgorski, MS; Schulman, BA			Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8	NATURE			English	Article							PROTEIN MODIFICATION PATHWAY; MECHANISM; COMPLEX; SYSTEM; CONJUGATION; SITE; FAMILY; LIGASE; SMT3P	Post-translational modification by ubiquitin-like proteins (Ublps) is an essential cellular regulatory mechanism(1-3). The Ublp NEDD8 regulates cell division, signalling and embryogenesis(4-6). Ublps are conjugated to their targets by the sequential action of E1, E2 and often E3 enzymes(3). Each Ublp has a dedicated E1, or activating enzyme, that initiates its conjugation cascade(1,3,7-10). First, E1 associates with the Ublp and catalyses adenylation of the carboxy terminus of the Ublp. Second, E1 forms a thioester between its catalytic cysteine and the Ublp. Next, E1 is loaded with a second Ublp molecule, adenylating the C terminus of this second Ublp while still carrying the first thioester-bound LTblp. Last, E1 binds E2 and promotes Ublp transfer to the catalytic cysteine of E2. We report here the structure and mutational analysis of human APPBP1-UBA3, the heterodimeric E1 enzyme for NEDD8 (ref. 11). Each E1 activity is specified by a domain: an adenylation domain resembling bacterial adenylating enzymes 12, an E1-specific domain organized around the catalytic cysteine, and a domain involved in E2 recognition resembling ubiquitin. The domains are arranged around two clefts that coordinate protein and nucleotide binding so that each of E1's reactions drives the next, in an assembly-line fashion.	St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Genet Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	Brenda.schulman@stjude.org						Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HATFIELD PM, 1990, J BIOL CHEM, V265, P15813; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WHITEHEAD GW, 1983, B AM MATH SOC, V8, P1, DOI 10.1090/S0273-0979-1983-15072-3	30	170	176	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2003	422	6929					330	334		10.1038/nature01456	http://dx.doi.org/10.1038/nature01456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646924				2022-12-24	WOS:000181637300044
J	Heath, DD; Heath, JW; Bryden, CA; Johnson, RM; Fox, CW				Heath, DD; Heath, JW; Bryden, CA; Johnson, RM; Fox, CW			Rapid evolution of egg size in captive salmon	SCIENCE			English	Article							OFFSPRING SIZE; PACIFIC SALMON; CHINOOK SALMON; NUMBER; SELECTION; POPULATIONS; RECOVERY; FITNESS; LIFE	Captive breeding and release programs, widely used to supplement populations of declining species, minimize juvenile mortality to achieve rapid population growth. However, raising animals in benign environments may promote traits that are adaptive in captivity but maladaptive in nature. In chinook salmon, hatchery rearing relaxes natural selection favoring large eggs, allowing fecundity selection to drive exceptionally rapid evolution of small eggs. Trends toward small eggs are also evident in natural populations heavily supplemented by hatcheries, but not in minimally supplemented populations. Unintentional selection in captivity can lead to rapid changes in critical life-history traits that may reduce the success of supplementation or reintroduction programs.	Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada; Yellow Isl Aquaculture Ltd, Campbell River, BC V9W 6K9, Canada; AXYS Environm Consulting Ltd, Sidney, BC V8L 3S8, Canada; Univ No British Columbia, Coll Sci & Management, Prince George, BC V2N 4Z9, Canada; Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	University of Windsor; University of Windsor; University of Northern British Columbia; University of Kentucky	Heath, DD (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	dheath@uwindsor.ca	Fox, Charles W/I-5274-2012	Fox, Charles W/0000-0002-7545-7967				ALLENDORF FW, 1993, CONSERV BIOL, V7, P416, DOI 10.1046/j.1523-1739.1993.07020416.x; Duchesne P, 2002, CONSERV GENET, V3, P47; EBENHARD T, 1995, TRENDS ECOL EVOL, V10, P438, DOI 10.1016/S0169-5347(00)89176-4; Einum S, 2002, P ROY SOC B-BIOL SCI, V269, P2325, DOI 10.1098/rspb.2002.2150; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Gippoliti S, 1997, CONSERV BIOL, V11, P806, DOI 10.1046/j.1523-1739.1997.96342.x; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Heath DD, 2002, CAN J FISH AQUAT SCI, V59, P77, DOI 10.1139/F01-192; Heath DD, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P178; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hendry AP, 2001, AM NAT, V157, P387, DOI 10.1086/319316; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LLOYD DG, 1987, AM NAT, V129, P800, DOI 10.1086/284676; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; Mousseau T. A., 1998, MATERNAL EFFECTS ADA; Noakes DJ, 2000, AQUACULTURE, V183, P363, DOI 10.1016/S0044-8486(99)00294-X; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; PHILIPPART JC, 1995, BIOL CONSERV, V72, P281, DOI 10.1016/0006-3207(94)00090-D; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reisenbichler RR, 1999, ICES J MAR SCI, V56, P459, DOI 10.1006/jmsc.1999.0455; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Roff Derek A., 1992; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; Wang JL, 2001, CONSERV BIOL, V15, P1619, DOI 10.1046/j.1523-1739.2001.00173.x; WAPLES RS, 1994, CONSERV BIOL, V8, P884, DOI 10.1046/j.1523-1739.1994.08030863-12.x; WINKLER DW, 1987, AM NAT, V129, P708, DOI 10.1086/284667	28	245	256	1	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2003	299	5613					1738	1740		10.1126/science.1079707	http://dx.doi.org/10.1126/science.1079707			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637746				2022-12-24	WOS:000181519500047
J	Treiner, E; Duban, L; Bahram, S; Radosavljevic, M; Wanner, V; Tilloy, F; Affaticati, P; Gilfillan, S; Lantz, O				Treiner, E; Duban, L; Bahram, S; Radosavljevic, M; Wanner, V; Tilloy, F; Affaticati, P; Gilfillan, S; Lantz, O			Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1	NATURE			English	Article							MHC CLASS-I; POSITIVE SELECTION; HEMATOPOIETIC-CELLS; MUTANT MICE; MU-CHAIN; GENE; MOUSE; GENERATION; EXPRESSION; BINDING	The evolutionary conservation of T lymphocyte subsets bearing T-cell receptors (TCRs) using invariant alpha-chains is indicative of unique functions. CD1d-restricted natural killer T (NK-T) cells that express an invariant Valpha14 TCRalpha chain have been implicated in microbial and tumour responses, as well as in auto-immunity(1,2) Here we show that T cells that express the canonical hValpha7.2-Jalpha33 or mValpha19-Jalpha33 TCR rearrangement' are preferentially located in the gut lamina propria of humans and mice, respectively, and are therefore genuine mucosal-associated invariant T (MAIT) cells. Selection and/or expansion of this population requires B lymphocytes, as MAIT cells are absent in B-cell-deficient patients and mice. In addition, we show that MAIT cells are selected and/or restricted by MR1, a monomorphic major histocompatibility complex class I-related molecule that is markedly conserved in diverse mammalian species'. MAIT cells are not present in germfree mice, indicating that commensal flora is required for their expansion in the gut lamina propria. This indicates that MAIT cells are probably involved in the host response at the site of pathogen entry, and may regulate intestinal B-cell activity.	Inst Curie, Immunol Lab, F-75005 Paris, France; Inst Curie, INSERM, U520, F-75005 Paris, France; Ctr Rech Immunol & Hematol, CReS, INSERM, F-67085 Strasbourg, France; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Washington University (WUSTL)	Lantz, O (corresponding author), Inst Curie, Immunol Lab, F-75005 Paris, France.		Bahram, Seiamak/GZA-7150-2022; Lantz, Olivier J/J-4960-2012	Lantz, Olivier J/0000-0003-3161-7719; Radosavljevic, Mirjana/0000-0003-3925-0640; Bahram, Seiamak/0000-0002-6928-9952				Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; Bahram S, 2000, Adv Immunol, V76, P1; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BENVENISTE J, 1971, J IMMUNOL, V107, P1656; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JAKOBOVITS A, 1993, P NATL ACAD SCI USA, V90, P2551, DOI 10.1073/pnas.90.6.2551; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lee N, 1998, J IMMUNOL, V160, P4951; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; Riegert P, 1998, J IMMUNOL, V161, P4066; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Tourne S, 1996, P NATL ACAD SCI USA, V93, P1464, DOI 10.1073/pnas.93.4.1464; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; Ugolini S, 2001, NAT IMMUNOL, V2, P198, DOI 10.1038/85246; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3	30	737	760	3	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					164	169		10.1038/nature01433	http://dx.doi.org/10.1038/nature01433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634786				2022-12-24	WOS:000181488900045
J	Gurwitz, JH; Field, TS; Harrold, LR; Rothschild, J; Debellis, K; Seger, AC; Cadoret, C; Garber, L; Kelleher, M; Bates, DW				Gurwitz, JH; Field, TS; Harrold, LR; Rothschild, J; Debellis, K; Seger, AC; Cadoret, C; Garber, L; Kelleher, M; Bates, DW			Incidence and preventability of adverse drug events among older persons in the ambulatory setting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICATION ERRORS; ELDERLY PATIENTS; UNITED-STATES; MEDICINE; QUALITY; PRESCRIPTION; POPULATION; DEATHS; SAFETY; COSTS	Context Adverse drug events, especially those that may be preventable, are among the most serious concerns about medication use in older persons cared for in the ambulatory clinical setting. Objective To assess the incidence and preventability of adverse drug events among older persons in the ambulatory clinical setting. Design, Setting, and Patients Cohort study of all Medicare enrollees (30 397 person-years of observation) cared for by a multispecialty group practice during a 12-month study period (July 1, 1999, through June 30, 2000), in which possible drug-related incidents occurring in the ambulatory clinical setting were detected using multiple methods, including reports from health care providers; review of hospital discharge summaries; review of emergency department notes; computer-generated signals; automated free-text review of electronic clinic notes; and review of administrative incident reports concerning medication errors. Main Outcome Measures Number of adverse drug events, severity of the events (classified as significant, serious, life-threatening, or fatal), and whether the events were preventable. Results There were 1523 identified adverse drug events, of which 27.6% (421) were considered preventable. The overall rate of adverse drug events was 50.1 per 1000 person-years, with a rate of 13.8 preventable adverse drug events per 1000 person-years. Of the adverse drug events, 578 (38.0%) were categorized as serious, life-threatening, or fatal; 244 (42.2%) of these more severe events were deemed preventable compared with 177 (18.7%) of the 945 significant adverse drug events. Errors associated with preventable adverse drug events occurred most often at the stages of prescribing (n = 246, 58.4%) and monitoring (n = 256, 60.8%), and errors involving patient adherence (n = 89, 21.1%) also were common. Cardiovascular medications (24.5%), followed by diuretics (22.1%), nonopioid analgesics (15.4%), hypoglytemics (10.9%), and anticoagulants (10.2%) were the most common medication categories associated with preventable adverse drug events. Electrolyte/renal (26.6%), gastrointestinal tract (21.1%), hemorrhagic (15.9%), metabolic/endocrine (13.8%), and neuropsychiatric (8.6%) events were the most common types of preventable adverse drug events. Conclusions Adverse drug events are common and often preventable among older persons in the ambulatory Clinical setting. More serious adverse drug events are more likely to be preventable. Prevention strategies should target the prescribing and monitoring stages of. pharmaceutical care. Interventions focused on improving patient adherence with prescribed regimens and monitoring of prescribed medications also may be beneficial.	Meyers Primary Care Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Partners Healthcare Syst, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Gurwitz, JH (corresponding author), Meyers Primary Care Inst, 630 Plantat St, Worcester, MA 01605 USA.	jgurwitz@meyersprimary.org		Cadoret, Cynthia/0000-0001-6713-2823	NATIONAL INSTITUTE ON AGING [R01AG015979] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Applegate WB, 2002, JAMA-J AM MED ASSOC, V288, P495, DOI 10.1001/jama.288.4.495; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Chertow GM, 2001, JAMA-J AM MED ASSOC, V286, P2839, DOI 10.1001/jama.286.22.2839; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; *CTR MED MED SERV, MED MAN CAR CONTR PL; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Gurwitz JH, 2002, ARCH INTERN MED, V162, P1670, DOI 10.1001/archinte.162.15.1670; Hanlon JT, 2000, PHARMACOTHERAPY, V20, P575, DOI 10.1592/phco.20.6.575.35163; Hanlon JT, 2002, J AM GERIATR SOC, V50, P26, DOI 10.1046/j.1532-5415.2002.50004.x; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Honigman B, 2001, INT J MED INFORM, V61, P21, DOI 10.1016/S1386-5056(00)00131-3; Honigman B, 2001, J AM MED INFORM ASSN, V8, P254, DOI 10.1136/jamia.2001.0080254; KATZ JN, 1992, ARTHRITIS RHEUM-US, V35, P1257, DOI 10.1002/art.1780351103; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kaushal R, 2001, ARCH PEDIAT ADOL MED, V155, P1002, DOI 10.1001/archpedi.155.9.1002; Knight EL, 2001, ANN INTERN MED, V135, P703, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00009; Kohn LT, 2000, ERR IS HUMAN BUILDIN; KOZAK LJ, 2002, ADV DATA VITAL HLTH, V13; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; *LEAPFR GROUP, 2002, PAT SAF SURV RES SUM; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Matchar DB, 2002, AM J MED, V113, P42, DOI 10.1016/S0002-9343(02)01131-2; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; *NAT CTR HLTH STAT, POP AG SEX RAC NAT S; Pitkala KH, 2002, ARCH INTERN MED, V162, P1707, DOI 10.1001/archinte.162.15.1707; Rosner B., 2015, FUNDAMENTALS BIOSTAT; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; SHOJANIA K, 2001, AHRQ PUBLICATION; Sox H C Jr, 2000, Eff Clin Pract, V3, P277; Thomas EJ, 2002, ANN INTERN MED, V136, P812, DOI 10.7326/0003-4819-136-11-200206040-00009; WALTON RT, 2001, COCHRANE DB SYST REV, V1; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823	45	1080	1115	1	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1107	1116		10.1001/jama.289.9.1107	http://dx.doi.org/10.1001/jama.289.9.1107			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622580	Bronze			2022-12-24	WOS:000181289400026
J	Spodick, DH				Spodick, DH			Acute pericarditis - Current concepts and practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIAC-TAMPONADE; DIAGNOSIS; FREQUENCY; ETIOLOGY; DISEASE		Univ Massachusetts, Sch Med, Cardiovasc Med Fellowship Program, St Vincent Hosp, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Spodick, DH (corresponding author), Worcester Med Ctr, Div Cardiovasc, 20 Worcester Ctr Blvd, Worcester, MA 01608 USA.							BRUCE MA, 1980, J ELECTROCARDIOL, V13, P61, DOI 10.1016/S0022-0736(80)80011-2; FOWLER NO, 1991, JAMA-J AM MED ASSOC, V266, P99, DOI 10.1001/jama.266.1.99; FRIEDMAN PL, 1981, NEW ENGL J MED, V305, P1171, DOI 10.1056/NEJM198111123052002; LEE KS, 1993, CLEV CLIN J MED, V60, P336, DOI 10.3949/ccjm.60.4.336; Lieng LH, 1996, J AM COLL CARDIOL, V27, p32A; MAISCH B, 1994, CURR OPIN CARDIOL, V9, P379, DOI 10.1097/00001573-199405000-00017; Merce J, 1999, AM HEART J, V138, P759, DOI 10.1016/S0002-8703(99)70193-6; Myers RBH, 1999, AM HEART J, V138, P219, DOI 10.1016/S0002-8703(99)70105-5; PERMANYER G, 1988, ENFERMEDADES PERICAR, P5; PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9; REDDY PS, 1990, AM J CARDIOL, V66, P1487, DOI 10.1016/0002-9149(90)90540-H; REYDEL B, 1990, AM HEART J, V119, P1160, DOI 10.1016/S0002-8703(05)80248-0; Spodick DH, 1997, AM J CARDIOL, V80, P102, DOI 10.1016/S0002-9149(97)00296-8; SPODICK DH, 1984, AM J CARDIOL, V53, P842, DOI 10.1016/0002-9149(84)90416-8; SPODICK DH, 1973, CIRCULATION, V48, P575, DOI 10.1161/01.CIR.48.3.575; Spodick DH, 1997, PERICARDIUM COMPREHE; Spodick DH, 2001, HEART DIS, P823; SPODICK DH, 2002, EVALUATION PATIENT H, P339; SWAMI A, IN PRESS CLIN CARDIO; ZAYAS R, 1995, AM J CARDIOL, V75, P378, DOI 10.1016/S0002-9149(99)80558-X	20	117	121	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1150	1153		10.1001/jama.289.9.1150	http://dx.doi.org/10.1001/jama.289.9.1150			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622586				2022-12-24	WOS:000181289400032
J	Bose, A; Coen, P; Tully, J; Viner, R; Booy, R				Bose, A; Coen, P; Tully, J; Viner, R; Booy, R			Effectiveness of meningococcal C conjugate vaccine in teenagers in England	LANCET			English	Article							EFFICACY	Meningococcal C conjugate vaccine was introduced into clinical practice in the UK before phase 3 trials had been undertaken. We therefore did a case-control study,in teenagers to assess vaccine effectiveness. All cases (n=31) enrolled had laboratory confirmed meningococcal C disease. We also enrolled between one and three controls (n=65) per case, matched by age, sex, and general practitioner. Three patients and 23 controls had been vaccinated. The protective effectiveness of the vaccine, estimated by conditional logistic regression, was 93% (95% CI 39-99), which is similar to screening method estimates. The estimated protective effectiveness varied little when potential confounding risk factors were taken into account. Our findings indicate that the vaccine is highly protective against invasive meningococcal C disease.	Royal London Hosp, Acad Dept Child Hlth, London E1 1BB, England; Inst Child Hlth, London, England; UCL Hosp, Adolescent Res Unit, London, England; Great Ormond St Hosp Sick Children, London, England	Barts Health NHS Trust; Royal London Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Booy, R (corresponding author), Royal London Hosp, Acad Dept Child Hlth, London E1 1BB, England.	R.Booy@qmul.ac.uk	Viner, Russell M/A-1441-2009; Booy, Robert/D-4188-2011	Viner, Russell M/0000-0003-3047-2247; Tully, Joanna/0000-0002-3918-6063				MARYKRAUSE M, 1993, REV EPIDEMIOL SANTE, V41, P155; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Simondon F, 1999, INT J EPIDEMIOL, V28, P113, DOI 10.1093/ije/28.1.113; TULLY J, ARCH DIS CHILD S, V82, pA5	5	33	35	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					675	676		10.1016/S0140-6736(03)12563-9	http://dx.doi.org/10.1016/S0140-6736(03)12563-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606181				2022-12-24	WOS:000181129500019
J	Alexander, EK; Hurwitz, S; Heering, JP; Benson, CB; Frates, MC; Doubilet, PM; Cibas, ES; Larsen, PR; Marqusee, E				Alexander, EK; Hurwitz, S; Heering, JP; Benson, CB; Frates, MC; Doubilet, PM; Cibas, ES; Larsen, PR; Marqusee, E			Natural history of benign solid and cystic thyroid nodules	ANNALS OF INTERNAL MEDICINE			English	Article							TERM FOLLOW-UP; SUPPRESSIVE THERAPY; LEVOTHYROXINE; ULTRASOUND; THYROXINE; GOITER	Background: Thyroid nodules are common and most often benign. The natural history of benign thyroid nodules, however, is unclear. Objective: To determine the natural history of cytologically benign thyroid nodules using ultrasonography. Design: Retrospective case series. Setting: Single tertiary care clinic. Participants: All patients referred to the Brigham and Women's Hospital Thyroid Nodule Clinic, Boston, Massachusetts, who had benign cytologic results on ultrasonography-guided fine-needle aspiration of a thyroid nodule between 1995 and 2000 and returned for a requested follow-up examination 1 month to 5 years later. Measurements: Nodule dimensions were measured at both visits, and growth was defined as an increase in calculated volume of 15% or greater. These results were correlated with the time between examinations, age, sex, baseline serum thyroid-stimulating hormone concentration, and cystic content of each nodule. Results: Nodule volume increased over time (P < 0.001). The estimated proportion of nodules with an increase in volume of 15% or greater after 5 years was 89%. Nodules with greater cystic content were less likely to grow than solid nodules (P = 0.01). Seventy-four of the 330 nodules were reaspirated on the second visit. Despite an average increase in volume of 69%, only 1 of 74 reaspirated nodules was malignant. Conclusion: Most solid, benign thyroid nodules grow. Therefore, an increase in nodule volume alone is not a reliable predictor of malignancy.	Brigham & Womens Hosp, Div Endocrine, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Alexander, EK (corresponding author), Brigham & Womens Hosp, Div Endocrine, 221 Longwood Ave,2nd Floor, Boston, MA 02115 USA.	ekalexander@partners.org	Doubilet, Peter/AAY-7351-2021		NHLBI NIH HHS [HL-07609] Funding Source: Medline; NIDDK NIH HHS [DK-07529] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGHOUT A, 1990, LANCET, V336, P193, DOI 10.1016/0140-6736(90)91730-X; BRANDER A, 1992, J CLIN ULTRASOUND, V20, P37, DOI 10.1002/jcu.1870200107; Brander AEE, 2000, RADIOLOGY, V215, P801, DOI 10.1148/radiology.215.3.r00jn07801; BRUNN J, 1981, DEUT MED WOCHENSCHR, V106, P1338, DOI 10.1055/s-2008-1070506; CHEUNG PSY, 1989, WORLD J SURG, V13, P818, DOI 10.1007/BF01658447; Danese D, 1998, THYROID, V8, P15, DOI 10.1089/thy.1998.8.15; Daniels Gilbert H., 1996, Comprehensive Therapy, V22, P239; Erdogan MF, 1998, THYROID, V8, P1087, DOI 10.1089/thy.1998.8.1087; GHARIB H, 1987, NEW ENGL J MED, V317, P70, DOI 10.1056/NEJM198707093170202; GRANT CS, 1989, SURGERY, V106, P980; KUMA K, 1994, WORLD J SURG, V18, P495, DOI 10.1007/BF00353745; KUMA K, 1992, WORLD J SURG, V16, P583, DOI 10.1007/BF02067327; LAROSA GL, 1995, ANN INTERN MED, V122, P1, DOI 10.7326/0003-4819-122-1-199501010-00001; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Papini E, 1998, J CLIN ENDOCR METAB, V83, P780, DOI 10.1210/jc.83.3.780; REVERTER JL, 1992, CLIN ENDOCRINOL, V36, P25, DOI 10.1111/j.1365-2265.1992.tb02898.x; RIDGWAY EC, 2000, WERNER INGBARS THYRO, P949; Singer PA, 1996, ARCH INTERN MED, V156, P2165, DOI 10.1001/archinte.156.19.2165; TANNIRANDORN P, 2001, 83 M END SOC DENV CO	20	191	204	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					315	318		10.7326/0003-4819-138-4-200302180-00010	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585829				2022-12-24	WOS:000181019400005
J	Henry, G; Li, W; Garner, W; Woodley, DT				Henry, G; Li, W; Garner, W; Woodley, DT			Migration of human keratinocytes in plasma and serum and wound re-epithelialisation	LANCET			English	Article								When skin is wounded, human keratinocytes at the wound edge stop differentiating and start migrating to resurface the wound. How this change takes place is unclear. Because keratinocytes at the wound edge are for the first time surrounded by serum rather than plasma, serum could contain some migration-promoting factor or factors that is absent in plasma. We did standard computer-assisted in-vitro migration assays of human keratinocytes in the presence of either human plasma or serum. We also did a semiquantitative western blot analysis to determine if p38 mitogen-activated protein kinase (p38MAPK) was activated by either serum or plasma. Our results showed that keratinocytes migrating on collagen in the presence of serum produced migration indices in the range of 28, whereas those in the presence of plasma were about 12-the same level as control assays without either serum or plasma. We also showed that induced keratinocyte polarisation, activation of p38MAPK, and production of matrix metalloprotease 9 are possible mechanisms for promotion of re-epithelialisation of skin wounds by human serum.	Univ So Calif, Keck Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Surg, Div Plast Surg, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Woodley, DT (corresponding author), Univ So Calif, Keck Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90033 USA.				NIAMS NIH HHS [R01 AR46538] Funding Source: Medline; NIGMS NIH HHS [R01 GM/AR66193] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066193] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Johansson N, 2000, J CELL SCI, V113, P227; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; Woodley DT, 1996, MOL CELLULAR BIOL WO, P339	5	38	39	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					574	576		10.1016/S0140-6736(03)12510-X	http://dx.doi.org/10.1016/S0140-6736(03)12510-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598145				2022-12-24	WOS:000181033400013
J	Zeyl, C; Vanderford, T; Carter, M				Zeyl, C; Vanderford, T; Carter, M			An evolutionary advantage of haploidy in large yeast populations	SCIENCE			English	Article							LIFE-CYCLES; DIPLOIDY; ADAPTATION	Although seed plants and multicellular animals are predominantly diploid, the prominence of diploidy varies greatly among eukaryote life cycles, and no general evolutionary advantage of diploidy has been demonstrated. By doubling the copy number of each gene, diploidy may increase the rate at which adaptive mutations are produced. However, models suggest that this does not necessarily accelerate adaptation by diploid populations. We tested model predictions regarding rates of adaptation using asexual yeast populations. Adaptive mutations were on average partially recessive. As predicted, diploidy slowed adaptation by large populations but not by small populations.	Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Zeyl, C (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.							Bell G, 1982, MASTERPIECE NATURE E; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Hiraoka M, 2000, GENETICS, V156, P1531; JENKINS CD, 1995, EVOLUTION, V49, P512, DOI [10.1111/j.1558-5646.1995.tb02283.x, 10.2307/2410275]; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; ORR HA, 1994, GENETICS, V136, P1475; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.1111/j.1558-5646.1998.tb01823.x, 10.2307/2411226]; OTTO S, 1994, THEORIES EVOLUTION H, P69; OTTO SP, 1992, GENETICS, V131, P745; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; PERROT V, 1991, NATURE, V351, P315, DOI 10.1038/351315a0; VALERO M, 1992, TRENDS ECOL EVOL, V7, P25, DOI 10.1016/0169-5347(92)90195-H	13	104	107	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					555	558		10.1126/science.1078417	http://dx.doi.org/10.1126/science.1078417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543972				2022-12-24	WOS:000180559800046
J	Weimerskirch, H; Chastel, O; Barbraud, C; Tostain, O				Weimerskirch, H; Chastel, O; Barbraud, C; Tostain, O			Frigatebirds ride high on thermals - This bird's bizarre physique and sparse hunting grounds account for its languid lifestyle.	NATURE			English	Article									CNRS, UPR 1934, Ctr Etud Biol Chize, F-79360 Villiersen Bois, France; Assoc Aratai, F-97357 Remire Montjoly, Guyane, France; DIREN, F-97328 Cayenne, Guyane, French Guiana	Centre National de la Recherche Scientifique (CNRS)	Weimerskirch, H (corresponding author), CNRS, UPR 1934, Ctr Etud Biol Chize, F-79360 Villiersen Bois, France.	henriw@cebc.cnrs.fr	Barbraud, Christophe/A-5870-2012; Weimerskirch, Henri/K-7306-2019; Herberstein, Marie E./D-2042-2011; Weimerskirch, Henri/F-5562-2013	Barbraud, Christophe/0000-0003-0146-212X; Weimerskirch, Henri/0000-0002-0457-586X; Herberstein, Marie E./0000-0001-5071-2952; 				Alerstam T, 1990, BIRD MIGRATION; AUGSTEIN E, 1980, METEOROLOGY TROPICAL; Ballance L. T., 1999, P INT ORN C, P2057; DIAMOND AW, 1973, CONDOR, V75, P200, DOI 10.2307/1365868; GOULD PJ, 1974, PELAGIC STUDIES SEAB, P6; LACK D, 1956, SWIFTSIN TOWER; NELSON J B, 1975, Living Bird, V14, P113; Orta J., 1992, P362; PENNYCUICK CJ, 1983, J EXP BIOL, V102, P307; Weimerskirch H, 2001, BIOL MARINE BIRDS, P115	10	79	87	6	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					333	334		10.1038/421333a	http://dx.doi.org/10.1038/421333a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540890				2022-12-24	WOS:000180533000030
J	Vassilopoulos, G; Wang, PR; Russell, DW				Vassilopoulos, G; Wang, PR; Russell, DW			Transplanted bone marrow regenerates liver by cell fusion	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; FOAMY VIRUS VECTORS; FUMARYLACETOACETATE HYDROLASE; HEPATIC-DYSFUNCTION; KUPFFER CELLS; MOUSE-LIVER; ORIGIN; HEPATOCYTES; PHENOTYPE; KINETICS	Results from several experimental systems suggest that cells from one tissue type can form other tissue types after transplantation. This could be due to the presence of multipotential or several types of adult stem cells in donor tissues, or alternatively, to fusion of donor and recipient cells. In a model of tyrosinaemia type I, mice with mutations in the fumarylacetoacetate hydrolase gene (Fah(-/-)) regain normal liver function after transplantation of Fah(+/+) bone marrow cells, and form regenerating liver nodules with normal histology that express Fah(1). Here we show that these hepatic nodules contain more mutant than wild-type Fah alleles, and that their hepatocytes express both donor and host genes, consistent with polyploid genome formation by fusion of host and donor cells. Using bone marrow cells marked with integrated foamy virus vectors that express green fluorescent protein, we identify common proviral junctions in hepatic nodules and haematopoietic cells. We also show that the haematopoietic donor genome adopts a more hepatocyte-specific expression profile after cell fusion, as the wild-type Fah gene was activated and the pan-haematopoietic CD45 marker was no longer expressed.	Univ Washington, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Div Hematol, Seattle, WA 98195 USA.		Vassilopoulos, George/AAK-8069-2020					ARIAS IM, 1994, LIVER; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BOHM N, 1981, HISTOCHEMISTRY, V72, P55, DOI 10.1007/BF00496779; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; GALE RP, 1978, SCIENCE, V201, P937, DOI 10.1126/science.356266; GOLDENBERG DM, 1971, CANCER RES, V31, P1148; GROMPE M, 1992, BIOCHEM MED METAB B, V48, P26, DOI 10.1016/0885-4505(92)90044-Y; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Josephson NC, 2002, P NATL ACAD SCI USA, V99, P8295, DOI 10.1073/pnas.122131099; KERBEL RS, 1983, MOL CELL BIOL, V3, P523, DOI 10.1128/MCB.3.4.523; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P592, DOI 10.1073/pnas.58.2.592; PARADIS K, 1990, J PEDIATR GASTR NUTR, V11, P525, DOI 10.1097/00005176-199011000-00014; PARWARESCH MR, 1986, VIRCHOWS ARCH B, V51, P89, DOI 10.1007/BF02899019; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Vassilopoulos G, 2001, BLOOD, V98, P604, DOI 10.1182/blood.V98.3.604; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3; WIENER F, 1974, P NATL ACAD SCI USA, V71, P148, DOI 10.1073/pnas.71.1.148; WIENER F, 1972, NATURE-NEW BIOL, V238, P155, DOI 10.1038/newbio238155a0; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; ZAKIM D, 1990, HEPATOLOGY	26	1002	1093	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					901	904		10.1038/nature01539	http://dx.doi.org/10.1038/nature01539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12665833				2022-12-24	WOS:000182432600057
J	Dutzler, R; Campbell, EB; MacKinnon, R				Dutzler, R; Campbell, EB; MacKinnon, R			Gating the selectivity filter in ClC chloride channels	SCIENCE			English	Article							TORPEDO ELECTROPLAX; MOLECULAR-BASIS; K+ CHANNEL; CONDUCTION; MECHANISM; RECEPTOR; CLONING; ANION	ClC channels conduct chloride (Cl-) ions across cell membranes and thereby govern the electrical activity of muscle cells and certain neurons, the transport of fluid and electrolytes across epithelia, and the acidification of intracellular vesicles. The structural basis of ClC channel gating was studied. Crystal structures of wild-type and mutant Escherichia coli ClC channels bound to a monoclonal Fab fragment reveal three Cl- binding sites within the 15-angstrom neck of an hourglass-shaped pore. The Cl- binding site nearest the extracellular solution can be occupied either by a Cl- ion or by a glutamate carboxyl group. Mutations of this glutamate residue in Torpedo ray ClC channels alter gating in electrophysiological assays. These findings reveal a form of gating in which the glutamate carboxyl group closes the pore by mimicking a Cl- ion.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu						Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Harlow E., 1989, ANTIBODIES LAB MANUA; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Miller C., 1980, Annals of the New York Academy of Sciences, V341, P534, DOI 10.1111/j.1749-6632.1980.tb47197.x; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	26	620	641	0	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					108	112		10.1126/science.1082708	http://dx.doi.org/10.1126/science.1082708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12649487				2022-12-24	WOS:000181988900042
J	Tran, SD; Pillemer, SR; Dutra, A; Barrett, AJ; Brownstein, MJ; Key, S; Pak, E; Leakan, RA; Kingman, A; Yamada, KM; Baum, BJ; Mezey, E				Tran, SD; Pillemer, SR; Dutra, A; Barrett, AJ; Brownstein, MJ; Key, S; Pak, E; Leakan, RA; Kingman, A; Yamada, KM; Baum, BJ; Mezey, E			Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study	LANCET			English	Article							HEMATOPOIETIC STEM-CELLS; OSTEOGENESIS IMPERFECTA; MESENCHYMAL CELLS; TRANSPLANTS; CHILDREN; FUSION	Background Adult bone marrow-derived (BMD) cells could be used to repair damaged organs and tissues, but the intrinsic plasticity of these cells has been questioned by results of in-vitro studies suggesting that such cells might fuse with other cells giving the appearance of differentiation. We aimed to determine whether fusion events are important in vivo. Methods To test whether BMD cells can colonise an epithelial tissue and differentiate there without fusion, we did in-situ hybridisation with Y and X chromosome probes labelled with 35-sulphur or digoxigenin, or labelled fluorescently. We did immunohistochemistry with anticytokeratin 13 along with fluorescence in-situ hybridisation to identify Y-chromosome positive buccal epithelial cells in cheek scrapings obtained from five females who had received either a bone-marrow transplant or an allogeneic mobilised peripheral-blood progenitor-cell transplant (enriched in CD34+ cells) from male donors. Findings When examined 4-6 years after male-to-female marrow-cell transplantation, all female recipients had Y-chromosome-positive buccal cells (0.8-12.7%). In more than 9700 cells studied, we detected only one XXXY-positive cell (0.01%) and one XXY cell (0.01%), both of which could have arisen when an XY cell fused with an XX cell. Interpretation Male BMD cells migrate into the cheek and differentiate into epithelial cells, an occurrence that does not depend on fusion of BMD cells to recipient cells. This finding might be an example of transdifferentiation of haemopoietic or stromal progenitor cells. Plasticity of BMD cells could be useful in regenerative medicine.	NIDCR, NIH, Gene Therapy & Therapeut Branch, Bethesda, MD 20892 USA; NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD USA; NIDCR, Biostat Core, NIH, Bethesda, MD USA; NHGRI, Cytogenet Core, NIH, Bethesda, MD 20892 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; NIMH, Genet Lab, NIH, Bethesda, MD 20892 USA; NINDS, Basic Neurosci Programme, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tran, SD (corresponding author), NIDCR, NIH, Gene Therapy & Therapeut Branch, 10 Ctr Dr,Room 1N113,MSC 1190, Bethesda, MD 20892 USA.	stran@dir.nidcr.nih.gov	Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691; Yamada, Kenneth/0000-0003-1512-6805	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002342, Z01HL002342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000525, Z01DE000336, ZIADE000336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002996] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abkowitz JL, 2002, NEW ENGL J MED, V346, P770, DOI 10.1056/NEJM200203073461012; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Brouard M, 2002, NEW ENGL J MED, V347, P218; Clarke D, 2001, CURR OPIN GENET DEV, V11, P575, DOI 10.1016/S0959-437X(00)00235-5; Fogt F, 2002, HEPATOLOGY, V36, P173, DOI 10.1053/jhep.2002.33994; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; *LAB CELL MOL REC, 2003, SECT NEUR GEN EXPR; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; NAKAHORI Y, 1986, NUCLEIC ACIDS RES, V14, P7569, DOI 10.1093/nar/14.19.7569; Nelson JL, 2002, TRENDS MOL MED, V8, P109, DOI 10.1016/S1471-4914(01)02269-9; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Verfaillie CM, 2002, TRENDS CELL BIOL, V12, P502, DOI 10.1016/S0962-8924(02)02386-3; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wells WA, 2002, J CELL BIOL, V157, P15, DOI 10.1083/jcb.200203037; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	18	133	144	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 29	2003	361	9363					1084	1088		10.1016/S0140-6736(03)12894-2	http://dx.doi.org/10.1016/S0140-6736(03)12894-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672312				2022-12-24	WOS:000181865200010
J	Xiao, Y; Patolsky, F; Katz, E; Hainfeld, JF; Willner, I				Xiao, Y; Patolsky, F; Katz, E; Hainfeld, JF; Willner, I			"Plugging into enzymes": Nanowiring of redox enzymes by a gold nanoparticle	SCIENCE			English	Article							GLUCOSE-OXIDASE; ELECTRON-TRANSFER; RECONSTITUTION; INTEGRATION; BIOSENSORS; MONOLAYER; SUPPORTS; POLYMER; SYSTEMS; SURFACE	The reconstitution of an apo-flavoenzyme, apo-glucose oxidase, on a 1.4-nanometer gold nanocrystal functionalized with the cofactor flavin adenine dinucleotide and integrated into a conductive film yields a bioelectrocatalytic system with exceptional electrical contact with the electrode support. The electron transfer turnover rate of the reconstituted bioelectrocatalyst is similar to5000 per second, compared with the rate at which molecular oxygen, the natural cosubstrate of the enzyme, accepts electrons (similar to700 per second). The gold nanoparticle acts as an electron relay or "electrical nanoplug" for the alignment of the enzyme on the conductive support and for the electrical wiring of its redox-active center.	Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; Brookhaven Natl Lab, Dept Biol, Upton, NY 11873 USA	Hebrew University of Jerusalem; United States Department of Energy (DOE); Brookhaven National Laboratory	Willner, I (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.		patolsky, Fernando/AAD-1188-2021; Xiao, Yi/L-6606-2016	patolsky, Fernando/0000-0002-1382-5357; Xiao, Yi/0000-0001-7278-9811				Armstrong FA, 2000, ELECTROCHIM ACTA, V45, P2623, DOI 10.1016/S0013-4686(00)00342-X; BADIA A, 1993, J AM CHEM SOC, V115, P7053, DOI 10.1021/ja00069a001; Bard A. J., 1980, ELECTROCHEMICAL METH; BOURDILLON C, 1993, J AM CHEM SOC, V115, P12264, DOI 10.1021/ja00079a005; DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001; Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8; Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404; HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002; HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007; Kranz C, 1998, ELECTROANAL, V10, P546, DOI 10.1002/(SICI)1521-4109(199807)10:8<546::AID-ELAN546>3.3.CO;2-R; LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3; Raitman OA, 2002, J AM CHEM SOC, V124, P6487, DOI 10.1021/ja012680r; Rajagopalan R, 1996, J PHYS CHEM-US, V100, P3719, DOI 10.1021/jp952160g; SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048; WILLNER I, 1992, BIOELECTROCH BIOENER, V29, P29, DOI 10.1016/0302-4598(92)80051-H; Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611; WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E; Zayats M, 2002, J AM CHEM SOC, V124, P2120, DOI 10.1021/ja025503e	19	1101	1127	8	440	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1877	1881		10.1126/science.1080664	http://dx.doi.org/10.1126/science.1080664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649477				2022-12-24	WOS:000181669700041
J	Watkins, DN; Berman, DM; Burkholder, SG; Wang, BL; Beachy, PA; Baylin, SB				Watkins, DN; Berman, DM; Burkholder, SG; Wang, BL; Beachy, PA; Baylin, SB			Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer	NATURE			English	Article							SONIC HEDGEHOG; CYCLOPAMINE; INHIBITION; GROWTH; SHH; MEDULLOBLASTOMA; DIFFERENTIATION; MORPHOGENESIS; CEREBELLUM; MUTANTS	Embryonic signalling pathways regulate progenitor cell fates in mammalian epithelial development and cancer(1,2). Prompted by the requirement for sonic hedgehog (Shh) signalling in lung development(3,4), we investigated a role for this pathway in regeneration and carcinogenesis of airway epithelium. Here we demonstrate extensive activation of the hedgehog (Hh) pathway within the airway epithelium during repair of acute airway injury. This mode of Hh signalling is characterized by the elaboration and reception of the Shh signal within the epithelial compartment, and immediately precedes neuroendocrine differentiation. We reveal a similar pattern of Hh signalling in airway development during normal differentiation of pulmonary neuroendocrine precursor cells, and in a subset of small-cell lung cancer (SCLC), a highly aggressive and frequently lethal human tumour with primitive neuroendocrine features. These tumours maintain their malignant phenotype in vitro and in vivo through ligand-dependent Hh pathway activation. We propose that some types of SCLC might recapitulate a critical, Hh-regulated event in airway epithelial differentiation. This requirement for Hh pathway activation identifies a common lethal malignancy that may respond to pharmacological blockade of the Hh signalling pathway.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Watkins, DN (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.		Watkins, David N/I-6113-2013	berman, david/0000-0001-5985-3698				Bellusci S, 1997, DEVELOPMENT, V124, P53; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hogan B, 1994, MANIPULATING MOUSE E; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Johnson DH, 1999, CHEST, V116, p525S, DOI 10.1378/chest.116.suppl_3.525S; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Lee J, 1997, DEVELOPMENT, V124, P2537; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Nakakura EK, 2001, P NATL ACAD SCI USA, V98, P4010, DOI 10.1073/pnas.051014098; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Park HL, 2000, DEVELOPMENT, V127, P1593; Peake JL, 2000, AM J PATHOL, V156, P279, DOI 10.1016/S0002-9440(10)64728-1; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Weaver M, 1999, DEVELOPMENT, V126, P4005; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	30	877	974	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					313	317		10.1038/nature01493	http://dx.doi.org/10.1038/nature01493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12629553				2022-12-24	WOS:000181637300040
J	Kerner, M; Hohenberg, H; Ertl, S; Reckermann, M; Spitzy, A				Kerner, M; Hohenberg, H; Ertl, S; Reckermann, M; Spitzy, A			Self-organization of dissolved organic matter to micelle-like microparticles in river water	NATURE			English	Article							PARTICLES; COLLOIDS; CARBON; ACID	In aquatic systems, the concept of the 'microbial loop' is invoked to describe the conversion of dissolved organic matter to particulate organic matter by bacteria(1). This process mediates the transfer of energy and matter from dissolved organic matter to higher trophic levels, and therefore controls (together with primary production) the productivity of aquatic systems. Here we report experiments on laboratory incubations of sterile filtered river water in which we find that up to 25% of the dissolved organic carbon (DOC) aggregates abiotically to particles of diameter 0.4-0.8 micrometres, at rates similar to bacterial growth. Diffusion drives aggregation of low- to high-molecular-mass DOC and further to larger micelle-like microparticles. The chemical composition of these microparticles suggests their potential use as food by planktonic bacterivores. This pathway is apparent from differences in the stable carbon isotope compositions of picoplankton and the microparticles. A large fraction of dissolved organic matter might therefore be channelled through microparticles directly to higher trophic levels-bypassing the microbial loop-suggesting that current concepts of carbon conversion in aquatic systems require revision.	Univ Hamburg, Inst Hydrobiol & Fishery Sci, D-22765 Hamburg, Germany; Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; Univ Kiel, Res & Technol Ctr Westcoast, D-25761 Busum, Hafentorn, Germany	University of Hamburg; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University of Kiel	Kerner, M (corresponding author), Univ Hamburg, Inst Hydrobiol & Fishery Sci, Zeiseweg 9, D-22765 Hamburg, Germany.							AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bianchi A, 1996, APPL ENVIRON MICROB, V62, P174, DOI 10.1128/AEM.62.1.174-177.1996; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Ducklow Hugh W., 1993, P261; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; GREENSPAN P, 1985, J LIPID RES, V26, P781; HARRIS JR, 1997, NEGATIVE STAINING CR, P12; Hertkorn N, 2002, J ENVIRON QUAL, V31, P375, DOI 10.2134/jeq2002.0375; HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x; HUBER SA, 1991, ANAL CHEM, V63, P2122, DOI 10.1021/ac00019a011; Hullar MAJ, 1996, APPL ENVIRON MICROB, V62, P2489, DOI 10.1128/AEM.62.7.2489-2493.1996; KEPKAY PE, 1994, MAR ECOL PROG SER, V109, P293, DOI 10.3354/meps109293; Kerner M, 2001, MICROBIAL ECOL, V41, P69; LEPPARD GG, 1995, SCI TOTAL ENVIRON, V165, P103, DOI 10.1016/0048-9697(95)04546-D; Nagata T, 1997, ADV MICROB ECOL, V15, P81; Nanny MA, 2001, ENVIRON SCI TECHNOL, V35, P379, DOI 10.1021/es0012927; Niedergesass R., 1995, WASSERWIRTSCHAFT WAS, V7, P22; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; POLLARD TD, 2002, CELL BIOL, P277; Posch T, 1996, AQUAT MICROB ECOL, V10, P45, DOI 10.3354/ame010045; RAIMBAULT P, 1991, LIMNOL OCEANOGR, V36, P405, DOI 10.4319/lo.1991.36.2.0405; RILEY GA, 1963, LIMNOL OCEANOGR, V8, P372, DOI 10.4319/lo.1963.8.4.0372; Santschi PH, 1998, LIMNOL OCEANOGR, V43, P896, DOI 10.4319/lo.1998.43.5.0896; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Volke F, 1997, CHEM PHYS LIPIDS, V85, P115, DOI 10.1016/S0009-3084(96)02649-7	25	118	127	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					150	154		10.1038/nature01469	http://dx.doi.org/10.1038/nature01469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634782				2022-12-24	WOS:000181488900041
J	Vidal-Madjar, A; des Etangs, AL; Desert, JM; Ballester, GE; Ferlet, R; Hebrand, G; Mayor, M				Vidal-Madjar, A; des Etangs, AL; Desert, JM; Ballester, GE; Ferlet, R; Hebrand, G; Mayor, M			An extended upper atmosphere around the extrasolar planet HD209458b	NATURE			English	Article							LYMAN-ALPHA; 51 PEGASI; SEARCH; TRANSITS	The planet in the system HD209458 is the first one for which repeated transits across the stellar disk have been observed(1,2). Together with radial velocity measurements', this has led to a determination of the planet's radius and mass, confirming it to be a gas giant. But despite numerous searches for an atmospheric signature(4-6), only the dense lower atmosphere of HD209458b has been observed, through the detection of neutral sodium absorption(7). Here we report the detection of atomic hydrogen absorption in the stellar Lyman alpha line during three transits of HD209458b. An absorption of 15 +/- 4% (1sigma) is observed. Comparison with models shows that this absorption should take place beyond the Roche limit and therefore can be understood in terms of escaping hydrogen atoms.	UPMC, CNRS, Inst Astrophys Paris, F-75014 Paris, France; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Observ Geneva, CH-1290 Sauverny, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Arizona; University of Geneva	Vidal-Madjar, A (corresponding author), UPMC, CNRS, Inst Astrophys Paris, 98bis Blvd Arago, F-75014 Paris, France.	alfred@iap.fr	Lecavelier des Etangs, Alain/GLU-6503-2022	Lecavelier des Etangs, Alain/0000-0002-5637-5253				Bundy KA, 2000, PUBL ASTRON SOC PAC, V112, P1421, DOI 10.1086/317706; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; CUMMING A, 2002, ASTROPH0209199; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; Konacki M, 2003, NATURE, V421, P507, DOI 10.1038/nature01379; Lemaire P, 2002, ESA SPEC PUBL, V508, P219; Mazeh T, 2000, ASTROPHYS J, V532, pL55, DOI 10.1086/312558; Moutou C, 2001, ASTRON ASTROPHYS, V371, P260, DOI 10.1051/0004-6361:20010406; PACZYNSKI B, 1971, ANNU REV ASTRON ASTR, V9, P183, DOI 10.1146/annurev.aa.09.090171.001151; PRINZ DK, 1974, ASTROPHYS J, V187, P369, DOI 10.1086/152641; Rauer H, 2000, ASTRON ASTROPHYS, V355, P573; VIDALMADJAR A, 1975, SOL PHYS, V40, P69, DOI 10.1007/BF00183153	13	847	851	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					143	146		10.1038/nature01448	http://dx.doi.org/10.1038/nature01448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634780				2022-12-24	WOS:000181488900039
J	Klein, RG				Klein, RG			Whither the Neanderthals?	SCIENCE			English	Editorial Material							EVOLUTION; DNA		Stanford Univ, Program Human Biol, Stanford, CA 94305 USA	Stanford University	Klein, RG (corresponding author), Stanford Univ, Program Human Biol, Stanford, CA 94305 USA.		Klein, Richard G/B-5910-2009	Klein, Richard/0000-0002-6180-2168				Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Duarte C, 1999, P NATL ACAD SCI USA, V96, P7604, DOI 10.1073/pnas.96.13.7604; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; HUBLIN JJ, 1995, CR ACAD SCI II A, V321, P931; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Klein R. G., 1999, HUMAN CAREER HUMAN B; Mellars P., 1996, NEANDERTHAL LEGACY, DOI [10.1515/9781400843602, DOI 10.1515/9781400843602]; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; SANTALUCA AP, 1978, J HUM EVOL, V7, P619, DOI 10.1016/S0047-2484(78)80047-5; Smith NP, 1999, COMPUT SCI ENG, V1, P96; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Trinkaus E., 1993, NEANDERTALS CHANGING; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685	17	114	117	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1525	1527		10.1126/science.1082025	http://dx.doi.org/10.1126/science.1082025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624250				2022-12-24	WOS:000181367900020
J	Meneghini, MD; Wu, M; Madhani, HD				Meneghini, MD; Wu, M; Madhani, HD			Conserved histone variant H2A.Z protects euchromatin from the ectopic spread of silent heterochromatin	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; GENE-EXPRESSION; ACTIVE GENES; TRANSCRIPTIONAL ACTIVATION; IN-VIVO; YEAST; CHROMATIN; H3; METHYLATION	Boundary elements hinder the spread of heterochromatin, yet these sites do not fully account for the preservation of adjacent euchromatin. Histone variant H2A.Z (Htz1 in yeast) replaces conventional H2A in many nucleosomes. Microarray analysis revealed that HTZ1-activated genes cluster near telomeres. The reduced expression of most of these genes in htz1Delta cells was reversed by the deletion of SIR2 (sir2Delta) suggesting that H2A.Z antagonizes telomeric silencing. Other Htz1-activated genes flank the silent HMR mating-type locus. Their requirement for Htz1 can be bypassed by sir2Delta or by a deletion encompassing the silencing nucleation sites in HMR. In htz1Delta cells, Sir2 and Sir3 spread into flanking euchromatic regions, producing changes in histone H4 acetylation and H3 4-methylation indicative of ectopic heterochromatin formation. Htz1 is enriched in these euchromatic regions and acts synergistically with a boundary element to prevent the spread of heterochromatin. Thus, euchromatin and heterochromatin each contains components that antagonize switching to the opposite chromatin state.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Madhani, Hiten/0000-0001-7400-6657				Abbott DW, 2001, J BIOL CHEM, V276, P41945, DOI 10.1074/jbc.M108217200; ALLIS CD, 1980, CELL, V20, P609, DOI 10.1016/0092-8674(80)90307-4; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fourel G, 2002, BIOESSAYS, V24, P828, DOI 10.1002/bies.10139; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oki M, 2002, CURR OPIN CELL BIOL, V14, P299, DOI 10.1016/S0955-0674(02)00327-7; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1998, GENETICS, V149, P1205; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	53	480	496	1	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					725	736		10.1016/S0092-8674(03)00123-5	http://dx.doi.org/10.1016/S0092-8674(03)00123-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628191	Bronze			2022-12-24	WOS:000181443600014
J	White, AR; Enever, P; Tayebi, M; Mushens, R; Linehan, J; Brandner, S; Anstee, D; Collinge, J; Hawke, S				White, AR; Enever, P; Tayebi, M; Mushens, R; Linehan, J; Brandner, S; Anstee, D; Collinge, J; Hawke, S			Monoclonal antibodies inhibit prion replication and delay the development of prion disease	NATURE			English	Article							FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; SCRAPIE AGENT; INCUBATION PERIOD; MICE LACKING; VARIANT CJD; CONGO RED; PROTEIN; PRP; ACCUMULATION	Prion diseases such as Creutzfeldt-Jakob disease (CJD) are fatal, neuro-degenerative disorders with no known therapy. A proportion of the UK population has been exposed to a bovine spongiform encephalopathy-like prion strain(1-3) and are at risk of developing variant CJD(4). A hallmark of prion disease is the transformation of normal cellular prion protein (PrP(C)) into an infectious disease-associated isoform(5), PrP(Sc). Recent in vitro studies indicate that anti-PrP monoclonal antibodies with little or no affinity for PrP(Sc) can prevent the incorporation of PrP(C) into propagating prions(6,7). We therefore investigated in a murine scrapie model whether anti-PrP monoclonal antibodies show similar inhibitory effects on prion replication in vivo. We found that peripheral PrP(Sc) levels and prion infectivity were markedly reduced, even when the antibodies were first administered at the point of near maximal accumulation of PrP(Sc) in the spleen. Furthermore, animals in which the treatment was continued remained healthy for over 300 days after equivalent untreated animals had succumbed to the disease. These findings indicate that immunotherapeutic strategies for human prion diseases are worth pursuing.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Neurosci & Psychol Med, Dept Neurogenet,CNS Infect & Immun Grp, London W2 1PG, England; Natl Blood Serv, IBGRL, Bristol BS10 5ND, Avon, England; UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	Imperial College London; University of London; University College London; University of London; University College London	Hawke, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Neurosci & Psychol Med, Dept Neurogenet,CNS Infect & Immun Grp, Norfolk Pl, London W2 1PG, England.	s.hawke@imperial.ac.uk	TAYEBI, MOURAD/F-7404-2010; Brandner, Sebastian/J-4562-2014; White, Anthony/P-5596-2016	Brandner, Sebastian/0000-0002-9821-0342; White, Anthony/0000-0003-1802-9891; TAYEBI, MOURAD/0000-0001-8664-6918				ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; AVENT ND, 1988, BIOCHEM J, V256, P1043, DOI 10.1042/bj2561043; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Beringue V, 2000, J VIROL, V74, P5432, DOI 10.1128/JVI.74.12.5432-5440.2000; BERINGUE V, UNPUB BRAIN; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Brown P, 2002, NEUROLOGY, V58, P1720, DOI 10.1212/WNL.58.12.1720; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; MCKENZIE D, 1994, J VIROL, V68, P7534, DOI 10.1128/JVI.68.11.7534-7536.1994; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Souan L, 2001, EUR J IMMUNOL, V31, P2338, DOI 10.1002/1521-4141(200108)31:8&lt;2338::AID-IMMU2338&gt;3.0.CO;2-V; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Westaway D, 2002, TRENDS BIOCHEM SCI, V27, P301, DOI 10.1016/S0968-0004(02)02106-0; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	30	382	410	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					80	83		10.1038/nature01457	http://dx.doi.org/10.1038/nature01457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621436	Green Published			2022-12-24	WOS:000181343100041
J	Baba, H; Aziz, F; Kaifu, Y; Suwa, G; Kono, RT; Jacob, T				Baba, H; Aziz, F; Kaifu, Y; Suwa, G; Kono, RT; Jacob, T			Homo erectus calvarium from the Pleistocene of Java	SCIENCE			English	Article							RELATIVE BRAIN SIZE; CRANIAL VARIATION; ARCHITECTURE; EVOLUTION; REMAINS; SAPIENS; BASE	A Homo erectus calvarium [Sambungmacan 4 (Sm 4)] was recovered from Pleistocene sediments at Sambungmacan in central Java. Micro-computed tomography analysis shows a modern human-like cranial base flexion associated with a low platycephatic vault, implying that the evolution of human cranial globularity was independent of cranial base flexion. The overall morphology of Sm 4 is intermediate between that of earlier and later Javanese Homo erectus; apparent morphological specializations are more strongly expressed in the latter. This supports the hypothesis that later Pleistocene Javanese populations were substantially isolated and made minimal contributions to the ancestry of modern humans.	Museum Nat Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan; Univ Tokyo, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Geol Res & Dev Ctr, Lab Vertebrate Paleontol, Bandung 40122, Indonesia; Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; Gadjah Mada Univ, Lab Bio & Palaeomanthropol, Yogyakarta 55002, Indonesia	University of Tokyo; University of Tokyo; Gadjah Mada University	Baba, H (corresponding author), Museum Nat Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan.	baba@kahaku.go.jp		Kaifu, Yousuke/0000-0003-0483-104X				Anton SC, 2002, AM J PHYS ANTHROPOL, V118, P301, DOI 10.1002/ajpa.10091; Anton SC, 2002, J HUM EVOL, V43, P555, DOI 10.1006/jhev.2002.0577; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; BHAT M, 1985, ANGLE ORTHOD, V55, P269; Bookstein F, 1999, ANAT RECORD, V257, P217, DOI 10.1002/(SICI)1097-0185(19991215)257:6<217::AID-AR7>3.0.CO;2-W; Delson E, 2001, ANAT RECORD, V262, P380, DOI 10.1002/ar.1048; Gathorne-Hardy FJ, 2002, BIOL J LINN SOC, V75, P453, DOI 10.1046/j.1095-8312.2002.00031.x; Hawks J, 2000, J HUM EVOL, V39, P1, DOI 10.1006/jhev.1999.0384; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOLLOWAY R, 1999, HDB HUMAN SYMBOLIC E, P74; Hyodo M, 2002, J HUM EVOL, V43, P27, DOI 10.1006/jhev.2002.0555; Jacob T., 1981, HOMO ERECTUS PAPERS, P87; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Matsu'ura S, 2000, CURR ANTHROPOL, V41, P297, DOI 10.1086/300136; McCarthy RC, 2001, J HUM EVOL, V40, P41, DOI 10.1006/jhev.2000.0446; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; ROSS C, 1995, AM J PHYS ANTHROPOL, V98, P575, DOI 10.1002/ajpa.1330980413; Santa Luca A.P., 1980, NGANDONG FOSSIL HOMI; Seidler H, 1997, J HUM EVOL, V33, P691, DOI 10.1006/jhev.1997.0163; Spoor F, 2000, AM J PHYS ANTHROPOL, P288; Spoor F, 1997, S AFR J SCI, V93, P182; Spoor F, 1999, NATURE, V397, P572, DOI 10.1038/17505; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; van den Bergh G.D., 1996, B INDO PACIFIC PREHI, V14, P7, DOI [10.7152/bippa.v14i0.11583, DOI 10.7152/BIPPA.V14I0.11583]; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Weidenreich F., 1951, ANTHROPOLOGICAL PAPE, V43, P205; Wolpoff M. H., 1999, PALEOANTHROPOLOGY	31	74	78	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1384	1388		10.1126/science.1081676	http://dx.doi.org/10.1126/science.1081676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610302				2022-12-24	WOS:000181192300049
J	Schmitt, JP; Kamisago, M; Asahi, M; Li, GH; Ahmad, F; Mende, U; Kranias, EG; MacLennan, DH; Seidman, JG; Seidman, CE				Schmitt, JP; Kamisago, M; Asahi, M; Li, GH; Ahmad, F; Mende, U; Kranias, EG; MacLennan, DH; Seidman, JG; Seidman, CE			Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban	SCIENCE			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; SARCOPLASMIC-RETICULUM; TRANSGENIC MICE; CALCIUM; CONTRACTILITY; CA2+; PHOSPHORYLATION; CA2+-ATPASES; EXPRESSION; DOMAIN	Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars annually, remain poorly understood. Here we report that an inherited human dilated cardiomyopathy with refractory congestive heart failure is caused by a dominant Arg --> Cys missense mutation at residue 9 (R9C) in phospholamban (PLN), a transmembrane phosphoprotein that inhibits the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase (SERCA2a) pump. Transgenic PLNR9C mice recapitulated human heart failure with premature death. Cellular and biochemical studies revealed that, unlike wild-type PLN, PLNR9C did not directly inhibit SERCA2a. Rather, PLNR9C trapped protein kinase A (PKA), which blocked PKA-mediated phosphorylation of wild-type PLN and in turn delayed decay of calcium transients in myocytes. These results indicate that myocellular calcium dysregulation can initiate human heart failure-a finding that may lead to therapeutic opportunities.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Cincinnati, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Toronto; University System of Ohio; University of Cincinnati	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.		Schmitt, Joachim/GQP-7068-2022	Ahmad, Ferhaan/0000-0003-2877-4641				Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Frank K, 2000, ANN MED, V32, P572, DOI 10.3109/07853890008998837; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kubo H, 2001, CIRCULATION, V104, P1012, DOI 10.1161/hc3401.095073; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Reiken S, 2001, CIRCULATION, V104, P2843, DOI 10.1161/hc4701.099578; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Solaro RJ, 1999, NAT MED, V5, P1353, DOI 10.1038/70916; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; TOYOFUKU T, 1992, J BIOL CHEM, V267, P14490; Zhai J, 2000, J BIOL CHEM, V275, P10538, DOI 10.1074/jbc.275.14.10538; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	22	438	460	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1410	1413		10.1126/science.1081578	http://dx.doi.org/10.1126/science.1081578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610310				2022-12-24	WOS:000181192300057
J	Hannonen, M; Sundstrom, L				Hannonen, M; Sundstrom, L			Sociobiology - Worker nepotism among polygynous ants	NATURE			English	Editorial Material							REPRODUCTIVE-SKEW; EVOLUTION; INSECT		Univ Helsinki, Dept Systemat & Ecol, FIN-00014 Helsinki, Finland	University of Helsinki	Hannonen, M (corresponding author), Univ Helsinki, Dept Systemat & Ecol, POB 65, FIN-00014 Helsinki, Finland.	liselotte.sundstrom@helsinki.fi	Sundstrom, Liselotte/G-5080-2010	Sundstrom, Liselotte/0000-0002-6176-8940				COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hannonen M, 2002, ETHOLOGY, V108, P961, DOI 10.1046/j.1439-0310.2002.00829.x; KELLER L, 1993, SCIENCE, V260, P1107, DOI 10.1126/science.260.5111.1107; Keller L, 1999, MG BEH ECOL, P153; PAGE RE, 1989, NATURE, V338, P576, DOI 10.1038/338576a0; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Sundstrom L, 2001, HEREDITY, V86, P515, DOI 10.1046/j.1365-2540.2001.00884.x; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197	10	73	75	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					910	910		10.1038/421910a	http://dx.doi.org/10.1038/421910a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606988				2022-12-24	WOS:000181186900036
J	Hamm, CE; Merkel, R; Springer, O; Jurkojc, P; Maier, C; Prechtel, K; Smetacek V				Hamm, CE; Merkel, R; Springer, O; Jurkojc, P; Maier, C; Prechtel, K; Smetacek, V			Architecture and material properties of diatom shells provide effective mechanical protection	NATURE			English	Article							ZOOPLANKTON; MORPHOLOGY; FRUSTULE; SILICA; CYCLE; BONE	Diatoms are the major contributors to phytoplankton blooms in lakes and in the sea and hence are central in aquatic ecosystems and the global carbon cycle(1). All free-living diatoms differ from other phytoplankton groups in having silicified cell walls in the form of two 'shells' (the frustule) of manifold shape and intricate architecture(2) whose function and role, if any, in contributing to the evolutionary success of diatoms is under debate(3-5). We explored the defence potential of the frustules as armour against predators by measuring their strength. Real and virtual loading tests (using calibrated glass microneedles and finite element analysis) were performed on centric and pennate diatom cells. Here we show that the frustules are remarkably strong by virtue of their architecture and the material properties of the diatom silica. We conclude that diatom frustules have evolved as mechanical protection for the cells because exceptional force is required to break them. The evolutionary arms race between diatoms and their specialized predators will have had considerable influence in structuring pelagic food webs and biogeochemical cycles.	Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Tech Univ Munich, Dept Phys, Biophys Grp E22, D-85748 Garching, Germany; Forschungszentrum Julich, Res Ctr, Inst Thin Films & Interfaces, D-52425 Julich, Germany; Hsch bramen Univ Appl Sci, D-28199 Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Technical University of Munich; Helmholtz Association; Research Center Julich; Bremen University of Applied Sciences	Hamm, CE (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.	chamm@awi-bremerhaven.de	Merkel, Rudolf/G-3647-2013	Merkel, Rudolf/0000-0003-3178-3282; Hamm, Christian/0000-0002-5121-9542				ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0; ATKINSON A, 1995, ICES J MAR SCI, V52, P385, DOI 10.1016/1054-3139(95)80054-9; BURKHARDT B, 1984, DIATOMS 1 SHELLS NAT; Cifuentes AO, 1992, FINITE ELEM ANAL DES, V12, P313; Crawford SA, 2001, J PHYCOL, V37, P543, DOI 10.1046/j.1529-8817.2001.037004543.x; Ehrenberg CG., 1838, INFUSIONSTHIERCHEN A, DOI [10.5962/bhl.title.58475, DOI 10.5962/BHL.TITLE.58475]; Fortin D., 2000, J AM DENT ASSOC, V131, p26S, DOI DOI 10.14219/JADA.ARCHIVE.2000.0399; FOWLER SW, 1983, DEEP-SEA RES, V30, P963, DOI 10.1016/0198-0149(83)90051-1; Gersonde R, 1990, PROC OCEAN DRILL SCI, P365, DOI DOI 10.2973/0DP.PR0C.SR.113.127.1990; HAECKEL Ernst, 2004, KUNSTFORMEN NATUR; Hale MS, 2001, AQUAT MICROB ECOL, V24, P287, DOI 10.3354/ame024287; Jacobson DM, 1999, J EUKARYOT MICROBIOL, V46, P376, DOI 10.1111/j.1550-7408.1999.tb04616.x; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; Round F.E., 1990, DIATOMS BIOL MORPHOL, P747, DOI 10.1017/S0025315400059245; Round F. E., 1972, NOVA HEDWIGIA, V23, P291; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; SMETACEK V, 1981, MAR BIOL, V63, P1, DOI 10.1007/BF00394657; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; STEUCEK G, 1989, BEITR 1 INT S SOND 2, P194; Suh HL, 1996, HYDROBIOLOGIA, V321, P235, DOI 10.1007/BF00143753; SULLIVAN BK, 1975, MAR BIOL, V30, P175, DOI 10.1007/BF00391591; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; TILMAN D, 1976, LIMNOL OCEANOGR, V21, P409; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Weis-Fogh T., 1977, SCALE EFFECTS ANIMAL, P511; WILLEMS G, 1992, DENT MATER, V8, P310, DOI 10.1016/0109-5641(92)90106-M	27	634	661	10	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					841	843		10.1038/nature01416	http://dx.doi.org/10.1038/nature01416			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594512	Green Published			2022-12-24	WOS:000181044700047
J	Ramsay, ME; Andrews, NJ; Trotter, CL; Kaczmarski, EB; Miller, E				Ramsay, ME; Andrews, NJ; Trotter, CL; Kaczmarski, EB; Miller, E			Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis	BRITISH MEDICAL JOURNAL			English	Article									Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Manchester Publ Hlth Lab, Meningococcal Reference Unit, Publ Hlth Lab Serv, Manchester M20 2LR, Lancs, England	Public Health England	Ramsay, ME (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.		Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	Trotter, Caroline/0000-0003-4000-2708; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Trotter C L, 2002, Commun Dis Public Health, V5, P220; Trotter CL, 2002, BRIT MED J, V324, P809, DOI 10.1136/bmj.324.7341.809	5	306	320	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					365	366		10.1136/bmj.326.7385.365	http://dx.doi.org/10.1136/bmj.326.7385.365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586669	Bronze, Green Published			2022-12-24	WOS:000181165500019
J	Piperno, DR; Stothert, KE				Piperno, DR; Stothert, KE			Phytolith evidence for early Holocene Cucurbita domestication in Southwest Ecuador	SCIENCE			English	Article								Cucurbita (squash and gourd) phytoliths recovered from two early Holocene archaeological sites in southwestern Ecuador and directly dated to 10,130 to 9320 carbon-14 years before the present (about 12,000 to 10,000 calendar years ago) are identified as derived from domesticated plants because they are considerably larger than those from modern wild taxa. The beginnings of plant husbandry appear to have been preceded by the exploitation of a wild species of Cucurbita during the terminal Pleistocene. These data provide evidence for an independent emergence of plant food production in lowland South America that was contemporaneous with or slightly before that in highland Mesoamerica.	Univ Texas, Ctr Archaeol Res, San Antonio, TX 78249 USA; Smithsonian Trop Res Inst, Balboa, Panama	University of Texas System; Smithsonian Institution; Smithsonian Tropical Research Institute	Piperno, DR (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.							Andres T. C, 2002, CUCURBITACEAE 2002, P95; BOZARTH SR, 1987, AM ANTIQUITY, V52, P607, DOI 10.2307/281602; Flannery K., 1986, GUILA NAQUITZ ARCHAI; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; LATHRAP DW, 1975, ANCIENT ECUADOR CULT; NEE M, 1990, ECON BOT, V44, P56, DOI 10.1007/BF02860475; PEARSALL DM, 1996, DUMB OAKS C EC FORM, P213; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 2000, J ARCHAEOL SCI, V27, P193, DOI 10.1006/jasc.1999.0443; Piperno DR, 2002, P NATL ACAD SCI USA, V99, P10923, DOI 10.1073/pnas.152275499; Sanjur OI, 2002, P NATL ACAD SCI USA, V99, P535, DOI 10.1073/pnas.012577299; Sauer Carl O., 1952, AGR ORIGINS DISPERSA; Smith BD, 1997, SCIENCE, V276, P932, DOI 10.1126/science.276.5314.932; STOTHERT KE, 1985, AM ANTIQUITY, V50, P613, DOI 10.2307/280325; STOTHERT KE, IN PRESS QUAT INT	16	156	173	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1054	1057		10.1126/science.1080365	http://dx.doi.org/10.1126/science.1080365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	645DB	12586940				2022-12-24	WOS:000180960000044
J	Etienne-Manneville, S; Hall, A				Etienne-Manneville, S; Hall, A			Cdc42 regulates GSK-3 beta and adenomatous polyposis coli to control cell polarity	NATURE			English	Article							BETA-CATENIN; XENOPUS EMBRYOS; PROTEIN EB1; C-ELEGANS; KINASE; PHOSPHORYLATION; MICROTUBULES; COMPLEX; BINDING; ACTIVATION	Cell polarity is a fundamental property of all cells. In higher eukaryotes, the small GTPase Cdc42, acting through a Par6-atypical protein kinase C (aPKC) complex, is required to establish cellular asymmetry during epithelial morphogenesis, asymmetric cell division and directed cell migration(1-5). However, little is known about what lies downstream of this complex. Here we show, through the use of primary rat astrocytes in a cell migration assay, that Par6-PKCzeta interacts directly with and regulates glycogen synthase kinase-3beta (GSK-3beta) to promote polarization of the centrosome and to control the direction of cell protrusion. Cdc42-dependent phosphorylation of GSK-3beta induces the interaction of adenomatous polyposis coli (Apc) protein with the plus ends of microtubules. The association of Apc with microtubules is essential for cell polarization. We conclude that Cdc42 regulates cell polarity through the spatial regulation of GSK-3beta and Apc. This role for Apc may contribute to its tumour-suppressor activity. occurs specifically at the leading edge of migrating cells, and	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Canc Res UK Oncogene & Signal Transduct Grp, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675				Barth AIM, 2002, J CELL SCI, V115, P1583; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Emily-Fenouil F, 1998, DEVELOPMENT, V125, P2489; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ferkey DM, 2000, DEV BIOL, V225, P471, DOI 10.1006/dbio.2000.9816; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Lucas FR, 1998, J CELL SCI, V111, P1351; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Oriente F, 2001, J BIOL CHEM, V276, P37109, DOI 10.1074/jbc.M104405200; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SU LK, 1995, CANCER RES, V55, P2972; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Wagner U, 1996, J CELL SCI, V109, P1537; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	28	682	706	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					753	756		10.1038/nature01423	http://dx.doi.org/10.1038/nature01423			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610628				2022-12-24	WOS:000180938000046
J	Young, B; Dixon-Woods, M; Windridge, KC; Heney, D				Young, B; Dixon-Woods, M; Windridge, KC; Heney, D			Managing communication with young people who have a potentially life threatening chronic illness: qualitative study of patients and parents	BRITISH MEDICAL JOURNAL			English	Article							CANCER-PATIENTS; INFORMATION; CHILDREN; PREFERENCES; INTERVIEW	Objectives To examine young people's and parents' accounts of communication about cancer in childhood. Design Semistructured interviews analysed using the constant comparative method. Setting Paediatric oncology unit. Participants 13 families, comprising 19 parents (13 mothers, six fathers) and 13 patients aged 8-17 years. The patients had cancer or brain tumour. Results Most parents described acting in an executive-like capacity, managing what and how their children were told about their illness, particularly at the time of diagnosis. Their accounts were shaped by concerns to manage their identity as strong and optimistic parents and to protect their child's wellbeing. The patients identified elements of their parents' role that both facilitated and constrained their communication, and while they welcomed their parents' involvement, some expressed unease with the constraining aspects of their parents' role. Some young people described feeling marginalised in consultations and pointed to difficulties they experienced in encounters with some doctors. Conclusions There are difficulties in managing communication with young people who have a chronic, life threatening illness. Health professionals need to be aware of how the social positioning of young people (relative to adults) and the executive role of parents can contribute to the marginalisation of young people and hamper the development of successful relationships between themselves and young patients.	Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England; Leicester Royal Infirm, Childrens Hosp, Leicester LE1 5WW, Leics, England	University of Hull; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester	Young, B (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.		Young, Bridget/A-2184-2014	Dixon-Woods, Mary/0000-0002-5915-0041; Young, Bridget/0000-0001-6041-9901				Alderson P., 1993, CHILDRENS CONSENT SU; Barnes J, 2000, BRIT MED J, V321, P479, DOI 10.1136/bmj.321.7259.479; BLUEBONDLANGNER.M, 1978, PRIVATE WORLDS DYING; British Medical Association, 2001, CONS RIGHTS CHOIC HL; CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; CLAFLIN CJ, 1991, J PEDIATR PSYCHOL, V16, P169, DOI 10.1093/jpepsy/16.2.169; DAVIS A, 1982, CHILDREN CLIN; Dixon-Woods M, 1999, BRIT MED J, V319, P778, DOI 10.1136/bmj.319.7212.778; FALLOWFIELD L, 1995, PSYCHO-ONCOLOGY, V4, P197, DOI 10.1002/pon.2960040305; GAHAN C, 1998, DOING QUALITATIVE AN; Glaser B. G., 1978, AWARENESS DYING; Goffman Erving, 2002, PRESENTATION SELF EV; Green J, 1998, BMJ-BRIT MED J, V316, P1064; James A., 1990, CONSTRUCTING RECONST; JAMES N, 1989, SOV REV, V37, P118; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Mayall Berry., 1996, CHILDREN HLTH SOCIAL; SCOTT JT, 2002, COCHRANE LIB; STEWART TJ, 1981, J FAM PRACTICE, V13, P827; STRONG PM, 1979, CEREMONIAL ORDER CLI; Tates K, 2001, SOC SCI MED, V52, P839, DOI 10.1016/S0277-9536(00)00193-3; TIMMERMANS S, 1994, SOCIOL HEALTH ILL, V16, P322, DOI 10.1111/1467-9566.ep11348751; van Dulmen AM, 1998, PEDIATRICS, V102, P563, DOI 10.1542/peds.102.3.563	23	173	176	1	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					305	308B		10.1136/bmj.326.7384.305	http://dx.doi.org/10.1136/bmj.326.7384.305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645UD	12574042	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000180997000016
J	Deres, K; Schroder, CH; Paessens, A; Goldmann, S; Hacker, HJ; Weber, O; Kramer, T; Niewohner, U; Pleiss, U; Stoltefuss, J; Graef, E; Koletzki, D; Masantschek, RNA; Reimann, A; Jaeger, R; Gross, R; Beckermann, B; Schlemmer, KH; Haebich, D; Rubsamen-Waigmann, H				Deres, K; Schroder, CH; Paessens, A; Goldmann, S; Hacker, HJ; Weber, O; Kramer, T; Niewohner, U; Pleiss, U; Stoltefuss, J; Graef, E; Koletzki, D; Masantschek, RNA; Reimann, A; Jaeger, R; Gross, R; Beckermann, B; Schlemmer, KH; Haebich, D; Rubsamen-Waigmann, H			Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids	SCIENCE			English	Article							DNA-SYNTHESIS	Chronic hepatitis B virus (HBV) infection is a major cause of liver disease. Only interferon-alpha and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy. However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors. Potent new antiviral compounds suitable for monotherapy or combination therapy are highly desired. We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity. These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.	Bayer Res Ctr, Dept Virol, Wuppertal, Germany; Bayer Res Ctr, Chem, Wuppertal, Germany; Bayer Res Ctr, Isotope Chem, Wuppertal, Germany; Bayer Res Ctr, Preclin Pharmakokinet, Wuppertal, Germany; Bayer Res Ctr, Toxicol, Wuppertal, Germany; Bayer Res Ctr, Safety Pharmacol, Wuppertal, Germany; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; Bayer Corp, Div Pharmaceut, West Haven, CT 06516 USA	Bayer AG; Bayer AG; Bayer AG; Bayer AG; Bayer AG; Bayer AG; Helmholtz Association; German Cancer Research Center (DKFZ); Bayer AG	Deres, K (corresponding author), Bayer Res Ctr, Dept Virol, Wuppertal, Germany.							Delaney WE, 2001, ANTIVIR CHEM CHEMOTH, V12, P1; Deres K, 1999, INFECTION, V27, pS45, DOI 10.1007/BF02561672; Doyle ML, 1997, CURR OPIN BIOTECH, V8, P31, DOI 10.1016/S0958-1669(97)80154-1; Fischer KR, 2001, DRUG RESIST UPDATE, V4, P118, DOI 10.1054/drup.2001.0190; King RW, 1998, ANTIMICROB AGENTS CH, V42, P3179, DOI 10.1128/AAC.42.12.3179; LAMBERTS C, 1993, J VIROL, V67, P3756, DOI 10.1128/JVI.67.7.3756-3762.1993; Nassal M, 1996, CURR TOP MICROBIOL, V214, P297; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9	10	417	486	7	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					893	896		10.1126/science.1077215	http://dx.doi.org/10.1126/science.1077215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574631				2022-12-24	WOS:000180830900053
J	Pi-Sunyer, X				Pi-Sunyer, X			A clinical view of the obesity problem	SCIENCE			English	Editorial Material							WEIGHT-LOSS; LONG-TERM; MAINTENANCE		Columbia Univ, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West	Pi-Sunyer, X (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA.							KEYS A, 1950, BIOL HUMAN STARVATIO, P827; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Klem ML, 1997, AM J CLIN NUTR, V66, P239, DOI 10.1093/ajcn/66.2.239; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; PiSunyer FX, 1996, CLIN THER, V18, P1006, DOI 10.1016/S0149-2918(96)80057-9; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; PISUNYER FX, 1993, ANN INTERN MED, V119, P722, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00019; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WADDEN TA, 1994, J CONSULT CLIN PSYCH, V62, P165, DOI 10.1037/0022-006X.62.1.165; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Wing R. R., 1998, HDB OBESITY, P855; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	13	85	91	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					859	860		10.1126/science.1082319	http://dx.doi.org/10.1126/science.1082319			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574620				2022-12-24	WOS:000180830900041
J	Qaim, M; Zilberman, D				Qaim, M; Zilberman, D			Yield effects of genetically modified crops in developing countries	SCIENCE			English	Article								Onfarm field trials carried out with Bacillus thuringiensis (Bt) cotton in different states of India show that the technology substantially reduces pest damage and increases yields. The yield gains are much higher than what has been reported for other countries where genetically modified crops were used mostly to replace and enhance chemical pest control. In many developing countries, small-scale farmers especially suffer big pest-related yield losses because of technical and economic constraints. Pest-resistant genetically modified crops can contribute to increased yields and agricultural growth in those situations, as the case of Bt cotton in India demonstrates.	Univ Bonn, Ctr Dev Res, D-53113 Bonn, Germany; Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA	University of Bonn; University of California System; University of California Berkeley	Qaim, M (corresponding author), Univ Bonn, Ctr Dev Res, Walter Flex Str 3, D-53113 Bonn, Germany.	mqaim@uni-bonn.de	Qaim, Matin/P-4489-2016	Qaim, Matin/0000-0003-4143-0763				ALTIERI MA, 2001, 1 FOOD 1; Carpenter J, 2002, COMP ENV IMPACTS BIO; Committee on the Future Role of Pesticides in U.S. Agriculture, 2000, FUT ROL PEST US AGR; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 1999, J ECON ENTOMOL, V92, P1377, DOI 10.1093/jee/92.6.1377; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; *IND COUNC AGR RES, 2002, ALL IND COORD COTT I, P97; *ISAAA, 2002, BT COTT IND; *ISCI, 1999, HDB COTTON IND; ISMAEL Y, 2002, AGBIOFORUM, V5, P4; Jayaraman KS, 2002, NAT BIOTECHNOL, V20, P415, DOI 10.1038/nbt0502-415; Lauer J, 1999, J PROD AGRIC, V12, P373, DOI 10.2134/jpa1999.0373; Moffat AS, 1999, SCIENCE, V285, P370, DOI 10.1126/science.285.5426.370; Oerke EC., 1994, CROP PRODUCTION CROP; Paarlberg RobertL., 2001, POLITICS PRECAUTION; PINSTRUPANDERSE.P, 2001, SEEDS CONTENTION WOR; Pray CE, 2002, PLANT J, V31, P423, DOI 10.1046/j.1365-313X.2002.01401.x; Puri S.N., 1999, HDB COTTON INDIA, P233; QAIM M, 2002, 6 INT C INT CONS AGR; Qaim M., 2000, AGR BIOTECHNOLOGY DE; RUTTAN VW, 1999, AGBIOFORUM, V2, P54; *UK SOIL ASS, 2002, SEEDS DOUBT N AM FAR, P11; WIDAWSKY D, 1998, AGR EC, V19, P205; WOSSINK GAA, 1998, EC AGROCHEMICALS INT; ZILBERMAN D, 1991, SCIENCE, V253, P518, DOI 10.1126/science.253.5019.518	25	376	417	1	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					900	902		10.1126/science.1080609	http://dx.doi.org/10.1126/science.1080609			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574633				2022-12-24	WOS:000180830900055
J	Rich, P				Rich, P			The cost of living	NATURE			English	Editorial Material									UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London	Rich, P (corresponding author), UCL, Dept Biol, Gower St, London WC1E 6BT, England.							Gilbert G.N., 1984, OPENING PANDORAS BOX; Kiberstis PA, 1999, SCIENCE, V283, P1475; PREBBLE J, 2003, WANDERING GARDENS MI; 1997, CATALOGUE PAPERS COR	4	78	80	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					583	583		10.1038/421583a	http://dx.doi.org/10.1038/421583a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571574	Bronze			2022-12-24	WOS:000180803200021
J	Xiao, B; Jing, C; Wilson, JR; Walker, PA; Vasisht, N; Kelly, G; Howell, S; Taylor, IA; Blackburn, GM; Gamblin, SJ				Xiao, B; Jing, C; Wilson, JR; Walker, PA; Vasisht, N; Kelly, G; Howell, S; Taylor, IA; Blackburn, GM; Gamblin, SJ			Structure and catalytic mechanism of the human histone methyltransferase SET7/9	NATURE			English	Article							CHROMATIN-STRUCTURE; DOMAIN; METHYLATION; ACETYLATION; SITE	Acetylation(1,2), phosphorylation(3) and methylation(4) of the amino-terminal tails of histones are thought to be involved in the regulation of chromatin structure and function(5-7). With just one exception(8,9), the enzymes identified in the methylation of specific lysine residues on histones (histone methyltransferases) belong to the SET family(10). The high-resolution crystal structure of a ternary complex of human SET7/9 with a histone peptide and cofactor reveals that the peptide substrate and cofactor bind on opposite surfaces of the enzyme. The target lysine accesses the active site of the enzyme and the S-adenosyl-L-methionine (AdoMet) cofactor by inserting its side chain into a narrow channel that runs through the enzyme, connecting the two surfaces. Here we show from the structure and from solution studies that SET7/9, unlike most other SET proteins, is exclusively a mono-methylase. The structure indicates the molecular basis of the specificity of the enzyme for the histone target, and allows us to propose a model for the methylation reaction that accounts for the role of many of the residues that are invariant across the SET family.	Natl Inst Med Res, Struct Biol Grp, London NW7 1AA, England; Univ Sheffield, Dept Chem, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England	MRC National Institute for Medical Research; University of Sheffield	Gamblin, SJ (corresponding author), Natl Inst Med Res, Struct Biol Grp, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk	Wilson, Jon R/B-7362-2019	Wilson, Jon R/0000-0002-5157-5432; Gamblin, Steve/0000-0001-5331-639X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Spotswood HT, 2002, J CLIN INVEST, V110, P577, DOI 10.1172/JCI200216547; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	20	299	310	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					652	656		10.1038/nature01378	http://dx.doi.org/10.1038/nature01378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12540855	Green Accepted			2022-12-24	WOS:000180803200047
J	Forster, AJ; Murff, HJ; Peterson, JF; Gandhi, TK; Bates, DW				Forster, AJ; Murff, HJ; Peterson, JF; Gandhi, TK; Bates, DW			The incidence and severity of adverse events affecting patients after discharge from the hospital	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG EVENTS; CARE; PREVENTABILITY; INFECTIONS; QUALITY	Background: Studies of hospitalized patients identify safety as a significant problem, but few data are available regarding injuries occurring after discharge. Patients may be vulnerable during this transition period. Objective: To describe the incidence, severity, preventability, and "ameliorability" of adverse events affecting patients after discharge from the hospital and to develop strategies for improving patient safety during this interval. Design: Prospective cohort study. Setting: A tertiary care academic hospital. Patients: 400 consecutive patients discharged home from the general medical service. Measurements: The three main outcomes were adverse events, defined as injuries occurring as a result of medical management; preventable adverse events, defined as adverse events judged to have been caused by an error; and ameliorable adverse events, defined as adverse events whose severity could have been decreased. Posthospital course was determined by performing a medical record review and a structured telephone interview approximately 3 weeks after each patient's discharge. Outcomes were determined by independent physician reviews. Results: Seventy-six patients had adverse events after discharge (19% [95% Cl, 15% to 23%]). Of these, 23 had preventable adverse events (6% [Cl, 4% to 9%]) and 24 held ameliorable adverse events (6% [Cl, 4% to 9%]). Three percent of injuries were serious laboratory abnormalities, 65% were symptoms, 30% were symptoms associated with a nonpermanent disability, and 3% were permanent disabilities. Adverse drug events were the most common type of adverse event (66% [Cl, 55% to 76%]), followed by procedure-related injuries (17% [Cl, 86% to 26%]). Of the 25 adverse events resulting in at least a nonpermanent disability, 12 were preventable (48% [Cl, 28% to 68%]) and 6 were ameliorable (24% [Cl, 7% to 41%]). Conclusion: Adverse events occurred frequently in the peridischarge period, and many could potentially have been prevented or ameliorated with simple strategies.	Univ Ottawa, Ottawa, ON K1N 6N5, Canada; Harvard Univ, Sch Med, Boston, MA USA	University of Ottawa; Harvard University; Harvard Medical School	Bates, DW (corresponding author), Brigham & Womens Hosp, Div Gen Med, 75 Francis St,PBB-A3, Boston, MA 02115 USA.	dbates@partners.org	Bates, David/AAE-7283-2019					BATES DW, 1993, J GEN INTERN MED, V8, P289, DOI 10.1007/BF02600138; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; CAPLAN RA, 1991, JAMA-J AM MED ASSOC, V265, P1957, DOI 10.1001/jama.265.15.1957; Cook RI, 2000, BRIT MED J, V320, P791, DOI 10.1136/bmj.320.7237.791; Delgado-Rodriguez M, 2001, INFECT CONT HOSP EP, V22, P24, DOI 10.1086/501820; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; *I MED, 2000, ERR HUM BUILD SAF HL; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kelley MA, 1999, ANN INTERN MED, V130, P373, DOI 10.7326/0003-4819-130-4-199902161-00009; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Mitchell DH, 1999, AUST NZ J SURG, V69, P117, DOI 10.1046/j.1440-1622.1999.01500.x; PARKES J, 2000, COCHRANE DATABASE SY; SANAZARO PJ, 1991, JAMA-J AM MED ASSOC, V265, P1977, DOI 10.1001/jama.265.15.1977; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003	18	1203	1226	1	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					161	167		10.7326/0003-4819-138-3-200302040-00007	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558354				2022-12-24	WOS:000181018600001
J	Hammarstrom, P; Wiseman, RL; Powers, ET; Kelly, JW				Hammarstrom, P; Wiseman, RL; Powers, ET; Kelly, JW			Prevention of transthyretin amyloid disease by changing protein misfolding energetics	SCIENCE			English	Article							ALZHEIMERS-DISEASE; FIBRIL FORMATION; INHIBITORS	Genetic evidence suggests that inhibition of amyloid fibril formation by small molecules should be effective against amyloid diseases. Known amyloid inhibitors appear to function by shifting the aggregation equilibrium away from the amyloid state. Here, we describe a series of transthyretin amyloidosis inhibitors that functioned by increasing the kinetic barrier associated with misfolding, preventing amyloidogenesis by stabilizing the native state. The trans-suppressor mutation, threonine 119 --> methionine 119, which is known to ameliorate familial amyloid disease, also functioned through kinetic stabilization, implying that this small-molecule strategy should be effective in treating amyloid diseases.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jkelly@scripps.edu		Powers, Evan/0000-0001-8185-8487	NIDDK NIH HHS [DK 46335] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046335, R37DK046335, R01DK046335] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Coehlo T., 1996, NEUROMUSCUL DISORD, V6, P27; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Jacobson D R, 1991, Adv Hum Genet, V20, P69; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Peterson SA, 1998, P NATL ACAD SCI USA, V95, P12956, DOI 10.1073/pnas.95.22.12956; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; PURKEY HE, UNPUB; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; SCHLOSS JV, 1988, ACCOUNTS CHEM RES, V21, P348, DOI 10.1021/ar00153a005; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	28	416	430	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					713	716		10.1126/science.1079589	http://dx.doi.org/10.1126/science.1079589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560553				2022-12-24	WOS:000180687700049
J	Yankovskaya, V; Horsefield, R; Tornroth, S; Luna-Chavez, C; Miyoshi, H; Leger, C; Byrne, B; Cecchini, G; Iwata, S				Yankovskaya, V; Horsefield, R; Tornroth, S; Luna-Chavez, C; Miyoshi, H; Leger, C; Byrne, B; Cecchini, G; Iwata, S			Architecture of succinate dehydrogenase and reactive oxygen species generation	SCIENCE			English	Article							COLI FUMARATE REDUCTASE; QUINONE BINDING-SITES; ESCHERICHIA-COLI; COMPLEX-II; HEREDITARY PARAGANGLIOMA; RESPIRATORY-CHAIN; 2FE-2S CLUSTER; MUTATIONS; GENE; REPLACEMENT	The structure of Escherichia coli succinate dehydrogenase (SQR), analogous to the mitochondrial respiratory complex II, has been determined, revealing the electron transport pathway from the electron donor, succinate, to the terminal electron acceptor, ubiquinone. It was found that the SQR redox centers are arranged in a manner that aids the prevention of reactive oxygen species (ROS) formation at the flavin adenine dinucleotide. This is likely to be the main reason SQR is expressed during aerobic respiration rather than the related enzyme fumarate reductase, which produces high levels of ROS. Furthermore, symptoms of genetic disorders associated with mitochondrial SQR mutations may be a result of ROS formation resulting from impaired electron transport in the enzyme.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; Uppsala Univ, Dept Biochem, S-75123 Uppsala, Sweden; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England	Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Uppsala University; University of California System; University of California San Francisco; Kyoto University; University of Oxford; Imperial College London	Cecchini, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England.	ceccini@itsa.ucsf.edu; s.iwata@ic.ac.uk	Törnroth-Horsefield, Susanna/B-2702-2010; Léger, Christophe/C-7230-2016; Horsefield, Rob/B-1378-2010	Léger, Christophe/0000-0002-8871-6059; Tornroth-Horsefield, Susanna/0000-0002-9435-8243; Byrne, Bernadette/0000-0001-9598-9832	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61606] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; Hagen WR, 2000, J BIOL INORG CHEM, V5, P527, DOI 10.1007/s007750050013; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; Hederstedt L, 1999, SCIENCE, V284, P1941, DOI 10.1126/science.284.5422.1941; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Kita K, 2002, BBA-BIOENERGETICS, V1553, P123, DOI 10.1016/S0005-2728(01)00237-7; KROGER A, 1992, ARCH MICROBIOL, V158, P311, DOI 10.1007/BF00245358; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6; RUZICKA FJ, 1975, P NATL ACAD SCI USA, V72, P2886, DOI 10.1073/pnas.72.8.2886; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; WERTH MT, 1992, FEBS LETT, V299, P1, DOI 10.1016/0014-5793(92)80086-V; Yankovskaya V, 1996, J BIOL CHEM, V271, P21020, DOI 10.1074/jbc.271.35.21020; YU L, 1987, J BIOL CHEM, V262, P1137	31	652	686	19	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					700	704		10.1126/science.1079605	http://dx.doi.org/10.1126/science.1079605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560550				2022-12-24	WOS:000180687700045
J	Orlicky, S; Tang, XJ; Willems, A; Tyers, M; Sicheri, F				Orlicky, S; Tang, XJ; Willems, A; Tyers, M; Sicheri, F			Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase	CELL			English	Article							CYCLIN-E; MULTISITE PHOSPHORYLATION; PROTEOLYSIS; COMPLEX; DEGRADATION; PROTEINS; INSIGHTS; RECOGNITION; TARGETS; NOTCH	Cell cycle progression depends on precise elimination of cyclins and cyclin-dependent kinase (CDK) inhibitors by the ubiquitin system. Elimination of the CDK inhibitor Sic1 by the SCFCdc4 ubiquitin ligase at the onset of S phase requires phosphorylation of Sic1 on at least six of its nine Cdc4-phosphodegron (CPD) sites. A 2.7 Angstrom X-ray crystal structure of a Skp1-Cdc4 complex bound to a high-affinity CPD phosphopeptide from human cyclin E reveals a core CPD motif, Leu-Leu-pThr-Pro, bound to an eight-bladed WD40 propeller domain in Cdc4. The low affinity of each CPD motif in Sic1 reflects structural discordance with one or more elements of the Cdc4 binding site. Reengineering of Cdc4 to reduce selection against Sic1 sequences allows ubiquitination of lower phosphorylated forms of Sic1. These features account for the observed phosphorylation threshold in Sic1 recognition and suggest an equilibrium binding mode between a single receptor site in Cdc4 and multiple low-affinity CPD sites in Sic1.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Tyers, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	tyers@mshri.on.ca; sicheri@mshri.on.ca	Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021	Orlicky, Stephen/0000-0002-8172-2042				Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Harper JW, 2001, CURR BIOL, V11, pR431, DOI 10.1016/S0960-9822(01)00253-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck CH, 2002, CANCER RES, V62, P4535; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	418	427	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					243	256		10.1016/S0092-8674(03)00034-5	http://dx.doi.org/10.1016/S0092-8674(03)00034-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553912	Bronze			2022-12-24	WOS:000181191600013
J	Gupta, AK; Anderson, DM; Overpeck, JT				Gupta, AK; Anderson, DM; Overpeck, JT			Abrupt changes in the Asian southwest monsoon during the Holocene and their links to the North Atlantic Ocean	NATURE			English	Article							LATE QUATERNARY; ARABIAN-SEA; SUMMER MONSOON; CLIMATE; VARIABILITY; RECORD; OMAN; FORAMINIFERA; GREENLAND; SURFACE	During the last ice age, the Indian Ocean southwest monsoon exhibited abrupt changes that were closely correlated with millennial-scale climate events in the North Atlantic region(1-3), suggesting a mechanistic link. In the Holocene epoch, which had a more stable climate, the amplitude of abrupt changes in North Atlantic climate was much smaller, and it has been unclear whether these changes are related to monsoon variability. Here we present a continuous record of centennial-scale monsoon variability throughout the Holocene from rapidly accumulating and minimally bioturbated sediments in the anoxic Arabian Sea. Our monsoon proxy record reveals several intervals of weak summer monsoon that coincide with cold periods documented in the North Atlantic region(4)-including the most recent climate changes from the Medieval Warm Period to the Little Ice Age and then to the present. We therefore suggest that the link between North Atlantic climate and the Asian monsoon is a persistent aspect of global climate.	Indian Inst Technol, Dept Geol & Geophys, Kharagpur 721302, W Bengal, India; NOAA, Paleoclimatol Program, Boulder, CO 80305 USA; Univ Arizona, Ctr Study Planet Earth, Tucson, AZ 85721 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; National Oceanic Atmospheric Admin (NOAA) - USA; University of Arizona; University of Arizona	Gupta, AK (corresponding author), Indian Inst Technol, Dept Geol & Geophys, Kharagpur 721302, W Bengal, India.		anderson, david/E-6416-2011	Gupta, Anil/0000-0003-0536-3911				Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ANDERSON DM, 1993, PALEOCEANOGRAPHY, V8, P193, DOI 10.1029/93PA00256; Anderson DM, 2002, SCIENCE, V297, P596, DOI 10.1126/science.1072881; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; CURRY WB, 1992, UPWELLING SYSTEMS EV, P93; Gupta AK, 2001, GEOPHYS RES LETT, V28, P4131, DOI 10.1029/2001GL013315; Houghton J. T., 2001, CLIMATE CHANGE 2001; Janowiak JE, 1999, J CLIMATE, V12, P3335, DOI 10.1175/1520-0442(1999)012<3335:COAGSR>2.0.CO;2; Jennings AE, 1996, HOLOCENE, V6, P179, DOI 10.1177/095968369600600205; Keigwin LD, 1996, SCIENCE, V274, P1504, DOI 10.1126/science.274.5292.1504; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; MEEHL GA, 1994, J CLIMATE, V7, P1033, DOI 10.1175/1520-0442(1994)007<1033:IOTLSI>2.0.CO;2; Naidu PD, 1996, PALEOCEANOGRAPHY, V11, P129, DOI 10.1029/95PA03198; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; Prell W.L., 1984, CLIMATE PROCESSES CL, V29, P48; PRELL WL, 1986, NATURE, V323, P526, DOI 10.1038/323526a0; REYNOLDS RW, 1995, J CLIMATE, V8, P1571, DOI 10.1175/1520-0442(1995)008<1571:AHRGSS>2.0.CO;2; RIND D, 1993, QUATERNARY SCI REV, V12, P357, DOI 10.1016/S0277-3791(05)80002-2; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; SIROCKO F, 1999, MECH GLOBAL CLIMATE, P113; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TRENBERTH K, 1989, NCARTN388PLUSSTR, P1; Wang LJ, 1999, GEOPHYS RES LETT, V26, P2889, DOI 10.1029/1999GL900443	30	820	900	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					354	357		10.1038/nature01340	http://dx.doi.org/10.1038/nature01340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540924				2022-12-24	WOS:000180533000037
J	Chanteau, S; Rahalison, L; Ralafiarisoa, L; Foulon, J; Ratsitorahina, M; Ratsifasoamanana, L; Carniel, E; Nato, A				Chanteau, S; Rahalison, L; Ralafiarisoa, L; Foulon, J; Ratsitorahina, M; Ratsifasoamanana, L; Carniel, E; Nato, A			Development and testing of a rapid diagnostic test for bubonic and pneumonic plague	LANCET			English	Article							IMMUNOCHROMATOGRAPHIC ASSAY; MADAGASCAR; ANTIGEN	Background Plague is often fatal without prompt and appropriate treatment. It affects mainly poor and remote populations. Late diagnosis is one of the major causes of human death and spread of the disease, since it limits the effectiveness of control measures. We aimed to develop and assess a rapid diagnostic test (RDT) for plague. Methods We developed a test that used monoclonal antibodies to the F1 antigen of Yersinia pestis. Sensitivity and specificity were assessed with a range of bacterial cultures and clinical samples, and compared with findings from available ELISA and bacteriological tests for plague. Samples from patients thought to have plague were tested with the RDT in the laboratory and by health workers in 26 pilot sites in Madagascar. Findings The RDT detected concentrations of F1 antigen as low as 0.5 ng/mL in up to 15 min, and had a shelf life of 21 days at 60degreesC. Its sensitivity and specificity were both 100%. RDT detected 41.6% and 31% more positive clinical specimens than did bacteriological methods and ELISA, respectively. The agreement rate between tests done at remote centres and in the laboratory was 89.8%. With the combination of bacteriological methods and F1 ELISA as reference standard, the positive and negative predictive values of the ROT were 90.6% and 86.7%, respectively. Interpretation Our RDT is a specific, sensitive, and reliable test that can easily be done by health workers at the patient's bedside, for the rapid diagnosis of pneumonic and bubonic plague. This test will be of key importance for the control of plague in endemic countries.	WHO, Collaborating Ctr Plague, Inst Pasteur Madagascar, Antananarivo, Madagascar; Minist Hlth, Plague Natl Control Programme, Antananarivo, Madagascar; WHO, Collaborating Ctr Yersinia, Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization	Chanteau, S (corresponding author), CERMES, POB 10 887, Niamey, Niger.							BAKER EE, 1952, J IMMUNOL, V68, P131; Bellamy RJ, 2001, QJM-MON J ASSOC PHYS, V94, P227, DOI 10.1093/qjmed/94.4.227; BIMBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boisier P, 2002, EMERG INFECT DIS, V8, P311, DOI 10.3201/eid0803.010250; BRUBAKER R R, 1970, Infection and Immunity, V1, P446; Chanteau S, 2000, MICROBES INFECT, V2, P25, DOI 10.1016/S1286-4579(00)00289-6; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Chanteau S, 1998, T ROY SOC TROP MED H, V92, P572, DOI 10.1016/S0035-9203(98)90923-3; Chanteau S, 2000, INT J MED MICROBIOL, V290, P279; CHEN TH, 1966, B WORLD HEALTH ORGAN, V34, P911; Cole RA, 1996, TUBERCLE LUNG DIS, V77, P363, DOI 10.1016/S0962-8479(96)90103-3; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Makler MT, 1998, ANN TROP MED PARASIT, V92, P419, DOI 10.1080/00034989859401; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Rahalison L, 2000, J CLIN MICROBIOL, V38, P260; Ratsitorahina M, 2000, LANCET, V355, P111, DOI 10.1016/S0140-6736(99)05163-6; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; *WHO, 2000, WKLY EPIDEMIOL REC, V75, P337; WILLIAMS JE, 1986, B WORLD HEALTH ORGAN, V64, P745	21	129	149	1	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					211	216		10.1016/S0140-6736(03)12270-2	http://dx.doi.org/10.1016/S0140-6736(03)12270-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547544				2022-12-24	WOS:000180535400010
J	Hoy, D; Toole, MJ; Morgan, D; Morgan, C				Hoy, D; Toole, MJ; Morgan, D; Morgan, C			Low back pain in rural Tibet	LANCET			English	Article								In a baseline assessment of 30 rural villages surrounding Shigatse City, Tibet, many people, especially women, identified low back pain as a serious health problem. Consequently, we aimed to establish the prevalence of such pain and to develop appropriate interventions. We did a cross-sectional study of the prevalence of low back pain and related functional disability using two-stage random cluster sampling. We included 499 adults aged at least 15 years from 19 villages. The point prevalence of low back pain was 34.1% (95% CI 27.9-40.3% [170 people]); the 12-month prevalence was 41.9% (35.5-48.3% [209 people]). 100 (20%) villagers had substantial functional disability associated with low back pain. Low back pain is likely to be an important and under recognised problem in rural societies like Tibet.	Ctr Int Hlth, Burnet Inst, Melbourne, Vic 3001, Australia	Burnet Institute	Hoy, D (corresponding author), Ctr Int Hlth, Burnet Inst, POB 2284, Melbourne, Vic 3001, Australia.		Morgan, Chris/L-1613-2019	Morgan, Chris/0000-0003-0931-5474				Anderson R T, 1984, Med Anthropol, V8, P46; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; TOROPTSOVA NV, 1995, SPINE, V20, P328, DOI 10.1097/00007632-199502000-00012; WIGLEY RD, 1994, J RHEUMATOL, V21, P1484	4	51	52	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					225	226		10.1016/S0140-6736(03)12254-4	http://dx.doi.org/10.1016/S0140-6736(03)12254-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547548				2022-12-24	WOS:000180535400014
J	Younis, N; Broadbent, DM; Vora, JP; Harding, SP				Younis, N; Broadbent, DM; Vora, JP; Harding, SP			Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study	LANCET			English	Article							PROGRESSION; POPULATION; PREVALENCE; DISEASE; RISK; AGE; OPHTHALMOSCOPY; DIAGNOSIS; BLINDNESS; MELLITUS	Background Incidence data on which to base targets and protocols for screening for sight-threatening diabetic retinopathy are few. We aimed to investigate yearly and cumulative incidence of any retinopathy, maculopathy, and sight-threatening diabetic retinopathy in patients with type 2 diabetes in an established systematic programme and to calculate optimum screening intervals according to retinopathy grade at baseline. Methods We investigated all patients with type 2 diabetes registered with enrolled general practices (except those who were attending an ophthalmologist) who had retinopathy data available at baseline and at least one further screening event. To screen patients, we used non-stereoscopic three-field mydriatic photography and modified Wisconsin grading. Sight-threatening diabetic retinopathy was defined as moderate preproliferative retinopathy or worse, or clinically significant maculopathy in either or both eyes. Findings Results were obtained from 20 570 screening events. Yearly incidence of sight-threatening diabetic retinopathy in patients without retinopathy at baseline was 0.3% (95% CI 0.1-0.5) in the first year, rising to 1.8% (1.2-2.5) in the fifth year; cumulative incidence at 5 years was 3.9% (2.8-5.0). Rates of progression to sight-threatening diabetic retinopathy in year 1 by baseline status were: background 5.0% (3.5-6.5), and mild preproliferative 15% (10.2-19.8). For a 95% probability of remaining free of sight-threatening diabetic retinopathy, mean screening intervals by baseline status were: no retinopathy 5.4 years (95% CI 4.7-6.3), background 1.0 years (0.7-1.3), and mild preproliferative 0.3 years (0.2-0.5). Interpretation A 3-year screening interval could be safely adopted for patients with no retinopathy, but yearly or more frequent screening is needed for patients with higher grades of retinopathy.	Royal Liverpool Univ Hosp, Dept Endocrinol & Diabet, Liverpool, Merseyside, England; Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Younis, N (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Dept Endocrinol & Diabet, Walton Hosp Site,Rice Lane, Liverpool L9 1AE, Merseyside, England.	naveedy@tinyonline.co.uk		Harding, Simon/0000-0003-4676-1158				Aiello LP, 1998, DIABETES CARE, V21, P157; *AM AC OPHTH, 1992, COMPR AD EYE EV PREF; [Anonymous], 1976, Am J Ophthalmol, V81, P383; [Anonymous], 1991, Ophthalmology, V98, P786; [Anonymous], 1991, Diabet Med, V8, P263; Bachmann MO, 1998, J EPIDEMIOL COMMUN H, V52, P45, DOI 10.1136/jech.52.1.45; Broadbent DM, 1999, EYE, V13, P160, DOI 10.1038/eye.1999.43; BROADBENT DM, 2000, DIABETIC MED, V17, pP69; DWYER MS, 1985, DIABETES CARE, V8, P316, DOI 10.2337/diacare.8.4.316; Garvican L, 2000, DIABETIC MED, V17, P627, DOI 10.1046/j.1464-5491.2000.00353.x; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; Henricsson M, 1996, ACTA OPHTHALMOL SCAN, V74, P528; Henricsson M, 1996, ACTA OPHTHALMOL SCAN, V74, P523; Henricsson M, 1999, ACTA OPHTHALMOL SCAN, V77, P218, DOI 10.1034/j.1600-0420.1999.770221.x; James M, 2000, BRIT MED J, V320, P1627, DOI 10.1136/bmj.320.7250.1627; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P244, DOI 10.1001/archopht.1989.01070010250031; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; KLEIN R, 1985, OPHTHALMOLOGY, V92, P485; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1217, DOI 10.1001/archopht.1994.01090210105023; KOHNER EM, 1983, DIABETES, V32, P1010; Kohner EM, 2001, DIABETIC MED, V18, P178; KRISTINSSON JK, 1994, ACTA OPHTHALMOL, V72, P341; LEE ET, 1992, DIABETES CARE, V15, P1620, DOI 10.2337/diacare.15.11.1620; *NAT DEP LAB HHS E, 1988, NAT EYE HLTH ED PROG, P100; NIELSEN NV, 1984, ACTA OPHTHALMOL, V62, P266; *ROYAL COLLOPHTH, 1997, GUID DIAB RET; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Taylor R, 1998, DIABETIC MED, V15, P344; TEUSCHER A, 1988, DIABETES CARE, V11, P246, DOI 10.2337/diacare.11.3.246; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889	34	209	218	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					195	200		10.1016/S0140-6736(03)12267-2	http://dx.doi.org/10.1016/S0140-6736(03)12267-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547541				2022-12-24	WOS:000180535400007
J	Forkey, JN; Quinlan, ME; Shaw, MA; Corrie, JET; Goldman, YE				Forkey, JN; Quinlan, ME; Shaw, MA; Corrie, JET; Goldman, YE			Three-dimensional structural dynamics of myosin V by single-molecule fluorescence polarization	NATURE			English	Article							MUSCLE-CONTRACTION; KINETIC MECHANISM; ACTIN; MOTOR; FLUOROPHORE; KINESIN; MICROSCOPY; ROTATION; PURIFICATION; PROTEINS	The structural change that generates force and motion in actomyosin motility has been proposed to be tilting of the myosin light chain domain, which serves as a lever arm. Several experimental approaches have provided support for the lever arm hypothesis; however, the extent and timing of tilting motions are not well defined in the motor protein complex of functioning actomyosin. Here we report three-dimensional measurements of the structural dynamics of the light chain domain of brain myosin V using a single-molecule fluorescence polarization technique that determines the orientation of individual protein domains with 20-40-ms time resolution. Single fluorescent calmodulin light chains tilted back and forth between two well-defined angles as the myosin molecule processively translocated along actin. The results provide evidence for lever arm rotation of the calmodulin-binding domain in myosin V, and support a 'hand-over-hand' mechanism for the translocation of double-headed myosin V molecules along actin filaments. The technique is applicable to the study of real-time structural changes in other biological systems.	Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; Natl Inst Med Res, London NW7 1AA, England	University of Pennsylvania; MRC National Institute for Medical Research	Goldman, YE (corresponding author), Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA.							Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Block SM, 1998, CELL, V93, P5, DOI 10.1016/S0092-8674(00)81138-1; Bopp MA, 1997, P NATL ACAD SCI USA, V94, P10630, DOI 10.1073/pnas.94.20.10630; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Corrie JET, 1998, BIOCONJUGATE CHEM, V9, P160, DOI 10.1021/bc970174e; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dickson RM, 1998, PHYS REV LETT, V81, P5322, DOI 10.1103/PhysRevLett.81.5322; Empedocles SA, 1999, NATURE, V399, P126, DOI 10.1038/20138; Forkey JN, 2000, PROG BIOPHYS MOL BIO, V74, P1, DOI 10.1016/S0079-6107(00)00015-8; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Goldman YE, 1998, CELL, V93, P1, DOI 10.1016/S0092-8674(00)81137-X; Ha T, 1998, PHYS REV LETT, V80, P2093, DOI 10.1103/PhysRevLett.80.2093; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Irving M, 1997, NEWS PHYSIOL SCI, V12, P249; Mehta A, 2001, J CELL SCI, V114, P1981; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MOISESCU DG, 1979, BIOCHIM BIOPHYS ACTA, V546, P64, DOI 10.1016/0005-2728(79)90170-1; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Press WH., 1992, NUMERICAL RECIPES C; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; PUTKEY JA, 1983, J BIOL CHEM, V258, P1864; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; REEDY MK, 1965, NATURE, V207, P1276, DOI 10.1038/2071276a0; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Sosa H, 2001, NAT STRUCT BIOL, V8, P540, DOI 10.1038/88611; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Tanaka H, 2002, NATURE, V415, P192, DOI 10.1038/415192a; Vale R D, 1990, Adv Biophys, V26, P97, DOI 10.1016/0065-227X(90)90009-I; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Warshaw DM, 1998, P NATL ACAD SCI USA, V95, P8034, DOI 10.1073/pnas.95.14.8034	44	359	364	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					399	404		10.1038/nature01529	http://dx.doi.org/10.1038/nature01529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660775				2022-12-24	WOS:000181801200036
J	Gerlich, D; Beaudouin, J; Kalbfuss, B; Daigle, N; Eils, R; Ellenberg, J				Gerlich, D; Beaudouin, J; Kalbfuss, B; Daigle, N; Eils, R; Ellenberg, J			Global chromosome positions are transmitted through mitosis in mammalian cells	CELL			English	Article							LIVING HUMAN-CELLS; NUCLEAR-ORGANIZATION; PERICENTRIC HETEROCHROMATIN; CENTROMERE SEPARATION; SPATIAL-ORGANIZATION; GENE ACTIVITY; INTERPHASE; CHROMATIN; DYNAMICS; TERRITORIES	We investigated positioning of chromosomes during the cell cycle in live mammalian cells with a combined experimental and computational approach. By non-invasive labeling of chromosome subsets and tracking by 4D imaging, we could show that no global rearrangements occurred in interphase. Using the same assay, we also observed a striking order of chromosomes throughout mitosis. By contrast, our computer simulation based on stochastic movements of individual chromosomes predicted randomization of chromosome order in mitosis. In vivo, a quantitative assay for single chromosome positioning during mitosis revealed strong similarities between daughter and mother cells. These results demonstrate that global chromosome positions are heritable through the cell cycle in mammalian cells. Based on tracking of labeled chromosomes and centromeres during chromosome segregation and experimental perturbations of chromosomal order, we propose that chromosome specific timing of sister chromatid separation transmits chromosomal positions from one cell generation to the next.	German Canc Res Ctr, D-69120 Heidelberg, Germany; European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol Biophys Programme, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Eils, R (corresponding author), German Canc Res Ctr, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	r.eils@dkfz.de	Ellenberg, Jan/I-4688-2014; Eils, Roland/B-6121-2009; Gerlich, Daniel Wolfram W/A-6991-2016	Ellenberg, Jan/0000-0001-5909-701X; Eils, Roland/0000-0002-0034-4036; Gerlich, Daniel Wolfram W/0000-0003-1637-3365				Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; AGARD DA, 1983, NATURE, V302, P676, DOI 10.1038/302676a0; ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Allison DC, 1999, J CELL BIOL, V145, P1, DOI 10.1083/jcb.145.1.1; Baxter J, 2002, CURR OPIN CELL BIOL, V14, P372, DOI 10.1016/S0955-0674(02)00339-3; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; BORDEN J, 1988, SCIENCE, V242, P1687, DOI 10.1126/science.3201257; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; CHUNG HMM, 1990, EMBO J, V9, P2611, DOI 10.1002/j.1460-2075.1990.tb07443.x; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Ellenberg J, 1999, TRENDS CELL BIOL, V9, P52, DOI 10.1016/S0962-8924(98)01420-2; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Franklin AE, 1999, PLANT CELL, V11, P523, DOI 10.1105/tpc.11.4.523; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; Haaf T, 2000, CYTOGENET CELL GENET, V91, P113, DOI 10.1159/000056830; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Martou G, 2000, EXP CELL RES, V256, P131, DOI 10.1006/excr.1999.4793; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; NAGELE R, 1995, SCIENCE, V270, P1831, DOI 10.1126/science.270.5243.1831; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Rabl C, 1885, MORPHOL JB, V10, P214; Sachs RK, 1997, INT J RADIAT BIOL, V71, P1, DOI 10.1080/095530097144364; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Tvarusko W, 1999, P NATL ACAD SCI USA, V96, P7950, DOI 10.1073/pnas.96.14.7950; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Vig BK, 1998, CHROMOSOMA, V107, P417, DOI 10.1007/s004120050325; VIG BK, 1983, CANCER GENET CYTOGEN, V8, P249, DOI 10.1016/0165-4608(83)90142-5; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	53	217	225	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2003	112	6					751	764		10.1016/S0092-8674(03)00189-2	http://dx.doi.org/10.1016/S0092-8674(03)00189-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654243	Bronze			2022-12-24	WOS:000181818500004
J	Chaimanee, Y; Jolly, D; Benammi, M; Tafforeau, P; Duzer, D; Moussa, I; Jaeger, JJ				Chaimanee, Y; Jolly, D; Benammi, M; Tafforeau, P; Duzer, D; Moussa, I; Jaeger, JJ			A Middle Miocene hominoid from Thailand and orangutan origins	NATURE			English	Article							SIVAPITHECUS; PAKISTAN; NEOGENE; LUFENG; CHINA	The origin of orangutans has long been debated. Sivapithecus is considered to be the closest ancestor of orangutans because of its facial-palatal similarities(1), but its dental characteristics 2 and postcranial skeleton(2,3) do not confirm this phylogenetic position. Here we report a new Middle Miocene hominoid, cf. Lufengpithecus chiangmuanensis n. sp. from northern Thailand. Its dental morphology relates it to the Pongo clade, which includes Lufengpithecus(4,5), Sivapithecus(2), Gigantopithecus(6), Ankarapithecus(7) and possibly Griphopithecus(8). Our new species displays striking dental resemblances with living orangutans and appears as a more likely candidate to represent an ancestor of this ape. In addition, it originates from the geographic area of Pleistocene orangutans. But surprisingly, the associated flora shows strong African affinities, demonstrating the existence of a temporary floral and faunal dispersal corridor between southeast Asia and Africa during the Middle Miocene, which may have played a critical role in hominoid dispersion.	Univ Montpellier 2, ISEM, F-34095 Montpellier, France; Dept Mineral Resources, Geol Survey Div, Paleontol Sect, Bangkok 10400, Thailand; Univ Nacl Autonoma Mexico, Inst Geofis, Mexico City 04510, DF, Mexico	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Department of Mineral Resources - Thailand; Universidad Nacional Autonoma de Mexico	Jaeger, JJ (corresponding author), Univ Montpellier 2, ISEM, CC 064,Pl Eugene Bataillon, F-34095 Montpellier, France.	jaeger@isem.univ-montp2.fr		Tafforeau, Paul/0000-0002-5962-1683; chaimanee, yaowalak/0000-0002-8432-3880				ALPAGUT B, 1990, J HUM EVOL, V19, P397, DOI 10.1016/0047-2484(90)90052-D; BADGLEY C, 1988, NATL GEOGR RES, V4, P178; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Harrison T, 2002, J HUM EVOL, V43, P207, DOI 10.1006/jhev.2002.0570; Harrison Terry, 1997, P327; Hooijer D. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P175; JOHNSON NM, 1983, J GEOPHYS RES, V88, P1213, DOI 10.1029/JB088iB02p01213; KAPPELMAN J, IN PRESS GEOLOGY PAL; Kelley J, 1998, J HUM EVOL, V35, P577, DOI 10.1006/jhev.1998.0253; KELLEY J, 1995, J HUM EVOL, V28, P503, DOI 10.1006/jhev.1995.1039; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin L.B., 1983, THESIS U LONDON; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; PAJUNEN H, 1985, P S INT PEAT SOC JAM, P186; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; PILBEAM D, 1990, NATURE, V348, P237, DOI 10.1038/348237a0; Remus D., 1993, J SE ASIAN EARTH SCI, V8, P321, DOI [10. 1016/0743-9547(93)90043-O, DOI 10.1016/0743-9547(93)90043-O]; Schwartz Jeffrey H., 1997, P363; SCHWARTZ JH, 1990, J HUM EVOL, V19, P591, DOI 10.1016/0047-2484(90)90001-R; Simons E. L., 1969, Postilla, VNo. 138, P1; Swarts J.D., 1988, P263; Ward Steve, 1997, P269; WU R, 1987, ACTA ANTHR SIN, V6, P263; WU RK, 1983, NATURE, V306, P258, DOI 10.1038/306258a0	25	100	104	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					61	65		10.1038/nature01449	http://dx.doi.org/10.1038/nature01449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621432				2022-12-24	WOS:000181343100036
J	Wedlich-Soldner, R; Altschuler, SJ; Wu, LF; Li, R				Wedlich-Soldner, R; Altschuler, SJ; Wu, LF; Li, R			Spontaneous cell polarization through actomyosin-based delivery of the Cdc42 GTPase	SCIENCE			English	Article							EXCHANGE FACTOR CDC24; SACCHAROMYCES-CEREVISIAE; VESICULAR TRANSPORT; ACTIN CYTOSKELETON; SECRETORY VESICLES; PLASMA-MEMBRANE; YEAST; POLARITY; GROWTH; GENE	Cell polarization can occur in the absence of any spatial cues. To investigate the mechanism of spontaneous cell polarization, we used an assay in yeast where expression of an activated form of Cdc42, a Rho-type guanosine triphosphatase (GTPase) required for cell polarization, could generate cell polarity without any recourse to a preestablished physical cue. The polar distribution of Cdc42 in this assay required targeted secretion directed by the actin cytoskeleton. A mathematical simulation showed that a stable polarity axis could be generated through a positive feedback loop in which a stochastic increase in the local concentration of activated Cdc42 on the plasma membrane enhanced the probability of actin polymerization and increased the probability of further Cdc42 accumulation to that site.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Li, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	rong_li@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM057063] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Arkowitz RA, 1999, TRENDS CELL BIOL, V9, P20, DOI 10.1016/S0962-8924(98)01412-3; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Lechler T, 2001, J CELL BIOL, V155, P261, DOI 10.1083/jcb.200104094; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; NOVICK P, 1993, CIBA F SYMP, V176, P218; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Seeley TD, 2002, BIOL BULL-US, V202, P314, DOI 10.2307/1543484; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; WEDLICHSOLDNER R, UNPUB; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	30	309	314	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1231	1235		10.1126/science.1080944	http://dx.doi.org/10.1126/science.1080944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12560471				2022-12-24	WOS:000181065500040
J	Klausberger, T; Magill, PJ; Marton, LF; Roberts, JDB; Cobden, PM; Buzsaki, G; Somogyi, P				Klausberger, T; Magill, PJ; Marton, LF; Roberts, JDB; Cobden, PM; Buzsaki, G; Somogyi, P			Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo	NATURE			English	Article							PYRAMIDAL CELLS; RAT HIPPOCAMPUS; THETA-RHYTHM; IN-VIVO; NEURONS	Neural-network oscillations at distinct frequencies have been implicated in the encoding, consolidation and retrieval of information in the hippocampus. Some GABA (gamma-aminobutyric acid)-containing interneurons fire phase-locked to theta oscillations (4-8 Hz) or to sharp-wave-associated ripple oscillations (120-200 Hz), which represent different behavioural states(1-6). Interneurons also entrain pyramidal cells in vitro(7). The large diversity of interneurons(8-10) poses the question of whether they have specific roles in shaping distinct network activities in vivo. Here we report that three distinct interneuron types-basket, axo-axonic and oriens-lacunosum-moleculare cells-visualized and defined by synaptic connectivity as well as by neurochemical markers, contribute differentially to theta and ripple oscillations in anaesthetized rats. The firing patterns of individual cells of the same class are remarkably stereotyped and provide unique signatures for each class. We conclude that the diversity of interneurons, innervating distinct domains of pyramidal cells 11, emerged to coordinate the activity of pyramidal cells in a temporally distinct and brain-state-dependent manner.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	University of Oxford; Rutgers State University Newark; Rutgers State University New Brunswick	Klausberger, T (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	thomas.klausberger@pharm.ox.ac.uk		Buzsaki, Gyorgy/0000-0002-3100-4800; Magill, Peter/0000-0001-7141-7071				Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; FOX SE, 1989, EXP BRAIN RES, V77, P283, DOI 10.1007/BF00274985; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2001, NEURON, V32, P771, DOI 10.1016/S0896-6273(01)00528-1; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; SIK A, 1995, J NEUROSCI, V15, P6651; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YLINEN A, 1995, J NEUROSCI, V15, P30; Zar JH, 1999, BIOSTATISTICAL ANAL	30	942	993	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					844	848		10.1038/nature01374	http://dx.doi.org/10.1038/nature01374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594513				2022-12-24	WOS:000181044700048
J	Levene, MJ; Korlach, J; Turner, SW; Foquet, M; Craighead, HG; Webb, WW				Levene, MJ; Korlach, J; Turner, SW; Foquet, M; Craighead, HG; Webb, WW			Zero-mode waveguides for single-molecule analysis at high concentrations	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; INHIBITED SPONTANEOUS EMISSION; TOTAL INTERNAL-REFLECTION; CROSS-CORRELATION; DNA; DYNAMICS; MICROSCOPY	Optical approaches for observing the dynamics of single molecules have required pico- to nanomolar concentrations of fluorophore in order to isolate individual molecules. However, many biologically relevant processes occur at micromolar ligand concentrations, necessitating a reduction in the conventional observation volume by three orders of magnitude. We show that arrays of zero-mode waveguides consisting of subwavelength holes in a metal film provide a simple and highly parallel means for studying single-molecule dynamics at micromolar concentrations with microsecond temporal resolution. We present observations of DNA polymerase activity as an example of the effectiveness of zero-mode waveguides for performing single-molecule experiments at high concentrations.	Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA	Cornell University	Webb, WW (corresponding author), Cornell Univ, Grad Program Biochem Mol & Cell Biol, Clark Hall, Ithaca, NY 14853 USA.		Webb, Watt W./B-5905-2011		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004224] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR04224] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; BARAK LS, 1981, J CELL BIOL, V90, P595, DOI 10.1083/jcb.90.3.595; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Castro A, 1997, ANAL CHEM, V69, P3915, DOI 10.1021/ac970389h; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; de Lange F, 2001, J CELL SCI, V114, P4153; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Jackson J.D., 2007, CLASSICAL ELECTRODYN; Keller RA, 2002, ANAL CHEM, V74, p316a, DOI 10.1021/ac022035i; KLEPPNER D, 1981, PHYS REV LETT, V47, P233, DOI 10.1103/PhysRevLett.47.233; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; KORLACH J, 2000, Patent No. 0070073; Lerch HP, 2002, P NATL ACAD SCI USA, V99, P15410, DOI 10.1073/pnas.232376799; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; Mertz J, 1995, OPT LETT, V20, P2532, DOI 10.1364/OL.20.002532; Meyer-Almes FJ, 2000, BIOCHEMISTRY-US, V39, P13261, DOI 10.1021/bi000057y; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PURCELL EM, 1946, PHYS REV, V69, P681; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; RICKA J, 1989, PHYS REV A, V39, P2646, DOI 10.1103/PhysRevA.39.2646; Rippe K, 2000, BIOCHEMISTRY-US, V39, P2131, DOI 10.1021/bi9922190; Schomburg D, 2001, SPRINGER HDB ENZYMES; Starr TE, 2001, BIOPHYS J, V80, P1575, DOI 10.1016/S0006-3495(01)76130-9; THOMPSON NL, 1981, BIOPHYS J, V33, P435, DOI 10.1016/S0006-3495(81)84905-3; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; Xu, 2002, T FLUOR SP, P471; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059	30	1016	1452	10	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					682	686		10.1126/science.1079700	http://dx.doi.org/10.1126/science.1079700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560545				2022-12-24	WOS:000180687700039
J	Friedman, MA; den Besten, H; Attaran, A				Friedman, MA; den Besten, H; Attaran, A			Out-licensing: a practical approach for improvement of access to medicines in poor countries	LANCET			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Carr Ctr Human Rights Policy, Cambridge, MA 02138 USA; Int Dispensary Assoc, Amsterdam, Netherlands; Pharmacia Corp, Peapack, NJ USA	Harvard University; Pfizer	Attaran, A (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Carr Ctr Human Rights Policy, 79 JFK St, Cambridge, MA 02138 USA.	amir_attaran@harvard.edu						ACHMAT Z, 2002, 14 INT AIDS C BARC; ACHMAT Z, 2001, GUARDIAN        1201; *ACT UP, 2002, ACT UP DEM BREAK PAT; *AIDS HEALTHC FDN, 2002, US LARG AIDS ORG CAL; Attaran A, 2001, JAMA-J AM MED ASSOC, V286, P1886, DOI 10.1001/jama.286.15.1886; BAKER BK, 2001, TRIPS REFORM VOLUNTA; BOOKER S, 2001, NATION          0709; BOSELEY S, 2002, GUARDIAN        1004; *BRIST MYERS SQUIB, 2001, BRIST SQUIBB ANN ACC; COHEN M, 2001, ASS PRESS WORLD 0516; *CONS PROJ TECHN H, 2001, JOINT STAT WTO WHO D; *HLTH GAP, 2002, WHAT IS HLTH GAP; *MED SANS FRONT, 2002, DURB BARC OV TREATM; *MERCK, 2000, HIV AIDS DEV WORLD M; Murray CJL, 1996, GLOBAL BURDEN DIS CO; PEARL D, 2001, WALL STREET J   0216; *PFIZER, 2002, ALL BUILD 1ST LARG S; *TREATM ACT CAMP, 2002, DEF CAMP QUEST ANSW; *UNAIDS, 2002, 12 M GEN MAY 28; WALDHOLZ M, 2002, WALL STREET J   0627; *WHO COMM MACR HLT, 2002, MACR HLTH INV HLTH E; *WHO WORLD TRADE O, 2002, WORKSH DIFF PRIC FIN; World Health Organization, 2002, SEL US ESS MED REP W; 2002, OXFAM IMPLAUSIBLE DE; 2002, REUTERS MED NEW 1115	25	16	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					341	344		10.1016/S0140-6736(03)12331-8	http://dx.doi.org/10.1016/S0140-6736(03)12331-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559883				2022-12-24	WOS:000180643900029
J	Poremba, A; Saunders, RC; Crane, AM; Cook, M; Sokoloff, L; Mishkin, M				Poremba, A; Saunders, RC; Crane, AM; Cook, M; Sokoloff, L; Mishkin, M			Functional mapping of the primate auditory system	SCIENCE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; CORTEX; ORGANIZATION; AREAS; LOCALIZATION; AFFERENTS; PATHWAYS; NEURONS; MONKEYS; STREAMS	Cerebral auditory areas were delineated in the awake, passively listening, rhesus monkey by comparing the rates of glucose utilization in an intact hemisphere and in an acoustically isolated contralateral hemisphere of the same animal. The auditory system defined in this way occupied large portions of cerebral tissue, an extent probably second only to that of the visual system. Cortically, the activated areas included the entire superior temporal gyrus and large portions of the parietal, prefrontal, and limbic lobes. Several auditory areas overlapped with previously identified visual areas, suggesting that the auditory system, like the visual system, contains separate pathways for processing stimulus quality, location, and motion.	Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; Univ Iowa, Neurosci Program, Iowa City, IA 52242 USA; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA; NIMH, Cerebral Metab Lab, Bethesda, MD 20892 USA	University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Poremba, A (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	amy-poremba@uiowa.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH000882, Z01MH001101, ZIAMH001101] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Bell AH, 2001, CAN J EXP PSYCHOL, V55, P123, DOI 10.1037/h0087359; Bonin G, 1947, NEOCORTEX MACACA MUL; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURTON H, 1982, J COMP NEUROL, V210, P109, DOI 10.1002/cne.902100203; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Fernandez-Ruiz J, 2001, P NATL ACAD SCI USA, V98, P4196, DOI 10.1073/pnas.061022098; Fuster J.M., 1989, PREFRONTAL CORTEX; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; JULIANO SL, 1981, J NEUROPHYSIOL, V46, P1260, DOI 10.1152/jn.1981.46.6.1260; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; KENNEDY C, 1978, ANN NEUROL, V4, P293, DOI 10.1002/ana.410040402; Kosaki H, 1997, J COMP NEUROL, V386, P304; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; MACKO KA, 1982, SCIENCE, V218, P394, DOI 10.1126/science.7123241; MACKO KA, 1985, BRAIN IMAGING BRAIN; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; NEWMAN JD, 1976, EXP BRAIN RES, V25, P169; PANDYA DN, 1995, REV NEUROL, V151, P486; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; SAVAKI HE, 1993, J NEUROSCI, V13, P2772; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider LG., 1982, ANAL VISUAL BEHAV, P549; WALLACE MT, 1993, PROG BRAIN RES, V112, P301; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Woolsey C. N., 1982, CORTICAL SENSORY ORG, V3, P231	45	170	172	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					568	572		10.1126/science.1078900	http://dx.doi.org/10.1126/science.1078900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543977				2022-12-24	WOS:000180559800051
J	Juo, ZS; Kassavetis, GA; Wang, JM; Geiduschek, EP; Sigler, PB				Juo, ZS; Kassavetis, GA; Wang, JM; Geiduschek, EP; Sigler, PB			Crystal structure of a transcription factor IIIB core interface ternary complex	NATURE			English	Article							RNA-POLYMERASE-III; TATA-BINDING PROTEIN; FACTOR TFIIIB; YEAST TFIIIB; FACTOR BRF; DNA; BOX; REFINEMENT; MODEL; NOMENCLATURE	Transcription factor IIIB ( TFIIIB), consisting of the TATA-binding protein (TBP), TFIIB-related factor (Brf1) and Bdp1, is a central component in basal and regulated transcription by RNA polymerase III1-4. TFIIIB recruits its polymerase to the promoter and subsequently has an essential role in the formation of the open initiation complex. The amino-terminal half of Brf1 shares a high degree of sequence similarity with the polymerase II general transcription factor TFIIB, but it is the carboxy-terminal half of Brf1 that contributes most of its binding affinity with TBP5-8. The principal anchoring region is located between residues 435 and 545 of yeast Brf1, comprising its homology domain II. The same region also provides the primary interface for assembling Bdp1 into the TFIIIB complex(9). We report here a 2.95 Angstrom resolution crystal structure of the ternary complex containing Brf1 homology domain II, the conserved region of TBP and 19 base pairs of U6 promoter DNA. The structure reveals the core interface for assembly of TFIIIB and demonstrates how the loosely packed Brf1 domain achieves remarkable binding specificity with the convex and lateral surfaces of TBP.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	Yale University; University of California System; University of California San Diego	Juo, ZS (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	juo@csb.yale.edu						Andrau JC, 1999, J MOL BIOL, V288, P511, DOI 10.1006/jmbi.1999.2724; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; CHAUSSIVERT N, 1995, J BIOL CHEM, V270, P15353, DOI 10.1074/jbc.270.25.15353; Colbert T, 1998, MOL CELL BIOL, V18, P1682, DOI 10.1128/MCB.18.3.1682; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Huet J, 1997, J BIOL CHEM, V272, P18341, DOI 10.1074/jbc.272.29.18341; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kassavetis GA, 1998, MOL CELL BIOL, V18, P5587, DOI 10.1128/MCB.18.9.5587; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martel LS, 2002, MOL CELL BIOL, V22, P2788, DOI 10.1128/MCB.22.8.2788-2798.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patikoglou G, 1997, ANNU REV BIOPH BIOM, V26, P289, DOI 10.1146/annurev.biophys.26.1.289; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rost B, 1996, METHOD ENZYMOL, V266, P525; Ruth J, 1996, EMBO J, V15, P1941, DOI 10.1002/j.1460-2075.1996.tb00545.x; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Shen YH, 1998, MOL CELL BIOL, V18, P1692, DOI 10.1128/MCB.18.3.1692; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; WANG ZX, 1995, P NATL ACAD SCI USA, V92, P7026, DOI 10.1073/pnas.92.15.7026; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; Willis IM, 2002, GENE DEV, V16, P1337, DOI 10.1101/gad.998102; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	29	71	72	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2003	422	6931					534	539		10.1038/nature01534	http://dx.doi.org/10.1038/nature01534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12660736				2022-12-24	WOS:000181965400041
J	Ghosh, K; Shankarkumar, U; Shetty, S; Mohanty, D				Ghosh, K; Shankarkumar, U; Shetty, S; Mohanty, D			Chronic synovitis and HLA B27 in patients with severe haemophilia	LANCET			English	Article								Chronic synovitis affects about 10% of patients with severe haemophilia in India. This disease has some features in common with ankylosing spondylitis, which has been linked to HLA B27. We therefore aimed to test whether there is an association between HLA B27 and chronic synovitis. We studied 473 patients with severe haemophilia (33 of whom had chronic synovitis), and 1175 healthy controls using a standard serological technique and the reverse line strip assay. 64% (21 of 33) of patients with haemophilia and chronic synovitis were positive for HLA B27, compared with 5% (23 of 440) of those with severe haemophilia, but not chronic synovitis (odds ratio 31.6 [95% CI 9.28-39.38], p<0.0001), and 9% (100 of 1175) of healthy controls (18.81 [9.6-27.7], p<0.0001). We conclude that there is a strong association between HLA B27 and chronic synovitis in Indian patients with severe haemophilia and screening in this population could allow treatment and prevention of the complication.	Inst Immunohaematol, Bombay 400012, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Mohanty, D (corresponding author), Inst Immunohaematol, Floor 13,New Bldg,KEM Hosp Campus, Bombay 400012, Maharashtra, India.		Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565				Ghosh K, 2001, HAEMOPHILIA, V7, P273, DOI 10.1046/j.1365-2516.2001.00505.x; MACK SJ, 2000, HLA 2000 IHWG TECHNI; Rodriguez-Merchan EC, 1998, HAEMOPHILIA, V4, P506, DOI 10.1046/j.1365-2516.1998.440506.x; SENGUPTA S, 1977, LANCET, V1, P1209; SHANKARKUMAR U, 2002, BRIT J BIOMED SCI, V59, P11	5	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 15	2003	361	9361					933	934		10.1016/S0140-6736(03)12763-8	http://dx.doi.org/10.1016/S0140-6736(03)12763-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648975				2022-12-24	WOS:000181741600014
J	Aguilaniu, H; Gustafsson, L; Rigoulet, M; Nystrom, T				Aguilaniu, H; Gustafsson, L; Rigoulet, M; Nystrom, T			Asymmetric inheritance of oxidatively damaged proteins during cytokinesis	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DAUGHTER CELLS; MOTHER; YEAST; RESPIRATION; LONGEVITY; MUTATION; SIR2	Carbonylated proteins were visualized in single cells of the budding yeast Saccharomyces cerevisiae, revealing that they accumulate with replicative age. Furthermore, carbonylated proteins were not inherited by daughter cells during cytokinesis. Mother cells of a yeast strain lacking the sir2 gene, a life-span determinant, failed to retain oxidatively damaged proteins during cytokinesis. These findings suggest that a genetically determined, Sir2p-dependent asymmetric inheritance of oxidatively damaged proteins may contribute to free-radical defense and the fitness of newborn cells.	Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden; Chalmers Univ Technol, Dept Mol Biotechnol, S-41296 Gothenburg, Sweden; Univ Victor Segalen, CNRS, Inst Biochim & Genet Cellulaires, Bordeaux, France	University of Gothenburg; Chalmers University of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Nystrom, T (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden.							Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; Barker MG, 1999, FEMS MICROBIOL LETT, V177, P199, DOI 10.1016/S0378-1097(99)00308-0; Bindokas VP, 1996, J NEUROSCI, V16, P1324; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lai CY, 2002, GENETICS, V162, P73; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Nestelbacher R, 2000, EXP GERONTOL, V35, P63, DOI 10.1016/S0531-5565(99)00087-X; Park PU, 2002, METHOD ENZYMOL, V351, P468; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616	15	490	505	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1751	1753		10.1126/science.1080418	http://dx.doi.org/10.1126/science.1080418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12610228				2022-12-24	WOS:000181519500051
J	Ose, T; Watanabe, K; Mie, T; Honma, M; Watanabe, H; Yao, M; Oikawa, H; Tanaka, I				Ose, T; Watanabe, K; Mie, T; Honma, M; Watanabe, H; Yao, M; Oikawa, H; Tanaka, I			Insight into a natural Diels-Alder reaction from the structure of macrophomate synthase	NATURE			English	Article							UNUSUAL MULTISTEP TRANSFORMATION; SHAPE COMPLEMENTARITY; ENZYMATIC-ACTIVITY; REACTION-MECHANISM; 2-PYRONES; CATALYSIS; BINDING	The Diels-Alder reaction, which forms a six-membered ring from an alkene (dienophile) and a 1,3-diene, is synthetically very useful for construction of cyclic products with high regio- and stereoselectivity under mild conditions(1). It has been applied to the synthesis of complex pharmaceutical and biologically active compounds(2). Although evidence(3-7) on natural Diels-Alderases has been accumulated in the biosynthesis of secondary metabolites(8), there has been no report on the structural details of the natural Diels-Alderases. The function and catalytic mechanism of the natural Diels-Alderase are of great interest owing to the diversity of molecular skeletons in natural Diels-Alder adducts(8). Here we present the 1.70 Angstrom resolution crystal structure of the natural Diels-Alderase, fungal macrophomate synthase (MPS)(3), in complex with pyruvate. The active site of the enzyme is large and hydrophobic, contributing amino acid residues that can hydrogen-bond to the substrate 2-pyrone. These data provide information on the catalytic mechanism of MPS, and suggest that the reaction proceeds via a large-scale structural reorganization of the product.	Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Oikawa, H (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan.	hoik@chem.agr.hokudai.ac.jp; tmaka@castor.sci.hokudai.ac.jp	yao, min/F-5287-2011; Watanabe, Kenji/N-2012-2015; Oikawa, Hideaki/F-9128-2012	yao, min/0000-0003-1687-5904; Watanabe, Kenji/0000-0002-0463-4831; Oikawa, Hideaki/0000-0002-6947-3397				AFARINKIA K, 1992, TETRAHEDRON, V48, P9111, DOI 10.1016/S0040-4020(01)85607-6; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLAKE JF, 1991, J AM CHEM SOC, V113, P7430, DOI 10.1021/ja00019a055; BRAISTED AC, 1990, J AM CHEM SOC, V112, P7430, DOI 10.1021/ja00176a073; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carruthers W., 1990, CYCLOADDITION REACTI; Chen JG, 2000, CHEMBIOCHEM, V1, P255, DOI 10.1002/1439-7633(20001117)1:4<255::AID-CBIC255>3.0.CO;2-S; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Desimoni G., 1983, NATURAL PRODUCTS SYN; GOUVERNEUR VE, 1993, SCIENCE, V262, P204, DOI 10.1126/science.8211138; Heine A, 1998, SCIENCE, V279, P1934, DOI 10.1126/science.279.5358.1934; HILVERT D, 1989, J AM CHEM SOC, V111, P9261, DOI 10.1021/ja00208a037; ICHIHARA A, 1987, TETRAHEDRON, V43, P5245, DOI 10.1016/S0040-4020(01)87700-0; ICHIHARA A, 1999, COMPREHENSIVE NATURA, V1, P367; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Katayama K, 1998, BBA-PROTEIN STRUCT M, V1384, P387, DOI 10.1016/S0167-4838(98)00040-5; Oikawa H, 1998, J ORG CHEM, V63, P8748, DOI 10.1021/jo980743r; OIKAWA H, 1995, J CHEM SOC CHEM COMM, P1321, DOI 10.1039/c39950001321; Oikawa H, 1999, TETRAHEDRON LETT, V40, P6983, DOI 10.1016/S0040-4039(99)01441-0; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; SAKURAI I, 1988, CHEM PHARM BULL, V36, P2003; SAUER J, 1980, ANGEW CHEM INT EDIT, V19, P779, DOI 10.1002/anie.198007791; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200; Watanabe K, 2000, J BIOCHEM-TOKYO, V127, P467, DOI 10.1093/oxfordjournals.jbchem.a022629; Watanabe K, 2000, BIOSCI BIOTECH BIOCH, V64, P530, DOI 10.1271/bbb.64.530; Watanabe K, 2000, TETRAHEDRON LETT, V41, P1443, DOI 10.1016/S0040-4039(99)02311-4; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345; YLIKAUHALUOMA JT, 1995, J AM CHEM SOC, V117, P7041, DOI 10.1021/ja00132a001	29	159	161	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					185	189		10.1038/nature01454	http://dx.doi.org/10.1038/nature01454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634789				2022-12-24	WOS:000181488900050
J	Bentley, SD; Maiwald, M; Murphy, LD; Pallen, MJ; Yeats, CA; Dover, LG; Norbertczak, HT; Besra, GS; Quail, MA; Harris, DE; von Herbay, A; Goble, A; Rutter, S; Squares, R; Squares, S; Barrell, BG; Parkhill, J; Relman, DA				Bentley, SD; Maiwald, M; Murphy, LD; Pallen, MJ; Yeats, CA; Dover, LG; Norbertczak, HT; Besra, GS; Quail, MA; Harris, DE; von Herbay, A; Goble, A; Rutter, S; Squares, R; Squares, S; Barrell, BG; Parkhill, J; Relman, DA			Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei	LANCET			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACILLUS; ORIGIN; ADHERENCE; WHIPPELII; PROTEIN; DIVERSE	Background Whipple's disease is a rare multisystem chronic infection, involving the intestinal tract as well as various other organs. The causative agent, Tropheryma whipplei, is a Gram-positive bacterium about which little is known. Our aim was to investigate the biology of this organism by generating and analysing the complete DNA sequence of its genome. Methods We isolated and propagated T whipplei strain TWO8/27 from the cerebrospinal fluid of a patient diagnosed with Whipple's disease. We generated the complete sequence of the genome by the whole genome shotgun method, and analysed it with a combination of automatic and manual bioinformatic techniques. Findings Sequencing revealed a condensed 925 938 bp genome with a lack of key biosynthetic pathways and a reduced capacity for energy metabolism. A family of large surface proteins was identified, some associated with large amounts of non-coding repetitive DNA, and an unexpected degree of sequence variation. Interpretation The genome reduction and lack of metabolic capabilities point to a host-restricted lifestyle for the organism. The sequence variation indicates both known and novel mechanisms for the elaboration and variation of surface structures, and suggests that immune evasion and host interaction play an important part in the lifestyle of this persistent bacterial pathogen.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Birmingham, Birmingham, W Midlands, England; Heidelberg Univ, Dept Pathol, D-6900 Heidelberg, Germany	Wellcome Trust Sanger Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Birmingham; Ruprecht Karls University Heidelberg	Parkhill, J (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	Parkhill@sanger.ac.uk	Pallen, Mark J./E-7619-2011; Dover, Lynn G/F-3021-2010; Dover, Lynn George/Q-6778-2019; Quail, michael/ABE-6131-2020; Parkhill, Julian/G-4703-2011	Dover, Lynn G/0000-0002-4776-2665; Dover, Lynn George/0000-0002-4776-2665; Parkhill, Julian/0000-0002-7069-5958; Relman, David A./0000-0001-8331-1354; Besra, Gurdyal/0000-0002-5605-0395; Maiwald, Matthias/0000-0001-5448-8417; Pallen, Mark/0000-0003-1807-3657; Murphy, Lee/0000-0001-6467-7449	NIDDK NIH HHS [DK56339] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bansal AK, 2002, J BACTERIOL, V184, P2260, DOI 10.1128/JB.184.8.2260-2272.2002; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bhattacharjee MK, 2001, J BACTERIOL, V183, P5927, DOI 10.1128/JB.183.20.5927-5936.2001; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Dobbins 3rd WO, 1987, WHIPPLES DIS; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Fredricks DN, 2001, J INFECT DIS, V183, P1229, DOI 10.1086/319684; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Maiwald M, 1996, INT J SYST BACTERIOL, V46, P1078, DOI 10.1099/00207713-46-4-1078; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; MAIWALD M, 2002, SLEISENGER FORDTRANS, P1854; MARTH T, 1994, CLIN IMMUNOL IMMUNOP, V72, P217, DOI 10.1006/clin.1994.1134; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Salazar L, 1996, MOL MICROBIOL, V20, P283, DOI 10.1111/j.1365-2958.1996.tb02617.x; SILVA MT, 1985, J GEN MICROBIOL, V131, P1001; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; vonHerbay A, 1996, GASTROENTEROLOGY, V110, P1735, DOI 10.1053/gast.1996.v110.pm8964398; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z	30	174	392	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2003	361	9358					637	644		10.1016/S0140-6736(03)12597-4	http://dx.doi.org/10.1016/S0140-6736(03)12597-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606174				2022-12-24	WOS:000181129500012
J	MacDonald, TM; Wei, L				MacDonald, TM; Wei, L			Effect of ibuprofen on cardioprotective effect of aspirin	LANCET			English	Article								Treatment with ibuprofen might limit the cardioprotective effects of aspirin. We aimed to assess whether patients with known cardiovascular disease who take low-dose aspirin and ibuprofen have increased risk of cardiovascular mortality. We studied 7107 patients who were discharged after first admission for cardiovascular disease between April, 1989, and April, 1997, and who were prescribed low-dose aspirin (<325 mg/day) and survived for at least I month. Compared with those who used aspirin alone, patients taking aspirin plus ibuprofen had an increased risk of all-cause mortality (adjusted hazard ratio 1.93, 95% CI 1.30-2.87, p=0.0011) and cardiovascular mortality (1.73, 1.05-2.84, p=0.0305). Our finding lends support to the hypothesis that ibuproen may interact with the cardioprotective effects of aspirin, at least in patients with established cardiovascular disease.	Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Med Monitoring Unit, Dundee DD1 9SY, Scotland	University of Dundee	MacDonald, TM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Med Monitoring Unit, Dundee DD1 9SY, Scotland.			MacDonald, Thomas/0000-0001-5189-6669				Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Evans JMM, 1999, BRIT J CLIN PHARMACO, V47, P105, DOI 10.1046/j.1365-2125.1999.00853.x; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1	4	321	334	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					573	574		10.1016/S0140-6736(03)12509-3	http://dx.doi.org/10.1016/S0140-6736(03)12509-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598144				2022-12-24	WOS:000181033400012
J	Thompson, JK; Peterson, MR; Freeman, RD				Thompson, JK; Peterson, MR; Freeman, RD			Single-neuron activity and tissue oxygenation in the cerebral cortex	SCIENCE			English	Article							SENSORY STIMULATION; BLOOD OXYGENATION; FUNCTIONAL MRI; BRAIN; ACTIVATION; SIGNAL; FMRI; COLUMNS	Blood oxygen level-dependent functional magnetic resonance imaging uses alterations in brain hemodynamics to infer changes in neural activity. Are these hemodynamic changes regulated at a spatial scale capable of resolving functional columns within the cerebral cortex? To address this question, we made simultaneous measurements of tissue oxygenation and single-cell neural activity within the visual cortex. Results showed that increases in neuronal spike rate were accompanied by immediate decreases in tissue oxygenation. We used this decrease in tissue oxygenation to predict the orientation selectivity and ocular dominance of neighboring neurons. Our results establish a coupling between neural activity and oxidative metabolism and suggest that high-resolution functional magnetic resonance imaging may be used to localize neural activity at a columnar level.	Univ Calif Berkeley, Helen WIllis Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Helen WIllis Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.				NATIONAL EYE INSTITUTE [R01EY001175, P30EY003176, T32EY007043] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY 07043-24, EY03176, EY01175] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cannestra AF, 2001, CEREB CORTEX, V11, P773, DOI 10.1093/cercor/11.8.773; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; FATT I, 1976, POLAROGRAPHIC OXYGEN, P197; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; Kanaiwa H, 1995, SURG NEUROL, V44, P172, DOI 10.1016/0090-3019(95)00126-3; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Mayhew J, 1999, NEUROIMAGE, V10, P304, DOI 10.1006/nimg.1999.0460; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Yacoub E, 2001, NMR BIOMED, V14, P408, DOI 10.1002/nbm.715; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	21	251	252	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1070	1072		10.1126/science.1079220	http://dx.doi.org/10.1126/science.1079220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586942				2022-12-24	WOS:000180960000049
J	Check, E				Check, E			Cancer fears cast doubts on future of gene therapy	NATURE			English	News Item																		2003, NATURE, V421, P305	1	31	38	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					678	678		10.1038/421678b	http://dx.doi.org/10.1038/421678b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610583	Bronze			2022-12-24	WOS:000180938000005
J	Moller, PR; Nielsen, JG; Fossen, I				Moller, PR; Nielsen, JG; Fossen, I			Fish migration: Patagonian toothfish found off Greenland - This catch is evidence of transequatorial migration by a cold-water Antarctic fish	NATURE			English	Article									Univ Copenhagen, Zool Museum, DK-2100 Copenhagen O, Denmark; More Res, Sect Fisheries, N-6021 Alesund, Norway	University of Copenhagen	Moller, PR (corresponding author), Univ Copenhagen, Zool Museum, DK-2100 Copenhagen O, Denmark.		Møller, Peter/A-8807-2013	Møller, Peter/0000-0002-0177-0977				AGNEW D, 2002, IUCN SSC WILDLIFE TR; ANDRIASHEV AP, 1991, POLAR BIOL, V11, P213; [Anonymous], 1953, ZOOGEOGRAPHY SEA; Balushkin A.V., 2000, J ICHTHYOL+, V40, P74; Dewitt H.H., 1990, P279; DIETRICH G, 1968, ATLAS OCEANOGRAPHIE; Eastman J.T., 1990, P34; Hilbish TJ, 2000, MAR BIOL, V136, P69, DOI 10.1007/s002270050010; Wienecke B, 2002, FISH RES, V54, P253, DOI 10.1016/S0165-7836(00)00307-6; WILLIAMS R, 2002, J SCI COMMITTEE COMM, V9, P33	10	29	31	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					599	599		10.1038/421599a	http://dx.doi.org/10.1038/421599a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571586				2022-12-24	WOS:000180803200031
J	Munoz, N; Bosch, FX; de Sanjose, S; Herrero, R; Castellsague, X; Shah, KV; Snijders, PJF; Meijer, CJLM				Munoz, N; Bosch, FX; de Sanjose, S; Herrero, R; Castellsague, X; Shah, KV; Snijders, PJF; Meijer, CJLM		Int Agcy Res Canc Multicenter Cerv	Epidemiologic classification of human papillomavirus types associated with cervical cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; INFECTION; PCR; IDENTIFICATION; HYBRIDIZATION; NEOPLASIA	Background: Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed. Methods: We pooled data from 11 case-control studies from nine countries involving 1918 women with histologically confirmed squamous-cell cervical cancer and 1928 control women. A common protocol and questionnaire were used. Information on risk factors was obtained by personal interviews, and cervical cells were collected for detection of HPV DNA and typing in a central laboratory by polymerase-chain-reaction-based assays (with MY09/MY11 and GP5+/6+ primers). Results: HPV DNA was detected in 1739 of the 1918 patients with cervical cancer (90.7 percent) and in 259 of the 1928 control women (13.4 percent). With the GP5+/6+ primer, HPV DNA was detected in 96.6 percent of the patients and 15.6 percent of the controls. The most common HPV types in patients, in descending order of frequency, were types 16, 18, 45, 31, 33, 52, 58, and 35. Among control women, types 16, 18, 45, 31, 6, 58, 35, and 33 were the most common. For studies using the GP5+/6+ primer, the pooled odds ratio for cervical cancer associated with the presence of any HPV was 158.2 (95 percent confidence interval, 113.4 to 220.6). The odds ratios were over 45 for the most common and least common HPV types. Fifteen HPV types were classified as high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82); 3 were classified as probable high-risk types (26, 53, and 66); and 12 were classified as low-risk types (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108). There was good agreement between our epidemiologic classification and the classification based on phylogenetic grouping. Conclusions: In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.	Int Agcy Res Canc, F-69372 Lyon, France; Hosp Llobregat, Epidemiol & Canc Registrat Unit, Inst Catalad Oncol, Barcelona, Spain; Costa Rican Fdn Hlth Sci, San Jose, Costa Rica; Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands	World Health Organization; International Agency for Research on Cancer (IARC); Catalan Institute of Oncology; University of Barcelona; Johns Hopkins University; Vrije Universiteit Amsterdam	Munoz, N (corresponding author), Hosp Duran & Reynals, Inst Catalad Oncol, Serv Epidemiol & Registre Canc, Epidemiol & Canc Registrat Unit, Av Gran Via,S-N Km 2 7, Barcelona 08907, Spain.	cris@ico.scs.es	Eluf-Neto, Jose/B-2522-2009; Pique, Xavier Castellsagué/N-5795-2014; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; de Sanjosé Llongueras, Silvia/H-6339-2014	Eluf-Neto, Jose/0000-0001-7504-2115; Pique, Xavier Castellsagué/0000-0002-0802-3595; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; 				Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt;546::AID-IJC9&gt;3.0.CO;2-T; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; Davies P, 2001, BEST PRACT RES CL OB, V15, P677, DOI 10.1053/beog.2001.0214; de Sanjose S, 1999, DIAGN MOL PATHOL, V8, P26, DOI 10.1097/00019606-199903000-00005; De Villiers E-M, 2001, PAPILLOMAVIRUS REP, V12, P57; DURST M, 1987, ONCOGENE, V1, P251; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; *INT AG RES CANC, 1995, IARC MON EV CARC RIS, V64; JACOBS MV, 1995, J CLIN MICROBIOL, V33, P901, DOI 10.1128/JCM.33.4.901-905.1995; Kjaer SK, 1996, INT J CANCER, V65, P601, DOI 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; MANOS MM, 1989, CANCER CEL, V7, P209; McDougall J K, 1994, Curr Top Microbiol Immunol, V186, P101; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; Myers G, 1997, HUMAN PAPILLOMAVIRUS; Ngelangel C, 1998, JNCI-J NATL CANCER I, V90, P43, DOI 10.1093/jnci/90.1.43; Rolon PA, 2000, INT J CANCER, V85, P486, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;486::AID-IJC7&gt;3.0.CO;2-S; Santos C, 2001, BRIT J CANCER, V85, P966, DOI 10.1054/bjoc.2001.1948; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; VANRANST M, 1992, J GEN VIROL, V73, P2653, DOI 10.1099/0022-1317-73-10-2653; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	31	4366	4780	11	485	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					518	527		10.1056/NEJMoa021641	http://dx.doi.org/10.1056/NEJMoa021641			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571259	Green Published			2022-12-24	WOS:000180801400005
J	Moll, AC; Imhof, SM; Cruysberg, JRM; Schouten-van Meeteren, AYN; Boers, M; van Leeuwen, FE				Moll, AC; Imhof, SM; Cruysberg, JRM; Schouten-van Meeteren, AYN; Boers, M; van Leeuwen, FE			Incidence of retinoblastoma in children born after in-vitro fertilisation	LANCET			English	Article							FERTILIZATION; CANCER	Every year, 3000 women in the Netherlands are treated with in-vitro fertilisation (IVF), and results from studies suggest that the offspring of these women do not have a heightened risk of cancer. Between November, 2000, and February, 2002, we diagnosed retinoblastoma in five patients born after IVF. To calculate the relative risk of the disease, we assumed that the proportion of children conceived by IVF in the Netherlands is between 1.0 and 1.5%, and that the five patients who we diagnosed with the disease represent all new cases in the Netherlands during that period. Relative risks for retinoblastoma were significantly raised (7.2 [95% CI 2.4-17.0], and 4.9 [1.6-11.3], for 1% and 1.5% rates, respectively). This possible association of an increased risk of retinoblastoma in a population-based study needs to be established.	Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Paediat Oncol, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands; Univ Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Netherlands Cancer Institute	Moll, AC (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands.	a.moll@vumc.nl	Cruysberg, Johannes R. M./D-4313-2009	Cruysberg, Johannes R. M./0000-0002-5330-0774				Anteby I, 2001, ARCH OPHTHALMOL-CHIC, V119, P1525; Bruinsma F, 2000, HUM REPROD, V15, P604, DOI 10.1093/humrep/15.3.604; Klip H, 2001, HUM REPROD, V16, P2451, DOI 10.1093/humrep/16.11.2451; Koudstaal J, 1999, Ned Tijdschr Geneeskd, V143, P2375; Moll AC, 1997, BRIT J OPHTHALMOL, V81, P559, DOI 10.1136/bjo.81.7.559	5	211	227	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					309	310		10.1016/S0140-6736(03)12332-X	http://dx.doi.org/10.1016/S0140-6736(03)12332-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559867				2022-12-24	WOS:000180643900014
J	Nardi, F; Spinsanti, G; Boore, JL; Carapelli, A; Dallai, R; Frati, F				Nardi, F; Spinsanti, G; Boore, JL; Carapelli, A; Dallai, R; Frati, F			Hexapod origins: Monophyletic or paraphyletic?	SCIENCE			English	Article							MITOCHONDRIAL GENES; PHYLOGENY; ARTHROPODS; INSECTS; CRUSTACEANS; MYRIAPODS; NUCLEAR	Recent morphological and molecular evidence has changed interpretations of arthropod phylogeny and evolution. Here we compare complete mitochondrial genomes to show that Collembola, a wingless group traditionally considered as basal to all insects, appears instead to constitute a separate evolutionary lineage that branched much earlier than the separation of many crustaceans and insects and independently adapted to life on land. Therefore, the taxon Hexapoda, as commonly defined to include all six-legged arthropods, is not monophyletic.	Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Berkeley Lab, Walnut Creek, CA 94598 USA	University of Siena; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Nardi, F (corresponding author), Univ Siena, Dept Evolutionary Biol, Via Aldo Moro 2, I-53100 Siena, Italy.		Carapelli, Antonio/H-9216-2019; Nardi, Francesco/E-5516-2011	Carapelli, Antonio/0000-0002-3165-9620; Nardi, Francesco/0000-0003-0271-9855; Dallai, Romano/0000-0002-2258-8891				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Bitsch C, 2000, ZOOL SCR, V29, P131, DOI 10.1046/j.1463-6409.2000.00036.x; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BRIGGS DEG, 1989, SCIENCE, V246, P241, DOI 10.1126/science.246.4927.241; Carapelli A, 2000, PEDOBIOLOGIA, V44, P361, DOI 10.1078/S0031-4056(04)70055-4; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Dallai R, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P333; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Duman-Scheel M, 1999, DEVELOPMENT, V126, P2327; EMERSON MJ, 1997, ARTHROPOD RELATIONSH, P67; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Garcia-Machado E, 1999, J MOL EVOL, V49, P142, DOI 10.1007/PL00006527; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; Hennig W., 1981, INSECT PHYLOGENY; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Klass KD, 2001, ANN SOC ENTOMOL FR, V37, P265; KRAUS O., 1997, ARTHROPOD RELATIONSH, P295; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; SPEARS T, 1997, ARTHROPOD RELATIONSH, P169; Swofford David L., 1996, P407	24	279	306	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1887	1889		10.1126/science.1078607	http://dx.doi.org/10.1126/science.1078607			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649480				2022-12-24	WOS:000181669700044
J	Onoa, B; Dumont, S; Liphardt, J; Smith, SB; Tinoco, I; Bustamante, C				Onoa, B; Dumont, S; Liphardt, J; Smith, SB; Tinoco, I; Bustamante, C			Identifying kinetic barriers to mechanical unfolding of the T-thermophila ribozyme	SCIENCE			English	Article							CRYSTAL-STRUCTURE; RNA; STABILITY; DOMAIN	Mechanical unfolding trajectories for single molecules of the Tetrahymena thermophila ribozyme display eight intermediates corresponding to discrete kinetic barriers that oppose mechanical unfolding with lifetimes of seconds and rupture forces between 10 and 30 piconewtons. Barriers are magnesium dependent and correspond to known intra- and interdomain interactions. Several barrier structures are "brittle," breakage requiring high forces but small (1 to 3 nanometers) deformations. Barrier crossing is stochastic, leading to variable unfolding paths. The response of complex RNA structures to locally applied mechanical forces may be analogous to the responses of RNA during translation, messenger RNA export from the nucleus, and viral replication.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Liphardt, Jan/A-5906-2012	Liphardt, Jan/0000-0003-2835-5025; Bustamante, Carlos/0000-0002-2970-0073	NIGMS NIH HHS [GM-10840, R01 GM010840, GM-32543] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840, R37GM032543, R01GM032543, R37GM010840] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Bockelmann U, 2002, BIOPHYS J, V82, P1537, DOI 10.1016/S0006-3495(02)75506-9; Bockelmann U, 1998, PHYS REV E, V58, P2386, DOI 10.1103/PhysRevE.58.2386; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Gerland U, 2001, BIOPHYS J, V81, P1324, DOI 10.1016/S0006-3495(01)75789-X; GERLAND U, IN PRESS BIOPHYS; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Juneau K, 2001, STRUCTURE, V9, P221, DOI 10.1016/S0969-2126(01)00579-2; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; LIPHARDT J, UNPUB; Ralston CY, 2000, NAT STRUCT BIOL, V7, P371; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Silverman SK, 2000, BIOCHEMISTRY-US, V39, P12465, DOI 10.1021/bi000828y; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Thirumalai D, 2001, ANNU REV PHYS CHEM, V52, P751, DOI 10.1146/annurev.physchem.52.1.751; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Treiber DK, 2001, CURR OPIN STRUC BIOL, V11, P309, DOI 10.1016/S0959-440X(00)00206-2; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	23	205	211	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2003	299	5614					1892	1895		10.1126/science.1081338	http://dx.doi.org/10.1126/science.1081338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649482	Green Accepted			2022-12-24	WOS:000181669700046
J	Cooper, RS; Kaufman, JS; Ward, R				Cooper, RS; Kaufman, JS; Ward, R			Race and genomics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SOCIOECONOMIC-STATUS; GENETIC-STRUCTURE; HEART-FAILURE; BLACK; WHITE; POLYMORPHISMS; HYPERTENSION; POPULATIONS; PREVALENCE; PATTERNS		Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; Univ Oxford, Dept Biol Anthropol, Oxford, England	Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford	Cooper, RS (corresponding author), Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	rcooper@lumc.edu	Williams, Scott/Q-4812-2019; Templeton, Alan R./F-5963-2011	Williams, Scott/0000-0002-4835-9544; Kaufman, Jay/0000-0003-1606-401X				*ALLHAT OFF COORD, 2000, JAMA-J AM MED ASSOC, V288, P2981; Brancati FL, 1996, ANN EPIDEMIOL, V6, P67, DOI 10.1016/1047-2797(95)00095-X; Brewster LM, 2000, J HYPERTENS, V18, P1537, DOI 10.1097/00004872-200018110-00002; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Chase Allan, 1977, LEGACY MALTHUS SOCIA; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 1997, DIABETES CARE, V20, P343, DOI 10.2337/diacare.20.3.343; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; Dries DL, 2002, J AM COLL CARDIOL, V40, P1019; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Franciosa JA, 2002, J CARD FAIL, V8, P128, DOI 10.1054/jcaf.2002.124730; Freedman BI, 2002, NEPHROL DIAL TRANSPL, V17, P198, DOI 10.1093/ndt/17.2.198; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gould S.J., 1996, MISMEASURE MAN REVIS; Grim CE, 1996, SEMIN NEPHROL, V16, P83; Hajjar RJ, 2002, NEW ENGL J MED, V347, P1196, DOI 10.1056/NEJMe020105; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Henderson SO, 2000, AM J MED SCI, V320, P18, DOI 10.1097/00000441-200007000-00004; Kimm SYS, 2002, AM J CLIN NUTR, V75, P714, DOI 10.1093/ajcn/75.4.714; Montagu A., 1964, CONCEPT RACE; Muntaner C, 1996, AM J EPIDEMIOL, V144, P531; Risch Neil, 2002, GENOME BIO, V3, P1, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Robbins AS, 2000, AM J EPIDEMIOL, V151, P409; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens JC, 2001, SCIENCE, V293, P1048; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Wade N, 2002, N Y Times Web, pF2; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yancy Clyde W, 2002, Curr Cardiol Rep, V4, P218, DOI 10.1007/s11886-002-0054-0; 2002, NAT GENET, V30, P125	34	453	458	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1166	1170		10.1056/NEJMsb022863	http://dx.doi.org/10.1056/NEJMsb022863			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646675				2022-12-24	WOS:000181628400014
J	Wei, XP; Decker, JM; Wang, SY; Hui, HX; Kappes, JC; Wu, XY; Salazar-Gonzalez, JF; Salazar, MG; Kilby, JM; Saag, MS; Komarova, NL; Nowak, MA; Hahn, BH; Kwong, PD; Shaw, GM				Wei, XP; Decker, JM; Wang, SY; Hui, HX; Kappes, JC; Wu, XY; Salazar-Gonzalez, JF; Salazar, MG; Kilby, JM; Saag, MS; Komarova, NL; Nowak, MA; Hahn, BH; Kwong, PD; Shaw, GM			Antibody neutralization and escape by HIV-1	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; PRIMARY INFECTION; TYPE-1; VARIANTS; GLYCOSYLATION; INDIVIDUALS; EMERGENCE; RESPONSES; RESIDUES	Neutralizing antibodies (Nab) are a principal component of an effective human immune response to many pathogens, yet their role in HIV-1 infection is unclear(1-6). To gain a better understanding of this role, we examined plasma from patients with acute HIV infection. Here we report the detection of autologous Nab as early as 52 days after detection of HIV-specific antibodies. The viral inhibitory activity of Nab resulted in complete replacement of neutralization-sensitive virus by successive populations of resistant virus. Escape virus contained mutations in the env gene that were unexpectedly sparse, did not map generally to known neutralization epitopes, and involved primarily changes in N-linked glycosylation. This pattern of escape, and the exceptional density of HIV-1 envelope glycosylation generally(7,8) led us to postulate an evolving 'glycan shield' mechanism of neutralization escape whereby selected changes in glycan packing prevent Nab binding but not receptor binding. Direct support for this model was obtained by mutational substitution showing that Nab-selected alterations in glycosylation conferred escape from both autologous antibody and epitope-specific monoclonal antibodies. The evolving glycan shield thus represents a new mechanism contributing to HIV-1 persistence in the face of an evolving antibody repertoire.	Univ Alabama, Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Inst Adv Study, Princeton, NJ 08540 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Institute for Advanced Study - USA; National Institutes of Health (NIH) - USA	Shaw, GM (corresponding author), Univ Alabama, Howard Hughes Med Inst, 720 S 20th St,KAUL 816, Birmingham, AL 35294 USA.		Nowak, Martin A/A-6977-2008	Kilby, J. Michael/0000-0003-3222-1003; Hahn, Beatrice/0000-0002-9400-9887; Salazar-Gonzalez, Jesus F./0000-0003-4626-6448	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005023, Z01AI005023] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; KUIKEN CL, 2000, HUMAN RETROVIRUSES A; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; MARKOWITZ M, IN PRESS J VIROL; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; Montefiori DC, 2001, J VIROL, V75, P10200, DOI 10.1128/JVI.75.21.10200-10207.2001; Moog C, 1997, J VIROL, V71, P3734, DOI 10.1128/JVI.71.5.3734-3741.1997; MYERS G, 1992, AIDS RES HUM RETROV, V8, P1459, DOI 10.1089/aid.1992.8.1459; Nowak M.A., 2000, VIRAL DYNAMICS; Parren PWHI, 1999, AIDS, V13, pS137; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; RICHMAN DD, IN PRESS P NATL ACAD; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Stewart J. J., 1999, PROFILE QUASISPECIES; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	30	1882	1968	1	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					307	312		10.1038/nature01470	http://dx.doi.org/10.1038/nature01470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646921				2022-12-24	WOS:000181637300039
J	Li, CI; Anderson, BO; Daling, JR; Moe, RE				Li, CI; Anderson, BO; Daling, JR; Moe, RE			Trends in incidence rates of invasive lobular and ductal breast carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; ESTROGEN; CANCER; WOMEN; MANAGEMENT; DIAGNOSIS; PROGESTIN; PATTERNS; RISK	Context Research has suggested that use of combined estrogen and progestin hormone replacement therapy (CHRT) increases breast cancer risk and that CHRT use more strongly associated with the risk of invasive lobular breast carcinoma than that invasive ductal carcinoma. Lobular carcinoma is less common than ductal carcinoma can be more difficult to diagnose because of its subtle elusive. infiltrative pattern. Objective To evaluate trends in invasive lobular and ductal carcinoma incidence from 1987 through 1999, during which time use of CHRT increased in the United Design Descriptive epidemiologic study. Setting Nine cancer registries that participate in the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute and that cover Atlanta, Ga; Detroit, Mich; San Francisco-Oakland, Calif; Seattle, Wash; and Connecticut, Hawaii, Iowa, New Mexico, and Utah., Population Women 30 years of age and older residing in the areas covered by the 9 SEER registries. Main Outcome Measures Proportional changes in incidence rates of invasive lobular and ductal carcinoma among women with no prior history of breast cancer. Results A total of 190458 women were included in this analysis who were identified through the registries as having invasive breast cancer; 7682 of the 198140 potentially eligible women (ie, those identified as not having in situ breast cancer) were I excluded from this analysis because stage of cancer was unknown. Invasive breast cancer incidence rates adjusted for age and for SEER historic stage increased 1.04-fold (95% confidence interval [CI], 1.004-1.07) from 1987-1999 (206.7/100000 to 214.1/100000, age-adjusted). However, incidence rates of tumors classified as lobular increased 1.52-fold (95% CI, 1.42-1.63), and those classified as mixed ductal-lobular increased 1.96-fold (95% CI, 1.80-2.14); rates of these types combined increased 1.65-fold (95% CI, 1.55-1.78) (19.8/100000 to 33.4/100000, age-adjusted). In contrast, ductal carcinoma rates remained largely constant (153.8/100000 to 155.3/100000, age-adjusted; proportional change, 1.03 [95% CI, 0.99-1.061). The proportion of breast cancers with a lobular component increased from 9.5% in 1987 to 15.6% in 1999. Conclusions Ductal carcinoma incidence rates remained essentially constant from 1987-1999 while lobular carcinoma rates increased steadily. This increase presents a clinical challenge given that lobular carcinoma is more difficult to detect than ductal carcinoma by both physical examination and mammography.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Li, CI (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,MP 381,POB 19024, Seattle, WA 98109 USA.				NATIONAL CANCER INSTITUTE [T32CA009168, R01CA085913] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 85913, T32 CA 09168] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Brett KM, 1997, AM J EPIDEMIOL, V145, P536; Carr BR, 1996, EUR J OBSTET GYN R B, V64, pS17, DOI 10.1016/0301-2115(95)02351-8; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Daling JR, 2002, CANCER-AM CANCER SOC, V95, P2455, DOI 10.1002/cncr.10984; DAVIS RP, 1979, ARCH SURG-CHICAGO, V114, P485; DIXON JM, 1982, HISTOPATHOLOGY, V6, P149, DOI 10.1111/j.1365-2559.1982.tb02712.x; DUTOIT RS, 1991, EUR J SURG ONCOL, V17, P251; Evans N, 2000, CLIN RADIOL, V55, P261, DOI 10.1053/crad.1999.0291; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; HEMMINKI E, 1988, American Journal of Public Health, V78, P1479, DOI 10.2105/AJPH.78.11.1479; KENNEDY DL, 1985, OBSTET GYNECOL, V65, P441; Li CI, 2000, CANCER, V88, P2561, DOI 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.3.CO;2-O; Li CI, 2000, CANCER, V88, P2570, DOI 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O; Munot K, 2002, BRIT J SURG, V89, P1296, DOI 10.1046/j.1365-2168.2002.02208.x; *NAT CANC I, SEER DAT QUAL; *NAT CANC I, ABOUT SEER; *NAT CANC I, CHAR SEER POP COMP T; Newcomb PA, 2002, CANCER EPIDEM BIOMAR, V11, P593; Newcomer LM, 1999, AM J EPIDEMIOL, V149, pS79; ROSS RK, 1980, JAMA-J AM MED ASSOC, V243, P1635, DOI 10.1001/jama.243.16.1635; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SILVERSTEIN MJ, 1994, CANCER-AM CANCER SOC, V73, P1673, DOI 10.1002/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B; Skaane P, 1999, ACTA RADIOL, V40, P369, DOI 10.3109/02841859909177749; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; Weinstein SP, 2001, AM J ROENTGENOL, V176, P399, DOI 10.2214/ajr.176.2.1760399; WYSOWSKI DK, 1995, OBSTET GYNECOL, V85, P6, DOI 10.1016/0029-7844(94)00339-F; YEATMAN TJ, 1995, ANN SURG, V222, P549	28	350	361	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1421	1424		10.1001/jama.289.11.1421	http://dx.doi.org/10.1001/jama.289.11.1421			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656PM	12636465	Bronze			2022-12-24	WOS:000181616200034
J	Schoemaker, HE; Mink, D; Wubbolts, MG				Schoemaker, HE; Mink, D; Wubbolts, MG			Dispelling the myths - Biocatalysis in industrial synthesis	SCIENCE			English	Article							DIRECTED EVOLUTION; ENZYME; ACID; COMBINATORIAL; BIOSYNTHESIS; ALDOLASE	Biocatalysis has emerged as an important tool in the industrial synthesis of bulk chemicals, pharmaceutical and agrochemical intermediates, active pharmaceuticals, and food ingredients. However, the number and diversity of the applications are modest, perhaps in part because of perceived or real limitations of biocatalysts, such as limited enzyme availability, substrate scope, and operational stability. Recent scientific breakthroughs in genomics, directed enzyme evolution, and the exploitation of biodiversity should help to overcome these limitations. As a result, we expect many new industrial applications of biocatalysis to be realized, from single-step enzymatic conversions to customized multistep microbial synthesis by means of metabolic pathway engineering.	DSM Res & Patents, Life Sci Prod, NL-6160 MD Geleen, Netherlands; Univ Amsterdam, Inst Mol Chem, NL-1018 WS Amsterdam, Netherlands; DSM Biotech, D-52428 Julich, Germany	DSM NV; University of Amsterdam	Schoemaker, HE (corresponding author), DSM Res & Patents, Life Sci Prod, POB 18, NL-6160 MD Geleen, Netherlands.	hans.schoemaker@dsm.com						Berry A, 2002, J IND MICROBIOL BIOT, V28, P127, DOI 10.1038/sj/jim/7000228; Bruggink A, 1998, ORG PROCESS RES DEV, V2, P128, DOI 10.1021/op9700643; DeSantis G, 2002, J AM CHEM SOC, V124, P9024, DOI 10.1021/ja0259842; Doekel S, 2001, METAB ENG, V3, P64, DOI 10.1006/mben.2000.0170; DRATHS KM, 1994, J AM CHEM SOC, V116, P399, DOI 10.1021/ja00080a057; Drauz K., 2002, ENZYME CATALYSIS ORG; Effenberger F, 2000, CURR OPIN BIOTECH, V11, P532, DOI 10.1016/S0958-1669(00)00141-5; Fahrenkamp-Uppenbrink J, 2002, SCIENCE, V297, P798; Fong S, 2000, CHEM BIOL, V7, P873, DOI 10.1016/S1074-5521(00)00035-1; Gibson JM, 2001, ANGEW CHEM INT EDIT, V40, P1945, DOI 10.1002/1521-3773(20010518)40:10<1945::AID-ANIE1945>3.3.CO;2-X; Griengl H, 2000, TRENDS BIOTECHNOL, V18, P252, DOI 10.1016/S0167-7799(00)01452-9; Halling PJ, 2000, CURR OPIN CHEM BIOL, V4, P74, DOI 10.1016/S1367-5931(99)00055-1; Jokela J, 2002, ENZYME MICROB TECH, V31, P67, DOI 10.1016/S0141-0229(02)00074-1; Kimura T, 1997, J AM CHEM SOC, V119, P11734, DOI 10.1021/ja9720422; Lee MY, 2002, CURR OPIN BIOTECH, V13, P376, DOI 10.1016/S0958-1669(02)00337-3; Liese A., 2000, IND BIOTRANSFORMATIO; Liu JJ, 2002, ANGEW CHEM INT EDIT, V41, P1404, DOI 10.1002/1521-3773(20020415)41:8<1404::AID-ANIE1404>3.0.CO;2-G; May O, 2000, NAT BIOTECHNOL, V18, P317, DOI 10.1038/73773; Michels PC, 1998, TRENDS BIOTECHNOL, V16, P210, DOI 10.1016/S0167-7799(98)01190-1; OYAMA K, 1992, CHIRALITY IND; Panke S, 2002, CURR OPIN BIOTECH, V13, P111, DOI 10.1016/S0958-1669(02)00302-6; Patel R.N., 2000, STEREOSELECTIVE BIOC, Vfirst; Persson BA, 1999, J AM CHEM SOC, V121, P1645, DOI 10.1021/ja983819+; Petersen M, 1999, GREEN CHEM, V1, P99, DOI 10.1039/a809538h; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Reetz MT, 2001, ANGEW CHEM INT EDIT, V40, P284, DOI 10.1002/1521-3773(20010119)40:2<284::AID-ANIE284>3.0.CO;2-N; Reetz MT, 2002, TETRAHEDRON, V58, P6595, DOI 10.1016/S0040-4020(02)00668-3; Robin J, 2001, APPL MICROBIOL BIOT, V57, P357; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rutjes FPJT, 2000, J CHEM SOC PERK T 1, P4197, DOI 10.1039/b001538p; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Short JM, 1997, NAT BIOTECHNOL, V15, P1322, DOI 10.1038/nbt1297-1322; Stemmer Willem P. C., 2002, Biotechnology and Bioprocess Engineering, V7, P121; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Stewart JD, 2001, CURR OPIN CHEM BIOL, V5, P120, DOI 10.1016/S1367-5931(00)00180-0; Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9; Takayama S, 1997, ANNU REV MICROBIOL, V51, P285, DOI 10.1146/annurev.micro.51.1.285; Thomas SM, 2002, TRENDS BIOTECHNOL, V20, P238, DOI 10.1016/S0167-7799(02)01935-2; Ulijn RV, 2002, BIOTECHNOL BIOENG, V80, P509, DOI 10.1002/bit.10396; Wolf LB, 2001, ADV SYNTH CATAL, V343, P662, DOI 10.1002/1615-4169(200108)343:6/7<662::AID-ADSC662>3.0.CO;2-I; Yamada H, 1996, BIOSCI BIOTECH BIOCH, V60, P1391, DOI 10.1271/bbb.60.1391; ZAKS A, 1985, P NATL ACAD SCI USA, V82, P3192, DOI 10.1073/pnas.82.10.3192; Zhu MM, 2002, BIOTECHNOL PROGR, V18, P694, DOI 10.1021/bp020281+	43	615	656	3	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2003	299	5613					1694	1697		10.1126/science.1079237	http://dx.doi.org/10.1126/science.1079237			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637735				2022-12-24	WOS:000181519500034
J	Libby, RT; Smith, RS; Savinova, OV; Zabaleta, A; Martin, JE; Gonzalez, FJ; John, SWM				Libby, RT; Smith, RS; Savinova, OV; Zabaleta, A; Martin, JE; Gonzalez, FJ; John, SWM			Modification of ocular defects in mouse developmental glaucoma models by tyrosinase	SCIENCE			English	Article							PRIMARY CONGENITAL GLAUCOMA; TRANSCRIPTION FACTOR GENE; FETAL DEVELOPMENT; ADRENERGIC CELLS; RETINOIC ACID; NEURAL CREST; PHENOTYPES; PROMOTER; NEURONS; CYP1B1	Mutations in the cytochrome P450 family 1, subfamily B, polypeptide 1 (CYP1B1) gene are a common cause of human primary congenital glaucoma (PCG). Here we show that Cyp1b1(-/-) mice have ocular drainage structure abnormalities resembling those reported in human PCG patients. Using Cyp1b1(-/-) mice, we identified the tyrosinase gene (Tyr) as a modifier of the drainage structure phenotype, with Tyr deficiency increasing the magnitude of dysgenesis. The severe dysgenesis in eyes lacking both CYP1B1 and TYR was alleviated by administration of the tyrosinase product dihydroxyphenylalanine (L-dopa). Tyr also modified the drainage structure dysgenesis in mice with a mutant Foxc1 gene, which is also involved in PCG. These experiments raise the possibility that a tyrosinase/L-dopa pathway modifies human PCG, which could open new therapeutic avenues.	Jackson Lab, Bar Harbor, ME 04609 USA; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; NCI, Lab Metab, Bethesda, MD 20892 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Jackson Laboratory; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University	John, SWM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Libby, Richard/Q-6720-2019	Libby, Richard/0000-0003-2844-7632	NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NCI NIH HHS [CA34196] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN L, 1955, ARCH OPHTHALMOL-CHIC, V53, P783, DOI 10.1001/archopht.1955.00930010791002; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Boissy RE, 1997, PIGM CELL RES, V10, P12, DOI 10.1111/j.1600-0749.1997.tb00461.x; CATALANO RA, 1988, OPHTHALMIC PAED GEN, V9, P5, DOI 10.3109/13816818809031473; Cazorla P, 2000, J NEUROCHEM, V74, P1829, DOI 10.1046/j.1471-4159.2000.0741829.x; Chen H, 2000, DRUG METAB DISPOS, V28, P315; Dellovade TL, 1998, J COMP NEUROL, V402, P402; GENCIK A, 1980, CLIN GENET, V17, P241; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lebel M, 2001, J NEUROCHEM, V77, P558, DOI 10.1046/j.1471-4159.2001.00257.x; MAUMENEE EA, 1958, T AM OPHTHAL SOC, V56, P507; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; RITCH R, 1996, GLAUCOMAS CLIN SCI, V2; Rockwood JM, 1996, EXP CELL RES, V223, P250, DOI 10.1006/excr.1996.0079; Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126; SAVINOVA OV, UNPUB; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smith R S, 2001, BMC Dev Biol, V1, P3, DOI 10.1186/1471-213X-1-3; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; VANDORP DB, 1984, CLIN GENET, V26, P440; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Vitalis T, 2000, J NEUROSCI, V20, P6501, DOI 10.1523/JNEUROSCI.20-17-06501.2000; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	28	160	173	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1578	1581		10.1126/science.1080095	http://dx.doi.org/10.1126/science.1080095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624268				2022-12-24	WOS:000181367900039
J	Takahashi, T; Svoboda, K; Malinow, R				Takahashi, T; Svoboda, K; Malinow, R			Experience strengthening transmission by driving AMPA receptors into synapses	SCIENCE			English	Article							BARREL FIELD CORTEX; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; IN-VIVO; TRAFFICKING; RAT; POTENTIATION; EXPRESSION; MECHANISM	The mechanisms underlying experience-dependent plasticity in the brain may depend on the AMPA subclass of glutamate receptors (AMPA-Rs). We examined the trafficking of AMPA-Rs into synapses in the developing rat barrel cortex. In vivo gene delivery was combined with in vitro recordings to show that experience drives recombinant GluR1, an AMPA-R subunit, into synapses formed between layer 4 and layer 2/3 neurons. Moreover, expression of the GluR1 cytoplasmic tail, a construct that inhibits synaptic delivery of endogenous AMPA-Rs during long-term potentiation, blocked experience-driven synaptic potentiation. In general, synaptic incorporation of AMPA-Rs in vivo conforms to rules identified in vitro and contributes to plasticity driven by natural stimuli in the mammalian brain.	Cold Spring Harbor Lab, Jones Lab, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Malinow, R (corresponding author), Cold Spring Harbor Lab, Jones Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032827, R01NS038259] Funding Source: NIH RePORTER; NINDS NIH HHS [NS032827, NS038259] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; DURHAM D, 1984, J COMP NEUROL, V223, P424, DOI 10.1002/cne.902230308; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Frolov I, 1996, P NATL ACAD SCI USA, V93, P11371, DOI 10.1073/pnas.93.21.11371; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1999, IMAGING LIVING NEURO; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Vees AM, 1998, J COMP NEUROL, V400, P110; WINFIELD DA, 1981, BRAIN RES, V206, P166, DOI 10.1016/0006-8993(81)90110-4; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	29	229	234	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1585	1588		10.1126/science.1079886	http://dx.doi.org/10.1126/science.1079886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624270				2022-12-24	WOS:000181367900041
J	Rortveit, G; Daltveit, AK; Hannestad, YS; Hunskaar, S				Rortveit, G; Daltveit, AK; Hannestad, YS; Hunskaar, S		Norwegian EPINCONT Study	Urinary incontinence after vaginal delivery or cesarean section	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDEMIOLOGIC SURVEY; SEVERITY INDEX; RISK-FACTORS; STRESS-INCONTINENCE; NORWEGIAN EPINCONT; WOMEN; PREVALENCE; PRIMIPARAS; COMMUNITY; VALIDITY	Background: It is uncertain whether women who deliver by cesarean section have an increased risk of urinary incontinence as compared with nulliparous women and whether women who deliver vaginally have an even higher risk. Methods: We studied 15,307 women enrolled in the Epidemiology of Incontinence in the County of Nord-Trondelag (EPINCONT) study, which involved a community-based cohort. The data base for this study was linked to data from the Medical Birth Registry of Norway. We included women who answered questions related to urinary incontinence, were younger than 65 years of age, and had had no deliveries, cesarean sections only, or vaginal deliveries only. Results: The prevalence of any incontinence was 10.1 percent in the nulliparous group; age-standardized prevalences were 15.9 percent in the cesarean-section group and 21.0 percent in the vaginal-delivery group. Corresponding figures for moderate or severe incontinence were 3.7 percent, 6.2 percent, and 8.7 percent, respectively; figures for stress incontinence were 4.7 percent, 6.9 percent, and 12.2 percent, respectively; figures for urge incontinence were 1.6 percent, 2.2 percent, and 1.8 percent, respectively; and figures for mixed-type incontinence were 3.1 percent, 5.3 percent, and 6.1 percent, respectively. As compared with nulliparous women, women who had cesarean sections had an adjusted odds ratio for any incontinence of 1.5 (95 percent confidence interval, 1.2 to 1.9) and an adjusted odds ratio for moderate or severe incontinence of 1.4 (95 percent confidence interval, 1.0 to 2.1). Only stress and mixed-type incontinence were significantly associated with cesarean sections. The adjusted odds ratio for any incontinence associated with vaginal deliveries as compared with cesarean sections was 1.7 (95 percent confidence interval, 1.3 to 2.1), and the adjusted odds ratio for moderate or severe incontinence was 2.2 (95 percent confidence interval, 1.5 to 3.1). Only stress incontinence (adjusted odds ratio, 2.4; 95 percent confidence interval, 1.7 to 3.2) was associated with the mode of delivery. Conclusions: The risk of urinary incontinence is higher among women who have had cesarean sections than among nulliparous women and is even higher among women who have had vaginal deliveries. However, these findings should not be used to justify an increase in the use of cesarean sections.	Univ Bergen, Sect Gen Practice, Dept Publ Hlth & Primary Hlth Care, N-5009 Bergen, Norway; Univ Bergen, Dept Publ Hlth & Primary Hlth Care, EPINCONT, Bergen, Norway; Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Prevent Med, Bergen, Norway; Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Rortveit, G (corresponding author), Univ Bergen, Sect Gen Practice, Dept Publ Hlth & Primary Hlth Care, Ulriksdal 8C, N-5009 Bergen, Norway.							Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Chiarelli P, 1999, NEUROUROL URODYNAM, V18, P567, DOI 10.1002/(SICI)1520-6777(1999)18:6<567::AID-NAU7>3.0.CO;2-F; Farrell SA, 2001, OBSTET GYNECOL, V97, P350, DOI 10.1016/S0029-7844(00)01164-9; Hanley J, 2001, BRIT MED J, V322, P1096, DOI 10.1136/bmj.322.7294.1096; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; HOLMEN J, 1990, Tidsskrift for den Norske Laegeforening, V110, P1973; Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021; IOSIF CS, 1982, INT J GYNECOL OBSTET, V20, P87, DOI 10.1016/0020-7292(82)90017-0; JOLLEYS JV, 1988, BRIT MED J, V296, P1300, DOI 10.1136/bmj.296.6632.1300; King JK, 1998, BRIT J OBSTET GYNAEC, V105, P1300, DOI 10.1111/j.1471-0528.1998.tb10009.x; Kuh D, 1999, J EPIDEMIOL COMMUN H, V53, P453, DOI 10.1136/jech.53.8.453; Persson J, 2000, OBSTET GYNECOL, V96, P440, DOI 10.1016/S0029-7844(00)00950-9; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; SANDVIK H, 1995, J CLIN EPIDEMIOL, V48, P339, DOI 10.1016/0895-4356(94)00147-I; SEIM A, 1995, FAM PRACT, V12, P18, DOI 10.1093/fampra/12.1.18; SNOOKS SJ, 1990, BRIT J SURG, V77, P1358, DOI 10.1002/bjs.1800771213; Thom DH, 1998, J AM GERIATR SOC, V46, P1411; VIKTRUP L, 1992, OBSTET GYNECOL, V79, P945; Wilson PD, 1996, BRIT J OBSTET GYNAEC, V103, P154, DOI 10.1111/j.1471-0528.1996.tb09668.x	21	501	518	2	15	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					900	907		10.1056/NEJMoa021788	http://dx.doi.org/10.1056/NEJMoa021788			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621134	Bronze			2022-12-24	WOS:000181341100005
J	Bowler, JM; Johnston, H; Olley, JM; Prescott, JR; Roberts, RG; Shawcross, W; Spooner, NA				Bowler, JM; Johnston, H; Olley, JM; Prescott, JR; Roberts, RG; Shawcross, W; Spooner, NA			New ages for human occupation and climatic change at Lake Mungo, Australia	NATURE			English	Article							OLDEST HUMAN REMAINS; EXTINCTION; MEGAFAUNA; SKELETON; DATES; SITE	Australia's oldest human remains, found at Lake Mungo, include the world's oldest ritual ochre burial (Mungo III)(1) and the first recorded cremation (Mungo I)(2). Until now, the importance of these finds has been constrained by limited chronologies and palaeoenvironmental information(3). Mungo III, the source of the world's oldest human mitochondrial DNA(4), has been variously estimated at 30 thousand years (kyr) old(1), 42-45 kyr old(5,6) and 62 +/- 6 kyr old(7,8), while radiocarbon estimates placed the Mungo I cremation near 20-26 kyr ago(2,9,10). Here we report a new series of 25 optical ages showing that both burials occurred at 40 +/- 2 kyr ago and that humans were present at Lake Mungo by 50-46 kyr ago, synchronously with, or soon after, initial occupation of northern(11,12) and western Australia(13). Stratigraphic evidence indicates fluctuations between lake-full and drier conditions from 50 to 40 kyr ago, simultaneously with increased dust deposition, human arrival and continent-wide extinction of the megafauna(14),(15). This was followed by sustained aridity between 40 and 30 kyr ago. This new chronology corrects previous estimates for human burials at this important site and provides a new picture of Homo sapiens adapting to deteriorating climate in the world's driest inhabited continent.	Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; NSW Natl Parks & Wildlife Serv, Buronga, NSW 2739, Australia; CSIRO Land & Water, Canberra, ACT 2601, Australia; Univ Adelaide, Dept Phys & Math Phys, Adelaide, SA 5005, Australia; Univ Wollongong, Sch Geosci, Wollongong, NSW 2522, Australia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; University of Wollongong; Australian National University	Bowler, JM (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia.	j.bowler@earthsci.unimelb.edu.au	Roberts, Richard Graham/B-8245-2013	Roberts, Richard Graham/0000-0002-0128-4119				Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Aitken M.J., 1998, INTRO OPTICAL DATING; BARBETTI M, 1972, NATURE, V239, P327, DOI 10.1038/239327a0; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; BELL WT, 1991, ARCHAEOMETRY, V33, P43, DOI 10.1111/j.1475-4754.1991.tb00684.x; Bowler J.M., 1998, ARCHAEOL OCEAN, V33, P120, DOI DOI 10.1002/J.1834-4453.1998.TB00414.X; Bowler J. M., 1998, ARCHAEOL OCEAN, V33, P156; Bowler J.M., 1976, ORIGIN AUSTR, P127; BOWLER JM, 1970, WORLD ARCHAEOL, V2, P39, DOI 10.1080/00438243.1970.9979463; BOWLER JM, 1972, NATURE, V240, P48, DOI 10.1038/240048a0; Bowler JM, 2000, J HUM EVOL, V38, P719, DOI 10.1006/jhev.1999.0397; Burnett W.C., 1992, URANIUM SERIES DISEQ, P486; Gillespie R, 2000, J HUM EVOL, V38, P727, DOI 10.1006/jhev.1999.0398; Gillespie R, 1997, RADIOCARBON, V39, P239, DOI 10.1017/S0033822200053236; Grun R, 2000, J HUM EVOL, V38, P733, DOI 10.1006/jhev.2000.0399; Hope JH, 1978, ALCHERINGA, V2, P65, DOI 10.1080/03115517808619080; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; HUXTABLE J, 1977, NATURE, V265, P40, DOI 10.1038/265040a0; Laj C, 2000, PHILOS T ROY SOC A, V358, P1009, DOI 10.1098/rsta.2000.0571; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Oyston B, 1996, QUATERNARY SCI REV, V15, P739, DOI 10.1016/0277-3791(96)00025-X; RADCZEWSKI OE, 1960, SPECIAL PUBLICATION, V4, P496; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Shawcross W., 1998, ARCHAEOL OCEAN, V33, P183; Simpson JJ, 1998, QUATERNARY SCI REV, V17, P1009, DOI 10.1016/S0277-3791(97)00088-7; Thorne A, 1999, J HUM EVOL, V36, P591, DOI 10.1006/jhev.1999.0305; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195	29	455	473	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					837	840		10.1038/nature01383	http://dx.doi.org/10.1038/nature01383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	646QA	12594511				2022-12-24	WOS:000181044700046
J	Giles, J; Knight, J				Giles, J; Knight, J			Dolly's death leaves researchers woolly on clone ageing issue	NATURE			English	News Item																		Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262	2	4	6	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					776	776		10.1038/421776a	http://dx.doi.org/10.1038/421776a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594470	Bronze			2022-12-24	WOS:000181044700010
J	Lobell, DB; Asner, GP				Lobell, DB; Asner, GP			Climate and management contributions to recent trends in US agricultural yields	SCIENCE			English	Article							WORLD		Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Lobell, DB (corresponding author), Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA.		Zhong, Hong Lin/C-2633-2012; Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Lobell, David/0000-0002-5969-3476				Brown RA, 1997, AGR FOREST METEOROL, V83, P171, DOI 10.1016/S0168-1923(96)02352-0; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Conway G, 1999, NATURE, V402, pC55, DOI [10.1038/35011545, 10.1038/990141]; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0	5	538	609	5	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1032	1032		10.1126/science.1077838	http://dx.doi.org/10.1126/science.1077838			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586935				2022-12-24	WOS:000180960000036
J	Grodstein, F; Clarkson, TB; Manson, JE				Grodstein, F; Clarkson, TB; Manson, JE			Understanding the divergent data on postmenopausal hormone therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESTROGEN REPLACEMENT THERAPY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY EVENTS; WOMEN; ATHEROSCLEROSIS; MORTALITY; RISK; INFLAMMATION		Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Grodstein, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.							Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; Cline JM, 1996, AM J OBSTET GYNECOL, V174, P93, DOI 10.1016/S0002-9378(96)70379-4; Collaborative Group on Hormonal Factors in Breast Cancer, 1997, LANCET, V350, P1484; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1996, NEW ENGL J MED, V335, P1406; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; Grodstein F, 2001, ANN INTERN MED, V135, P1, DOI 10.7326/0003-4819-135-1-200107030-00003; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; GRODSTEIN F, 2002, THROMBOSIS THROMBOEM; Heckbert SR, 2001, ARCH INTERN MED, V161, P1709, DOI 10.1001/archinte.161.14.1709; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Herrington DM, 2001, ARTERIOSCL THROM VAS, V21, P1955, DOI 10.1161/hq1201.100241; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Manson JE, 2001, NEW ENGL J MED, V345, P34, DOI 10.1056/NEJM200107053450106; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; MCGILL HC, 1979, ATHER REV, V4, P157; Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7; Petitti Diana B., 1994, Annals of Epidemiology, V4, P115; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rimm EB, 2000, MED CLIN N AM, V84, P239, DOI 10.1016/S0025-7125(05)70216-9; Rodriguez C, 2001, AM J EPIDEMIOL, V153, P145, DOI 10.1093/aje/153.2.145; ROSENBERG L, 1993, AM J EPIDEMIOL, V137, P54, DOI 10.1093/oxfordjournals.aje.a116602; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; Sourander L, 1999, LANCET, V353, P330; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; TEJADA C, 1968, LAB INVEST, V18, P509; Zanger D, 2000, J AM COLL CARDIOL, V36, P1797, DOI 10.1016/S0735-1097(00)00952-9	40	258	265	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					645	650		10.1056/NEJMsb022365	http://dx.doi.org/10.1056/NEJMsb022365			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584376				2022-12-24	WOS:000180912900012
J	Buavirat, A; Page-Shafer, K; van Griensven, GJP; Mandel, JS; Evans, J; Chuaratanaphong, J; Chiamwongpat, S; Sacks, R; Moss, A				Buavirat, A; Page-Shafer, K; van Griensven, GJP; Mandel, JS; Evans, J; Chuaratanaphong, J; Chiamwongpat, S; Sacks, R; Moss, A			Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ATTRIBUTABLE RISK; PRISON SYSTEM; TRANSMISSION; PREVENTION; BEHAVIOR; INMATES; COHORT; POLICY	Objectives To identify risks for HIV infection related to incarceration among injecting drug users in Bangkok, Thailand. Design Case-control study of sexual and parenteral exposures occurring before, during, and after the most recent incarceration. Setting Metropolitan Bangkok. Participants Non-prison based injecting drug users formerly incarcerated for at least six months in the previous five years, with documented HIV serostatus since their most recent release; 175 HIV positive cases and 172 HIV negative controls from methadone clinics. Main outcome measure Injection of heroin and methamphetamine, sharing of needles, sexual behaviour, and tattooing before, during, and after incarceration. Results In the month before detention cases were more likely than controls to have injected methamphetamine and to have borrowed needles. More cases than controls reported using drugs (60% v 45%; P=0.005) and sharing needles (50% v 31%; P<0.01) in the holding cell before incarceration. Independent risk factors for prevalent HIV infection included injection of methamphetamine before detention (adjusted odds ratio 3.3, 95% confidence interval 1.01 to 10.7), sharing needles in the holding cell (1.9, 1.2 to 3.0), being tattooed while in prison (2.1, 1.3 to 3.4), and borrowing needles after release (2.5, 1.3 to 4.4). Conclusions Injecting drug users in Bangkok are at significantly increased risk of HIV infection through sharing needles with multiple partners while in holding cells before incarceration. The time spent in holding cells is an important opportunity to provide risk reduction counselling and intervention to reduce the incidence of HIV.	Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA 94105 USA; Dept Hlth, Hlth Promot Div, Bangkok 10400, Thailand; Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; Minist Publ Hlth, HIV AIDS Program, Thailand MOPH US CDC Collaborat, Nonthaburi 11000, Thailand; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ministry of Public Health - Thailand; University of California System; University of California San Francisco	Page-Shafer, K (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, 74 New Montgomery, San Francisco, CA 94105 USA.		; van Griensven, Frits/G-4719-2013	Page, Kimberly/0000-0002-7120-1673; van Griensven, Frits/0000-0002-0971-2843	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER; NIMH NIH HHS [5 P50 MH42459, P50 MH042459] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allwright S, 2000, BRIT MED J, V321, P78, DOI 10.1136/bmj.321.7253.78; *ASS STAT TERR HLT, 1999, WHY PUBL HLTH SHOULD, P1; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; Braithwaite RL, 1999, J PUBLIC HEALTH POL, V20, P459, DOI 10.2307/3343131; BREWER TF, 1988, AIDS, V2, P363, DOI 10.1097/00002030-198810000-00005; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; BUAVIRAT A, IN PRESS AIDS PUBLIC; Chesney MA, 1998, AM J PUBLIC HEALTH, V88, P113, DOI 10.2105/AJPH.88.1.113; CHOOPANYA K, 1991, AIDS, V5, P1509, DOI 10.1097/00002030-199112000-00014; Diaz RS, 1999, AIDS, V13, P1417, DOI 10.1097/00002030-199907300-00024; DOLAN K, 1995, AIDS, V9, P825, DOI 10.1097/00002030-199508000-00001; Dolan KA, 1999, MED J AUSTRALIA, V171, P14, DOI 10.5694/j.1326-5377.1999.tb123490.x; Edwards A, 1999, INT J STD AIDS, V10, P464, DOI 10.1258/0956462991914474; Entz AT, 2000, AIDS, V14, P1027, DOI 10.1097/00002030-200005260-00015; Frischer M, 1997, ADDICTION, V92, P419, DOI 10.1046/j.1360-0443.1997.9244196.x; Gaiter J, 1996, AM J PUBLIC HEALTH, V86, P1201, DOI 10.2105/AJPH.86.9.1201; Grinstead OA, 1999, HEALTH EDUC BEHAV, V26, P225, DOI 10.1177/109019819902600206; KITAYAPORN D, 1994, AIDS, V8, P1443, DOI 10.1097/00002030-199410000-00011; Kral AH, 1998, AM J PUBLIC HEALTH, V88, P108, DOI 10.2105/AJPH.88.1.108; Mahon N, 1996, AM J PUBLIC HEALTH, V86, P1211, DOI 10.2105/AJPH.86.9.1211; Sattah MV, 2002, ADDICTION, V97, P801, DOI 10.1046/j.1360-0443.2002.00131.x; Surasiengsunk S, 1998, AIDS, V12, P775, DOI 10.1097/00002030-199807000-00014; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013	24	87	92	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					308	310A		10.1136/bmj.326.7384.308	http://dx.doi.org/10.1136/bmj.326.7384.308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645UD	12574043	Green Published, Bronze			2022-12-24	WOS:000180997000017
J	Foth, BJ; Ralph, SA; Tonkin, CJ; Struck, NS; Fraunholz, M; Roos, DS; Cowman, AF; McFadden, GI				Foth, BJ; Ralph, SA; Tonkin, CJ; Struck, NS; Fraunholz, M; Roos, DS; Cowman, AF; McFadden, GI			Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum	SCIENCE			English	Article							CHLOROPLAST TRANSIT PEPTIDES; TOXOPLASMA-GONDII; SIGNAL PEPTIDES; LEADER SEQUENCE; IN-VIVO; MITOCHONDRIAL; IDENTIFICATION; PRECURSORS; PROTEINS; IMPORT	Transit peptides mediate protein targeting into plastids and are only poorly understood. We extracted amino acid features from transit peptides that target proteins to the relict plastid (apicoplast) of malaria parasites. Based on these amino acid characteristics, we identified 466 putative apicoplast proteins in the Plasmodium falciparum genome. Altering the specific charge characteristics in a model transit peptide by site-directed mutagenesis severely disrupted organellar targeting in vivo. Similarly, putative Hsp70 (DnaK) binding sites present in the transit peptide proved to be important for correct targeting.	Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Melbourne; University of Pennsylvania; Walter & Eliza Hall Institute	McFadden, GI (corresponding author), Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia.	gim@unimelb.edu.au	McFadden, Geoffrey McFadden I/F-7667-2014; Tonkin, Christopher/K-6534-2019; Cowman, Alan F/C-7642-2013; Ralph, Stuart/C-8590-2014	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Tonkin, Christopher/0000-0002-7036-6222; Cowman, Alan F/0000-0001-5145-9004; Ralph, Stuart/0000-0003-0114-7808; Roos, David Siker/0000-0001-6725-4089				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heard TS, 1998, J BIOL CHEM, V273, P29389, DOI 10.1074/jbc.273.45.29389; Ivey RA, 2000, PLANT PHYSIOL, V122, P1289, DOI 10.1104/pp.122.4.1289; Ivey RA, 2000, CELL STRESS CHAPERON, V5, P62, DOI 10.1379/1466-1268(2000)005<0062:IVAIVI>2.0.CO;2; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; Jarvis P, 2002, BBA-MOL CELL RES, V1590, P177, DOI 10.1016/S0167-4889(02)00176-3; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Ni L, 1999, J BIOL CHEM, V274, P12685, DOI 10.1074/jbc.274.18.12685; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2001, BBA-MOL CELL RES, V1541, P34, DOI 10.1016/S0167-4889(01)00154-9; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Yung S, 2001, MOL BIOCHEM PARASIT, V118, P11, DOI 10.1016/S0166-6851(01)00359-0; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	27	369	377	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					705	708		10.1126/science.1078599	http://dx.doi.org/10.1126/science.1078599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560551				2022-12-24	WOS:000180687700046
J	Yoshikawa, S; McKinnon, RD; Kokel, M; Thomas, JB				Yoshikawa, S; McKinnon, RD; Kokel, M; Thomas, JB			Wnt-mediated axon guidance via the Drosophila derailed receptor	NATURE			English	Article							TYROSINE KINASE FAMILY; ROBO RECEPTORS; CNS MIDLINE; COMMISSURAL AXONS; VENTRAL ECTODERM; WINGLESS GENE; EXPRESSION; PROTEIN; RYK; DIFFERENTIATION	In nervous systems with bilateral symmetry, many neurons project axons across the midline to the opposite side. In each segment of the Drosophila embryonic nervous system, axons that display this projection pattern choose one of two distinct tracts: the anterior or posterior commissure. Commissure choice is controlled by Derailed, an atypical receptor tyrosine kinase expressed on axons projecting in the anterior commissure. Here we show that Derailed keeps these axons out of the posterior commissure by acting as a receptor for Wnt5, a member of the Wnt family of secreted signalling molecules. Our results reveal an unexpected role in axon guidance for a Wnt family member, and show that the Derailed receptor is an essential component of Wnt signalling in these guidance events.	Salk Inst Biol Studies, Mol Neurobiol Lab, San Diego, CA 92186 USA; Robert Wood Johnson Med Sch, Dept Surg, Piscataway, NJ 08854 USA; Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol, Piscataway, NJ 08854 USA	Salk Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Thomas, JB (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, POB 85800, San Diego, CA 92186 USA.		McKinnon, Randall D/B-4699-2010	McKinnon, Randall/0000-0002-7539-9613				Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dittrich R, 1997, DEVELOPMENT, V124, P2515; EISENBERG LM, 1992, DEV BIOL, V154, P73, DOI 10.1016/0012-1606(92)90049-M; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Gieseler K, 1999, MECH DEVELOP, V85, P123, DOI 10.1016/S0925-4773(99)00097-0; Golembo M, 1996, DEVELOPMENT, V122, P3363; Halford MM, 1999, J BIOL CHEM, V274, P7379, DOI 10.1074/jbc.274.11.7379; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Katso RM, 1999, MOL CELL BIOL, V19, P6427; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moreau-Fauvarque C, 2002, NEUROREPORT, V13, P2309, DOI 10.1097/00001756-200212030-00028; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; RUSSELL J, 1992, DEVELOPMENT, V115, P475; Savant-Bhonsale S, 1999, GENE, V231, P155, DOI 10.1016/S0378-1119(99)00061-X; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yoshikawa S, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0002.2001	50	328	333	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					583	588		10.1038/nature01522	http://dx.doi.org/10.1038/nature01522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12660735				2022-12-24	WOS:000182111400033
J	Beroud, C; Karliova, M; Bonnefont, JP; Benachi, A; Munnich, A; Dumez, Y; Lacour, B; Paterlini-Brechot, P				Beroud, C; Karliova, M; Bonnefont, JP; Benachi, A; Munnich, A; Dumez, Y; Lacour, B; Paterlini-Brechot, P			Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells	LANCET			English	Article							MATERNAL BLOOD	Spinal muscular atrophy (SMA) has a prevalence of one in 6000 births and a one in 40 heterozygote frequency. We aimed to develop a routine test for non-invasive prenatal diagnosis. We tested blood with ISET (isolation by size of epithelial tumour or trophoblastic cells) in 12 pregnant women whose babies were at risk of SMA. Using genetic analysis of fetal cells, we identified SMA In all nine Isolated from the three mothers carrying an affected child. There was no mutation in any of the 26 fetal cells isolated from the nine women with an unaffected child. Our results show that non-invasive detection of genetic diseases by the analysis of maternal blood is feasible.	Hop Necker Enfants Malad, Lab Biochim A, Paris, France; Hop Necker Enfants Malad, Serv Matern, Paris, France; Hop Necker Enfants Malad, Med Genet Lab, Paris, France; Hop Necker Enfants Malad, Lab Biochim B, Paris, France; Fac Med Necker Enfants Malad, INSERM, U370, F-75730 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Paterlini-Brechot, P (corresponding author), Hop Necker Enfants Malad, Lab Biochim A, Paris, France.		BEROUD, Christophe/A-8381-2008	BEROUD, Christophe/0000-0003-2986-8738; BONNEFONT, Jean-Paul/0000-0002-4235-1197; Paterlini- Brechot, Patrizia/0000-0001-7981-6325				Bianchi DW, 1999, BRIT J HAEMATOL, V105, P574, DOI 10.1046/j.1365-2141.1999.01383.x; Chan V, 1998, LANCET, V352, P1196, DOI 10.1016/S0140-6736(05)60535-1; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Saugier-Veber P, 2001, J MED GENET, V38, P240, DOI 10.1136/jmg.38.4.240; Vona G, 2002, AM J PATHOL, V160, P51, DOI 10.1016/S0002-9440(10)64348-9	5	31	56	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 22	2003	361	9362					1013	1014		10.1016/S0140-6736(03)12798-5	http://dx.doi.org/10.1016/S0140-6736(03)12798-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658AP	12660061				2022-12-24	WOS:000181699700014
J	Wilczak, N; de Vos, RAI; De Keyser, J				Wilczak, N; de Vos, RAI; De Keyser, J			Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis	LANCET			English	Article							PROGRAMMED CELL-DEATH; FACTOR-I; ALS; SYSTEM; MUSCLE; CORDS; NERVE	Background Insulin-like growth factor-I (IGF-I) is a potent survival factor for motor neurons and is being investigated as possible therapeutic agent for amyotrophic lateral sclerosis. However, very little information is available on the components of the IGF-I system in this disease. Insulinlike growth factor binding proteins (IGFBPs) play an important part in regulating the bioavailability of IGF-I. Methods We investigated the components of the IGF-I system in spinal cord sections of ten patients with amyotrophic lateral sclerosis and in ten controls without neurological disease. IGF-I was studied by western immunoblotting. IGFBPs and IGF-I receptors were investigated by immunohistochemistry and Western immunoblotting. Findings Total IGF-I in ventral horn homogenates did not differ between patients and controls. However, free IGF-I was 53% lower in patients than in controls. Compared with controls, immunoreactivity in the spinal motor neurons of patients with amyotrophic lateral sclerosis was 64% higher for IGFBP2, 46% higher for IGFBP5, and 33% higher for IGFBP6, with upregulation of IGF-I receptors. Immunoreactivity for IGFBPs1, 3, and 4 did not differ between patients and controls. Interpretation In the ventral horns of patients, free IGF-I is reduced, which could be because of specific increases in IGFBPs 2, 5, and 6 in spinal motor neurons. This abnormality might have an important role in the processes leading to motor neuron death, and should be taken into account when developing treatments aimed to stimulate IGF-I receptors in motor neurons.	Acad Ziekenhuis Groningen, Dept Neurol, Groningen, Netherlands; Oost Nederland, Dept Pathol, Enschede, Netherlands	University of Groningen	De Keyser, J (corresponding author), Univ Groningen Hosp, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.		Wilczak, Nadine/G-4422-2011; De Keyser, Jacques/D-3725-2013	De Keyser, Jacques/0000-0002-3394-7757				ADEM A, 1994, MOL NEUROBIOL, V9, P225, DOI 10.1007/BF02816121; Babajko S, 1997, J ENDOCRINOL, V152, P221, DOI 10.1677/joe.0.1520221; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; BRAUNSTEIN GD, 1987, J NEUROL NEUROSUR PS, V50, P792, DOI 10.1136/jnnp.50.6.792; Brooke MH, 1996, NEUROLOGY, V47, pS108, DOI 10.1212/WNL.47.4_Suppl_2.108S; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Chou SM, 1998, J NEUROL SCI, V160, pS73, DOI 10.1016/S0022-510X(98)00202-0; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; D'Costa AP, 1998, J NEUROBIOL, V36, P379; DENYS EH, 1988, MUSCLE NERVE, V11, P1000; Dore S, 1996, MOL BRAIN RES, V41, P128, DOI 10.1016/0169-328X(96)00081-2; FESTOFF BW, 1995, J NEUROL SCI, V129, P114, DOI 10.1016/0022-510X(95)00080-L; Gustafsson T, 1999, J ENDOCRINOL, V161, P245, DOI 10.1677/joe.0.1610245; Hammarberg H, 1998, J COMP NEUROL, V400, P57; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KERKHOFF H, 1994, ACTA NEUROPATHOL, V87, P411, DOI 10.1007/BF00313611; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; LEWIS ME, 1993, EXP NEUROL, V124, P73, DOI 10.1006/exnr.1993.1177; Loddick SA, 1998, P NATL ACAD SCI USA, V95, P1894, DOI 10.1073/pnas.95.4.1894; Meins M, 2001, J NEUROSCI, V21, P8830, DOI 10.1523/JNEUROSCI.21-22-08830.2001; NEUHOFF V, 1979, H-S Z PHYSIOL CHEM, V360, P1657, DOI 10.1515/bchm2.1979.360.2.1657; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sueoka N, 2000, AM J RESP CELL MOL, V23, P297, DOI 10.1165/ajrcmb.23.3.4013; Sueoka N, 2000, ONCOGENE, V19, P4432, DOI 10.1038/sj.onc.1203813; Torres-Aleman I, 1998, NEUROLOGY, V50, P772, DOI 10.1212/WNL.50.3.772; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035	27	71	76	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 22	2003	361	9362					1007	1011		10.1016/S0140-6736(03)12828-0	http://dx.doi.org/10.1016/S0140-6736(03)12828-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658AP	12660059				2022-12-24	WOS:000181699700012
J	Grueber, WB; Jan, LY; Jan, YN				Grueber, WB; Jan, LY; Jan, YN			Different levels of the homeodomain protein cut regulate distinct dendrite branching patterns of Drosophila multidendritic neurons	CELL			English	Article							SENSORY ORGAN IDENTITY; PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE-COMPLEX; DNA-BINDING; BICOID PROTEIN; MOTOR-NEURON; EXPRESSION; LOCUS; SPECIFICATION; TRANSFORMATION	Functionally similar neurons can share common dendrite morphology, but how different neurons are directed into similar forms is not understood. Here, we show in embryonic and larval development that the level of Cut immunoreactivity in individual dendritic arborization (da) sensory neurons correlates with distinct patterns of terminal dendrites: high Cut in neurons with extensive unbranched terminal protrusions (dendritic spikes), medium levels in neurons with expansive and complex arbors, and low or nondetectable Cut in neurons with simple dendrites. Loss of Cut reduced dendrite growth and class-specific terminal branching, whereas overexpression of Cut or a mammalian homolog in lower-level neurons resulted in transformations toward the branch morphology of high-Cut neurons. Thus, different levels of a homeoprotein can regulate distinct patterns of dendrite branching.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, Dept Biochem, 533 Parnassus Ave,Room U226, San Francisco, CA 94143 USA.	ynjan@itsa.ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Grueber, Wesley/0000-0001-6751-256X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929, F32NS043027, T32NS007067] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS007067-23, 1R01 NS 40929-0, 1 F32 NS43027-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; ANDRES V, 1992, DEVELOPMENT, V116, P321; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Beck JC, 2000, J NEUROSCI METH, V98, P155, DOI 10.1016/S0165-0270(00)00200-4; BLOCHLINGER K, 1993, DEVELOPMENT, V117, P441; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; Brewster R, 2001, MECH DEVELOP, V105, P57, DOI 10.1016/S0925-4773(01)00375-6; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; DAMBLYCHAUDIERE C, 1987, GENE DEV, V1, P297, DOI 10.1101/gad.1.3.297; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; JACK JW, 1985, CELL, V42, P869, DOI 10.1016/0092-8674(85)90283-1; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; KOESTER SE, 1992, J NEUROSCI, V12, P1382; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LIU S, 1991, GENETICS, V127, P151; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Ludlow C, 1996, DEV BIOL, V178, P149, DOI 10.1006/dbio.1996.0205; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Merritt DJ, 1997, MICROSC RES TECHNIQ, V39, P492, DOI 10.1002/(SICI)1097-0029(19971215)39:6<492::AID-JEMT4>3.0.CO;2-G; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Quaggin SE, 1996, J BIOL CHEM, V271, P22624, DOI 10.1074/jbc.271.37.22624; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VALARCHE I, 1993, DEVELOPMENT, V119, P881; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; YOON SO, 1994, J BIOL CHEM, V269, P18453; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	47	225	230	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 21	2003	112	6					805	818		10.1016/S0092-8674(03)00160-0	http://dx.doi.org/10.1016/S0092-8674(03)00160-0			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654247	Bronze			2022-12-24	WOS:000181818500008
J	Whitfield, J				Whitfield, J			Alien-hunters get scope to search	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					249	249		10.1038/422249b	http://dx.doi.org/10.1038/422249b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646886	Bronze			2022-12-24	WOS:000181637300010
J	Kaniecki, R				Kaniecki, R			Headache assessment and management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TENSION-TYPE HEADACHE; AMERICAN MIGRAINE; UNITED-STATES; SUMATRIPTAN; POPULATION; EPIDEMIOLOGY; PREVALENCE; MEDICATION		Univ Pittsburgh, Dept Neurol, Headache Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaniecki, R (corresponding author), Univ Pittsburgh, Dept Neurol, Headache Ctr, 120 Lytton Ave,Suite 300, Pittsburgh, PA 15213 USA.	kanieckirg@msx.upmc.edu						*AM AC NEUR, 2003, AAN ENC KIT HEAD; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Barbanti P, 2002, CEPHALALGIA, V22, P256, DOI 10.1046/j.1468-2982.2002.00358.x; Bigal ME, 2000, HEADACHE, V40, P241, DOI 10.1046/j.1526-4610.2000.00035.x; Cady RK, 2000, CLIN THER, V22, P1035, DOI 10.1016/S0149-2918(00)80083-1; CARP H, 1994, ANESTH ANALG, V79, P180; DOWSON A, 2002, CEPHALALGIA, V22, P590; FRISHBERG BM, 2003, EVIDENCE BASED GUIDE; Halpern MT, 2002, HEADACHE, V42, P984, DOI 10.1046/j.1526-4610.2002.02228.x; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Jensen Rigmor, 2001, Curr Treat Options Neurol, V3, P169, DOI 10.1007/s11940-001-0052-3; Kaniecki RG, 2002, NEUROLOGY, V58, pS15, DOI 10.1212/WNL.58.9_suppl_6.S15; Kaniecki RG, 2001, HEADACHE, V41, P862, DOI 10.1046/j.1526-4610.2001.01157.x; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Lipton RB, 2000, JAMA-J AM MED ASSOC, V284, P2599, DOI 10.1001/jama.284.20.2599; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; MAIZELS M, 2002, HEADACHE, V42, P416; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; ROSENBERG J, 1995, NEUROLOGY, V45, P1411; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; SCHREIBER C, 2002, ANN SCI M AM HEAD SO; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Sheftell FD, 2002, HEADACHE, V42, P58, DOI 10.1046/j.1526-4610.2002.02015.x; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Snow V, 2002, ANN INTERN MED, V137, P840, DOI 10.7326/0003-4819-137-10-200211190-00014; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Wiest FC, 2002, JAMA-J AM MED ASSOC, V288, P2609, DOI 10.1001/jama.288.20.2609	28	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1430	1433		10.1001/jama.289.11.1430	http://dx.doi.org/10.1001/jama.289.11.1430			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656PM	12636467				2022-12-24	WOS:000181616200036
J	Langmore, NE; Hunt, S; Kilner, RM				Langmore, NE; Hunt, S; Kilner, RM			Escalation of a coevolutionary arms race through host rejection of brood parasitic young	NATURE			English	Article							CUCULUS-CANORUS; REED WARBLERS; CUCKOO; DISCRIMINATION; CONSTRAINTS; EVOLUTION; MODEL; EGGS	Cuckoo nestlings that evict all other young from the nest soon after hatching impose a high reproductive cost on their hosts(1). In defence, hosts have coevolved strategies to prevent brood parasitism. Puzzlingly, they do not extend beyond the egg stage(2-5). Thus, hosts adept at recognizing foreign eggs remain vulnerable to exploitation by cuckoo nestlings(6,7). Here we show that the breach of host egg defences by cuckoos creates a new stage in the coevolutionary cycle. We found that defences used during the egg-laying period by host superb fairy-wrens (Malurus cyaneus) are easily evaded by the Horsfield's bronze-cuckoo (Chrysococcyx basalis), a specialist fairy-wren brood parasite. However, although hosts never deserted their own broods, they later abandoned 40% of nests containing a lone Horsfield's bronze-cuckoo nestling, and 100% of nests with a lone shining bronze-cuckoo nestling (Chrysococcyx lucidus), an occasional fairy-wren brood parasite. Our experiments demonstrate that host discrimination against evictor-cuckoo nestlings is possible, and suggest that it has selected for the evolution of nestling mimicry in bronze-cuckoos.	Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Australian National University; University of Bristol; University of Cambridge	Langmore, NE (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia.	naomi.langmore@anu.edu.au	Langmore, Naomi E/C-9302-2009; Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758				BIBBY CJ, 1978, BIRD STUDY, V25, P207, DOI 10.1080/00063657809476599; BROOKE MD, 1988, NATURE, V335, P630; BROOKER MG, 1989, IBIS, V131, P528, DOI 10.1111/j.1474-919X.1989.tb04789.x; BROOKER MG, 1989, AUSTR ZOOLOGICAL REV, V2, P1; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; DAVIDSON LS, 1989, J MACROECON, V11, P1, DOI 10.1016/0164-0704(89)90014-1; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Fraga RM, 1998, OX ORN SER, V9, P173; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Kruger O, 2002, P ROY SOC B-BIOL SCI, V269, P375, DOI 10.1098/rspb.2001.1887; Lichtenstein G, 2001, ANIM BEHAV, V61, P401, DOI 10.1006/anbe.2000.1595; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; Lotem A, 1998, OX ORN SER, V9, P223; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Marchetti K, 2000, ANIM BEHAV, V59, P877, DOI 10.1006/anbe.1999.1388; MASON P, 1986, EVOLUTION, V40, P1207, DOI 10.1111/j.1558-5646.1986.tb05745.x; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; MULDER RA, 1992, EVOLUTIONARY ECOLOGY; NIAS RC, 1987, COOPERATIVE BREEDING; OGILVIE MA, 1992, HDB BIRDS EUROPE MID, V6, P193; Payne RB, 1998, OX ORN SER, V9, P152; Payne RB, 2001, ANIM BEHAV, V62, P473, DOI 10.1006/anbe.2001.1773; Rowley I., 1997, FAIRY WRENS GRASSWRE; Rowley Ian, 1965, Emu, V64, P251; TIDEMANN SC, 1983, BEHAV ECOLOGY TREE C	27	249	265	2	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					157	160		10.1038/nature01460	http://dx.doi.org/10.1038/nature01460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634784				2022-12-24	WOS:000181488900043
J	Falush, D; Wirth, T; Linz, B; Pritchard, JK; Stephens, M; Kidd, M; Blaser, MJ; Graham, DY; Vacher, S; Perez-Perez, GI; Yamaoka, Y; Megraud, F; Otto, K; Reichard, U; Katzowitsch, E; Wang, XY; Achtman, M; Suerbaum, S				Falush, D; Wirth, T; Linz, B; Pritchard, JK; Stephens, M; Kidd, M; Blaser, MJ; Graham, DY; Vacher, S; Perez-Perez, GI; Yamaoka, Y; Megraud, F; Otto, K; Reichard, U; Katzowitsch, E; Wang, XY; Achtman, M; Suerbaum, S			Traces of human migrations in Helicobacter pylori populations	SCIENCE			English	Article							GENETIC-STRUCTURE; ASIAN GENOTYPES; RECOMBINATION; STRAINS; MARKERS	Helicobacter pylori, a chronic gastric pathogen of human beings, can be divided into seven populations and subpopulations with distinct geographical distributions. These modern populations derive their gene pools from ancestral populations that arose in Africa, Central Asia, and East Asia. Subsequent spread can be attributed to human migratory fluxes such as the prehistoric colonization of Polynesia and the Americas, the neolithic introduction of farming to Europe, the Bantu expansion within Africa, and the stave trade.	Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA; Univ Bordeaux 2, F-33076 Bordeaux, France; Univ Wurzburg, Inst Hyg & Mikrobiol, D-97080 Wurzburg, Germany	Max Planck Society; University of Chicago; University of Washington; University of Washington Seattle; Yale University; New York University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); UDICE-French Research Universities; Universite de Bordeaux; University of Wurzburg	Achtman, M (corresponding author), Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany.	achtman@mpiib-berlin.mpg.de	Graham, David/AAL-2165-2021; Perez, Guillermo Perez/AAJ-3761-2020; Wirth, Thierry/B-4915-2008	Wirth, Thierry/0000-0002-7371-0172; Perez Perez, Guillermo/0000-0002-0131-5798; Achtman, Mark/0000-0001-6815-0070; Yamaoka, Yoshio/0000-0002-1222-5819	NIGMS NIH HHS [R02GM63270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Agostini HT, 1997, P NATL ACAD SCI USA, V94, P14542, DOI 10.1073/pnas.94.26.14542; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Diamond JM, 2000, NATURE, V403, P709, DOI 10.1038/35001685; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; FALUSH D, UNPUB; Feldman RA, 2001, HELICOBACTER PYLORI: MOLECULAR AND CELLULAR BIOLOGY, P29; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; Graham DY, 2000, HELICOBACTER, V5, pS3; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; LI WH, 1991, GENETICS, V129, P513; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; MUSSER JM, 1990, REV INFECT DIS, V12, P75; Oppenheimer Stephen, 2001, Science Progress, V84, P157, DOI 10.3184/003685001783238989; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; Pritchard JK, 2000, GENETICS, V155, P945; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0	25	704	739	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1582	1585		10.1126/science.1080857	http://dx.doi.org/10.1126/science.1080857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624269				2022-12-24	WOS:000181367900040
J	Carr, A; Emery, S; Law, I; Puls, R; Lundgren, JD; Powderly, WG; Carr, B; Cooper, DA; Grinspoon, S; Ioannidis, J; Lewis, R; Law, M; Lichtenstein, K; Murray, J; Pizzuti, D; Rozenbaum, W; Schambelan, M; Moore, A; Miller, J				Carr, A; Emery, S; Law, I; Puls, R; Lundgren, JD; Powderly, WG; Carr, B; Cooper, DA; Grinspoon, S; Ioannidis, J; Lewis, R; Law, M; Lichtenstein, K; Murray, J; Pizzuti, D; Rozenbaum, W; Schambelan, M; Moore, A; Miller, J		HIV Lipodystrophy Case Definition	An objective case definition of lipodystrophy in HIV-infected adults: a case-control study	LANCET			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; IMMUNODEFICIENCY-VIRUS INFECTION; PREADIPOCYTE DIFFERENTIATION; METABOLIC ABNORMALITIES; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; RISK; PREVALENCE	Background Lipodystrophy (peripheral lipoatrophy, central fat accumulation, and lipomatosis) is a common and disfiguring problem in adult patients with HIV-1 infection on antiretrovirals. However, an objective, validated definition of the disorder does not exist. We aimed to develop an objective, sensitive, specific, and broadly applicable case definition of HIV lipodystrophy. Methods In a case-control study, 1081 consecutive, HIV-infected, adult outpatients (261 [15%] women) without active AIDS were recruited from 32 sites worldwide. We classed patients with at least one moderate or severe subjective lipodystrophic feature, identified by lipodystrophy-specific physical examination and patient questionnaire, and apparent to both doctor and patient as cases (n=417). We classed patients with no such feature as controls (n=371), and patients without a clear diagnosis as non-assigned. We used objective clinical, metabolic, and body composition measurements to construct a logistic regression model with a subset of randomly selected cases and controls. The model was validated in the remaining patients. Findings A model including age, sex, duration of HIV infection, HIV disease stage, waist to hip ratio, anion gap, serum HDL cholesterol concentration, trunk to peripheral fat ratio, percentage leg fat, and intra-abdominal to extra-abdominal fat ratio had 79% (95% CI 70-85) sensitivity and 80% (95% Cl 71-87) specificity for diagnosis of lipodystrophy. Models that incorporated only clinical, or only clinical and metabolic variables had lower sensitivity and specificity than the inclusive model. Models for lipoatrophy, fat accumulation, and lipomatosis could not be developed since pure phenotypes occurred in fewer than 10% of patients with clinical diagnoses of these disorders. Interpretation Our objective case definition of HIV-associated lipodystrophy should improve assessment of lipodystrophy prevalence, risk factors, and pathogenesis; prevention and treatment approaches; and assist in diagnosis.	St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia; Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; Hvidovre Univ Hosp, Copenhagen, Denmark; Washington Univ, Sch Med, St Louis, MO USA; Forum Collaborat HIV Res, Baltimore, MD USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Ioannina, GR-45110 Ioannina, Greece; Agouron Pharmaceut, San Diego, CA USA; HIV Outpatient Study Ctr Dis Control & Prevent, Denver, CO USA; US FDA, US Dept HHS, Washington, DC 20204 USA; Bristol Myers Squibb Co, Princeton, NJ USA; Hop Rothschild, F-75571 Paris, France; Agence Natl Res SIDA, Paris, France; Univ Calif San Francisco, San Francisco, CA 94143 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; Kirby Institute; University of Copenhagen; Washington University (WUSTL); Harvard University; Massachusetts General Hospital; University of Ioannina; Pfizer; US Food & Drug Administration (FDA); Bristol-Myers Squibb; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco	Carr, A (corresponding author), St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia.	acarr@stvincents.com.au	Ioannidis, John P. A./G-9836-2011; Puls, Rebekah/A-3992-2013; Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017; Lundgren, Jens/AAE-6876-2019	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Rozenbaum, Willy/0000-0003-1975-3566; Lundgren, Jens/0000-0001-8901-7850; Law, Matthew/0000-0002-3540-8837; Powderly, William/0000-0001-7808-3086				Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Belloso WH, 2003, JAIDS-J ACQ IMM DEF, V32, P104, DOI 10.1097/00126334-200301010-00015; Caron M, 2001, DIABETES, V50, P1378, DOI 10.2337/diabetes.50.6.1378; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Carr A, 2002, LANCET, V360, P81, DOI 10.1016/S0140-6736(02)09341-8; Dowell P, 2000, J BIOL CHEM, V275, P41325, DOI 10.1074/jbc.M006474200; Duran S, 2001, AIDS, V15, P2441, DOI 10.1097/00002030-200112070-00012; Egger M, 2001, AIDS, V15, pS193, DOI 10.1097/00002030-200100005-00023; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grunfeld C., 2002, 14 INT AIDS C BARC S; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Hyams KC, 1998, EPIDEMIOL REV, V20, P148, DOI 10.1093/oxfordjournals.epirev.a017977; KINGSLEY L, 2001, 8 C RETR OPP INF CHI; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Marcos MA, 2001, LANCET, V357, P1499, DOI 10.1016/S0140-6736(00)04658-4; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; *NAT CHOL ED PROGR, FRAM CARD RISK EQ; Roche R, 2002, AIDS, V16, P13, DOI 10.1097/00002030-200201040-00003; Saint-Marc T, 2000, AIDS, V14, P37, DOI 10.1097/00002030-200001070-00005; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thiebaut R, 2000, CLIN INFECT DIS, V31, P1482, DOI 10.1086/317477; van der Valk M, 2001, AIDS, V15, P847, DOI 10.1097/00002030-200105040-00005; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; Yarasheski KE, 1999, J ACQ IMMUN DEF SYND, V21, P209, DOI 10.1097/00126334-199907010-00005	32	337	347	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					726	735		10.1016/S0140-6736(03)12656-6	http://dx.doi.org/10.1016/S0140-6736(03)12656-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620736				2022-12-24	WOS:000181232000007
J	Ong, ACM; Wheatley, DN				Ong, ACM; Wheatley, DN			Polycystic kidney disease - the ciliary connection	LANCET			English	Review							TRANSGENIC MICE; GENE HOMOLOG; C-ELEGANS	Context "Cystic degeneration" of the kidneys was first described pathologically in 1841 and "polycystic kidneys" as a clinical syndrome in 1888. The heritable nature in some families was noted in 1899, and autosomal dominant and, recessive patterns of inheritance of polycystic kidney disease (PKD) were later recognised. Autosomal dominant PKD is one, of the most common human genetic diseases and results, from mutations in PKD1 or PKD2. These genes encode two proteins, polycystin-1 and polycystin-2. Starting point Primary cilia are cellular organelles previously,thought by some to be vestigial. New findings from several, species, including algae, nematodes, and mice, implicate, defects in structure or function of primary cilia as a possible common mechanism central to the development of some forms of recessive PKD. Two recent reports propose a causal link between ciliary dysfunction and autosomal dominant PKD. B Yoder and colleagues (J Am Soc Nephrol 2002; 13:, 2508-16) show that polycystin-1 and polycystin-2 are localised to primary cilia in cultured renal epithelial cells. S Nauli and colleagues (Nat Genet 2003; 33: 129-37) show that polycystin-1 and polycystin-2 function as flow-sensitive mechanosensors in the same signal-transduction pathway. Where next? Cystic epithelial cells show many altered cellular properties, including changes in proliferation, apoptosis, adhesion, differentiation, polarity, extracellular matrix synthesis, and fluid transport. The next important steps in PKD research will be to define the physiological roles: of primary renal cilia and how defects in ciliary structure and function lead to the development of a cystic phenotype in: different forms of PKD.	Univ Sheffield, Div Clin Sci N, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England; Univ Aberdeen, Dept Cell Pathol, Aberdeen, Scotland	University of Sheffield; University of Aberdeen	Ong, ACM (corresponding author), Univ Sheffield, Div Clin Sci N, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; ARCHER FL, 1971, J ANAT, V109, P277; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43913; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; SCHAFFNER DL, 1993, AM J PATHOL, V142, P1051; Streets AJ, 2002, J AM SOC NEPHROL, V13, p46A; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zimmerman K., 1898, ARCH MIKROSK ANAT, V52, P552, DOI [10.1007/BF02975837, DOI 10.1007/BF02975837]	28	103	107	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					774	776		10.1016/S0140-6736(03)12662-1	http://dx.doi.org/10.1016/S0140-6736(03)12662-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620752				2022-12-24	WOS:000181232000022
J	Bridle, KR; Frazer, DM; Wilkins, SJ; Dixon, JL; Purdie, DM; Crawford, DHG; Subramaniam, VN; Powell, LW; Anderson, GJ; Ramm, GA				Bridle, KR; Frazer, DM; Wilkins, SJ; Dixon, JL; Purdie, DM; Crawford, DHG; Subramaniam, VN; Powell, LW; Anderson, GJ; Ramm, GA			Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis	LANCET			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; GENE; OVERLOAD; PROTEIN; EXPRESSION; MUTATIONS; CLONING; SLC11A3	Background The mechanisms responsible for disturbed iron homoeostasis in hereditary haemochromatosis are poorly understood. However, results of some studies indicate a link between hepcidin, a liver-derived peptide, and intestinal iron absorption, suggesting that this molecule could play a part in hepatic iron overload. To investigate this possible association, we studied the hepatic expression of the gene for hepcidin (HAMP) and a gene important in iron transport (IREG1) in patients with haemochromatosis, in normal controls, and in Hfe-knockout mice. Methods We extracted total RNA from the liver tissue of 27 patients with HFE-associated haemochromatosis, seven transplant donors (controls), and Hfe-knockout mice. HAMP and IREG1 mRNA concentrations were examined by ribonuclease protection assays and expressed relative to the housekeeping gene GAPD. Findings There was a significant decrease in HAMP expression in untreated patients compared with controls (5.4-fold, 95% CI 3.3-7.5; p<0.0001) despite significantly increased iron loading. Similarly, we noted a decrease in Hamp expression in iron-loaded Hfe-knockout mice. Hepatic IREG1 expression was greatly upregulated in patients with haemochromatosis (1.8-fold, 95% CI 1.5-2.2; p=0.002). There was a significant correlation between hepatic iron concentration and expression of HAMP (r=0.59, p=0.02) and IREG1 (r=0.67, p=0.007) in untreated patients. Interpretation Lack of HAMP upregulation in HFE-associated haemochromatosis despite significant hepatic iron loading indicates that HFE plays an important part in the regulation of hepcidin expression in response to iron overload. Our results imply that the liver is important in the pathophysiology of HFE-associated haemochromatosis. Furthermore, the increase in hepatic IREG1 expression in haemochromatosis suggests that IREG1 could function to facilitate the removal of excess iron from the liver.	Royal Brisbane Hosp, Queensland Inst Med Res, Lab Iron Metab, Iron Metab Grp, Herston, Qld 4029, Australia; Royal Brisbane Hosp, Queensland Inst Med Res, Hepat Fibrosis Grp, Herston, Qld 4029, Australia; Royal Brisbane Hosp, Queensland Inst Med Res, Membrane Transport Grp, Herston, Qld 4029, Australia; Univ Queensland, Dept Med, St Lucia, Qld 4067, Australia; Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Anderson, GJ (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Lab Iron Metab, Iron Metab Grp, Herston, Qld 4029, Australia.		Crawford, Darrell HG/F-2157-2010; Ramm, Grant A/G-2669-2013; Frazer, David M/L-3570-2014; Anderson, Gregory J/G-4148-2013; Subramaniam, V. Nathan/A-1901-2010; Bridle, Kim/F-6266-2010	Ramm, Grant A/0000-0001-7058-6201; Frazer, David M/0000-0003-4098-1379; Anderson, Gregory J/0000-0002-8814-5866; Subramaniam, V. Nathan/0000-0002-4583-7790; Bridle, Kim/0000-0002-7090-1387; Crawford, Darrell/0000-0001-8480-5954	NIDDK NIH HHS [R01 DK57648-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057648] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ANDERSON GJ, 2002, MOL CELLULAR IRON TR, P559; BASSETT ML, 1984, SEMIN LIVER DIS, V4, P217, DOI 10.1055/s-2008-1041772; BASSETT ML, 1986, HEPATOLOGY, V6, P24, DOI 10.1002/hep.1840060106; Cardoso EM, 2002, BLOOD, V100, P4239, DOI 10.1182/blood-2002-05-1565; Crawford D, 2002, HEPATOLOGY, V36, p194A; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; Jackson HA, 2001, BRIT J HAEMATOL, V114, P474, DOI 10.1046/j.1365-2141.2001.02949.x; Jouanolle AM, 1997, HUM GENET, V100, P544, DOI 10.1007/s004390050549; Kendall M.G., 1977, ADV THEORY STAT, V4th ed.; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MCLAREN GD, 1991, J LAB CLIN MED, V117, P390; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI13468; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; NIEDERAU C, 1994, BAILLIERE CLIN HAEM, V7, P881, DOI 10.1016/S0950-3536(05)80129-5; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; OLYNYK JK, 1994, POSTGRAD MED, V96, P151, DOI 10.1080/00325481.1994.11945914; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; POWELL LW, 1980, GASTROENTEROLOGY, V78, P374; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Waheed A, 1999, P NATL ACAD SCI USA, V96, P1579, DOI 10.1073/pnas.96.4.1579; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260	30	484	499	4	40	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					669	673		10.1016/S0140-6736(03)12602-5	http://dx.doi.org/10.1016/S0140-6736(03)12602-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606179				2022-12-24	WOS:000181129500017
J	Janata, K; Holzer, M; Laggner, AN; Mullner, M				Janata, K; Holzer, M; Laggner, AN; Mullner, M			Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study	BRITISH MEDICAL JOURNAL			English	Article							RIGHT-VENTRICULAR DYSFUNCTION		Univ Vienna, Allgemeines Krankenhaus Wien, Jkub BItfakkned, A-1090 Vienna, Austria	University of Vienna	Mullner, M (corresponding author), Univ Vienna, Allgemeines Krankenhaus Wien, Jkub BItfakkned, Wahringer Gurtel 18-20-6D, A-1090 Vienna, Austria.							Giannitsis E, 2000, CIRCULATION, V102, P211, DOI 10.1161/01.CIR.102.2.211; GROSSER KD, 1980, INTERNIST, V21, P273; Kasper W, 1997, HEART, V77, P346, DOI 10.1136/hrt.77.4.346; LUALDI JC, 1995, AM HEART J, V130, P1276, DOI 10.1016/0002-8703(95)90155-8; Meyer T, 2000, J AM COLL CARDIOL, V36, P1632, DOI 10.1016/S0735-1097(00)00905-0	5	77	85	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					312	313		10.1136/bmj.326.7384.312	http://dx.doi.org/10.1136/bmj.326.7384.312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574045	Bronze, Green Published			2022-12-24	WOS:000180997000019
J	Egan, MF; Kojima, M; Callicott, JH; Goldberg, TE; Kolachana, BS; Bertolino, A; Zaitsev, E; Gold, B; Goldman, D; Dean, M; Lu, B; Weinberger, DR				Egan, MF; Kojima, M; Callicott, JH; Goldberg, TE; Kolachana, BS; Bertolino, A; Zaitsev, E; Gold, B; Goldman, D; Dean, M; Lu, B; Weinberger, DR			The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function	CELL			English	Article							LONG-TERM POTENTIATION; HIGH-FREQUENCY STIMULATION; N-ACETYL ASPARTATE; NEUROTROPHIC FACTOR; SYNAPTIC TRANSMISSION; ALZHEIMERS-DISEASE; WORKING-MEMORY; RELATIVE RISK; KNOCKOUT MICE; SCHIZOPHRENIA	Brain-derived neurotrophic factor (BDNF) modulates hippocampal plasticity and hippocampal-dependent memory in cell models and in animals. We examined the effects of a valine (val) to methionine (met) substitution in the 5' pro-region of the human BDNF protein. In human subjects, the met allele was associated with poorer episodic memory, abnormal hippocampal activation assayed with fMRI, and lower hippocampal n-acetyl aspartate (NAA), assayed with MRI spectroscopy. Neurons transfected with met-BDNF-GFP showed lower depolarization-induced secretion, while constitutive secretion was unchanged. Furthermore, met-BDNF-GFP failed to localize to secretory granules or synapses. These results demonstrate a role for BDNF	NICHHD, Sect Neural Dev & Plast, NIH, DHHS, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA; NIAAA, Neurogenet Lab, Rockville, MD 20857 USA; NCI, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Natl Inst AIST, Cell Dynam Res Grp, Osaka 5638577, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Lu, B (corresponding author), NICHHD, Sect Neural Dev & Plast, NIH, DHHS, Bldg 49-6A67, Bethesda, MD 20892 USA.		Callicott, Joseph H/C-9102-2009; Majid, Salma/AAT-2616-2020; Dean, Michael C/G-8172-2012; Callicott, Joseph H/AAE-7243-2022; Goldman, David/F-9772-2010; Dean, Michael/R-7501-2019; Lu, Bai/A-4018-2012; BERTOLINO, ALESSANDRO/O-6352-2016	Callicott, Joseph H/0000-0003-1298-3334; Majid, Salma/0000-0002-1724-5405; Dean, Michael C/0000-0003-2234-0631; Goldman, David/0000-0002-1724-5405; Lu, Bai/0000-0001-5418-9759; BERTOLINO, ALESSANDRO/0000-0002-1251-1380	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002734, Z01MH002734, ZIAMH002716, Z01MH002716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000303, Z01AA000302] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bertolino A, 1996, AM J PSYCHIAT, V153, P1554; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 1998, BIOL PSYCHIAT, V44, P941, DOI 10.1016/S0006-3223(98)00264-9; de Geus EJC, 2001, BEHAV GENET, V31, P489, DOI 10.1023/A:1013360909048; Egan MF, 2001, BIOL PSYCHIAT, V50, P98, DOI 10.1016/S0006-3223(01)01133-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; GOODMAN LJ, 1996, MOL CELL NEUROSCI, V7, P223; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Jenkins BG, 2000, J NEUROCHEM, V74, P2108, DOI 10.1046/j.1471-4159.2000.0742108.x; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kojima M, 2001, J NEUROSCI RES, V64, P1, DOI 10.1002/jnr.1080; Kopelman MD, 1998, BRAIN, V121, P875, DOI 10.1093/brain/121.5.875; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Lu B, 2000, PROG BRAIN RES, V128, P231; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MAIER M, 1995, PSYCHOL MED, V25, P1201, DOI 10.1017/S0033291700033171; Mattay VS, 1996, J NEUROSCI, V16, P4816; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakatani A, 1998, J BIOCHEM-TOKYO, V123, P707; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Plomin R, 1999, NATURE, V402, pC25, DOI 10.1038/35011520; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Roses AD, 1998, ANN NY ACAD SCI, V855, P738, DOI 10.1111/j.1749-6632.1998.tb10653.x; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000	52	2884	2999	5	256	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					257	269		10.1016/S0092-8674(03)00035-7	http://dx.doi.org/10.1016/S0092-8674(03)00035-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553913	Bronze			2022-12-24	WOS:000181191600014
J	Bell, JI				Bell, JI			The double helix in clinical practice	NATURE			English	Article							ASSOCIATION; GENETICS; CANCER; ASTHMA	The discovery of the double helix half a century ago has so far been slow to affect medical practice, but significant transformations are likely over the next 50 years. Changes to the way medicine is practised and new doctors are trained will be required before potential benefits are realized.	Univ Oxford, Off Regius Professor Med, Oxford OX3 9DU, England	University of Oxford	Bell, JI (corresponding author), Univ Oxford, Off Regius Professor Med, Oxford OX3 9DU, England.	regius@medsci.ox.ac.uk						Abraham EP, 1941, LANCET, V2, P177; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; COOKSON WOCM, 1989, LANCET, V1, P1292; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; FISHER RA, 1958, NATURE, V182, P596, DOI 10.1038/182596a0; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Lewis T, 1944, LANCET, V1, P619; Osler W, 1892, PRINCIPLES PRACTICE; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WEBER WW, 1997, PHARMACOGENETICS	15	22	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					414	416		10.1038/nature01402	http://dx.doi.org/10.1038/nature01402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540912	Bronze			2022-12-24	WOS:000180533000053
J	Counihan, TJ				Counihan, TJ			Conjugal Parkinson's disease	LANCET			English	Editorial Material									Eastman Dent Ctr, Rochester, NY 14618 USA	Eastman Chemical Company; University of Rochester	Counihan, TJ (corresponding author), Eastman Dent Ctr, Rochester, NY 14618 USA.								0	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					252	252		10.1016/S0140-6736(03)12277-5	http://dx.doi.org/10.1016/S0140-6736(03)12277-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547554				2022-12-24	WOS:000180535400029
J	White, T				White, T			Paleoanthropology: Early hominids - Diversity or distortion?	SCIENCE			English	Editorial Material							AFRICA; CHAD		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	White, T (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.							Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; GOULD SJ, 1976, NAT HIST, V85, P24; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; LI TY, 1992, NATURE, V357, P404; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; MAYR E, 1950, COLD SPRING HARB SYM, V15, P109, DOI 10.1101/SQB.1950.015.01.013; SCHULTZ CB, 1956, B AM MUS NAT HIST, V109, P1; SIMPSON GG, 1963, CLASSIFICATION HUMAN, P4; Spoor F, 1999, NATURE, V397, P572, DOI 10.1038/17505; STEVENS MS, 1996, TERRESTRIAL EOCENE O, pCH25; TATTERSALL I, 2000, EXTINCT HUMANS; WILFORD JN, 2001, NY TIMES        0325; Wood B, 2002, NATURE, V418, P133, DOI 10.1038/418133a	13	81	84	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					1994	+		10.1126/science.1078294	http://dx.doi.org/10.1126/science.1078294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663903				2022-12-24	WOS:000181834200028
J	Kullander, K; Butt, SJB; Lebret, JM; Lundfald, L; Restrepo, CE; Rydstrom, A; Klein, R; Kiehn, O				Kullander, K; Butt, SJB; Lebret, JM; Lundfald, L; Restrepo, CE; Rydstrom, A; Klein, R; Kiehn, O			Role of EphA4 and EphrinB3 in local neuronal circuits that control walking	SCIENCE			English	Article							CENTRAL PATTERN GENERATOR; VITRO NEONATAL RAT; SPINAL-CORD; IN-VITRO; CORTICOSPINAL TRACT; AXONS; LOCOMOTION; MECHANISMS; RECEPTORS; NETWORKS	Local circuits in the spinal cord that generate locomotion are termed central pattern generators (CPGs). These provide coordinated bilateral control over the normal limb alternation that underlies walking. The molecules that organize the mammalian CPG are unknown. Isolated spinal cords from mice lacking either the EphA4 receptor or its ligand ephrinB3 have lost left-right limb alternation and instead exhibit synchrony. We identified EphA4-positive neurons as an excitatory component of the locomotor CPG. Our study shows that dramatic locomotor changes can occur as a consequence of local genetic rewiring and identifies genes required for the development of normal locomotor behavior.	Univ Gothenburg, Dept Biochem Med, S-40530 Gothenburg, Sweden; AstraZeneca Transgen & Comparat Genom, S-43183 Molndal, Sweden; Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	University of Gothenburg; AstraZeneca; Karolinska Institutet; Max Planck Society	Kullander, K (corresponding author), Univ Gothenburg, Dept Biochem Med, Medicinaregatan 9A, S-40530 Gothenburg, Sweden.	klas.kullander@medkem.gu.se; ole.kiehn@neuro.ki.se	Klein, Ruediger/C-6147-2008; Kiehn, Ole/C-4679-2008; kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019; Butt, Simon/I-2689-2019	Klein, Ruediger/0000-0002-3109-0163; Butt, Simon/0000-0002-2399-0102; Kullander, Klas/0000-0001-6418-5460; Kiehn, Ole/0000-0002-5954-469X				ARSHAVSKY YI, 1993, TRENDS NEUROSCI, V16, P227, DOI 10.1016/0166-2236(93)90161-E; Butt SJB, 2002, BRAIN RES REV, V40, P107, DOI 10.1016/S0165-0173(02)00194-7; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; KIEHN O, 1997, NEURONS NETWORKS MOT, P47; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Whelan PJ, 1997, J NEUROPHYSIOL, V78, P1643, DOI 10.1152/jn.1997.78.3.1643; Wickelgren I, 1998, SCIENCE, V279, P319, DOI 10.1126/science.279.5349.319; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	25	257	264	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2003	299	5614					1889	1892		10.1126/science.1079641	http://dx.doi.org/10.1126/science.1079641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649481				2022-12-24	WOS:000181669700045
J	Murray, M				Murray, M			Anthropology: Overkill and sustainable use	SCIENCE			English	Editorial Material									Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Murray, M (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.			Murray, Martyn/0000-0003-4371-388X				Bleek W.H.I., 1911, SPECIMENS BUSHMEN FO; Bowen-Jones E, 1999, ORYX, V33, P233, DOI 10.1046/j.1365-3008.1999.00066.x; Diamond Jared, 1992, RISE FALL 3 CHIMPANZ; Etnier M. A., 2002, THESIS U WASHINGTON; *IUCN, 2001, STRAT APPR INT BIOD; Jones Brian, 2001, P38; Kay Charles E., 2002, WILDERNESS POLITICAL; Krech Shepard, 1999, ECOLOGICAL INDIAN MY; Krech Shepard III, 1981, INDIANS ANIMALS FUR; LISTERKAYE J, 1994, 3 SCOTT NAT HER; Marshall Lorna., 1976, KUNG NYAE NYAE; Martin Calvin, 1978, KEEPERS GAME INDIAN; MARTIN PS, 1973, SCIENCE, V179, P969, DOI 10.1126/science.179.4077.969; MARTIN PS, 1966, NATURE, V212, P339, DOI 10.1038/212339a0; Milner-Gulland E., 1998, CONSERVATION BIOL RE; MUIR J, 1913, STORY MY BOYHOOD YOU, P161; Robinson J., 2000, HUNTING SUSTAINABILI; Silberbauer GeorgeB., 1981, HUNTER HABITAT CENTR; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Stevens S., 1997, CONSERVATION CULTURA; TRENCH CC, 1967, POACHER SQUIRE; *WORLD CONS UN UN, 1991, CAR EARTH STRAT SUST; Worthy TH., 2002, LOST WORLD MOA PREHI	23	13	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1851	1853		10.1126/science.1079823	http://dx.doi.org/10.1126/science.1079823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649469				2022-12-24	WOS:000181669700030
J	Sasaki, A; Itoh, H; Gomi, K; Ueguchi-Tanaka, M; Ishiyama, K; Kobayashi, M; Jeong, DH; An, G; Kitano, H; Ashikari, M; Matsuoka, M				Sasaki, A; Itoh, H; Gomi, K; Ueguchi-Tanaka, M; Ishiyama, K; Kobayashi, M; Jeong, DH; An, G; Kitano, H; Ashikari, M; Matsuoka, M			Accumulation of phosphorylated repressor for gibberellin signaling in an F-box mutant	SCIENCE			English	Article							RESPONSE MUTANT; GENE; DEGRADATION; RICE; ENCODES; PATHWAY; PROTEIN; ALPHA; SLN1	Gibberellin (GA) regulates growth and development in plants. We isolated and characterized a rice GA-insensitive dwarf mutant, gid2. The GID2 gene encodes a putative F-box protein, which interacted with the rice Skp1 homolog in a yeast two-hybrid assay. In gid2, a repressor for GA signaling, SLR1, was highly accumulated in a phosphorylated form and GA increased its concentration, whereas SLR1 was rapidly degraded by GA through ubiquitination in the wild type. We conclude that GID2 is a positive regulator of GA signaling and that regulated degradation of SLR1 is initiated through GA-dependent phosphorylation and finalized by an SCFGID2-proteasome pathway.	Nagoya Univ, Biosci Ctr, Nagoya, Aichi 4648601, Japan; RIKEN, Bioresources Ctr, Tsukuba, Ibaraki 3050074, Japan; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; RIKEN; Pohang University of Science & Technology (POSTECH); Nagoya University	Matsuoka, M (corresponding author), Nagoya Univ, Biosci Ctr, Nagoya, Aichi 4648601, Japan.	makoto@agr.nagoya-u.ac.jp	Kobayashi, Masatomo/A-5945-2016	Gomi, Kenji/0000-0002-6736-1113				Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Ashikari M, 2002, BREEDING SCI, V52, P143, DOI 10.1270/jsbbs.52.143; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Davies P. J, 1995, PLANT HORMONES; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; SASAKI A, UNPUB; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Steber CM, 1998, GENETICS, V149, P509; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang M, 1999, P NATL ACAD SCI USA, V96, P11416, DOI 10.1073/pnas.96.20.11416	24	463	533	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2003	299	5614					1896	1898		10.1126/science.1081077	http://dx.doi.org/10.1126/science.1081077			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649483				2022-12-24	WOS:000181669700047
J	Jamora, C; DasGupta, R; Kocieniewski, P; Fuchs, E				Jamora, C; DasGupta, R; Kocieniewski, P; Fuchs, E			Links between signal transduction, transcription and adhesion in epithelial bud development	NATURE			English	Article							HAIR FOLLICLE MORPHOGENESIS; E-CADHERIN; BETA-CATENIN; GENE-EXPRESSION; SONIC HEDGEHOG; FACTOR SNAIL; DIFFERENTIATION	The morphogenesis of organs as diverse as lungs, teeth and hair follicles is initiated by a downgrowth from a layer of epithelial stem cells(1,2). During follicular morphogenesis, stem cells form this bud structure by changing their polarity and cell-cell contacts. Here we show that this process is achieved through simultaneous receipt of two external signals: a Writ protein to stabilize beta-catenin, and a bone morphogenetic protein (BMP) inhibitor to produce Lef1. beta-Catenin then binds to, and activates, Lef1 transcription complexes that appear to act uncharacteristically by downregulating the gene encoding E-cadherin, an important component of polarity and intercellular adhesion. When either signal is missing, functional Lef1 complexes are not made, and E-cadherin downregulation and follicle morphogenesis are impaired. In Drosophila, E-cadherin can influence the plane of cell division and cytoskeletal dynamics(3). Consistent with this notion, we show that forced elevation of E-cadherin levels block invagination and follicle production. Our findings reveal an intricate molecular programme that links two extracellular signalling pathways to the formation of a nuclear transcription factor that acts on target genes to remodel cellular junctions and permit follicle formation.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10021 USA.	fuchs@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Dasgupta, Ramanuj/0000-0001-9015-3729	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR031737-24, R01 AR031737] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan SK, 2002, CELL, V111, P265, DOI 10.1016/S0092-8674(02)01037-1; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; HIRAI Y, 1989, DEVELOPMENT, V105, P271; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	29	454	481	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2003	422	6929					317	322		10.1038/nature01458	http://dx.doi.org/10.1038/nature01458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646922	Green Accepted			2022-12-24	WOS:000181637300041
J	Sirovich, BE; Schwartz, LM; Woloshin, S				Sirovich, BE; Schwartz, LM; Woloshin, S			Screening men for prostate and colorectal cancer in the United States - Does practice reflect the evidence?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED TRIAL; PRIMARY-CARE PHYSICIANS; PATIENTS SELF-REPORTS; PAP SMEAR; PART I; MORTALITY; ANTIGEN; QUEBEC; VALIDITY	Context The debate about the efficacy of prostate-specific antigen (PSA) screening for prostate cancer has received substantial attention in the medical literature and the media, but the extent to which men are actually screened is unknown. If practice were evidence-based, PSA screening would be less common among men than colorectal cancer screening, a preventive service of broad acceptance and proven efficacy. Objective To compare the prevalences of PSA and colorectal cancer screening among US men. Design, Setting, and Population The 2001 Behavioral Risk Factor Surveillance System, an annual population-based telephone survey of US adults conducted by the Centers for Disease Control and Prevention, was used to gather data on a representative sample of men aged 40 years or older from all 50 states and the District of Columbia (n=49315). Main Outcome Measures Proportions of men ever screened and up to date on screening for prostate cancer (with PSA testing) and colorectal cancer (with fecal occult blood testing, flexible sigmoidoscopy, or colonoscopy). Results Overall, men are more likely to report having ever been screened for prostate cancer than for colorectal cancer; 75% of those aged 50 years or older have had a PSA test vs 63% for any colorectal cancer test (risk ratio [RR], 1.20; 95% confidence interval [CI], 1.18-1.21). Up-to-date PSA screening is also more common than colorectal cancer screening for men of all ages. Among men aged 50 to 69 years (those for whom there is the greatest consensus in favor of screening), 54% reported an up-to-date PSA screen, while 45% reported up-to-date testing for colorectal cancer (RR, 1.19; 95% CI, 1.16-1.21). In state-level analyses of this age group, men were significantly more likely to be up to date on prostate cancer screening compared with colorectal cancer screening in 27 states, while up-to-date colorectal cancer screening was more common in only 1 state. Conclusion Among men in the United States, prostate cancer screening is more common than colorectal cancer screening. Physicians should ensure that men who choose to be screened for cancer are aware of the known mortality benefit of colorectal cancer screening and the uncertain benefits of screening for prostate cancer.	Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03756 USA	VA Outcomes Group; Dartmouth College; Norris Cotton Cancer Center	Sirovich, BE (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, 111B,, White River Jct, VT 05009 USA.				NCI NIH HHS [CA91052-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander FE, 1999, PROSTATE, V40, P135; [Anonymous], 2001, MMWR MORB MORTAL WKL, V50, P162; Baier M, 2000, CANCER EPIDEM BIOMAR, V9, P229; Barry MJ, 2000, J GEN INTERN MED, V15, P749, DOI 10.1046/j.1525-1497.2000.00816.x; Boer R, 1999, PROSTATE, V40, P130; BOWMAN JA, 1991, HEALTH SERV RES, V26, P97; Brawer MK, 1999, CA-CANCER J CLIN, V49, P264, DOI 10.3322/canjclin.49.5.264; Carroll P, 2001, UROLOGY, V57, P217, DOI 10.1016/S0090-4295(00)00993-6; Catalona WJ, 2000, UROLOGY, V55, P791, DOI 10.1016/S0090-4295(99)00602-0; *CDCP, 2002, 2001 BEH RISK FACT S; Centers for Disease Control and Prevention, 2002, BEH RISK FACT SURV S; Coley CM, 1997, ANN INTERN MED, V126, P480; Donovan JL, 2001, BMJ-BRIT MED J, V323, P763, DOI 10.1136/bmj.323.7316.763; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; FARRELL MH, 2002, EFF CLIN PRACT, V5, P91; Fowler FJ, 1998, AM J MED, V104, P526, DOI 10.1016/S0002-9343(98)00124-7; Hahn DL, 1999, J FAM PRACTICE, V48, P679; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Hawley ST, 2001, CANCER DETECT PREV, V25, P309; Hoffman RM, 1996, AM J PREV MED, V12, P277, DOI 10.1016/S0749-3797(18)30325-8; Jordan TR, 1999, PREV MED, V28, P297, DOI 10.1006/pmed.1998.0430; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Labrie F, 2000, PROSTATE, V43, P215, DOI 10.1002/(SICI)1097-0045(20000515)43:3<215::AID-PROS7>3.0.CO;2-G; Labrie F, 1999, PROSTATE, V38, P83, DOI 10.1002/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B; Labrie F, 1999, PROSTATE, V40, P132; Labrie F, 1999, PROSTATE, V40, P137; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandelson MT, 1999, AM J EPIDEMIOL, V150, P617; McGovern PG, 1998, AM J PREV MED, V14, P201, DOI 10.1016/S0749-3797(97)00076-7; Mettlin C, 1997, PROSTATE, V31, P71; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; *NAT CTR HLTH STAT, 2000, NAT HLTH INT SURV DA; *NAT CTR HLTH STAT, 2002, NCHS DEF ALPH LIST M; *NCI, 2002, SEER INC US MORT STA; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; *POP EST PROGR POP, 2002, ANN POP EST AG GROUP; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Ransohoff DF, 2002, NEW ENGL J MED, V346, P40, DOI 10.1056/NEJMcp010886; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Ries LA, 2002, SEER CANC STAT REV 1; Schroy PC, 2001, PREV MED, V33, P381, DOI 10.1006/pmed.2001.0903; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Smith RA, 2002, CA-CANCER J CLIN, V52, P8, DOI 10.3322/canjclin.52.1.8; Standaert B, 1997, CANCER, V80, P1830; SUAREZ L, 1995, AM J PREV MED, V11, P94, DOI 10.1016/S0749-3797(18)30483-5; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P119; US Preventive Services Task Force United States. Office of Disease Prevention Health Promotion, 1996, GUID CLIN PREV SERV, P89; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; Volk RJ, 2002, AM J PREV MED, V22, P56, DOI 10.1016/S0749-3797(01)00397-X; Voss JD, 2001, J GEN INTERN MED, V16, P831, DOI 10.1046/j.1525-1497.2001.10133.x; WHITMAN S, 1993, INT J EPIDEMIOL, V22, P393, DOI 10.1093/ije/22.3.393; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Woloshin S, 1999, NEW ENGL J MED, V340, P884, DOI 10.1056/NEJM199903183401112	54	266	271	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1414	1420		10.1001/jama.289.11.1414	http://dx.doi.org/10.1001/jama.289.11.1414			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656PM	12636464				2022-12-24	WOS:000181616200033
J	Toma, TP; Hopkinson, NS; Hillier, J; Hansell, DM; Morgan, C; Goldstraw, PG; Polkey, MI; Geddes, DM				Toma, TP; Hopkinson, NS; Hillier, J; Hansell, DM; Morgan, C; Goldstraw, PG; Polkey, MI; Geddes, DM			Bronchoscopic volume reduction with valve implants in patients with severe emphysema.	LANCET			English	Article								Eight patients with severe emphysema entered a pilot study of unilateral volume reduction by endobronchial valve insertion. Five patients had emphysema judged too severe for volume reduction surgery and three refused the operation. After valve insertions, the median forced expiratory volume in 1 s (FEV1) increased from 0.79 L (range 0.61-1.07) to 1.06 L (0.75-1.22) (difference 34%, p=0.028) and the median diffusing capacity (TLco) increased from 3.05 mL/min/mm Hg (2.35-4.71) to 3.92 mL/min/mm Hg (2.89-5.40) (difference 29%, p=0.017). CT scans showed a substantial reduction in regional volume in four of the eight patients. Two patients developed a transient pneumothorax (one requiring drainage) but we recorded no other important adverse effects during follow-up. Lung-volume reduction can be achieved with unilateral bronchoscopically placed valve implants in patients with severe emphysema with acceptable short-term safety and worthwhile functional benefits.	Royal Brompton Hosp, Dept Resp Med, London SW3 6NP, England; Royal Brompton Hosp, Dept Radiol, London SW3 6NP, England; Royal Brompton Hosp, Dept Anaesthesia, London SW3 6NP, England; Royal Brompton Hosp, Dept Thorac Surg, London SW3 6NP, England; Natl Heart & Lung Inst, Dept Thorac Med, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London	Geddes, DM (corresponding author), Royal Brompton Hosp, Dept Resp Med, London SW3 6NP, England.			Hillier, James/0000-0001-9591-6510				Fishman A, 2001, NEW ENGL J MED, V345, P1075; Geddes D, 2000, NEW ENGL J MED, V343, P239, DOI 10.1056/NEJM200007273430402; Ingenito EP, 2003, AM J RESP CRIT CARE, V167, P771, DOI 10.1164/rccm.200208-842OC; SNELL GI, 2001, ACCP M; Toma TP, 2001, LANCET, V357, P1621, DOI 10.1016/S0140-6736(00)04761-9	5	208	239	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 15	2003	361	9361					931	933		10.1016/S0140-6736(03)12762-6	http://dx.doi.org/10.1016/S0140-6736(03)12762-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648974				2022-12-24	WOS:000181741600013
J	Huang, CY; Ayliffe, MA; Timmis, JN				Huang, CY; Ayliffe, MA; Timmis, JN			Direct measurement of the transfer rate of chloroplast DNA into the nucleus	NATURE			English	Article							PLASTID GENOME; GENE; TOBACCO; PLANTS; ARABIDOPSIS; EXPRESSION; REVEALS; INSERTION	Gene transfer from the chloroplast to the nucleus has occurred over evolutionary time(1). Functional gene establishment in the nucleus is rare, but DNA transfer without functionality is presumably more frequent. Here, we measured directly the transfer rate of chloroplast DNA (cpDNA) into the nucleus of tobacco plants (Nicotiana tabacum). To visualize this process, a nucleus-specific neomycin phosphotransferase gene (neoSTLS2) was integrated into the chloroplast genome, and the transfer of cpDNA to the nucleus was detected by screening for kanamycin-resistant seedlings in progeny. A screen for kanamycin-resistant seedlings was conducted with about 250,000 progeny produced by fertilization of wild-type females with pollen from plants containing cp-neoSTLS2. Sixteen plants of independent origin were identified and their progenies showed stable inheritance of neoSTLS2, characteristic of nuclear genes. Thus, we provide a quantitative estimate of one transposition event in about 16,000 pollen grains for the frequency of transfer of cpDNA to the nucleus. In addition to its evident role in organellar evolution, transposition of cpDNA to the nucleus in tobacco occurs at a rate that must have significant consequences for existing nuclear genes.	Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia; CSIRO Plant Ind, Canberra, ACT 2601, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Timmis, JN (corresponding author), Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia.	jeremy.timmis@adelaide.edu.au	Ayliffe, Michael A/A-2089-2010					Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Babiychuk E, 1997, P NATL ACAD SCI USA, V94, P12722, DOI 10.1073/pnas.94.23.12722; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Daniell H, 2002, TRENDS PLANT SCI, V7, P84, DOI 10.1016/S1360-1385(01)02193-8; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; ECKES P, 1986, MOL GEN GENET, V205, P14, DOI 10.1007/BF02428027; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Horser C, 2002, GENET ENG P, V24, P239; Huang CY, 2000, PLANT PHYSIOL, V124, P415, DOI 10.1104/pp.124.1.415; Kaneko T, 1996, DNA Res, V3, P109; Maas C, 1997, MOL BREEDING, V3, P15, DOI 10.1023/A:1009602923403; Maliga P, 2002, CURR OPIN PLANT BIOL, V5, P164, DOI 10.1016/S1369-5266(02)00248-0; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Scott SE, 1999, NAT BIOTECHNOL, V17, P390, DOI 10.1038/7952; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; TIMMIS JN, 1983, NATURE, V305, P65, DOI 10.1038/305065a0; Whitney SM, 2001, PLANT CELL, V13, P193, DOI 10.1105/tpc.13.1.193; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1; ZOUBENKO OV, 1994, NUCLEIC ACIDS RES, V22, P3819, DOI 10.1093/nar/22.19.3819	26	217	234	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					72	76		10.1038/nature01435	http://dx.doi.org/10.1038/nature01435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12594458				2022-12-24	WOS:000181343100039
J	Allen, M				Allen, M			Liability for climate change	NATURE			English	Editorial Material									Univ Oxford, Dept Phys, Oxford OX1 3PU, England	University of Oxford	Allen, M (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.	myles.allen@physics.ox.ac.uk							0	286	287	4	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					891	892		10.1038/421891a	http://dx.doi.org/10.1038/421891a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606972				2022-12-24	WOS:000181186900017
J	Lou, ZK; Minter-Dykhouse, K; Wu, XL; Chen, JJ				Lou, ZK; Minter-Dykhouse, K; Wu, XL; Chen, JJ			MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways	NATURE			English	Article							ATAXIA-TELANGIECTASIA; FHA DOMAIN; CHECKPOINT; PHOSPHORYLATION; PROTEIN; THREONINE-68; KINASE; ATM; REPAIR; BRCA1	Forkhead-homology-associated (FHA) domains function as protein-protein modules that recognize phosphorylated serine/threonine motifs(1-5). Interactions between FHA domains and phosphorylated proteins are thought to have essential roles in the transduction of DNA damage signals; however, it is unclear how FHA-domain-containing proteins participate in mammalian DNA damage responses. Here we report that a FHA-domain-containing protein-mediator of DNA damage checkpoint protein 1 (MDC1; previously known as KIAA0170)-is involved in DNA damage responses. MDC1 localizes to sites of DNA breaks and associates with CHK2 after DNA damage. This association is mediated by the MDC1 FHA domain and the phosphorylated Thr 68 of CHK2. Furthermore, MDC1 is phosphorylated in an ATM/CHK2-dependent manner after DNA damage, suggesting that MDC1 may function in the ATM-CHK2 pathway. Consistent with this hypothesis, suppression of MDC1 expression results in defective S-phase checkpoint and reduced apoptosis in response to DNA damage, which can be restored by the expression of wildtype MDC1 but not MDC1 with a deleted FHA domain. Suppression of MDC1 expression results in decreased p53 stabilization in response to DNA damage. These results suggest that MDC1 is recruited through its FHA domain to the activated CHK2, and has a critical role in CHK2-mediated DNA damage responses.	Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA	Mayo Clinic	Chen, JJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Oncol, 200 1st St SW, Rochester, MN 55905 USA.	chen.junjie@mayo.edu	Minter Dykhouse, Katherine/L-4573-2013	Minter Dykhouse, Katherine/0000-0003-4363-5826				Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Jack MT, 2002, P NATL ACAD SCI USA, V99, P9825, DOI 10.1073/pnas.152053599; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shieh SY, 2000, GENE DEV, V14, P289; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Wang P, 2000, J MOL BIOL, V302, P927, DOI 10.1006/jmbi.2000.4095; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	30	272	293	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					957	961		10.1038/nature01447	http://dx.doi.org/10.1038/nature01447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607004				2022-12-24	WOS:000181186900052
J	Warren, LA; Kauffman, ME				Warren, LA; Kauffman, ME			Microbial geoengineers	SCIENCE			English	Editorial Material							ACID-MINE DRAINAGE; MICROORGANISMS		McMaster Univ, Sch Geog & Geol, Hamilton, ON L8S 4K1, Canada; Idaho Natl Engn & Environm Lab, Idaho Falls, ID 83415 USA	McMaster University; United States Department of Energy (DOE); Idaho National Laboratory	Warren, LA (corresponding author), McMaster Univ, Sch Geog & Geol, Hamilton, ON L8S 4K1, Canada.							Beliaev AS, 2002, J BACTERIOL, V184, P4612, DOI 10.1128/JB.184.16.4612-4616.2002; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Edwards KJ, 2000, SCIENCE, V287, P1796, DOI 10.1126/science.287.5459.1796; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; HAACK EA, 2002, FALL AGU M SAN FRANC; HANSEL CM, 2002, FALL AGU M SAN FRANC; MORIN G, 2002, FALL AGU M SAN FRANC; Nealson KH, 1997, REV MINERAL, V35, P5; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; O'Day PA, 1999, REV GEOPHYS, V37, P249, DOI 10.1029/1998RG900003; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; 2002, FALL AGU M SAN FRANC	15	11	23	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1027	+		10.1126/science.1072076	http://dx.doi.org/10.1126/science.1072076			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586932				2022-12-24	WOS:000180960000033
J	Langenau, DM; Traver, D; Ferrando, AA; Kutok, JL; Aster, JC; Kanki, JP; Lin, S; Prochownik, E; Trede, NS; Zon, LI; Look, AT				Langenau, DM; Traver, D; Ferrando, AA; Kutok, JL; Aster, JC; Kanki, JP; Lin, S; Prochownik, E; Trede, NS; Zon, LI; Look, AT			Myc-induced T cell leukemia in transgenic zebrafish	SCIENCE			English	Article							NEOPLASTIC PHENOTYPE; C-MYC; MODELS; HEART	The zebrafish is an attractive model organism for studying cancer development because of its genetic accessibility. Here we describe the induction of clonally derived T cell acute lymphoblastic leukemia in transgenic zebrafish expressing mouse c-myc under control of the zebrafish Rag2 promoter. Visualization of leukemic cells expressing a chimeric transgene encoding Myc fused to green fluorescent protein (GFP) revealed that leukemias arose in the thymus, spread locally into gill arches and retro-orbital soft tissue, and then disseminated into skeletal muscle and abdominal organs. Leukemic cells homed back to the thymus in irradiated fish transplanted with GFP-labeled leukemic lymphoblasts. This transgenic model provides a platform for drug screens and for genetic screens aimed at identifying mutations that suppress or enhance c-myc-induced carcinogenesis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15213 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	thomas_look@dfci.harvard.edu	Langenau, David/GXI-0197-2022; Aster, Jon C/B-6857-2009	Langenau, David/0000-0001-6664-8318; 	NCI NIH HHS [CA-06516, CA-68484] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA068484, P30CA006516] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Beckwith LG, 2000, LAB INVEST, V80, P379, DOI 10.1038/labinvest.3780042; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Driever W, 1996, DEVELOPMENT, V123, P37; Haffter P, 1996, DEVELOPMENT, V123, P1; Haire RN, 2000, IMMUNOGENETICS, V51, P915, DOI 10.1007/s002510000229; Hsu K, 2001, CURR OPIN HEMATOL, V8, P245, DOI 10.1097/00062752-200107000-00011; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jessen JR, 1999, NAT GENET, V23, P15, DOI 10.1038/12609; Jessen JR, 2001, GENESIS, V29, P156, DOI 10.1002/gene.1019; LOOK AT, 1998, GENETIC BASIS HUMAN, pCH5; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; STUART GW, 1988, DEVELOPMENT, V103, P403; Thisse C, 2002, SCIENCE, V295, P457, DOI 10.1126/science.1063654; TRAVER D, UNPUB; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Wu XM, 2001, TRENDS CELL BIOL, V11, pS2, DOI 10.1016/S0962-8924(01)82000-6; Yin XY, 2001, ONCOGENE, V20, P4650, DOI 10.1038/sj.onc.1204606	24	408	442	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					887	890		10.1126/science.1080280	http://dx.doi.org/10.1126/science.1080280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574629				2022-12-24	WOS:000180830900051
J	Keavney, B; Parish, S; Palmer, A; Clark, S; Youngman, L; Danesh, J; McKenzie, C; Delepine, M; Lathrop, M; Peto, R; Collins, R				Keavney, B; Parish, S; Palmer, A; Clark, S; Youngman, L; Danesh, J; McKenzie, C; Delepine, M; Lathrop, M; Peto, R; Collins, R		ISIS Collaborators	Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E epsilon 2/epsilon 3/epsilon 4 genotype	LANCET			English	Article							CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; MEN	Results from two small studies, involving a total of only 174 cases, have suggested that the increased. risk of coronary heart disease conferred by cigarette smoking Is substantially affected by genotype at the apolipoprotein E (APOE) epsilon2/epsilon3/epsilon4 polymorphism. We have established APOE genotypes in 4484 patients With acute myocardial infarction diagnosed before the age of 55 years for male and 65 years for female patients, and in 5757 controls with no history of cardiovascular disease. On average, the hazard ratio for myocardial infarction was 1.17 (95% CI 1.09-1.25; p<0.00001) per stepwise change from &epsilon;3/2 to &epsilon;3/3 to &epsilon;3/4 genotype. Among individuals in this study with known cigarette smoking status, the hazard ratio for myocardial infarction in smokers versus non-smokers was 4.6 (4.2-5.1). There was, however, no significant difference between the smoker/non-smoker hazard ratios for those with different APOE genotypes (&chi;(2)(2)=0.69; p=0.7). When differences in risk between different genotypes are not extreme (as with this APOE polymorphism), reliable assessment of hypothesised gene-environment interactions will often require the study of many thousands of disease cases.	Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England; Univ W Indies, Trop Metab Res Unit, Kingston 7, Jamaica; Ctr Natl Genotypage, Paris, France	Newcastle University - UK; University of Oxford; University of Oxford; University West Indies Mona Jamaica; CEA	Keavney, B (corresponding author), Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.			Keavney, Bernard/0000-0001-9573-0812				Humphries SE, 2001, LANCET, V358, P115, DOI 10.1016/S0140-6736(01)05330-2; Keavney B, 2000, LANCET, V355, P434; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Stengard JH, 1999, CLIN GENET, V56, P367; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250	5	40	42	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					396	398		10.1016/S0140-6736(03)12386-0	http://dx.doi.org/10.1016/S0140-6736(03)12386-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573381				2022-12-24	WOS:000180787000017
J	van Leeuwen, R; Vingerling, JR; Hofman, A; de Jong, PTVM; Stricker, BH				van Leeuwen, R; Vingerling, JR; Hofman, A; de Jong, PTVM; Stricker, BH			Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement	BRITISH MEDICAL JOURNAL			English	Article							MACULAR DEGENERATION		Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr Rotterdam, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Jong, PTVM (corresponding author), Netherlands Ophthalm Res Inst, KNAW, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.							Arnold JJ, 2000, BRIT MED J, V321, P741, DOI 10.1136/bmj.321.7263.741; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Hall NF, 2001, BRIT MED J, V323, P375, DOI 10.1136/bmj.323.7309.375; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x	5	60	61	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					255	256		10.1136/bmj.326.7383.255	http://dx.doi.org/10.1136/bmj.326.7383.255			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560276	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000180908300019
J	Shu, DG; Morris, SC; Han, J; Zhang, ZF; Yasui, K; Janvier, P; Chen, L; Zhang, XL; Liu, JN; Li, Y; Liu, HQ				Shu, DG; Morris, SC; Han, J; Zhang, ZF; Yasui, K; Janvier, P; Chen, L; Zhang, XL; Liu, JN; Li, Y; Liu, HQ			Head and backbone of the Early Cambrian vertebrate Haikouichthys	NATURE			English	Article							EVOLUTION; CHINA; PERSPECTIVES; AMPHIOXUS; HAGFISHES; INSIGHTS; LAMPREYS; ORIGIN	Agnathan fish hold a key position in vertebrate evolution, especially regarding the origin of the head and neural-crest-derived tissue(1). In contrast to amphioxus(2), lampreys and other vertebrates possess a complex brain and placodes that contribute to well-developed eyes, as well as auditory and olfactory systems(3). These sensory sytems were arguably a trigger to subsequent vertebrate diversifications. However, although they are known from skeletal impressions in younger Palaeozoic agnathans(4), information about the earliest records of these systems has been largely wanting. Here we report numerous specimens of the Lower Cambrian vertebrate Haikouichthys ercaicunensis, until now only known from the holotype(5). Haikouichthys shows significant differences from other fossil agnathans: key features include a small lobate extension to the head, with eyes and possible nasal sacs, as well as what may be otic capsules. A notochord with separate vertebral elements is also identifiable. Phylogenetic analysis indicates that this fish lies within the stem-group craniates. Although Haikouichthys somewhat resembles the ammocoete larva of modern lampreys, this is because of shared general craniate characters; adult lampreys and hagfishes (the cyclostomes if monophyletic(6,7)) are probably derived in many respects.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Kumamoto Univ, Div Dev & Biohist, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; CNRS, UMR 8569, Lab Paleontol, Museum Natl Hist Nat, F-75005 Paris, France; Museum Nat Hist, Dept Palaeontol, London SW7 5BD, England	Northwest University Xi'an; Northwest University Xi'an; China University of Geosciences; University of Cambridge; Kumamoto University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Natural History Museum London	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.			zhang, zhifei/0000-0003-0325-5116				Bardack D., 1971, BIOL LAMPREYS, V1, P67; Cohn MJ, 2002, NATURE, V416, P386, DOI 10.1038/416386a; COLE WC, 1982, AM J ANAT, V165, P131, DOI 10.1002/aja.1001650205; Farris JS, 1988, HENNIG86 VERSION 1 5; Fritzsch B, 1998, OTOLARYNG HEAD NECK, V119, P182, DOI 10.1016/S0194-5998(98)70053-1; GABBOTT SE, 1995, NATURE, V374, P800, DOI 10.1038/374800a0; Gagnier P. Y., 1993, Annales de Paleontologie, V79, P119; Gagnier Pierre-Yves, 1993, Annales de Paleontologie, V79, P19; Holland LZ, 2001, J ANAT, V199, P85, DOI 10.1046/j.1469-7580.199.parts1-2.8.x; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 1999, NATURE, V402, P21, DOI 10.1038/46909; Janvier P., 1996, EARLY VERTEBRATES; KLEEREKOPER H, 1972, BIOL LAMPREYS, V2, P373; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; Lacalli TC, 1996, PHILOS T ROY SOC B, V351, P243, DOI 10.1098/rstb.1996.0022; Lacalli TC, 2001, PHILOS T ROY SOC B, V356, P1565, DOI 10.1098/rstb.2001.0974; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; Northcutt R. Glenn, 1996, Israel Journal of Zoology, V42, P273; RAMOS TC, 1996, TREE GARDNERER VERSI; Ritchie A., 1968, Palaeontology, V11, P21; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Shu DG, 2001, NATURE, V411, P472, DOI 10.1038/35078069; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	29	207	228	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					526	529		10.1038/nature01264	http://dx.doi.org/10.1038/nature01264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556891				2022-12-24	WOS:000180670600043
J	Bunge, M; Adrian, L; Kraus, A; Opel, M; Lorenz, WG; Andreesen, JR; Gorisch, H; Lechner, U				Bunge, M; Adrian, L; Kraus, A; Opel, M; Lorenz, WG; Andreesen, JR; Gorisch, H; Lechner, U			Reductive dehalogenation of chlorinated dioxins by an anaerobic bacterium	NATURE			English	Article							DIBENZO-P-DIOXINS; MICROBIAL CONSORTIUM; ESTUARINE SEDIMENTS; DECHLORINATION; TETRACHLOROETHENE; DIVERSITY; CULTURES; PCDD/F; RIVER	Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) are among the most notorious environmental pollutants. Some congeners, particularly those with lateral chlorine substitutions at positions 2, 3, 7 and 8, are extremely toxic and carcinogenic to humans(1). One particularly promising mechanism for the detoxification of PCDDs and PCDFs is microbial reductive dechlorination. So far only a limited number of phylogenetically diverse anaerobic bacteria have been found that couple the reductive dehalogenation of chlorinated compounds-the substitution of a chlorine for a hydrogen atom-to energy conservation and growth in a process called dehalorespiration(2). Microbial dechlorination of PCDDs occurs in sediments and anaerobic mixed cultures from sediments, but the responsible organisms have not yet been identified or isolated. Here we show the presence of a Dehalococcoides species in four dioxin-dechlorinating enrichment cultures from a freshwater sediment highly contaminated with PCDDs and PCDFs. We also show that the previously described chlorobenzene-dehalorespiring bacterium Dehalococcoides sp. strain CBDB1 (ref. 3) is able to reductively dechlorinate selected dioxin congeners. Reductive dechlorination of 1, 2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD) demonstrates that environmentally significant dioxins are attacked by this bacterium.	Univ Halle Wittenberg, Inst Mikrobiol, D-06099 Halle Saale, Germany; Univ Halle Wittenberg, Inst Analyt & Umweltchem, D-06099 Halle Saale, Germany; Tech Univ Berlin, Inst Biotechnol, Fachgebiet Tech Biochem, D-13353 Berlin, Germany; GfA Gesell Arbeitsplatz & Umweltanalyt mbH, D-06896 Straach, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Technical University of Berlin	Bunge, M (corresponding author), Univ Halle Wittenberg, Inst Mikrobiol, D-06099 Halle Saale, Germany.		Adrian, Lorenz/A-4443-2012; Bunge, Michael/J-6261-2012	Adrian, Lorenz/0000-0001-8205-0842; Bunge, Michael/0000-0001-7124-2750				ADRIAENS P, 1994, CHEMOSPHERE, V29, P2253, DOI 10.1016/0045-6535(94)90392-1; ADRIAENS P, 1995, ENVIRON SCI TECHNOL, V29, P2252, DOI 10.1021/es00009a015; Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Albrecht ID, 1999, ENVIRON SCI TECHNOL, V33, P737, DOI 10.1021/es980791t; Ballerstedt H, 1997, ENVIRON SCI TECHNOL, V31, P1749, DOI 10.1021/es960737h; Barkovskii AL, 1996, APPL ENVIRON MICROB, V62, P4556, DOI 10.1128/AEM.62.12.4556-4562.1996; BEURSKENS JEM, 1995, ENVIRON TOXICOL CHEM, V14, P939, DOI 10.1002/etc.5620140603; BEURSKENS JEM, 1993, ENVIRON TOXICOL CHEM, V12, P1549, DOI 10.1002/etc.5620120905; Breitenstein A, 2001, ARCH MICROBIOL, V175, P133, DOI 10.1007/s002030000248; Brzuzy LP, 1996, ENVIRON SCI TECHNOL, V30, P1797, DOI 10.1021/es950714n; Bunge M, 2001, CHEMOSPHERE, V43, P675, DOI 10.1016/S0045-6535(00)00420-3; Cutter LA, 2001, ENVIRON MICROBIOL, V3, P699, DOI 10.1046/j.1462-2920.2001.00246.x; *DIN EN, 1997, 19483 DIN EN; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; GRIBBLE GW, 1998, ENCY ENV ANAL REMEDI, P972; Hendrickson ER, 2002, APPL ENVIRON MICROB, V68, P485, DOI 10.1128/AEM.68.2.485-495.2002; Hoekstra EJ, 1999, ENVIRON SCI TECHNOL, V33, P2543, DOI 10.1021/es9900104; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Kaiser J, 2000, SCIENCE, V288, P1941; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; MEHARG AA, 1995, NATURE, V375, P353, DOI 10.1038/375353a0; Muller JF, 1999, CHEMOSPHERE, V39, P1707, DOI 10.1016/S0045-6535(99)00065-X; RAPPE C, 1999, ORGANOHALOGEN COMPD, V43, P111; von Wintzingerode F, 1999, APPL ENVIRON MICROB, V65, P283; Wu QZ, 2002, APPL ENVIRON MICROB, V68, P807, DOI 10.1128/AEM.68.2.807-812.2002; ZOLLER W, 1985, FRESEN Z ANAL CHEM, V321, P247, DOI 10.1007/BF00470365	28	264	280	11	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					357	360		10.1038/nature01237	http://dx.doi.org/10.1038/nature01237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540897				2022-12-24	WOS:000180533000038
J	Azam, M; Latek, RR; Daley, GQ				Azam, M; Latek, RR; Daley, GQ			Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE; C-ABL; CLINICAL RESISTANCE; BLAST CRISIS; SH3 DOMAINS; INTRAMOLECULAR INTERACTIONS; REGULATORY DOMAINS	The Bcr-Abl fusion protein kinase causes chronic myeloid leukemia and is targeted by the signal transduction inhibitor STI-571/Gleevec/imatinib (STI-571). Sequencing of the BCR-ABL gene in patients who have relapsed after STI-571 chemotherapy has revealed a limited set of kinase domain mutations that mediate drug resistance. To obtain a more comprehensive survey of the amino acid substitutions that confer STI-571 resistance, we performed an in vitro screen of randomly mutagenized BCR-ABL and recovered all of the major mutations previously identified in patients and numerous others that illuminate novel mechanisms of acquired drug resistance. Structural modeling implies that a novel class of variants acts allosterically to destabilize the autoinhibited conformation of the ABL kinase to which STI-571 preferentially binds' This screening strategy is a paradigm applicable to a growing list of target-directed anti-cancer agents and provides a means of anticipating the drug-resistant amino acid substitutions that are likely to be clinically problematic.	Whitehead Inst, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Daley, GQ (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	daley@wi.mit.edu			NCI NIH HHS [CA86991, CA76418] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA076418, R01CA086991] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Bradshaw JM, 2000, J MOL BIOL, V299, P521; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Brasher BB, 2001, ONCOGENE, V20, P7744, DOI 10.1038/sj.onc.1204978; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Corbin AS, 2002, J BIOL CHEM, V277, P32214, DOI 10.1074/jbc.M111525200; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Emini EA, 1995, ADV EXP MED BIOL, V390, P187; FAINSTEIN E, 1989, ONCOGENE, V4, P1477; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hochhaus A, 2001, SCIENCE, V293, P2163; Hofmann WK, 2002, BLOOD, V99, P1860, DOI 10.1182/blood.V99.5.1860; Hoover RR, 2002, BLOOD, V100, P1068, DOI 10.1182/blood.V100.3.1068; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KANTARJIAN HM, 2002, BLOOD, V29, P29; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nam HJ, 1996, STRUCTURE, V4, P1105, DOI 10.1016/S0969-2126(96)00116-5; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Panni S, 2002, J BIOL CHEM, V277, P21666, DOI 10.1074/jbc.M109788200; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANETTEN RA, 1995, ONCOGENE, V10, P1977; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wisniewski D, 2002, CANCER RES, V62, P4244; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	47	517	541	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2003	112	6					831	843		10.1016/S0092-8674(03)00190-9	http://dx.doi.org/10.1016/S0092-8674(03)00190-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654249	Bronze			2022-12-24	WOS:000181818500010
J	Vermeer, PD; Einwalter, LA; Moniger, TO; Rokhlina, T; Kern, JA; Zabner, J; Welsh, MJ				Vermeer, PD; Einwalter, LA; Moniger, TO; Rokhlina, T; Kern, JA; Zabner, J; Welsh, MJ			Segregation of receptor and ligand regulates activation of epithelial growth factor receptor	NATURE			English	Article							CELL POLARITY; EXPRESSION; LUNG; PRECURSOR	Interactions between ligands and receptors are central to communication between cells and tissues. Human airway epithelia constitutively produce both a ligand, the growth factor heregulin, and its receptors-erbB2, erbB3 and erbB4 (refs 1-3). Although heregulin binding initiates cellular proliferation and differentiation(8), airway epithelia have a low rate of cell division(8). This raises the question of how ligand-receptor interactions are controlled in epithelia. Here we show that in differentiated human airway epithelia, heregulin-alpha is present exclusively in the apical membrane and the overlying airway surface liquid, physically separated from erbB2-4, which segregate to the basolateral membrane. This physical arrangement creates a ligand-receptor pair poised for activation whenever epithelial integrity is disrupted. Indeed, immediately following a mechanical injury, heregulin-alpha activates erbB2 in cells at the edge of the wound, and this process hastens restoration of epithelial integrity. Likewise, when epithelial cells are not separated into apical and basolateral membranes ('polarized'), or when tight Junctions between adjacent cells are opened, heregulin-alpha activates its receptor. This mechanism of ligand-receptor segregation on either side of epithelial tight junctions may be vital for rapid restoration of integrity following injury, and hence critical for survival. This model also suggests a mechanism for abnormal receptor activation in diseases with increased epithelial permeability.	Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Roy J & Lucille A Carver Coll Med, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; University Hospitals of Cleveland	Zabner, J (corresponding author), Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu; michael-weish@uiowa.edu	Vermeer, Paola D/O-2572-2013	Welsh, Michael/0000-0002-1646-6206; Kern, Jeffrey/0000-0001-9709-9622; Zabner, Joseph/0000-0002-9606-1339				Aguilar Z, 2001, J BIOL CHEM, V276, P44099, DOI 10.1074/jbc.M103442200; AIDA S, 1994, RESPIRATION, V61, P161; Al Moustafa AE, 1999, ANTICANCER RES, V19, P481; Campiglio M, 1999, J CELL BIOCHEM, V73, P522, DOI 10.1002/(SICI)1097-4644(19990615)73:4<522::AID-JCB10>3.0.CO;2-4; Dempsey PJ, 1997, J CELL BIOL, V138, P747, DOI 10.1083/jcb.138.4.747; Godfrey RWA, 1997, MICROSC RES TECHNIQ, V38, P488, DOI 10.1002/(SICI)1097-0029(19970901)38:5<488::AID-JEMT5>3.0.CO;2-E; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KENNEDY SM, 1984, AM REV RESPIR DIS, V129, P143; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Polosa R, 1999, AM J RESP CELL MOL, V20, P914, DOI 10.1165/ajrcmb.20.5.3308; SOBONYA RE, 1986, AM REV RESPIR DIS, V134, P290; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Walker RA, 1998, J PATHOL, V185, P234, DOI 10.1002/(SICI)1096-9896(199807)185:3<234::AID-PATH128>3.0.CO;2-8; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang GS, 1998, J VIROL, V72, P9818, DOI 10.1128/JVI.72.12.9818-9826.1998; Wodarz A, 2000, CURR BIOL, V10, pR624, DOI 10.1016/S0960-9822(00)00658-8; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	19	287	304	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2003	422	6929					322	326		10.1038/nature01440	http://dx.doi.org/10.1038/nature01440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646923				2022-12-24	WOS:000181637300042
J	Vasan, RS; Beiser, A; D'Agostino, RB; Levy, D; Selhub, J; Jacques, PF; Rosenberg, IH; Wilson, PWF				Vasan, RS; Beiser, A; D'Agostino, RB; Levy, D; Selhub, J; Jacques, PF; Rosenberg, IH; Wilson, PWF			Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; FOLIC-ACID; CORONARY; HYPERHOMOCYSTEINEMIA; POPULATION; CLASSIFICATION; DETERMINANTS; FOLATE; SERUM	Context Elevated plasma homocysteine levels are associated with increased risk of vascular disease. It is unclear whether elevated homocysteine levels are a risk factor for congestive heart failure (CHF). Objective To study prospectively the-association between nonfasting plasma homocysteine and incidence of CHF. Design, Setting, and Participants Community-based prospective cohort study of 2491 adults (mean age 72 years, 1547 women) who participated in the Framingham Heart Study during the 1979-1982 and 1986-1990 examinations and were free of CHIF or prior myocardial infarction (recognized or unrecognized) at baseline. Main Outcome Measure incidence of a first episode of CHIF during an 8-year follow-up period. Results During follow-up, 156 subjects (88 women) developed CHF. In multivariable analyses controlling for established risk factors for CHF including the occurrence of myocardial infarction (recognized or unrecognized) during follow-up, plasma homocysteine levels higher than the sex-specific median value were associated with an adjusted hazards ratio,for heart failure of 1.93 in women (95% confidence interval, 1.19-3.14)and 1.84 in men (95% confidence interval, 1.06-3.17). The relation of plasma homocysteine levels to CHF risk was more continuous in women than in men. In analyses restricted to participants without any manifestation of coronary heart disease at baseline, the association of plasma homocysteine levels with risk of CHF was maintained in men and women. Conclusions An increased plasma homocysteine level independently predicts risk of the development of CHF in adults without prior myocardial infarction. Additional investigations are warranted to confirm these findings.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Clin Epidemiol, Boston, MA 02215 USA; NHLBI, Bethesda, MD 20892 USA; Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Site 2, Framingham, MA 01702 USA.	vasan@fram.nhlbi.nih.gov	Wilson, Peter W.F./J-2455-2016; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Beiser, Alexa/0000-0001-8551-7778	NHLBI NIH HHS [N01-HC-25195, 1K24 HL04334, R01 HL71039] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, R01HL071039] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Obaidi MK, 2000, J AM COLL CARDIOL, V36, P1217, DOI 10.1016/S0735-1097(00)00820-2; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; *AM HEART ASS, 2000, 2001 HEART STROK STA, P19; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Blacher J, 1999, J NEPHROL, V12, P248; Bostom AG, 1999, CIRCULATION, V99, P2361, DOI 10.1161/01.CIR.99.18.2361; Chao CL, 1999, ATHEROSCLEROSIS, V147, P379, DOI 10.1016/S0021-9150(99)00208-7; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chilian WM, 1997, CIRCULATION, V95, P522; Clarke R, 2001, J CARDIOVASC RISK, V8, P363, DOI 10.1097/00043798-200112000-00005; Cooke GE, 2000, J AM COLL CARDIOL, V36, P509, DOI 10.1016/S0735-1097(00)00756-7; Cowie MR, 1997, EUR HEART J, V18, P208; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kannel W., 1987, SOME RISK FACTORS RE; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lentz SR, 1997, LIFE SCI, V61, P1205, DOI 10.1016/S0024-3205(97)00392-5; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJV, 1998, EUR HEART J, V19, pP9; Miller A, 2002, AM J HYPERTENS, V15, P157, DOI 10.1016/S0895-7061(01)02286-5; Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491; Nurk E, 2001, J NUTR, V131, P1214, DOI 10.1093/jn/131.4.1214; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; *SAS I INC, 1997, PHREG PROC CHANG ENH; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Symons JD, 2002, ARTERIOSCL THROM VAS, V22, P772, DOI 10.1161/01.ATV.0000014588.71807.0A; UELAND PM, 1993, CLIN CHEM, V39, P1764; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Ventura P, 2001, METABOLISM, V50, P1466, DOI 10.1053/meta.2001.28079; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Whincup PH, 1999, HEART, V82, P448, DOI 10.1136/hrt.82.4.448; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; 1997, ARCH INTERN MED, V157, P2413; 1996, FED REG, V61, P8781	41	161	177	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1251	1257		10.1001/jama.289.10.1251	http://dx.doi.org/10.1001/jama.289.10.1251			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633186	Bronze			2022-12-24	WOS:000181466500026
J	Acevedo-Whitehouse, K; Gulland, F; Greig, D; Amos, W				Acevedo-Whitehouse, K; Gulland, F; Greig, D; Amos, W			Disease susceptibility in California sea lions	NATURE			English	Article							ZALOPHUS-CALIFORNIANUS; MICROSATELLITES		Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Marine Mammal Ctr, Sausalito, CA 94965 USA	University of Cambridge	Acevedo-Whitehouse, K (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	w.amos@zoo.cam.ac.uk		Greig, Denise/0000-0003-0783-1002				Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Buchanan FC, 1998, MOL ECOL, V7, P1083; Coltman DW, 1996, MOL ECOL, V5, P161, DOI 10.1111/j.1365-294X.1996.tb00303.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Frankham R, 2010, INTRO CONSERVATION G; GAGE LJ, 1993, J ZOO WILDLIFE MED, V24, P41; Goldstein T., 1999, Aquatic Mammals, V25, P43; Gulland FMD, 2002, VET REC, V150, P475; Hoelzel AR, 2001, P ROY SOC B-BIOL SCI, V268, P325; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lipscomb TP, 2000, VET PATHOL, V37, P609, DOI 10.1354/vp.37-6-609; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499	13	267	273	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					35	35		10.1038/422035a	http://dx.doi.org/10.1038/422035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621424	Bronze			2022-12-24	WOS:000181343100027
J	Herridge, MS; Cheung, AM; Tansey, CM; Matte-Martyn, A; Diaz-Granados, N; Al-Saidi, F; Cooper, AB; Guest, CB; Mazer, CD; Mehta, S; Stewart, TE; Barr, A; Cook, D; Slutsky, AS				Herridge, MS; Cheung, AM; Tansey, CM; Matte-Martyn, A; Diaz-Granados, N; Al-Saidi, F; Cooper, AB; Guest, CB; Mazer, CD; Mehta, S; Stewart, TE; Barr, A; Cook, D; Slutsky, AS		Canadian Critical Care Trials Grp	One-year outcomes in survivors of the acute respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; ACUTE LUNG INJURY; TERM-FOLLOW-UP; PULMONARY-FUNCTION; RECOVERY; ABNORMALITIES; DYSFUNCTION; SF-36; ARDS	BACKGROUND: As more patients survive the acute respiratory distress syndrome, an understanding of the long-term outcomes of this condition is needed. METHODS: We evaluated 109 survivors of the acute respiratory distress syndrome 3, 6, and 12 months after discharge from the intensive care unit. At each visit, patients were interviewed and underwent a physical examination, pulmonary-function testing, a six-minute-walk test, and a quality-of-life evaluation. RESULTS: Patients who survived the acute respiratory distress syndrome were young (median age, 45 years) and severely ill (median Acute Physiology, Age, and Chronic Health Evaluation score, 23) and had a long stay in the intensive care unit (median, 25 days). Patients had lost 18 percent of their base-line body weight by the time they were discharged from the intensive care unit and stated that muscle weakness and fatigue were the reasons for their functional limitation. Lung volume and spirometric measurements were normal by 6 months, but carbon monoxide diffusion capacity remained low throughout the 12-month follow-up. No patients required supplemental oxygen at 12 months, but 6 percent of patients had arterial oxygen saturation values below 88 percent during exercise. The median score for the physical role domain of the Medical Outcomes Study 36-item Short-Form General Health Survey (a health-related quality-of-life measure) increased from 0 at 3 months to 25 at 12 months (score in the normal population, 84). The distance walked in six minutes increased from a median of 281 m at 3 months to 422 m at 12 months; all values were lower than predicted. The absence of systemic corticosteroid treatment, the absence of illness acquired during the intensive care unit stay, and rapid resolution of lung injury and multiorgan dysfunction were associated with better functional status during the one-year follow-up. CONCLUSIONS: Survivors of the acute respiratory distress syndrome have persistent functional disability one year after discharge from the intensive care unit. Most patients have extrapulmonary conditions, with muscle wasting and weakness being most prominent.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Univ Hlth Network, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Interdept Div Crit Care Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Publ Hlth Sci, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Anaesthesia, Toronto, ON, Canada; St Michaels Hosp, Dept Anesthesia & Crit Care Med, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Dept Med & Crit Care Med, Toronto, ON M5B 1W8, Canada; Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Anesthesia, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University Health Network Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; McMaster University; McMaster University	Herridge, MS (corresponding author), Toronto Gen Hosp, EN 10-212,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	margaret.herridge@uhn.on.ca	Slutsky, Arthur/M-3325-2019; Mehta, Sangeeta/C-4623-2015; Slutsky, Arthur S/A-6013-2008	Slutsky, Arthur S/0000-0002-6063-3876; Cheung, Angela M./0000-0001-8332-0744; Herridge, Margaret/0000-0002-2903-1631; Mazer, Cyril David/0000-0003-2566-4308	Canadian Institutes of Health Research [44917] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; ALBERTS WM, 1983, CHEST, V84, P272, DOI 10.1378/chest.84.3.272; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Anzueto A, 1999, CLIN CHEST MED, V20, P435, DOI 10.1016/S0272-5231(05)70151-9; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; CLEMENTS NC, 1993, CHEST, V104, P1526, DOI 10.1378/chest.104.5.1526; Cooper AB, 1999, CRIT CARE MED, V27, P2616, DOI 10.1097/00003246-199912000-00002; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; DOWNS JB, 1974, CHEST, V65, P92, DOI 10.1378/chest.65.1.92; ELLIOTT CG, 1987, AM REV RESPIR DIS, V135, P634; ELLIOTT CG, 1981, AM REV RESPIR DIS, V123, P492; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; GHIO AJ, 1989, AM REV RESPIR DIS, V140, P862; GHIO AJ, 1989, AM REV RESPIR DIS, V139, P1158, DOI 10.1164/ajrccm/139.5.1158; HALEVY A, 1984, RESPIR CARE, V29, P132; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hupcey J E, 2000, Am J Crit Care, V9, P192; Jacobs JWG, 1999, RHEUMATOLOGY, V38, P1145, DOI 10.1093/rheumatology/38.11.1145; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; KLEIN JJ, 1976, CHEST, V69, P350, DOI 10.1378/chest.69.3.350; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; LAKSHMINARAYAN S, 1978, CHEST, V74, P489, DOI 10.1378/chest.74.5.489; LAKSHMINARAYAN S, 1976, AM REV RESPIR DIS, V113, P7; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MCHUGH LG, 1994, AM J RESP CRIT CARE, V150, P90, DOI 10.1164/ajrccm.150.1.8025779; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; MONTGOMERY AB, 1989, AM REV RESPIR DIS, V139, P1548, DOI 10.1164/ajrccm/139.6.1548; PETERS JI, 1989, AM REV RESPIR DIS, V139, P1163, DOI 10.1164/ajrccm/139.5.1163; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; RICHARDSON JV, 1976, SOUTH MED J, V69, P735, DOI 10.1097/00007611-197606000-00022; RICHARDSON JV, 1976, SOUTH MED J, V69, P740; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; ROTMAN HH, 1977, CHEST, V72, P190, DOI 10.1378/chest.72.2.190; Schelling G, 2000, INTENS CARE MED, V26, P1304, DOI 10.1007/s001340051342; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; SHAW RA, 1981, ARCH INTERN MED, V141, P741, DOI 10.1001/archinte.141.6.741; SIMPSON DL, 1978, AM REV RESPIR DIS, V117, P449; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Weisman IM, 2001, CLIN CHEST MED, V22, P679, DOI 10.1016/S0272-5231(05)70060-5; YAHAV J, 1978, CHEST, V74, P247, DOI 10.1378/chest.74.3.247; YERNAULT JC, 1975, THORAX, V30, P252, DOI 10.1136/thx.30.3.252	45	1464	1534	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					683	693		10.1056/NEJMoa022450	http://dx.doi.org/10.1056/NEJMoa022450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594312				2022-12-24	WOS:000181014400003
J	LeCouter, J; Moritz, DR; Li, B; Phillips, GL; Liang, XH; Gerber, HP; Hillan, KJ; Ferrara, N				LeCouter, J; Moritz, DR; Li, B; Phillips, GL; Liang, XH; Gerber, HP; Hillan, KJ; Ferrara, N			Angiogenesis-independent endothelial protection of liver: Role of VEGFR-1	SCIENCE			English	Article							GROWTH-FACTOR VEGF; TYROSINE KINASE; FLT-1 VEGFR-1; RECEPTOR; CELLS; BINDING; REGENERATION; MIGRATION; MITOGEN; KDR	The vascular endothelium was once thought to function primarily in nutrient and oxygen delivery, but recent evidence suggests that it may play a broader role in tissue homeostasis. To explore the role of sinusoidal endothelial cells (LSECs) in the adult liver, we studied the effects of vascular endothelial growth factor (VEGF) receptor activation on mouse hepatocyte growth. Delivery of VEGF-A increased liver mass in mice but did not stimulate growth of hepatocytes in vitro, unless LSECs were also present in the culture. Hepatocyte growth factor (HGF) was identified as one of the LSEC-derived paracrine mediators promoting hepatocyte growth. Selective activation of VEGF receptor-1 (VEGFR-1) stimulated hepatocyte but not endothelial proliferation in vivo and reduced liver damage in mice exposed to a hepatotoxin. Thus, VEGFR-1 agonists may have therapeutic potential for preservation of organ function in certain liver disorders.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.							Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BARUCH Y, 1995, J HEPATOL, V23, P328, DOI 10.1016/0168-8278(95)80477-3; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; ITO N, 1994, BIOCHEM BIOPH RES CO, V198, P25, DOI 10.1006/bbrc.1994.1004; JAKEMAN LB, 1992, J CLIN INVEST, V89, P244, DOI 10.1172/JCI115568; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kliche S, 2001, IUBMB LIFE, V52, P61, DOI 10.1080/15216540252774784; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LECOUTER J, UNPUB; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273; PARK JE, 1994, J BIOL CHEM, V269, P25646; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; SIMIONESCU N, 1992, ENDOTHELIAL CELL FUN; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; YAMANE A, 1994, ONCOGENE, V9, P2683; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200	30	502	527	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					890	893		10.1126/science.1079562	http://dx.doi.org/10.1126/science.1079562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574630				2022-12-24	WOS:000180830900052
J	Evans, WE; McLeod, HL				Evans, WE; McLeod, HL			Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONVERTING ENZYME-INHIBITOR; SINGLE-NUCLEOTIDE POLYMORPHISMS; S-METHYLTRANSFERASE DEFICIENCY; APOLIPOPROTEIN-E POLYMORPHISM; LEFT-VENTRICULAR HYPERTROPHY; SEROTONIN TRANSPORTER GENE; MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN; BETA(2)-ADRENERGIC RECEPTOR; CORONARY ATHEROSCLEROSIS		St Jude Childrens Res Hosp, Memphis, TN 38101 USA; Univ Tennessee, Coll Pharm, Memphis, TN USA; Univ Tennessee, Coll Med, Memphis, TN USA; Washington Univ, Sch Med, St Louis, MO USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Washington University (WUSTL)	Evans, WE (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38101 USA.	william.evans@stjude.org	McLeod, Howard/ABD-8364-2021; Evans, William E./C-2069-2012	McLeod, Howard/0000-0002-9004-9232; Evans, William E./0000-0002-9333-5322	NCI NIH HHS [R37 CA36401, R01 CA78224, CA21765, CA091842] Funding Source: Medline; NIGMS NIH HHS [U01 GM61394, U01 GM63340, U01 GM61393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078224, R37CA036401, P30CA021765, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061394, U01GM063340, U01GM061393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Ameyaw MM, 2001, PHARMACOGENETICS, V11, P217, DOI 10.1097/00008571-200104000-00005; Arranz MJ, 2000, LANCET, V355, P1615, DOI 10.1016/S0140-6736(00)02221-2; Ballantyne CM, 2000, J AM COLL CARDIOL, V36, P1572, DOI 10.1016/S0735-1097(00)00918-9; Basile VS, 1999, NEUROPSYCHOPHARMACOL, V21, P17, DOI 10.1016/S0893-133X(98)00114-6; Black AJ, 1998, ANN INTERN MED, V129, P716, DOI 10.7326/0003-4819-129-9-199811010-00007; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Brinkmann U, 2001, DRUG DISCOV TODAY, V6, P835, DOI 10.1016/S1359-6446(01)01892-X; Cargill M, 2000, Pharmacogenomics, V1, P27, DOI 10.1517/14622416.1.1.27; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Cockcroft JR, 2000, HYPERTENSION, V36, P371, DOI 10.1161/01.HYP.36.3.371; de Maat MPM, 1999, AM J CARDIOL, V83, P852, DOI 10.1016/S0002-9149(98)01073-X; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Eichhammer P, 2000, AM J MED GENET, V96, P187, DOI 10.1002/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Farlow MR, 1998, NEUROLOGY, V50, P669, DOI 10.1212/WNL.50.3.669; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; HUGHES HB, 1954, AM REV TUBERC PULM, V70, P266; Hwu HG, 1998, BIOL PSYCHIAT, V44, P483, DOI 10.1016/S0006-3223(98)00134-6; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Israel E, 2001, INT ARCH ALLERGY IMM, V124, P183, DOI 10.1159/000053705; Issa AM, 2000, CAN J PSYCHIAT, V45, P917, DOI 10.1177/070674370004501007; Jacobsen P, 1998, KIDNEY INT, V53, P1002, DOI 10.1046/j.1523-1755.1998.00847.x; Kaiser R, 2000, MOL PSYCHIATR, V5, P418, DOI 10.1038/sj.mp.4000729; Kalow W, 1998, PHARMACOGENETICS, V8, P283; KALOW W, 1956, LANCET, V2, P576; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kohno M, 1999, AM J MED, V106, P544, DOI 10.1016/S0002-9343(99)00067-4; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; Liggett SB, 2000, AM J RESP CRIT CARE, V161, pS197, DOI 10.1164/ajrccm.161.supplement_2.a1q4-10; Lima JJ, 1999, CLIN PHARMACOL THER, V65, P519, DOI 10.1016/S0009-9236(99)70071-8; Liotta LA, 2001, JAMA-J AM MED ASSOC, V286, P2211, DOI 10.1001/jama.286.18.2211; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Marian AJ, 2000, J AM COLL CARDIOL, V35, P89, DOI 10.1016/S0735-1097(99)00535-5; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; McDonald OG, 2002, PHARMACOGENETICS, V12, P93, DOI 10.1097/00008571-200203000-00003; McLeod HL, 2002, LANCET, V359, P78, DOI 10.1016/S0140-6736(02)07296-3; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Michelson AD, 2000, CIRCULATION, V101, P1013, DOI 10.1161/01.CIR.101.9.1013; Mukae S, 2000, HYPERTENSION, V36, P127, DOI 10.1161/01.HYP.36.1.127; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; NESTRUCK AC, 1987, METABOLISM, V36, P743, DOI 10.1016/0026-0495(87)90110-7; Ohmichi N, 1997, AM J HYPERTENS, V10, P951, DOI 10.1016/S0895-7061(97)00121-0; Okamura A, 1999, ANGIOLOGY, V50, P811, DOI 10.1177/000331979905001005; Ongphiphadhanakul B, 2000, CLIN ENDOCRINOL, V52, P581, DOI 10.1046/j.1365-2265.2000.00979.x; ORDOVAS JM, 1995, ATHEROSCLEROSIS, V113, P157, DOI 10.1016/0021-9150(94)05439-P; Pedro-Botet J, 2001, ATHEROSCLEROSIS, V158, P183, DOI 10.1016/S0021-9150(01)00410-5; Penno G, 1998, DIABETES, V47, P1507, DOI 10.2337/diabetes.47.9.1507; Perna A, 2000, KIDNEY INT, V57, P274, DOI 10.1046/j.1523-1755.2000.00818.x; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; Prasad A, 2000, CIRCULATION, V102, P35, DOI 10.1161/01.CIR.102.1.35; Psaty BM, 2002, JAMA-J AM MED ASSOC, V287, P1680, DOI 10.1001/jama.287.13.1680; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; Richard F, 1997, LANCET, V349, P539, DOI 10.1016/S0140-6736(97)80089-X; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sakaeda T, 2001, PHARMACEUT RES, V18, P1400, DOI 10.1023/A:1012244520615; Sasaki M, 1996, J HYPERTENS, V14, P1403, DOI 10.1097/00004872-199612000-00003; Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sham P, 2001, PHARMACOGENOMICS, V2, P195, DOI 10.1517/14622416.2.3.195; Siest G, 2000, CLIN CHEM LAB MED, V38, P841, DOI 10.1515/CCLM.2000.122; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stavroulakis GA, 2000, CARDIOVASC DRUG THER, V14, P427, DOI 10.1023/A:1007820401377; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; VESELL ES, 1989, PHARMACOL THERAPEUT, V41, P535, DOI 10.1016/0163-7258(89)90130-7; WATANABE J, 1993, DIABETES RES CLIN PR, V20, P21, DOI 10.1016/0168-8227(93)90018-Z; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Whale R, 2000, PSYCHOPHARMACOLOGY, V150, P120, DOI 10.1007/s002130000432; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	95	1212	1343	2	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					538	549		10.1056/NEJMra020526	http://dx.doi.org/10.1056/NEJMra020526			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571262				2022-12-24	WOS:000180801400008
J	Huopio, H; Otonkoski, T; Vauhkonen, I; Reimann, F; Ashcroft, FM; Laakso, M				Huopio, H; Otonkoski, T; Vauhkonen, I; Reimann, F; Ashcroft, FM; Laakso, M			A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1	LANCET			English	Article							K-ATP CHANNEL; INSULIN-SECRETION; SEQUENCE VARIANTS; HYPERINSULINEMIC HYPOGLYCEMIA; KNOCKOUT MICE; MELLITUS; PANCREAS; GLUCOSE; NESIDIOBLASTOSIS; DEFINITION	Background ATP-sensitive potassium (K-ATP) channels are major regulators of glucose-induced insulin secretion in pancreatic P cells. We have described a dominant heterozygous mutation-E1506K-in the sulfonylurea receptor 1 (SUR1) gene (ABCC8) in a Finnish family, which leads to congenital hyperinsulinaemia due to reduction of K-ATP-channel activity. We aimed to characterise glucose metabolism in adults heterozygous for the E1506K mutation. Methods Glucose tolerance was assessed by an oral glucose tolerance test, insulin secretion by the intravenous glucose tolerance test and hyperglycaemic clamp, and insulin sensitivity by hyperinsulinaemic euglycaemic clamp in 11 people heterozygous for the E1506K mutation and 19 controls. Findings Four people who were heterozygous for the SUR1 E1506K mutation had diabetes, five had impaired glucose tolerance, one had impaired fasting glucose, and one had normal glucose tolerance. Although glucose-induced, first-phase insulin secretion was normal in children younger than 10 years of age who were heterozygous for the SUR1 E1506K mutation (n=2; 66 and 334 pmol/L), it fell rapidly after puberty (n=3; 12-32 pmol/L), and was almost completely lost in adulthood (n=11; 12-32 pmol/L). Furthermore, these heterozygous people had a substantial reduction in maximum glucose-stimulated insulin secretion during hyperglycemic clamp (carriers without diabetes 422 pmol/L; carriers with diabetes 97 pmol/L). By contrast, insulin sensitivity (M/I value) was normal in carriers of the E1506K mutation who did not have diabetes and was reduced by 15% in those who were heterozygous with diabetes (0.07 in those without diabetes and 0.05 in those with the disorder; not significantly different from controls). Interpretation Heterozygous E1506K substitution in the SUR1 gene causes congenital hyperinsulinism in infancy, loss of insulin secretory capacity in early adulthood, and diabetes in middle-age. This variant represents a new subtype of autosomal dominant diabetes.	Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; Univ Kuopio, Dept Paediat, FIN-70211 Kuopio, Finland; Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; Addenbrookes Hosp, Dept Clin Biochem, Cambridge, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Eastern Finland; University of Eastern Finland; University of Helsinki; University of Helsinki; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford	Laakso, M (corresponding author), Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland.	Markku.Laakso@kuh.fi	Otonkoski, Timo/F-1189-2011	Reimann, Frank/0000-0001-9399-6377				Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; AYNSLEYGREEN A, 1981, ARCH DIS CHILD, V56, P496, DOI 10.1136/adc.56.7.496; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DORIA A, 2000, CURR OPIN ENDOCRINOL, V7, P203; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; Glaser B, 1999, DIABETES, V48, P1652, DOI 10.2337/diabetes.48.8.1652; Goksel DL, 1998, HUM GENET, V103, P280, DOI 10.1007/s004390050817; Hansen T, 1998, DIABETES, V47, P598, DOI 10.2337/diabetes.47.4.598; Huopio H, 2000, J CLIN INVEST, V106, P897, DOI 10.1172/JCI9804; Inoue H, 1996, DIABETES, V45, P825, DOI 10.2337/diabetes.45.6.825; Ishiyama-Shigemoto S, 1998, DIABETIC MED, V15, P826, DOI 10.1002/(SICI)1096-9136(199810)15:10<826::AID-DIA685>3.0.CO;2-H; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281; LEIBOWITZ G, 1995, J CLIN ENDOCR METAB, V80, P386, DOI 10.1210/jc.80.2.386; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Miki T, 2001, DIABETES, V50, pS48, DOI 10.2337/diabetes.50.2007.S48; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; RANKE M, 1996, TESTS BETA CELL FUNC, P448; Saltiel AR, 2000, J CLIN INVEST, V106, P163, DOI 10.1172/JCI10533; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2000, DIABETES, V49, P311, DOI 10.2337/diabetes.49.3.311; 't Hart LM, 1999, DIABETOLOGIA, V42, P617, DOI 10.1007/s001250051203; Vauhkonen I, 1998, J CLIN INVEST, V101, P86, DOI 10.1172/JCI716; Weisnagel SJ, 2001, DIABETES, V50, P697, DOI 10.2337/diabetes.50.3.697; *WHO, 1985, DIAB MELL, P10	28	120	129	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					301	307		10.1016/S0140-6736(03)12325-2	http://dx.doi.org/10.1016/S0140-6736(03)12325-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559865				2022-12-24	WOS:000180643900012
J	Zeineh, MM; Engel, SA; Thompson, PM; Bookheimer, SY				Zeineh, MM; Engel, SA; Thompson, PM; Bookheimer, SY			Dynamics of the hippocampus during encoding and retrieval of face-name pairs	SCIENCE			English	Article							EVENT-RELATED FMRI; SPATIAL MEMORY DEFICITS; RECOGNITION MEMORY; FUNCTIONAL MRI; PARAHIPPOCAMPAL CORTEX; PREFRONTAL CORTEX; BRAIN ACTIVITY; HUMANS; ACTIVATIONS; LESIONS	The medial temporal lobe (MTL) is critical in forming new memories, but how subregions within the MTL carry out encoding and retrieval processes in humans is unknown. Using new high-resolution functional magnetic resonance imaging (fMRI) acquisition and analysis methods, we identified mnemonic properties of different subregions within the hippocampal circuitry as human subjects learned to associate names with faces. The cornu ammonis (CA) fields 2 and 3 and the dentate gyrus were active relative to baseline only during encoding, and this activity decreased as associations were learned. Activity in the subiculum showed the same temporal decline, but primarily during retrieval. Our results demonstrate that subdivisions within the hippocampus make distinct contributions to new memory formation.	Univ Calif Los Angeles, Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Med Scientist Training Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Lab Neuroimaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bookheimer, SY (corresponding author), Univ Calif Los Angeles, Sch Med, Ahmanson Lovelace Brain Mapping Ctr, 660 Charles Young Dr S, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867; Bookheimer, Susan/0000-0002-3417-5891; Zeineh, Michael/0000-0002-6940-9096	NIA NIH HHS [AG 13308] Funding Source: Medline; NIMH NIH HHS [MH12167] Funding Source: Medline; OHS HRSA HHS [MSTP GM08042] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013308] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OHS HRSA HHS; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Crane J, 2002, NEUROPSYCHOLOGIA, V40, P530, DOI 10.1016/S0028-3932(01)00131-2; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Ploner CJ, 2000, CEREB CORTEX, V10, P1211, DOI 10.1093/cercor/10.12.1211; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; THOMPSON PM, 1998, BRAIN WARPING, P311; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Zeineh MM, 2000, NEUROIMAGE, V11, P668, DOI 10.1006/nimg.2000.0561; Zeineh MM, 2001, ANAT RECORD, V265, P111, DOI 10.1002/ar.1061	28	384	393	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					577	580		10.1126/science.1077775	http://dx.doi.org/10.1126/science.1077775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543980				2022-12-24	WOS:000180559800054
J	Chakravarti, A; Little, P				Chakravarti, A; Little, P			Nature, nurture and human disease	NATURE			English	Article								What has been learnt about individual human biology and common diseases 50 years on from the discovery of the structure of DNA? Unfortunately the double helix has not, so far, revealed as much as one would have hoped. The primary reason is an inability to determine how nurture fits into the DNA paradigm. We argue here that the environment exerts its influence at the DNA level and so will need to be understood before the underlying causal factors of common human diseases can be fully recognized.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Johns Hopkins University; University of New South Wales Sydney	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 600 N Wolfe St,Jefferson St Bldg 2-109, Baltimore, MD 21287 USA.							Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Cox NJ, 2001, HUM MOL GENET, V10, P2301, DOI 10.1093/hmg/10.20.2301; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Jaroff Leon, 1989, Time, V133, P62; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; MacGregor AJ, 2000, TRENDS GENET, V16, P131, DOI 10.1016/S0168-9525(99)01946-0; Munger K, 2002, CANCER INVEST, V20, P71, DOI 10.1081/CNV-120000369; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Stucker I, 2002, CARCINOGENESIS, V23, P1475, DOI 10.1093/carcin/23.9.1475; Sullivan PF, 2001, AM J MED GENET, V105, P266, DOI 10.1002/ajmg.1324; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Wertz DC, 2002, NAT REV GENET, V3, P496, DOI 10.1038/nrg854; Wright A. F., 2002, Pharmacogenomics Journal, V2, P75, DOI 10.1038/sj.tpj.6500085	17	100	106	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					412	414		10.1038/nature01401	http://dx.doi.org/10.1038/nature01401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540911	Bronze			2022-12-24	WOS:000180533000052
J	Gatenby, RA; Maini, PK				Gatenby, RA; Maini, PK			Mathematical oncology: Cancer summed up	NATURE			English	Editorial Material							MODEL		Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA; Univ Arizona, Dept Appl Math, Tucson, AZ 85724 USA; Math Inst, Ctr Math Biol, Oxford OX1 3LB, England	University of Arizona; University of Arizona; University of Oxford	Gatenby, RA (corresponding author), Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA.							ADAM JA, 1996, SURVEY MODELS TUMOUR; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gatenby RA, 1996, CANCER RES, V56, P5745; Keener J. P., 1998, MATH PHYSL	4	151	156	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					321	321		10.1038/421321a	http://dx.doi.org/10.1038/421321a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540881	Bronze			2022-12-24	WOS:000180533000023
J	Moore, T; Armstrong, KM				Moore, T; Armstrong, KM			Selective gating of visual signals by microstimulation of frontal cortex	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; SPATIAL ATTENTION; CORTICAL AREAS; MACAQUE; FIELDS; V4; REPRESENTATIONS; STIMULATION; TOPOGRAPHY; PRIMATES	Several decades of psychophysical and neurophysiological studies have established that visual signals are enhanced at the locus of attention(1-5). What remains a mystery is the mechanism that initiates biases in the strength of visual representations(6). Recent evidence argues that, during spatial attention, these biases reflect nascent saccadic eye movement commands(7,8). We examined the functional interaction of saccade preparation and visual coding by electrically stimulating sites within the frontal eye fields (FEF) and measuring its effect on the activity of neurons in extrastriate visual cortex. Here we show that visual responses in area V4 could be enhanced after brief stimulation of retinotopically corresponding sites within the FEF using currents below that needed to evoke saccades. The magnitude of the enhancement depended on the effectiveness of receptive field stimuli as well as on the presence of competing stimuli outside the receptive field. Stimulation of non-corresponding FEF representations could suppress V4 responses. The results suggest that the gain of visual signals is modified according to the strength of spatially corresponding eye movement commands.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Moore, T (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.							Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; GODOY J, 1990, NEUROLOGY, V40, P296, DOI 10.1212/WNL.40.2.296; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Moore T, 1999, SCIENCE, V285, P1914, DOI 10.1126/science.285.5435.1914; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nakamura K, 1999, J NEUROPHYSIOL, V81, P2374, DOI 10.1152/jn.1999.81.5.2374; Penfield W., 1950, CEREBRAL CORTEX MAN, DOI DOI 10.1001/JAMA.1950.02920160086033; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Schiller PH, 2001, PROG BRAIN RES, V134, P127; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; VANHOOFF JAR, 1972, NONVERBAL COMMUNICAT, pCH7; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zipser K, 1996, J NEUROSCI, V16, P7376	26	824	830	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					370	373		10.1038/nature01341	http://dx.doi.org/10.1038/nature01341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540901				2022-12-24	WOS:000180533000042
J	Schadt, EE; Monks, SA; Drake, TA; Lusis, AJ; Che, N; Colinayo, V; Ruff, TG; Milligan, SB; Lamb, JR; Cavet, G; Linsley, PS; Mao, M; Stoughton, RB; Friend, SH				Schadt, EE; Monks, SA; Drake, TA; Lusis, AJ; Che, N; Colinayo, V; Ruff, TG; Milligan, SB; Lamb, JR; Cavet, G; Linsley, PS; Mao, M; Stoughton, RB; Friend, SH			Genetics of gene expression surveyed in maize, mouse and man	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; MODEL; SUSCEPTIBILITY; IDENTIFICATION; DISSECTION; DENSITY; LINKAGE; MICE	Treating messenger RNA transcript abundances as quantitative traits and mapping gene expression quantitative trait loci for these traits has been pursued in gene-specific ways. Transcript abundances often serve as a surrogate for classical quantitative traits in that the levels of expression are significantly correlated with the classical traits across members of a segregating population. The correlation structure between transcript abundances and classical traits has been used to identify susceptibility loci for complex diseases such as diabetes' and allergic asthma(2). One study recently completed the first comprehensive dissection of transcriptional regulation in budding yeast(3), giving a detailed glimpse of a genome-wide survey of the genetics of gene expression. Unlike classical quantitative traits, which often represent gross clinical measurements that may be far removed from the biological processes giving rise to them, the genetic linkages associated with transcript abundance affords a closer look at cellular biochemical processes. Here we describe comprehensive genetic screens of mouse, plant and human transcriptomes by considering gene expression values as quantitative traits. We identify a gene expression pattern strongly associated with obesity in a murine cross, and observe two distinct obesity subtypes. Furthermore, we find that these obesity subtypes are under the control of different loci.	Rosetta Inpharmat LLC, Kirkland, WA 98034 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Monsanto Co, St Louis, MO 63167 USA; Merck & Co Inc, Merck Res Labs, West Point, PA 19486 USA	Merck & Company; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Monsanto; Merck & Company	Schadt, EE (corresponding author), Rosetta Inpharmat LLC, 12040 115th Ave NE, Kirkland, WA 98034 USA.	eric_schadt@merck.com; stephen_friend@merck.com	Califano, Andrea/F-7239-2012					AMOS CI, 1994, AM J HUM GENET, V54, P535; BASTEN CA, 1999, QTL CARTOGRAPHER USE; Borecki I B, 1994, Obes Res, V2, P213; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Byrne PF, 1996, P NATL ACAD SCI USA, V93, P8820, DOI 10.1073/pnas.93.17.8820; CAUSSE M, 1995, MOL BREEDING, V1, P259, DOI 10.1007/BF02277426; Claudio L, 1997, FUND APPL TOXICOL, V35, P84, DOI 10.1006/faat.1996.2265; DAMERVAL C, 1994, GENETICS, V137, P289; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Drake TA, 2001, PHYSIOL GENOMICS, V5, P205, DOI 10.1152/physiolgenomics.2001.5.4.205; Eaves IA, 2002, GENOME RES, V12, P232, DOI 10.1101/gr.214102. Article published online before print in January 2002; Fisch RD, 1996, GENETICS, V143, P571; Huang YH, 2002, NUCLEIC ACIDS RES, V30, P186, DOI 10.1093/nar/30.1.186; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; LINCOLN SE, 1993, MAPMAKERQTL USERS MA; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Swift LL, 2001, J LIPID RES, V42, P218; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; TOSATIO G, 1991, CURR PROTOC IMMUNOL, V1; Troyer AF, 1999, CROP SCI, V39, P601, DOI 10.2135/cropsci1999.0011183X003900020001x; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yan L, 1998, DNA CELL BIOL, V17, P659, DOI 10.1089/dna.1998.17.659	25	1087	1152	0	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2003	422	6929					297	302		10.1038/nature01434	http://dx.doi.org/10.1038/nature01434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646919				2022-12-24	WOS:000181637300037
J	Moller, JE; Connolly, HM; Rubin, J; Seward, JB; Modesto, K; Pellikka, PA				Moller, JE; Connolly, HM; Rubin, J; Seward, JB; Modesto, K; Pellikka, PA			Factors associated with progression of carcinoid heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRICUSPID REGURGITATION; NEUROENDOCRINE TUMORS; SOMATOSTATIN ANALOG; ENDOCRINE TUMORS; PHASE-II; SEROTONIN; OCTREOTIDE; EFFICACY; ECHOCARDIOGRAPHY; ABNORMALITIES	Background: By releasing vasoactive substances into the circulation, carcinoid tumors can cause right-sided valvular heart disease. Factors associated with the progression of carcinoid heart disease are poorly understood. We conducted a retrospective study to identify such factors. Methods: Our sample included 71 patients with the carcinoid syndrome who underwent serial echocardiographic studies performed more than one year apart and 32 patients referred directly for surgical intervention after an initial echocardiographic evaluation. A score for carcinoid heart disease was determined on the basis of an assessment of valvular anatomy and function and the function of the right ventricle. An increase of more than 25 percent in the score between studies was considered suggestive of disease progression. Tumor progression was assessed on the basis of abdominal computed tomographic scans and changes in the level of urinary 5-hydroxyindoleacetic acid (5-HIAA), a metabolite of serotonin. Results: Of the patients with serial echocardiographic studies, 25 (35 percent) had an increase of more than 25 percent in the cardiac score. As compared with patients whose score changed by 25 percent or less, these patients had higher urinary peak 5-HIAA levels (median, 265 mg per 24 hours [interquartile range, 209 to 593] vs. 189 mg per 24 hours [interquartile range, 75 to 286]; P=0.004) and were more likely to have biochemical progression (10 of 25 patients vs. 9 of 46, P=0.05) and to have received chemotherapy (13 of 25 vs. 10 of 46, P=0.009). Logistic-regression analysis showed that a higher peak urinary 5-HIAA level and previous chemotherapy were predictors of an increase in the cardiac score that exceeded 25 percent (odds ratio for each increase in 5-HIAA of 25 mg per 24 hours, 1.08 [95 percent confidence interval, 1.03 to 1.13]; P=0.009); odds ratio associated with chemotherapy, 3.65 [95 percent confidence interval, 1.74 to 7.48]; P=0.001). Conclusions: Serotonin is related to the progression of carcinoid heart disease, and the risk of progressive heart disease is higher in patients who receive chemotherapy than in those who do not.	Mayo Clin & Mayo Fdn, Echocardiog Lab, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Med Oncol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Pellikka, PA (corresponding author), Mayo Clin & Mayo Fdn, Echocardiog Lab, Div Cardiovasc Dis, Gonda 6-138 NW,200 1st St SW, Rochester, MN 55905 USA.		Pellikka, Patricia A/N-5387-2014	Pellikka, Patricia A/0000-0001-6800-3521; Moller, Jacob Eifer/0000-0003-2873-5845				Ansell SM, 2001, CANCER-AM CANCER SOC, V91, P1543, DOI 10.1002/1097-0142(20010415)91:8<1543::AID-CNCR1163>3.0.CO;2-N; Caplin ME, 1998, LANCET, V352, P799, DOI 10.1016/S0140-6736(98)02286-7; CUBEDDU LX, 1992, BRIT J CANCER, V66, P198, DOI 10.1038/bjc.1992.242; CUBEDDU LX, 1990, NEW ENGL J MED, V322, P810, DOI 10.1056/NEJM199003223221204; Denney WD, 1998, J AM COLL CARDIOL, V32, P1017, DOI 10.1016/S0735-1097(98)00354-4; DiBartolomeo M, 1996, CANCER-AM CANCER SOC, V77, P402, DOI 10.1002/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO;2-4; Eriksson BK, 1998, CANCER, V83, P2293, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.3.CO;2-5; KUBOTA A, 1994, J CLIN INVEST, V93, P1321, DOI 10.1172/JCI117090; Kulke MH, 1999, NEW ENGL J MED, V340, P858, DOI 10.1056/NEJM199903183401107; KVOLS LK, 1986, NEW ENGL J MED, V315, P663, DOI 10.1056/NEJM198609113151102; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; LUNDIN L, 1988, CIRCULATION, V77, P264, DOI 10.1161/01.CIR.77.2.264; Modlin IM, 1997, CANCER-AM CANCER SOC, V79, P813, DOI 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2; OBERG K, 1987, ACTA ONCOL, V26, P429; Oberg K, 2001, ANN ONCOL, V12, pS111, DOI 10.1093/annonc/12.suppl_2.S111; PELLIKKA PA, 1993, CIRCULATION, V87, P1188, DOI 10.1161/01.CIR.87.4.1188; PENNESTRI F, 1984, AM J CARDIOL, V54, P363, DOI 10.1016/0002-9149(84)90198-X; Rajamannan NM, 2001, J HEART VALVE DIS, V10, P827; Rivera J M, 1994, J Am Soc Echocardiogr, V7, P480; ROBIOLIO PA, 1995, CIRCULATION, V92, P790, DOI 10.1161/01.CIR.92.4.790; Roy A, 2000, J HEART VALVE DIS, V9, P256; Rubin J, 1999, J CLIN ONCOL, V17, P600, DOI 10.1200/JCO.1999.17.2.600; RUSZNIEWSKI P, 1993, CANCER, V71, P2624, DOI 10.1002/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO;2-B; SEUWEN K, 1988, NATURE, V335, P254, DOI 10.1038/335254a0; SUZUKI Y, 1986, AM J CARDIOL, V57, P811, DOI 10.1016/0002-9149(86)90619-3	25	194	198	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2003	348	11					1005	1015		10.1056/NEJMoa021451	http://dx.doi.org/10.1056/NEJMoa021451			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653YT	12637610				2022-12-24	WOS:000181465200005
J	Ruta, V; Jiang, YX; Lee, A; Chen, JY; MacKinnon, R				Ruta, V; Jiang, YX; Lee, A; Chen, JY; MacKinnon, R			Functional analysis of an archaebacterial voltage-dependent K+ channel	NATURE			English	Article							SHAKER POTASSIUM CHANNELS; GATING MODIFIER; ION CHANNELS; WILD-TYPE; CHARYBDOTOXIN; ACTIVATION; PEPTIDE; INACTIVATION; HANATOXIN; SEQUENCE	All living organisms use ion channels to regulate the transport of ions across cellular membranes'. Certain ion channels are classed as voltage-dependent because they have a voltage-sensing structure that induces their pores to open in response to changes in the cell membrane voltage. Until recently, the voltage-dependent K+, Ca2+ and Na+ channels were regarded as a unique development of eukaryotic cells, adapted to accomplish specialized electrical signalling, as exemplified in neurons. Here we present the functional characterization of a voltage-dependent K+ (K-V) channel from a hyperthermophilic archaebacterium from an oceanic thermal vent. This channel possesses all the functional attributes of classical neuronal K-V channels. The conservation of function reflects structural conservation in the voltage sensor as revealed by specific, high-affinity interactions with tarantula venom toxins, which evolved to inhibit eukaryotic K-V channels.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Ruta, Vanessa/0000-0002-4963-2768				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	30	205	216	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					180	185		10.1038/nature01473	http://dx.doi.org/10.1038/nature01473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12629550				2022-12-24	WOS:000181488900049
J	Fan, ZS; Beresford, PJ; Oh, DY; Zhang, D; Lieberman, J				Fan, ZS; Beresford, PJ; Oh, DY; Zhang, D; Lieberman, J			Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor	CELL			English	Article							DIPHOSPHATE KINASE; HISTONE ACETYLATION; CELL-DEATH; FRAGMENTATION; REPAIR; CLEAVAGE; TARGET; TRANSCRIPTION; NUCLEASE; GENE	Granzyme A (GzmA) induces a caspase-independent cell death pathway characterized by single-stranded DNA nicks and other features of apoptosis. A GzmA-activated DNase (GAAD) is in an ER associated complex containing pp32 and the GzmA substrates SET, HMG-2, and Ape1. We show that GAAD is NM23-H1, a nucleoside diphosphate kinase implicated in suppression of tumor metastasis, and its specific inhibitor (IGAAD) is SET. NM23-H1 binds to SET and is released from inhibition by GzmA cleavage of SET. After GzmA loading or CTL attack, SET and NM23-H1 translocate to the nucleus and SET is degraded, allowing NM23-H1 to nick chromosomal DNA. GzmA-treated cells with silenced NM23-H1 expression are resistant to GzmA-mediated DNA damage and cytolysis, while cells over-expressing NM23-H1 are more sensitive.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015	ZHANG, DONG/0000-0002-1068-8334	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045587, R01AI045587] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45587] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Gaiddon C, 1999, EMBO J, V18, P5609, DOI 10.1093/emboj/18.20.5609; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; IZUMIYA H, 1995, J BIOL CHEM, V270, P27859, DOI 10.1074/jbc.270.46.27859; Jans DA, 1999, J BIOL CHEM, V274, P3953, DOI 10.1074/jbc.274.7.3953; KOKILEVA L, 1994, INT ARCH ALLERGY IMM, V105, P339, DOI 10.1159/000236779; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Krystosek A, 1999, HISTOCHEM CELL BIOL, V111, P265, DOI 10.1007/s004180050357; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; LAGARKOVA MA, 1995, J BIOL CHEM, V270, P20239, DOI 10.1074/jbc.270.35.20239; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P213; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; Monteiro ANA, 2000, TRENDS BIOCHEM SCI, V25, P469, DOI 10.1016/S0968-0004(00)01632-7; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; Postel EH, 2002, BIOCHEMISTRY-US, V41, P6330, DOI 10.1021/bi025606+; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 1999, J BIOL CHEM, V274, P22821, DOI 10.1074/jbc.274.32.22821; Postel EH, 1996, P NATL ACAD SCI USA, V93, P6892, DOI 10.1073/pnas.93.14.6892; Postel EH, 2000, P NATL ACAD SCI USA, V97, P14194, DOI 10.1073/pnas.97.26.14194; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099; Thomas DA, 2000, IMMUNITY, V12, P621, DOI 10.1016/S1074-7613(00)80213-7; Toh SY, 1998, BIOCHEM BIOPH RES CO, V250, P598, DOI 10.1006/bbrc.1998.9369; WEAVER VM, 1993, BIOCHEM CELL BIOL, V71, P488, DOI 10.1139/o93-071; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	50	436	471	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					659	672		10.1016/S0092-8674(03)00150-8	http://dx.doi.org/10.1016/S0092-8674(03)00150-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628186	Bronze			2022-12-24	WOS:000181443600009
J	Olesen, AW; Basso, O				Olesen, AW; Basso, O			Risk of recurrence of prolonged pregnancy	BRITISH MEDICAL JOURNAL			English	Article							POSTTERM		Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University	Olesen, AW (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark.		Basso, Olga/E-5384-2010	Basso, Olga/0000-0001-9298-4921; Olesen, Annette Wind/0000-0002-0586-4815				Campbell MK, 1997, OBSTET GYNECOL, V89, P543; Mackie J., 1974, CEMENT UNIVERSE STUD; Olsen J, 1997, EPIDEMIOLOGY, V8, P6, DOI 10.1097/00001648-199701000-00001; Shea KM, 1998, EPIDEMIOLOGY, V9, P199, DOI 10.1097/00001648-199803000-00017; Stornes I, 1996, Ugeskr Laeger, V158, P422	5	33	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					476	476		10.1136/bmj.326.7387.476	http://dx.doi.org/10.1136/bmj.326.7387.476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609943	Green Published, Bronze			2022-12-24	WOS:000181421400017
J	Moreno, MA				Moreno, MA			The cross-cover resident	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					956	957		10.1001/jama.289.8.956	http://dx.doi.org/10.1001/jama.289.8.956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597732				2022-12-24	WOS:000181129800001
J	Sehgal, AR				Sehgal, AR			Impact of quality improvement efforts on race and sex disparities in hemodialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALBUMIN CONCENTRATION; ETHNIC DISPARITIES; OF-LIFE; HEALTH; PREDICTORS; CARE; INEQUALITY; MORTALITY; SURVIVAL; DIALYSIS	Context By improving the process of care, quality improvement efforts have the potential to reduce race and sex disparities. However, little is known about whether reductions actually occur. National quality improvement activities targeting hemodialysis patients provide an opportunity to examine this issue. Objective To determine the effect of quality improvement efforts on race and sex disparities among hemodialysis patients. Design, Setting, and Subjects Longitudinal study of 58700 randomly selected hemodialysis patients from throughout the United States in 1993 through 2000. Intervention Medicare-funded quality improvement project involving monitoring of patient outcomes, feedback of performance data, and education of clinicians at dialysis centers. Main Outcome Measures Changes in hemodialysis dose (Kt/V), anemia management (hemoglobin level), and nutritional status (albumin level). Results The proportion of all patients with an adequate hemodialysis dose increased 2-fold. In 1993, 46% of white patients and 36% of black patients received an adequate hemodialysis dose compared with 2000 when the proportions were 87% and 84%, respectively. Thus, the gap between white and black patients decreased from 10% to 3% (P<.001). The gap between female and male patients decreased from 23% to 9% over the same period (P=.008). The proportion of all patients with adequate hemoglobin levels increased 3-fold. The proportion of all patients with adequate albumin levels remained unchanged. Race and sex disparities in anemia management and nutritional status did not change significantly. Conclusions Quality improvement efforts have a variable impact on race and sex disparities in health outcomes. Further work is needed to determine how quality improvement methods can be targeted to reduce health disparities.	Case Western Reserve Univ, Metrohlth Med Ctr, Div Nephrol, 2500 Metrohlth Dr, Cleveland, OH 44109 USA; Case Western Reserve Univ, Metrohlth Med Ctr, Ctr Hlth Care Res & Policy, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Biomed Eth, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Sehgal, AR (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Div Nephrol, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	axs81@po.cwru.edu			NIDDK NIH HHS [DK54178, DK51472] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051472, P50DK054178] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; [Anonymous], 1997, Am J Kidney Dis, V30, pS15; [Anonymous], 1997, Am J Kidney Dis, V30, pS192; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Bierman A S, 2001, J Am Med Womens Assoc (1972), V56, P155; COLLINS AJ, 1994, AM J KIDNEY DIS, V23, P272, DOI 10.1016/S0272-6386(12)80984-X; Cooper LA, 2002, J GEN INTERN MED, V17, P477, DOI 10.1046/j.1525-1497.2002.10633.x; EVANS RW, 1990, JAMA-J AM MED ASSOC, V263, P825; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Hakim RM, 2001, HDB DIALYSIS, V3rd, P236; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; *HLTH CAR FIN ADM, 1994, ANN REP END STAG REN; IGLEHART JK, 1993, NEW ENGL J MED, V328, P366, DOI 10.1056/NEJM199302043280528; Kaysen GA, 1997, AM J KIDNEY DIS, V29, P658, DOI 10.1016/S0272-6386(97)90117-7; KEPPEL KG, 2002, HLTH PEOPLE 2000 STA, V23, P1; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; Leon JB, 2001, AM J NEPHROL, V21, P200, DOI 10.1159/000046248; Leon JB, 2001, J RENAL NUTR, V11, P9, DOI 10.1016/S1051-2276(01)79890-1; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; McClellan WM, 1999, AM J KIDNEY DIS, V34, P1075, DOI 10.1016/S0272-6386(99)70013-2; McClellan WM, 1998, AM J KIDNEY DIS, V31, P584, DOI 10.1053/ajkd.1998.v31.pm9531173; *NAT KIDN FDN, 2000, AM J KIDNEY DIS S, V35, pS1, DOI DOI 10.1053/KD.2000.6671; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; SCHOENBACH VJ, 2002, AM PUBL HLTH ASS ANN; Sehgal A R, 1998, J Ren Nutr, V8, P179, DOI 10.1016/S1051-2276(98)90016-4; Sehgal AR, 2002, JAMA-J AM MED ASSOC, V287, P1961, DOI 10.1001/jama.287.15.1961; Sehgal AR, 2001, AM J KIDNEY DIS, V37, P1223, DOI 10.1053/ajkd.2001.24526; Smith JL, 2001, MED CARE, V39, P910, DOI 10.1097/00005650-200109000-00002; Stamler R, 1987, HYPERTENSION, V9, P641; *US DEPT HHS, 1998, 1998 ANN REP END STA; *US DEPT HHS, 1996, 1995 ANN REP END STA; *US DEPT HHS, 1999, 1999 ANN REP END STA; *US DEPT HHS, 1997, 1997 ANN REP END STA; *US DEPT HHS, 2000, 2000 ANN REP END STA; *US DEPT HHS, 1997, 1996 ANN REP END STA; *US DHHS, 2001, 2001 ANN REP END STA; *USRDS, 2002, 2002 ANN DAT REP; Williams DR, 2000, HEALTH CARE FINANC R, V21, P75	40	143	145	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					996	1000		10.1001/jama.289.8.996	http://dx.doi.org/10.1001/jama.289.8.996			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597751	Bronze			2022-12-24	WOS:000181129800025
J	Catteruccia, F; Godfray, HCJ; Crisanti, A				Catteruccia, F; Godfray, HCJ; Crisanti, A			Impact of genetic manipulation on the fitness of Anopheles stephensi mosquitoes	SCIENCE			English	Article							GERMLINE TRANSFORMATION; MALARIA; VECTOR	Genetic modification of mosquitoes offers exciting possibilities for controlling malaria, but success will depend on how transformation affects the fitness of modified insects. The expression of an exogenous gene, the mutations caused by its insertion, and inbreeding while transformed lines are established can all lead to reductions in fitness. Factors influencing fitness were investigated in cage experiments with four lines of transgenic Anopheles stephensi, a vector species of human malaria. The results indicate direct costs of the introduced transgene in at least three out of the four lines, as well as an apparent cost of the inbreeding involved in making transgenic homozygotes.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Perugia, I-06100 Perugia, Italy	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Perugia	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, SAF Bldg,S Kensington Campus, London SW7 2AZ, England.	acrs@ic.ac.uk		Catteruccia, Flaminia/0000-0003-3295-6683; Crisanti, Andrea/0000-0002-2406-4426	Biotechnology and Biological Sciences Research Council [S19551] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Arca B, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P483; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Hartl DL, 1997, PRINCIPLES POPULATIO; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Nolan T, 2002, J BIOL CHEM, V277, P8759, DOI 10.1074/jbc.C100766200; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117	14	156	165	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1225	1227		10.1126/science.1081453	http://dx.doi.org/10.1126/science.1081453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595691				2022-12-24	WOS:000181065500038
J	Bates, SH; Stearns, WH; Dundon, TA; Schubert, M; Tso, AWK; Wang, YP; Banks, AS; Lavery, HJ; Haq, AK; Maratos-Flier, E; Neel, BG; Schwartz, MW; Myers, MG				Bates, SH; Stearns, WH; Dundon, TA; Schubert, M; Tso, AWK; Wang, YP; Banks, AS; Lavery, HJ; Haq, AK; Maratos-Flier, E; Neel, BG; Schwartz, MW; Myers, MG			STAT3 signalling is required for leptin regulation of energy balance but not reproduction	NATURE			English	Article							HYPOTHALAMIC NEURONS; CYTOKINE RECEPTORS; NEUROPEPTIDE-Y; POMC NEURONS; FEMALE MICE; EARLY-ONSET; OB-R; ACTIVATION; OBESITY; MOUSE	Secretion of leptin from adipocytes communicates body energy status to the brain by activating the leptin receptor long form (LRb). LRb regulates energy homeostasis and neuroendocrine function; the absence of LRb in db/db mice results in obesity, impaired growth, infertility and diabetes(1-4). Tyr 1138 of LRb mediates activation of the transcription factor STAT3 during leptin action(5-8). To investigate the contribution of STAT3 signalling to leptin action in vivo, we replaced the gene encoding the leptin receptor (lepr) in mice with an allele coding for a replacement of Tyr 1138 in LRb with a serine residue (lepr(S1138)) that specifically disrupts the LRb-STAT3 signal. Here we show that, like db/db mice, lepr(S1138) homozygotes (s/s) are hyperphagic and obese. However, whereas db/db mice are infertile, short and diabetic, s/s mice are fertile, long and less hyperglycaemic. Furthermore, hypothalamic expression of neuropeptide Y (NPY) is elevated in db/db mice but not s/s mice, whereas the hypothalamic melanocortin system is suppressed in both db/db and s/s mice. LRb-STAT3 signalling thus mediates the effects of leptin on melanocortin production and body energy homeostasis, whereas distinct LRb signals regulate NPY and the control of fertility, growth and glucose homeostasis.	Beth Israel Deaconess Med Ctr, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98122 USA	Harvard University; Beth Israel Deaconess Medical Center; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harborview Medical Center; University of Washington; University of Washington Seattle	Myers, MG (corresponding author), Beth Israel Deaconess Med Ctr, Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.		Schwartz, Michael W/H-9950-2012; Banks, Alexander/B-4832-2012; Schubert, Markus/F-5150-2010	Banks, Alexander/0000-0003-1787-6925; 				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; CATZEFLIS C, 1993, ENDOCRINOLOGY, V132, P224, DOI 10.1210/en.132.1.224; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chehab FF, 1997, SCIENCE, V275, P88, DOI 10.1126/science.275.5296.88; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Malik NM, 2001, ENDOCRINOLOGY, V142, P5198, DOI 10.1210/en.142.12.5198; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065	25	763	794	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					856	859		10.1038/nature01388	http://dx.doi.org/10.1038/nature01388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594516				2022-12-24	WOS:000181044700051
J	Genty, D; Blamart, D; Ouahdi, R; Gilmour, M; Baker, A; Jouzel, J; Van-Exter, S				Genty, D; Blamart, D; Ouahdi, R; Gilmour, M; Baker, A; Jouzel, J; Van-Exter, S			Precise dating of Dansgaard-Oeschger climate oscillations in western Europe from stalagmite data	NATURE			English	Article							LAST GLACIAL PERIOD; GREENLAND ICE-CORE; OXYGEN-ISOTOPE; SPELEOTHEMS; CAVE; RECORDS; PAST; TEMPERATURE; INSTABILITY; ANTARCTICA	The signature of Dansgaard-Oeschger events-millennial-scale abrupt climate oscillations during the last glacial period-is well established in ice cores and marine records(1-3). But the effects of such events in continental settings are not as clear, and their absolute chronology is uncertain beyond the limit of C-14 dating and annual layer counting for marine records and ice cores, respectively. Here we present carbon and oxygen isotope records from a stalagmite collected in southwest France which have been precisely dated using U-234/Th-230 ratios. We find rapid climate oscillations coincident with the established Dansgaard-Oeschger events between 83,000 and 32,000 years ago in both isotope records. The oxygen isotope signature is similar to a record from Soreq cave, Israel(4), and deep-sea records(5,6), indicating the large spatial scale of the climate oscillations. The signal in the carbon isotopes gives evidence of drastic and rapid vegetation changes in western Europe, an important site in human cultural evolution. We also find evidence for a long phase of extremely cold climate in southwest France between 61.2 6 +/- 0.6 and 67.4 +/- 0.9 kyr ago.	CEA, CNRS, UMR 1572, IPSL Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Open Univ, Dept Earth Sci, Uranium Series Facil, Milton Keynes MK7 6AA, Bucks, England; Univ Newcastle Upon Tyne, Ctr Land Use & Water Resouces Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Montpellier 2, Lab Hydrosci, CNRS,UMR 5569, IRD, F-34095 Montpellier 5, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Open University - UK; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Genty, D (corresponding author), CEA, CNRS, UMR 1572, IPSL Lab Sci Climat & Environm, Bat 709,Lorme Merisiers CEA Saclay, F-91191 Gif Sur Yvette, France.		Baker, Andy/O-5362-2019	Baker, Andy/0000-0002-1552-6166				Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; BAKER A, 1993, NATURE, V364, P518, DOI 10.1038/364518a0; Bar-Matthews M, 2000, CHEM GEOL, V169, P145, DOI 10.1016/S0009-2541(99)00232-6; Beck JW, 2001, SCIENCE, V292, P2453, DOI 10.1126/science.1056649; BENDER M, 1994, NATURE, V372, P663, DOI 10.1038/372663a0; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Cayre O, 1999, PALEOCEANOGRAPHY, V14, P384, DOI 10.1029/1998PA900027; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Dennis PF, 2001, GEOCHIM COSMOCHIM AC, V65, P871, DOI 10.1016/S0016-7037(00)00576-7; Dorale JA, 1998, SCIENCE, V282, P1871, DOI 10.1126/science.282.5395.1871; Genty D, 1996, J SEDIMENT RES, V66, P275; Genty D, 2001, GEOCHIM COSMOCHIM AC, V65, P3443, DOI 10.1016/S0016-7037(01)00697-4; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; GUIOT J, 1993, PALAEOGEOGR PALAEOCL, V103, P73, DOI 10.1016/0031-0182(93)90053-L; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Labeyrie L, 2000, SCIENCE, V290, P1905, DOI 10.1126/science.290.5498.1905; Lang C, 1999, SCIENCE, V286, P934, DOI 10.1126/science.286.5441.934; Mook W.G., 1980, HDB ENV ISOTOPE GEOC, P49, DOI DOI 10.1016/B978-0-444-41780-0.50008-0; ONEIL JR, 1969, J CHEM PHYS, V51, P5547, DOI 10.1063/1.1671982; ROZANSKI K, 1985, CHEM GEOL, V52, P349, DOI 10.1016/0168-9622(85)90045-4; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Stringer C, 2001, NATURE, V413, P791, DOI 10.1038/35101688; Urbanc J., 1985, ACTA CARSOLOGICA, V13, P99; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Yiou F, 1997, J GEOPHYS RES-OCEANS, V102, P26783, DOI 10.1029/97JC01265	30	457	502	2	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					833	837		10.1038/nature01391	http://dx.doi.org/10.1038/nature01391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594510				2022-12-24	WOS:000181044700045
J	Sudlow, CLM; Counsell, CE				Sudlow, CLM; Counsell, CE			Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; SECONDARY PROGRESSIVE MS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INTERFERON BETA-1B; GLATIRAMER ACETATE; NATURAL-HISTORY; CLINICAL-TRIALS; FINAL REPORT; RELAPSE RATE	The government plans to make interferon beta and glatiramer available to patients with multiple sclerosis through a risk sharing scheme, despite lack of evidence of cost effectiveness. Sudlow and colleagues argue that the money would be better spent on independent research.	Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; Aberdeen Royal Infirm, Dept Neurol, Aberdeen AB25 2ZN, Scotland	University of Edinburgh; University of Aberdeen	Sudlow, CLM (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	csudlow@skull.dcn.ed.ac.uk		Sudlow, Cathie/0000-0002-7725-7520	Wellcome Trust [063668] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*ASS BRIT NEUR, 2001, GUID US BET INT GLAT; *ASS BRIT NEUR WOR, 2002, AC NEUR EM AD; BORNSTEIN MB, 1991, NEUROLOGY, V41, P533, DOI 10.1212/WNL.41.4.533; BORNSTEIN MB, 1987, NEW ENGL J MED, V317, P408, DOI 10.1056/NEJM198708133170703; CLEGG A, 2000, HLTH TECHNOLOGY ASSE, V4; Collins R, 1996, OXFORD TXB MED, V1, P21; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Confavreux C, 1996, NEUROLOGY, V46, P1607, DOI 10.1212/WNL.46.6.1607; Department of Health, 2002, 2002004 DEP HLTH HLT; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; ELLISON GW, 1989, NEUROLOGY, V39, P1018, DOI 10.1212/WNL.39.8.1018; GHEZZI A, 1989, INT CONGR SER, V863, P345; GOODKIN DE, 1991, NEUROLOGY, V41, P20, DOI 10.1212/WNL.41.1.20; Goodkin DE, 2000, NEUROLOGY, V54, P2352; HUGHES RAC, 1988, LANCET, V2, P179; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; King J, 2001, NEUROLOGY, V56, P1496; KINLEN LJ, 1985, AM J MED, V78, P44, DOI 10.1016/0002-9343(85)90245-1; Kremenchutzky M, 1999, BRAIN, V122, P1941, DOI 10.1093/brain/122.10.1941; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; MERTIN J, 1982, LANCET, V2, P351; MILANESE C, 1993, J NEUROL, V240, P295, DOI 10.1007/BF00838165; *MS STUD GROUP, 1999, LANCET, V53, P679; *NAT I CLIN EXC, BET INT GLAT AC TREA; *NO YORKSH REG DRU, 2000, ASS INT GLAT TREATM; NOSEWORTHY JH, 1994, NEUROLOGY, V44, P16, DOI 10.1212/WNL.44.1.16; Rice G, 1998, ARCH NEUROL-CHICAGO, V55, P1578, DOI 10.1001/archneur.55.12.1578; Rice GP, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002002; Rudick RA, 1997, NEUROLOGY, V49, P358, DOI 10.1212/WNL.49.2.358; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; SWINBURN WR, 1973, J NEUROL NEUROSUR PS, V36, P124, DOI 10.1136/jnnp.36.1.124; Tappenden P, 2001, COST EFFECTIVENESS B; WEINSHENKER BG, 1991, BRAIN, V114, P1045, DOI 10.1093/brain/114.2.1045; YUDKIN PL, 1991, LANCET, V338, P1051, DOI 10.1016/0140-6736(91)91909-E	42	50	50	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					388	392		10.1136/bmj.326.7385.388	http://dx.doi.org/10.1136/bmj.326.7385.388			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586677	Green Submitted, Green Published			2022-12-24	WOS:000181165500027
J	Cho, HS; Mason, K; Ramyar, KX; Stanley, AM; Gabelli, SB; Denney, DW; Leahy, DJ				Cho, HS; Mason, K; Ramyar, KX; Stanley, AM; Gabelli, SB; Denney, DW; Leahy, DJ			Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab	NATURE			English	Article							ERBB SIGNALING NETWORK; BREAST-CANCER; TRASTUZUMAB HERCEPTIN; MOLECULAR REPLACEMENT; MONOCLONAL-ANTIBODY; RECEPTORS; ONCOGENE; PROGRAM; DOMAIN; CELLS	HER2 (also known as Neu, ErbB2) is a member of the epidermal growth factor receptor (EGFR; also known as ErbB) family of receptor tyrosine kinases, which in humans includes HER1 (EGFR, ERBB1), HER2, HER3 (ERBB3) and HER4 (ERBB4)(1). ErbB receptors are essential mediators of cell proliferation and differentiation in the developing embryo and in adult tissues(2), and their inappropriate activation is associated with the development and severity of many cancers(3). Overexpression of HER2 is found in 20-30% of human breast cancers, and correlates with more aggressive tumours and a poorer prognosis(4). Anticancer therapies targeting ErbB receptors have shown promise, and a monoclonal antibody against HER2, Herceptin (also known as trastuzumab), is currently in use as a treatment for breast cancer(5). Here we report crystal structures of the entire extracellular regions of rat HER2 at 2.4 Angstrom and human HER2 complexed with the Herceptin antigen-binding fragment (Fab) at 2.5 Angstrom. These structures reveal a fixed conformation for HER2 that resembles a ligand-activated state, and show HER2 poised to interact with other ErbB receptors in the absence of direct ligand binding. Herceptin binds to the juxtamembrane region of HER2, identifying this site as a target for anticancer therapies.	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Genitope Corp, Redwood City, CA 94063 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.		Mieszkowska, Magdalena/O-6753-2017; Gabelli, Sandra B/A-3705-2008	Gabelli, Sandra B/0000-0003-1205-5204				Banfield MJ, 1997, PROTEINS, V29, P161, DOI 10.1002/(SICI)1097-0134(199710)29:2<161::AID-PROT4>3.0.CO;2-G; Berezov A, 2002, J BIOL CHEM, V277, P28330, DOI 10.1074/jbc.M202880200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke CL, 1997, ONCOGENE, V14, P687, DOI 10.1038/sj.onc.1200873; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; DENNEY DW, 1998, Patent No. 5776746; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; FERGUSON KM, IN PRESS MOL CELL; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Molina MA, 2001, CANCER RES, V61, P4744; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Tang CK, 1998, HORMONES SIGNALING, P113; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	30	1121	1291	6	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					756	760		10.1038/nature01392	http://dx.doi.org/10.1038/nature01392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610629				2022-12-24	WOS:000180938000047
J	Cua, DJ; Sherlock, J; Chen, Y; Murphy, CA; Joyce, B; Seymour, B; Lucian, L; To, W; Kwan, S; Churakova, T; Zurawski, S; Wiekowski, M; Lira, SA; Gorman, D; Kastelein, RA; Sedgwick, JD				Cua, DJ; Sherlock, J; Chen, Y; Murphy, CA; Joyce, B; Seymour, B; Lucian, L; To, W; Kwan, S; Churakova, T; Zurawski, S; Wiekowski, M; Lira, SA; Gorman, D; Kastelein, RA; Sedgwick, JD			Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; IFN-GAMMA; ENCEPHALOMYELITIS; EXPRESSION; DISEASE; IL-12; MICE; ANTIBODIES; RESPONSES; IL-23	Interleukin-12 (IL-12) is a heterodimeric molecule composed of p35 and p40 subunits. Analyses in vitro have defined IL-12 as an important factor for the differentiation of naive T cells into T-helper type 1 CD4(+) lymphocytes secreting interferon-gamma (refs 1, 2). Similarly, numerous studies(3-7) have concluded that IL-12 is essential for T-cell-dependent immune and inflammatory responses in vivo, primarily through the use of IL-12 p40 gene-targeted mice and neutralizing antibodies against p40. The cytokine IL-23, which comprises the p40 subunit of IL-12 but a different p19 subunit(8), is produced predominantly by macrophages and dendritic cells, and shows activity on memory T cells. Evidence from studies of IL-23 receptor expression(9) and IL-23 overexpression in transgenic mice(10) suggest, however, that IL-23 may also affect macrophage function directly. Here we show, by using gene-targeted mice lacking only IL-23 and cytokine replacement studies, that the perceived central role for IL-12 in autoimmune inflammation, specifically in the brain, has been misinterpreted and that IL-23, and not IL-12, is the critical factor in this response. In addition, we show that IL-23, unlike IL-12, acts more broadly as an end-stage effector cytokine through direct actions on macrophages.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Genom, Palo Alto, CA 94304 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Prot & Antibody Technol, Palo Alto, CA 94304 USA; Schering Plough Corp, Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Schering Plough Corporation	Cua, DJ (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, 901 Calif Ave, Palo Alto, CA 94304 USA.							Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Caspi NR, 1998, CLIN IMMUNOL IMMUNOP, V88, P4, DOI 10.1006/clin.1998.4540; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chen SC, 2001, J IMMUNOL, V166, P3362, DOI 10.4049/jimmunol.166.5.3362; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Constantinescu CS, 1998, J IMMUNOL, V161, P5097; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Falcone M, 1999, CURR OPIN IMMUNOL, V11, P670, DOI 10.1016/S0952-7915(99)00035-7; FRUCHT DM, 2002, SCI STKE, V114; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; ISSAZADEH S, 1995, J NEUROIMMUNOL, V61, P205, DOI 10.1016/0165-5728(95)00100-G; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Leonard JP, 1996, ANN NY ACAD SCI, V795, P216, DOI 10.1111/j.1749-6632.1996.tb52671.x; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Matthys P, 2001, TRENDS IMMUNOL, V22, P367, DOI 10.1016/S1471-4906(01)01937-8; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Piccotti JR, 1998, J IMMUNOL, V160, P1132; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Willenborg DO, 1996, J IMMUNOL, V157, P3223	29	2158	2381	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					744	748		10.1038/nature01355	http://dx.doi.org/10.1038/nature01355			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610626				2022-12-24	WOS:000180938000044
J	Mougeot, F; Redpath, SM; Leckie, F; Hudson, PJ				Mougeot, F; Redpath, SM; Leckie, F; Hudson, PJ			The effect of aggressiveness on the population dynamics of a territorial bird	NATURE			English	Article							HOST-PARASITE SYSTEM; RED GROUSE; TRICHOSTRONGYLUS-TENUIS; CYCLES; KIN; PREDATION; DENSITY; FLUCTUATIONS; PREVENTION; STABILITY	A central issue in ecology lies in identifying the importance of resources, natural enemies and behaviour in the regulation of animal populations. Much of the debate on this subject has focused on animals that show cyclic fluctuations in abundance(1-7). However, there is still disagreement about the role of extrinsic (food, parasites or predators) and intrinsic (behaviour) factors in causing cycles(2,8-10). Recent studies have examined the impact of natural enemies(1,3,4,7), although spatial patterns resulting from restricted dispersal or recruitment are increasingly recognized as having the potential to influence unstable population dynamics(5,6,11-13). We tested the hypothesis that population cycles in a territorial bird, red grouse Lagopus lagopus scoticus, are caused by delayed density-dependent changes in the aggressiveness and spacing behaviour of males. Here we show that increasing aggressiveness experimentally for a short period in autumn reduced recruitment and subsequent breeding density by 50%, and changed population trajectories from increasing to declining. Intrinsic processes can therefore have fundamental effects on population dynamics.	CEH Banchory, Banchory AB31 4BW, Aberdeen, Scotland; Univ Stirling, Dept Biol & Mol Sci, Stirling FK9 4LA, Scotland	UK Centre for Ecology & Hydrology (UKCEH); University of Stirling	Mougeot, F (corresponding author), CEH Banchory, Hills Brathens, Banchory AB31 4BW, Aberdeen, Scotland.		Hudson, Peter/AAB-8080-2020; Mougeot, Francois/B-1894-2009; Mougeot, Francois/Y-9569-2019; Redpath, Stephen/B-4640-2012	Hudson, Peter/0000-0003-0468-3403; Mougeot, Francois/0000-0002-5819-6275; Mougeot, Francois/0000-0002-5819-6275; Redpath, Stephen/0000-0001-5399-9477				Berryman AA, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P3; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; CHARNOV EL, 1980, OECOLOGIA, V45, P1, DOI 10.1007/BF00346698; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fox A, 2001, ECOL LETT, V4, P139, DOI 10.1046/j.1461-0248.2001.00207.x; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hudson P. J., 1985, Ecology and genetics of host-parasite interactions. International symposium, Keele University, 12-13 July 1984, P77; Hudson PJ, 1997, WILDLIFE BIOL, V3, P79, DOI 10.2981/wlb.1997.010; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; Hudson PJ, 2002, PHILOS T R SOC B, V357, P1259, DOI 10.1098/rstb.2002.1126; Korpimaki E, 2002, P ROY SOC B-BIOL SCI, V269, P991, DOI 10.1098/rspb.2002.1972; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Lambin X, 1998, J ANIM ECOL, V67, P1, DOI 10.1046/j.1365-2656.1998.00181.x; Lambin X, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P155; Matthiopoulos J, 2000, ECOL MODEL, V127, P53, DOI 10.1016/S0304-3800(99)00199-4; Moss R, 2001, ADV ECOL RES, V32, P53, DOI 10.1016/S0065-2504(01)32011-1; Moss R, 1996, ECOLOGY, V77, P1512, DOI 10.2307/2265548; MOSS R, 1994, P ROY SOC B-BIOL SCI, V258, P175, DOI 10.1098/rspb.1994.0159; Mountford M.D., 1990, P78; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; Stenseth NC, 1996, P ROY SOC B-BIOL SCI, V263, P1423, DOI 10.1098/rspb.1996.0208; Thirgood SJ, 2000, J ANIM ECOL, V69, P504, DOI 10.1046/j.1365-2656.2000.00413.x; Turchin P, 1999, SCIENCE, V285, P1068, DOI 10.1126/science.285.5430.1068; WATSON A, 1994, J ANIM ECOL, V63, P39, DOI 10.2307/5581	27	88	92	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					737	739		10.1038/nature01395	http://dx.doi.org/10.1038/nature01395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610624				2022-12-24	WOS:000180938000042
J	Steinman, MA; Landefeld, CS; Gonzales, R				Steinman, MA; Landefeld, CS; Gonzales, R			Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE BRONCHITIS; PATIENTS EXPECTATIONS; EDUCATIONAL OUTREACH; PHYSICIANS BEHAVIOR; CLINICAL-PRACTICE; CONTROLLED TRIAL; DRUG COMPANIES; PERCEPTIONS; PRESCRIPTION; PRINCIPLES	Context Broad-spectrum antibiotics are commonly prescribed, but little is known about the physicians who prescribe and the patients who take these agents. Objective To identify factors associated with prescribing of broad-spectrum antibiotics by physicians caring for patients with nonpneumonic acute respiratory tract infections (ARTIs). Design, Setting, and Patients Cross-sectional study using data from the National Ambulatory Medical Care Survey between 1997 and 1999. Information was collected on a national sample of 1981 adults seen by physicians for the common cold and nonspecific upper respiratory tract infections (URTIs) (24%), acute sinusitis (24%), acute bronchitis (23%), otitis media (5%), pharyngitis, laryngitis, and tracheitis (11%), or more than 1 of the above diagnoses (13%). Main Outcome Measure Prescription of broad-spectrum antibiotics, defined for this study as quinolones; amoxicillin/clavulanate, second- and third-generation cephalosporins, and azithromycin and clarithromycin. Results, Antibiotics were prescribed to 63% of patients with an ARTI, ranging from 46% of patients with,the common cold or nonspecific URTIs to 69% of patients with acute sinusitis. Broad-spectrum agents were chosen in 54% of patients prescribed an antibiotic, including 51% of patients with the common cold and nonspecific URTIs, 53% with acute sinusitis, 62% with acute bronchitis, and 65% with otitis media. Multivariable analysis identified several clinical and nonclinical factors associated with choice of a broad-spectrum agent. After adjusting for diagnosis and chronic comorbid illnesses, the strongest independent predictors of broad-spectrum antibiotic prescribing were physician specialty (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.6-3.5 for internal medicine physicians compared with general and family physicians) and geographic region (OR, 2.6; 95% CI, 1.4-4.8 for Northeast and OR, 2.4; 95% CI, 1.4-4.2 for South [both compared with West]). Other independent predictors of choosing a broad-spectrum agent included black race, lack of health insurance, and health maintenance organization membership, each of which was associated with lower rates of broad-spectrum prescribing. Patient age, sex, and urban vs rural location were not significantly associated with prescribing choice. Conclusions Broad-spectrum antibiotics are commonly prescribed for the treatment of ARTIs, especially by internists and physicians in the Northeast and South. These high rates of prescribing, wide variations in practice patterns, and the strong association of nonclinical factors with antibiotic choice suggest opportunities to improve prescribing patterns.	San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; San Francisco VA Med Ctr, VA Natl Qual Scholars Program, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Steinman, MA (corresponding author), San Francisco VA Med Ctr, Div Geriatr, 4150 Clement St,Box 181-G, San Francisco, CA 94121 USA.							Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Avery AJ, 1997, BRIT J GEN PRACT, V47, P810; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Bell RA, 1999, J FAM PRACTICE, V48, P446; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CARRIN G, 1987, HEALTH POLICY, V7, P73, DOI 10.1016/0168-8510(87)90048-0; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P800; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; CHREN MM, 1989, JAMA-J AM MED ASSOC, V262, P3448, DOI 10.1001/jama.262.24.3448; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; EPSTEIN AM, 1984, AM J MED, V77, P313, DOI 10.1016/0002-9343(84)90709-5; Gonzales R, 1998, J GEN INTERN MED, V13, P541, DOI 10.1046/j.1525-1497.1998.00165.x; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Hadley J, 1999, HEALTH SERV RES, V34, P307; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Hasty M, 1999, J GEN INTERN MED, V14, P756, DOI 10.1046/j.1525-1497.1999.04099.x; HEMMINKI E, 1975, SOC SCI MED, V9, P111, DOI 10.1016/0037-7856(75)90103-1; Hutchinson JM, 1999, CAN MED ASSOC J, V160, P1013; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Ioannidis JPA, 2001, J ANTIMICROB CHEMOTH, V48, P677, DOI 10.1093/jac/48.5.677; Lambert BL, 1997, SOC SCI MED, V45, P1767, DOI 10.1016/S0277-9536(97)00108-1; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mainous AG, 1998, ARCH PEDIAT ADOL MED, V152, P349; Mainous AG, 1997, LANCET, V350, P1077, DOI 10.1016/S0140-6736(05)70457-8; Mather J. L., 1994, Canadian Journal of Hospital Pharmacy, V47, P111; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; Metlay JP, 2002, J GEN INTERN MED, V17, P87, DOI 10.1046/j.1525-1497.2002.10711.x; *NAT CTR HLTH STAT, 2001, PUBL US MICR FIL DOC; *NAT CTR HLTH STAT, 2000, PUBL US MICR FIL DOC; *NAT CTR HLTH STAT, 1999, PUBL US MICR FIL DOC; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Piccirillo JF, 2001, JAMA-J AM MED ASSOC, V286, P1849, DOI 10.1001/jama.286.15.1849; Reschovsky J, 2001, MED CARE, V39, P254, DOI 10.1097/00005650-200103000-00006; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; SAFAVI KT, 1992, J GEN INTERN MED, V7, P32, DOI 10.1007/BF02599099; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Snow V, 2001, ANN INTERN MED, V134, P487, DOI 10.7326/0003-4819-134-6-200103200-00014; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Soumerai SB, 2000, PHARMACOEPIDEM DR S, P483; Takata GS, 2001, PEDIATRICS, V108, P239, DOI 10.1542/peds.108.2.239; *US DEP HHS, 1988, INT CLASS DIS 9 REV; Walker S, 2000, CAN MED ASSOC J, V163, P273; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296	58	210	214	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					719	725		10.1001/jama.289.6.719	http://dx.doi.org/10.1001/jama.289.6.719			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585950	Bronze			2022-12-24	WOS:000180886000026
J	Tassicker, R; Savulescu, J; Skene, L; Marshall, P; Fitzgerald, L; Delatycki, MB				Tassicker, R; Savulescu, J; Skene, L; Marshall, P; Fitzgerald, L; Delatycki, MB			Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal, and ethical viewpoints	BRITISH MEDICAL JOURNAL			English	Article									Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Fac Law, Parkville, Vic 3052, Australia; Launceston Gen Hosp, Dept Psychiat, Launceston, Tas 7250, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Delatycki, MB (corresponding author), Royal Childrens Hosp, Genet Hlth Serv Victoria, Flemington Rd, Parkville, Vic 3052, Australia.		Delatycki, Martin B/A-5409-2013					Binedell J, 1998, CLIN GENET, V54, P477; Craufurd D, 1996, PRENATAL DIAG, V16, P1237, DOI 10.1002/(SICI)1097-0223(199612)16:13<1237::AID-PD98>3.0.CO;2-T; Decruyenaere M, 1996, J MED GENET, V33, P737, DOI 10.1136/jmg.33.9.737; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Myers RH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P301; Richards F, 1997, AUST SOC WORK, V50, P61, DOI DOI 10.1080/03124079708415747; ROSE P, 1999, PRACTICAL GENETICS P; Savulescu J, 1997, J MED ETHICS, V23, P282, DOI 10.1136/jme.23.5.282; WENT L, 1994, J MED GENET, V31, P555	9	14	14	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					331	333		10.1136/bmj.326.7384.331	http://dx.doi.org/10.1136/bmj.326.7384.331			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574051	Green Published			2022-12-24	WOS:000180997000025
J	Culi, J; Mann, RS				Culi, J; Mann, RS			Boca, an endoplasmic reticulum protein required for wingless signaling and trafficking of LDL receptor family members in Drosophila	CELL			English	Article							LONG-RANGE ACTION; VITELLOGENIN RECEPTOR; GENOME SEQUENCE; VESTIGIAL GENE; IN-VIVO; POLARITY; MELANOGASTER; TRANSDUCTION; EXPRESSION; HOMOLOG	The maturation of cell surface receptors through the secretory pathway often requires chaperones that aid in protein folding and trafficking from one organelle to another. Here we describe boca, an evolutionarily conserved gene in Drosophila melanogaster, which encodes an endoplasmic reticulum protein that is specifically required for the intracellular trafficking of members of the low-density lipoprotein family of receptors (LDLRs). Two LDLRs in flies, Arrow, which is required for Wingless signal transduction, and Yolkless, which is required for yolk protein uptake during oogenesis, both require boca function. Consequently, boca is an essential component of the Wingless pathway but is more generally required for the activities of multiple LDL receptor family members.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Mann, RS (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.		Culi, Joaquim/Y-6270-2019	Culi, Joaquim/0000-0001-6233-7379	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510, R01GM058575] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054510, R01 GM058575] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; BAKER NE, 1988, DEVELOPMENT, V102, P489; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Bu GJ, 2001, INT REV CYTOL, V209, P79; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COUSO JP, 1994, DEVELOPMENT, V120, P621; Dantuma NP, 1999, J LIPID RES, V40, P973; DEAK II, 1978, DEV BIOL, V66, P422, DOI 10.1016/0012-1606(78)90249-X; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Grandea AG, 2001, TRENDS IMMUNOL, V22, P194, DOI 10.1016/S1471-4906(01)01861-0; HEITZLER P, 1993, GENETICS, V135, P105; HOLDENER BC, 1994, DEVELOPMENT, V120, P1335; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Milanesi L, 1999, BIOINFORMATICS, V15, P612, DOI 10.1093/bioinformatics/15.7.612; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; PEIFER M, 1991, DEVELOPMENT, V111, P1029; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511, DOI 10.1091/mbc.11.2.511; Sen J, 2000, DEVELOPMENT, V127, P5541; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Uden E, 1999, NEUROSCIENCE, V88, P687, DOI 10.1016/S0306-4522(98)00272-3; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wines ME, 2001, GENOMICS, V72, P88, DOI 10.1006/geno.2000.6466; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	57	117	129	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					343	354		10.1016/S0092-8674(02)01279-5	http://dx.doi.org/10.1016/S0092-8674(02)01279-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581524	Bronze			2022-12-24	WOS:000181252200006
J	Hill, JO; Wyatt, HR; Reed, GW; Peters, JC				Hill, JO; Wyatt, HR; Reed, GW; Peters, JC			Obesity and the environment: Where do we go from here?	SCIENCE			English	Editorial Material							ENERGY-EXPENDITURE; COST		Univ Colorado, Hlth Sci Ctr, Ctr Human Nutr, Denver, CO 80262 USA; Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA 01655 USA; Procter & Gamble Co, Cincinnati, OH 45252 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Massachusetts System; University of Massachusetts Worcester; Procter & Gamble	Hill, JO (corresponding author), Univ Colorado, Hlth Sci Ctr, Ctr Human Nutr, 4200 E 9th Ave, Denver, CO 80262 USA.	james.hill@uchsc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042549, P30DK048520, R01DK042549] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42549, DK48520] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2001, SURG GEN CALL ACT PR; Bell AC, 2001, INT J OBESITY, V25, P1079, DOI 10.1038/sj.ijo.0801651; Blundell JE, 1998, INT J OBESITY, V22, pS22; DONNELLY JD, IN PRESS ARCH INTERN; Economos CD, 2001, NUTR REV, V59, pS40; FRENCH SA, 2001, ANNU REV PUBL HEALTH, V22, P63, DOI DOI 10.1146/ANNUREV.PUBLHEALTH.22.1.309; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gleick J., 1999, ACCELERATION JUST EV; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; HORTON TJ, 1995, AM J CLIN NUTR, V62, P19, DOI 10.1093/ajcn/62.1.19; Kortt MA, 1998, CLIN THER, V20, P772, DOI 10.1016/S0149-2918(98)80140-9; Lewis CE, 2001, CIRCULATION, V104, P787; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Reich R., 2001, FUTURE SUCCESS; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; TREMBLAY A, 1992, AM J CLIN NUTR, V56, P857, DOI 10.1093/ajcn/56.5.857; Wadden T. A., 2002, Handbook of obesity treatment, P144; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x	19	1521	1548	3	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					853	855		10.1126/science.1079857	http://dx.doi.org/10.1126/science.1079857			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574618				2022-12-24	WOS:000180830900039
J	Mazmanian, SK; Skaar, EP; Gaspar, AH; Humayun, M; Gornicki, P; Jelenska, J; Joachmiak, A; Missiakas, DM; Schneewind, O				Mazmanian, SK; Skaar, EP; Gaspar, AH; Humayun, M; Gornicki, P; Jelenska, J; Joachmiak, A; Missiakas, DM; Schneewind, O			Passage of heme-iron across the envelope of Staphylococcus aureus	SCIENCE			English	Article							GRAM-POSITIVE BACTERIA; SURFACE-PROTEINS; CELL-WALL; PENICILLIN; HEMOGLOBIN; VIRULENCE; SORTASE; ANCHOR; FUR	The cell wall envelope of Gram-positive pathogens functions as a scaffold for the attachment of virulence factors and as a sieve that prevents diffusion of molecules. Here the isd genes (iron-regulated surface determinant) of Staphylococcus aureus were found to encode factors responsible for hemoglobin binding and passage of heme-iron to the cytoplasm, where it acts as an essential nutrient. Heme-iron passage required two sortases that tether Isd proteins to unique locations within the cell wall. Thus, Isd appears to act as an import apparatus that uses cell wall-anchored proteins to relay heme-iron across the bacterial envelope.	Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Schneewind, O (corresponding author), Univ Chicago, Comm Microbiol, 920 E 58th St, Chicago, IL 60637 USA.		Humayun, Munir/A-1247-2007	Humayun, Munir/0000-0001-8516-9435	NIAID NIH HHS [AI5474, AI38897] Funding Source: Medline; NIGMS NIH HHS [GM58266] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058266] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNHEIMER AW, 1968, J BACTERIOL, V96, P487, DOI 10.1128/JB.96.2.487-491.1968; BHAKDI S, 1984, PHILOS T R SOC B, V306, P311, DOI 10.1098/rstb.1984.0092; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; STROMINGER JL, 1967, SCIENCE, V156, P213, DOI 10.1126/science.156.3772.213	23	461	495	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					906	909		10.1126/science.1081147	http://dx.doi.org/10.1126/science.1081147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574635				2022-12-24	WOS:000180830900057
J	Allen, SA; Spaulding, AC; Osei, AM; Taylor, LE; Cabral, AM; Rich, JD				Allen, SA; Spaulding, AC; Osei, AM; Taylor, LE; Cabral, AM; Rich, JD			Treatment of chronic hepatitis C in a state correctional facility	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIVIRAL TREATMENT; INFECTION	Background: Approximately 1 in 4 of the nearly 2 million individuals in state and federal correctional facilities are infected with hepatitis C virus (HCV). Currently, there are few reports of treatment outcomes of this common infection in this setting. Objective: To describe HCV therapy in the incarcerated setting. Design: Retrospective, descriptive observational study. Setting: Rhode Island Department of Corrections, Cranston, Rhode island. Patients: 93 inmates with chronic HCV infection. Intervention: Interferon-alpha with ribavirin. Measurements: HCV RNA levels 6 months after treatment. Results: Response rates are similar to previously published rates achieved in the community; 63% (50 of 79) of patients achieved viral clearance after 6 months of therapy, and 46% (26 of 57) achieved sustained response 6 months after treatment. Conclusion: The incarcerated population (which is disproportionately affected by addiction and psychiatric illness) can be effectively treated for HCV infection with interferon and ribavirin. The correctional setting may provide an opportunity to safely treat patients with these two challenging comorbid conditions.	Miriam Hosp, Providence, RI 02906 USA; Rhode Isl Dept Correct, Cranston, RI USA; Brown Univ, Sch Med, Providence, RI 02912 USA	Lifespan Health Rhode Island; Miriam Hospital; Brown University	Rich, JD (corresponding author), Miriam Hosp, 164 Summit Ave, Providence, RI 02906 USA.	jrich@lifespan.org	Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714; Taylor, Lynn/0000-0002-0472-8125	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NIAID NIH HHS [P30-AI-42853] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1997, HEPATOLOGY, V26, pS2; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Fontana RJ, 2000, DIGEST DIS, V18, P107, DOI 10.1159/000051384; HAMMET TM, 2002, NAT HIV PREV C ATL G; MACALINO GE, 2002, 1999 NAT HIV PREV C; *NIH, 2002, CONS DEV C STAT MAN; Reindollar Robert W., 1999, American Journal of Medicine, V107, p100S; Rich JD, 2001, AM J PUBLIC HEALTH, V91, P699, DOI 10.2105/AJPH.91.5.699; Spaulding A, 1999, PREV MED, V28, P92, DOI 10.1006/pmed.1998.0418; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 1998, JAMA-J AM MED ASSOC, V280, P2088, DOI 10.1001/jama.280.24.2088; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	13	98	99	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					187	190		10.7326/0003-4819-138-3-200302040-00010	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558357				2022-12-24	WOS:000181018600004
J	Carney, PA; Miglioretti, DL; Yankaskas, BC; Kerlikowske, K; Rosenberg, R; Rutter, CM; Geller, BM; Abraham, LA; Taplin, SH; Dignan, M; Cutter, G; Ballard-Barbash, R				Carney, PA; Miglioretti, DL; Yankaskas, BC; Kerlikowske, K; Rosenberg, R; Rutter, CM; Geller, BM; Abraham, LA; Taplin, SH; Dignan, M; Cutter, G; Ballard-Barbash, R			Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER RISK; SENSITIVITY; ESTROGEN; WOMEN; ASSOCIATION; SPECIFICITY; PROGESTIN; HISTORY; TRIAL	Background: The relationships among breast density, age, and use of hormone replacement therapy (HRT) in breast cancer detection have not been fully evaluated. Objective: To determine how breast density, age, and use of HRT individually and in combination affect the accuracy of screening mammography. Design: Prospective cohort study. Setting: 7 population-based mammography registries in North Carolina; New Mexico; New Hampshire; Vermont; Colorado; Seattle, Washington; and San Francisco, California. Participants: 329 495 women 40 to 89 years of age who had 463 372 screening mammograms from 1996 to 1998; 2223 women received a diagnosis of breast cancer. Measurements: Breast density, age, HRT use, rate of breast cancer occurrence, and sensitivity and specificity of screening mammography. Results: Adjusted sensitivity ranged from 62.9% in women with extremely dense breasts to 87.0% in women with almost entirely fatty breasts; adjusted sensitivity increased with age from 68.6% in women 40 to 44 years of age to 83.3% in women 80 to 89 years of age. Adjusted specificity increased from 89.1% in women with extremely dense breasts to 96.9% in women with almost entirely fatty breasts. In women who did not use HRT, adjusted specificity increased from 91.4% in women 40 to 44 years of age to 94.4% in women 80 to 89 years of age. In women who used HRT, adjusted specificity was about 91.7% for all ages. Conclusions: Mammographic breast density and age are important predictors of the accuracy of screening mammography. Although HRT use is not an independent predictor of accuracy, it probably affects accuracy by increasing breast density.	Dartmouth Coll, Sch Med, Dept Community & Family Med, Lebanon, NH 03756 USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; Univ N Carolina, Chapel Hill, NC 27599 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Univ Vermont, Burlington, VT 05405 USA; AMC Canc Res Ctr, Denver, CO USA; NCI, Bethesda, MD 20892 USA	Dartmouth College; Group Health Cooperative; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of New Mexico; University of Vermont; AMC Cancer Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Carney, PA (corresponding author), Dartmouth Coll, Sch Med, Dept Community & Family Med, 1 Med Ctr Dr,HB 7925, Lebanon, NH 03756 USA.	Patricia.A.Carney@dartmouth.edu	Cutter, Gary/AAY-5392-2021; Rutter, Carolyn/AAZ-3677-2021; SALAZAR, ANTONIO/A-5806-2013	Cutter, Gary/0000-0002-8455-980X; SALAZAR, ANTONIO/0000-0003-2639-2340	NCI NIH HHS [UO1CA63740, UO1CA70013, UO1CA63731, UO1CA63736, R01 CA80888, UO1CA86082, UO1CA70040, UO1CA86076, UO1CA69976] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA063731, R01CA080888, U01CA063736, U01CA070013, U01CA069976, U01CA070040, U01CA086076, U01CA063740, U01CA086082] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American College of Radiology (ACR), 1998, ILL BREAST IM REP DA; [Anonymous], 1994, AHCPR PUBL, V94-0592; Baines CJ, 1997, CANCER-AM CANCER SOC, V80, P720; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Byrne C, 1997, J NATL CANCER I, V89, P531, DOI 10.1093/jnci/89.8.531; Carney PA, 2000, AM J EPIDEMIOL, V152, P371, DOI 10.1093/aje/152.4.371; COVENEY EC, 1994, CLIN RADIOL, V49, P123, DOI 10.1016/S0009-9260(05)83454-3; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Harvey SC, 1996, AM J ROENTGENOL, V167, P394, DOI 10.2214/ajr.167.2.8686614; HOUN F, 1995, RADIOL CLIN N AM, V33, P1059; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Lam PB, 2000, CANCER, V89, P369, DOI 10.1002/1097-0142(20000715)89:2&lt;369::AID-CNCR23&gt;3.0.CO;2-J; Laya MB, 1996, J NATL CANCER I, V88, P643, DOI 10.1093/jnci/88.10.643; Leung W, 1997, SURGERY, V122, P669, DOI 10.1016/S0039-6060(97)90072-6; Litherland JC, 1997, CLIN RADIOL, V52, P276, DOI 10.1016/S0009-9260(97)80053-0; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; MORRISON AS, 1988, JNCI-J NATL CANCER I, V80, P1540, DOI 10.1093/jnci/80.19.1540; Pankow JS, 1997, J NATL CANCER I, V89, P549, DOI 10.1093/jnci/89.8.549; Persson I, 1997, J CLIN ONCOL, V15, P3201, DOI 10.1200/JCO.1997.15.10.3201; Rosenberg RD, 2000, ACAD RADIOL, V7, P1058, DOI 10.1016/S1076-6332(00)80057-4; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Taplin SH, 2002, RADIOLOGY, V222, P529, DOI 10.1148/radiol.2222010647; Thurfjell EL, 1997, RADIOLOGY, V203, P339, DOI 10.1148/radiology.203.2.9114085; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; White E, 1998, J NATL CANCER I, V90, P906, DOI 10.1093/jnci/90.12.906; Yankaskas BC, 2001, AM J ROENTGENOL, V177, P543, DOI 10.2214/ajr.177.3.1770543	33	781	803	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					168	175		10.7326/0003-4819-138-3-200302040-00008	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558355				2022-12-24	WOS:000181018600002
J	Read, RC; Cannings, C; Naylor, SC; Timms, JM; Maheswaran, R; Borrow, R; Kaczmarski, EB; Duff, GW				Read, RC; Cannings, C; Naylor, SC; Timms, JM; Maheswaran, R; Borrow, R; Kaczmarski, EB; Duff, GW			Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; PLASMINOGEN-ACTIVATOR-INHIBITOR-1 GENE; CYTOKINE PRODUCTION; ULCERATIVE-COLITIS; INCREASED RISK; ALLELE 2; POLYMORPHISM; ASSOCIATION; SUSCEPTIBILITY; IL-1-BETA	Background: Genetically determined variation in proinflammatory cytokine release influences severity of meningococcal disease and other serious infections. Objective: To ascertain the relative frequencies of single nucleotide polymorphisms within the interleukin-1 gene locus among patients who survived and those who died of meningococcal disease and a control population of blood donors. Design: Association study. Setting: England and Wales. Patients: 1106 consecutively received blood samples from persons with microbiologically confirmed meningococcal disease and 839 samples from blood donors. Measurements: Patient demographic and outcome data, infecting meningococcal serogroups, and genotype at the IL1B(-511) and IL1RN(+2018) loci of patients and blood donor controls. Results: Genotype frequency did not differ between patients with meningococcal disease and blood donor controls. Logistic regression analysis revealed that the likelihood of death was significantly influenced by age but not socioeconomic status and was higher in patients who were infected with serogroup C (odds ratio for survival, 0.50 [95% Cl, 0.33 to 0.78]). Patients carrying the common allele at IL1B(-511) were more likely to survive (odds ratio, 2.01 [Cl, 1.11 to 3.79]). Patients with this allele were less likely to survive if they also carried the rare allele at IL1RN(+2018) (odds ratio, 0.61 [Cl, 0.38 to 0.993]). Conclusion: Genotype at the interleukin-1 gene locus influences likelihood of survival of meningococcal disease but has no effect on susceptibility to the infection. Increasing age and infection with serogroup C also influence the likelihood of death.	Univ Sheffield, Sch Med, Div Genom Med, Sheffield S10 2RX, S Yorkshire, England; Manchester Publ Hlth Lab, Meningococcal Ref Unit England & Wales, Manchester, Lancs, England	University of Sheffield	Read, RC (corresponding author), Univ Sheffield, Sch Med, Div Genom Med, F Floor,Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	r.c.read@sheffield.ac.uk		Read, Robert/0000-0002-4297-6728; Maheswaran, Ravi/0000-0002-3899-4421				Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Carter MJ, 2001, GUT, V48, P461, DOI 10.1136/gut.48.4.461; Cox A, 1999, HUM MOL GENET, V8, P1707, DOI 10.1093/hmg/8.9.1707; Cox A, 1998, AM J HUM GENET, V62, P1180, DOI 10.1086/301817; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Di Giovine F. S., 1992, Human Molecular Genetics, V1, P450; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Donaldson P, 2001, GUT, V48, P397, DOI 10.1136/gut.48.3.397; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fijen CAP, 2000, CLIN EXP IMMUNOL, V120, P338, DOI 10.1046/j.1365-2249.2000.01208.x; Francis SE, 1999, CIRCULATION, V99, P861, DOI 10.1161/01.CIR.99.7.861; GIRAUD T, 1991, ARCH INTERN MED, V151, P310, DOI 10.1001/archinte.151.2.310; Hefler LA, 2001, FERTIL STERIL, V76, P377, DOI 10.1016/S0015-0282(01)01914-8; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Kondaveeti S, 1999, PEDIATR INFECT DIS J, V18, P893, DOI 10.1097/00006454-199910000-00011; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Makela S, 2001, NEPHROL DIAL TRANSPL, V16, P1368, DOI 10.1093/ndt/16.7.1368; Momiyama Y, 2001, J AM COLL CARDIOL, V38, P712, DOI 10.1016/S0735-1097(01)01438-3; Murphy GM, 2001, NEUROLOGY, V56, P1595, DOI 10.1212/WNL.56.11.1595; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; NICKLIN MJH, 1994, GENOMICS, V19, P382, DOI 10.1006/geno.1994.1076; Niino M, 2001, J NEUROIMMUNOL, V118, P295, DOI 10.1016/S0165-5728(01)00339-3; Read RC, 2000, J INFECT DIS, V182, P1557, DOI 10.1086/315889; RIORDAN FAI, 1995, EUR J PEDIATR, V154, P472; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; TARLOW JK, 1993, HUM GENET, V91, P403; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; Townsend PP., 1988, HLTH DEPRIVATION INE; Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855; vanDeuren M, 1997, BLOOD, V90, P1101, DOI 10.1182/blood.V90.3.1101.1101_1101_1108; Westendorp RGJ, 1999, LANCET, V354, P561, DOI 10.1016/S0140-6736(98)09376-3; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Whyte M, 2000, AM J RESP CRIT CARE, V162, P755, DOI 10.1164/ajrccm.162.2.9909053	37	55	55	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2003	138	7					534	541		10.7326/0003-4819-138-7-200304010-00009	http://dx.doi.org/10.7326/0003-4819-138-7-200304010-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661BV	12667023				2022-12-24	WOS:000181872100002
J	Gu, LH; Baldocchi, DD; Wofsy, SC; Munger, JW; Michalsky, JJ; Urbanski, SP; Boden, TA				Gu, LH; Baldocchi, DD; Wofsy, SC; Munger, JW; Michalsky, JJ; Urbanski, SP; Boden, TA			Response of a deciduous forest to the Mount Pinatubo eruption: Enhanced photosynthesis	SCIENCE			English	Article							CARBON-DIOXIDE; VOLCANIC SIGNAL; ATMOSPHERIC O-2; CO2; AEROSOLS; EXCHANGE; CLIMATE; CLOUDS; FLUXES; WATER	Volcanic aerosols from the 1991 Mount Pinatubo eruption greatly increased diffuse radiation worldwide for the following 2 years. We estimated that this increase in diffuse radiation alone enhanced noontime photosynthesis of a deciduous forest by 23% in 1992 and 8% in 1993 under cloudless conditions. This finding indicates that the aerosol-induced increase in diffuse radiation by the volcano enhanced the terrestrial carbon sink and contributed to the temporary decline in the growth rate of atmospheric carbon dioxide after the eruption.	Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; SUNY Albany, Atmospher Sci Res Ctr, Albany, NY 12203 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Berkeley; Harvard University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Gu, LH (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, Bldg 1509, Oak Ridge, TN 37831 USA.	lianhong-gu@ornl.gov	Gu, Lianhong/H-8241-2014; Manchun, Kang/D-3194-2011; Baldocchi, Dennis/A-1625-2009; Munger, J William/H-4502-2013	Gu, Lianhong/0000-0001-5756-8738; Baldocchi, Dennis/0000-0003-3496-4919; Munger, J William/0000-0002-1042-8452				Baldocchi D, 1997, PLANT CELL ENVIRON, V20, P1108, DOI 10.1046/j.1365-3040.1997.d01-147.x; Baldocchi DD, 2002, TREE PHYSIOL, V22, P1065, DOI 10.1093/treephys/22.15-16.1065; BARAN AJ, 1994, J GEOPHYS RES-ATMOS, V99, P25673, DOI 10.1029/94JD02044; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; BLUMTHALER M, 1994, TELLUS B, V46, P76, DOI 10.1034/j.1600-0889.1994.00007.x; BLUTH GJS, 1992, GEOPHYS RES LETT, V19, P151, DOI 10.1029/91GL02792; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; DUTTON EG, 1992, GEOPHYS RES LETT, V19, P2313, DOI 10.1029/92GL02495; Freedman JM, 2001, J CLIMATE, V14, P180, DOI 10.1175/1520-0442(2001)013<0180:BLCAVA>2.0.CO;2; GOUDRIAAN J, 1977, P249; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Gu LH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001242; Hansen J, 1996, GEOPHYS RES LETT, V23, P1665, DOI 10.1029/96GL01040; Herber A, 1996, J GEOPHYS RES-ATMOS, V101, P3921, DOI 10.1029/95JD02462; HOLLINGER DY, 1994, ECOLOGY, V75, P134, DOI 10.2307/1939390; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Jones CD, 2001, GLOBAL BIOGEOCHEM CY, V15, P453, DOI 10.1029/2000GB001281; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; MCCORMICK MP, 1995, NATURE, V373, P399, DOI 10.1038/373399a0; MICHALSKY JJ, 1994, SOL ENERGY, V52, P205, DOI 10.1016/0038-092X(94)90070-1; MINNIS P, 1993, SCIENCE, V259, P1411, DOI 10.1126/science.259.5100.1411; Molineaux B, 1996, SOL ENERGY, V58, P91, DOI 10.1016/0038-092X(96)00051-5; Olmo FJ, 1996, SOL ENERGY, V57, P433; Parker DE, 1996, INT J CLIMATOL, V16, P487, DOI 10.1002/(SICI)1097-0088(199605)16:5<487::AID-JOC39>3.0.CO;2-J; PRICE DT, 1990, AGR FOREST METEOROL, V50, P139, DOI 10.1016/0168-1923(90)90050-G; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Randel DL, 1996, B AM METEOROL SOC, V77, P1233, DOI 10.1175/1520-0477(1996)077<1233:ANGWVD>2.0.CO;2; ROBOCK A, 1995, J CLIMATE, V8, P1086, DOI 10.1175/1520-0442(1995)008<1086:TVSIST>2.0.CO;2; Robock A, 2002, SCIENCE, V295, P1242, DOI 10.1126/science.1069903; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; Schimel DS, 1996, GLOBAL BIOGEOCHEM CY, V10, P677, DOI 10.1029/96GB01524; Song NH, 1996, GEOPHYS RES LETT, V23, P2657, DOI 10.1029/96GL02372; Stenchikov GL, 1998, J GEOPHYS RES-ATMOS, V103, P13837, DOI 10.1029/98JD00693; STOWE LL, 1992, GEOPHYS RES LETT, V19, P159, DOI 10.1029/91GL02958; TREPTE CR, 1993, J GEOPHYS RES-ATMOS, V98, P18563, DOI 10.1029/93JD01362; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314	42	437	486	5	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2003	299	5615					2035	2038		10.1126/science.1078366	http://dx.doi.org/10.1126/science.1078366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663919				2022-12-24	WOS:000181834200045
J	Xu, J; Bjursell, MK; Himrod, J; Deng, S; Carmichael, LK; Chiang, HC; Hooper, LV; Gordon, JI				Xu, J; Bjursell, MK; Himrod, J; Deng, S; Carmichael, LK; Chiang, HC; Hooper, LV; Gordon, JI			A genomic view of the human-Bacteroides thetaiotaomicron symbiosis	SCIENCE			English	Article							OUTER-MEMBRANE PROTEINS; COMMENSAL; STARCH	The human gut is colonized with a vast community of indigenous microorganisms that help shape our biology. Here, we present the complete genome sequence of the Gram-negative anaerobe Bacteroides thetaiotaomicron, a dominant member of our normal distal intestinal microbiota. Its 4779-member proteome includes an elaborate apparatus for acquiring and hydrolyzing otherwise indigestible dietary polysaccharides and an associated environment-sensing system consisting of a large repertoire of extracytoplasmic function sigma factors and one- and two-component signal transduction systems. These and other expanded paralogous groups shed light on the molecular mechanisms underlying symbiotic host-bacterial relationships in our intestine.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	jgordon@molecool.wustl.edu	Xu, Jian/G-8430-2012; Xu, Jian/A-6831-2008	Xu, Jian/0000-0002-0548-8477; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK30292] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Della JN, 1996, J BACTERIOL, V178, P7180; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; SALYERS AA, 1993, GENETICS MOL BIOL AN, P505; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Whittle G, 2002, J BACTERIOL, V184, P3839, DOI 10.1128/JB.184.14.3839-3847.2002; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4	20	964	1452	5	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2003	299	5615					2074	2076		10.1126/science.1080029	http://dx.doi.org/10.1126/science.1080029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663928				2022-12-24	WOS:000181834200057
J	Bowers, JE; Chapman, BA; Rong, JK; Paterson, AH				Bowers, JE; Chapman, BA; Rong, JK; Paterson, AH			Unravelling angiosperm genome evolution by phylogenetic analysis of chromosomal duplication events	NATURE			English	Article							NUCLEOTIDE SUBSTITUTION; ARABIDOPSIS; RICE; ORGANIZATION; SEGMENTS; SEQUENCE; SYNTENY; DICOTS; TOMATO; PLANTS	Conservation of gene order in vertebrates is evident after hundreds of millions of years of divergence(1,2), but comparisons of the Arabidopsis thaliana sequence(3) to partial gene orders of other angiosperms (flowering plants) sharing common ancestry, similar to170-235 million years ago(4) yield conflicting results(5-11). This difference may be largely due to the propensity of angiosperms to undergo chromosomal duplication ('polyploidization') and subsequent gene loss(12) ('diploidization'); these evolutionary mechanisms have profound consequences for comparative biology. Here we integrate a phylogenetic approach (relating chromosomal duplications to the tree of life) with a genomic approach (mitigating information lost to diploidization) to show that a genome-wide duplication(3,13-17) post-dates the divergence of Arabidopsis from most dicots. We also show that an inferred ancestral gene order for Arabidopsis reveals more synteny with other dicots (exemplified by cotton), and that additional, more ancient duplication events affect more distant taxonomic comparisons. By using partial sequence data for many diverse taxa to better relate the evolutionary history of completely sequenced genomes to the tree of life, we foster comparative approaches to the study of genome organization, consequences of polyploidy, and the molecular basis of quantitative traits.	Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@uga.edu	Bowers, John/AAD-7601-2019; Bowers, John/B-9245-2009	Bowers, John/0000-0001-8984-9796; Bowers, John/0000-0001-5693-2796; Chapman, Brad/0000-0002-3026-1856				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; BENTON MJ, 1993, FOSSIL RECORD, V2; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Eckardt NA, 2001, PLANT CELL, V13, P1699, DOI 10.1105/tpc.13.8.1699; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grant D, 2000, P NATL ACAD SCI USA, V97, P4168, DOI 10.1073/pnas.070430597; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koch M, 1999, PLANT BIOLOGY, V1, P529, DOI 10.1055/s-2007-978548; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Lee JM, 2001, THEOR APPL GENET, V103, P765, DOI 10.1007/s001220100658; Liu H, 2001, GENOME RES, V11, P2020, DOI 10.1101/gr.194501; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mayer K, 2001, GENOME RES, V11, P1167, DOI 10.1101/gr.GR-1617R; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Paterson AH, 1996, NAT GENET, V14, P380, DOI 10.1038/ng1296-380; Rossberg M, 2001, PLANT CELL, V13, P979, DOI 10.1105/tpc.13.4.979; Salse J, 2002, NUCLEIC ACIDS RES, V30, P2316, DOI 10.1093/nar/30.11.2316; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Smith SF, 2002, GENOME RES, V12, P776, DOI 10.1101/gr.221802; Strauss E, 1999, SCIENCE, V283, P1435, DOI 10.1126/science.283.5407.1435; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang CQ, 2000, TEXT CHEM COLOR AM D, V32, P43; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Zhang LQ, 2002, MOL BIOL EVOL, V19, P1464, DOI 10.1093/oxfordjournals.molbev.a004209	30	1145	1203	7	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2003	422	6930					433	438		10.1038/nature01521	http://dx.doi.org/10.1038/nature01521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660784				2022-12-24	WOS:000181801200045
J	Burchard, EG; Ziv, E; Coyle, N; Gomez, SL; Tang, H; Karter, AJ; Mountain, JL; Perez-Stable, EJ; Sheppard, D; Risch, N				Burchard, EG; Ziv, E; Coyle, N; Gomez, SL; Tang, H; Karter, AJ; Mountain, JL; Perez-Stable, EJ; Sheppard, D; Risch, N			The importance of race and ethnic background in biomedical research and clinical practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FACTOR-V-LEIDEN; GENETIC-STRUCTURE; AFRICAN-AMERICAN; CROHNS-DISEASE; ADMIXTURE; POPULATIONS; DISPARITIES; ASSOCIATION; PREVALENCE; EVOLUTION		Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Med Effectiveness Res Ctr Diverse Populat, San Francisco, CA 94143 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Stanford Univ, Dept Anthropol Sci, Stanford, CA 94305 USA; No Calif Canc Ctr, Union City, CA USA; Kaiser Permanente, Div Res, Dept Epidemiol & Hlth Serv Res, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Stanford University; Stanford University; Stanford University; Stanford University; Kaiser Permanente	Burchard, EG (corresponding author), Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA.		Ziv, Elad/L-5396-2014		NCI NIH HHS [K22 CA109351] Funding Source: Medline; NHLBI NIH HHS [K23 HL004464] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA109351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM CIV RIGHTS COA, 2002, RAC PRIV IN; Angier Natalie, 2000, NY TIMES        1107, pF1; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; DEAN M, 1994, AM J HUM GENET, V55, P788; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Gifford AL, 2002, NEW ENGL J MED, V346, P1373, DOI 10.1056/NEJMsa011565; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Judson R, 2002, PHARMACOGENOMICS, V3, P379, DOI 10.1517/14622416.3.3.379; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; LANDER E, 2001, CRACKING CODE LIFE; Merryweather-Clarke AT, 2000, GENET TEST, V4, P183, DOI 10.1089/10906570050114902; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; RISCH N, 2002, GENOME BIOL, V3; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Schulman KA, 1999, NEW ENGL J MED, V340, P1130; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shen MC, 1997, THROMB RES, V87, P377, DOI 10.1016/S0049-3848(97)00141-2; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stephens JC, 2001, SCIENCE, V293, P1048; Williams RC, 2000, AM J HUM GENET, V66, P527, DOI 10.1086/302773; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; YU MC, 1994, J NATL CANCER I, V86, P712, DOI 10.1093/jnci/86.9.712	35	756	784	1	37	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1170	1175		10.1056/NEJMsb025007	http://dx.doi.org/10.1056/NEJMsb025007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646676				2022-12-24	WOS:000181628400015
J	Schulze, ED; Mollicone, D; Achard, F; Matteucci, G; Federici, S; Eva, HD; Valentini, R				Schulze, ED; Mollicone, D; Achard, F; Matteucci, G; Federici, S; Eva, HD; Valentini, R			Climate change - Making deforestation pay under the Kyoto Protocol?	SCIENCE			English	Editorial Material							FORESTS		Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, TP 440, I-21020 Ispra, Italy; Max Planck Inst Biogeochem, D-07701 Jena, Germany; Univ Tuscia, Dept Forest Environm & Resources, I-01100 Viterbo, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; Max Planck Society; Tuscia University	Achard, F (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, TP 440, I-21020 Ispra, Italy.		Valentini, Riccardo/D-1226-2010; Schulze, Ernst-Detlef/K-9627-2014; Matteucci, Giorgio/N-3526-2015; EVA, Hugh D/F-8412-2011; Matteucci, Giorgio/AAB-7022-2021	Valentini, Riccardo/0000-0002-6756-5634; Matteucci, Giorgio/0000-0002-4790-9540; 				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; BROWN S, 2000, LAND USE LAND USE CH, pCH5; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schulze ED, 2002, GLOBAL CHANGE BIOL, V8, P505, DOI 10.1046/j.1365-2486.2002.00523.x; Steffen W, 1998, SCIENCE, V280, P1393; *UNFCCC, 2002, ACT IMPL JOINTL LIST; *UNFCCC, 2001, BONN AGR IMPL BUEN A; *UNFCCC, 2002, METH ISS SUBM PART; UNFCCC, 2002, MARR ACC; UNFCCC, 1997, KYOT PROT; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; *WINR INT, 2000, PRACT EXP PIL PROJ N	12	16	16	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1669	1669		10.1126/science.1079024	http://dx.doi.org/10.1126/science.1079024			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637722				2022-12-24	WOS:000181519500021
J	Aebersold, R				Aebersold, R			Constellations in a cellular universe	NATURE			English	Editorial Material									Univ Washington, Dept Biol Mol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Aebersold, R (corresponding author), Univ Washington, Dept Biol Mol, Seattle, WA 98195 USA.								0	74	83	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					115	116		10.1038/422115a	http://dx.doi.org/10.1038/422115a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634755				2022-12-24	WOS:000181488900017
J	Delneri, D; Colson, I; Grammenoudi, S; Roberts, IN; Louis, EJ; Oliver, SG				Delneri, D; Colson, I; Grammenoudi, S; Roberts, IN; Louis, EJ; Oliver, SG			Engineering evolution to study speciation in yeasts	NATURE			English	Article							SENSU-STRICTO COMPLEX; SACCHAROMYCES-CEREVISIAE; REDUNDANCY; GENOME; TRANSLOCATION; STERILITY; BAYANUS; SYSTEM; HYBRID; CELLS	The Saccharomyces 'sensu stricto' yeasts are a group of species that will mate with one another, but interspecific pairings produce sterile hybrids. A retrospective analysis of their genomes revealed that translocations between the chromosomes of these species do not correlate with the group's sequence-based phylogeny(1) (that is, translocations do not drive the process of speciation). However, that analysis was unable to infer what contribution such rearrangements make to reproductive isolation between these organisms. Here, we report experiments that take an interventionist, rather than a retrospective approach to studying speciation, by reconfiguring the Saccharomyces cerevisiae genome so that it is collinear with that of Saccharomyces mikatae. We demonstrate that this imposed genomic collinearity allows the generation of interspecific hybrids that produce a large proportion of spores that are viable, but extensively aneuploid. We obtained similar results in crosses between wild-type S. cerevisiae and the naturally collinear species Saccharomyces paradoxus, but not with non-collinear crosses. This controlled comparison of the effect of chromosomal translocation on species barriers suggests a mechanism for the generation of redundancy in the S. cerevisiae genome(2).	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Inst Food Res, Natl Collect Yeast Cultures, Norwich NR4 7UA, Norfolk, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Leicester	Oliver, SG (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	steve.oliver@man.ac.uk	Oliver, Stephen/AAQ-5992-2021; Louis, Edward/B-7920-2008; Roberts, Ian N/B-9743-2008	Oliver, Stephen/0000-0003-3410-6439; Louis, Edward/0000-0003-1157-3608; Delneri, Daniela/0000-0001-8070-411X				ADAMS A, 1997, METHODS YEAST GENETI, P145; [Anonymous], SACCHAROMYCES GENOME; BENGTSSON BO, 1976, ANN HUM GENET, V40, P253, DOI 10.1111/j.1469-1809.1976.tb00188.x; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Delneri D, 1999, GENETICS, V153, P1591; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Fischer G, 2001, GENOME RES, V11, P2009, DOI 10.1101/gr.212701; GARDNER DCJ, 1993, YEAST, V9, P1053, DOI 10.1002/yea.320091003; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kielland-Brandt MC, 1983, YEAST GENETICS FUNDA, P421; Llorente B, 2000, FEBS LETT, V487, P122, DOI 10.1016/S0014-5793(00)02291-2; Loidl J, 1998, CHROMOSOMA, V107, P247, DOI 10.1007/s004120050304; Lynch M, 2001, GENETICS, V159, P1789; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Naumov GI, 1997, SYST APPL MICROBIOL, V20, P595, DOI 10.1016/S0723-2020(97)80031-8; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; NAUMOV GI, 1987, EXPANDING REALM YEAS; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ryu SL, 1998, CURR GENET, V33, P345, DOI 10.1007/s002940050346; Sebastiani F, 2002, RES MICROBIOL, V153, P53, DOI 10.1016/S0923-2508(01)01286-4; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Tamai Y, 1998, YEAST, V14, P923, DOI 10.1002/(SICI)1097-0061(199807)14:10<923::AID-YEA298>3.3.CO;2-9; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	26	181	187	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					68	72		10.1038/nature01418	http://dx.doi.org/10.1038/nature01418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621434				2022-12-24	WOS:000181343100038
J	Boffelli, D; McAuliffe, J; Ovcharenko, D; Lewis, KD; Ovcharenko, I; Pachter, L; Rubin, EM				Boffelli, D; McAuliffe, J; Ovcharenko, D; Lewis, KD; Ovcharenko, I; Pachter, L; Rubin, EM			Phylogenetic shadowing of primate sequences to find functional regions of the human genome	SCIENCE			English	Article							CORONARY-HEART-DISEASE; EPSILON-GLOBIN; LIPOPROTEIN(A); APOLIPOPROTEIN(A); GENES; GAMMA	Nonhuman primates represent the most relevant model organisms to understand the biology of Homo sapiens. The recent divergence and associated overall sequence conservation between individual members of this taxon have nonetheless largely precluded the use of primates in comparative sequence studies. We used sequence comparisons of an extensive set of Old World and New World monkeys and hominoids to identify functional regions in the human genome. Analysis of these data enabled the discovery of primate-specific gene regulatory elements and the demarcation of the exons of multiple genes. Much of the information content of the comprehensive primate sequence comparisons could be captured with a small subset of phylogenetically close primates. These results demonstrate the utility of intraprimate sequence comparisons to discover common mammalian as well as primate-specific functional elements in the human genome, which are unattainable through the evaluation of more evolutionarily distant species.	USDA, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	United States Department of Agriculture (USDA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rubin, EM (corresponding author), USDA, Joint Genome Inst, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov		Ovcharenko, Dmitriy/0000-0003-1271-1099; Pachter, Lior/0000-0002-9164-6231	NHGRI NIH HHS [R01-HG02362-01] Funding Source: Medline; NHLBI NIH HHS [HL66728] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066728] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002362] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAWN RM, 1995, J BIOL CHEM, V270, P24004, DOI 10.1074/jbc.270.41.24004; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; Notredame C, 2001, BIOINFORMATICS, V17, P373, DOI 10.1093/bioinformatics/17.4.373; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; WADE DP, 1994, J BIOL CHEM, V269, P19757; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	14	392	423	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1391	1394		10.1126/science.1081331	http://dx.doi.org/10.1126/science.1081331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610304	Green Submitted			2022-12-24	WOS:000181192300051
J	Mayor, U; Guydosh, NR; Johnson, CM; Grossmann, JG; Sato, S; Jas, GS; Freund, SMV; Alonso, DOV; Daggett, V; Fersht, AR				Mayor, U; Guydosh, NR; Johnson, CM; Grossmann, JG; Sato, S; Jas, GS; Freund, SMV; Alonso, DOV; Daggett, V; Fersht, AR			The complete folding pathway of a protein from nanoseconds to microseconds	NATURE			English	Article							DIFFUSION-COLLISION MODEL; DENATURED STATE; ENERGY; DOMAIN; HELIX	Combining experimental and simulation data to describe all of the structures and the pathways involved in folding a protein is problematical. Transition states can be mapped experimentally by phi values(1,2), but the denatured state(3) is very difficult to analyse under conditions that favour folding. Also computer simulation at atomic resolution is currently limited to about a microsecond or less. Ultrafast-folding proteins fold and unfold on timescales accessible by both approaches(4,5), so here we study the folding pathway of the three-helix bundle protein Engrailed homeodomain(6). Experimentally, the protein collapses in a microsecond to give an intermediate with much native alpha-helical secondary structure, which is the major component of the denatured state under conditions that favour folding. A mutant protein shows this state to be compact and contain dynamic, native-like helices with unstructured side chains. In the transition state between this and the native state, the structure of the helices is nearly fully formed and their docking is in progress, approximating to a classical diffusion-collision model. Molecular dynamics simulations give rate constants and structural details highly consistent with experiment, thereby completing the description of folding at atomic resolution.	MRC, Ctr Prot Engn, Cambridge CB2 2QH, England; CLRC Daresbury Lab, Warrington WA4 4AD, Cheshire, England; NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Cambridge; STFC Daresbury Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Washington; University of Washington Seattle	Fersht, AR (corresponding author), MRC, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008; Mayor, Ugo/F-5890-2011	Mayor, Ugo/0000-0003-2812-8287				BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Blanco FJ, 1998, J MOL BIOL, V284, P1153, DOI 10.1006/jmbi.1998.2229; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13008, DOI 10.1073/pnas.221467398; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grossmann JG, 2002, BIOCHEMISTRY-US, V41, P3613, DOI 10.1021/bi015955o; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; HUANG GS, 1995, P NATL ACAD SCI USA, V92, P6878, DOI 10.1073/pnas.92.15.6878; Islam SA, 2002, J MOL BIOL, V318, P199, DOI 10.1016/S0022-2836(02)00029-3; Itzhaki LS, 1997, J MOL BIOL, V270, P89, DOI 10.1006/jmbi.1997.1049; KARPLUS M, 1994, PROTEIN SCI, V3, P650; KIPPEN AD, 1994, BIOCHEMISTRY-US, V33, P10013, DOI 10.1021/bi00199a027; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; Oliveberg M, 1996, BIOCHEMISTRY-US, V35, P2738, DOI 10.1021/bi950967t; Sandstrom J., 1982, DYNAMIC NMR SPECTROS; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Spector S, 1999, BIOPOLYMERS, V49, P29, DOI 10.1002/(SICI)1097-0282(199901)49:1<29::AID-BIP4>3.0.CO;2-7; Thompson PA, 1997, BIOCHEMISTRY-US, V36, P9200, DOI 10.1021/bi9704764; Witty M, 2002, EMBO J, V21, P4207, DOI 10.1093/emboj/cdf417; Zhang Y.Z., 1995, THESIS U PENNSYLVANI	29	414	421	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					863	867		10.1038/nature01428	http://dx.doi.org/10.1038/nature01428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594518				2022-12-24	WOS:000181044700053
J	Scholtz, G; Braband, A; Tolley, L; Reimann, A; Mittmann, B; Lukhaup, C; Steuerwald, F; Vogt, G				Scholtz, G; Braband, A; Tolley, L; Reimann, A; Mittmann, B; Lukhaup, C; Steuerwald, F; Vogt, G			Ecology - Parthenogenesis in an outsider crayfish	NATURE			English	Article							FISH		Humboldt Univ, Inst Biol Vergleichende Zool, D-10115 Berlin, Germany; Heidelberg Univ, Inst Zool, INF 230, D-69120 Heidelberg, Germany	Humboldt University of Berlin; Ruprecht Karls University Heidelberg	Scholtz, G (corresponding author), Humboldt Univ, Inst Biol Vergleichende Zool, D-10115 Berlin, Germany.	gerhard.scholtz@rz.hu-berlin.de						Bauer RT, 1998, MAR BIOL, V132, P223, DOI 10.1007/s002270050388; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Gruner H-E, 1993, LEHRBUCH SPEZIELLEN; LUKHAUP C, 2001, AQUARISTIK AKTUELL, V7, P48; Nam YK, 2000, TRANSGENIC RES, V9, P463, DOI 10.1023/A:1026596422225; Reynolds JD, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P152; Scholtz G, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P30; Soderhall Kenneth, 1999, Freshwater Crayfish, V12, P11; Vogt G, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P53; VRIJENHOEK RC, 1994, ANNU REV ECOL SYST, V25, P71, DOI 10.1146/annurev.es.25.110194.000443	10	152	157	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					806	806		10.1038/421806a	http://dx.doi.org/10.1038/421806a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594502				2022-12-24	WOS:000181044700037
J	Harrod, HL				Harrod, HL			An essay on desire	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					813	814		10.1001/jama.289.7.813	http://dx.doi.org/10.1001/jama.289.7.813			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588245				2022-12-24	WOS:000181072200001
J	Evans, JG				Evans, JG			Drugs and falls in later life	LANCET			English	Editorial Material							RISK		Univ Oxford Green Coll, Oxford OX2 6HE, England	University of Oxford	Evans, JG (corresponding author), Univ Oxford Green Coll, Oxford OX2 6HE, England.	john.grimleyevans@geratology.oxford.ac.uk						COOK PJ, 1986, ACTA PSYCHIAT S S332, V73, P149; Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; EVANS JG, 1990, AGE AGEING, V19, P268, DOI 10.1093/ageing/19.4.268; EVANS JG, 1992, FALLS, BALANCE AND GAIT DISORDERS IN THE ELDERLY, P39; HECKMAN GA, 2002, COCHRANE LIB; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; MURPHY J, 1982, GERONTOLOGY, V28, P265, DOI 10.1159/000212543; PRUDHAM D, 1981, AGE AGEING, V10, P264; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303	10	32	36	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					448	448		10.1016/S0140-6736(03)12502-0	http://dx.doi.org/10.1016/S0140-6736(03)12502-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583941				2022-12-24	WOS:000180900600006
J	Dajee, M; Lazarov, M; Zhang, JY; Cai, T; Green, CL; Russell, AJ; Marinkovich, MP; Tao, SY; Lin, Q; Kubo, Y; Khavari, PA				Dajee, M; Lazarov, M; Zhang, JY; Cai, T; Green, CL; Russell, AJ; Marinkovich, MP; Tao, SY; Lin, Q; Kubo, Y; Khavari, PA			NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia	NATURE			English	Article							SQUAMOUS-CELL CARCINOMAS; HUMAN BREAST-CANCER; SKIN; ALPHA-6-BETA-4; CARCINOGENESIS; ACTIVATION; EXPRESSION; APOPTOSIS; LAMININ-5; SUBUNITS	The nuclear factor NF-kappaB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cancer(1,2). These proteins are implicated in epidermal squamous cell carcinoma in mice(3-5), however, the potential effects of altering their function are uncertain. Whereas inhibition of NF-kappaB enhances apoptosis in certain tumours(6), blockade of NF-kappaB predisposes murine skin to squamous cell carcinoma(5,7). Because therapeutics inhibiting Ras and NF-kappaB pathways are being developed to treat human cancer(8,9), it is essential to assess the effects of altering these regulators. The medical relevance of murine studies is limited, however, by differences between mouse and human skin, and by the greater ease of transforming murine cells. Here we show that in normal human epidermal cells both NF-kappaB and oncogenic Ras trigger cell-cycle arrest. Growth arrest triggered by oncogenic Ras can be bypassed by IkappaBalpha-mediated blockade of NF-kappaB, generating malignant human epidermal tissue resembling squamous cell carcinoma. Human cell tumorigenesis is dependent on laminin 5 and alpha6beta4 integrin. Thus, IkappaBalpha circumvents restraints on growth promotion induced by oncogenic Ras and can act with Ras to induce invasive human tissue neoplasia.	Stanford Univ, Sch Med, Vet Affairs Palo Alto Healthcare Syst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Khavari, PA (corresponding author), Stanford Univ, Sch Med, Vet Affairs Palo Alto Healthcare Syst, Stanford, CA 94305 USA.		Zhang, Junyi/HDN-7815-2022	Russell, Alan/0000-0001-7545-5008; Zhang, Jennifer Y./0000-0002-4485-1750				Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; LAAROV M, 2002, NAT MED, V8, P1105; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MARINKOVICH MP, 1999, DERMATOLOGY GEN MED, P690; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; Nordemar S, 2001, ANTICANCER RES, V21, P509; Pazzaglia S, 2001, MOL CARCINOGEN, V30, P111, DOI 10.1002/1098-2744(200102)30:2<111::AID-MC1019>3.0.CO;2-L; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Robbins PB, 2001, P NATL ACAD SCI USA, V98, P5193, DOI 10.1073/pnas.091484998; SAVOIA P, 1993, J INVEST DERMATOL, V101, P352, DOI 10.1111/1523-1747.ep12365531; Seitz CS, 2000, CANCER RES, V60, P4085; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; VAN AD, 1996, SCIENCE, V274, P787; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; YUSPA SH, 1994, CANCER RES, V54, P1178; Zimonjic D, 2001, CANCER RES, V61, P8838	30	452	465	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					639	643		10.1038/nature01283	http://dx.doi.org/10.1038/nature01283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571598				2022-12-24	WOS:000180803200044
J	Inadomi, JM; Sampliner, R; Lagergren, J; Lieberman, D; Fendrick, AM; Vakil, N				Inadomi, JM; Sampliner, R; Lagergren, J; Lieberman, D; Fendrick, AM; Vakil, N			Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX DISEASE; SPECIALIZED INTESTINAL METAPLASIA; PROSPECTIVE MULTIVARIATE-ANALYSIS; ENDOSCOPIC SURVEILLANCE; FOLLOW-UP; GASTROINTESTINAL-ENDOSCOPY; SURGICAL-TREATMENT; OVERRATED RISK; CANCER-RISK	Background: Once-in-a-lifetime screening for Barrett esophagus has been proposed for patients with gastroesophageal reflux disease (GERD) but there is little evidence of its cost-effectiveness. Objective: 1) To determine the cost-effectiveness of screening high-risk groups for Barrett esophagus and providing surveillance to patients with Barrett esophagus and dysplasia or to all patients With Barrett esophagus and 2) to compare the results with the cost-effectiveness of no screening or surveillance. Design: A decision analytic model was developed to examine no screening or surveillance and screening and surveillance for Barrett esophagus with dysplasia only or Barrett esophagus without dysplasia every 2 to 5 years. Low- or high-grade dysplasia received surveillance every 6 or 3 months, respectively. Data Sources: Published literature and the Health Care Financing Administration. Target Population: 50-year-old white men with symptoms of GERD. Time Horizon: 50 years of age until 80 years of age or death. Perspective: Third-party payer. Outcome Measure: incremental cost-effectiveness ratio. Results of Base-Case Analysis: Screening with surveillance limited to patients with Barrett esophagus with dysplasia required $10 440 per quality-adjusted life-year (QALY) saved compared to no screening or surveillance. The incremental cost-effectiveness ratio of surveillance every 5 years in patients with Barrett esophagus without dysplasia compared to surveillance of patients with Barrett esophagus with dysplasia was $596 000 per QALY saved. Results of Sensitivity Analysis: The annual incidence of adenocarcinoma must exceed 1 case per 54 patient-years of follow-up (1.9%) foe surveillance of Barrett esophagus without dysplasia every 5 years to yield an incremental cost-effectiveness ratio less than $50 000 per QALY saved. Conclusions: Screening 50-year-old men with symptoms of GERD to detect adenocarcinoma associated with Barrett esophagus is probably cost-effective. However, subsequent surveillance of patients with Barrett esophagus but no dysplasia, even at 5-year intervals, is an expensive practice.	Univ Wisconsin, Sch Med, Aurora Sinai Med Ctr, Div Gastroenterol, Milwaukee, WI 53233 USA; Univ Michigan, Vet Adm Ctr Practice Management & Outcomes Res, Ann Arbor, MI 48109 USA; Consortium Hlth Outcomes Innovat & Cost Effective, Ann Arbor, MI USA; SO Arizona Vet Affairs Healthcare Syst, Tucson, AZ USA; Univ Arizona, Tucson, AZ 85724 USA; Karolinska Inst, S-10521 Stockholm, Sweden; Karolinska Hosp, S-10401 Stockholm, Sweden; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System; University of Arizona; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Oregon Health & Science University	Vakil, N (corresponding author), Univ Wisconsin, Sch Med, Aurora Sinai Med Ctr, Div Gastroenterol, 945 N 12th St,Room 4040, Milwaukee, WI 53233 USA.	nvakil@wisc.edu	Inadomi, John/A-6221-2014	Inadomi, John/0000-0001-6776-8661; Lagergren, Jesper/0000-0002-5143-5448				ACHKAR E, 1988, AM J GASTROENTEROL, V83, P291; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; BONELLI L, 1993, ENDOSCOPY, V25, P652, DOI 10.1055/s-2007-1010425; CAMERON AJ, 1985, NEW ENGL J MED, V313, P857, DOI 10.1056/NEJM198510033131404; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; Caygill CPJ, 1999, EUR J GASTROEN HEPAT, V11, P1355, DOI 10.1097/00042737-199912000-00003; Caygill CPJ, 1999, EUR J CANCER PREV, V8, P539, DOI 10.1097/00008469-199912000-00010; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; DEMEESTER TR, 1988, J THORAC CARDIOV SUR, V95, P42; DENT J, 1991, J GASTROEN HEPATOL, V6, P1, DOI 10.1111/j.1440-1746.1991.tb01137.x; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; EARLAM R, 1980, BRIT J SURG, V67, P381, DOI 10.1002/bjs.1800670602; Ellis FH, 1997, J THORAC CARDIOV SUR, V113, P836, DOI 10.1016/S0022-5223(97)70256-3; ELLIS FH, 1983, ANN SURG, V198, P531, DOI 10.1097/00000658-198310000-00013; Eloubeidi MA, 1999, AM J GASTROENTEROL, V94, P2033; Eloubeidi MA, 2001, J CLIN GASTROENTEROL, V33, P306, DOI 10.1097/00004836-200110000-00010; Eloubeidi MA, 2000, AM J GASTROENTEROL, V95, P1881; GALANDIUK S, 1986, ANN SURG, V203, P101, DOI 10.1097/00000658-198601000-00016; Gorelick AB, 2001, J CLIN GASTROENTEROL, V33, P210, DOI 10.1097/00004836-200109000-00008; HABRGAMA A, 1989, WORLD J SURG, V13, P193, DOI 10.1007/BF01658399; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; Hirota WK, 1999, GASTROENTEROLOGY, V116, P277, DOI 10.1016/S0016-5085(99)70123-X; Johnston MH, 1996, AM J GASTROENTEROL, V91, P1507; Katz D, 1998, AM J GASTROENTEROL, V93, P536; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; MENKEPLUYMERS MBE, 1992, GUT, V33, P1454, DOI 10.1136/gut.33.11.1454; *NAT CTR HLTH STAT, 2001, VIT STAT US 2000; Nguyen NT, 2000, SURGERY, V127, P284, DOI 10.1067/msy.2000.103489; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; PERA M, 1992, ANN THORAC SURG, V54, P199, DOI 10.1016/0003-4975(92)91370-O; PETERS JH, 1994, J THORAC CARDIOV SUR, V108, P813, DOI 10.1016/S0022-5223(94)70178-4; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; PROVENZALE D, 1994, AM J GASTROENTEROL, V89, P670; ROBERTSON CS, 1988, BRIT J SURG, V75, P760, DOI 10.1002/bjs.1800750813; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; Schnell TG, 2001, GASTROENTEROLOGY, V120, P1607, DOI 10.1053/gast.2001.25065; Schoenfeld P, 1998, AM J GASTROENTEROL, V93, P906; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 1997, AM J GASTROENTEROL, V92, P2012; Sharma P, 2001, GASTROENTEROLOGY, V120, pA16, DOI 10.1016/S0016-5085(01)80081-0; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; SILVIS SE, 1976, JAMA-J AM MED ASSOC, V235, P928, DOI 10.1001/jama.235.9.928; SKINNER DB, 1983, J THORAC CARDIOV SUR, V85, P59; Soni A, 2000, AM J GASTROENTEROL, V95, P2086; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; SPECHLER SJ, 1984, GASTROENTEROLOGY, V87, P927; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; Streitz JM, 1998, AM J GASTROENTEROL, V93, P911; STREITZ JM, 1993, J THORAC CARDIOV SUR, V105, P383; van Sandick JW, 1998, GUT, V43, P216, DOI 10.1136/gut.43.2.216; VANDERVEEN AH, 1989, GUT, V30, P14, DOI 10.1136/gut.30.1.14; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weston AP, 2000, AM J GASTROENTEROL, V95, P1888; Weston AP, 1996, AM J GASTROENTEROL, V91, P981; Weston AP, 1999, AM J GASTROENTEROL, V94, P3413, DOI 10.1111/j.1572-0241.1999.01602.x; Weston AP, 1999, AM J GASTROENTEROL, V94, P3420, DOI 10.1016/S0002-9270(99)00662-0; WILLIAMSON WA, 1991, ARCH INTERN MED, V151, P2212, DOI 10.1001/archinte.151.11.2212; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X; WOLFE WG, 1993, J THORAC CARDIOV SUR, V105, P749; Wright TA, 1996, GUT, V39, P574, DOI 10.1136/gut.39.4.574; WU YK, 1979, ANN SURG, V190, P361	63	296	302	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					176	186		10.7326/0003-4819-138-3-200302040-00009	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558356				2022-12-24	WOS:000181018600003
J	Sosic, D; Richardson, JA; Yu, K; Ornitz, DM; Olson, EN				Sosic, D; Richardson, JA; Yu, K; Ornitz, DM; Olson, EN			Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappa B activity	CELL			English	Article							TRANSCRIPTION FACTORS; DROSOPHILA EMBRYO; BHLH PROTEIN; INFLAMMATORY DISEASES; MESODERMAL CELLS; ZYGOTIC GENE; ACTIVATION; CACHEXIA; PATTERN; ENHANCER	During Drosophila embryogenesis, the dorsal transcription factor activates the expression of twist, a transcription factor required for mesoderm formation. We show here that the mammalian twist proteins, twist-1 and -2, are induced by a cytokine signaling pathway that requires the dorsal-related protein RelA, a member of the NF-kappaB family of transcription factors. Twist-1 and -2 repress cytokine gene expression through interaction with RelA. Mice homozygous for a twist-2 null allele or doubly heterozygous for twist-1 and -2 alleles show elevated expression of proinflammatory cytokines, resulting in perinatal death from cachexia. These findings reveal an evolutionarily conserved signaling circuit in which twist proteins regulate cytokine signaling by establishing a negative feedback loop that represses the NF-kappaB-dependent cytokine pathway.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.			Ornitz, David/0000-0003-1592-7629	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039952] Funding Source: NIH RePORTER; NICHD NIH HHS [HD39952] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Castanon I, 2001, DEVELOPMENT, V128, P3145; Charite J, 2001, GENE DEV, V15, P3039, DOI 10.1101/gad.931701; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; DEKOSSODO S, 1995, J INVEST DERMATOL, V104, P318, DOI 10.1111/1523-1747.ep12665361; Fearon KCH, 2002, INT J CARDIOL, V85, P73, DOI 10.1016/S0167-5273(02)00235-8; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; IP TY, 1992, GENE DEV, V6, P1518; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; KHABAR KSA, 1995, IMMUNOL LETT, V46, P107, DOI 10.1016/0165-2478(95)00026-2; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Ling PR, 1996, AM J PHYSIOL-ENDOC M, V270, pE305, DOI 10.1152/ajpendo.1996.270.2.E305; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Misra S, 1998, DEVELOPMENT, V125, P1261; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PAN D, 1992, EMBO J, V11, P1837, DOI 10.1002/j.1460-2075.1992.tb05235.x; Protonotariou E, 1999, EARLY HUM DEV, V56, P31, DOI 10.1016/S0378-3782(99)00029-8; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Sheehan D.C., 1980, THEORY PRACTICE HIST; Shirokawa JM, 1997, MOL CELL BIOL, V17, P3345, DOI 10.1128/MCB.17.6.3345; Sosic D, 1997, DEV BIOL, V185, P229, DOI 10.1006/dbio.1997.8561; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; STJOHNSTON D, 1992, CELL, V68, P201; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; THISSE B, 1987, GENE DEV, V1, P709, DOI 10.1101/gad.1.7.709; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; WURST W, 1993, GENE TARGETING PRACT	43	338	372	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					169	180		10.1016/S0092-8674(03)00002-3	http://dx.doi.org/10.1016/S0092-8674(03)00002-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553906	Bronze			2022-12-24	WOS:000181191600007
J	Hoag, H				Hoag, H			Transgenic salmon still out in the cold in United States	NATURE			English	News Item																		Reichhardt T, 2000, NATURE, V406, P10, DOI 10.1038/35017657	1	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					304	304		10.1038/421304b	http://dx.doi.org/10.1038/421304b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540865	Bronze			2022-12-24	WOS:000180533000010
J	Rolland-Lagan, AG; Bangham, JA; Coen, E				Rolland-Lagan, AG; Bangham, JA; Coen, E			Growth dynamics underlying petal shape and asymmetry	NATURE			English	Article							CELL LINEAGE PATTERNS; LEAF DEVELOPMENT; CLONAL ANALYSIS; TOBACCO; PARAMETERS	Development commonly involves the generation of complex shapes from simpler ones. One way of following this process is to use landmarks to track the fate of particular points in a developing organ(1-7), but this is limited by the time over which it can be monitored. Here we use an alternative method, clonal analysis', whereby dividing cells are genetically marked and their descendants identified visually, to observe the development of Antirrhinum (snapdragon) petals. Clonal analysis has previously been used to estimate growth parameters of leaves(9-11) and Drosophila wings(12-14) but these results were not integrated within a dynamic growth model. Here we develop such a model and use it to show that a key aspect of shape-petal asymmetry-in the petal lobe of Antirrhinum depends on the direction of growth rather than regional differences in growth rate. The direction of growth is maintained parallel to the proximodistal axis of the flower, irrespective of changes in shape, implying that long-range signals orient growth along the petal as a whole. Such signals may provide a general mechanism for orienting growth in other growing structures.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Informat Syst, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk Colney, Norwich NR4 7UH, Norfolk, England.	Enrico.Coen@bbsrc.ac.uk						Almeida J, 1997, DEVELOPMENT, V124, P1387; Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Dolan L, 1998, AM J BOT, V85, P315, DOI 10.2307/2446322; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; Efremova N, 2001, DEVELOPMENT, V128, P2661; ERICKSON RO, 1976, ANNU REV PLANT PHYS, V27, P407, DOI 10.1146/annurev.pp.27.060176.002203; ERICKSON RO, 1966, J EXP BOT, V17, P390, DOI 10.1093/jxb/17.2.390; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1; HARRISON BJ, 1964, HEREDITY, V19, P237, DOI 10.1038/hdy.1964.28; HERNANDEZ LF, 1991, PLANTA, V185, P139, DOI 10.1007/BF00194054; LLOYD CW, 1988, DEVELOPMENT, V102, P211; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; MAKSYMOWYCH R, 1973, DEV CELL BIOL SERIES, V1; Perbal MC, 1996, DEVELOPMENT, V122, P3433; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1987, AM J BOT, V74, P581, DOI 10.2307/2443838; POETHIG RS, 1995, MAYDICA, V40, P67; Resino J, 2002, P NATL ACAD SCI USA, V99, P7502, DOI 10.1073/pnas.072208199; Richards OW, 1943, AM NAT, V77, P385, DOI 10.1086/281140; Sachs T, 1991, PATTERN FORMATION PL; SUBTELNY S, 1978, CLONAL BASIS DEV; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Thompson DW, 1942, GROWTH FORM, V2; TILNEYBASSET RAE, 1986, PLANT CHIMERAS; Vincent CA, 2003, PLANT J, V33, P765, DOI 10.1046/j.1365-313X.2003.01666.x; Vincent CA, 1995, CURR BIOL, V5, P1449, DOI 10.1016/S0960-9822(95)00282-X; WOLF S, 1986, SILICON PROCESSING V, V1, P73	30	123	128	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					161	163		10.1038/nature01443	http://dx.doi.org/10.1038/nature01443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634785				2022-12-24	WOS:000181488900044
J	Karst, SM; Wobus, CE; Lay, M; Davidson, J; Virgin, HW				Karst, SM; Wobus, CE; Lay, M; Davidson, J; Virgin, HW			STAT1-dependent innate immunity to a Norwalk-like virus	SCIENCE			English	Article							MICE; GASTROENTERITIS	Norwalk-like caliciviruses (Noroviruses) cause over 90% of nonbacterial epidemic gastroenteritis worldwide, but the pathogenesis of norovirus infection is poorly understood because these viruses do not grow in cultured cells and there is no small animal model. Here, we report a previously unknown murine norovirus. Analysis of Murine Norovirus 1 infection revealed that signal transducer and activator of transcription 1-dependent innate immunity, but not T and B cell-dependent adaptive immunity, is essential for norovirus resistance. The identification of host molecules essential for murine norovirus resistance may provide targets for prevention or control of an important human disease.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Virgin@immunology.wustl.edu	Lay, Margarita/AAW-6352-2021	Lay, Margarita/0000-0002-4081-7977	NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049286] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA09547] Funding Source: Medline; NIAID NIH HHS [R01 AI49286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; GREEN KY, 2001, FIELDS VIROLOGY, V1, pCH27; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; KARST S, UNPUB; MACMICKING, 1995, CELL, V81, pU17; Matsui SM, 2000, J INFECT DIS, V181, pS331, DOI 10.1086/315587; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Pastorian K, 2000, ANAL BIOCHEM, V283, P89, DOI 10.1006/abio.2000.4622; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TREANOR J, 1995, PRINCIPLES PRACTICE, pCH153; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	19	604	639	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1575	1578		10.1126/science.1077905	http://dx.doi.org/10.1126/science.1077905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624267				2022-12-24	WOS:000181367900038
J	Kondoh, M				Kondoh, M			Foraging adaptation and the relationship between food-web complexity and stability	SCIENCE			English	Article							CAPITA INTERACTION STRENGTH; TEMPORAL VARIATION; RAPID EVOLUTION; COMMUNITIES; RESOLUTION; NETWORKS; STREAM; MODEL; FISH	Ecological theory suggests that complex food webs should not persist because of their inherent instability. "Real" ecosystems often support a large number of interacting species. A mathematical model shows that fluctuating short-term selection on trophic links, arising from a consumer's adaptive food choice, is a key to the long-term stability of complex communities. Without adaptive foragers, food-web complexity destabilizes community composition; whereas in their presence, complexity may enhance community persistence through facilitation of dynamical food-web reconstruction that buffers environmental fluctuations. The model predicts a linkage pattern consistent with field observations.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Kyoto University	Kondoh, M (corresponding author), Cardiff Univ, Cardiff Business Sch, POB 915, Cardiff CF10 3TL, S Glam, Wales.	kondohm@cf.ac.uk	Seman, Norhudah/L-9662-2016; rahim, sharul kamal abdul/I-1584-2014; rahim, sharul kamal abdul/K-6346-2012; Kondoh, Michio/AAE-4332-2019	Seman, Norhudah/0000-0003-3881-271X; rahim, sharul kamal abdul/0000-0003-4511-1989; rahim, sharul kamal abdul/0000-0003-4511-1989; 				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Abrams Peter A., 1996, P113; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Bernays EA, 1999, P ROY SOC B-BIOL SCI, V266, P151, DOI 10.1098/rspb.1999.0615; Chen X, 2001, P ROY SOC B-BIOL SCI, V268, P869, DOI 10.1098/rspb.2001.1596; Chen X, 2001, J THEOR BIOL, V212, P223, DOI 10.1006/jtbi.2001.2370; CLOSS GP, 1994, ECOL MONOGR, V64, P1, DOI 10.2307/2937053; Cohen JE, 1990, COMMUNITY FOOD WEBS; DEANGELIS DL, 1975, ECOLOGY, V56, P238; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Egas M, 2001, ECOL LETT, V4, P190, DOI 10.1046/j.1461-0248.2001.00219.x; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; HUMPHREYS WF, 1979, J ANIM ECOL, V48, P427, DOI 10.2307/4171; Joshi A, 1997, EVOLUTION, V51, P846, DOI 10.1111/j.1558-5646.1997.tb03666.x; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Matsuda H, 1996, EVOL ECOL, V10, P13, DOI 10.1007/BF01239343; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Pimm S.L., 1991, BALANCE NATURE; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis Gary A., 1996, P275; Raffaelli David G., 1996, P185; Robbins C.T., 1983, WILDLIFE FEEDING NUT; SCHOENLY K, 1991, ECOL MONOGR, V61, P267, DOI 10.2307/2937109; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stephens DW, 1987, FORAGING THEORY; TavaresCromar AF, 1996, ECOL MONOGR, V66, P91, DOI 10.2307/2963482; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2	34	431	447	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1388	1391		10.1126/science.1079154	http://dx.doi.org/10.1126/science.1079154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610303				2022-12-24	WOS:000181192300050
J	Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; Madrigal, JA				Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; Madrigal, JA			MHC typing in variant Creutzfeldt-Jakob disease	LANCET			English	Article								Identification of factors that cause susceptibility to, and clinical expression of, variant Creutzfeldt-Jakob disease (vCJD) is essential for future management of the disease. We established MHC genotypes of 76 individuals with vCJD and 131 controls, and analysed MHC phenotypes in relation to age of onset of vCJD and its duration from presentation to death. There were no significant differences between vCJD and control populations in frequencies of any MHC types, nor were there associations between MHC type and age of onset or duration of vCJD disease. Our results do not support the idea of an association between MHC types and either susceptibility to, or expression of, vCJD.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England; Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh, Midlothian, Scotland; UCL Royal Free Hosp, Anthony Nolan Res Inst & Histocompatibil Labs, London NW3 2QG, England	University of London; University College London; UCL Medical School; University of Edinburgh; University of London; University College London	Pepys, MB (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, Rowland Hill St, London NW3 2PF, England.	m.pepys@rfc.ucl.ac.uk		Madrigal, Alejandro/0000-0001-8359-9917				Arguello JR, 1998, BONE MARROW TRANSPL, V22, P527, DOI 10.1038/sj.bmt.1701383; Arguello JR, 1998, NAT GENET, V18, P192, DOI 10.1038/ng0298-192; Jackson GS, 2001, NATURE, V414, P269, DOI 10.1038/35104694; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; McDermott AB, 1997, TISSUE ANTIGENS, V50, P8, DOI 10.1111/j.1399-0039.1997.tb02827.x	5	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					487	489		10.1016/S0140-6736(03)12455-5	http://dx.doi.org/10.1016/S0140-6736(03)12455-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583949				2022-12-24	WOS:000180900600014
J	Mackey, D; Belkhadir, Y; Alonso, JM; Ecker, JR; Dangl, JL				Mackey, D; Belkhadir, Y; Alonso, JM; Ecker, JR; Dangl, JL			Arabidopsis RIN4 is a target of the type III virulence effector AvrRpt2 and modulates RPS2-mediated resistance	CELL			English	Article							NUCLEOTIDE-BINDING SITE; SYRINGAE PV. TOMATO; DISEASE-RESISTANCE; GENE-PRODUCT; SECRETION SYSTEM; AVIRULENCE GENE; PLANT-PATHOGENS; BACTERIAL; PROTEIN; THALIANA	Type III pili deliver effector proteins (virulence factors) from bacterial pathogens to host cells. Plants express disease resistance (R) proteins that respond specifically to a particular type III effector by activating immune responses. We demonstrated previously that two unrelated type III effectors from Pseudomonas syringae target and modify the Arabidopsis RIN4 protein. Here, we show that AvrRpt2, a third, unrelated type III effector, also targets RIN4 and induces its post-transcriptional disappearance. This effect is independent of the presence of RPS2, the Arabidopsis R protein that senses AvrRpt2. RIN4 overexpression inhibits multiple phenotypes associated with AvrRpt2 function. Conversely, disruption of RIN4 results in RPS2-dependent lethality. RPS2 and RIN4 physically associate in the plant. We suggest that RIN4 is the target of the AvrRpt2 virulence function, and that perturbation of RIN4 activates RPS2. Thus, RIN4 is a point of convergence for the activity of at least three unrelated P. syringae type III effectors.	Univ N Carolina, Curriculum Genet, Dept Biol, Chapel Hill, NC 27599 USA; Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; Univ N Carolina, Curriculum Genet, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; Salk Institute	Dangl, JL (corresponding author), Univ N Carolina, Curriculum Genet, Dept Biol, Coker Hall CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Belkhadir, Youssef/GXM-6743-2022; Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; Belkhadir, Youssef/0000-0001-7149-7139				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Chang JH, 2000, MOL PLANT MICROBE IN, V13, P568, DOI 10.1094/MPMI.2000.13.5.568; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lawrence G, 1995, TRENDS MICROBIOL, V3, P475, DOI 10.1016/S0966-842X(00)89014-9; LAWRENCE GJ, 1981, PHYTOPATHOLOGY, V71, P12, DOI 10.1094/Phyto-71-12; Leister RT, 2000, PLANT J, V22, P345, DOI 10.1046/j.1365-313x.2000.00744.x; LORANG JM, 1994, MOL PLANT MICROBE IN, V7, P508, DOI 10.1094/MPMI-7-0508; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2001, CURR OPIN PLANT BIOL, V4, P288, DOI 10.1016/S1369-5266(00)00175-8; Oldroyd GED, 1998, P NATL ACAD SCI USA, V95, P10300, DOI 10.1073/pnas.95.17.10300; ORLANDI EW, 1992, PHYSIOL MOL PLANT P, V40, P173, DOI 10.1016/0885-5765(92)90058-4; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Schneider DS, 2002, CELL, V109, P537, DOI 10.1016/S0092-8674(02)00764-X; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439	45	707	738	2	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					379	389		10.1016/S0092-8674(03)00040-0	http://dx.doi.org/10.1016/S0092-8674(03)00040-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581527	Bronze			2022-12-24	WOS:000181252200009
J	Wetzel, MS; Kaptchuk, TJ; Haramati, A; Eisenberg, DM				Wetzel, MS; Kaptchuk, TJ; Haramati, A; Eisenberg, DM			Complementary and alternative medical therapies: Implications for medical education	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; JOHNS WORT; SCHOOLS; TRENDS; CARE	Increased use of complementary and alternative medicine (CAM) has made it imperative that these topics be included in medical education from the preclinical years through residency and beyond. There has been progress in this direction in recent years, with a steady increase in the number of medical schools that include CAM therapies in their curricula. There remains, however, a lack of clear goals and concrete suggestions for implementing these changes. This article examines the questions that arise when medical educators consider how to incorporate CAM therapies as an integral part of the medical curriculum. It offers practical suggestions for finding time in an already packed curriculum, getting started, including faculty and students in the process, and sustaining the initiative with the necessary administrative and institutional support.	Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Georgetown Univ, Sch Med, Washington, DC 20057 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Georgetown University	Wetzel, MS (corresponding author), Harvard Univ, Sch Med, 10 Shattuck St,Suite 612, Boston, MA 02115 USA.		Haramati, Aviad/ABB-1587-2020		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR 43441] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM ASS MED COLL, 1998, LEARN OBJ MED STUD E, V6, P8; *AM MED ASS COUNC, 1997, ENC MED STUD ED COMP; Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Barzansky B, 2000, JAMA-J AM MED ASSOC, V284, P1114, DOI 10.1001/jama.284.9.1114; Berman BM, 2001, BRIT MED J, V322, P121, DOI 10.1136/bmj.322.7279.121; Carlston M, 1997, Fam Med, V29, P559; Caspi O, 2000, ARCH INTERN MED, V160, P3193, DOI 10.1001/archinte.160.21.3193; Coulter I, 1998, ALTERN THER HEALTH M, V4, P64; DESAINTONGE DMC, 1994, LANCET, V344, P995, DOI 10.1016/S0140-6736(94)91647-0; Eisenberg DM, 1997, ANN INTERN MED, V127, P61, DOI 10.7326/0003-4819-127-1-199707010-00010; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; Frenkel M, 2001, ACAD MED, V76, P251, DOI 10.1097/00001888-200103000-00012; *HARV MED SCH CTR, 2000, WOM HLTH 10 CURR THE, V2, P1; *HARV MED SCH OFF, 2000, NEW HMS DIV PROB COM; JENSEN CB, 1997, ALTERN COMPLEMENT TH, V3, P276; Kligler B, 2000, FAM MED, V32, P30; Laken M P, 1995, J Altern Complement Med, V1, P93, DOI 10.1089/acm.1995.1.93; Marshall E, 2000, SCIENCE, V288, P1571, DOI 10.1126/science.288.5471.1571; MUEHSAM PA, 2000, GEA CORRESPONDENT, V13, P8; MUEHSAM PA, 1999, GEA CORRESPONDENT, V12, P13; *NAT CTR COMPL ALT, 1999, REQ PROP CAM ED GRAN; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; OH VMS, 1994, BRIT MED J, V309, P69, DOI 10.1136/bmj.309.6947.69; Pelletier KR, 1999, AM J HEALTH PROMOT, V14, P125, DOI 10.4278/0890-1171-14.2.125; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; Ruschitzka F, 2000, LANCET, V355, P548, DOI 10.1016/S0140-6736(99)05467-7; SLOAN DA, 1995, ANN SURG, V222, P735, DOI 10.1097/00000658-199512000-00007; Wetzel MS, 1998, JAMA-J AM MED ASSOC, V280, P784, DOI 10.1001/jama.280.9.784	30	106	109	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					191	196		10.7326/0003-4819-138-3-200302040-00011	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558358				2022-12-24	WOS:000181018600005
J	Wang, JW; Wong, AM; Flores, J; Vosshall, LB; Axel, R				Wang, JW; Wong, AM; Flores, J; Vosshall, LB; Axel, R			Two-photon calcium imaging reveals an odor-evoked map of activity in the fly brain	CELL			English	Article							RAT OLFACTORY-BULB; ANTENNAL LOBE; DROSOPHILA-MELANOGASTER; PYRAMIDAL NEURONS; DENDRITIC SPINES; REPRESENTATIONS; RECEPTORS; ORGANIZATION; INFORMATION; EXPRESSION	An understanding of the logic of odor perception requires a functional analysis of odor-evoked patterns of activity in neural assemblies in the brain. We have developed a sensitive imaging system in the Drosophila brain that couples two-photon microscopy with the specific expression of the calcium-sensitive fluorescent protein, G-CaMP. At natural odor concentration, each odor elicits a distinct and sparse spatial pattern of activity in the antennal lobe that is conserved in different flies. Patterns of glomerular activity are similar upon imaging of sensory and projection neurons, suggesting the faithful transmission of sensory input to higher brain centers. Finally, we demonstrate that the response pattern of a given glomerulus is a function of the specificity of a single odorant receptor. The development of this imaging system affords an opportunity to monitor activity in defined neurons throughout the fly brain with high sensitivity and excellent spatial resolution.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA	Columbia University; Rockefeller University	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.		Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Vosshall, Leslie/0000-0002-6060-8099; Axel, Richard/0000-0002-3141-4076	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 50733] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Delaney K, 2001, EUR J NEUROSCI, V13, P1658, DOI 10.1046/j.1460-9568.2001.01545.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DETHIER VG, 1952, J GEN PHYSIOL, V35, P823, DOI 10.1085/jgp.35.6.823; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LAURENT G, 1994, J NEUROSCI, V14, P2993; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Meister M, 2001, J NEUROSCI, V21, P1351; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SINGLETON K, 1994, DEV BIOL, V161, P154, DOI 10.1006/dbio.1994.1017; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wang JW, 2001, J NEUROPHYSIOL, V85, P977, DOI 10.1152/jn.2001.85.2.977; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	56	598	612	5	87	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					271	282		10.1016/S0092-8674(03)00004-7	http://dx.doi.org/10.1016/S0092-8674(03)00004-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553914	Bronze			2022-12-24	WOS:000181191600015
J	Sanchez, I; Mahlke, C; Yuan, JY				Sanchez, I; Mahlke, C; Yuan, JY			Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders	NATURE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE; PROTEIN AGGREGATION; TERMINAL FRAGMENTS; MUTANT HUNTINGTIN; HEAT-SHOCK; CAG REPEAT; CONGO RED; TOXICITY; INHIBITION	The expansion of a CAG repeat coding for polyglutamine in otherwise unrelated gene products is central to eight neurodegenerative disorders including Huntington's disease(1). It has been well documented that expanded polyglutamine fragments, cleaved from their respective full-length proteins, form microscopically visible aggregates in affected individuals and in transgenic mice(2-7). The contribution of polyglutamine oligomers to neurodegeneration, however, is controversial. The azo-dye Congo red binds preferentially to beta-sheets containing amyloid fibrils(8,9) and can specifically inhibit oligomerization(10) and disrupt preformed oligomers. Here we show that inhibition of polyglutamine oligomerization by Congo red prevents ATP depletion and caspase activation, preserves normal cellular protein synthesis and degradation functions, and promotes the clearance of expanded polyglutamine repeats in vivo and in vitro. Infusion of Congo red into a transgenic mouse model of Huntington's disease, well after the onset of symptoms, promotes the clearance of expanded repeats in vivo and exerts marked protective effects on survival, weight loss and motor function. We conclude that oligomerization is a crucial determinant in the biochemical properties of expanded polyglutamine that are central to their chronic cytotoxicity.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sanchez, I (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 715 Albany St, Boston, MA 02118 USA.		Sanchez, Ivelisse/E-3856-2010; Sánchez, Ivelisse/H-8765-2013	Sanchez, Ivelisse/0000-0002-7605-5337; Sánchez, Ivelisse/0000-0002-7605-5337				BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; Carter RJ, 1999, J NEUROSCI, V19, P3248; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chai YH, 1999, J NEUROSCI, V19, P10338; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; FARRER LA, 1985, CLIN GENET, V27, P62; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Howlett DR, 1999, BIOCHEM J, V343, P419, DOI 10.1042/0264-6021:3430419; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; KLUNK WE, 1995, NEUROBIOL AGING, V16, P541, DOI 10.1016/0197-4580(95)00058-M; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Moulder KL, 1999, J NEUROSCI, V19, P705; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898	30	392	404	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					373	379		10.1038/nature01301	http://dx.doi.org/10.1038/nature01301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540902				2022-12-24	WOS:000180533000043
J	Wang, X; Willenbring, H; Akkari, Y; Torimaru, Y; Foster, M; Al-Dhalimy, M; Lagasse, E; Finegold, M; Olson, S; Grompe, M				Wang, X; Willenbring, H; Akkari, Y; Torimaru, Y; Foster, M; Al-Dhalimy, M; Lagasse, E; Finegold, M; Olson, S; Grompe, M			Cell fusion is the principal source of bone-marrow-derived hepatocytes	NATURE			English	Article							FUMARYLACETOACETATE HYDROLASE; HEPATIC-DYSFUNCTION; GENE-THERAPY; MURINE MODEL; STEM-CELLS; LIVER; MICE; REPOPULATION; PHENOTYPE; VIVO	Evidence suggests that haematopoietic stem cells might have unexpected developmental plasticity, highlighting therapeutic potential. For example, bone-marrow-derived hepatocytes can repopulate the liver of mice with fumarylacetoacetate hydrolase deficiency and correct their liver disease(1). To determine the underlying mechanism in this murine model, we performed serial transplantation of bone-marrow-derived hepatocytes. Here we show by Southern blot analysis that the repopulating hepatocytes in the liver were heterozygous for alleles unique to the donor marrow, in contrast to the original homozygous donor cells. Furthermore, cytogenetic analysis of hepatocytes transplanted from female donor mice into male recipients demonstrated 80,XXXY (diploid to diploid fusion) and 120,XXXXYY (diploid to tetraploid fusion) karyotypes, indicative of fusion between donor and host cells. We conclude that hepatocytes derived form bone marrow arise from cell fusion and not by differentiation of haematopoietic stem cells.	Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; Stem Cells Inc, Palo Alto, CA 94304 USA; Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Oregon Health & Science University; Baylor College of Medicine	Grompe, M (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.	grompem@ohsu.edu		Grompe, Markus/0000-0002-6616-4345				Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; FAKTOR VM, 1975, TSITOLOGIYA+, V17, P909; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LABELLE Y, 1993, BIOCHIM BIOPHYS ACTA, V1180, P250, DOI 10.1016/0925-4439(93)90046-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MARTIN G M, 1970, Experimental Cell Research, V63, P466, DOI 10.1016/0014-4827(70)90241-7; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Overturf K, 1998, HUM GENE THER, V9, P295, DOI 10.1089/hum.1998.9.3-295; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; Overturf K, 1997, AM J PATHOL, V151, P1273; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PEREIRA RF, 1997, SCIENCE, V276, P71; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pira GL, 1998, HUM IMMUNOL, V59, P137, DOI 10.1016/S0198-8859(98)00004-4; Sambrook JFE, 1989, MOL CLONING LAB MANU; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Whitney MA, 1996, BLOOD, V88, P49; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	30	1243	1364	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					897	901		10.1038/nature01531	http://dx.doi.org/10.1038/nature01531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12665832				2022-12-24	WOS:000182432600056
J	Salzman, NH; Ghosh, D; Huttner, KM; Paterson, Y; Bevins, CL				Salzman, NH; Ghosh, D; Huttner, KM; Paterson, Y; Bevins, CL			Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin	NATURE			English	Article							INNATE HOST-DEFENSE; PANETH CELL; ANTIMICROBIAL PEPTIDE; EPITHELIAL-CELLS; ALPHA-DEFENSINS; GENE; LOCALIZATION; MACROPHAGES; SECRETION; GROWTH	Genetically encoded antibiotic peptides are evolutionarily ancient and widespread effector molecules of immune defence(1-3). Mammalian defensins, one subset of such peptides, have been implicated in the antimicrobial defence capacity of phagocytic leukocytes and various epithelial cells(4), but direct evidence of the magnitude of their in vivo effects have not been clearly demonstrated. Paneth cells, specialized epithelia of the small intestinal crypt, secrete abundant alpha-defensins and other antimicrobial polypeptides(5,6) including human defensin 5 (HD-5; also known as DEFA5)(7-9). Although antibiotic activity of HD-5 has been demonstrated in vitro(9,10), functional studies of HD-5 biology have been limited by the lack of in vivo models. To study the in vivo role of HD-5, we developed a transgenic mouse model using a 2.9-kilobase HD-5 minigene containing two HD-5 exons and 1.4 kilobases of 5'-flanking sequence. Here we show that HD-5 expression in these mice is specific to Paneth cells and reflects endogenous enteric defensin gene expression. The storage and processing of transgenic HD-5 also matches that observed in humans. HD-5 transgenic mice were markedly resistant to oral challenge with virulent Salmonella typhimurium. These findings provide support for a critical in vivo role of epithelial-derived defensins in mammalian host defence.	Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; Med Coll Wisconsin, Dept Pediat, Div Gastroenterol, Milwaukee, WI 53226 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Neonatol, Boston, MA 02114 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; Medical College of Wisconsin; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bevins, CL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bevinsc@ccf.org	Bevins, Charles L/P-4438-2015	Bevins, Charles L/0000-0003-2725-2622; Paterson, Yvonne/0000-0002-9406-4958; Salzman, Nita/0000-0003-0939-6139	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001525] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI001525-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Bevins CL, 1996, GENOMICS, V31, P95, DOI 10.1006/geno.1996.0014; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Cole AM, 2000, BIOTECHNIQUES, V29, P822, DOI 10.2144/00294rv01; COUTO MA, 1994, INFECT IMMUN, V62, P2375, DOI 10.1128/IAI.62.6.2375-2378.1994; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Darmoul D, 1996, AM J PHYSIOL-GASTR L, V271, pG68, DOI 10.1152/ajpgi.1996.271.1.G68; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; HARPER ME, 1982, AM J HUM GENET, V34, P227; IWABUCHI Y, 1994, ARCH INT PHARMACOD T, V328, P315; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kisich KO, 2001, INFECT IMMUN, V69, P2692, DOI 10.1128/IAI.69.4.2692-2699.2001; LEHRER RI, 1998, MUCOSAL IMMUNOLOGY, P89; Mallow EB, 1996, J BIOL CHEM, V271, P4038; Meister M, 2000, CURR TOP MICROBIOL, V248, P17; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; OUELLETTE AJ, 1999, DEV GASTROINTESTINAL, P147; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; SATOH Y, 1995, GASTROENTEROLOGY, V108, P1345, DOI 10.1016/0016-5085(95)90681-9; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Wang MSC, 1997, ANAL BIOCHEM, V253, P225, DOI 10.1006/abio.1997.2347; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	30	584	618	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					522	526		10.1038/nature01520	http://dx.doi.org/10.1038/nature01520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12660734				2022-12-24	WOS:000181965400038
J	La Scola, B; Audic, S; Robert, C; Jungang, L; de Lamballerie, X; Drancourt, M; Birtles, R; Claverie, JM; Raoult, D				La Scola, B; Audic, S; Robert, C; Jungang, L; de Lamballerie, X; Drancourt, M; Birtles, R; Claverie, JM; Raoult, D			A giant virus in amoebae	SCIENCE			English	Article									CNRS, UPR 2589, Struct & Genom Informat Lab, Marseille, France; Univ Mediterranee, CNRS, UMR 6020, Unite Rickettsies, F-13385 Marseille, France; Univ Mediterranee, UVE, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Claverie, JM (corresponding author), CNRS, UPR 2589, Struct & Genom Informat Lab, Marseille, France.		RAOULT, Didier/A-8434-2008; Claverie, Jean-Michel/AAG-4889-2019; LA SCOLA, Bernard/P-6477-2016; Claverie, Jean Michel/Z-2183-2019	RAOULT, Didier/0000-0002-0633-5974; Claverie, Jean-Michel/0000-0003-1424-0315; LA SCOLA, Bernard/0000-0001-8006-7704; Audic, Stephane/0000-0001-6193-4374; Birtles, Richard/0000-0002-4216-5044				Birtles RJ, 1997, LANCET, V349, P925, DOI 10.1016/S0140-6736(05)62701-8; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; HUTSON MS, 1995, BIOPOLYMERS, V35, P297, DOI 10.1002/bip.360350305; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Sandaa RA, 2001, VIROLOGY, V290, P272, DOI 10.1006/viro.2001.1161; van Regenmortel M.H.V., 2000, VIRUS TAXONOMY 7 REP	6	563	580	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2033	2033						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663918				2022-12-24	WOS:000181834200044
J	Paulsen, IT; Banerjei, L; Myers, GSA; Nelson, KE; Seshadri, R; Read, TD; Fouts, DE; Eisen, JA; Gill, SR; Heidelberg, JF; Tettelin, H; Dodson, RJ; Umayam, L; Brinkac, L; Beanan, M; Daugherty, S; DeBoy, RT; Durkin, S; Kolonay, J; Madupu, R; Nelson, W; Vamathevan, J; Tran, B; Upton, J; Hansen, T; Shetty, J; Khouri, H; Utterback, T; Radune, D; Ketchum, KA; Dougherty, BA; Fraser, CM				Paulsen, IT; Banerjei, L; Myers, GSA; Nelson, KE; Seshadri, R; Read, TD; Fouts, DE; Eisen, JA; Gill, SR; Heidelberg, JF; Tettelin, H; Dodson, RJ; Umayam, L; Brinkac, L; Beanan, M; Daugherty, S; DeBoy, RT; Durkin, S; Kolonay, J; Madupu, R; Nelson, W; Vamathevan, J; Tran, B; Upton, J; Hansen, T; Shetty, J; Khouri, H; Utterback, T; Radune, D; Ketchum, KA; Dougherty, BA; Fraser, CM			Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis	SCIENCE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PLASMID PAD1; VIRULENCE; PRECURSORS; TOLERANCE	The complete genome sequence of Enterococcusfaecalis V583, a vancomycin-resistant clinical isolate, revealed that more than a quarter of the genome consists of probable mobile or foreign DNA. One of the predicted mobile elements is a previously unknown vanB vancomycin-resistance conjugative transposon. Three plasmids were identified, including two pheromone-sensing conjugative plasmids, one encoding a previously undescribed pheromone inhibitor. The apparent propensity for the incorporation of mobile elements probably contributed to the rapid acquisition and dissemination of drug resistance in the enterococci.	Inst Genom Res, Rockville, MD 20850 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; George Washington Univ, Sch Med, Dept Pharmacol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Microbiol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Trop Med, Washington, DC 20037 USA	J. Craig Venter Institute; Johns Hopkins University; George Washington University; George Washington University; George Washington University	Paulsen, IT (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Eisen, Jonathan A./H-2706-2019; Nelson, William C/E-9263-2016; Read, Timothy/E-6240-2011; Paulsen, Ian T/K-3832-2012; Myers, Garry/E-7708-2011	Eisen, Jonathan A./0000-0002-0159-2197; Nelson, William C/0000-0002-1873-3929; Paulsen, Ian T/0000-0001-9015-9418; Vamathevan, Jessica/0000-0003-2016-9754; Heidelberg, John/0000-0003-0673-3224; Myers, Garry/0000-0002-4756-4810; Read, Timothy/0000-0001-8966-9680; Fraser, Claire/0000-0003-1462-2428	NIAID NIH HHS [AI40963-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040963] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARTHUR M, 1992, ANTIMICROB AGENTS CH, V36, P867, DOI 10.1128/AAC.36.4.867; Bensing BA, 2001, INFECT IMMUN, V69, P6186, DOI 10.1128/IAI.69.10.6186-6192.2001; Clewell DB, 2000, MOL MICROBIOL, V35, P246, DOI 10.1046/j.1365-2958.2000.01687.x; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Francia MV, 2001, PLASMID, V46, P117, DOI 10.1006/plas.2001.1533; Garnier F, 2000, MICROBIOL-UK, V146, P1481, DOI 10.1099/00221287-146-6-1481; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; Klare I, 2001, Contrib Microbiol, V8, P108; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; PONTIUS LT, 1991, PLASMID, V26, P172, DOI 10.1016/0147-619X(91)90041-T; Robertson GT, 2002, J BACTERIOL, V184, P6987, DOI 10.1128/JB.184.24.6987-7000.2002; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Sussmuth SD, 2000, INFECT IMMUN, V68, P4900; TAILOR SAN, 1993, ANN PHARMACOTHER, V27, P1231, DOI 10.1177/106002809302701014; WELLS CL, 1990, J INFECT DIS, V162, P82, DOI 10.1093/infdis/162.1.82; [No title captured]	18	700	1206	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2071	2074		10.1126/science.1080613	http://dx.doi.org/10.1126/science.1080613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663927				2022-12-24	WOS:000181834200056
J	Foreman, J; Demidchik, V; Bothwell, JHF; Mylona, P; Miedema, H; Torres, MA; Linstead, P; Costa, S; Brownlee, C; Jones, JDG; Davies, JM; Dolan, L				Foreman, J; Demidchik, V; Bothwell, JHF; Mylona, P; Miedema, H; Torres, MA; Linstead, P; Costa, S; Brownlee, C; Jones, JDG; Davies, JM; Dolan, L			Reactive oxygen species produced by NADPH oxidase regulate plant cell growth	NATURE			English	Article							ROOT HAIRS; CALCIUM-CHANNELS; ARABIDOPSIS; CA2+; GENERATION; HOMOLOGS; DEFENSE; PROTEIN; TIP	Cell expansion is a central process in plant morphogenesis, and the elongation of roots and root hairs is essential for uptake of minerals and water from the soil. Ca2+ influx from the extracellular store is required for ( and sets the rates of) cell elongation in roots(1). Arabidopsis thaliana rhd2 mutants are defective in Ca2+ uptake and consequently cell expansion is compromised rhd2 mutants have short root hairs(2,3) and stunted roots. To determine the regulation of Ca2+ acquisition in growing root cells we show here that RHD2 is an NADPH oxidase, a protein that transfers electrons from NADPH to an electron acceptor leading to the formation of reactive oxygen species (ROS). We show that ROS accumulate in growing wild-type (WT) root hairs but their levels are markedly decreased in rhd2 mutants. Blocking the activity of the NADPH oxidase with diphenylene iodonium (DPI) inhibits ROS formation and phenocopies Rhd2(-). Treatment of rhd2 roots with ROS partly suppresses the mutant phenotype and stimulates the activity of plasma membrane hyperpolarization-activated Ca2+ channels, the predominant root Ca2+ acquisition system. This indicates that NADPH oxidases control development by making ROS that regulate plant cell expansion through the activation of Ca2+ channels.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Marine Biol Assoc UK, Plymouth PL1 2PB, Devon, England; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Cambridge; Marine Biological Association United Kingdom; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Demidchik, Vadim/N-9314-2019; Jones, Jonathan DG/J-5129-2012; Lacruz, Miguel Angel Torres/H-6969-2015	Demidchik, Vadim/0000-0003-3765-8386; Jones, Jonathan DG/0000-0002-4953-261X; Lacruz, Miguel Angel Torres/0000-0002-0435-1786; Bothwell, John/0000-0003-2964-5980; Dolan, Liam/0000-0003-1206-7096; Costa, Silvia/0000-0001-9931-3493	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000168] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bolwell GP, 1997, PHYSIOL MOL PLANT P, V51, P347, DOI 10.1006/pmpp.1997.0129; Carroll AD, 1998, PLANT CELL, V10, P1267, DOI 10.1105/tpc.10.8.1267; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cramer GR, 1996, PLANT CELL ENVIRON, V19, P1291, DOI 10.1111/j.1365-3040.1996.tb00007.x; Demidchik V, 2002, PLANT J, V32, P799, DOI 10.1046/j.1365-313X.2002.01467.x; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Felle HH, 1997, PLANT PHYSIOL, V114, P39, DOI 10.1104/pp.114.1.39; Fry SC, 1998, BIOCHEM J, V332, P507, DOI 10.1042/bj3320507; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kiegle E, 2000, PLANT J, V21, P225, DOI 10.1046/j.1365-313x.2000.00659.x; KISS T, 1994, PHARMACOL REV, V46, P245; Miedema H, 2001, TRENDS PLANT SCI, V6, P514, DOI 10.1016/S1360-1385(01)02124-0; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235, DOI 10.1105/tpc.2.3.235; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Very AA, 2000, P NATL ACAD SCI USA, V97, P9801, DOI 10.1073/pnas.160250397; WILLIAMS AJ, 1981, THORAX, V36, P866, DOI 10.1136/thx.36.11.866; Wymer CL, 1997, PLANT J, V12, P427, DOI 10.1046/j.1365-313X.1997.12020427.x; Zhang WH, 1998, PLANT J, V15, P147, DOI 10.1046/j.1365-313X.1998.00188.x	29	1609	1738	21	430	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 27	2003	422	6930					442	446		10.1038/nature01485	http://dx.doi.org/10.1038/nature01485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660786				2022-12-24	WOS:000181801200047
J	Schwab, JM; Schluesener, HJ; Laufer, S				Schwab, JM; Schluesener, HJ; Laufer, S			COX-3: just another COX or the solitary elusive target of paracetamol?	LANCET			English	Editorial Material							EXPRESSION; TRANSCRIPT; MICE		Sch Med, Inst Brain Res, D-72076 Tubingen, Germany; Univ Tubingen, Inst Pharm, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schwab, JM (corresponding author), Sch Med, Inst Brain Res, D-72076 Tubingen, Germany.			Schwab, Jan/0000-0001-6784-4919; Laufer, Stefan/0000-0001-6952-1486				Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Botting RM, 2000, CLIN INFECT DIS, V31, pS202, DOI 10.1086/317520; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Hla T, 1996, PROSTAG OTH LIPID M, V51, P81, DOI 10.1016/0090-6980(95)00158-1; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Laulederkind SJF, 2002, LAB INVEST, V82, P919, DOI 10.1097/01.LAB.0000020407.98665.98; Mazario J, 2001, NEUROPHARMACOLOGY, V40, P937, DOI 10.1016/S0028-3908(01)00020-X; Plant MH, 1999, BIOCHEM J, V344, P677, DOI 10.1042/0264-6021:3440677; VANE JR, 1971, NATURE, V23, P232; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; Willoughby DA, 2000, LANCET, V355, P646, DOI 10.1016/S0140-6736(99)12031-2	12	68	74	0	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 22	2003	361	9362					981	982		10.1016/S0140-6736(03)12841-3	http://dx.doi.org/10.1016/S0140-6736(03)12841-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658AP	12660052				2022-12-24	WOS:000181699700005
J	Fassin, D; Schneider, H				Fassin, D; Schneider, H			The politics of AIDS in South Africa: beyond the controversies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VIOLENCE	At the beginning of 2000 Thabo Mbeki sent a letter to world leaders expressing his doubt that HIV was the exclusive cause of AIDS and arguing for a consideration of socioeconomic causes. He subsequently invited scientists who shared his view to sit with orthodox experts on AIDS on a presidential panel to advise him on appropriate responses to the epidemic in South Africa. Until April 2002, when Mbeki formally distanced himself from the AIDS "dissidents," the international scientific community's interest in South African policies on AIDS was almost exclusively focused on the polemic raised by the president. His statements questioning the AIDS statistics, on poverty as a cause of immune deficiency, and on the dangers of antiretrovirals, together with government stalling on the roll out of nevirapine to prevent transmission of HIV from pregnant mothers to their babies, dominated the debate.(1-3) However, the July 2002 Constitutional Court judgment ordering the government to make nevirapine universally available to pregnant women infected with HIV, followed in October by a cabinet statement supporting wider access to antiretrovirals, may have finally ushered in a new era. It should now be possible to discuss the reality of AIDS in South Africa without reducing the argument to simple dualisms (such as being for or against a viral cause of AIDS, for or against the president). We propose an approach to discussing AIDS in South Africa that is rooted in political economy and political anthropology. Such an approach will shed light not only on the objective determinants of the epidemic, especially social inequalities, but also on subjective responses, such as those of Mbeki.	Univ Paris 13, INSERM, Ctr Rech Enjeux Contemporains Sante Publ, F-93017 Bobigny, France; Univ Witwatersrand, Sch Publ Hlth, Ctr Hlth Policy, ZA-2000 Johannesburg, South Africa	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; University of Witwatersrand	Fassin, D (corresponding author), Univ Paris 13, INSERM, Ctr Rech Enjeux Contemporains Sante Publ, 74 Rue Marcel Cachin, F-93017 Bobigny, France.	dfassin@ehess.fr						Bloom SS, 2002, SEX TRANSM INFECT, V78, P261, DOI 10.1136/sti.78.4.261; Campbell C, 1997, SOC SCI MED, V45, P273, DOI 10.1016/S0277-9536(96)00343-7; Cottereau Alain., 1999, EXPERIENCE DENI, P159; *DEP HLTH, 2000, NAT HIV SYPH SER PRE; Dorrington R. E., 2001, IMPACT HIV AIDS ADUL; Farmer P., 1999, INFECT INEQUALITIES; Farmer Paul, 1992, AIDS ACCUSATION HAIT; FASSIN D., 2002, TEMPS MODERNES, V620, P429; Fassin Didier, 2002, Afr J AIDS Res, V1, P63, DOI 10.2989/16085906.2002.9626545; GOULD C, 2000, SUNDAY INDEPEND 1008, P7; JOHNSON L, 2002, HIV RISK FACTORS REV; Lurie M, 2000, S AFR J SCI, V96, P343; Makgoba MW, 2000, SCIENCE, V288, P1171, DOI 10.1126/science.288.5469.1171; Packard Randall M., 1990, WHITE PLAGUE BLACK L; Schneider H, 2002, AIDS, V16, pS45, DOI 10.1097/00002030-200216004-00007; Schneider H, 2002, AFRICAN STUDIES, V61, P145, DOI DOI 10.1080/00020180220140118; Seidman G, 1999, ANNU REV SOCIOL, V25, P419, DOI 10.1146/annurev.soc.25.1.419; Sidley, 2000, BMJ, V320, P1016, DOI 10.1136/bmj.320.7240.1016; SWANSON MW, 1977, J AFR HIST, V18, P387, DOI 10.1017/S0021853700027328; Taylor Charles, 1992, POLITICS RECOGNITION; van der Vliet V, 2001, DAEDALUS, V130, P151; WILLIAMS BG, 2000, NATURAL HIST HIV AID; Wojcicki JM, 2002, MED ANTHROPOL Q, V16, P267, DOI 10.1525/maq.2002.16.3.267; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4	24	82	83	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2003	326	7387					495	497		10.1136/bmj.326.7387.495	http://dx.doi.org/10.1136/bmj.326.7387.495			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653EC	12609950	Green Published			2022-12-24	WOS:000181421400026
J	James, LC; Roversi, P; Tawfik, DS				James, LC; Roversi, P; Tawfik, DS			Antibody multispecificity mediated by conformational diversity	SCIENCE			English	Article							PEPTIDE LIBRARIES; MOLECULAR-BASIS; ANTIGEN; BINDING; SITE; TRANSITION; CATALYSIS; INSIGHTS; LIGANDS; MIMICRY	A single antibody was shown to adopt different binding-site conformations and thereby bind unrelated antigens. Analysis by both x-ray crystallography and pre-steady-state kinetics revealed an equilibrium between different preexisting isomers, one of which possessed a promiscuous, low-affinity binding site for aromatic ligands, including the immunizing hapten. A subsequent induced-fit isomerization led to high-affinity complexes with a deep and narrow binding site. A protein antigen identified by repertoire selection made use of an unrelated antibody isomer with a wide, shallow binding site. Conformational diversity, whereby one sequence adopts multiple structures and multiple functions, can increase the effective size of the antibody repertoire but may also lead to autoimmunity and allergy.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; MRC, Ctr Prot Engn, Cambridge CB2 2HQ, England; Global Phasing Ltd, Cambridge, England	Weizmann Institute of Science; University of Cambridge; Global Phasing Limited	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	Roversi, Pietro/AAK-4241-2021; Roversi, Pietro/F-8925-2011	Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437				AREVALO JH, 1994, J MOL BIOL, V241, P663, DOI 10.1006/jmbi.1994.1543; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; CHRISTIAN RB, 1992, J MOL BIOL, V227, P711, DOI 10.1016/0022-2836(92)90219-A; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; EHRLICH P, 1901, BERL KLIN WOCHENSCHR, V38, P569; ESHHAR Z, 1980, J IMMUNOL, V124, P775; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Hitchens TK, 2001, BIOCHEMISTRY-US, V40, P11660, DOI 10.1021/bi010909+; JAMES L, UNPUB; Joyce GF, 1997, SCIENCE, V276, P1658, DOI 10.1126/science.276.5319.1658; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KAPLAN MH, 1962, LANCET, V1, P706; Kramer A, 1997, CELL, V91, P799, DOI 10.1016/S0092-8674(00)80468-7; LANCET D, 1976, P NATL ACAD SCI USA, V73, P3549, DOI 10.1073/pnas.73.10.3549; LANDSTEINER K, 1897, WIEN KLIN WOCHENSCHR, V10, P439; Lindner AB, 1999, J MOL BIOL, V285, P421, DOI 10.1006/jmbi.1998.2309; LU ZJ, 1995, BIO-TECHNOL, V13, P366, DOI 10.1038/nbt0495-366; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; NOBLE MEM, UNPUB; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; Santiago ML, 1998, INT ARCH ALLERGY IMM, V117, P94, DOI 10.1159/000023995; Trinh CH, 1997, STRUCTURE, V5, P937, DOI 10.1016/S0969-2126(97)00247-5; VARGA JM, 1991, MOL IMMUNOL, V28, P641, DOI 10.1016/0161-5890(91)90133-5; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	37	590	611	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1362	1367		10.1126/science.1079731	http://dx.doi.org/10.1126/science.1079731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610298				2022-12-24	WOS:000181192300043
J	Shu, DG; Morris, SC; Zhang, ZF; Liu, JN; Han, J; Chen, L; Zhang, XL; Yasui, K; Li, Y				Shu, DG; Morris, SC; Zhang, ZF; Liu, JN; Han, J; Chen, L; Zhang, XL; Yasui, K; Li, Y			A new species of yunnanozoan with implications for deuterostome evolution	SCIENCE			English	Article							CHORDATE; VERTEBRATES; INSIGHTS; CHINA	Yunnanozoans are a distinctive clade of Lower Cambrian metazoans. Although widely accepted as deuterostomes, their exact placement within this super-phylum is controversial. Here we describe a new species of Haikouella (H. jianshanensis) from the Chengjiang Lagerstatte (Yunnan, China) with exceptional preservation of a number of features. These include external gills, which suggest that the origin of the pharyngeal clefts was independent of the gills. The diagnostic branchial arches of chordates may, therefore, be composite structures. No evidence was found for the chorwdate-like structures that have been described in other yunnanozoans. We propose that yunnanozoans are stem-group deuterostomes, allied to the vetulicolians.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Kumamoto Univ, Dept Dev & Biohist, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Changan Univ, Coll Earth Sci & Land Resources, Xian 710054, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; China University of Geosciences; University of Cambridge; Kumamoto University; Chang'an University	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.		Zhang, Zhifei/F-2532-2011	Zhang, Zhifei/0000-0003-0325-5116				BABCOCK L. E., 2001, GSA TODAY, V11, P4, DOI DOI 10.1130/1052-5173(2001)011<0004:TCBROT>2.0.CO;2; BRIGGS DEG, 1994, LETHAIA, V26, P275, DOI DOI 10.1111/J.1502-3931.1993.TB01532.X); Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; Dzik Jerzy, 1995, Acta Palaeontologica Polonica, V40, P341; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; HOU XG, 1991, ZOOL SCR, V20, P395; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	15	80	95	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1380	1384		10.1126/science.1079846	http://dx.doi.org/10.1126/science.1079846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610301				2022-12-24	WOS:000181192300048
J	Kramer, C; Loros, JJ; Dunlap, JC; Crosthwaite, SK				Kramer, C; Loros, JJ; Dunlap, JC; Crosthwaite, SK			Role for antisense RNA in regulating circadian clock function in Neurospora crassa	NATURE			English	Article							GENE-FREQUENCY; ANTHERAEA-PERNYI; FEEDBACK LOOP; LIGHT INPUT; PERIOD; RHYTHMICITY; INITIATION; SILKMOTH; DEFINES; WC-2	The prevalence of antisense RNA in eukaryotes is not known and only a few naturally occurring antisense transcripts have been assigned a function(1-4). However, the recent identification of a large number of putative antisense transcripts(5) strengthens the view that antisense RNAs might affect a wider variety of processes than previously thought. Here we show that in the model organism Neurospora crassa entrainment of the circadian clock, which is critical for the correct temporal expression of genes and their products, is controlled partly by an antisense RNA arising from a clock component locus. In a wild-type strain, levels of antisense frequency (frq) transcripts cycle in antiphase to sense frq transcripts in the dark, and are inducible by light. In mutant strains in which the induction of antisense frq RNA by light is abolished, the time of the internal clock is delayed relative to the wild-type strain, and resetting of the clock by light is altered. These data provide an unexpected link between antisense RNA and circadian timing and provide a new example of a eukaryotic cellular process regulated by naturally occurring antisense RNA.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	University of Manchester; Dartmouth College; Dartmouth College	Crosthwaite, SK (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.		Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457				Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BELLPEDERSEN D, 1992, GENE DEV, V6, P2382, DOI 10.1101/gad.6.12a.2382; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Collett MA, 2001, MOL CELL BIOL, V21, P2619, DOI 10.1128/MCB.21.8.2619-2628.2001; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gotter AL, 1999, NEURON, V24, P953, DOI 10.1016/S0896-6273(00)81042-9; Hastings MH, 2000, NAT REV NEUROSCI, V1, P143, DOI 10.1038/35039080; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; JOHNSON KA, 1993, THESIS DARTMOUTH COL; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; MERROW MW, 1994, EMBO J, V13, P2257, DOI 10.1002/j.1460-2075.1994.tb06507.x; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a	30	127	137	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					948	952		10.1038/nature01427	http://dx.doi.org/10.1038/nature01427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607002				2022-12-24	WOS:000181186900050
J	Stewart, GS; Wang, B; Bignell, CR; Taylor, AMR; Elledge, SJ				Stewart, GS; Wang, B; Bignell, CR; Taylor, AMR; Elledge, SJ			MDC1 is a mediator of the mammalian DNA damage checkpoint	NATURE			English	Article							DOUBLE-STRAND BREAKS; BUDDING YEAST RAD9; BRCT DOMAIN; IN-VIVO; PROTEIN; REPAIR; KINASE; 53BP1; ATM	To counteract the continuous exposure of cells to agents that damage DNA, cells have evolved complex regulatory networks called checkpoints to sense DNA damage and coordinate DNA replication, cell-cycle arrest and DNA repair(1). It has recently been shown that the histone H2A variant H2AX specifically controls the recruitment of DNA repair proteins to the sites of DNA damage(2-4). Here we identify a novel BRCA1 carboxy-terminal (BRCT) and forkhead-associated (FHA) domain-containing protein, MDC1 (mediator of DNA damage checkpoint protein 1), which works with H2AX to promote recruitment of repair proteins to the sites of DNA breaks and which, in addition, controls damage-induced cell-cycle arrest checkpoints. MDC1 forms foci that co-localize extensively with gamma-H2AX foci within minutes after exposure to ionizing radiation. H2AX is required for MDC1 foci formation, and MDC1 forms complexes with phosphorylated H2AX. Furthermore, this interaction is phosphorylation dependent as peptides containing the phosphorylated site on H2AX bind MDC1 in a phosphorylation-dependent manner. We have shown by using small interfering RNA (siRNA) that cells lacking MDC1 are sensitive to ionizing radiation, and that MDC1 controls the formation of damage-induced 53BP1, BRCA1 and MRN foci, in part by promoting efficient H2AX phosphorylation. In addition, cells lacking MDC1 also fail to activate the intra-S phase and G2/M phase cell-cycle checkpoints properly after exposure to ionizing radiation, which was associated with an inability to regulate Chk1 properly. These results highlight a crucial role for MDC1 in mediating transduction of the DNA damage signal.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Birmingham, CRC Inst Canc Studies, Birmingham B15 2TT, W Midlands, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Birmingham	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.			Stewart, Grant/0000-0002-0960-3241				Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HUANG M, 2000, COLD SPRING HARB SYM, V65, P1; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Liu QH, 2000, GENE DEV, V14, P1448; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Takai H, 2000, GENE DEV, V14, P1439; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Venkitaraman AR, 2001, J CELL SCI, V114, P3591; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang Y, 2000, GENE DEV, V14, P927; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	664	707	4	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					961	966		10.1038/nature01446	http://dx.doi.org/10.1038/nature01446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607005				2022-12-24	WOS:000181186900053
J	Bozzette, SA; Ake, CF; Tam, HK; Chang, SW; Louis, TA				Bozzette, SA; Ake, CF; Tam, HK; Chang, SW; Louis, TA			Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL-CELL CULTURES; HIV PROTEASE INHIBITORS; INSULIN-RESISTANCE; PERIPHERAL LIPODYSTROPHY; HYPERLIPIDEMIA; CLEARANCE; APOPTOSIS; MORTALITY	BACKGROUND: Metabolic abnormalities associated with human immunodeficiency virus (HIV) infection, including dysglycemia and hyperlipidemia, are increasingly prevalent, and there is concern about the possibility of an association with accelerated cardiovascular and cerebrovascular disease. METHODS: We conducted a retrospective study of the risk of cardiovascular and cerebrovascular disease among the 36,766 patients who received care for HIV infection at Veterans Affairs facilities between January 1993 and June 2001. RESULTS: For antiretroviral therapy, 70.2 percent of the patients received nucleoside analogues, 41.6 percent received protease inhibitors, and 25.6 percent received nonnucleoside reverse-transcriptase inhibitors for a median of 17 months, 16 months, and 9 months, respectively. Approximately 1000 patients received combination therapy with a protease inhibitor for at least 48 months, and approximately 1000 patients received combination therapy with a nonnucleoside reverse-transcriptase inhibitor for at least 24 months. Between 1995 and 2001, the rate of admissions for cardiovascular or cerebrovascular disease decreased from 1.7 to 0.9 per 100 patient-years, and the rate of death from any cause decreased from 21.3 to 5.0 deaths per 100 patient-years. Patient-level regression analyses indicated that there was no relation between the use of nucleoside analogues, protease inhibitors, or nonnucleoside reverse-transcriptase inhibitors and the hazard of cardiovascular or cerebrovascular events, but the use of antiretroviral drugs was associated with a decreased hazard of death from any cause. CONCLUSIONS: Use of newer therapies for HIV was associated with a large benefit in terms of mortality that was not diminished by any increase in the rate of cardiovascular or cerebrovascular events or related mortality. Fear of accelerated vascular disease need not compromise antiretroviral therapy over the short term. However, prolonged survival among HIVinfected patients means that longer-term observation and analysis are required.	Vet Affairs San Diego Hlth Care Syst, Vet Affairs Qual Enhancement Res Initiat HIV, San Diego, CA USA; Vet Affairs San Diego Hlth Care Syst, Ctr Res Patient Oriented Care, San Diego, CA USA; Univ Calif San Diego, La Jolla, CA 92093 USA; RAND Hlth, Santa Monica, CA USA; Vet Affairs Ctr Qual Management Publ Hlth, Palo Alto, CA USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; RAND Corporation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bozzette, SA (corresponding author), San Diego Vet Affairs Med Ctr, Dept Med, 3350 La Jolla Village Dr, La Jolla, CA 92161 USA.							Backus L, 2001, J CLIN EPIDEMIOL, V54, pS12, DOI 10.1016/S0895-4356(01)00442-5; Behrens G, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(98)26026-0; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; CURRIER J, 2001, ANTIVIR THER, V6, P36; Dube M, 2002, POSTCOLONIALISM FEMI, P100; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; FISHER A, 1998, 12 WORLD AIDS C GEN, P575; Gallet B, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(05)78643-8; GEFFNER ME, 1993, PEDIATR RES, V34, P66, DOI 10.1203/00006450-199307000-00016; GRUNFELD C, 1989, AM J MED, V86, P27, DOI 10.1016/0002-9343(89)90225-8; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Heath KV, 2001, AIDS, V15, P231, DOI 10.1097/00002030-200101260-00013; HOMMES MJT, 1991, METABOLISM, V40, P651, DOI 10.1016/0026-0495(91)90059-6; Huang MB, 1999, AIDS RES HUM RETROV, V15, P1265, DOI 10.1089/088922299310160; Huang MB, 2001, J ACQ IMMUN DEF SYND, V27, P213; Jia HY, 2001, BIOCHEM BIOPH RES CO, V283, P469, DOI 10.1006/bbrc.2001.4790; Jia HY, 2001, BIOCHEM BIOPH RES CO, V284, P245, DOI 10.1006/bbrc.2001.4930; Lenert LA, 2002, AM J MED, V113, P229, DOI 10.1016/S0002-9343(02)01156-7; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; *NAT CTR HLTH STAT, 2002, CLASS DIS FUNCT DIS; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Park IW, 2001, J IMMUNOL, V167, P2766, DOI 10.4049/jimmunol.167.5.2766; Vittecoq D, 1998, LANCET, V351, P1959, DOI 10.1016/S0140-6736(05)78644-X; [No title captured]	26	451	475	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					702	710		10.1056/NEJMoa022048	http://dx.doi.org/10.1056/NEJMoa022048			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594314	Bronze			2022-12-24	WOS:000181014400005
J	Antoine, C; Muller, S; Cant, A; Cavazzana-Calvo, M; Veys, P; Vossen, J; Fasth, A; Heilmann, C; Wulffraat, N; Seger, R; Blanche, S; Friedrich, W; Abinun, M; Davies, G; Bredius, R; Schulz, A; Landais, P; Fischer, A				Antoine, C; Muller, S; Cant, A; Cavazzana-Calvo, M; Veys, P; Vossen, J; Fasth, A; Heilmann, C; Wulffraat, N; Seger, R; Blanche, S; Friedrich, W; Abinun, M; Davies, G; Bredius, R; Schulz, A; Landais, P; Fischer, A		European Grp Blood Marrow Transpla	Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99	LANCET			English	Article							BONE-MARROW TRANSPLANTATION; T-CELL; DEFICIENCY	Background Transplantation of allogeneic haemopoietic stem cells can cure several primary immunodeficiencies. This European report focuses on the long-term results of such procedures done between 1968 and December, 1999, for primary immunodeficiencies. Methods The report includes data from 37 centres in 18 countries, which participated in a European registry for stem-cell transplantation in severe combined immunodeficiencies (SCID) and in other immunodeficiency disorders (non-SCID). 1082 transplants in 919 patients were studied (566 in 475 SCID patients, 512 in 444 non-SCID patients; four procedures excluded owing to insufficient data). Minimum follow-up of 6 months was required. Findings In SCID, 3-year survival with sustained engraftment was significantly better after HLA-identical than after mismatched transplantation (77% vs 54%; p=0.002) and survival improved over time. In HLA-mismatched stem-cell transplantation, B(-) SCID had poorer prognosis than B(+) SCID. However, improvement with time occurred in both SCID phenotypes. In non-SCID, 3-year survival after genotypically HLA-matched, phenotypically HLA-matched, HLA-mismatched related, and unrelated-donor transplantation was 71%, 42%, 42%, and 59%, respectively (p=0.0006). Acute graft versus host disease predicted poor prognosis whatever the donor origin except in related HLA-identical transplantation in SCID. Interpretation The improvement in survival over time indicates more effective prevention and treatment of disease-related and procedure-related complications-eg, infections and graft versus host disease. An important factor is better prevention of graft versus host disease in the HLA-non-identical setting by use of more efficient methods of T-cell depletion. For non-SCID, stem-cell transplantation can provide a cure, and grafts from unrelated donors are almost as beneficial as those from genetically HLA-identical relatives.	Hop Necker Enfants Malad, Serv Immunol & Hematol Pediat, F-75743 Paris, France; Hop Necker Enfants Malad, Serv Biostat, Paris, France; Univ Ulm, Kinderklin, Ulm, Germany; Newcastle Gen Hosp, Dept Paediat Immunol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Great Ormond St Hosp Sick Children, Dept Immunol, London, England; Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplant, London, England; Acad Hosp Leiden, Dept Paediat, Leiden, Netherlands; Queen Silvia Childrens Hosp, Gothenburg, Sweden; Rigshosp, Dept Paediat, DK-2100 Copenhagen, Denmark; Wilhelmina Childrens Hosp, Utrecht, Netherlands; Univ Childrens Hosp, Div Immunol Haematol, Zurich, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Ulm University; Newcastle General Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Leiden University; Leiden University Medical Center (LUMC); Queen Silvia Children's Hospital; Rigshospitalet; University of Copenhagen; Wilhelmina Kinderziekenhuis; University Children's Hospital Zurich	Fischer, A (corresponding author), Hop Necker Enfants Malad, Serv Immunol & Hematol Pediat, 149 Rue Sevres, F-75743 Paris, France.		Bredius, Robbert/AAF-2592-2019; Wulffraat, Nico M/AAE-8929-2020; Fasth, Anders/I-1109-2019	Wulffraat, Nico M/0000-0001-9548-5562; Cavazzana, Marina/0000-0002-0264-0891; Bredius, Robbert/0000-0001-8151-1539; Fasth, Anders/0000-0002-0033-740X				Bertrand Y, 1999, J PEDIATR-US, V134, P740, DOI 10.1016/S0022-3476(99)70291-X; Buckley RH, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P459; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Filipovich AH, 2001, BLOOD, V97, P1598, DOI 10.1182/blood.V97.6.1598; FISCHER A, 1986, LANCET, V2, P1080; FISCHER A, 1990, LANCET, V336, P850, DOI 10.1016/0140-6736(90)92348-L; Fischer A, 2001, LANCET, V357, P1863, DOI 10.1016/S0140-6736(00)04959-X; FISCHER A, 1994, BLOOD, V83, P1149; GENTLEMAN R, 1997, INTERFACE FDN N AM; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Haddad E, 1998, BLOOD, V91, P3646; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; KLEIN C, 1995, BLOOD, V85, P580; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; PETER HH, 1983, J IMMUNOL, V131, P2332; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; REISNER Y, 1983, BLOOD, V61, P341	19	399	415	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					553	560		10.1016/S0140-6736(03)12513-5	http://dx.doi.org/10.1016/S0140-6736(03)12513-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598139				2022-12-24	WOS:000181033400007
J	Hope, MD				Hope, MD			Pain and forgetting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Hope, MD (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.								0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					617	617		10.1001/jama.289.5.617	http://dx.doi.org/10.1001/jama.289.5.617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578502	Bronze			2022-12-24	WOS:000180787500036
J	Herting, E; Stichtenoth, G; Robertson, B				Herting, E; Stichtenoth, G; Robertson, B			Syringes with rubber-coated plungers and inactivation of surfactant	LANCET			English	Article								Injectable drugs are generally administered to newborns with 1 mL syringes. During in-vitro measurements of surface tension with a pulsating bubble surfactometer, we noticed that surfactant was inactivated after repeated aspiration into a 1 mL syringe with a rubber-coated plunger. Inactivation did not take place, however, when we used rubber-free two-part syringes with polyethylene pistons. Results of further studies showed that the silicone fluid used to lubricate the rubber surface of the syringe was inactivating the surfactant. Our findings suggest that contact with rubber surfaces should be avoided in the handling of surfactant material for biophysical assessment or clinical use.	Univ Gottingen, Dept Paediat, D-37075 Gottingen, Germany; Karolinska Hosp, Dept Surg Sci, Lab Survactant Res, S-10401 Stockholm, Sweden	University of Gottingen; Karolinska Institutet; Karolinska University Hospital	Herting, E (corresponding author), Univ Gottingen, Dept Paediat, Robert Koch Str 40, D-37075 Gottingen, Germany.							Herting E, 2001, PEDIATR RES, V50, P44, DOI 10.1203/00006450-200107000-00010; JOBE AH, 1993, NEW ENGL J MED, V328, P861; Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278; Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627	5	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					311	313		10.1016/S0140-6736(03)12334-3	http://dx.doi.org/10.1016/S0140-6736(03)12334-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559869				2022-12-24	WOS:000180643900016
J	Schneider, RA; Helms, JA				Schneider, RA; Helms, JA			The cellular and molecular origins of beak morphology	SCIENCE			English	Article							NEURAL CREST; SONIC HEDGEHOG; CRANIOFACIAL MORPHOGENESIS; EXPRESSION; MESODERM; REGION; EMBRYO; FGF8	Cellular and molecular mechanisms underlying differences in beak morphology likely involve interactions among multiple embryonic populations. We exchanged neural crest cells destined to participate in beak morphogenesis between two anatomically distinct species. Quail neural crest cells produced quail beaks in duck hosts and duck neural crest produced duck bills in quail hosts. These transformations involved morphological changes to non neural crest host beak tissues. To achieve these changes, donor neural crest cells executed autonomous molecular programs and regulated gene expression in adjacent host tissues. Thus, neural crest cells are a source of molecular information that generates interspecific variation in beak morphology.	Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Helms, JA (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, 533 Parnassus Ave,Suite U-453, San Francisco, CA 94143 USA.			Helms, Jill/0000-0002-0463-396X; Schneider, Richard/0000-0002-2626-3111	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007236, R29DE012462, R03DE014795, K02DE000421] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-7-3263] Funding Source: Medline; NIDCR NIH HHS [K02 DE 00421, R03 DE014795-01, R03 DE014795, T32 DE07236, R29 DE12462-03] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; ANDRES G., 1949, GENETICA, V24, P387, DOI 10.1007/BF01487210; Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Coppinger Raymond, 1995, P21; Couly G, 2002, DEVELOPMENT, V129, P1061; COULY GF, 1993, DEVELOPMENT, V117, P409; Darwin C, 1962, ORIGIN SPECIES; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harrison RG, 1933, AM NAT, V67, P306, DOI 10.1086/280493; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; Hu D, 1999, DEVELOPMENT, V126, P4873; Kontges G, 1996, DEVELOPMENT, V122, P3229; LUCAS AM, 1972, AGR HDB USDA, V362; MINA M, 1995, DEV DYNAM, V202, P195, DOI 10.1002/aja.1002020211; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Schneider RA, 1999, DEV BIOL, V208, P441, DOI 10.1006/dbio.1999.9213; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; SOHAL GS, 1976, BRAIN RES, V113, P35, DOI 10.1016/0006-8993(76)90004-4; TRAINOR PA, 1995, DEVELOPMENT, V121, P2569; Wagner G., 1959, Roux Archiv fuer Entwicklungsmechanik Organismen, V151, P136	22	224	227	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					565	568		10.1126/science.1077827	http://dx.doi.org/10.1126/science.1077827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543976				2022-12-24	WOS:000180559800050
J	Tsang, KW; Ho, PL; Ooi, GC; Yee, WK; Wang, T; Chan-Yeung, M; Lam, WK; Seto, WH; Yam, LY; Cheung, TM; Wong, PC; Lam, B; Ip, MS; Chan, J; Yuen, KY; Lai, KN				Tsang, KW; Ho, PL; Ooi, GC; Yee, WK; Wang, T; Chan-Yeung, M; Lam, WK; Seto, WH; Yam, LY; Cheung, TM; Wong, PC; Lam, B; Ip, MS; Chan, J; Yuen, KY; Lai, KN			A cluster of cases of severe acute respiratory syndrome in Hong Kong	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORGANIZING PNEUMONIA; CT FINDINGS	BACKGROUND Information on the clinical features of the severe acute respiratory syndrome (SARS) will be of value to physicians caring for patients suspected of having this disorder. METHODS We abstracted data on the clinical presentation and course of disease in 10 epidemiologically linked Chinese patients (5 men and 5 women 38 to 72 years old) in whom SARS was diagnosed between February 22, 2003, and March 22, 2003, at our hospitals in Hong Kong, China. RESULTS Exposure between the source patient and subsequent patients ranged from minimal to that between patient and health care provider. The incubation period ranged from 2 to 11 days. All patients presented with fever (temperature, >38 degreesC for over 24 hours), and most presented with rigor, dry cough, dyspnea, malaise, headache, and hypoxemia. Physical examination of the chest revealed crackles and percussion dullness. Lymphopenia was observed in nine patients, and most patients had mildly elevated aminotransferase levels but normal serum creatinine levels. Serial chest radiographs showed progressive air-space disease. Two patients died of progressive respiratory failure; histologic analysis of their lungs showed diffuse alveolar damage. There was no evidence of infection by Mycoplasma pneumoniae, Chlamydia pneumoniae, or Legionella pneumophila. All patients received corticosteroid and ribavirin therapy a mean (+/-SD) of 9.6+/-5.42 days after the onset of symptoms, and eight were treated earlier with a combination of beta-lactams and macrolide for 4+/-1.9 days, with no clinical or radiologic efficacy. CONCLUSIONS SARS appears to be infectious in origin. Fever followed by rapidly progressive respiratory compromise is the key complex of signs and symptoms from which the syndrome derives its name. The microbiologic origins of SARS remain unclear. .	Univ Hong Kong, Dept Clin Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Diagnost Radiol, Hong Kong, Hong Kong, Peoples R China; Kwong Wah Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Kwong Wah Hospital; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong	Lai, KN (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam, Hong Kong, Peoples R China.		Yuen, Kwok Yung/C-4465-2009; 何栢良, Pak-Leung HO/C-4310-2009; Lai, Kar Neng/C-4300-2009; Ip, Mary Sau Man/C-4284-2009	何栢良, Pak-Leung HO/0000-0002-8811-1308; Ip, Mary Sau Man/0000-0002-8692-6933; Yuen, Kwok-yung/0000-0002-2083-1552; Seto, Wing Hong/0000-0002-1139-9200				*CDCP, 2003, SEV AC RESP SYNDR SA; HAWKER J, 2001, COMMUNICABLE DIS CON, P152; JACKSON LA, 2000, MANDELL DOUGLAS BENN, V2, P2007; LEE KS, 1994, AM J ROENTGENOL, V162, P543, DOI 10.2214/ajr.162.3.8109493; MULLER NL, 1990, AM J ROENTGENOL, V154, P983; PRIMACK SL, 1993, RADIOLOGY, V188, P817, DOI 10.1148/radiology.188.3.8351354; *WHO, 2003, AC RESP SYNDR CHIN U; *WHO, 2003, CASE DEF SURV SEV AC	8	731	848	1	82	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1977	1985		10.1056/NEJMoa030666	http://dx.doi.org/10.1056/NEJMoa030666			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12671062	Bronze			2022-12-24	WOS:000182823400006
J	Yoder, CF; Konopliv, AS; Yuan, DN; Standish, EM; Folkner, WM				Yoder, CF; Konopliv, AS; Yuan, DN; Standish, EM; Folkner, WM			Fluid core size of mars from detection of the solar tide	SCIENCE			English	Article							INTERIOR STRUCTURE; GRAVITY-FIELD; MODEL; PATHFINDER; TRACKING	The solar tidal deformation of Mars, measured by its k(2) potential Love number, has been obtained from an analysis of Mars Global Surveyor radio tracking. The observed k(2) of 0.153 +/- 0.017 is large enough to rule out a solid iron core and so indicates that at least the outer part of the core is liquid. The inferred core radius is between 1520 and 1840 kilometers and is independent of many interior properties, although partial melt of the mantle is one factor that could reduce core size. Ice-cap mass changes can be deduced from the seasonal variations in air pressure and the odd gravity harmonic J(3), given knowledge of cap mass distribution with latitude. The south cap seasonal mass change is about 30 to 40% larger than that of the north cap.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Yoder, CF (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Charles.F.Yoder@jpl.nasa.gov; Alex.Konopliv@jpl.nasa.gov						Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; DICKEY JO, 1994, SCIENCE, V265, P482, DOI 10.1126/science.265.5171.482; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Groten E, 1996, ASTRON J, V111, P1388, DOI 10.1086/117885; Haberle RM, 1999, J GEOPHYS RES-PLANET, V104, P8957, DOI 10.1029/1998JE900040; JUSTUS CJ, 1996, 108513 NASA; Konopliv AS, 1996, GEOPHYS RES LETT, V23, P1857, DOI 10.1029/96GL01589; Konopliv AS, 2001, ICARUS, V150, P1, DOI 10.1006/icar.2000.6573; Ray RD, 1996, NATURE, V381, P595, DOI 10.1038/381595a0; REASENBERG RD, 1977, J GEOPHYS RES, V82, P369, DOI 10.1029/JB082i002p00369; Smith DE, 1999, J GEOPHYS RES-PLANET, V104, P1885, DOI 10.1029/1998JE900024; Smith DE, 2001, SCIENCE, V294, P2141, DOI 10.1126/science.1066556; Sohl F, 1997, J GEOPHYS RES-PLANET, V102, P1613, DOI 10.1029/96JE03419; Turcotte DL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001594; WAHR J, 1995, HDB PHYSICAL CONSTAN, V1, P40; YODER CF, 1983, NATURE, V303, P757, DOI 10.1038/303757a0; Yoder CF, 1997, J GEOPHYS RES-PLANET, V102, P4065, DOI 10.1029/96JE03642; YODER CF, 1995, ICARUS, V117, P250, DOI 10.1006/icar.1995.1156; YODER CF, 1995, HDB PHYSICAL CONSTAN, V1, P1; Yuan DN, 2001, J GEOPHYS RES-PLANET, V106, P23377, DOI 10.1029/2000JE001302; Zharkov VN, 2000, PHYS EARTH PLANET IN, V117, P407, DOI 10.1016/S0031-9201(99)00110-7; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	22	227	235	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					299	303		10.1126/science.1079645	http://dx.doi.org/10.1126/science.1079645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12624177				2022-12-24	WOS:000182135400048
J	Spehr, M; Gisselmann, G; Poplawski, A; Riffell, JA; Wetzel, CH; Zimmer, RK; Hatt, H				Spehr, M; Gisselmann, G; Poplawski, A; Riffell, JA; Wetzel, CH; Zimmer, RK; Hatt, H			Identification of a testicular odorant receptor mediating human sperm chemotaxis	SCIENCE			English	Article							FUNCTIONAL EXPRESSION; OLFACTORY RECEPTORS; HUMAN SPERMATOZOA; ADENYLYL-CYCLASE; GERM-CELLS; PROGESTERONE; CHANNEL; SYSTEM	Although it has been known for some time that olfactory receptors (ORs) reside in spermatozoa, the function of these ORs is unknown. Here, we identified, cloned, and functionally expressed a previously undescribed human testicular OR, hOR17-4. With the use of raticifluorometric imaging, Ca2+ signals were induced by a small subset of applied chemical stimuli, establishing the molecular receptive fields for the recombinantly expressed receptor in human embryonic kidney (HEK) 293 cells and the native receptor in human spermatozoa. Bourgeonal was a powerful agonist for both recombinant and native receptor types, as well as a strong chemoattractant in subsequent behavioral bioassays. In contrast, undecanal was a potent OR antagonist to bourgeonal and related compounds. Taken together, these results indicate that hOR17-4 functions in human sperm chemotaxis and may be a critical component of the fertilization process.	Ruhr Univ Bochum, Dept Cell Physiol, D-44780 Bochum, Germany; Univ Calif Los Angeles, Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	Ruhr University Bochum; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hatt, H (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, 150 Univ St, D-44780 Bochum, Germany.		Wetzel, Christian/F-1366-2018; Spehr, Marc/AAK-3162-2021; Spehr, Marc/B-3140-2011; Wetzel, Christian H/N-9880-2017; Wetzel, Christian/C-2501-2009	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Wetzel, Christian H/0000-0002-5762-0003; Wetzel, Christian/0000-0002-5762-0003				Baldi E, 2002, J REPROD IMMUNOL, V53, P121, DOI 10.1016/S0165-0378(01)00089-4; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Eisenbach M, 1999, BIOESSAYS, V21, P203, DOI 10.1002/(SICI)1521-1878(199903)21:3<203::AID-BIES4>3.0.CO;2-T; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Garcia MA, 1999, BIOL REPROD, V60, P102, DOI 10.1095/biolreprod60.1.102; Gautier-Courteille C, 1998, ENDOCRINOLOGY, V139, P2588, DOI 10.1210/en.139.5.2588; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Kobori H, 2000, BIOL REPROD, V63, P113, DOI 10.1095/biolreprod63.1.113; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; Wellerdieck C, 1997, CHEM SENSES, V22, P467, DOI 10.1093/chemse/22.4.467; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0	19	554	581	6	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2054	2058		10.1126/science.1080376	http://dx.doi.org/10.1126/science.1080376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663925				2022-12-24	WOS:000181834200051
J	Betschinger, J; Mechtler, K; Knoblich, JA				Betschinger, J; Mechtler, K; Knoblich, JA			The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl	NATURE			English	Article							II HEAVY-CHAIN; TUMOR-SUPPRESSOR PROTEIN; DROSOPHILA NEUROBLASTS; PLASMA-MEMBRANE; PROSPERO; POLARITY; BAZOOKA; MYOSIN; LOCALIZATION; MITOSIS	To generate different cell types, some cells can segregate protein determinants into one of their two daughter cells during mitosis. In Drosophila neuroblasts, the Par protein complex localizes apically(1-5) and directs localization of the cell fate determinants Prospero(6-8) and Numb(9) and the adaptor proteins Miranda(10,11) and Pon(12) to the basal cell cortex, to ensure their segregation into the basal daughter cell. The Par protein complex has a conserved function in establishing cell polarity(13) but how it directs proteins to the opposite side is unknown. We show here that a principal function of this complex is to phosphorylate the cytoskeletal protein Lethal (2) giant larvae (Lgl; also known as L(2)gl). Phosphorylation by Drosophila atypical protein kinase C (aPKC), a member of the Par protein complex, releases Lgl from its association with membranes and the actin cytoskeleton. Genetic and biochemical experiments show that Lgl phosphorylation prevents the localization of cell fate determinants to the apical cell cortex. Lgl promotes cortical localization of Miranda(14,15),, and we propose that phosphorylation of Lgl by aPKC at the apical neuroblast cortex restricts Lgl activity and Miranda localization to the opposite, basal side of the cell.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Knoblich, JA (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Knoblich, Juergen A/C-2974-2015; Mechtler, Karl/AAF-2717-2019	Knoblich, Juergen A/0000-0002-6751-3404; Mechtler, Karl/0000-0002-3392-9946; Betschinger, Joerg/0000-0002-2627-8479				BRAND AH, 1993, DEVELOPMENT, V118, P401; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kagami M, 1998, GENETICS, V149, P1717; Kalmes A, 1996, J CELL SCI, V109, P1359; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schulze KL, 1996, GENETICS, V144, P1713; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAND D, 1994, J CELL BIOL, V127, P1345, DOI 10.1083/jcb.127.5.1345; STRAND D, 1995, ONCOGENE, V11, P291; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	30	447	457	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					326	330		10.1038/nature01486	http://dx.doi.org/10.1038/nature01486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12629552				2022-12-24	WOS:000181637300043
J	Hoag, H				Hoag, H			Tougher rules aim to prevent gene flow into crops	NATURE			English	News Item																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					103	103		10.1038/422103b	http://dx.doi.org/10.1038/422103b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634744	Bronze			2022-12-24	WOS:000181488900008
J	Susser, E; Terry, MB				Susser, E; Terry, MB			A conception-to-death cohort	LANCET			English	Editorial Material							SCHIZOPHRENIA		Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Epidemiol Brain Disorders, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Susser, E (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.	ess8@columbia.edu		Terry, Mary Beth/0000-0002-4106-5033				Barker DJP, 1992, FETAL INFANT ORIGINS; Broman S., 1984, HDB LONGITUDINAL RES, V1, P185; Delongchamp RR, 1997, RADIAT RES, V147, P385, DOI 10.2307/3579348; Eaton WW, 2002, ANN EPIDEMIOL, V12, P445, DOI 10.1016/S1047-2797(01)00314-3; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; Kuh D, 1997, LIFE COURSE APPROACH; Susser E, 1999, PSYCHIAT ANN, V29, P161, DOI 10.3928/0048-5713-19990301-13; Susser E, 1998, AM J EPIDEMIOL, V147, P213; Terry MB, 2001, INT J EPIDEMIOL, V30, P95, DOI 10.1093/ije/30.1.95; VANDENBERG BJ, 1984, HDB LONGITUDINAL RES, V1, P166; Wadsworth M. E. J., 1991, IMPRINT TIME CHILDHO; Wyatt RJ, 2000, SCHIZOPHRENIA BULL, V26, P255, DOI 10.1093/oxfordjournals.schbul.a033450	12	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2003	361	9360					797	798		10.1016/S0140-6736(03)12721-3	http://dx.doi.org/10.1016/S0140-6736(03)12721-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642043				2022-12-24	WOS:000181466600005
J	Margarit, SM; Sondermann, H; Hall, BE; Nagar, B; Hoelz, A; Pirruccello, M; Bar-Sagi, D; Kuriyan, J				Margarit, SM; Sondermann, H; Hall, BE; Nagar, B; Hoelz, A; Pirruccello, M; Bar-Sagi, D; Kuriyan, J			Structural evidence for feedback activation by Ras-GTP of the Ras-specific nucleotide exchange factor SOS	CELL			English	Article							SIGNAL-TRANSDUCTION; GENE-PRODUCT; BINDING; SWITCH	Growth factor receptors activate Ras by recruiting the nucleotide exchange factor son of sevenless (SOS) to the cell membrane, thereby triggering the production of GTP-loaded Ras. Crystallographic analyses of Ras bound to the catalytic module of SOS have led to the unexpected discovery of a highly conserved Ras binding site on SOS that is located distal to the active site and is specific for Ras-GTP. The crystal structures suggest that Ras-GTP stabilizes the active site of SOS allosterically, and we show that Ras-GTP forms ternary complexes with SOScat in solution and increases significantly the rate of SOScat-stimulated nucleotide release from Ras. These results demonstrate the existence of a positive feedback mechanism for the spatial and temporal regulation of Ras.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Rockefeller Univ, New York, NY 10021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rockefeller University	Bar-Sagi, D (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	barsagi@pharm.sunysb.edu; kuriyan@uclink.berkeley.edu	Nagar, Bhushan/C-1297-2010; Hoelz, Andre/AAB-6978-2021	Bar-Sagi, Dafna/0000-0003-2597-8948; Pirruccello-Straub, Michelle/0000-0002-7996-857X				Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARSAGI D, 1994, TRENDS ENDOCRIN MET, V5, P165, DOI 10.1016/1043-2760(94)90014-0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang C, 2000, EMBO J, V19, P3283, DOI 10.1093/emboj/19.13.3283; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kuhn K, 2001, J AM CHEM SOC, V123, P1023, DOI 10.1021/ja002723o; LAI SHY, 1993, COMPUT IND ENG, V25, P13, DOI 10.1016/0360-8352(93)90209-G; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MARGARIT SM, 2002, THESIS STATE U NEW Y; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wyatt PJ, 1997, INSTRUM SCI TECHNOL, V25, P1, DOI 10.1080/10739149709351443	32	327	361	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					685	695		10.1016/S0092-8674(03)00149-1	http://dx.doi.org/10.1016/S0092-8674(03)00149-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628188	Bronze			2022-12-24	WOS:000181443600011
J	Wang, YC; Shirogane, T; Liu, D; Harper, JW; Elledge, SJ				Wang, YC; Shirogane, T; Liu, D; Harper, JW; Elledge, SJ			Exit from exit: Resetting the cell cycle through Amn1 inhibition of G protein signaling	CELL			English	Article							SPINDLE POLE BODIES; SACCHAROMYCES-CEREVISIAE; MITOTIC EXIT; BUDDING YEAST; TRANSCRIPTION FACTOR; PHOSPHATASE CDC14; KINASE COMPLEX; TEM1 GTPASE; CHECKPOINT; MITOSIS	In S. cerevisiae cells undergoing anaphase, a ras-related GTPase, Tem1, is located on the spindle pole body that enters the daughter cell and activates a signal transduction pathway, MEN, to allow mitotic exit. MEN activation must be reversed after mitotic exit to reset the cell cycle in G1. We find that daughter cells activate an Antagonist of MEN pathway (AMEN) in part through induction of the Amn1 protein that binds directly to Tem1 and prevents its association with its target kinase Cdc15. Failure of Amn1 function results in defects of both the spindle assembly and nuclear orientation checkpoints and delays turning off Cdc14 in G1. Thus Amn1 is part of a daughter-specific switch that helps cells exit from mitotic exit and reset the cell cycle.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.			Wang, Yanchang/0000-0001-6782-0570; Harper, Jeffrey/0000-0002-6944-7236	NIA NIH HHS [T32 AG00183] Funding Source: Medline; NIGMS NIH HHS [GM44664, GM54137] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM054137, R01GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Asakawa K, 2001, GENETICS, V157, P1437; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Geymonat M, 2002, J BIOL CHEM, V277, P28439, DOI 10.1074/jbc.M202540200; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lee SE, 2001, J CELL SCI, V114, P2345; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LIU HP, 1992, GENETICS, V132, P665; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Ro HS, 2002, P NATL ACAD SCI USA, V99, P5436, DOI 10.1073/pnas.062059999; ROSE M, 1995, YEAST, V11, P865, DOI 10.1002/yea.320110908; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9	42	66	70	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					697	709		10.1016/S0092-8674(03)00121-1	http://dx.doi.org/10.1016/S0092-8674(03)00121-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628189	Bronze			2022-12-24	WOS:000181443600012
J	Yajnik, V; Paulding, C; Sordella, R; McClatchey, AI; Saito, M; Wahrer, DCR; Reynolds, P; Bell, DW; Lake, R; van den Heuvel, S; Settleman, J; Haber, DA				Yajnik, V; Paulding, C; Sordella, R; McClatchey, AI; Saito, M; Wahrer, DCR; Reynolds, P; Bell, DW; Lake, R; van den Heuvel, S; Settleman, J; Haber, DA			DOCK4, a GTPase activator, is disrupted during tumorigenesis	CELL			English	Article							REPRESENTATIONAL DIFFERENCE ANALYSIS; TUMOR-SUPPRESSOR GENE; E-CADHERIN; LYMPHOCYTE MIGRATION; BINDING-PROTEIN; PROSTATE-CANCER; CELL-MIGRATION; FREQUENT LOSS; ADHESION; COMPLEX	We used representational difference analysis to identify homozygous genomic deletions selected during tumor progression in the mouse NF2 and TP53 tumor model. We describe a deletion targeting DOCK4, a member of the CDM gene family encoding regulators of small GTPases. DOCK4 specifically activates Rap GTPase, enhancing the formation of adherens junctions. DOCK4 mutations are present in a subset of human cancer cell lines; a recurrent missense mutant identified in human prostate and ovarian cancers encodes a protein that is defective in Rap1 activation. The engulfment defect of C. elegans mutants lacking the CDM gene ced-5 is rescued by wild-type DOCK4, but not by the mutant allele. Expression of wild-type, but not mutant, DOCK4 in mouse osteosarcoma cells with a deletion of the endogenous gene suppresses growth in soft agar and tumor invasion in vivo. DOCK4 therefore encodes a CDM family member that regulates intercellular junctions and is disrupted during tumorigenesis.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Med Sch, Gastrointestinal Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.		van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463; Reynolds, Paul/0000-0001-8738-1245	NATIONAL CANCER INSTITUTE [R37CA058596, R01CA058596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063081] Funding Source: NIH RePORTER; NCI NIH HHS [CA58596] Funding Source: Medline; NIDDK NIH HHS [5T32DK07191] Funding Source: Medline; NIGMS NIH HHS [GM63081] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chen Q, 2002, J CELL BIOL, V158, P79, DOI 10.1083/jcb.200110151; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Koike M, 1997, GENE CHROMOSOME CANC, V19, P1, DOI 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO;2-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang H, 2000, GENOMICS, V66, P226, DOI 10.1006/geno.2000.6198; LISITSYN N, 1995, METHOD ENZYMOL, V254, P291; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; LISITSYN NA, 1994, COLD SPRING HARB SYM, V59, P585, DOI 10.1101/SQB.1994.059.01.066; LISITSYN NA, 1995, TRENDS GENET, V11, P303, DOI 10.1016/S0168-9525(00)89087-3; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McClatchey AI, 1998, CURR OPIN GENET DEV, V8, P304, DOI 10.1016/S0959-437X(98)80086-5; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Perego C, 2002, J CELL SCI, V115, P3331; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; SEKIDO Y, 1995, CANCER RES, V55, P1227; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; TAKAHASHI S, 1995, CANCER RES, V55, P4114; Thomas DM, 1996, J BONE MINER RES, V11, P1312; Thomas NA, 2001, NAT GENET, V29, P379, DOI 10.1038/ng784; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	59	186	193	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					673	684		10.1016/S0092-8674(03)00155-7	http://dx.doi.org/10.1016/S0092-8674(03)00155-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628187	Bronze			2022-12-24	WOS:000181443600010
J	Tang, FS; Kauffman, EJ; Novak, JL; Nau, JJ; Catlett, NL; Weisman, LS				Tang, FS; Kauffman, EJ; Novak, JL; Nau, JJ; Catlett, NL; Weisman, LS			Regulated degradation of a class V myosin receptor directs movement of the yeast vacuole	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; CELL-CYCLE; ACTIN; INHERITANCE; MYO2P; LOCALIZATION; PROTEIN; COMPLEX; MOTOR	Normal cellular function requires that organelles be positioned in specific locations. The direction in which molecular motors move organelles is based in part on the polarity of microtubules and actin filaments(1-3). However, this alone does not determine the intracellular destination of organelles. For example, the yeast class V myosin, Myo2p, moves several organelles to distinct locations during the cell cycle(4-8). Thus the movement of each type of Myo2p cargo must be regulated uniquely. Here we report a regulatory mechanism that specifically provides directionality to vacuole movement. The vacuole-specific Myo2p receptor, Vac17p, has a key function in this process. Vac17p binds simultaneously to Myo2p and to Vac8p, a vacuolar membrane protein. The transport complex, Myo2p-Vac17p-Vac8p, moves the vacuole to the bud, and is then disrupted through the degradation of Vac17p. The vacuole is ultimately deposited near the centre of the bud. Removal of a PEST sequence (a potential signal for rapid protein degradation) within Vac17p causes its stabilization and the subsequent 'backward' movement of vacuoles, which mistargets them to the neck between the mother cell and the bud. Thus the regulated disruption of this transport complex places the vacuole in its proper location. This may be a general mechanism whereby organelles are deposited at their terminal destination.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Weisman, LS (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.							Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Catlett NL, 2000, CURR OPIN CELL BIOL, V12, P509, DOI 10.1016/S0955-0674(00)00124-1; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; deMesquita DSG, 1996, EUR J CELL BIOL, V71, P237; DEMESQUITA DSG, 1991, J GEN MICROBIOL, V137, P2447, DOI 10.1099/00221287-137-10-2447; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; ISHIKAWA K, IN PRESS J CELL BIOL; James P, 1996, GENETICS, V144, P1425; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/0968-0004(96)10031-1; Reck-Peterson SL, 1999, MOL BIOL CELL, V10, P1001, DOI 10.1091/mbc.10.4.1001; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yang ZQ, 1998, CHINESE CHEM LETT, V9, P261; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	29	93	96	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					87	92		10.1038/nature01453	http://dx.doi.org/10.1038/nature01453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12594460				2022-12-24	WOS:000181343100043
J	Elia, AEH; Cantley, LC; Yaffe, MB				Elia, AEH; Cantley, LC; Yaffe, MB			Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates	SCIENCE			English	Article							MAMMALIAN POLO KINASE; CELL-CYCLE; PROTEIN; SPECIFICITY; EXTRACTS; CLONING; PEPTIDE; SRC	We have developed a proteomic approach for identifying phosphopeptide binding domains that modulate kinase-dependent signaling pathways. An immobilized library of partially degenerate phosphopeptides biased toward a particular protein kinase phosphorylation motif is used to isolate phospho-binding domains that bind to proteins phosphorylated by that kinase. Applying this approach to cyclin-dependent kinases (Cdks), we identified the polo-box domain (PBD) of the mitotic kinase polo-like kinase 1 (Plk1) as a specific phosphoserine (pSer) or phosphothreonine (pThr) binding domain and determined its optimal binding motif. This motif is present in known Plk1 substrates such as Cdc25, and an optimal phosphopeptide containing the motif disrupted PBD-substrate binding and localization of the PBD to centrosomes. This finding reveals how Plk1 can localize to specific sites within cells in response to Cdk phosphorylation at those sites and provides a structural mechanism for targeting the Plk1 kinase domain to its substrates.	MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA; Beth Israel Deaconess Hosp, Div Signal Transduct, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Dept Biol, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56203, R01 GM056203, GM52981] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lee KS, 1999, P NATL ACAD SCI USA, V96, P14360, DOI 10.1073/pnas.96.25.14360; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pawson T, 2000, GENE DEV, V14, P1027; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7	22	556	570	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1228	1231		10.1126/science.1079079	http://dx.doi.org/10.1126/science.1079079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595692				2022-12-24	WOS:000181065500039
J	Zanusso, G; Ferrari, S; Cardone, F; Zampieri, P; Gelati, M; Fiorini, M; Farinazzo, A; Gardiman, M; Cavallaro, T; Bentivoglio, M; Righetti, PG; Pocchiari, M; Rizzuto, N; Monaco, S				Zanusso, G; Ferrari, S; Cardone, F; Zampieri, P; Gelati, M; Fiorini, M; Farinazzo, A; Gardiman, M; Cavallaro, T; Bentivoglio, M; Righetti, PG; Pocchiari, M; Rizzuto, N; Monaco, S			Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; NEURODEGENERATIVE DISEASES; DIAGNOSTIC-CRITERIA; CEREBROSPINAL-FLUID; CLINICAL-DIAGNOSIS; MOLECULAR-BASIS; SCRAPIE; MUCOSA; EXPRESSION; ACCURACY	BACKGROUND: Olfactory cortexes and the olfactory tracts are involved in sporadic Creutzfeldt-Jakob disease. We examined peripheral regions of the olfactory sensory pathway, including the olfactory mucosa, to assess whether pathologic infectious prion protein (PrP(sup Sc)) is deposited in the epithelium lining the nasal cavity. METHODS: We studied nine patients with neuropathologically confirmed sporadic Creutzfeldt-Jakob disease. We obtained the brain, the cribriform plate with the attached olfactory mucosa, and the surrounding respiratory epithelium at autopsy. Control samples of nasal mucosa were obtained post mortem or at biopsy from age-matched control subjects and from control patients with other neurodegenerative diseases. The olfactory and respiratory mucosa and the intracranial olfactory system were analyzed by light microscopy, immunohistochemistry, and Western blotting for pathological changes and for deposition of PrP(sup Sc). RESULTS: In all nine patients with sporadic Creutzfeldt-Jakob disease, PrP(sup Sc) was found in the olfactory cilia and central olfactory pathway but not in the respiratory mucosa. No PrP(sup Sc) was detected in any of the tissue samples from the 11 controls. CONCLUSIONS: Our pathological and biochemical studies show that PrP(sup Sc) is deposited in the neuroepithelium of the olfactory mucosa in patients with sporadic Creutzfeldt-Jakob disease, indicating that olfactory biopsy may provide diagnostic information in living patients. The olfactory pathway may represent a route of infection and a means of spreading prions.	Univ Verona, Policlin GB Rossi, Dept Neurol & Visual Sci, Sect Clin Neurol, I-37134 Verona, Italy; Univ Verona, Dept Ear Nose & Throat, I-37134 Verona, Italy; Univ Verona, Dept Morphol & Biomed Sci, I-37134 Verona, Italy; Univ Verona, Dept Agr & Ind Biotechnol, I-37134 Verona, Italy; Ist Super Sanita, Virol Lab, I-00161 Rome, Italy; Univ Padua, Dept Pathol, I-35100 Padua, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; University of Verona; Istituto Superiore di Sanita (ISS); University of Padua	Monaco, S (corresponding author), Univ Verona, Policlin GB Rossi, Dept Neurol & Visual Sci, Sect Clin Neurol, Piazzale LA Scuro 10, I-37134 Verona, Italy.	salvatore.monaco@mail.univr.it	Pocchiari, Maurizio/J-8443-2018; Monaco, Salvatore/K-4659-2018; Bentivoglio, Marina/K-1008-2016; Ferrari, Sergio/AAE-5649-2019; Zanusso, Gianluigi/K-2823-2018; Gelati, Matteo/AAR-1692-2020; Cardone, Franco/D-1724-2009	Pocchiari, Maurizio/0000-0002-7269-2486; Monaco, Salvatore/0000-0003-3191-8597; Bentivoglio, Marina/0000-0003-4958-9795; Zanusso, Gianluigi/0000-0001-5199-6264; Cardone, Franco/0000-0002-2376-0470; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716				BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Castellani R, 1996, NEUROLOGY, V46, P1690, DOI 10.1212/WNL.46.6.1690; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; DeArmond SJ, 1999, COLD SPRING HARBOR M, V38, P585; Duda JE, 1999, EXP NEUROL, V160, P515, DOI 10.1006/exnr.1999.7228; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Haywood AM, 1997, NEW ENGL J MED, V337, P1821, DOI 10.1056/NEJM199712183372508; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ingrosso L, 1999, J GEN VIROL, V80, P3043, DOI 10.1099/0022-1317-80-11-3043; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; KITAMOTO T, 1987, LAB INVEST, V57, P230; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kovacs GG, 2002, BRAIN PATHOL, V12, P1; Kretzschmar HA, 1996, ARCH NEUROL-CHICAGO, V53, P913, DOI 10.1001/archneur.1996.00550090125018; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reuber M, 2001, J NEUROL NEUROSUR PS, V71, P412, DOI 10.1136/jnnp.71.3.412; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SALVATORE M, 1994, HUM GENET, V94, P375, DOI 10.1007/BF00201596; SALVATORE M, 1995, HUM GENET, V95, P605; SHIPLEY MT, 1996, HAND CHEM N, V12, P469; Steinhoff BJ, 1996, ARCH NEUROL-CHICAGO, V53, P162, DOI 10.1001/archneur.1996.00550020074017; TABATON M, 1991, NEUROLOGY, V41, P391, DOI 10.1212/WNL.41.3.391; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Zanusso G, 2001, BRAIN PATHOL, V11, P182; Zanusso G, 2001, J BIOL CHEM, V276, P40377, DOI 10.1074/jbc.C100458200; Zerr I, 2000, ANN NEUROL, V48, P323, DOI 10.1002/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	38	117	120	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					711	719		10.1056/NEJMoa022043	http://dx.doi.org/10.1056/NEJMoa022043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594315				2022-12-24	WOS:000181014400006
J	Helms, M; Vastrup, P; Gerner-Smidt, P; Molbak, K				Helms, M; Vastrup, P; Gerner-Smidt, P; Molbak, K			Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study	BRITISH MEDICAL JOURNAL			English	Article							CHARLSON COMORBIDITY INDEX; ADMINISTRATIVE DATA; UNITED-STATES; SALMONELLA; MORBIDITY	Objectives To determine the excess mortality associated with infections with Salmonella, Campylobacter, Yersinia enterocolitica, and Shigella and to examine the effect of pre-existing illness. Design Registry based, matched cohort study. Setting Denmark. Participants 48 857 people with gastrointestinal infections plus 487 138 controls from the general population. Main outcome measure One year mortality among patients with gastrointestinal infections compared with controls after adjustment for comorbidity. Results 1071 (2.2%) people with gastrointestinal infections died within one year after infection compared with 3636 (0.7%) controls. The relative mortality within one year was 3.1 times higher in patients than in controls. The relative mortality within 30 days of infection was high in all four bacterial groups. Furthermore, there was excess mortality one to six months after infection with Yersinia enterocolitica (relative risk 2.53, 95% confidence interval 1.38 to 4.62) and from six months to one year after infection with Campylobacter (1.35, 1.02 to 1.80) and Salmonella (1.53,1.31 to 1.79). Conclusions Infections with all these bacteria were associated with an increased short term risk of death, even after pre-existing illnesses were taken into account. Salmonella, Campylobacter, and Yersinia enterocolitica infections were also associated with increased long term mortality.	Statens Serum Inst, Dept Gastrointestinal Infect, DK-2300 Copenhagen S, Denmark; Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Aarhus University; Statens Serum Institut	Molbak, K (corresponding author), Statens Serum Inst, Dept Gastrointestinal Infect, DK-2300 Copenhagen S, Denmark.			Molbak, Kare/0000-0002-3100-4990				Altekruse SF, 1997, EMERG INFECT DIS, V3, P285, DOI 10.3201/eid0303.970304; Banatvala N, 1999, EPIDEMIOL INFECT, V122, P201, DOI 10.1017/S0950268899002162; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves MA, 1997, J CLIN EPIDEMIOL, V50, P903, DOI 10.1016/S0895-4356(97)00091-7; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; de Wit MAS, 2000, EUR J EPIDEMIOL, V16, P713, DOI 10.1023/A:1026754218713; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FANG FC, 1991, MEDICINE, V70, P198, DOI 10.1097/00005792-199105000-00004; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; Lester A, 1995, Ugeskr Laeger, V157, P20; LESTER A, 1990, Ugeskrift for Laeger, V152, P529; MAUSKOPF JA, 1991, RISK ANAL, V11, P619, DOI 10.1111/j.1539-6924.1991.tb00651.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; Potter Morris E., 1997, World Health Statistics Quarterly, V50, P24; RYAN CA, 1987, JAMA-J AM MED ASSOC, V258, P3269, DOI 10.1001/jama.258.22.3269; Todd Ewen C. D., 1997, World Health Statistics Quarterly, V50, P30	19	160	162	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					357	359		10.1136/bmj.326.7385.357	http://dx.doi.org/10.1136/bmj.326.7385.357			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586666	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000181165500015
J	Ment, LR; Vohr, B; Allan, W; Katz, KH; Schneider, KC; Westerveld, M; Duncan, CC; Makuch, RW				Ment, LR; Vohr, B; Allan, W; Katz, KH; Schneider, KC; Westerveld, M; Duncan, CC; Makuch, RW			Change in cognitive function over time in very low-birth-weight infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTICENTER RANDOMIZED TRIAL; HEMORRHAGE PREVENTION TRIAL; LOW-DOSE INDOMETHACIN; AGE 8 YEARS; INTRAVENTRICULAR HEMORRHAGE; PRETERM INFANTS; DEVELOPMENT PROGRAM; EARLY INTERVENTION; PREMATURE-INFANTS; GESTATIONAL-AGE	Context Preterm very low-birth-weight (VLBW) infants have a high prevalence of neurodevelopmental disability when evaluated during the first several years of life. However, recent experimental data suggest that the developing brain may recover from or compensate for injury. Objective To determine if there is cognitive improvement throughout early and middle childhood following VLBW birth. Design, Setting, and Participants Follow-up data of 296 infants born weighing 600 to 1250 g who participated in a prospective, randomized, placebo-controlled intraventricular hemorrhage (IVH) prevention study performed at 3 northeastern US hospitals between September 1989 and August 1992 and who were serially evaluated at 36, 54, 72, and 96 months of corrected age (CA). Main Outcome Measures The age-normed Peabody Picture Vocabulary Test-Revised (PPVT-R) score and measures of intelligence. Results Overall,,the median PPVT-R score increased from 88 at 36 months of CA to 99 at 96 months of CA; when data from 36 and 96 months of CA were compared, 45% of children gained 10 points or more and 12.5% showed a 5- to 9-point increase in test scores. Similar findings were noted for full-scale and verbal IQ scores. Multivariate analyses demonstrated that increasing age, residence in a 2-parent household, and higher levels of maternal education were all significantly associated with higher PPVT-R scores (for each, P<.001). In addition, early intervention led to greater increases over time in PPVT-R scores among children whose mothers had less than a high school education compared with those with a high school education level or greater (P=.03 by test for interaction). Although most children showed improvement in PPVT-R scores with increasing CA, children with early-onset IVH and subsequent significant central nervous system injury had the lowest PPVT-R scores initially and the scores declined over time (P=.009 by test for interaction). Conclusions The majority of VLBW children had improvement in verbal and IQ test scores over time. Only children with early-onset IVH followed by significant central nervous system injury had low PPVT-R scores that declined over time.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; Brown Univ, Sch Med, Dept Pediat, Providence, RI 02912 USA; Maine Med Ctr, Dept Neurol, Portland, ME 04102 USA	Yale University; Yale University; Yale University; Yale University; Brown University; Maine Medical Center	Ment, LR (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St, New Haven, CT 06520 USA.				NCRR NIH HHS [RR 06022] Funding Source: Medline; NINDS NIH HHS [NS 27116] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027116] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan WC, 1997, ARCH PEDIAT ADOL MED, V151, P580, DOI 10.1001/archpedi.1997.02170430046010; BROOKSGUNN J, 1994, JAMA-J AM MED ASSOC, V272, P1257, DOI 10.1001/jama.272.16.1257; CONSTANTINE NA, 1987, J PEDIATR-US, V110, P921, DOI 10.1016/S0022-3476(87)80416-X; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Dunn L. M., 1981, PPVT PEABODY PICTURE; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; HACK M, 1995, AM J OBSTET GYNECOL, V172, P457, DOI 10.1016/0002-9378(95)90557-X; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Horwood LJ, 1998, ARCH DIS CHILD-FETAL, V79, pF12, DOI 10.1136/fn.79.1.F12; Johnston M V, 2001, Adv Pediatr, V48, P1; LEVINE SC, 1987, DEV MED CHILD NEUROL, V29, P27; McCarton CM, 1997, JAMA-J AM MED ASSOC, V277, P126, DOI 10.1001/jama.277.2.126; McCormick MC, 1996, PEDIATRICS, V97, P18; MENT LR, 1994, J PEDIATR-US, V124, P951, DOI 10.1016/S0022-3476(05)83191-9; Ment LR, 2000, PEDIATRICS, V105, P485, DOI 10.1542/peds.105.3.485; Ment LR, 2002, NEUROLOGY, V58, P1726, DOI 10.1212/WNL.58.12.1726; Ment LR, 1996, PEDIATRICS, V98, P714; MENT LR, 1994, PEDIATRICS, V93, P543; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Petrou S, 2001, CHILD CARE HLTH DEV, V27, P97, DOI 10.1046/j.1365-2214.2001.00203.x; Pinto-Martin JA, 1999, DEV MED CHILD NEUROL, V41, P826, DOI 10.1017/S0012162299001644; Roth S, 2001, EARLY HUM DEV, V65, P81, DOI 10.1016/S0378-3782(01)00173-6; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; SAIGAL S, 1995, J PEDIATR-US, V126, pS61, DOI 10.1016/S0022-3476(95)70009-9; Saigal S, 2001, PEDIATRICS, V108, P407, DOI 10.1542/peds.108.2.407; Salokorpi T, 2001, ACTA PAEDIATR, V90, P218, DOI 10.1080/080352501300049505; Singer LT, 2001, J DEV BEHAV PEDIATR, V22, P19, DOI 10.1097/00004703-200102000-00003; Soll Roger F., 1992, P325; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Taylor HG, 2000, DEV NEUROPSYCHOL, V17, P289, DOI 10.1207/S15326942DN1703_2; TERMAN LM, 1973, STANFORDBINET SCALE; VERLOOVEVANHORICK SP, 1994, PEDIATRICS, V93, P576; Vohr B, 1999, SEMIN PERINATOL, V23, P212, DOI 10.1016/S0146-0005(99)80065-2; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Wechsler D., 2014, WECHSLER PRESCHOOL P; Wechsler D., 1991, WISC 3 WECHSLER INTE; Weiss B, 1997, MENT RETARD DEV D R, V3, P246, DOI 10.1002/(SICI)1098-2779(1997)3:3<246::AID-MRDD5>3.0.CO;2-N; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	42	237	244	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					705	711		10.1001/jama.289.6.705	http://dx.doi.org/10.1001/jama.289.6.705			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585948	Bronze			2022-12-24	WOS:000180886000024
J	Meier, C; Trittibach, P; Guglielmetti, M; Staub, JJ; Muller, B				Meier, C; Trittibach, P; Guglielmetti, M; Staub, JJ; Muller, B			Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Basel Hosp, Dept Med, Div Endocrinol, CH-4031 Basel, Switzerland	University of Basel	Meier, C (corresponding author), Univ Basel Hosp, Dept Med, Div Endocrinol, CH-4031 Basel, Switzerland.		Mueller, Beat/G-2662-2012					Canaris GJ, 1997, J GEN INTERN MED, V12, P544, DOI 10.1046/j.1525-1497.1997.07109.x; FRANKLYN JA, 1993, CLIN ENDOCRINOL, V38, P453, DOI 10.1111/j.1365-2265.1993.tb00339.x; RIDGWAY EC, 1980, CLIN ENDOCRINOL, V13, P479, DOI 10.1111/j.1365-2265.1980.tb03414.x; STAUB JJ, 1992, AM J MED, V92, P631, DOI 10.1016/0002-9343(92)90782-7; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	5	30	32	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					311	312		10.1136/bmj.326.7384.311	http://dx.doi.org/10.1136/bmj.326.7384.311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574044	Bronze, Green Published			2022-12-24	WOS:000180997000018
J	Niven, JE; Vahasoyrinki, M; Kauranen, M; Hardie, RC; Juusola, M; Weckstrom, M				Niven, JE; Vahasoyrinki, M; Kauranen, M; Hardie, RC; Juusola, M; Weckstrom, M			The contribution of Shaker K+ channels to the information capacity of Drosophila photoreceptors	NATURE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; POTASSIUM CHANNELS; CONDUCTANCE; PROPAGATION; DENDRITES; DIVERSITY; MEMBRANE; MUTANTS	An array of rapidly inactivating voltage-gated K+ channels is distributed throughout the nervous systems of vertebrates and invertebrates(1-5). Although these channels are thought to regulate the excitability of neurons by attenuating voltage signals, their specific functions are often poorly understood. We studied the role of the prototypical inactivating K+ conductance, Shaker(6,7), in Drosophila photoreceptors(8,9) by recording intracellularly from wild-type and Shaker mutant photoreceptors. Here we show that loss of the Shaker K+ conductance produces a marked reductionin the signal-to-noise ratio of photoreceptors, generating a 50% decrease in the information capacity of these cells in fully light-adapted conditions. By combining experiments with modelling, we show that the inactivation of Shaker K+ channels amplifies voltage signals and enables photoreceptors to use their voltage range more effectively. Loss of the Shaker conductance attenuated the voltage signal and induced a compensatory decrease in impedance. Our results demonstrate the importance of the Shaker K+ conductance for neural coding precision and as a mechanism for selectively amplifying graded signals in neurons, and highlight the effect of compensatory mechanisms on neuronal information processing.	Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England; Univ Oulu, Dept Phys Sci, Div Biophys, Oulu, Finland; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge; University of Oulu; University of Cambridge	Juusola, M (corresponding author), Univ Cambridge, Physiol Lab, Downing St, Cambridge CB2 3EG, England.	mj216@cus.cam.ac.uk	Niven, Jeremy E/A-5883-2011; Juusola, Mikko/E-6948-2011	Juusola, Mikko/0000-0002-4428-5330; Hardie, Roger/0000-0001-5531-3264				Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1991, J NEUROSCI, V11, P3079; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HEVERS W, 1995, NEURON, V14, P845, DOI 10.1016/0896-6273(95)90228-7; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D., 1995, FDN CELLULAR NEUROPH; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; KAPLAN WD, 1969, GENETICS, V61, P399; KOUVALAINEN E, 1994, VISUAL NEUROSCI, V11, P1221, DOI 10.1017/S095252380000701X; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAURENT G, 1990, J NEUROSCI, V10, P2268; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WECKSTROM M, 1995, TRENDS NEUROSCI, V18, P17, DOI 10.1016/0166-2236(95)93945-T	30	67	67	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					630	634		10.1038/nature01384	http://dx.doi.org/10.1038/nature01384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571596				2022-12-24	WOS:000180803200042
J	Doiron, B; Chacron, MJ; Maler, L; Longtin, A; Bastian, J				Doiron, B; Chacron, MJ; Maler, L; Longtin, A; Bastian, J			Inhibitory feedback required for network oscillatory responses to communication but not prey stimuli	NATURE			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; ENCODING NEURAL ASSEMBLIES; CORTICOTHALAMIC FEEDBACK; SENSORY SEARCHLIGHT; VISUAL-CORTEX; SYNCHRONIZATION; NEURONS; CELLS; MECHANISMS	Stimulus-induced oscillations occur in visual(1,2), olfactory(3-6) and somatosensory(7) systems. Several experimental(2,3,5) and theoretical(8-13) studies have shown how such oscillations can be generated by inhibitory connections between neurons. But the effects of realistic spatiotemporal sensory input on oscillatory network dynamics and the overall functional roles of such oscillations in sensory processing are poorly understood. Weakly electric fish must detect electric field modulations produced by both prey (spatially localized)(14) and communication (spatially diffuse)(15) signals. Here we show, through in vivo recordings, that sensory pyramidal neurons in these animals produce an oscillatory response to communication-like stimuli, but not to prey-like stimuli. On the basis of well-characterized circuitry(16), we construct a network model of pyramidal neurons that predicts that diffuse delayed inhibitory feedback is required to achieve oscillatory behaviour only in response to communication-like stimuli. This prediction is experimentally verified by reversible blockade of feedback inhibition that removes oscillatory behaviour in the presence of communication-like stimuli. Our results show that a sensory system can use inhibitory feedback as a mechanism to 'toggle' between oscillatory and non-oscillatory firing states, each associated with a naturalistic stimulus.	Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Ottawa; University of Ottawa; University of Oklahoma System; University of Oklahoma - Norman	Doiron, B (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.		Longtin, Andre/D-2443-2009	Chacron, Maurice/0000-0002-3032-452X				AHISSAR E, 1990, P NATL ACAD SCI USA, V87, P8935, DOI 10.1073/pnas.87.22.8935; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; Berman NJ, 1998, J NEUROPHYSIOL, V80, P3197, DOI 10.1152/jn.1998.80.6.3197; Berman NJ, 1999, J EXP BIOL, V202, P1243; Berman NJ, 1997, J NEUROPHYSIOL, V78, P1869, DOI 10.1152/jn.1997.78.4.1869; Bressloff PC, 2000, NEURAL COMPUT, V12, P91, DOI 10.1162/089976600300015907; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Dayan P., 2001, THEORETICAL NEUROSCI; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kloeden P. E., 1992, NUMERICAL SOLUTIONS; Lemon N, 2000, J NEUROPHYSIOL, V84, P1519, DOI 10.1152/jn.2000.84.3.1519; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MALER L, 1994, J COMP NEUROL, V345, P224, DOI 10.1002/cne.903450206; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; Metzner W, 1999, J EXP BIOL, V202, P1365; Nelson ME, 1999, J EXP BIOL, V202, P1195; Pauluis Q, 1999, J COMPUT NEUROSCI, V6, P27, DOI 10.1023/A:1008804916112; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; van Vreeswijk C, 2001, NEURAL COMPUT, V13, P959, DOI 10.1162/08997660151134280; WANG XJ, 1993, NEUROSCIENCE, V53, P899, DOI 10.1016/0306-4522(93)90474-T; Wessel R, 1996, J NEUROPHYSIOL, V75, P2280, DOI 10.1152/jn.1996.75.6.2280	30	133	134	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					539	543		10.1038/nature01360	http://dx.doi.org/10.1038/nature01360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556894				2022-12-24	WOS:000180670600047
J	Ma, D; Yang, CH; McNeill, H; Simon, MA; Axelrod, JD				Ma, D; Yang, CH; McNeill, H; Simon, MA; Axelrod, JD			Fidelity in planar cell polarity signalling	NATURE			English	Article							TISSUE POLARITY; DROSOPHILA EYE; CADHERIN SUPERFAMILY; GENE; ENCODES; MEMBER; PROTEIN; MORPHOGENESIS; MUTATIONS; GROWTH	The polarity of Drosophila wing hairs displays remarkable fidelity. Each of the approximately 30,000 wing epithelial cells constructs an actin-rich prehair that protrudes from its distal vertex and points distally. The distal location and orientation of the hairs is virtually error free, thus forming a nearly perfect parallel array. This process is controlled by the planar cell polarity signalling pathway(1-4). Here we show that interaction between two tiers of the planar cell polarity signalling mechanism results in the observed high fidelity. The first tier, mediated by the cadherin Fat(5), dictates global orientation by transducing a directional signal to individual cells. The second tier, orchestrated by the 7-pass transmembrane receptor Frizzled(6,7), aligns each cell's polarity with that of its neighbours through the action of an intercellular feedback loop, enabling polarity to propagate from cell to cell(8). We show that all cells need not respond correctly to the presumably subtle signal transmitted by Fat. Subsequent action of the Frizzled feedback loop is sufficient to align all the cells cooperatively. This economical system is therefore highly robust, and produces virtually error-free arrays.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Canc Res UK, London Res Inst, London WC2A 3PX, England	Stanford University; Stanford University; Cancer Research UK	Axelrod, JD (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.		McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154				Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Adler PN, 1998, DEVELOPMENT, V125, P959; Axelrod JD, 2001, GENE DEV, V15, P1182; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Chae J, 1999, DEVELOPMENT, V126, P5421; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Taylor J, 1998, GENETICS, V150, P199; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wolff T, 1998, DEVELOPMENT, V125, P1149; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	30	256	257	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					543	547		10.1038/nature01366	http://dx.doi.org/10.1038/nature01366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540853				2022-12-24	WOS:000180670600048
J	Komiyama, T; Johnson, WA; Luo, LQ; Jefferis, GSXE				Komiyama, T; Johnson, WA; Luo, LQ; Jefferis, GSXE			From lineage to wiring specificity: POU domain transcription factors control precise connections of Drosophila olfactory projection neurons	CELL			English	Article							C-ELEGANS; MOTOR-NEURONS; CELL LINEAGE; SENSORY MAP; IDENTITY; CODES; ACJ6; DIFFERENTIATION; REPRESENTATION; MELANOGASTER	Axonal selection of synaptic partners is generally believed to determine wiring specificity in the nervous system. However, we have recently found evidence for specific dendritic targeting in the olfactory system of Drosophila: second order olfactory neurons (Projection Neurons) from the anterodorsal (adPN) and lateral (IPN) lineages send their dendrites to stereotypical, intercalating but non-overlapping glomeruli. Here we show that POU domain transcription factors, Acj6 and Drifter, are expressed in adPNs and IPNs respectively, and are required for their dendritic targeting. Moreover, misexpression of Acj6 in IPNs, or Drifter in adPNs, results in dendritic targeting to glomeruli normally reserved for the other PN lineage. Thus, Acj6 and Drifter translate PN lineage information into distinct dendritic targeting specificity. Acj6 also controls stereotypical axon terminal arborization of PNs in a central target, suggesting that the connectivity of PN axons and dendrites in different brain centers is coordinately regulated.	Stanford Univ, Dept Biol Sci, Neurosci Program, Stanford, CA 94305 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Stanford University; University of Iowa	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Neurosci Program, Stanford, CA 94305 USA.	lluo@stanford.edu	Jefferis, Gregory/C-6386-2012	Johnson, Wayne/0000-0002-6961-5498; Komiyama, Takaki/0000-0001-9609-4600; Jefferis, Gregory/0000-0002-0587-9355; Luo, Liqun/0000-0001-5467-9264				ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; Certel K, 2000, DEVELOPMENT, V127, P3173; Certel SJ, 2000, DEVELOPMENT, V127, P2395; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	34	125	125	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					157	167		10.1016/S0092-8674(03)00030-8	http://dx.doi.org/10.1016/S0092-8674(03)00030-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553905	Bronze			2022-12-24	WOS:000181191600006
J	Schefuss, E; Schouten, S; Jansen, JHF; Damste, JSS				Schefuss, E; Schouten, S; Jansen, JHF; Damste, JSS			African vegetation controlled by tropical sea surface temperatures in the mid-Pleistocene period	NATURE			English	Article							MIDPLEISTOCENE CLIMATE TRANSITION; ATMOSPHERIC CO2; LATE MIOCENE; C-4 GRASSES; ATLANTIC; PAST; EXPANSION; PLANTS; MODEL; CYCLE	The dominant forcing factors for past large-scale changes in vegetation are widely debated. Changes in the distribution of C-4 plants-adapted to warm, dry conditions and low atmospheric CO2 concentrations(1)-have been attributed to marked changes in environmental conditions, but the relative impacts of changes in aridity, temperature(2,3) and CO2 concentration(4,5) are not well understood. Here, we present a record of African C-4 plant abundance between 1.2 and 0.45 million years ago, derived from compound-specific carbon isotope analyses of wind-transported terrigenous plant waxes. We find that large-scale changes in African vegetation are linked closely to sea surface temperatures in the tropical Atlantic Ocean. We conclude that, in the mid-Pleistocene, changes in atmospheric moisture content-driven by tropical sea surface temperature changes and the strength of the African monsoon-controlled aridity on the African continent, and hence large-scale vegetation changes.	Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Schefuss, E (corresponding author), Royal Netherlands Inst Sea Res, POB 59, NL-1790 AB Den Burg, Netherlands.		Schefuß, Enno/A-7101-2015; Damste, Jaap S Sinninghe/F-6128-2011	Schefuß, Enno/0000-0002-5960-930X; Damste, Jaap S Sinninghe/0000-0002-8683-1854				BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; COLLISTER JW, 1994, ORG GEOCHEM, V21, P619, DOI 10.1016/0146-6380(94)90008-6; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Dupont LM, 2001, GEOLOGY, V29, P195, DOI 10.1130/0091-7613(2001)029<0195:MPECIT>2.0.CO;2; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FONTAINE B, 1993, INT J CLIMATOL, V13, P271, DOI 10.1002/joc.3370130304; Ganopolski A, 1998, NATURE, V391, P351, DOI 10.1038/34839; Huang Y, 2001, SCIENCE, V293, P1647, DOI 10.1126/science.1060143; JANSEN JHF, 2001, P OC DRILL PROGR SCI, V175; Katz EJ, 1982, J MAR RES, V40, P307; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; McIntyre A, 1989, PALEOCEANOGRAPHY, V4, P19, DOI 10.1029/PA004i001p00019; Mudelsee M, 1997, EARTH PLANET SC LETT, V151, P117, DOI 10.1016/S0012-821X(97)00114-3; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Partridge TC, 1997, QUATERNARY SCI REV, V16, P1125, DOI 10.1016/S0277-3791(97)00005-X; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; PHILANDER SGH, 1986, J GEOPHYS RES-OCEANS, V91, P14192, DOI 10.1029/JC091iC12p14192; PRELL WL, 1987, J GEOPHYS RES-ATMOS, V92, P8411, DOI 10.1029/JD092iD07p08411; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P546, DOI 10.1029/97PA01019; Sage RF, 2001, PLANT BIOLOGY, V3, P202, DOI 10.1055/s-2001-15206; SCHEFUSS E, IN PRESS GEOCHIM COS; SCHNEIDER RR, 1995, PALEOCEANOGRAPHY, V10, P197, DOI 10.1029/94PA03308; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Shackleton NJ., 1976, GEOLOGICAL SOC AM ME, P449, DOI DOI 10.1130/MEM145-P449; Wyputta U, 1999, PALAEOGEOGR PALAEOCL, V146, P53, DOI 10.1016/S0031-0182(98)00142-4	30	169	181	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					418	421		10.1038/nature01500	http://dx.doi.org/10.1038/nature01500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660780				2022-12-24	WOS:000181801200041
J	Blankenburg, F; Taskin, B; Ruben, J; Moosmann, M; Ritter, P; Curio, G; Villringer, A				Blankenburg, F; Taskin, B; Ruben, J; Moosmann, M; Ritter, P; Curio, G; Villringer, A			Imperceptible stimuli and sensory processing impediment	SCIENCE			English	Article							SOMATOSENSORY CORTEX; BLOOD-FLOW		Humboldt Univ, Charite, Dept Neurol, D-10117 Berlin, Germany; Free Univ Berlin, Benjamin Franklin Hosp, Dept Neurol, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Blankenburg, F (corresponding author), Humboldt Univ, Charite, Dept Neurol, Schumannstr 20-21, D-10117 Berlin, Germany.		Ritter, Petra/B-6953-2008	Ritter, Petra/0000-0002-4643-4782; Villringer, Arno/0000-0003-2604-2404; Curio, Gabriel/0000-0002-3377-7735				DREVETS WC, 1995, NATURE, V373, P249, DOI 10.1038/373249a0; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; LIBET B, 1967, SCIENCE, V158, P1597, DOI 10.1126/science.158.3808.1597; Paus T, 1998, J NEUROPHYSIOL, V79, P1102, DOI 10.1152/jn.1998.79.2.1102; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802	8	77	77	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1864	1864		10.1126/science.1080806	http://dx.doi.org/10.1126/science.1080806			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649475				2022-12-24	WOS:000181669700036
J	Campion, EW				Campion, EW			A death at Duke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	28	28	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1083	1084		10.1056/NEJMp030033	http://dx.doi.org/10.1056/NEJMp030033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646664				2022-12-24	WOS:000181628400003
J	Quinlivan, JA; Box, H; Evans, SF				Quinlivan, JA; Box, H; Evans, SF			Postnatal home visits in teenage mothers: a randomised controlled trial	LANCET			English	Article							ADOLESCENT PREGNANCY; MATERNAL AGE; PROGRAM; CHILDBEARING; PREVENTION; VISITATION; INFANCY; NURSES; RISK	Background Teenage pregnancies are associated with negative socioeconomic effects. Our aim was to ascertain whether a postnatal home-visiting service for teenage mothers younger than age 18 years could reduce the frequency of adverse neonatal outcomes and improve knowledge of contraception, breastfeeding, and infant vaccination schedules in this parent group. Methods We enrolled 139 adolescents, attending a teenage pregnancy clinic, in a randomised controlled trial. After completing an antenatal questionnaire designed to assess their knowledge of contraception, infant vaccination, and breastfeeding, we assigned participants to either receive five structured postnatal home visits by nurse-midwives (n=65) or not (n=71). Assessment interviews were done 6 months postpartum. Our primary endpoint was unadjusted difference in knowledge between groups, and incidence of predefined adverse neonatal outcomes. Analysis was by intention to treat. Findings Three women withdrew before randomisation because of late fetal loss, 11 mothers withdrew because of adverse neonatal outcomes (adverse neonatal outcome was a primary endpoint, but resulted in withdrawal from the study for knowledge outcomes), and one left voluntarily. Follow-up data were, therefore, available for 124 teenagers. Postnatal home visits were associated with a reduction in adverse neonatal outcomes (intervention: 2; control: 9; relative risk 0.24, 95% CI 0.05-1.08), and a significant increase in contraception knowledge (mean difference 0.92, 95% CI 0.32-1.52). However, there was no significant increase in knowledge with respect to breastfeeding or infant vaccination schedules associated with the home visits. Interpretation Postnatal home-visiting services by nurse-midwives reduce adverse neonatal events and improve contraception outcomes, but do not affect breastfeeding or infant vaccination knowledge or compliance.	Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; King Edward Mem Hosp, Obstet Clin Care Unit, Perth, WA, Australia; Univ Western Australia, Dept Obstet & Gynaecol, Nedlands, WA 6009, Australia; Univ Western Australia, Womens & Infants Res Fdn, Nedlands, WA 6009, Australia	University of Melbourne; King Edward Memorial Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Quinlivan, JA (corresponding author), Univ Melbourne, Royal Womens Hosp, Univ Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia.	julieq@unimelb.edu.au		Quinlivan, Julie/0000-0003-4706-2412				Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; [Anonymous], 1973, OB GYN NEWS, V8, P1; BABSON SG, 1983, J PEDIATR-US, V103, P391, DOI 10.1016/S0022-3476(83)80409-0; Chase-Lansdale PL, 2002, FUTURE CHILD, V12, P167; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; FURSTENBERG FF, 1989, AM PSYCHOL, V44, P313, DOI 10.1037/0003-066X.44.2.313; Gueorguieva RV, 2001, AM J EPIDEMIOL, V154, P212, DOI 10.1093/aje/154.3.212; Guyatt GH, 2000, J CLIN EPIDEMIOL, V53, P167, DOI 10.1016/S0895-4356(99)00160-2; Hippisley-Cox J, 2000, BRIT MED J, V320, P842, DOI 10.1136/bmj.320.7238.842; HOBBS CJ, 1999, CHILD ABUSE NEGLECT; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Korfmacher J, 1999, AM J PUBLIC HEALTH, V89, P1847, DOI 10.2105/AJPH.89.12.1847; Magann EF, 1996, AM J OBSTET GYNECOL, V175, P182, DOI 10.1016/S0002-9378(96)70272-7; MCANARNEY ER, 1987, AM J DIS CHILD, V141, P1053, DOI 10.1001/archpedi.1987.04460100031017; Miller F C, 2000, J Pediatr Adolesc Gynecol, V13, P5, DOI 10.1016/S1083-3188(99)00035-2; Morrell CJ, 2000, BRIT MED J, V321, P593, DOI 10.1136/bmj.321.7261.593; Nair P, 1997, CHILD ABUSE NEGLECT, V21, P1039, DOI 10.1016/S0145-2134(97)00064-1; OLDS DL, 1986, PEDIATRICS, V78, P65; Pierre Natalie, 1997, Current Opinion in Pediatrics, V9, P310, DOI 10.1097/00008480-199708000-00003; POLIT DF, 1986, AM J PUBLIC HEALTH, V76, P167, DOI 10.2105/AJPH.76.2.167; Quinlivan J A, 2001, J Pediatr Adolesc Gynecol, V14, P17, DOI 10.1016/S1083-3188(00)00078-4; Quinlivan JA, 1999, AUST NZ J PSYCHIAT, V33, P864, DOI 10.1046/j.1440-1614.1999.00592.x; Social Exclusion Unit, 1999, TEEN PREGN REP PARL; Stevens-Simon C, 1998, ARCH PEDIAT ADOL MED, V152, P893; Stevens-Simon C, 2001, CHILD ABUSE NEGLECT, V25, P753, DOI 10.1016/S0145-2134(01)00237-X; StevensSimon C, 1997, JAMA-J AM MED ASSOC, V277, P977, DOI 10.1001/jama.277.12.977; WILLIAMS S, 1987, BRIT MED J, V294, P20, DOI 10.1136/bmj.294.6563.20-a; 1989, HOME VISITING OPENIN	28	83	83	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2003	361	9361					893	900		10.1016/S0140-6736(03)12770-5	http://dx.doi.org/10.1016/S0140-6736(03)12770-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	658VP	12648967				2022-12-24	WOS:000181741600006
J	Duncan, RR; Greaves, J; Wiegand, UK; Matskovich, I; Bodammer, G; Apps, DK; Shipston, MJ; Chow, RH				Duncan, RR; Greaves, J; Wiegand, UK; Matskovich, I; Bodammer, G; Apps, DK; Shipston, MJ; Chow, RH			Functional and spatial segregation of secretory vesicle pools according to vesicle age	NATURE			English	Article							ADRENAL CHROMAFFIN CELLS; EXOCYTOSIS; GRANULES; CALCIUM; BARIUM; SYNAPTOTAGMINS; BIOSYNTHESIS; MICROSCOPY; TRANSPORT; DYNAMICS	Synaptic terminals and neuroendocrine cells are packed with secretory vesicles, only a few of which are docked at the plasma membrane and readily releasable. The remainder are thought to constitute a large cytoplasmic reserve pool awaiting recruitment into the readily releasable pool (RRP) for exocytosis'. How vesicles are prioritized in recruitment is still unknown: the choice could be random, or else the oldest or the newest ones might be favoured. Here we show, using a fluorescent cargo protein(2) that changes colour with time(3), that vesicles in bovine adrenal chromaffin cells segregate into distinct populations, based on age. Newly assembled vesicles are immobile (morphologically docked) at the plasma membrane shortly after biogenesis, whereas older vesicles are mobile and located deeper in the cell. Different secretagogues selectively release vesicles from the RRP or, surprisingly, selectively from the deeper cytoplasmic pool. Thus, far from being equal, vesicles are segregated functionally and spatially according to age.	Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; Univ Edinburgh, Membrane Biol Grp, Edinburgh EH8 9XD, Midlothian, Scotland	University of Southern California; University of Edinburgh	Chow, RH (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA.		Chow, Robert/B-8155-2013; Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; Duncan, Rory/0000-0003-0693-910X; Greaves, Jennifer/0000-0001-8445-789X				Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; CHEN TT, 1989, ENDOCRINOLOGY, V125, P1904, DOI 10.1210/endo-125-4-1904; CORCORAN JJ, 1984, J BIOL CHEM, V259, P6208; Cuchillo-Ibanez I, 1999, FEBS LETT, V459, P22, DOI 10.1016/S0014-5793(99)01115-1; Duncan RR, 1999, BIOCHEM J, V342, P497, DOI 10.1042/0264-6021:3420497; FREESTONE S, 1989, BRIT J CLIN PHARMACO, V27, P13, DOI 10.1111/j.1365-2125.1989.tb05329.x; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; HELDMAN E, 1989, J BIOL CHEM, V264, P7914; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lundstrom K, 2001, HISTOCHEM CELL BIOL, V115, P83, DOI 10.1007/s004180000223; Morgan A, 1997, SEMIN CELL DEV BIOL, V8, P141, DOI 10.1006/scdb.1996.0133; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; NGUYEN TT, 1988, FEBS LETT, V231, P393, DOI 10.1016/0014-5793(88)80857-3; Ogawa T, 1999, AM J PHYSIOL-HEART C, V276, pH1977, DOI 10.1152/ajpheart.1999.276.6.H1977; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PHILLIPS JH, 1982, NEUROSCIENCE, V7, P1595, DOI 10.1016/0306-4522(82)90017-3; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; Seward EP, 1996, J NEUROSCI, V16, P1370; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; TERBUSH DR, 1992, J NEUROCHEM, V58, P680, DOI 10.1111/j.1471-4159.1992.tb09771.x; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Winkler H, 1998, CELL MOL NEUROBIOL, V18, P193, DOI 10.1023/A:1022516919932	27	174	178	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					176	180		10.1038/nature01389	http://dx.doi.org/10.1038/nature01389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634788				2022-12-24	WOS:000181488900048
J	Hakin-Smith, V; Jellinek, DA; Levy, D; Carroll, T; Teo, M; Timperley, WR; McKay, MJ; Reddel, RR; Royds, JA				Hakin-Smith, V; Jellinek, DA; Levy, D; Carroll, T; Teo, M; Timperley, WR; McKay, MJ; Reddel, RR; Royds, JA			Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme	LANCET			English	Article							MECHANISM	Despite advances In the molecular pathogenesis of giloblastoma multiforme, no reliable prognostic markers have been Identified. We analysed telomerase activity and telomere lengths In giloblastoma multiformes from 77 patients. 19 patients (25%) had tumours with the alternative-lengthening-of-telomere (ALT) phenotype. Median survival for patients with this phenotype was 542 days (95% CI 114-970) compared with 247 days (224-270) for glioblastoma multiformes with normal telomeres (p=0.0003). Cox's regression analysis showed that this association is independent of age. In patients with non-ALT tumours, telomerase activity did not affect survival (median 287 [199-375] vs 236 [230-242] days, p=0.275). We conclude that ALT Is a prognostic Indicator for patients with glioblastoma multiforme.	Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield, S Yorkshire, England; Royal Hallamshire Hosp, Dept Neuropathol, Sheffield S10 2JF, S Yorkshire, England; Royal Hallamshire Hosp, Dept Neurosurg, Sheffield S10 2JF, S Yorkshire, England; Weston Pk Hosp, Sheffield, S Yorkshire, England; Peter MacCallum Canc Inst, Div Res, Melbourne, Vic 3000, Australia; Childrens Med Res Inst, Sydney, NSW, Australia	University of Sheffield; University of Sheffield; University of Sheffield; Weston Park Hospital; Peter Maccallum Cancer Center; Children's Medical Research Institute - Australia; University of Sydney	Royds, JA (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, POB 913, Dunedin, New Zealand.		Reddel, Roger R/A-6635-2014; Teo, Mario/AAE-5804-2020; McKay, Michael/ABA-9029-2021	Reddel, Roger R/0000-0002-6302-6107; Teo, Mario/0000-0002-0051-3303; 				Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Bryant JE, 1997, BIOTECHNIQUES, V23, P476, DOI 10.2144/97233st05; Carroll T, 1999, J PATHOL, V188, P395; Latif AZB, 1998, J NEUROL NEUROSUR PS, V64, P747, DOI 10.1136/jnnp.64.6.747; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599	5	213	223	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					836	838		10.1016/S0140-6736(03)12681-5	http://dx.doi.org/10.1016/S0140-6736(03)12681-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642053				2022-12-24	WOS:000181466600015
J	Depege, N; Bellafiore, S; Rochaix, JD				Depege, N; Bellafiore, S; Rochaix, JD			Role of chloroplast protein kinase Stt7 in LHCII phosphorylation and state transition in Chlamydomonas	SCIENCE			English	Article							LIGHT ENERGY-DISTRIBUTION; REINHARDTII; PHOTOSYNTHESIS; MUTANTS; POLYPEPTIDE; ACTIVATION; SUBUNIT	Photosynthetic organisms adapt to changes in light quality by redistributing light excitation energy between two photosystems through state transition. This reorganization of antenna systems leads to an enhanced photosynthetic yield. Using a genetic approach in Chlamydomonas reinhardtii to dissect the signal transduction pathway of state transition, we identified a chloroplast thylakoid-associated serine-threonine protein kinase, Stt7, that has homologs in land plants. Stt7 is required for the phosphorylation of the major light-harvesting protein (LHCII) and for state transition.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Rochaix, JD (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean-david.rochaix@molbio.unige.ch	Bellafiore, stephane/AFS-1835-2022; Bellafiore, stephane/J-4756-2014; Rochaix, Jean-David/ABC-5243-2020	Bellafiore, stephane/0000-0002-4394-0866; Bellafiore, stephane/0000-0002-4394-0866; Fargeix, Nathalie/0000-0003-4591-1791				ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; DEPEGE N, UNPUB; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Kruse O, 1999, PHOTOSYNTH RES, V61, P43, DOI 10.1023/A:1006229308606; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; PURTON S, 1994, PLANT MOL BIOL, V24, P533, DOI 10.1007/BF00024121; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; Ruelland E, 1999, TRENDS PLANT SCI, V4, P136, DOI 10.1016/S1360-1385(99)01391-6; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	19	394	413	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1572	1575		10.1126/science.1081397	http://dx.doi.org/10.1126/science.1081397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624266				2022-12-24	WOS:000181367900037
J	Vanhamme, L; Paturiaux-Hanocq, F; Poelvoorde, P; Nolan, DP; Lins, L; Van den Abbeele, J; Pays, A; Tebabi, P; Van Xong, H; Jacquet, A; Moguilevsky, N; Dieu, M; Kane, JP; De Baetselier, P; Brasseur, R; Pays, E				Vanhamme, L; Paturiaux-Hanocq, F; Poelvoorde, P; Nolan, DP; Lins, L; Van den Abbeele, J; Pays, A; Tebabi, P; Van Xong, H; Jacquet, A; Moguilevsky, N; Dieu, M; Kane, JP; De Baetselier, P; Brasseur, R; Pays, E			Apolipoprotein L-I is the trypanosome lytic factor of human serum	NATURE			English	Article							HAPTOGLOBIN-RELATED PROTEIN; L GENE-CLUSTER; BRUCEI; EXPRESSION; IDENTIFICATION; GLYCOPROTEIN; RHODESIENSE; ENDOCYTOSIS; RESISTANCE; CLONING	Human sleeping sickness in east Africa is caused by the parasite Trypanosoma brucei rhodesiense. The basis of this pathology is the resistance of these parasites to lysis by normal human serum (NHS)(1,2). Resistance to NHS is conferred by a gene that encodes a truncated form of the variant surface glycoprotein termed serum resistance associated protein (SRA)(3,4). We show that SRA is a lysosomal protein, and that the amino-terminal alpha-helix of SRA is responsible for resistance to NHS. This domain interacts strongly with a carboxy-terminal alpha-helix of the human-specific serum protein apolipoprotein L-I (apoL-I). Depleting NHS of apoL-I, by incubation with SRA or anti-apoL-I, led to the complete loss of trypanolytic activity. Addition of native or recombinant apoL-I either to apoL-I-depleted NHS or to fetal calf serum induced lysis of NHS-sensitive, but not NHS-resistant, trypanosomes. Confocal microscopy demonstrated that apoL-I is taken up through the endocytic pathway into the lysosome. We propose that apoL-I is the trypanosome lytic factor of NHS, and that SRA confers resistance to lysis by interaction with apoL-I in the lysosome.	Univ Brussels, IBMM, Mol Parasitol Lab, B-6041 Gosselies, Belgium; Univ Gembloux, Ctr Biophys Mol Numer, B-5030 Gembloux, Belgium; Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; Free Univ Brussels, Cellular Immunol Lab, B-1640 Rhode St Genese, Belgium; Univ Brussels, IBMM, Lab Appl Genet, B-6041 Brussels, Belgium; Univ Namur, Unit Cellular Biochem & Biol, B-5000 Namur, Belgium; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Universite Libre de Bruxelles; University of Liege; Institute of Tropical Medicine (ITM); University of Namur; University of California System; University of California San Francisco	Pays, E (corresponding author), Univ Brussels, IBMM, Mol Parasitol Lab, 12 Rue Prof Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	LINS, LAURENCE/Y-1661-2019; Jacquet, Alain/GQI-0546-2022; De Baetselier, Patrick/D-3866-2014; Jacquet, Alain/T-8611-2019	LINS, LAURENCE/0000-0001-7772-6748; Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741; Nolan, Derek/0000-0002-3742-4304; Van Den Abbeele, Jan/0000-0002-4533-4480; Dieu, Marc/0000-0002-3902-542X				BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; BRASSEUR R, 1994, J MOL GRAPHICS, V12, P212; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; DOTHI CD, 1991, MOL BIOCHEM PARASIT, V48, P199; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; GUEX N, 1997, ELECTROPHORESIS, V18, P14; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Hatada S, 2002, MOL BIOCHEM PARASIT, V119, P291, DOI 10.1016/S0166-6851(01)00420-0; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lins L, 2001, PROTEINS, V44, P435, DOI 10.1002/prot.1109; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Raper J, 2001, CURR OPIN MICROBIOL, V4, P402, DOI 10.1016/S1369-5274(00)00226-5; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Shimamura M, 2001, MOL BIOCHEM PARASIT, V115, P227, DOI 10.1016/S0166-6851(01)00292-4; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	21	351	365	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					83	87		10.1038/nature01461	http://dx.doi.org/10.1038/nature01461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621437				2022-12-24	WOS:000181343100042
J	Nath, U; Crawford, BCW; Carpenter, R; Coen, E				Nath, U; Crawford, BCW; Carpenter, R; Coen, E			Genetic control of surface curvature	SCIENCE			English	Article							LEAF DEVELOPMENT; GROWTH; ARABIDOPSIS; ANTIRRHINUM; EXPRESSION; ASYMMETRY; PATTERNS; DIVISION; TOBACCO; PLANTS	Although curvature of biological surfaces has been considered from mathematical and biophysical perspectives, its molecular and developmental basis is unclear. We have studied the cin mutant of Antirrhinum, which has crinkly rather than flat leaves. Leaves of cin display excess growth in marginal regions, resulting in a gradual introduction of negative curvature during development. This reflects a change in the shape and the progression of a cell-cycle arrest front moving from the leaf tip toward the base. CIN encodes a TCP protein and is expressed downstream of the arrest front. We propose that CIN promotes zero curvature (flatness) by making cells more sensitive to an arrest signal, particularly in marginal regions.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk						Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; BALL P, 2002, NATURE SCI UPDATE; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; DOONAN JH, COMMUNICATION; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; FOBERT PR, 1994, EMBO J, V13, P616, DOI 10.1002/j.1460-2075.1994.tb06299.x; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Gaudin V, 2000, PLANT PHYSIOL, V122, P1137, DOI 10.1104/pp.122.4.1137; Green PB, 1999, AM J BOT, V86, P1059, DOI 10.2307/2656967; Green PB, 1996, ANN BOT-LONDON, V78, P269, DOI 10.1006/anbo.1996.0121; Kosugi S, 1997, PLANT CELL, V9, P1607, DOI 10.1105/tpc.9.9.1607; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; KRSEK P., 1998, MATH SURFACES 8, P1; Lawrence A.D, UNPUB; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; MARDER M, IN PRESS COND MAT; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1985, PLANTA, V165, P158, DOI 10.1007/BF00395038; PYKE KA, 1991, J EXP BOT, V42, P1407, DOI 10.1093/jxb/42.11.1407; Stubbe H, 1966, GENETIK ZYTOLOGIE AN; SYLVESTER AW, 1990, DEVELOPMENT, V110, P985; TODD PH, 1985, J THEOR BIOL, V113, P63, DOI 10.1016/S0022-5193(85)80075-8; Waddington CH, 1940, J GENET, V41, P75, DOI 10.1007/BF02982977; WOLF SD, 1986, AM J BOT, V73, P832, DOI 10.2307/2444294	27	524	568	11	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1404	1407		10.1126/science.1079354	http://dx.doi.org/10.1126/science.1079354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610308				2022-12-24	WOS:000181192300055
J	Gaunt, MW; Yeo, M; Frame, IA; Stothard, JR; Carrasco, HJ; Taylor, MC; Mena, SS; Veazey, P; Miles, GAJ; Acosta, N; de Arias, AR; Miles, MA				Gaunt, MW; Yeo, M; Frame, IA; Stothard, JR; Carrasco, HJ; Taylor, MC; Mena, SS; Veazey, P; Miles, GAJ; Acosta, N; de Arias, AR; Miles, MA			Mechanism of genetic exchange in American trypanosomes	NATURE			English	Article							CRUZI; IDENTIFICATION; EVOLUTION; LINEAGES; STRAINS	The kinetoplastid Protozoa are responsible for devastating diseases(1). In the Americas, Trypanosoma cruzi is the agent of Chagas' disease-a widespread disease transmissible from animals to humans (zoonosis)-which is transmitted by exposure to infected faeces of blood-sucking triatomine bugs(2). The presence of genetic exchange in T. cruzi and in Leishmania is much debated(3,4). Here, by producing hybrid clones, we show that T. cruzi has an extant capacity for genetic exchange. The mechanism is unusual and distinct from that proposed for the African trypanosome, Trypanosoma brucei(5). Two biological clones(6) of T. cruzi were transfected to carry different drug-resistance markers(7,8), and were passaged together through the entire life cycle. Six double-drug-resistant progeny clones, recovered from the mammalian stage of the life cycle, show fusion of parental genotypes, loss of alleles, homologous recombination, and uniparental inheritance of kinetoplast maxicircle DNA. There are strong genetic parallels between these experimental hybrids and the genotypes among natural isolates of T. cruzi. In this instance, aneuploidy through nuclear hybridization results in recombination across far greater genetic distances than mendelian genetic exchange. This mechanism also parallels genome duplication(9,10).	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Cent Univ Venezuela, Fac Med, Caracas, Venezuela; Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Trop Med, Asuncion, Paraguay	University of London; London School of Hygiene & Tropical Medicine; Natural History Museum London; University of Central Venezuela; Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion	Miles, MA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.		Stothard, John Russell/AAK-4829-2021; Carrasco, Hernan Jose/AAU-6492-2020	Stothard, John Russell/0000-0002-9370-3420; Carrasco, Hernan Jose/0000-0001-7500-0927; Rojas de Arias, Antonieta/0000-0002-6207-1870; Taylor, Martin/0000-0003-4147-0693; Acosta, Nidia/0000-0003-2652-354X				[Anonymous], 2003, MANSONS TROPICAL DIS; Bingle LEH, 2001, MICROBIOL-SGM, V147, P3231, DOI 10.1099/00221287-147-12-3231; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Carrasco HJ, 1996, AM J TROP MED HYG, V54, P418, DOI 10.4269/ajtmh.1996.54.418; Chamnanpunt J, 2001, P NATL ACAD SCI USA, V98, P14530, DOI 10.1073/pnas.251464498; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; DOPAZO J, 1993, P NATL ACAD SCI USA, V90, P10320, DOI 10.1073/pnas.90.21.10320; Gaunt M, 2000, MEM I OSWALDO CRUZ, V95, P557, DOI 10.1590/S0074-02762000000400019; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; GIBSON WC, 1996, MOL BIOCHEM PARASIT, V64, P241; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Kelly JM, 1997, ADV PARASIT, V39, P227, DOI 10.1016/S0065-308X(08)60047-0; Knight J, 2002, NATURE, V417, P374, DOI 10.1038/417374a; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; MacLeod A, 2000, P NATL ACAD SCI USA, V97, P13442, DOI 10.1073/pnas.230434097; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Mendonca MBA, 2002, PARASITOLOGY, V124, P177, DOI 10.1017/S0031182001001172; MILES MA, 1981, LANCET, V1, P1338; MILES MA, 1992, PROTOCOLS MOL PARASI, P15; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; Robello C, 2000, GENE, V246, P331, DOI 10.1016/S0378-1119(00)00074-3; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Stothard JR, 1999, MEM I OSWALDO CRUZ, V94, P189, DOI 10.1590/S0074-02761999000700027; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200	30	277	283	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					936	939		10.1038/nature01438	http://dx.doi.org/10.1038/nature01438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606999				2022-12-24	WOS:000181186900047
J	Busch, MP; Kleinman, SH; Nemo, GJ				Busch, MP; Kleinman, SH; Nemo, GJ			Current and emerging infectious risks of blood transfusions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; SAFETY; CONTAMINATION; BACK; NAT		Blood Ctr Pacific, San Francisco, CA 94118 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Blood Syst Inc, Scottsdale, AZ USA; Westat Corp, Rockville, MD USA; Univ British Columbia, Victoria, BC, Canada; NHLBI, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; Vitalant; Westat; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Busch, MP (corresponding author), Blood Ctr Pacific, 270 Masonic Ave, San Francisco, CA 94118 USA.	mpbusch@itsa.ucsf.edu			NHLBI NIH HHS [N01-HB-97077] Funding Source: Medline; PHS HHS [47114-97082, 47114-77078, 47114-97081, 47114-97079, 47114-97080] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097077] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AuBuchon JP, 1997, TRANSFUSION, V37, P1211, DOI 10.1046/j.1537-2995.1997.37111298088055.x; Blajchman Morris A., 2001, Transfusion Medicine Reviews, V15, P108, DOI 10.1053/tm.2001.22614; Busch M, 1999, VOX SANG, V77, P67, DOI 10.1159/000031079; Busch MP, 2000, TRANSFUSION, V40, P1157, DOI 10.1046/j.1537-2995.2000.40101157.x; Busch MP, 2001, BLOOD SAFETY IN THE NEW MILLENNIUM, P33; Cannon MJ, 2001, NEW ENGL J MED, V344, P637, DOI 10.1056/NEJM200103013440904; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P879; Chamberland ME, 2002, CLIN INFECT DIS, V34, P797, DOI 10.1086/338787; CHAMBERLAND ME, 2001, AIDS REV, V3, P24; DELWART EL, IN PRESS TRANSFUSION; *DEP HLTH, CREUTZF J DIS CJD BO; Dodd RY, 2002, TRANSFUSION, V42, P509, DOI 10.1046/j.1537-2995.2002.00143.x; JACKSON BR, IN PRESS TRANSFUSION; Jacobs MR, 2001, TRANSFUSION, V41, P1331, DOI 10.1046/j.1537-2995.2001.41111331.x; Klein HG, 2000, JAMA-J AM MED ASSOC, V284, P238, DOI 10.1001/jama.284.2.238; Kleinman S, 2001, TRANSFUS MED REV, V15, P201, DOI 10.1053/tmrv.2001.24589; Kleinman SH, 2000, BEST PRACT RES CL HA, V13, P631, DOI 10.1053/beha.2000.0104; Kleinman SH, 2001, TRANSFUSION, V41, P1081, DOI 10.1046/j.1537-2995.2001.41091081.x; Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968; Leiby DA, 1997, J INFECT DIS, V176, P1047, DOI 10.1086/516534; Leiby DA, 2001, BLOOD SAFETY IN THE NEW MILLENNIUM, P55; Mungai M, 2001, NEW ENGL J MED, V344, P1973, DOI 10.1056/NEJM200106283442603; Popovsky MA, 2000, CURR OPIN HEMATOL, V7, P402, DOI 10.1097/00062752-200011000-00014; Schmidt I, 2001, VOX SANG, V81, P228, DOI 10.1046/j.1423-0410.2001.00120.x; Sibinga CTS, 2000, TRANSFUS MED REV, V14, P269, DOI 10.1053/tm.2000.7396; Stramer SL, 2000, TRANSFUSION, V40, P1165, DOI 10.1046/j.1537-2995.2000.40101165.x; Turner ML, 2000, TRANSFUS MED REV, V14, P216, DOI 10.1053/tm.2000.7357; Weinberg PD, 2002, ANN INTERN MED, V136, P312, DOI 10.7326/0003-4819-136-4-200202190-00011	28	206	217	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					959	962		10.1001/jama.289.8.959	http://dx.doi.org/10.1001/jama.289.8.959			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597733				2022-12-24	WOS:000181129800002
J	Wisborg, K; Kesmodel, L; Bech, BH; Hedegaard, M; Henriksen, TB				Wisborg, K; Kesmodel, L; Bech, BH; Hedegaard, M; Henriksen, TB			Maternal consumption of coffee during pregnancy and stillbirth and infant death in first year of life: prospective study	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; CAFFEINE INTAKE; FETAL GROWTH; BIRTH; RISK; REPRODUCTION; POPULATION; EXPOSURE; TOBACCO	Objective To study the association between coffee consumption during pregnancy and the risk of stillbirth and infant death in the first year of life. Design Prospective follow up study. Setting Aarhus University Hospital, Denmark, 1989-96. Participants 18 478 singleton pregnancies in women with valid information about coffee consumption during pregnancy. Main outcome measures Stillbirth (delivery of a dead fetus at greater than or equal to 28 weeks' gestation) and infant death (death of a liveborn infant during the first year of life). Results Pregnant women who drank eight or more cups of coffee per day during pregnancy had an increased risk of stillbirth compared with women who did not drink coffee (odds ratio=3.0,95% confidence interval 1.5 to 5.9). After adjustment for smoking habits and alcohol intake during pregnancy, the relative risk of stillbirth decreased slightly. Adjustment for parity, maternal age, marital status, years of education, occupational status, and body mass index did not substantially change the estimates of association. There was no significant association between coffee consumption and death in the first year of life after adjustment for smoking habits during pregnancy. Conclusion Drinking coffee during pregnancy is associated with an increased risk of stillbirth but not with infant death.	Aarhus Univ Hosp, Dept Obstet & Gynaecol, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark; Aarhus Univ Hosp, Dept Paediat, DK-8200 Aarhus, Denmark; Aarhus Univ, Dept Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Wisborg, K (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynaecol, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark.		Bech, Bodil Hammer/B-9646-2016	Bech, Bodil Hammer/0000-0002-0287-3687				BUNKER ML, 1979, J AM DIET ASSOC, V74, P28; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; DOMINGUEZROJAS V, 1994, EUR J EPIDEMIOL, V10, P665, DOI 10.1007/BF01719278; Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; GILBERT SG, 1988, J PHARMACOL EXP THER, V245, P1048; GOLDING J, 1995, EARLY HUM DEV, V43, P1, DOI 10.1016/0378-3782(95)01660-U; Juel K, 1999, DAN MED BULL, V46, P354; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0; WATKINSON B, 1985, NEUROBEH TOXICOL TER, V7, P9; WEATHERSBEE PS, 1977, J REPROD MED, V19, P55; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322	16	59	63	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					420	422		10.1136/bmj.326.7386.420	http://dx.doi.org/10.1136/bmj.326.7386.420			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595379	Bronze, Green Published			2022-12-24	WOS:000181318000016
J	Aizenberg, J; Muller, DA; Grazul, JL; Hamann, DR				Aizenberg, J; Muller, DA; Grazul, JL; Hamann, DR			Direct fabrication of large micropatterned single crystals	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; AMORPHOUS CALCIUM-CARBONATE; BIOMIMETIC SYNTHESIS; CRYSTALLIZATION; PRECURSOR; GROWTH; TRANSFORMATION; FILMS; PHASE	Micropatterning of single crystals for technological applications is a complex, multistep process. Nature provides alternative fabrication strategies, when crystals with exquisite micro-ornamentation directly develop within preorganized frameworks. We report a bio-inspired approach to growing large micropatterned single crystals. Micropatterned templates organically modified to induce the formation of metastable amorphous calcium carbonate were imprinted with calcite nucleation sites. The template-directed deposition and crystallization of the amorphous phase resulted in the fabrication of millimeter-sized single calcite crystals with sub-10-mum patterns and controlled crystallographic orientation. We suggest that in addition to regulating the shape, micropatterned frameworks act as sites for stress and impurity release during the amorphous-to-crystalline transition. The proposed mechanisms may have direct biological relevance and broad implications in materials synthesis.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; Mat Sim Res, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Aizenberg, J (corresponding author), Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA.		Sanguansri, Luz/B-6630-2011; Muller, David/A-7745-2010	Sanguansri, Luz/0000-0003-1908-7604; Muller, David/0000-0003-4129-0473				ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; ALPER M, 1991, MAT SYNTHESIS BASED; Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X; Beniash E, 1999, J STRUCT BIOL, V125, P50, DOI 10.1006/jsbi.1998.4081; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54; Fendler JH, 1996, CHEM MATER, V8, P1616, DOI 10.1021/cm960116n; GONIS A, 2000, NUCLEATION GROWTH PR; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; Koga N, 1998, THERMOCHIM ACTA, V318, P239, DOI 10.1016/S0040-6031(98)00348-7; KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003; Loste E, 2001, CHEM COMMUN, P901, DOI 10.1039/b101563j; Lowenstam HA, 1989, BIOMINERALIZATION; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Merten H.L., 1980, Patent version, Patent No. [4237147, 4,237,147, 431,002]; Pedersen TPL, 2001, APPL PHYS LETT, V79, P3597, DOI 10.1063/1.1415419; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Sawada K, 1997, PURE APPL CHEM, V69, P921, DOI 10.1351/pac199769050921; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Vere A. W., 1988, CRYSTAL GROWTH PRINC; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wilt FH, 1999, J STRUCT BIOL, V126, P216, DOI 10.1006/jsbi.1999.4105; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108	30	428	444	15	299	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1205	1208		10.1126/science.1079204	http://dx.doi.org/10.1126/science.1079204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595685				2022-12-24	WOS:000181065500032
J	Kriebel, PW; Barr, VA; Parent, CA				Kriebel, PW; Barr, VA; Parent, CA			Adenylyl cyclase localization regulates streaming during chemotaxis	CELL			English	Article							DEPENDENT PROTEIN-KINASE; MYOSIN HEAVY-CHAIN; DICTYOSTELIUM-DISCOIDEUM; CHEMOATTRACTANT RECEPTOR; MEDIATED ACTIVATION; CELL POLARITY; NEUTROPHIL CHEMOTAXIS; LIVING CELLS; CAMP; MORPHOGENESIS	We studied the role of the adenylyl cyclase ACA in Dictyostelium discoideum chemotaxis and streaming. In this process, cells orient themselves in a head to tail fashion as they are migrating to form aggregates. We show that cells lacking ACA are capable of moving up a chemoattractant gradient, but are unable to stream. Imaging of ACA-YFP reveals plasma membrane labeling highly enriched at the uropod of polarized cells. This localization requires the actin cytoskeleton but is independent of the regulator CRAC and the effector PKA. A constitutively active mutant of ACA shows dramatically reduced uropod enrichment and has severe streaming defects. We propose that the asymmetric distribution of ACA provides a compartment from which cAMP is secreted to locally act as a chemoattractant, thereby providing a unique mechanism to amplify chemical gradients. This could represent a general mechanism that cells use to amplify chemotactic responses.	NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37 Room 1E24, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [Z01BC010418, ZIABC010418] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anjard C, 1997, DIFFERENTIATION, V62, P43, DOI 10.1046/j.1432-0436.1997.6210043.x; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; BRICKEY DA, 1990, MOL CELL BIOCHEM, V97, P17; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; HARVATH L, 1991, J IMMUNOL, V146, P224; HAUERT AB, 2002, INT J BIOCHEM CELL B, V34, P1467; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; INSALL R, 1994, J CELL BIOL, V126, P1537, DOI 10.1083/jcb.126.6.1537; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILLY PJ, 1995, J CELL BIOL, V129, P1659, DOI 10.1083/jcb.129.6.1659; Mann SKO, 1997, DEV BIOL, V183, P208, DOI 10.1006/dbio.1996.8499; MANN SKO, 1992, P NATL ACAD SCI USA, V89, P10701, DOI 10.1073/pnas.89.22.10701; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; Parent CA, 1996, J BIOL CHEM, V271, P18333, DOI 10.1074/jbc.271.31.18333; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; SEGALL JE, 1995, J CELL BIOL, V128, P405, DOI 10.1083/jcb.128.3.405; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SHELDEN E, 1995, J CELL SCI, V108, P1105; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; VANMENTSCOHEN M, 1989, J BIOL CHEM, V264, P8717; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	45	120	122	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					549	560		10.1016/S0092-8674(03)00081-3	http://dx.doi.org/10.1016/S0092-8674(03)00081-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600317	Bronze			2022-12-24	WOS:000181252600012
J	Liakopoulos, D; Kusch, J; Grava, S; Vogel, J; Barral, Y				Liakopoulos, D; Kusch, J; Grava, S; Vogel, J; Barral, Y			Asymmetric loading of Kar9 onto spindle poles and microtubules ensures proper spindle alignment	CELL			English	Article							CYCLIN-DEPENDENT KINASE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CYTOPLASMIC MICROTUBULES; NUCLEAR MIGRATION; MITOTIC SPINDLE; PROTEIN COMPLEX; CELL-CYCLE; ORIENTATION; PHOSPHORYLATION	Spindle alignment is the process in which the two spindle poles are directed toward preselected and opposite cell ends. In budding yeast, the APC-related molecule Kar9 is required for proper alignment of the spindle with the mother-bud axis. We find that Kar9 localizes to the prospective daughter cell spindle pole. Kar9 is transferred from the pole to cytoplasmic microtubules, which are then guided in a myosin-dependent manner to the bud. Clb4/Cdc28 kinase phosphorylates Kar9 and accumulates on the pole destined to the mother cell. Mutations that block phosphorylation at Cdc28 consensus sites result in localization of Kar9 to both poles and target them both to the bud. Thus, Clb4/Cdc28 prevents Kar9 loading on the mother bound pole. In turn, asymmetric distribution of Kar9 ensures that only one pole orients toward the bud. Our results indicate that Cdk1-dependent spindle asymmetry ensures proper alignment of the mitotic spindle with the cell division axis.	ETH Honggerberg, HPM, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; McGill Univ, Montreal, PQ H3A 1B1, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; McGill University	Barral, Y (corresponding author), ETH Honggerberg, HPM, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland.			Barral, Yves/0000-0002-0989-3373				Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Bienz M, 2001, NAT CELL BIOL, V3, pE67, DOI 10.1038/35060140; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Dikovskaya D, 2001, TRENDS CELL BIOL, V11, P378, DOI 10.1016/S0962-8924(01)02069-4; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Guthrie C, 1991, GUIDE YEAST GENETICS; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Kaltschmidt JA, 2002, J CELL SCI, V115, P2257; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rehberg M, 2002, MOL BIOL CELL, V13, P2301, DOI 10.1091/mbc.E02-01-0054; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Segal M, 1998, J CELL BIOL, V143, P135, DOI 10.1083/jcb.143.1.135; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; SIKORSKI RS, 1989, GENETICS, V122, P19; SU LK, 1995, CANCER RES, V55, P2972; Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; Trzepacz C, 1997, J BIOL CHEM, V272, P21681, DOI 10.1074/jbc.272.35.21681; TYERS M, 1991, COLD SH Q B, V56, P21; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	38	206	207	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					561	574		10.1016/S0092-8674(03)00119-3	http://dx.doi.org/10.1016/S0092-8674(03)00119-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600318	Bronze			2022-12-24	WOS:000181252600013
J	Annas, GJ				Annas, GJ			The right to health and the nevirapine case in South Africa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Baleta A, 2002, LANCET, V360, P467, DOI 10.1016/S0140-6736(02)09697-6; Barnard D, 2002, KENNEDY INST ETHIC J, V12, P159, DOI 10.1353/ken.2002.0008; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; Farmer P, 2001, NEW ENGL J MED, V345, P208, DOI 10.1056/NEJM200107193450310; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; INNOCENTI NG, 2002, FINANCIAL TIMES 1018, P29; Makgoba MW, 2000, SCIENCE, V288, P1171, DOI 10.1126/science.288.5469.1171; MANDELA N, 2002, 14 INT AIDS C BARC S; Mann JM., 1999, HLTH HUMAN RIGHTS RE, P216; MCGREAL C, 2002, GUARDIAN LONDON 1101, P2; Ngwena C, 2000, Health Hum Rights, V5, P26, DOI 10.2307/4065221; STEINER HJ, 2000, INT HUMAN RIGHTS CON, P1395; SWARNS RL, 2002, NY TIMES        0331, P4; Tarantola Daniel, 1998, Health Hum Rights, V3, P60, DOI 10.2307/4065285; Torres Mary Ann, 2002, Chic J Int Law, V3, P105; *UN EC SOC COUNC C, 2000, GEN COMM 14 RIGHT HI	16	25	25	1	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					750	754		10.1056/NEJMlim022737	http://dx.doi.org/10.1056/NEJMlim022737			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594322	Green Published			2022-12-24	WOS:000181014400013
J	Barbour, DL; Wang, XQ				Barbour, DL; Wang, XQ			Contrast tuning in auditory cortex	SCIENCE			English	Article							TOPOGRAPHY; RESPONSES; NUCLEUS	The acoustic features useful for converting auditory information into perceived objects are poorly understood. Although auditory cortex neurons have been described as being narrowly tuned and preferentially responsive to narrowband signals, naturally occurring sounds are generally wideband with unique spectral energy profiles. Through the use of parametric wideband acoustic stimuli, we found that such neurons in awake marmoset monkeys respond vigorously to wideband sounds having complex spectral shapes, preferring stimuli of either high or low spectral contrast. Low contrast-preferring neurons cannot be studied thoroughly with narrowband stimuli and have not been previously described. These findings indicate that spectral contrast reflects an important stimulus decomposition in auditory cortex and may contribute to the recognition of acoustic objects.	Johns Hopkins Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Barbour, DL (corresponding author), Johns Hopkins Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, 720 Rutland Ave,424 Ross Bldg, Baltimore, MD 21205 USA.	dbarbour@bme.jhu.edu		Barbour, Dennis/0000-0003-0851-0665	NIDCD NIH HHS [R01 DC003180, DC-03180] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AITKIN LM, 1986, J COMP NEUROL, V252, P175, DOI 10.1002/cne.902520204; Barbour DL, 2002, J NEUROPHYSIOL, V88, P2684, DOI 10.1152/jn.00253.2002; CALHOUN BM, 1998, PSYCHOPHYSICAL PHYSL, P170; Dan Y, 1996, J NEUROSCI, V16, P3351; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; EHRET G, 1985, SCIENCE, V227, P1245, DOI 10.1126/science.3975613; EHRET G, 1988, BRAIN RES REV, V13, P139, DOI 10.1016/0165-0173(88)90018-5; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SEIDEN HR, 1957, THESIS PRINCETON U P; SUGA N, 1988, AUDITORY FUNCTION NE, P679; Suga N., 1994, COGNITIVE NEUROSCIEN, P295; WANG X, 2003, P NATL ACAD SCI USA, V97, P11843; Young E. D., 1998, SYNAPTIC ORG BRAIN, P121; Young ED, 1998, P NATL ACAD SCI USA, V95, P933, DOI 10.1073/pnas.95.3.933; Yu JJ, 2000, P NATL ACAD SCI USA, V97, P11780, DOI 10.1073/pnas.97.22.11780	24	83	84	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1073	1075		10.1126/science.1080425	http://dx.doi.org/10.1126/science.1080425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586943	Green Submitted, Green Accepted			2022-12-24	WOS:000180960000050
J	Friedman, JM				Friedman, JM			A war on obesity, not the obese	SCIENCE			English	Editorial Material							BODY-MASS INDEX; EARLY-ONSET OBESITY; DIABETES-MELLITUS; LIFE-STYLE; LEPTIN; WEIGHT; ADULTS; PREVALENCE; MUTATIONS; MORTALITY		Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 New York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041096] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK41096] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1996, INT J OBESITY, V20, P501; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Critser G., 2003, FAT LAND AM BECAME F; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Diamond, 1999, GUNS GERMS STEEL FAT; DIAMOND JM, 1992, NATURE, V357, P362, DOI 10.1038/357362a0; DOWSE GK, 1990, DIABETES, V39, P390, DOI 10.2337/diabetes.39.3.390; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; FAROOQI S, COMMUNICATION; FLEGAL K, COMMUNICATION; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; HOWARD BV, 1991, AM J CLIN NUTR, V53, pS1577, DOI 10.1093/ajcn/53.6.1577S; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kumanyika Shiriki, 2002, Ethnicity and Disease, V12, P316; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Murray JE, 1997, J ECON HIST, V57, P585, DOI 10.1017/S0022050700113373; NEEL JV, 1962, AM J HUM GENET, V14, P353; RAVUSSIN E, 1995, METABOLISM, V44, P12, DOI 10.1016/0026-0495(95)90312-7; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 1998, J CLIN ENDOCR METAB, V83, P214, DOI 10.1210/jc.83.1.214; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Weiner, 1995, BEAK FINCH STORY EVO; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmet P, 1984, Diabetes Res, V1, P13; 2002, NY TIMES        1124	37	277	284	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					856	858		10.1126/science.1079856	http://dx.doi.org/10.1126/science.1079856			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574619				2022-12-24	WOS:000180830900040
J	Chan, CLH; Facer, P; Davis, JB; Smith, GD; Egerton, J; Bountra, C; Williams, NS; Anand, P				Chan, CLH; Facer, P; Davis, JB; Smith, GD; Egerton, J; Bountra, C; Williams, NS; Anand, P			Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency	LANCET			English	Article							RAT; IMMUNOREACTIVITY; DISTENSION; SENSATION; PEPTIDE; NEURONS	Background Faecal urgency and incontinence with rectal hypersensitivity is a distressing, unexplained disorder that is inadequately treated. We aimed to determine whether expression of the heat and capsaicin receptor vanilloid receptor 1 (TRPV1 or VR1) was changed in rectal sensory fibres, and to correlate nerve fibre density with sensory abnormalities. Methods We compared full-thickness rectal biopsy samples from nine patients with physiologically characterised rectal hypersensitivity with tissue samples from 12 controls. Sensory thresholds to rectal balloon distension and heating the rectal mucosa were measured before biopsy. We assessed specimens with immunohistochemistry and image analysis using specific antibodies to TRPV1; nerve growth factor (NGF) receptor tyrosine kinase A; glial cell line-derived neurotrophic factor (GDNF); neuropeptides calcitonin gene-related peptide (CGRP) and substance P; the related vanilloid receptor-like protein (VRL) 2; glial markers S-100 and glial fibrillary acid protein (GFAP); and the nerve structural marker peripherin. Findings In rectal hypersensitivity, nerve fibres immunoreactive to TRPV1 were increased in muscle, submucosal, and mucosal layers: in the mucosal layer, the median % area positive was 0.44 (range 0.30-0.59) in patients who were hypersensitive and 0.11 (0.00-0.21) in controls (p=0.0005). The numbers of peripherin-positive fibres also increased in the mucosal layer (hypersensitive 3.00 [1.80-6.50], controls 1.20 [0.39-2.10]: (p=0.0002). The increase in TRVP1 correlated significantly with the decrease in rectal heat (p=0.03) and the distension (p=0.02) sensory thresholds. The thresholds for heat and distension were also significantly correlated (p=0.0028). Expression of nerve fibres positive for GDNF (p=0.001) and tyrosine kinase A (p=0.002) was also increased, as were cell bodies of the submucosal ganglia immunoreactive to CGRP (P=0.0009). Interpretation Faecal urgency and rectal hypersensitivity could result from increased numbers of polymodal sensory nerve fibres expressing TRPV1. The triggering factor or factors remain uncertain, but drugs that target nerve terminals that express this receptor, such as topical resiniferatoxin, deserve consideration.	Hammersmith Hosp, Imperial Coll London, Div Neurosci & Psychol Med, Peripheral Neuropathy Unit, London W12 0NN, England; GlaxoSmithKline, Neurol CEDD, Harlow, Essex, England; Barts & London Queen Marys Sch Med & Dent, Acad Dept Surg, London, England	Imperial College London; GlaxoSmithKline; University of London; Queen Mary University London	Anand, P (corresponding author), Hammersmith Hosp, Imperial Coll London, Div Neurosci & Psychol Med, Peripheral Neuropathy Unit, Du Cane Rd, London W12 0NN, England.	p.anand@ic.ac.uk						Anavi-Goffer S, 2002, NEUROSCI LETT, V319, P53, DOI 10.1016/S0304-3940(01)02480-6; Avelino A, 2000, AUTON NEUROSCI-BASIC, V86, P37, DOI 10.1016/S1566-0702(00)00204-6; BREWER DB, 1990, J PATHOL, V161, P301, DOI 10.1002/path.1711610406; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CERVERO F, 1992, TRENDS NEUROSCI, V15, P374, DOI 10.1016/0166-2236(92)90182-8; CHAN CL, 2001, COLORECTAL DIS S, V3, P78; Dasgupta P, 2000, BJU INT, V85, P238, DOI 10.1046/j.1464-410x.2000.00427.x; DUTHIE HL, 1960, BRIT J SURG, V47, P585, DOI 10.1002/bjs.18004720602; FARTHING MJG, 1978, GUT, V19, P64, DOI 10.1136/gut.19.1.64; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271, DOI 10.1016/0016-5085(94)90086-8; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Peters RJ, 1998, J AUTONOM NERV SYST, V70, P115, DOI 10.1016/S0165-1838(98)00044-7; PILOWSKY I, 1984, GEN HOSP PSYCHIAT, V6, P123, DOI 10.1016/0163-8343(84)90070-7; Plourde V, 1997, AM J PHYSIOL-GASTR L, V273, pG191, DOI 10.1152/ajpgi.1997.273.1.G191; PRIOR A, 1992, GUT, V33, P264, DOI 10.1136/gut.33.2.264; Sloots CEJ, 2000, NEUROGASTROENT MOTIL, V12, P361; SNAITH RP, 1986, BMJ-BRIT MED J, V292, P344, DOI [DOI 10.1136/BMJ.292.6516.344, 10.1136/bmj.292.6516.344]; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; Su X, 1998, J NEUROPHYSIOL, V80, P2632, DOI 10.1152/jn.1998.80.5.2632; SUN WM, 1992, GUT, V33, P807, DOI 10.1136/gut.33.6.807; WALKER K, 2001, SOC NEUR ABSTR, V27; Williams NS, 2001, DIS COLON RECTUM, V44, P192, DOI 10.1007/BF02234292; WINNING AJ, 1986, CLIN SCI, V71, P519, DOI 10.1042/cs0710519; WINTER J, 1988, NEURON, V1, P973, DOI 10.1016/0896-6273(88)90154-7; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7	27	253	279	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2003	361	9355					385	391		10.1016/S0140-6736(03)12392-6	http://dx.doi.org/10.1016/S0140-6736(03)12392-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573376				2022-12-24	WOS:000180787000012
J	Burgio, GR; Gluckman, E; Locatelli, F				Burgio, GR; Gluckman, E; Locatelli, F			Ethical reappraisal of 15 years of cord-blood transplantation	LANCET			English	Review							BONE-MARROW; PREIMPLANTATION DIAGNOSIS; FANCONIS ANEMIA; LEUKEMIA; CHILDREN; BANKING; DISEASE; DONORS	Since the first successful use of cord blood as source of haemopoietic stem cells for transplantation in 1988, more than 2000 patients with malignant or non-malignant disorders have been treated with this procedure. Collection and storage of cord blood has prompted ethical considerations, mainly dealing with the issues of autonomy in making decisions about donation of cord blood, and of privacy and confidentiality in the tests required before use of placental cells for transplantation. The ethical implications of possible storage of cord-blood cells for autologous use has also been discussed. Preimplantation selection of HLA-matched embryos to obtain a donor of cells for cord-blood transplantation of a sibling with a life-threatening disease has raised the issue of the extent to which this approach complies with the principles of bioethics.	Hop St Louis, Serv Greffe Moelle, Paris, France; Univ Pavia, Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, Dept Paediat, I-27100 Pavia, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Fondazione San Matteo; University of Pavia	Locatelli, F (corresponding author), Univ Pavia, Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, Dept Paediat, Ple Golgi 2, I-27100 Pavia, Italy.							Alby N., 1987, REV MED PSYCHOSOM, V9, P15; Annas GJ, 1999, NEW ENGL J MED, V340, P1521, DOI 10.1056/NEJM199905133401923; Bauchamp TL, 1994, PRINCIPLES BIOMEDICA; BERTOLINI F, 1995, BLOOD, V85, P3361, DOI 10.1182/blood.V85.11.3361.bloodjournal85113361; BURGIO GR, 1987, LANCET, V1, P1484; Burgio GR, 2000, LANCET, V356, P1868, DOI 10.1016/S0140-6736(00)03254-2; Burgio GR, 1997, BONE MARROW TRANSPL, V19, P1163, DOI 10.1038/sj.bmt.1700825; Damewood MD, 2001, JAMA-J AM MED ASSOC, V285, P3143, DOI 10.1001/jama.285.24.3143; Dufour C, 2001, BRIT J HAEMATOL, V112, P796, DOI 10.1046/j.1365-2141.2001.02572.x; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HOROWITZ MM, 1990, BLOOD, V75, P555; *INT WORK GROUP PR, 2000, J ASSIST REPROD GEN, V17, P75; Jones HW, 1999, BEST PRACT RES CL OB, V13, P473, DOI 10.1053/beog.1999.0043; Locatelli F, 1999, BLOOD, V93, P3662; Marshall E, 1996, SCIENCE, V271, P586, DOI 10.1126/science.271.5249.586; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Sugarman J, 1997, JAMA-J AM MED ASSOC, V278, P938, DOI 10.1001/jama.278.11.938; Verlinsky Y, 2001, JAMA-J AM MED ASSOC, V285, P3130, DOI 10.1001/jama.285.24.3130; WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1	22	46	49	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					250	252		10.1016/S0140-6736(03)12276-3	http://dx.doi.org/10.1016/S0140-6736(03)12276-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547553				2022-12-24	WOS:000180535400028
J	Dunder, K; Lind, L; Zethelius, B; Berglund, L; Lithell, H				Dunder, K; Lind, L; Zethelius, B; Berglund, L; Lithell, H			Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							DEPENDENT DIABETES-MELLITUS; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; ESSENTIAL-HYPERTENSION; TREATED HYPERTENSION; RISK-FACTORS; FOLLOW-UP; VASODILATION; SENSITIVITY; TOLERANCE	Objective To investigate the impact of an increase in blood glucose on the risk of developing myocardial infarction, with particular emphasis on people taking antihypertensive drugs. Design Prospective population based cohort study. Setting Uppsala, Sweden. Participants 1860 men who had participated in 1970-3 at age 50 in a health survey aimed at identifying risk factors for cardiovascular disease and were re-examined at age 60 and then followed for 17.4 years. Main outcome measure Myocardial infarction after age 60. Results The incidence of myocardial infarction was significantly higher in men treated for hypertension than in those without such treatment (23% v 13.5%, P < 0.0001). Participants who developed,myocardial infarction after the age of 60 (n=253) showed a significantly larger increase in blood glucose between age 50 and 60 than did those without myocardial infarction. In multivariate Cox proportional hazard models increase in blood glucose was an independent risk factor for myocardial infarction (P=0.0001) in men receiving antihypertensive treatment at age 60 (n=291, mainly &beta; blockers and thiazide diuretics) but not in those without such treatment. The impact of increase in blood glucose declined after inclusion of serum proinsulin concentrations at baseline but was still significant. A significant interaction existed between proinsulin concentration (a marker of insulin resistance) at baseline and antihypertensive treatment on increase in blood glucose. Conclusions Increase in blood glucose between the ages of 50 and 60 and baseline proinsulin concentration were important risk factors for myocardial infarction in men receiving antihypertensive treatment, indicating that both an insulin resistant state and the metabolic impact of P blockers and diuretics increase the risk of myocardial infarction.	Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, SE-75125 Uppsala, Sweden; Uppsala Univ, Dept Med Sci, Akad Sjukhuset, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Dunder, K (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, POB 609, SE-75125 Uppsala, Sweden.	kristina.dunder@pubcare.uu.se	Berglund, Lars/AAD-3856-2019; Berglund, Lars/AAA-3188-2019	Berglund, Lars/0000-0002-7437-9047; 				Andersson OK, 1998, BMJ-BRIT MED J, V317, P167, DOI 10.1136/bmj.317.7152.167; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; FULLER JH, 1980, LANCET, V1, P1373; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Haffner SM, 1999, AM J CARDIOL, V84, p11J; HARPER R, 1994, BRIT MED J, V309, P226, DOI 10.1136/bmj.309.6949.226; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; LUNDGREN H, 1988, BRIT MED J, V297, P1512, DOI 10.1136/bmj.297.6662.1512; MCVEIGH GE, 1992, DIABETOLOGIA, V35, P771; MYKKANEN L, 1994, J HYPERTENS, V12, P1425; Mykkanen L, 1999, DIABETOLOGIA, V42, P1060, DOI 10.1007/s001250051271; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; POLLARE T, 1990, METABOLISM, V39, P167, DOI 10.1016/0026-0495(90)90071-J; POLLARE T, 1989, BRIT MED J, V298, P1152, DOI 10.1136/bmj.298.6681.1152; POLLARE T, 1988, DIABETOLOGIA, V31, P415, DOI 10.1007/BF00271585; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; RAMSAY LE, 1992, EUR HEART J, V13, P68, DOI 10.1093/eurheartj/13.suppl_G.68; REAVEN GM, 1991, DIABETES CARE, V14, P33, DOI 10.2337/diacare.14.4.33; Samuelsson O, 1996, BMJ-BRIT MED J, V313, P660; Sarabi M, 1999, J INTERN MED, V246, P265, DOI 10.1046/j.1365-2796.1999.00542.x; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; SOWERS JR, 1991, AM HEART J, V122, P932, DOI 10.1016/0002-8703(91)90814-X; Williams SB, 1996, J AM COLL CARDIOL, V27, P567, DOI 10.1016/0735-1097(95)00522-6; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695	26	89	95	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 29	2003	326	7391					681	684		10.1136/bmj.326.7391.681	http://dx.doi.org/10.1136/bmj.326.7391.681			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663WL	12663403	Green Published, Bronze			2022-12-24	WOS:000182029500014
J	Kirkham, M; Muller-Reichert, T; Oegema, K; Grill, S; Hyman, AA				Kirkham, M; Muller-Reichert, T; Oegema, K; Grill, S; Hyman, AA			SAS-4 is a C-elegans centriolar protein that controls centrosome size	CELL			English	Article							HAMSTER OVARY CELLS; CAENORHABDITIS-ELEGANS; GAMMA-TUBULIN; SPINDLE POLES; CYCLE; MATURATION; DUPLICATION; NEMATODE; EMBRYO; ORGANIZATION	Centrosomes consist of a centriole pair surrounded by pericentriolar material (PCM). Previous work suggested that centrioles are required to organize PCM to form a structurally stable organelle. Here, we characterize SAS-4, a centriole component in Caenorhabditis elegans. Like tubulin, SAS-4 is incorporated into centrioles during their duplication and remains stably associated thereafter. In the absence of SAS-4, centriole duplication falls. Partial depletion of SAS-4 results in structurally defective centrioles that contain reduced levels of SAS-4 and organize proportionally less PCM. Thus, SAS-4 is a centriole-associated component whose amount dictates centrosome size. These results provide novel insight into the poorly understood role of centrioles as centrosomal organizers.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Oegema, K (corresponding author), CMM-E 3080,9500 Gilman Dr, La Jolla, CA 92093 USA.		Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Kirkham, Matthew/I-5458-2012; Grill, Stephan/D-9427-2012	Hyman, Anthony A/0000-0003-3664-154X; Kirkham, Matthew/0000-0003-0920-5355				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; CALLAINI G, 1990, J CELL SCI, V97, P539; Chapman MJ, 2000, Q REV BIOL, V75, P409, DOI 10.1086/393621; Fry AM, 2000, CURR TOP DEV BIOL, V49, P291; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; GOULD RR, 1977, J CELL BIOL, V73, P601, DOI 10.1083/jcb.73.3.601; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lange BMH, 2000, CURR TOP DEV BIOL, V49, P235; Lonsdale JE, 2001, MICROWAVE TECHNIQUES AND PROTOCOLS, P139, DOI 10.1007/978-1-59259-128-2_11; Marshall WF, 2001, CURR BIOL, V11, pR487, DOI 10.1016/S0960-9822(01)00289-5; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; Mignot JP, 1996, BIOL CELL, V86, P81, DOI 10.1016/0248-4900(96)84770-8; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Praitis V, 2001, GENETICS, V157, P1217; Preble AM, 2000, CURR TOP DEV BIOL, V49, P207; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; RIEDER CL, 1982, BIOL CELL, V44, P117; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Schnackenberg BJ, 1998, P NATL ACAD SCI USA, V95, P9295, DOI 10.1073/pnas.95.16.9295; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; VOROBJEV IA, 1987, INT REV CYTOL, V106, P227, DOI 10.1016/S0074-7696(08)61714-3; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	39	238	241	2	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					575	587		10.1016/S0092-8674(03)00117-X	http://dx.doi.org/10.1016/S0092-8674(03)00117-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600319	Bronze			2022-12-24	WOS:000181252600014
J	Reissmann, S; Hochleitner, E; Wang, HF; Paschos, A; Lottspeich, F; Glass, RS; Bock, A				Reissmann, S; Hochleitner, E; Wang, HF; Paschos, A; Lottspeich, F; Glass, RS; Bock, A			Taming of a poison: Biosynthesis of the NiFe-hydrogenase cyanide ligands	SCIENCE			English	Article							MARINE	NiFe-hydrogenases have an Ni-Fe site in which the iron has one CO and two CN groups as ligands. Synthesis of the CN ligands requires the activity of two hydrogenase maturation proteins: HypF and HypE. HypF is a carbamoyltransferase that transfers the carbamoyl moiety of carbamoyladenylate to the COOH-terminal cysteine of HypE and thus forms an enzyme-thiocarbamate. HypE dehydrates the S-carbamoyl moiety in an adenosine triphosphate-dependent process to yield the enzyme thiocyanate. Chemical model reactions corroborate the feasibility of this unprecedented biosynthetic route and show that thiocyanates can donate CN to iron. This finding underscores a striking parallel between biochemistry and organometallic chemistry in the formation of an iron-cyano complex.	Univ Munich, Dept Biol 1, D-80638 Munich, Germany; Max Planck Inst Biochem, Prot Chem Abt, D-82152 Martinsried, Germany; Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Munich; Max Planck Society; University of Arizona	Bock, A (corresponding author), Univ Munich, Dept Biol 1, Maria Ward Str 1A, D-80638 Munich, Germany.							Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; BURKHARDT G, 1965, J AM CHEM SOC, V87, P591, DOI 10.1021/ja01081a035; BUSETTO L, 1968, INORG CHIM ACTA, V2, P391; FREY M, 2001, HDB METALLOPROTEINS, P880; HAUSINGER RP, 1996, MECH METALLOCENTER A, P1; HOCHLEITNER E, UNPUB; JIMENEZ C, 1991, TETRAHEDRON, V47, P2097, DOI 10.1016/S0040-4020(01)96120-4; JUNGBAUER A, 1980, J ORGANOMET CHEM, V186, P361, DOI 10.1016/S0022-328X(00)82417-1; Lai CH, 1998, J AM CHEM SOC, V120, P10103, DOI 10.1021/ja982053a; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; PASCHOS A, UNPUB; PHAM AT, 1991, TETRAHEDRON LETT, V32, P4843, DOI 10.1016/S0040-4039(00)93475-0; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; RANGANATHAN D, 1990, J ORG CHEM, V55, P2351, DOI 10.1021/jo00295a022; RIERA V, 1990, J ORGANOMET CHEM, V384, P339, DOI 10.1016/0022-328X(90)87126-X; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Simpson JS, 1998, TETRAHEDRON LETT, V39, P5819, DOI 10.1016/S0040-4039(98)01149-6; VANWAZER JR, 1996, J AM CHEM SOC, V88, P4415; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1016/S0168-6445(01)00063-8	21	170	178	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1067	1070		10.1126/science.1080972	http://dx.doi.org/10.1126/science.1080972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586941				2022-12-24	WOS:000180960000048
J	Bower, P; Roland, M; Campbell, J; Mead, N				Bower, P; Roland, M; Campbell, J; Mead, N			Setting standards based on patients' views on access and continuity: secondary analysis of data from the general practice assessment survey	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; QUALITY; PRIORITIES	Objectives To examine patients' views on access and continuity in general practice to derive quality standards. Design Secondary analysis of data from general practice research studies and routine quality assessment activities undertaken by practices and primary care trusts. Setting General practice. Participants General practice patients. Results Satisfactory standards of access were next day appointments with general practitioners and a 6-10 minute wait for consultations to begin. A satisfactory level of continuity was seeing the same general practitioner "a lot of the time." Standards varied with the analytic method used and by sociodemographic group. Conclusions Standards expected by patients in primary care can be derived from linked report-assessment pairs. Patients may have expectations of access that are in excess of government targets. Patients also have high expectations of continuity of care. It is unclear the degree to which such standards are reliable or valid, how conflicts between access and continuity should be resolved, or how these standards relate to other priorities of patients such as high quality interpersonal care.	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Peninsula Med Sch, Dept Gen Practice & Primary Care, Exeter EX2 5DW, Devon, England	University of Manchester; University of Exeter	Bower, P (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.		Bower, Peter/A-1508-2011	Bower, Peter/0000-0001-9558-3349; Campbell, John/0000-0002-6752-3493				Bamford C, 1992, Qual Health Care, V1, P153, DOI 10.1136/qshc.1.3.153; Bower P, 2002, FAM PRACT, V19, P489, DOI 10.1093/fampra/19.5.489; Campbell JL, 2001, QUAL HEALTH CARE, V10, P90, DOI 10.1136/qhc.10.2.90; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; GROL R, 2000, PATIENTS EVALUATE GE; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kearley KE, 2001, BRIT J GEN PRACT, V51, P712; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; MEAD N, 2002, THESIS U MANCHESTER; Neuberger J, 1998, BMJ-BRIT MED J, V317, P260, DOI 10.1136/bmj.317.7153.260; *NHS EX, 1998, 1 CLASS SERV QUAL NE; *NHS EX, 1999, NAT SURV NHS PAT; *PMS NAT EV TEAM, 2000, NAT EV 1 WAV NHS PER; Ramsay J, 2000, FAM PRACT, V17, P372, DOI 10.1093/fampra/17.5.372; Roland M., 2002, GEN PRACTICE ASSESSM; Salisbury C, 2002, BRIT J GEN PRACT, V52, P554; Scott A, 1999, SCOT J POLIT ECON, V46, P111, DOI 10.1111/1467-9485.00124; Scott A., 2001, EVIDENCE BASED PATIE, P66; Secretary of State for Health, 2000, NHS PLAN; SMITH CH, 1989, BRIT MED J, V299, P494, DOI 10.1136/bmj.299.6697.494; Stewart M, 2001, BRIT MED J, V322, P444, DOI 10.1136/bmj.322.7284.444; Vick S, 1998, J HEALTH ECON, V17, P587, DOI 10.1016/S0167-6296(97)00035-0; Wensing M, 1998, SOC SCI MED, V47, P1573, DOI 10.1016/S0277-9536(98)00222-6; Williamson C, 2000, QUAL HEALTH CARE, V9, P190, DOI 10.1136/qhc.9.3.190	26	57	60	1	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					258	260A		10.1136/bmj.326.7383.258	http://dx.doi.org/10.1136/bmj.326.7383.258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560279	Bronze, Green Published			2022-12-24	WOS:000180908300022
J	Cheutin, T; McNairn, AJ; Jenuwein, T; Gilbert, DM; Singh, PB; Misteli, T				Cheutin, T; McNairn, AJ; Jenuwein, T; Gilbert, DM; Singh, PB; Misteli, T			Maintenance of stable heterochromatin domains by dynamic HP1 binding	SCIENCE			English	Article							MAMMALIAN-CELLS; HISTONE H3; LYSINE 9; CHROMATIN; PROTEINS; DROSOPHILA; YEAST; RNA	One function of heterochromatin is the epigenetic silencing by sequestration of genes into transcriptionally repressed nuclear neighborhoods. Heterochromatin protein 1 (HP1) is a major component of heterochromatin and thus is a candidate for establishing and maintaining the transcriptionally repressive heterochromatin structure. Here we demonstrate that maintenance of stable heterochromatin domains in living cells involves the transient binding and dynamic exchange of HP1 from chromatin. HP1 exchange kinetics correlate with the condensation level of chromatin and are dependent on the histone methyltransferase Suv39h. The chromodomain and the chromoshadow domain of HP1 are both required for binding to native chromatin in vivo, but they contribute differentially to binding in euchromatin and heterochromatin. These data argue against HP1 repression of transcription by formation of static, higher order oligomeric networks but support a dynamic competition model, and they demonstrate that heterochromatin is accessible to regulatory factors.	NCI, NIH, Bethesda, MD 20892 USA; SUNY Upstate Med Univ, Syracuse, NY 13210 USA; Inst Mol Pathol, A-1030 Vienna, Austria; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.		Singh, Prim/G-1088-2014	Singh, Prim/0000-0002-9571-0974; McNairn, Adrian/0000-0003-4727-3770	NATIONAL CANCER INSTITUTE [ZIABC010309, Z01BC010309] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Cheng TH, 2000, GENE DEV, V14, P452; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kirschmann DA, 2000, CANCER RES, V60, P3359; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000	24	486	491	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					721	725		10.1126/science.1078572	http://dx.doi.org/10.1126/science.1078572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560555				2022-12-24	WOS:000180687700052
J	Alder, NN; Theg, SM				Alder, NN; Theg, SM			Energetics of protein transport across biological membranes: A study of the thylakoid Delta pH-dependent/cpTat pathway	CELL			English	Article							TWIN-ARGININE MOTIF; ESCHERICHIA-COLI TRANSLOCASE; OXYGEN-EVOLVING COMPLEX; SIGNAL PEPTIDE; EXPORT PATHWAY; IN-VITRO; ELECTRON STOICHIOMETRY; ESSENTIAL COMPONENT; PRECURSOR PROTEINS; PH/TAT MACHINERY	Among the pathways for protein translocation across biological membranes, the DeltapH-dependent/Tat system is unusual in its sole reliance upon the transmembrane pH gradient to drive protein transport. The free energy cost of protein translocation via the chloroplast DeltapH-dependent/Tat pathway was measured by conducting in vitro transport assays with isolated thylakoids while concurrently monitoring energetic parameters. These experiments revealed a substrate-specific energetic barrier to cpTat-mediated transport as well as direct utilization of protons from the gradient, consistent with a H+/protein antiporter mechanism. The magnitude of proton flux was assayed by four independent approaches and averaged 7.9 x 10(4) protons released from the gradient per transported protein. This corresponds to a DeltaG(transport) of 6.9 x 10(5) W-mol protein translocated(-1), representing the utilization of an energetic equivalent of 10(4) molecules of ATP. At this cost, we estimate that the DeltapH-dependent/cpTat pathway utilizes approximately 3% of the total energy output of the chloroplast.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Theg, SM (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	smtheg@ucdavis.edu		Alder, Nathan/0000-0003-4474-7803				Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder N ., 2002, THESIS U CALIFORNIA; Asai T, 1999, J BIOL CHEM, V274, P20075, DOI 10.1074/jbc.274.29.20075; Berghofer J, 1999, FEBS LETT, V460, P328, DOI 10.1016/S0014-5793(99)01365-4; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 2000, BBA-BIOENERGETICS, V1459, P325, DOI 10.1016/S0005-2728(00)00168-7; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berry S, 1996, BBA-BIOENERGETICS, V1276, P51, DOI 10.1016/0005-2728(96)00031-X; Berry S, 1999, BBA-BIOENERGETICS, V1410, P248, DOI 10.1016/S0005-2728(99)00003-1; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Brink S, 1998, FEBS LETT, V434, P425, DOI 10.1016/S0014-5793(98)01028-X; BROCK IW, 1995, J BIOL CHEM, V270, P1657, DOI 10.1074/jbc.270.4.1657; CAPELLOS C, 1980, KINETIC SYSTEMS; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chance B., 1967, METHODS ENZYMOL, V10, P641; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; CLINE K, 1992, J BIOL CHEM, V267, P2688; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; DRIESSEN AJM, 1991, P NATL ACAD SCI USA, V88, P2471, DOI 10.1073/pnas.88.6.2471; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; GRZESIEK S, 1988, BIOCHIM BIOPHYS ACTA, V938, P411, DOI 10.1016/0005-2736(88)90139-3; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Herrmann JM, 2000, BBA-BIOENERGETICS, V1459, P331, DOI 10.1016/S0005-2728(00)00169-9; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; JUNGE W, 1979, BIOCHIM BIOPHYS ACTA, V546, P121, DOI 10.1016/0005-2728(79)90175-0; JUNGE W, 1989, ANN NY ACAD SCI, V574, P268; KAWASAKI S, 1993, J BIOL CHEM, V268, P8193; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Leheny EA, 1998, PLANT PHYSIOL, V116, P805, DOI 10.1104/pp.116.2.805; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Mills J. D., 1986, Photosynthesis: energy transduction: a practical approach, P143; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Musser SM, 2000, BIOCHEMISTRY-US, V39, P8228, DOI 10.1021/bi000115f; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; NISHIMURA H, 1993, LASER PART BEAMS, V11, P89, DOI 10.1017/S0263034600006947; Nishiyama K, 1999, EMBO J, V18, P1049, DOI 10.1093/emboj/18.4.1049; Nouwen N, 1996, MOL MICROBIOL, V19, P1205, DOI 10.1111/j.1365-2958.1996.tb02466.x; PROKS P, 1992, GEN PHYSL BIOPHYS, V11, P411; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Robinson C, 2001, NAT REV MOL CELL BIO, V2, P350, DOI 10.1038/35073038; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Roffey RA, 1996, PLANT PHYSIOL, V111, P1329, DOI 10.1104/pp.111.4.1329; ROTTENBERG H, 1979, BIOCHIM BIOPHYS ACTA, V549, P225, DOI 10.1016/0304-4173(79)90001-6; ROTTENBERG H, 1973, BIOPHYS J, V13, P503, DOI 10.1016/S0006-3495(73)86004-7; RUMBERG B, 1976, BIOELECTROCH BIOENER, V3, P393, DOI 10.1016/0302-4598(76)80033-5; Sacksteder CA, 2000, P NATL ACAD SCI USA, V97, P14283, DOI 10.1073/pnas.97.26.14283; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SCHONKNECHT G, 1990, FEBS LETT, V277, P65, DOI 10.1016/0014-5793(90)80810-6; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; SIGALAT C, 1993, BIOCHEMISTRY-US, V32, P10193, DOI 10.1021/bi00089a040; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; TANI K, 1990, J BIOL CHEM, V265, P17341; Teter SA, 1998, P NATL ACAD SCI USA, V95, P1590, DOI 10.1073/pnas.95.4.1590; THEG SM, 1989, J BIOL CHEM, V264, P6730; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; van Dalen A, 1999, J BIOL CHEM, V274, P19913, DOI 10.1074/jbc.274.28.19913; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VREDENBERG WJ, 1976, INTACT CHLOROPLAST; Walker MB, 1999, J CELL BIOL, V147, P267, DOI 10.1083/jcb.147.2.267; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WICKNER WT, 1994, SCIENCE, V266, P1197, DOI 10.1126/science.7973701; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	82	83	87	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					231	242		10.1016/S0092-8674(03)00032-1	http://dx.doi.org/10.1016/S0092-8674(03)00032-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553911	Bronze			2022-12-24	WOS:000181191600012
J	Xu, X; Zhou, ZH; Wang, XL; Kuang, XW; Zhang, FC; Du, XK				Xu, X; Zhou, ZH; Wang, XL; Kuang, XW; Zhang, FC; Du, XK			Four-winged dinosaurs from China	NATURE			English	Article							EARLY EVOLUTION; ORIGIN; BIRD; ARCHAEOPTERYX; PALEONTOLOGY; FEATHERS; FLIGHT	Although the dinosaurian hypothesis of bird origins is widely accepted, debate remains about how the ancestor of birds first learned to fly. Here we provide new evidence suggesting that basal dromaeosaurid dinosaurs were four-winged animals and probably could glide, representing an intermediate stage towards the active, flapping-flight stage. The new discovery conforms to the predictions of early hypotheses that proavians passed through a tetrapteryx stage.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Tianjin Museum Nat Hist, Tianjin 300074, Peoples R China; Beijing Univ, Peoples Hosp, Dept Radiol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Peking University	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xing_xu@sina.com						Arnold EN, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P195; BEEBE CW, 1915, TETRAPTERYX STAGE AN; BOCK WJ, 1986, MEM CALIF ACAD SCI, V8, P57; Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; Burns T, 2000, HIST HUM SCI, V13, P1, DOI 10.1177/09526950022120845; Chatterjee S., 1997, THE RISE OF BIRDS; Chiappe LM, 1999, B AM MUS NAT HIST, P3; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; FEDUCCIA A, 1979, SCIENCE, V203, P1021, DOI 10.1126/science.203.4384.1021; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HEILMANN G, 1927, ORIGIN BIRDS; Holtz Jr T. R., 2000, GAIA, V15, P5; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Norberg U.M., 1985, P293; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; Norberg UML, 1990, VERTEBRATE FLIGHT; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; OSTROM JH, 1986, MEM CALIF ACAD SCI, V8, P73; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Rayner J.M.V., 1985, P289; Rayner J.M.V., 1985, P279; Rowe T, 2001, NATURE, V410, P539, DOI 10.1038/35069145; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1992, SCIENCE, V255, P845, DOI 10.1126/science.255.5046.845; SMITH PE, 1995, CAN J EARTH SCI, V32, P1426, DOI 10.1139/e95-115; SPEAKMAN JR, 1994, NATURE, V370, P514, DOI 10.1038/370514a0; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2002, THESIS CHINESE ACAD; Yalden D.W., 1997, Archaeopteryx, V15, P107; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang Xiao-Hong, 2001, Vertebrata Palasiatica, V39, P282; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237	46	321	364	8	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					335	340		10.1038/nature01342	http://dx.doi.org/10.1038/nature01342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540892	Green Published			2022-12-24	WOS:000180533000032
J	Osterhaus, A; Fouchier, R				Osterhaus, A; Fouchier, R			Human metapneumovirus in the community	LANCET			English	Editorial Material							CHILDREN		Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Osterhaus, A (corresponding author), Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869				Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Jartti T, 2002, LANCET, V360, P1393, DOI 10.1016/S0140-6736(02)11391-2; Nissen MD, 2002, MED J AUSTRALIA, V176, P188, DOI 10.5694/j.1326-5377.2002.tb04354.x; Pelletier G, 2002, EMERG INFECT DIS, V8, P976, DOI 10.3201/eid0809.020238; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; Stockton J, 2002, EMERG INFECT DIS, V8, P897, DOI 10.3201/eid0809.020084; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098	8	90	98	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 15	2003	361	9361					890	891		10.1016/S0140-6736(03)12785-7	http://dx.doi.org/10.1016/S0140-6736(03)12785-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648965				2022-12-24	WOS:000181741600004
J	Williams, BF; French, JK; White, HD				Williams, BF; French, JK; White, HD		HERO-2 Consent Substudy Investigat	Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; COMPETENCE	Background Anxiety, fear, pain, and treatment with morphine might compromise the ability of patients to comprehend information about, and give informed consent for, participation in clinical trials. We aimed to assess whether patients with acute myocardial infarction could understand written and verbal information and whether they were competent to give autonomous informed consent to participate in a clinical trial. Methods We prospectively studied 399 patients with acute myocardial infarction in 16 hospitals in New Zealand and Australia who were eligible for participation in the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. We assessed readability of patient information sheets, patients' educational status, their views of the consent process, comprehension of verbal and written information, and competence to give consent. Findings The patient information sheet needed a year 13 (age 18) educational level for comprehension, although only 75 of 345 patients (22%) had been educated beyond secondary school. Only 63 of 346 (18%) read the patient. information sheet before giving or refusing consent to participate. Patients who gave consent were more likely to report good or partial comprehension of the information provided than were those who refused consent (272 [89%] vs 14 [70%], respectively; p=0.009). In an assessment of competence to make an autonomous decision, 75 of 145 (52%) were ranked at the lowest grade and 26 (18%) were not competent to consent. Interpretation Although the consent process for HERO-2 met regulatory requirements for clinical trials, it was inappropriate for the needs of most patients. The patients' comprehension of the information provided and their competence to autonomously give consent was less than optimum.	Green Lane Hosp, Cardiovasc Res Unit, Auckland 1030, New Zealand		Williams, BF (corresponding author), Green Lane Hosp, Cardiovasc Res Unit, CCU Res Suite,Private Bag 92189, Auckland 1030, New Zealand.	barbaraw@adhb.govt.nz						Agard A, 2001, HEART, V86, P632, DOI 10.1136/heart.86.6.632; [Anonymous], 1990, LANCET, V336, P65; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1986, HIST THEORY INFORM C; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Colaizzi P., 1978, EXISTENTIAL PHENOMEN, P48; DeLuca S A, 1995, J Cardiovasc Nurs, V9, P54; *EUR PARL, 2001, OFFICIAL J L, V121, P34; Flesch R., 1974, ART READABLE WRITING; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; HOLMBERG S, 1990, AM J CARDIOL, V65, P401; Kucia AM, 2000, AM HEART J, V140, P94, DOI 10.1067/mhj.2000.106625; KUTNER JS, 1991, CHEST, V100, P1404, DOI 10.1378/chest.100.5.1404; Marson DC, 1996, NEUROLOGY, V46, P666, DOI 10.1212/WNL.46.3.666; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; OCKENE IS, 1991, CLIN RES, V39, P13; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; Seedhouse D, 1998, ETHICS HEART HLTH CA; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; US Dept of Health and Human Services (HHS) Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM), ICH HARM TRIP GUID G; VEHEGGEN FW, 1998, PATIENT EDUC COUNS, V35, P111; White HD, 2001, LANCET, V358, P1855; Williams BF, 1997, NEW ZEAL MED J, V110, P298; Williams C, 1992, INTRO NEW TREATMENTS, P49; WILLIAMS CJ, 1994, EUR J CANCER, V30A, P907, DOI 10.1016/0959-8049(94)90111-2; *WORLD MED ASS DEC, 2000, P 52 WORLD MED ASS G; 1949, NUREMBERG CODE TRIAL, P181	28	97	98	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2003	361	9361					918	922		10.1016/S0140-6736(03)12773-0	http://dx.doi.org/10.1016/S0140-6736(03)12773-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648970				2022-12-24	WOS:000181741600009
J	Cui, HM; Cruz-Correa, M; Giardiello, FM; Hutcheon, DF; Kafonek, DR; Brandenburg, S; Wu, YQ; He, XB; Powe, NR; Feinberg, AP				Cui, HM; Cruz-Correa, M; Giardiello, FM; Hutcheon, DF; Kafonek, DR; Brandenburg, S; Wu, YQ; He, XB; Powe, NR; Feinberg, AP			Loss of IGF2 imprinting: A potential marker of colorectal cancer risk	SCIENCE			English	Article							GROWTH-FACTOR-II; CELL-LINE; STIMULATION	Loss of imprinting (LOI), an epigenetic alteration affecting the insulin-like growth factor II gene (IGF2), is found in normal colonic mucosa of about 30% of colorectal cancer (CRC) patients, but it is found in only 10% of healthy individuals. In a pilot study to investigate the utility of LOI as a marker of CRC risk, we evaluated 172 patients at a colonoscopy clinic. The adjusted odds ratio for LOI in lymphocytes was 5.15 for patients with a positive family history [95% confidence interval (95% CI), 1.70 to 16.96; probability P = 0.002], 3.46 for patients with adenomas (95% CI, 1.14 to 11.37; P = 0.026), and 21.7 for patients with CRC (95% CI, 3.48 to 153.6; P = 0.0005). LOI can be assayed with a DNA-based blood test, and it may be a valuable predictive marker of an individual's risk for CRC.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 1064 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.		Feinberg, Andrew/AAY-7666-2020; Cui, Hengmi/A-2598-2008	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [K07CA092445, R01CA065145] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA65145, K07 CA092445] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2002, CANCER RES, V62, P6442; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEINBERG AP, 2002, METABOLIC MOL BASES, pCH18; GELATO MC, 1990, J CLIN ENDOCR METAB, V71, P1168, DOI 10.1210/jcem-71-5-1168; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; LAHM H, 1992, BRIT J CANCER, V65, P341, DOI 10.1038/bjc.1992.69; LAMONERIE T, 1995, INT J CANCER, V61, P587, DOI 10.1002/ijc.2910610425; Markey Kristina, 2002, Curr Gastroenterol Rep, V4, P404, DOI 10.1007/s11894-002-0011-5; Percesepe A, 2001, J CLIN ONCOL, V19, P3944, DOI 10.1200/JCO.2001.19.19.3944; POMMIER GJ, 1992, CANCER RES, V52, P3182; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; YEE D, 1988, CANCER RES, V48, P6691	17	580	627	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1753	1755		10.1126/science.1080902	http://dx.doi.org/10.1126/science.1080902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637750				2022-12-24	WOS:000181519500052
J	Lack, G; Fox, D; Northstone, K; Golding, J				Lack, G; Fox, D; Northstone, K; Golding, J		Avon Longitudinal Study Parents Ch	Factors associated with the development of peanut allergy in childhood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATOPIC-DERMATITIS; FOOD HYPERSENSITIVITY; CHILDREN; SENSITIZATION; SKIN; FORMULAS; INFANTS; PROTEIN; ANTIGEN; SOY	Background: The prevalence of peanut allergy appears to have increased in recent decades. Other than a family history of peanut allergy and the presence of atopy, there are no known risk factors. Methods: We used data from the Avon Longitudinal Study of Parents and Children, a geographically defined cohort study of 13,971 preschool children, to identify those with a convincing history of peanut allergy and the subgroup that reacted to a double-blind peanut challenge. We first prospectively collected data on the whole cohort and then collected detailed information retrospectively by interview from the parents of children with peanut reactions and of children from two groups of controls (a random sample from the cohort and a group of children whose mothers had a history of eczema and who had had eczema themselves in the first six months of life). Results: Forty-nine children had a history of peanut allergy; peanut allergy was confirmed by peanut challenge in 23 of 36 children tested. There was no evidence of prenatal sensitization from the maternal diet, and peanut-specific IgE was not detectable in the cord blood. Peanut allergy was independently associated with intake of soy milk or soy formula (odds ratio, 2.6; 95 percent confidence interval, 1.3 to 5.2), rash over joints and skin creases (odds ratio, 2.6; 95 percent confidence interval, 1.4 to 5.0), and oozing, crusted rash (odds ratio, 5.2; 95 percent confidence interval, 2.7 to 10.2). Analysis of interview data showed a significant independent relation of peanut allergy with the use of skin preparations containing peanut oil (odds ratio, 6.8; 95 percent confidence interval, 1.4 to 32.9). Conclusions: Sensitization to peanut protein may occur in children through the application of peanut oil to inflamed skin. The association with soy protein could arise from cross-sensitization through common epitopes. Confirmation of these risk factors in future studies could lead to new strategies to prevent sensitization in infants who are at risk for subsequent peanut allergy.	Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Paediat Allergy & Immunol, London W2 1NY, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Bristol, Avon, England	Imperial College London; University of Bristol	Lack, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Paediat Allergy & Immunol, Ground Floor,Salton House,Praed St, London W2 1NY, England.		Northstone, Kate/A-8165-2011	Northstone, Kate/0000-0002-0602-1983; Golding, Jean/0000-0003-2826-3307; Lack, Gideon/0000-0001-7350-4021				ASSEM ESK, 1990, BRIT MED J, V300, P1377, DOI 10.1136/bmj.300.6736.1377; BARNETT D, 1987, J ALLERGY CLIN IMMUN, V79, P433, DOI 10.1016/0091-6749(87)90359-9; BERNHISELBROADBENT J, 1989, J ALLERGY CLIN IMMUN, V83, P435, DOI 10.1016/0091-6749(89)90130-9; BOCK SA, 1989, J ALLERGY CLIN IMMUN, V83, P900, DOI 10.1016/0091-6749(89)90103-6; BOCK SA, 1978, J ALLERGY CLIN IMMUN, V62, P327, DOI 10.1016/0091-6749(78)90132-X; BURKS AW, 1989, ALLERGY PROC, V10, P265, DOI 10.2500/108854189778960045; CARSWELL F, 1986, LANCET, V2, P13, DOI 10.1016/S0140-6736(86)92560-2; CHANDRA RK, 1991, ANN ALLERGY, V67, P129; DEKRUYFF RH, 1992, J IMMUNOL, V149, P3468; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Hourihane JO, 1996, BRIT MED J, V313, P1046; Legendre C, 1997, NEW ENGL J MED, V337, P822, DOI 10.1056/NEJM199709183371204; Lever LR, 1996, BRIT MED J, V313, P299, DOI 10.1136/bmj.313.7052.299; Moneret-Vautrin D A, 1994, Pediatr Allergy Immunol, V5, P184, DOI 10.1111/j.1399-3038.1994.tb00236.x; Moneret-Vautrin DA, 1998, CLIN EXP ALLERGY, V28, P1113, DOI 10.1046/j.1365-2222.1998.00370.x; Nelson HS, 1997, J ALLERGY CLIN IMMUN, V99, P744, DOI 10.1016/S0091-6749(97)80006-1; Oldaeus G, 1997, ARCH DIS CHILD, V77, P4, DOI 10.1136/adc.77.1.4; Olszewski A, 1998, CLIN EXP ALLERGY, V28, P850, DOI 10.1046/j.1365-2222.1998.00325.x; RENZ H, 1993, J IMMUNOL, V151, P7206; SALOGA J, 1994, AM J RESP CRIT CARE, V149, P65, DOI 10.1164/ajrccm.149.1.8111600; Sampson HA, 1998, J ALLERGY CLIN IMMUN, V101, pS240; SAMPSON HA, 1985, J PEDIATR-US, V107, P669, DOI 10.1016/S0022-3476(85)80390-5; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sicherer SH, 2000, ALLERGY, V55, P515, DOI 10.1034/j.1398-9995.2000.00119.x; Tariq SM, 1996, BRIT MED J, V313, P514, DOI 10.1136/bmj.313.7056.514; *U BRIST, 2003, ALSPAC; van Reijsen FC, 1998, J ALLERGY CLIN IMMUN, V101, P207, DOI 10.1016/S0091-6749(98)70410-5; ZIMMERMAN B, 1989, J ALLERGY CLIN IMMUN, V83, P764, DOI 10.1016/0091-6749(89)90012-2	29	648	661	2	68	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2003	348	11					977	985		10.1056/NEJMoa013536	http://dx.doi.org/10.1056/NEJMoa013536			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653YT	12637607				2022-12-24	WOS:000181465200002
J	Cowan, F; Rutherford, M; Groenendaal, F; Eken, P; Mercuri, E; Bydder, GM; Meiners, LC; Dubowitz, LMS; de Vries, LS				Cowan, F; Rutherford, M; Groenendaal, F; Eken, P; Mercuri, E; Bydder, GM; Meiners, LC; Dubowitz, LMS; de Vries, LS			Origin and timing of brain lesions in term infants with neonatal encephalopathy	LANCET			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; CEREBRAL INFARCTION; ASPHYXIA; CHILDREN; PALSY	Background The role of intrapartum asphyxia in neonatal encephalopathy and seizures in term infants is not clear, and antenatal factors are being implicated in the causal pathway for these disorders. However, there is no evidence that brain damage occurs before birth. We aimed to test the hypothesis that neonatal encephalopathy, early neonatal seizures, or both result from early antenatal insults. Methods We used brain MRI or post-mortem examination in 351 fullterm infants with neonatal encephalopathy, early seizures, or both to distinguish between lesions acquired antenatally and those that developed in the intrapartum and early post-partum period. We excluded infants with major congenital malformations or obvious chromosomal disorders. Infants were divided into two groups: those with neonatal encephalopathy (with or without seizures), and evidence of perinatal asphyxia (group 1); and those without other evidence of encephalopathy, but who presented with seizures within 3 days of birth (group 2). Findings Brain images showed evidence of an acute insult without established injury or atrophy in 197 (80%) of infants in group 1, MRI showed evidence of established injury in only 2 infants (<1%), although tiny foci of established white matter gliosis, in addition to acute injury, were seen in three of 21 on post-mortem examination. In group 2, acute focal damage was noted in 62 (69%) of infants. Two (3%) also had evidence of antenatal injury. Interpretation Although our results cannot exclude the possibility that antenatal or genetic factors might predispose some infants to perinatal brain injury, our data strongly suggest that events in the immediate perinatal period are most important in neonatal brain injury.	Hammersmith Hosp, Imperial Coll, Fac Med, Dept Paediat, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Fac Med, Dept Neonatal Med, London W12 0NN, England; Univ Med Ctr, Wilhelmina Childrens Hosp, Utrecht, Netherlands; Catholic Univ, Dept Paediat Neurol, Rome, Italy	Imperial College London; Imperial College London; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Cowan, F (corresponding author), Hammersmith Hosp, Imperial Coll, Fac Med, Dept Paediat, London W12 0NN, England.	f.cowan@imperial.ac.uk	Groenendaal, Floris/P-6872-2019; de Vries, Linda S/AAB-6454-2021	Groenendaal, Floris/0000-0002-9284-1637; 				ALNAKEB L, 1999, EUR J PAED NEUROL, V29, P124; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; BADAWI N, 1998, ANTEPARTUM RISK FACT, P1549; BADAWI N, 1998, INTRAPARTUM RISK FAC, P1554; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P427; BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; *CHILD GROWTH FDN, 1996, BOYS GIRLS 4 IN ON G; COWAN EM, 1994, NEUROPEDIATRICS, V25, P172, DOI 10.1055/s-2008-1073018; Cowan F, 2000, Semin Neonatol, V5, P127, DOI 10.1053/siny.2000.0011; COWAN F, 2003, DEV MED CHILD NE S93, V45, P24; Draper ES, 2002, ARCH DIS CHILD-FETAL, V87, P176; EKEN P, 1994, NEUROPEDIATRICS, V25, P301, DOI 10.1055/s-2008-1073044; Felix JF, 2000, DEV MED CHILD NEUROL, V42, P803; GAFFNEY G, 1994, ARCH DIS CHILD-FETAL, V70, pF195, DOI 10.1136/fn.70.3.F195; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; HELLER G, 2000, EARLY NEONATAL MORTA, P274; HOPE PL, 1984, LANCET, V2, P366; Jouvet P, 1999, AM J NEURORADIOL, V20, P1343; LOW JA, 1989, AM J OBSTET GYNECOL, V160, P608, DOI 10.1016/S0002-9378(89)80040-7; MERCURI E, 1995, ARCH DIS CHILD-FETAL, V73, pF67, DOI 10.1136/fn.73.2.F67; Mercuri E, 1999, PEDIATRICS, V103, P39, DOI 10.1542/peds.103.1.39; Mercuri E, 2002, NEUROPEDIATRICS, V33, P150, DOI 10.1055/s-2002-33412; Mercuri E, 2001, PEDIATRICS, V107, P1400, DOI 10.1542/peds.107.6.1400; NELSON KB, 1991, AM J DIS CHILD, V145, P1325, DOI 10.1001/archpedi.1991.02160110117034; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; Roland EP, 1998, ANN NEUROL, V44, P161, DOI 10.1002/ana.410440205; Rutherford M, 1996, ARCH DIS CHILD-FETAL, V75, pF145, DOI 10.1136/fn.75.3.F145; RUTHERFORD MA, 1995, NEUROPEDIATRICS, V26, P183, DOI 10.1055/s-2007-979751; Rutherford MA, 1998, PEDIATRICS, V102, P323, DOI 10.1542/peds.102.2.323; Sie LTL, 2000, NEUROPEDIATRICS, V31, P128, DOI 10.1055/s-2000-7496; SQUIER M, 1991, NEUROPATH APPL NEURO, V17, P29, DOI 10.1111/j.1365-2990.1991.tb00691.x; YUDKIN PL, 1994, BRIT J OBSTET GYNAEC, V101, P774, DOI 10.1111/j.1471-0528.1994.tb11945.x	33	406	418	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					736	742		10.1016/S0140-6736(03)12658-X	http://dx.doi.org/10.1016/S0140-6736(03)12658-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620738				2022-12-24	WOS:000181232000009
J	Gunturkun, O				Gunturkun, O			Adult persistence of head-turning asymmetry	NATURE			English	Article							FUNCTIONAL LATERALITIES; PRETERM INFANTS; POSITION		Ruhr Univ Bochum, Fak Psychol, D-44780 Bochum, Germany	Ruhr University Bochum	Gunturkun, O (corresponding author), Ruhr Univ Bochum, Fak Psychol, D-44780 Bochum, Germany.			Gunturkun, Onur/0000-0003-4173-5233				Casey MB, 2000, DEV PSYCHOBIOL, V37, P13, DOI 10.1002/1098-2302(200007)37:1<13::AID-DEV3>3.0.CO;2-M; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; Coryell J. F., 1978, INFANT BEHAV DEV, V1, P245, DOI [DOI 10.1016/S0163-6383(78)80036-8, 10.1016/S0163-6383(78)80036-8]; GENTRY V, 1995, J GEN PSYCHOL, V122, P37, DOI 10.1080/00221309.1995.9921220; KONISHI Y, 1986, DEV MED CHILD NEUROL, V28, P450; KONISHI Y, 1987, DEV MED CHILD NEUROL, V29, P751; Michel GF, 2002, DEV PSYCHOBIOL, V40, P1; Nicholls MER, 1999, P ROY SOC B-BIOL SCI, V266, P1517, DOI 10.1098/rspb.1999.0809; Reiss M, 1997, PERCEPT MOTOR SKILL, V85, P569, DOI 10.2466/PMS.85.6.569-574; Rogers LJ., 2002, COMP VERTEBRATE LATE; Skiba M, 2002, BEHAV BRAIN RES, V134, P149, DOI 10.1016/S0166-4328(01)00463-6; VERVERS IAP, 1994, EARLY HUM DEV, V39, P83, DOI 10.1016/0378-3782(94)90157-0	12	89	89	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					711	711		10.1038/421711a	http://dx.doi.org/10.1038/421711a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	644UP	12610611	Bronze			2022-12-24	WOS:000180938000029
J	Kochendoerfer, GG; Chen, SY; Mao, F; Cressman, S; Traviglia, S; Shao, HY; Hunter, CL; Low, DW; Cagle, EN; Carnevali, M; Gueriguian, V; Keogh, PJ; Porter, H; Stratton, SM; Wiedeke, MC; Wilken, J; Tang, J; Levy, JJ; Miranda, LP; Crnogorac, MM; Kalbag, S; Botti, P; Schindler-Horvat, J; Savatski, L; Adamson, JW; Kung, A; Kent, SBH; Bradburne, JA				Kochendoerfer, GG; Chen, SY; Mao, F; Cressman, S; Traviglia, S; Shao, HY; Hunter, CL; Low, DW; Cagle, EN; Carnevali, M; Gueriguian, V; Keogh, PJ; Porter, H; Stratton, SM; Wiedeke, MC; Wilken, J; Tang, J; Levy, JJ; Miranda, LP; Crnogorac, MM; Kalbag, S; Botti, P; Schindler-Horvat, J; Savatski, L; Adamson, JW; Kung, A; Kent, SBH; Bradburne, JA			Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein	SCIENCE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; POLYETHYLENE-GLYCOL; TRANSFER-RNAS; LIGATION; CSF	We report the design and total chemical synthesis of "synthetic erythropoiesis protein" (SEP), a 51-kilodalton protein-polymer construct consisting of a 166-amino-acid polypeptide chain and two covalently attached, branched, and monodisperse polymer moieties that are negatively charged. The ability to control the chemistry allowed us to synthesize a macromolecule of precisely defined covalent structure. SEP was homogeneous as shown by high-resolution analytical techniques, with a mass of 50,825+/-10 daltons by electrospray mass spectrometry, and with a pI of 5.0. In cell and animal assays for erythropoiesis, SEP displayed potent biological activity and had significantly prolonged duration of action in vivo. These chemical methods are a powerful tool in the rational design of protein constructs with potential therapeutic applications.	Gryphon Therapeut, San Francisco, CA 94080 USA; Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin	Kochendoerfer, GG (corresponding author), Gryphon Therapeut, 250 E Grand Ave,Suite 90, San Francisco, CA 94080 USA.		Mao, Feng/B-8280-2019					Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Clark R, 1996, J BIOL CHEM, V271, P21969, DOI 10.1074/jbc.271.36.21969; Cload ST, 1996, CHEM BIOL, V3, P1033, DOI 10.1016/S1074-5521(96)90169-6; DAVIS JM, 1987, BIOCHEMISTRY-US, V26, P2633, DOI 10.1021/bi00383a034; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Eliason JF, 2001, BIODRUGS, V15, P705, DOI 10.2165/00063030-200115110-00001; FUKUDA MN, 1989, BLOOD, V73, P84; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; KOCHENDOERFER G, UNPUB; Kochendoerfer G G, 2001, Curr Opin Drug Discov Devel, V4, P205; KOMATSU N, 1993, BLOOD, V82, P456; LAI PH, 1986, J BIOL CHEM, V261, P3116; MAO F, UNPUB; MISAIZU T, 1995, BLOOD, V86, P4097, DOI 10.1182/blood.V86.11.4097.bloodjournal86114097; Morstyn G, 2001, ACTA HAEMATOL-BASEL, V105, P151, DOI 10.1159/000046557; Rose K, 1999, J AM CHEM SOC, V121, P7034, DOI 10.1021/ja9909879; ROSE K, 1994, J AM CHEM SOC, V116, P30, DOI 10.1021/ja00080a004; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; SCHNOLZER M, 1992, SCIENCE, V256, P221, DOI 10.1126/science.1566069; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SPIVAK JL, 1989, BLOOD, V73, P90; TSUTSUMI Y, 1994, JPN J CANCER RES, V85, P9, DOI 10.1111/j.1349-7006.1994.tb02879.x; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; YAMASAKI M, 1994, J BIOCHEM-TOKYO, V115, P814, DOI 10.1093/oxfordjournals.jbchem.a124421	27	271	307	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					884	887		10.1126/science.1079085	http://dx.doi.org/10.1126/science.1079085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574628				2022-12-24	WOS:000180830900050
J	Mohler, PJ; Schott, JJ; Gramolini, AO; Dilly, KW; Guatimosim, S; duBell, WH; Haurogne, K; Kyndt, F; Ali, ME; Rogers, TB; Lederer, WJ; Escande, D; Le Marec, H; Bennett, V				Mohler, PJ; Schott, JJ; Gramolini, AO; Dilly, KW; Guatimosim, S; duBell, WH; Haurogne, K; Kyndt, F; Ali, ME; Rogers, TB; Lederer, WJ; Escande, D; Le Marec, H; Bennett, V			Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death	NATURE			English	Article							SODIUM-CALCIUM EXCHANGE; VENTRICULAR MYOCYTES; SPECTRIN; CHANNELS; GENE	Mutations in ion channels involved in the generation and termination of action potentials constitute a family of molecular defects that underlie fatal cardiac arrhythmias in inherited long-QT syndrome(1). We report here that a loss-of-function (E1425G) mutation in ankyrin-B (also known as ankyrin(2)), a member of a family of versatile membrane adapters(2),causes dominantly inherited type 4 long-QT cardiac arrhythmia in humans. Mice heterozygous for a null mutation in ankyrin-B are haploinsufficient and display arrhythmia similar to humans. Mutation of ankyrin-B results in disruption in the cellular organization of the sodium pump, the sodium/calcium exchanger, and inositol-1,4,5-trisphosphate receptors (all ankyrin-B-binding proteins), which reduces the targeting of these proteins to the transverse tubules as well as reducing overall protein level. Ankyrin-B mutation also leads to altered Ca2+ signalling in adult cardiomyocytes that results in extrasystoles, and provides a rationale for the arrhythmia. Thus, we identify a new mechanism for cardiac arrhythmia due to abnormal coordination of multiple functionally related ion channels and transporters.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurosci, Durham, NC 27710 USA; Hop Hotel Dieu, INSERM, U533, Lab Physiopathol & Pharmacol Cellulaires & Mol, Paris, France; Hosp G&R Laennec, Dept Cardiol, Nantes, France; Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21021 USA; Univ Maryland, Inst Biotechnol, Dept Physiol, Baltimore, MD 21021 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21021 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.		Guatimosim, Silvia/AAN-7441-2021; Schott, jean-Jacques/F-8842-2013; Le Marec, Hervé/D-2718-2015; Lederer, William/B-1285-2010; KYNDT, Florence/D-6370-2015	Guatimosim, Silvia/0000-0001-8386-3722; Schott, jean-Jacques/0000-0002-9578-9475; Le Marec, Hervé/0000-0002-8288-8693; KYNDT, Florence/0000-0001-6651-1696; Song, Long-Sheng/0000-0002-6035-8106				Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; duBell WH, 1996, J PHYSIOL-LONDON, V493, P793, DOI 10.1113/jphysiol.1996.sp021423; FRANK JS, 1997, MYOCARDIUM, P1; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Marks AR, 2002, J CELL PHYSIOL, V190, P1, DOI 10.1002/jcp.10031; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reuter H, 2002, CIRC RES, V90, P305, DOI 10.1161/hh0302.104562; Santana LF, 1997, J PHYSIOL-LONDON, V503, P21, DOI 10.1111/j.1469-7793.1997.021bi.x; Santana LF, 1998, SCIENCE, V279, P1027, DOI 10.1126/science.279.5353.1027; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; Towbin JA, 2001, AM J MED, V110, P385, DOI 10.1016/S0002-9343(00)00715-4; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995	19	716	759	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					634	639		10.1038/nature01335	http://dx.doi.org/10.1038/nature01335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571597				2022-12-24	WOS:000180803200043
J	Li, J; Precht, DH; Mortensen, PB; Olsen, J				Li, J; Precht, DH; Mortensen, PB; Olsen, J			Mortality in parents after death of a child in Denmark: a nationwide follow-up study	LANCET			English	Article							CONJUGAL BEREAVEMENT; CANCER INCIDENCE; STRESS; LIFE; EDUCATION; SMOKING; ADULTS; COHORT; SPOUSE; RISK	Background Little is known about the effect of parental bereavement on physical health. We investigated whether the death of a child increased mortality in parents. Methods We undertook a follow-up study based on national registers. From 1980 to 1996, we enrolled 21062 parents in Denmark who had a child who had died (exposed cohort), and 293 745 controls-ie, parents whose children were alive, and whose family structure matched that of the exposed cohort. Natural deaths were defined with ICD8 codes 0000-7969 and ICD10 codes A00-R99, and unnatural deaths with codes 8000-9999 and V01-Y98. We used Cox's proportional-hazards regression models to assess the mortality rate, of parents up to 18 years after bereavement. Findings We observed an increased overall mortality rate in mothers whose child had died (hazards ratio 1.43, 95% CI 1.24-1.64; p<0.0001). An excess mortality from natural causes (1.44, 1.15-1.78; p<0.0001) was noted in mothers only during the 10th-18th year of follow-up. Mothers had increased mortality rates from unnatural causes throughout follow-up, with the highest rate recorded during the first 3 years (3.84,.2.48-5.88; p<0.0001). Bereaved fathers had only an early excess mortality from unnatural causes (1.57, 1.06-2.32; p=0.04). Mothers who lost a child due to an unnatural death or an unexpected death had a hazard ratio of 1.72 (1.38-2.15; p=0.0040) and 1.67 (1.37-2.03; p=0.0037), respectively. Interpretation The death of a child is associated with an overall increased mortality from both natural and unnatural causes in mothers, and an early increased mortality from unnatural causes in fathers.	Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark; Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus, Denmark; Natl Inst Publ Hlth, Copenhagen, Denmark	Aarhus University; Aarhus University	Olsen, J (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark.		Mortensen, Preben B/D-2358-2015; Harding, Richard/G-9729-2012; li, jiong/L-6534-2014	Mortensen, Preben B/0000-0002-5230-9865; li, jiong/0000-0002-1716-8067; li, jiong/0000-0003-1125-026X				*AM PSYCH ASS, 1987, DSM3R DIAGN STAT MAN; ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; BATTEN PJ, 1992, AM J FOREN MED PATH, V13, P159, DOI 10.1097/00000433-199206000-00016; DYRGROVEN A, 1990, SCAND J PSYCHOL, V31, P266; Goodkin K, 2001, HDB BEREAVEMENT RES, P671; Johansen C, 1997, BRIT J CANCER, V75, P144, DOI 10.1038/bjc.1997.24; KLATSKY AL, 1993, ALCOHOL CLIN EXP RES, V17, P1156, DOI 10.1111/j.1530-0277.1993.tb05221.x; KRAUSE N, 1986, J GERONTOL, V41, P512, DOI 10.1093/geronj/41.4.512; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; Leistikow BN, 1998, PREV MED, V27, P871, DOI 10.1006/pmed.1998.0374; LEVAV I, 1981, ISRAEL J MED SCI, V17, P176; Levav I, 2000, AM J PUBLIC HEALTH, V90, P1601, DOI 10.2105/AJPH.90.10.1601; LEVAV I, 1988, NEW ENGL J MED, V319, P457, DOI 10.1056/NEJM198808253190801; LI GH, 1994, AM J PUBLIC HEALTH, V84, P1402, DOI 10.2105/AJPH.84.9.1402; Lichtenstein P, 1998, PSYCHOL MED, V28, P635, DOI 10.1017/S0033291798006692; Lusyne P, 2001, POP STUD-J DEMOG, V55, P281, DOI 10.1080/00324720127701; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Martikainen P, 1998, EPIDEMIOLOGY, V9, P530, DOI 10.1097/00001648-199809000-00010; Matthews KA, 2002, ARCH INTERN MED, V162, P309, DOI 10.1001/archinte.162.3.309; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Moriarty HJ, 1996, RES NURS HEALTH, V19, P461, DOI 10.1002/(SICI)1098-240X(199612)19:6<461::AID-NUR2>3.0.CO;2-M; Parkes CM, 1998, BRIT MED J, V316, P856, DOI 10.1136/bmj.316.7134.856; REES WD, 1967, BRIT MED J, V4, P13, DOI 10.1136/bmj.4.5570.13; Roed AS, 1999, DAN MED BULL, V46, P269; Rubin Simon Shimshon, 1993, P285, DOI 10.1017/CBO9780511664076.020; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; VANCE JC, 1991, MED J AUSTRALIA, V155, P292, DOI 10.5694/j.1326-5377.1991.tb142283.x; Vassilas CA, 1997, BRIT J PSYCHIAT, V170, P453, DOI 10.1192/bjp.170.5.453; 1998, FERTILITY DATABASE G	29	312	315	0	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					363	367		10.1016/S0140-6736(03)12387-2	http://dx.doi.org/10.1016/S0140-6736(03)12387-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642CP	12573371				2022-12-24	WOS:000180787000007
J	McCormack, VA; Silva, ID; De Stavola, BL; Mohsen, R; Leon, DA; Lithell, HO				McCormack, VA; Silva, ID; De Stavola, BL; Mohsen, R; Leon, DA; Lithell, HO			Fetal growth and subsequent risk of breast cancer: results from long term follow up of Swedish cohort	BRITISH MEDICAL JOURNAL			English	Article							BIRTH-WEIGHT; FACTOR-I; WOMEN; HEIGHT	Objective To investigate whether size at birth and rate of fetal growth influence the risk of breast cancer in adulthood. Design Cohort identified from detailed birth records, with 97% follow up. Setting Uppsala Academic Hospital, Sweden. Participants 5358 singleton females born during 1915-29, alive and traced to the 1960 census. Main outcome measures Incidence of breast cancer before (at age < 50 years) and after (&GE; 50 years) the menopause. Results Size at birth was positively associated with rates of breast cancer in premenopausal women. In women who weighed &GE; 4000 g at birth rates of breast cancer were 3.5 times (95% confidence interval 1.3 to 9.3) those in women of similar gestational age who weighed < 3000 g at birth. Rates in women in the top fifths of the distributions of birth length and head circumference were 3.4 (1.5 to 7.9) and 4.0 (1.6 to 10.0) times those in the lowest fifths (adjusted for gestational age). The effect of birth weight disappeared after adjustment for birth length or head circumference, whereas the effects of birth length and head circumference remained significant after adjustment for birth weight. For a given size at birth, gestational age was inversely associated with risk (P=0.03 for linear trend). Adjustment for markers of adult risk factors did not affect these findings. Birth size was not associated with rates of breast cancer in postmenopausal women. Conclusions Size at birth, particularly length and head circumference, is associated with risk of breast cancer in women aged < 50 years. Fetal growth rate, as measured by birth size adjusted for gestational age, rather than size at birth may be the aetiologically relevant factor in premenopausal breast cancer.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Uppsala Univ, Dept Geriatr, S-75125 Uppsala, Sweden	University of London; London School of Hygiene & Tropical Medicine; Uppsala University	McCormack, VA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.		Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762; McCormack, Valerie/0000-0001-7397-3442; De Stavola, Bianca Lucia/0000-0001-7853-0528; dos Santos Silva, Isabel/0000-0002-6596-8798				De Stavola BL, 2000, BRIT J CANCER, V83, P964, DOI 10.1054/bjoc.2000.1370; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Ekbom A, 1997, JNCI-J NATL CANCER I, V89, P71, DOI 10.1093/jnci/89.1.71; EKBOM A, 1992, LANCET, V340, P1015, DOI 10.1016/0140-6736(92)93019-J; Ekbom A, 2000, J NATL CANCER I, V92, P840, DOI 10.1093/jnci/92.10.840; GARNE JP, 1995, ACTA ONCOL, V34, P153, DOI 10.3109/02841869509093949; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Innes K, 2000, AM J EPIDEMIOL, V152, P1121, DOI 10.1093/aje/152.12.1121; LEMARCHAND L, 1988, BRIT J CANCER, V57, P437, DOI 10.1038/bjc.1988.99; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LEON DA, 1999, FETAL PROGRAMMING IN; MARUBINI E, 1994, ANAL SURVIVAL DATA C; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Sanderson M, 2002, BRIT J CANCER, V86, P84, DOI 10.1038/sj.bjc.6600009; Sanderson M, 1996, EPIDEMIOLOGY, V7, P34, DOI 10.1097/00001648-199601000-00007; Sorensen HT, 1999, AM J EPIDEMIOL, V149, P726; Thomas HV, 1997, BRIT J CANCER, V75, P1075, DOI 10.1038/bjc.1997.183; Titus-Ernstoff L, 2002, CANCER EPIDEM BIOMAR, V11, P207; Toniolo P, 2000, INT J CANCER, V88, P828, DOI 10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Tuvemo T, 1999, PEDIATR RES, V46, P491, DOI 10.1203/00006450-199911000-00001; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Vatten LJ, 2002, BRIT J CANCER, V86, P89, DOI 10.1038/sj.bjc.6600011	24	107	107	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					248	251		10.1136/bmj.326.7383.248	http://dx.doi.org/10.1136/bmj.326.7383.248			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560272	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000180908300015
J	Carroll, D; Corfield, A; Spicer, R; Cairns, P				Carroll, D; Corfield, A; Spicer, R; Cairns, P			Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis	LANCET			English	Article								Calprotectin has been proposed as a useful marker of inflammatory bowel disease in children. We did a pilot study to establish whether it can be used to aid diagnosis of necrotising enterocolitis in preterm infants. Patients with clinical features of necrotising enterocolitis had raised faecal calprotectin concentrations at the time of diagnosis compared with matched controls (288.4 mg/L [SD 49.1] and 98.0 mg/L [60.6], respectively; p=0.0006). Faecal calprotectin might be a useful marker of gastrointestinal mucosal inflammation in neonates.	Royal Hosp Sick Children, Dept Paediat Surg, Bristol BS2 8BJ, Avon, England	Bristol Royal Hospital For Children	Carroll, D (corresponding author), Royal Hosp Sick Children, Dept Paediat Surg, Bristol BS2 8BJ, Avon, England.							Fagerhol M. K., 1990, STIMULUS RESPONSE CO, P187; Fagerhol MK, 2000, LANCET, V356, P1783, DOI 10.1016/S0140-6736(00)03224-4; Olafsdottir E, 2002, ACTA PAEDIATR, V91, P45, DOI 10.1080/080352502753457932; Rugtveit J, 2002, J PEDIATR GASTR NUTR, V34, P323, DOI 10.1097/00005176-200203000-00022; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506	5	94	100	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					310	311		10.1016/S0140-6736(03)12333-1	http://dx.doi.org/10.1016/S0140-6736(03)12333-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559868				2022-12-24	WOS:000180643900015
J	Rekart, ML; Patrick, DM; Chakraborty, B; Maginley, JJL; Jones, HD; Bajdik, CD; Pourbohloul, B; Brunham, RC				Rekart, ML; Patrick, DM; Chakraborty, B; Maginley, JJL; Jones, HD; Bajdik, CD; Pourbohloul, B; Brunham, RC			Targeted mass treatment for syphilis with oral azithromycin	LANCET			English	Article								From mid 1997 to end of 1999, there was a sexually-transmitted infectious syphilis outbreak mainly in heterosexual people in British Columbia, Canada, that was concentrated in Vancouver. The rate across the province increased from less than 0.5 to 3.4 per 100 000, and the rate in Vancouver reached 12.9 per 100 000. We aimed to eliminate the syphillis outbreak by treating people at risk of infection. In 2000, a targeted mass treatment programme provided azithromycin (1.8 g orally) to 4384 at-risk residents in this city. After the programme, syphilis frequency fell significantly for 6 months (p=0.016), but rose again in 2001. Results from curve fitting analyses showed that the number of cases in 2001 (177) was higher than expected (0.0001<p<0.0044). This rate rebound and the absence of a sustained effect suggest that targeted mass treatment for syphilis, even though feasible, should not be done routinely.	Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada; British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; British Columbia Canc Agcy, Canc Control Res Programme, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency	Rekart, ML (corresponding author), Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada.							HIBBS JR, 1991, AM J PUBLIC HEALTH, V81, P1259, DOI 10.2105/AJPH.81.10.1259; Hook EW, 1999, ANN INTERN MED, V131, P434, DOI 10.7326/0003-4819-131-6-199909210-00007; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Patrick DM, 2002, SEX TRANSM INFECT, V78, pI164, DOI 10.1136/sti.78.suppl_1.i164; ROSSI MA, 1990, CAN J CARDIOL, V6, P293	5	47	48	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					313	314		10.1016/S0140-6736(03)12335-5	http://dx.doi.org/10.1016/S0140-6736(03)12335-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559870				2022-12-24	WOS:000180643900017
J	Steinman, MA; Gonzales, R; Linder, JA; Landefeld, CS				Steinman, MA; Gonzales, R; Linder, JA; Landefeld, CS			Changing use of antibiotics in community-based outpatient practice, 1991-1999	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; RESPIRATORY-TRACT INFECTIONS; ACUTE OTITIS-MEDIA; ANTIMICROBIAL RESISTANCE; JUDICIOUS USE; PHARMACEUTICAL-INDUSTRY; UNITED-STATES; PRIMARY-CARE; INCREASING PREVALENCE; PHYSICIANS BEHAVIOR	Background: Judicious use of antibiotics can slow the spread of antimicrobial resistance. However, overall patterns of antibiotic use among ambulatory patients are not well understood. Objective: To study patterns of outpatient antibiotic use in the United States, focusing on broad-spectrum antibiotics. Design: Cross-sectional survey in three 2-year periods (1991-1992, 1994-1995, and 1998-1999). Setting: The National Ambulatory Medical Care Survey, a nationally representative sample of community-based outpatient visits. Patients: Patients visiting community-based outpatient clinics. Measurements: Rates of overall antibiotic use and use of broad-spectrum antibiotics (azithromycin and clarithromycin, quinolones, amoxicillin-clavulanate, and second- and third-generation cephalosporins). All comparisons were made between the first study period (1991-1992) and the final study period (1998-1999). Results: Between 1991-1992 and 1998-1999, antibiotics were used less frequently to treat acute respiratory tract infections, such as the common cold and pharyngitis. However, use of broad-spectrum agents increased from 24% to 48% of antibiotic prescriptions in adults (P < 0.001) and from 23% to 40% in children (P < 0.001). Use of broad-spectrum antibiotics increased across many conditions, increasing two- to threefold as a percentage of total antibiotic use for a variety of diagnoses in both adults and children. By 1998-1999, 22% of adult and 14% of pediatric prescriptions for broad-spectrum antibiotics were for the common cold, unspecified upper respiratory tract infections, and acute bronchitis, conditions that are primarily viral. Conclusions: Antibiotic use in ambulatory patients is decreasing in the United States. However, physicians are increasingly turning to expensive, broad-spectrum agents, even when there is little clinical rationale for their use.	Univ Calif San Francisco, Vet Adm Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Steinman, MA (corresponding author), Univ Calif San Francisco, Vet Adm Med Ctr, Div Geriatr, Box 18-G,4150 Clement St, San Francisco, CA 94121 USA.	mstein@itsa.ucsf.edu	Linder, Jeffrey/AAF-3424-2021	Linder, Jeffrey/0000-0003-2217-184X	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; BHP HRSA HHS [5T32PE11001-12] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); BHP HRSA HHS		Appelbaum PC, 2000, CLIN INFECT DIS, V31, pS29, DOI 10.1086/314057; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; Bloom BS, 2001, BMJ-BRIT MED J, V323, P647, DOI 10.1136/bmj.323.7314.647; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P800; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; ClavoSanchez AJ, 1997, CLIN INFECT DIS, V24, P1052, DOI 10.1086/513628; Doern GV, 2001, CLIN INFECT DIS, V33, pS187, DOI 10.1086/321847; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Dowell SF, 1999, PEDIATR INFECT DIS J, V18, P1, DOI 10.1097/00006454-199901000-00002; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; GONZALES R, 1995, LANCET, V345, P665, DOI 10.1016/S0140-6736(95)90861-7; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; Gupta K, 2001, ANN INTERN MED, V135, P41, DOI 10.7326/0003-4819-135-1-200107030-00012; Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880; Hamm RM, 1996, J FAM PRACTICE, V43, P56; HEMMINKI E, 1975, SOC SCI MED, V9, P111, DOI 10.1016/0037-7856(75)90103-1; Huang ES, 2002, ARCH INTERN MED, V162, P41, DOI 10.1001/archinte.162.1.41; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Ioannidis JPA, 2001, J ANTIMICROB CHEMOTH, V48, P677, DOI 10.1093/jac/48.5.677; Jain A, 1999, BRIT MED J, V318, P1596, DOI 10.1136/bmj.318.7198.1596; Jernigan DB, 1996, JAMA-J AM MED ASSOC, V275, P206, DOI 10.1001/jama.275.3.206; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Low DE, 2001, CLIN INFECT DIS, V33, pS206, DOI 10.1086/321849; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; Marshall WF, 1999, MAYO CLIN PROC, V74, P187, DOI 10.4065/74.2.187; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; *MED EC, 1999, DRUG TOP RED BOOK; *NAT CTR HLTH STAT, 2001, PUBL US MICR FIL DOC; *NAT CTR HLTH STAT, 1994, PUBL US DAT TAP DOC; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; O'Brien KL, 1998, PEDIATRICS, V101, P178; O'Brien KL, 1998, PEDIATRICS, V101, P174; Piccirillo JF, 2001, JAMA-J AM MED ASSOC, V286, P1849, DOI 10.1001/jama.286.15.1849; *PRACT MAN INF, 1998, INT CLASS DIS; Rosenstein N, 1998, PEDIATRICS, V101, P181; SABLE CA, 1993, GERIATRICS, V48, P41; Sargent J, 2001, Eff Clin Pract, V4, P136; Schwartz B, 1998, PEDIATRICS, V101, P171; SENSAKOVIC JW, 1995, MED CLIN N AM, V79, P695, DOI 10.1016/S0025-7125(16)30033-5; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Snow V, 2001, ANN INTERN MED, V134, P495, DOI 10.7326/0003-4819-134-6-200103200-00016; Snow V, 2001, ANN INTERN MED, V134, P487, DOI 10.7326/0003-4819-134-6-200103200-00014; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; *STAT CORP, 1999, OV SURV EST STAT US, P321; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Takata GS, 2001, PEDIATRICS, V108, P239, DOI 10.1542/peds.108.2.239; Walker S, 2000, CAN MED ASSOC J, V163, P273; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; 2000, RESIDENT POPULATION	63	235	244	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2003	138	7					525	533		10.7326/0003-4819-138-7-200304010-00008	http://dx.doi.org/10.7326/0003-4819-138-7-200304010-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661BV	12667022				2022-12-24	WOS:000181872100001
J	Hantschel, O; Nagar, B; Guettler, S; Kretzschmar, J; Dorey, K; Kuriyan, J; Superti-Furga, G				Hantschel, O; Nagar, B; Guettler, S; Kretzschmar, J; Dorey, K; Kuriyan, J; Superti-Furga, G			A myristoyl/phosphotyrosine switch regulates c-Abl	CELL			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; SRC-FAMILY; SH3 DOMAINS; CRYSTAL-STRUCTURES; PROTEIN-KINASES; F-ACTIN; B-CELL; PHOSPHORYLATION; HCK	The c-Abl tyrosine kinase is inhibited by mechanisms that are poorly understood. Disruption of these mechanisms in the Bcr-Abl oncoprotein leads to several forms of human leukemia. We found that like Src kinases, c-Abl 1b is activated by phosphotyrosine ligands. Ligand-activated c-Abl is particularly sensitive to the anti-cancer drug STI-571/Gleevec/imatinib (STI-571). The SH2 domain-phosphorylated tail interaction in Src kinases is functionally replaced in c-Abl by an intramolecular engagement of the N-terminal myristoyl modification with the kinase domain. Functional studies coupled with structural analysis define a myristoyl/phosphotyrosine switch in c-Abl that regulates docking and accessibility of the SH2 domain. This mechanism offers an explanation for the observed cellular activation of c-Abl by tyrosine-phosphorylated proteins, the intracellular mobility of c-Abl, and it provides new insights into the mechanism of action of STI-571.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Cellzome AG, D-69117 Heidelberg, Germany; European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; GlaxoSmithKline; Cellzome GmbH; European Molecular Biology Laboratory (EMBL)	Superti-Furga, G (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA.	kuriyan@uclink.berkeley.edu; superti@embl-heidelberg.de	Nagar, Bhushan/C-1297-2010; Superti-Furga, Giulio/F-4755-2015; Hantschel, Oliver D/H-4705-2013; Superti-Furga, Giulio/AAE-5681-2019; Hantschel, Oliver/M-7016-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Hantschel, Oliver D/0000-0001-8569-8169; Hantschel, Oliver/0000-0001-8569-8169; Guettler, Sebastian/0000-0002-3135-1546; Dorey, Karel/0000-0003-0846-5286				Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brasher BB, 2001, ONCOGENE, V20, P7744, DOI 10.1038/sj.onc.1204978; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; DALEY GQ, 1992, MOL CELL BIOL, V12, P1864, DOI 10.1128/MCB.12.4.1864; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; Hardin JD, 1996, ONCOGENE, V12, P2669; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 2002, CURR OPIN STRUC BIOL, V12, P735, DOI 10.1016/S0959-440X(02)00383-4; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; LIU XQ, 1993, ONCOGENE, V8, P1119; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; RENSHAW MW, 1988, MOL CELL BIOL, V8, P4547, DOI 10.1128/MCB.8.10.4547; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; Sawyers CL, 2002, CANCER CELL, V1, P13, DOI 10.1016/S1535-6108(02)00022-3; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Smith JM, 2002, FRONT BIOSCI, V7, pD31; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X; Taylor SS, 1997, CURR OPIN CHEM BIOL, V1, P219, DOI 10.1016/S1367-5931(97)80013-0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yano H, 2000, J NEUROSCI RES, V59, P356, DOI 10.1002/(SICI)1097-4547(20000201)59:3<356::AID-JNR9>3.0.CO;2-G; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Zhou Songyang, 1995, Nature (London), V373, P536; ZHU GC, 1994, ONCOGENE, V9, P1379; Zipfel PA, 2000, J IMMUNOL, V165, P6872, DOI 10.4049/jimmunol.165.12.6872	63	323	333	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2003	112	6					845	857		10.1016/S0092-8674(03)00191-0	http://dx.doi.org/10.1016/S0092-8674(03)00191-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654250	Bronze			2022-12-24	WOS:000181818500011
J	Farooqi, IS; Keogh, JM; Yeo, GSH; Lank, EJ; Cheetham, T; O'Rahilly, S				Farooqi, IS; Keogh, JM; Yeo, GSH; Lank, EJ; Cheetham, T; O'Rahilly, S			Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL LEPTIN DEFICIENCY; BODY-WEIGHT REGULATION; EARLY-ONSET OBESITY; MORBID-OBESITY; ENERGY-EXPENDITURE; HUMANS; MICE; DYSFUNCTION; PROTEIN	Background: Melanocortin 4 receptor (MC4R) deficiency is the commonest monogenic form of obesity. However, the clinical spectrum and mode of inheritance have not been defined, pathophysiological mechanisms leading to obesity are poorly understood, and there is little information regarding genotype-phenotype correlations. Methods: We determined the nucleotide sequence of the MC4R gene in 500 probands with severe childhood obesity. Family studies were undertaken to examine cosegregation of identified mutations with obesity. Subjects with MC4R deficiency underwent metabolic and endocrine evaluation; the results were correlated with the signaling properties of mutant receptors. Results: Twenty-nine probands (5.8 percent) had mutations in MC4R; 23 were heterozygous, and 6 were homozygous. Mutation carriers had severe obesity, increased lean mass, increased linear growth, hyperphagia, and severe hyperinsulinemia; homozygotes were more severely affected than heterozygotes. Subjects with mutations retaining residual signaling capacity had a less severe phenotype. Conclusions: Mutations in MC4R result in a distinct obesity syndrome that is inherited in a codominant manner. Mutations leading to complete loss of function are associated with a more severe phenotype. The correlation between the signaling properties of these mutant receptors and energy intake emphasizes the key role of this receptor in the control of eating behavior in humans.	Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Med, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Cambridge Inst Med Res, Genet Obes Collaborat Grp, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Clin Biochem, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Rahilly, S (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Med, Hills Rd, Cambridge CB2 2QQ, England.		Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504; Yeo, Giles See How/0000-0001-8823-3615	Wellcome Trust [068086] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; DeLany JP, 2002, AM J CLIN NUTR, V75, P705, DOI 10.1093/ajcn/75.4.705; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jacobson P, 2002, J CLIN ENDOCR METAB, V87, P4442, DOI 10.1210/jc.2002-020568; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Ohshiro Y, 1999, ANN HUM GENET, V63, P483, DOI 10.1017/S0003480099007782; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PERSANI L, 1993, J ENDOCRINOL INVEST, V16, P511, DOI 10.1007/BF03348894; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Van der Ploeg LHT, 2002, P NATL ACAD SCI USA, V99, P11381, DOI 10.1073/pnas.172378699; WAHNER HW, 1994, J BONE MINER RES, V9, P951; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 2000, QJM-INT J MED, V93, P7, DOI 10.1093/qjmed/93.1.7; ZHANG YY, 1995, NATURE, V374, P479, DOI 10.1038/374479a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	35	1120	1166	1	65	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1085	1095		10.1056/NEJMoa022050	http://dx.doi.org/10.1056/NEJMoa022050			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646665				2022-12-24	WOS:000181628400004
J	Kushiro, T; Nambara, E; McCourt, P				Kushiro, T; Nambara, E; McCourt, P			The key to signalling	NATURE			English	Article									RIKEN, Plant Sci Ctr, Lab Reprod Growth Regulat, Wako, Saitama 35101, Japan; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada	RIKEN; University of Toronto	Kushiro, T (corresponding author), RIKEN, Plant Sci Ctr, Lab Reprod Growth Regulat, 2-1 Hirosawa, Wako, Saitama 35101, Japan.		Nambara, Eiji/E-5533-2012	Kushiro, Tetsuo/0000-0002-7598-4791				Bogan AA, 1998, NAT STRUCT BIOL, V5, P679, DOI 10.1038/1372; McCourt P, 2001, MOL CELL, V8, P1157, DOI 10.1016/S1097-2765(01)00420-8; Mussig C, 2001, TRENDS ENDOCRIN MET, V12, P398, DOI 10.1016/S1043-2760(01)00477-5; Ourisson G, 1994, CHEM BIOL, V1, P11, DOI 10.1016/1074-5521(94)90036-1; Szostak JW, 2002, NATURE, V419, P890, DOI 10.1038/419890a	5	35	35	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					122	122		10.1038/422122a	http://dx.doi.org/10.1038/422122a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634761	Bronze			2022-12-24	WOS:000181488900022
J	Loconto, J; Papes, F; Chang, E; Stowers, L; Jones, EP; Takada, T; Kumanovics, A; Lindahl, KF; Dulac, C				Loconto, J; Papes, F; Chang, E; Stowers, L; Jones, EP; Takada, T; Kumanovics, A; Lindahl, KF; Dulac, C			Functional expression of murine V213 pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules	CELL			English	Article							MULTIGENE FAMILY; AXONAL PROJECTIONS; VOMERONASAL SYSTEM; ODORANT RECEPTORS; CRYSTAL-STRUCTURE; SENSORY NEURONS; H2-M REGION; FC RECEPTOR; MAMMALS; GENES	The vomeronasal organ (VNO) of the mouse has two neuronal compartments expressing distinct families of pheromone receptors, the V1Rs and the V2Rs. We report here that two families of major histocompatibility complex (MHC) class Ib molecules, the M10 and the M1 families, show restricted expression in V2R-expressing neurons. Our data suggest that neurons expressing a given V2R specifically co-express one or a few members of the M10 family. Biochemical and immunocytochemical analysis demonstrates that in VNO sensory dendrites M10s belong to large multi-molecular complexes that include pheromone receptors and beta2-microglobulin (beta2m). In cultured cells, M10s appear to function as escort molecules in transport of V2Rs to the cell surface. Accordingly, beta2m-deficient mice exhibit mislocalization of V2Rs in the VNO and a specific defect in male-male aggressive behavior. The functional characterization of M10 highlights an unexpected role for MHC molecules in pheromone detection by mammalian VNO neurons.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Texas, Ctr Immunol, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Howard Hughes Med Inst, SW Med Ctr, Dallas, TX 75390 USA	Harvard University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Papes, Fabio/E-3774-2013; Stowers, Lisa/K-6137-2015; Takada, Toyoyuki/U-3206-2018	Papes, Fabio/0000-0001-5034-4088; Stowers, Lisa/0000-0002-4403-1269; Dulac, Catherine/0000-0001-5024-5418	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037818] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37818] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arepalli SR, 1998, IMMUNOGENETICS, V47, P264, DOI 10.1007/s002510050356; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Halpern M, 1998, MICROSC RES TECHNIQ, V41, P519, DOI 10.1002/(SICI)1097-0029(19980615)41:6<519::AID-JEMT7>3.3.CO;2-C; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hotta C, 2000, IMMUNOGENETICS, V51, P624, DOI 10.1007/s002510000195; Houimel M, 2001, INT J CANCER, V92, P748, DOI 10.1002/1097-0215(20010601)92:5<748::AID-IJC1258>3.0.CO;2-1; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jones EP, 1999, IMMUNOGENETICS, V49, P183, DOI 10.1007/s002510050479; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Praetor A, 2002, J CELL SCI, V115, P2389; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TAKADA T, 2003, IN PRESS GENOME RES; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilson IA, 1998, CURR OPIN IMMUNOL, V10, P67, DOI 10.1016/S0952-7915(98)80034-4; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	42	217	225	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					607	618		10.1016/S0092-8674(03)00153-3	http://dx.doi.org/10.1016/S0092-8674(03)00153-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628182	Bronze			2022-12-24	WOS:000181443600005
J	Cox, H; Hargreaves, S				Cox, H; Hargreaves, S			To treat or not to treat? Implementation of DOTS in Central Asia	LANCET			English	Editorial Material							TUBERCULOSIS		Med Sans Frontieres, Tashkent 700000, Uzbekistan		Cox, H (corresponding author), Med Sans Frontieres, POB 333, Tashkent 700000, Uzbekistan.	hom@msfh-tashkent.uz		Cox, Helen/0000-0002-6538-7192; Hargreaves, Sally/0000-0003-2974-4348				Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; ILKHAMOV FA, 2001, EUROPEAN OBSERVATORY, P179; RAVIGLIONE MC, 2002, 33 IUATLD WORLD C LU; Small I, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3455025; Trebucq A, 1999, INT J TUBERC LUNG D, V3, P466; *WHO, 1996, WHO REP TUB EP 1996; World Health Organization, 1998, TUB HDB; World Health Organization, 2002, WHOCDSTB2002295	9	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					714	715		10.1016/S0140-6736(03)12667-0	http://dx.doi.org/10.1016/S0140-6736(03)12667-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620733				2022-12-24	WOS:000181232000004
J	Simon, AF; Shih, C; Mack, A; Benzer, S				Simon, AF; Shih, C; Mack, A; Benzer, S			Steroid control of longevity in Drosophila melanogaster	SCIENCE			English	Article							ECDYSONE; RECEPTOR; METAMORPHOSIS; MECHANISMS; L(3)3DTS; DEATH; FLIES	Ecdysone, the major steroid hormone of Drosophila melanogaster, is known for its role in development and reproduction. Flies that are heterozygous for mutations of the ecdysone receptor exhibit increases in life-span and resistance to various stresses, with no apparent deficit in fertility or activity. A mutant involved in the biosynthesis of ecdysone displays similar effects, which are suppressed by feeding ecdysone to the flies. These observations demonstrate the importance of the ecdysone hormonal pathway, a new player in regulating longevity.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Benzer, S (corresponding author), CALTECH, Div Biol 156 29, 1201 Calif Blvd, Pasadena, CA 91125 USA.	benzer@caltech.edu	Simon, Anne/J-9199-2015	Simon, Anne/0000-0002-6509-4541	NIA NIH HHS [AG16630] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG016630] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Carney GE, 2000, GENETICS, V154, P1203; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; HOLDEN JJA, 1986, DEV GENET, V6, P153; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; LUO Y, 1991, MOL CELL BIOL, V11, P3660, DOI 10.1128/MCB.11.7.3660; MAROY P, COMMUNICATION; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Perry HM, 1999, CLIN CHEM, V45, P1369; Radyuk SN, 2000, ARCH INSECT BIOCHEM, V45, P79, DOI 10.1002/1520-6327(200010)45:2&lt;79::AID-ARCH4&gt;3.0.CO;2-Y; Riddiford LM, 2001, VITAM HORM, V60, P1; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; WALKER VK, 1987, J INSECT PHYSIOL, V33, P137, DOI 10.1016/0022-1910(87)90139-9	21	189	201	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1407	1410		10.1126/science.1080539	http://dx.doi.org/10.1126/science.1080539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610309				2022-12-24	WOS:000181192300056
J	Sieber, OM; Lipton, L; Crabtree, M; Heinimann, K; Fidalgo, P; Phillips, RKS; Bisgaard, M; Orntoft, TF; Aaltonen, LA; Hodgson, SV; Thomas, HJW; Tomlinson, IPM				Sieber, OM; Lipton, L; Crabtree, M; Heinimann, K; Fidalgo, P; Phillips, RKS; Bisgaard, M; Orntoft, TF; Aaltonen, LA; Hodgson, SV; Thomas, HJW; Tomlinson, IPM			Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OXIDATIVE DNA-DAMAGE; MUTY HOMOLOG HMYH; ESCHERICHIA-COLI; LUNG-CANCER; 8-HYDROXYGUANINE 7,8-DIHYDRO-8-OXOGUANINE; INTRACELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; REPAIR ENZYME; HOGG1	BACKGROUND Germ-line mutations in the base-excision-repair gene MYH have been associated with recessive inheritance of multiple colorectal adenomas. Tumors from affected persons displayed excess somatic transversions of a guanine-cytosine pair to a thymine-adenine pair (G:C(rightarrow)T:A) in the APC gene. METHODS We screened for germ-line MYH mutations in 152 patients with multiple (3 to 100) colorectal adenomas and 107 APC-mutation-negative probands with classic familial adenomatous polyposis (>100 adenomas). Subgroups were analyzed for changes in the related genes MTH1 and OGG1. Adenomas were tested for somatic APC mutations. RESULTS Six patients with multiple adenomas and eight patients with polyposis had biallelic germline MYH variants. Missense and protein-truncating mutations were found, and the spectrums of mutations were very similar in the two groups of patients. In the tumors of carriers of biallelic mutations, all somatic APC mutations were G:C(rightarrow)T:A transversions. In the group with multiple adenomas, about one third of patients with more than 15 adenomas had biallelic MYH mutations. In the polyposis group, no patient with biallelic MYH mutations had severe disease (>1000 adenomas), but three had extracolonic disease. No clearly pathogenic MTH1 or OGG1 mutations were identified. CONCLUSIONS Germ-line MYH mutations predispose persons to a recessive phenotype, multiple adenomas, or polyposis coli. For patients with about 15 or more colorectal adenomas -- especially if no germ-line APC mutation has been identified and the family history is compatible with recessive inheritance - genetic testing of MYH is indicated for diagnosis and calculation of the level of risk in relatives. Clinical care of patients with biallelic MYH mutations should be similar to that of patients with classic or attenuated familial adenomatous polyposis.	Canc Res UK, Mol & Populat Genet Lab, London Res Inst, London WC2A 3PX, England; St Marks Hosp, Canc Res UK Colorectal Unit, Harrow, Middx, England; St Marks Hosp, Polyposis Registry, Harrow, Middx, England; Guys Hosp, Dept Clin Genet, London, England; Univ Clin, Div Med Genet, Res Grp Human Genet, Basel, Switzerland; Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; Hvidovre Univ Hosp, Dept Gastroenterol, Danish Polyposis Register, DK-2650 Hvidovre, Denmark; Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, Helsinki, Finland	Cancer Research UK; Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Portuguese Institute of Oncology; University of Copenhagen; Aarhus University; University of Helsinki	Tomlinson, IPM (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Sieber, Oliver/ABA-9211-2021; Aaltonen, Lauri/A-5375-2010; Sieber, Oliver/M-9473-2015	Sieber, Oliver/0000-0001-9480-0786; Aaltonen, Lauri/0000-0001-6839-4286; Sieber, Oliver/0000-0001-9480-0786; Fidalgo, Paulo/0000-0001-7199-3810				Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Halliwell B, 1996, PATHOL BIOL, V44, P6; Hanaoka T, 2001, CANCER LETT, V170, P53, DOI 10.1016/S0304-3835(01)00565-1; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Lamlum H, 2000, HUM MOL GENET, V9, P2215, DOI 10.1093/oxfordjournals.hmg.a018912; LOTHE RA, 1995, GENE CHROMOSOME CANC, V14, P182, DOI 10.1002/gcc.2870140305; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; LYNCH HT, 1995, SEMIN SURG ONCOL, V11, P406, DOI 10.1002/ssu.2980110607; MALINS DC, 1991, CANCER RES, V51, P5430; McLennan AG, 1999, INT J MOL MED, V4, P79; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; *NAT CANC I, 2003, SURV EP END RES; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Oda H, 1997, J BIOL CHEM, V272, P17843, DOI 10.1074/jbc.272.28.17843; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; OKAMOTO K, 1994, INT J CANCER, V58, P825, DOI 10.1002/ijc.2910580613; OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2; PRAML C, 1995, ONCOGENE, V11, P1357; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Shinmura K, 1997, MUTAT RES-DNA REPAIR, V385, P75, DOI 10.1016/S0921-8777(97)00041-4; Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996; Slupska MM, 1999, J BACTERIOL, V181, P6210, DOI 10.1128/JB.181.19.6210-6213.1999; Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638; TANAKA K, 1993, ONCOGENE, V8, P2253; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Wikman H, 2000, INT J CANCER, V88, P932, DOI 10.1002/1097-0215(20001215)88:6<932::AID-IJC15>3.0.CO;2-P	36	613	647	0	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					791	799		10.1056/NEJMoa025283	http://dx.doi.org/10.1056/NEJMoa025283			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606733	Bronze			2022-12-24	WOS:000181173300005
J	Horak, E; Lanigan, A; Roberts, M; Welsh, L; Wilson, J; Carlin, JB; Olinsky, A; Robertson, CF				Horak, E; Lanigan, A; Roberts, M; Welsh, L; Wilson, J; Carlin, JB; Olinsky, A; Robertson, CF			Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; CAFFEINE INTAKE; FETAL GROWTH; ADULT LIFE; PREGNANCY; RISK; BIRTH; REPRODUCTION; CONSUMPTION; POPULATION	Longitudinal studies have reported that asthma in childhood has a good prognosis. However, most of these studies have not taken into account the severity of childhood symptoms.' The Melbourne Epidemiological Study of Childhood Asthma recruited children at age 7 years and followed them up through adolescence to adulthood.(2-5) This report describes outcome at age 42 years in relation to symptoms in childhood.	Royal Childrens Hosp, Dept Resp Med, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia; Alfred Hosp, Dept Resp Med, Melbourne, Vic, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Florey Institute of Neuroscience & Mental Health	Robertson, CF (corresponding author), Royal Childrens Hosp, Dept Resp Med, Flemington Rd, Parkville, Vic 3052, Australia.		Carlin, John B/B-3492-2012; Carlin, John/AAG-4332-2020	Carlin, John B/0000-0002-2694-9463; Carlin, John/0000-0002-2694-9463				Ahmed IH, 1999, LUNG BIOL HEALTH DIS, V126, P41; Andersen K V, 1991, Ugeskr Laeger, V153, P1494; BUNKER ML, 1979, J AM DIET ASSOC, V74, P28; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; DOMINGUEZROJAS V, 1994, EUR J EPIDEMIOL, V10, P665, DOI 10.1007/BF01719278; Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; GILBERT SG, 1988, J PHARMACOL EXP THER, V245, P1048; GOLDING J, 1995, EARLY HUM DEV, V43, P1, DOI 10.1016/0378-3782(95)01660-U; Juel K, 1999, DAN MED BULL, V46, P354; KELLY WJW, 1987, BRIT MED J, V294, P1059, DOI 10.1136/bmj.294.6579.1059; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; MCNICOL KN, 1973, BRIT MED J, V4, P7, DOI 10.1136/bmj.4.5883.7; Muhajarine N, 1997, CAN J PUBLIC HEALTH, V88, P375, DOI 10.1007/BF03403909; OSWALD H, 1994, BRIT MED J, V309, P95, DOI 10.1136/bmj.309.6947.95; RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0; WATKINSON B, 1985, NEUROBEH TOXICOL TER, V7, P9; WEATHERSBEE PS, 1977, J REPROD MED, V19, P55; WILLIAMS H, 1969, BRIT MED J, V4, P321, DOI 10.1136/bmj.4.5679.321; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322	23	83	83	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					422	+		10.1136/bmj.326.7386.422	http://dx.doi.org/10.1136/bmj.326.7386.422			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595380	Bronze, Green Published			2022-12-24	WOS:000181318000017
J	Luo, MM; Fee, MS; Katz, LC				Luo, MM; Fee, MS; Katz, LC			Encoding pheromonal signats in the accessory olfactory bulb of behaving mice	SCIENCE			English	Article							VOMERONASAL NEURONS; URINARY PROTEINS; RECEPTOR NEURONS; SEXUAL-BEHAVIOR; MALE HAMSTER; ORGANIZATION; PROJECTIONS; ORGAN; RAT; ACTIVATION	Many mammalian species rely on pheromones-semiochemicals produced by other members of the same species-to communicate social status and reproductive readiness. To assess how the central nervous system integrates the complex repertoire of pheromones, we recorded from single neurons in the accessory olfactory bulb, a nucleus that processes pheromonal signals, of mate mice engaged in natural behaviors. Neuronal firing was robustly modulated by physical contact with mate and female conspecifics, with individual neurons activated selectively by specific combinations of the sex and strain of conspecifics. We infer that mammals encode social and reproductive information by integrating vomeronasal sensory activity specific to sex and genetic makeup.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA	Duke University; Howard Hughes Medical Institute; Duke University; Alcatel-Lucent; Lucent Technologies; AT&T	Luo, MM (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	luo@neuro.duke.edu		Fee, Michale/0000-0001-7539-1745; Luo, Minmin/0000-0003-3535-6624				Albone E.S., 1984, J WILEY; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; BOOTH WD, 1972, J ENDOCRINOL, V55, P119, DOI 10.1677/joe.0.0550119; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; IMAMURA K, 1985, BRAIN RES, V328, P362, DOI 10.1016/0006-8993(85)91050-9; Inamura I, 1999, J PHYSIOL-LONDON, V517, P731, DOI 10.1111/j.1469-7793.1999.0731s.x; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Jia CP, 1999, J NEUROPHYSIOL, V81, P345, DOI 10.1152/jn.1999.81.1.345; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Lazar J, 2002, BIOCHEMISTRY-US, V41, P11786, DOI 10.1021/bi0256734; LEHMAN MN, 1980, SCIENCE, V210, P557, DOI 10.1126/science.7423209; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MEREDITH M, 1994, PHYSIOL BEHAV, V56, P345, DOI 10.1016/0031-9384(94)90205-4; MEREDITH M, 1979, J PHYSIOL-LONDON, V286, P301, DOI 10.1113/jphysiol.1979.sp012620; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; MORI K, 1987, PROG NEUROBIOL, V29, P275, DOI 10.1016/0301-0082(87)90024-4; MURPHY MR, 1970, SCIENCE, V167, P302, DOI 10.1126/science.167.3916.302; POWERS JB, 1975, SCIENCE, V187, P961, DOI 10.1126/science.1145182; POWERS JB, 1973, PHYSIOL BEHAV, V10, P361; Rasmussen LEL, 1998, ANIM REPROD SCI, V53, P19, DOI 10.1016/S0378-4320(98)00124-9; REINHARDT W, 1983, NEUROSCIENCE, V10, P131, DOI 10.1016/0306-4522(83)90087-8; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; THIESSEN D, 1976, PSYCHOL BULL, V83, P505, DOI 10.1037/0033-2909.83.4.505; WYSOCKI CJ, 1980, SCIENCE, V207, P781, DOI 10.1126/science.7352288; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	48	287	293	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1196	1201		10.1126/science.1082133	http://dx.doi.org/10.1126/science.1082133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595684				2022-12-24	WOS:000181065500030
J	Pasha, O; Del Rosso, J; Mukaka, M; Marsh, D				Pasha, O; Del Rosso, J; Mukaka, M; Marsh, D			The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi	LANCET			English	Article							MALARIA	Malaria is a major cause of death in school-age (5-18 years) children in Malawi. Save the Children Federation helped schools in Mangochi District, Malawi, to obtain pupil-treatment kits, which enabled teachers to dispense sulfadoxine-pyrimethamine tablets according to national guidelines. The overall and malaria-specific mortality rates were calculated for the 3 years before and 2 years after the intervention was introduced; rates dropped from 2.2 to 1.44 deaths/1000 student-years and from 1.28 to 0.44 deaths/1000 student-years, respectively. School-based interventions could play a part in mitigating malaria.	Save Children Federat, Int Program, Off Hlth, Westport, CT 06881 USA; Save Children Malawi, Malawi Field Off, Mangochi, Malawi	Save the Children; Save the Children	Del Rosso, J (corresponding author), Save Children Federat, Int Program, Off Hlth, Westport, CT 06881 USA.			Pasha, Omrana/0000-0003-4046-3918				Brooker S, 2000, PARASITOL TODAY, V16, P183, DOI 10.1016/S0169-4758(00)01663-X; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; Magnussen P, 2001, TROP MED INT HEALTH, V6, P273, DOI 10.1046/j.1365-3156.2001.00720.x; MURRAY CJL, 1996, GLOBAL HLTH STAT, P137; OGUTU RO, 1992, E AFR MED J, V69, P298	5	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					577	578		10.1016/S0140-6736(03)12511-1	http://dx.doi.org/10.1016/S0140-6736(03)12511-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598146				2022-12-24	WOS:000181033400014
J	Byrne, S; Ingersoll, AP				Byrne, S; Ingersoll, AP			A sublimation model for martian south polar ice features	SCIENCE			English	Article							SUMMER TEMPERATURES; CARBON-DIOXIDE; WATER-VAPOR; MARS; TOPOGRAPHY; STABILITY; MISSION; MERCURY; MOON; CO2	In their pioneering work, Leighton and Murray argued that the Mars atmosphere, which at present is 95% carbon dioxide, is controlled by vapor equilibrium with a much larger polar reservoir of solid carbon dioxide. Here we argue that the polar reservoir is small and cannot function as a long-term buffer to the more massive atmosphere. Our work is based on modeling of the circular depressions commonly found on the south polar cap. We argue that a carbon dioxide ice layer about 8 meters thick is being etched away to reveal water ice underneath. This is consistent with thermal infrared data from the Mars Odyssey mission.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Byrne, S (corresponding author), CALTECH, Div Geol & Planetary Sci, 1200 E Calif Blvd, Pasadena, CA 91125 USA.		Byrne, Shane/B-8104-2012					BARKER ES, 1970, SCIENCE, V170, P1308, DOI 10.1126/science.170.3964.1308; CHRISTENSEN PR, 1992, J GEOPHYS RES-PLANET, V97, P7719, DOI 10.1029/92JE00453; CHRISTENSEN PR, UNPUB; Durham WB, 1999, GEOPHYS RES LETT, V26, P3493, DOI 10.1029/1999GL008373; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; INGERSOL.AP, 1974, J GEOPHYS RES, V79, P3403, DOI 10.1029/JC079i024p03403; INGERSOLL AP, 1992, ICARUS, V100, P40, DOI 10.1016/0019-1035(92)90016-Z; JAMES PB, 1992, MARS, P934; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; MURRAY BC, 1973, SCIENCE, V182, P437, DOI 10.1126/science.182.4111.437; Nye JF, 2000, ICARUS, V144, P449, DOI 10.1006/icar.1999.6306; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Thomas P., 1992, MARS, P767; Thomas PC, 2000, NATURE, V404, P161, DOI 10.1038/35004528; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WOOD SE, 1992, ICARUS, V99, P1, DOI 10.1016/0019-1035(92)90166-5	22	131	131	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1051	1053		10.1126/science.1080148	http://dx.doi.org/10.1126/science.1080148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586939				2022-12-24	WOS:000180960000043
J	Fabiani, A; Hoelzel, AR; Galimberti, F; Muelbert, MMC				Fabiani, A; Hoelzel, AR; Galimberti, F; Muelbert, MMC			Long-range paternal gene flow in the southern elephant seal	SCIENCE			English	Article							MIROUNGA-LEONINA; POPULATIONS		Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; Elephant Seal Res Grp, I-20145 Milan, Italy; Univ Fed Rio Grande, BR-96200970 Rio Grande, Brazil	Durham University; Universidade Federal do Rio Grande	Hoelzel, AR (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.		Fabiani, Anna/B-8623-2011; Muelbert, Monica/T-3935-2019					Cornuet JM, 1999, GENETICS, V153, P1989; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; Hindell MA, 2000, MAR MAMMAL SCI, V16, P504, DOI 10.1111/j.1748-7692.2000.tb00944.x; HOELZEL AR, 1993, J HERED, V84, P443, DOI 10.1093/oxfordjournals.jhered.a111370; HOELZEL AR, 2001, P R SOC LONDON B, V268, P1; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Slade RW, 1998, GENETICS, V149, P1945	8	49	51	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					676	676		10.1126/science.299.5607.676	http://dx.doi.org/10.1126/science.299.5607.676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560542				2022-12-24	WOS:000180687700036
J	Fuat, A; Pali, A; Hungin, S; Murphy, JJ				Fuat, A; Pali, A; Hungin, S; Murphy, JJ			Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							OPEN-ACCESS ECHOCARDIOGRAPHY; GENERAL-PRACTITIONERS; INHIBITORS	Objective To ascertain the beliefs, current practices, and decision making of general practitioners in the diagnosis and management of suspected heart failure in primary care, with a view to identifying barriers to good care. Design A qualitative approach using focus groups with 30 general practitioners from four primary care groups. The sampling strategy was stratified and purposive. The contents of interviews were transcribed and analysed according to the principles of "pragmatic variant" grounded theory. Setting North east England. Results Three categories of difficulties contribute to variations in medical practice and to the reasons why general practitioners experience difficulties in diagnosing and managing heart failure. The first is uncertainty about clinical practice, including lack of confidence in establishing an accurate diagnosis and worries about using angiotensin converting enzyme inhibitors, beta blockers, and spironolactone in patients who are often elderly and frail, with comorbidity and polypharmacy. The second is a lack of awareness of relevant research evidence in what was perceived to be a complex and rapidly changing therapeutic field. Doubts about the applicability of research findings in primary care, and fear of information overload also ernerged. The third category consists of influences of individual preference and local organisational factors. Medical training, negative clinical experiences, and outside agencies influenced the behaviour of general practitioners and professional culture. Local factors included the availability of diagnostic services, resources (such as accessible cardiologists), and interactions between professionals in primary or secondary care, and they seemed to shape the practice and decision making processes in primary care. Conclusions The national service framework for coronary heart disease stresses that the substandard care of patients with heart failure is unacceptable. This study identified barriers to be overcome across primary and secondary care in implementation strategies that are specific to the locality and multifaceted. Single strategies-for example, the provision of guidelines-are unlikely to have an impact on clinical outcomes, and new, conjoint models of care need to be explored.	Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England; Darlington Mem Hosp, Darlington DL3 6HX, Durham, England	Durham University	Fuat, A (corresponding author), Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England.			hungin, amritpal Pali/0000-0001-7275-8927				Bloor M, 1997, CONTEXT METHOD QUALI, P37; CLARKE KW, 1994, BRIT HEART J, V71, P584; Cleland JGF, 1999, BRIT MED J, V318, P824, DOI 10.1136/bmj.318.7187.824; CLELAND JGF, 1988, BRIT MED J, P824; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; Glasser B.G., 1967, DISCOVERY GROUNDED T; GLASSER BG, 1967, DISCOVERY GROUNED TH; Guba EG., 1994, HDB QUALITATIVE RES, P105; Hobbs FDR, 2000, EUR HEART J, V21, P1877, DOI 10.1053/euhj.2000.2170; Hobbs FDR, 2000, BRIT J GEN PRACT, V50, P735; Horne R, 1999, BRIT J GEN PRACT, V49, P353; Houghton AR, 1997, INT J CARDIOL, V59, P7, DOI 10.1016/S0167-5273(96)02904-X; Khunti K, 2000, BRIT J GEN PRACT, V50, P50; MCMURRAY J, 1993, MED ECON, V6, P90; MCMURRAY J, 1993, BR J MED EC, V6, P99; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; Melia K.M, 1997, CONTEXT METHOD QUALI, P26; Murphy JJ, 1996, BRIT J GEN PRACT, V46, P475; ORAM JJ, 1997, CARING 4 AGE PRACTIC; Patton M. Q., 1990, QUALITATIVE EVALUATI; Patton MQ., 1999, QUALITATIVE EVALUATI; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; REMES J, 1996, EUR HEART J, V46, P475; Remme WJ, 1997, EUR HEART J, V18, P736; Rimington H, 1996, LANCET, V348, P555, DOI 10.1016/S0140-6736(05)64722-8; Toal M, 2000, EUR J HEART FAIL, V2, P201, DOI 10.1016/S1388-9842(00)00071-4; WHEELDON NM, 1993, Q J MED, V86, P17	28	188	194	0	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					196	200		10.1136/bmj.326.7382.196	http://dx.doi.org/10.1136/bmj.326.7382.196			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543836	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000180689600018
J	Eferl, R; Ricci, R; Kenner, L; Zenz, R; David, JP; Rath, M; Wagner, EF				Eferl, R; Ricci, R; Kenner, L; Zenz, R; David, JP; Rath, M; Wagner, EF			Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53	CELL			English	Article							NF-KAPPA-B; HUMAN HEPATOCELLULAR CARCINOMAS; STRESS-INDUCED APOPTOSIS; TERMINAL PHOSPHORYLATION; MOUSE DEVELOPMENT; TRANSGENIC MICE; JNK ACTIVATION; GENE; EXPRESSION; INDUCTION	The transcription factor c-Jun mediates several cellular processes, including proliferation and survival, and is upregulated in many carcinomas. Liver-specific inactivation of c-Jun at different stages of tumor development was used to study its role in chemically induced hepatocellular carcinomas (HCCs) in mice. The requirement for c-jun was restricted to early stages of tumor development, and the number and size of hepatic tumors was dramatically reduced when c-jun was inactivated after the tumor had initiated. The impaired tumor development correlated with increased levels of p53 and its target gene noxa, resulting in the induction of apoptosis without affecting cell proliferation. Primary hepatocytes lacking c-Jun showed increased sensitivity to TNF-alpha-induced apoptosis, which was abrogated in the absence of p53. These data indicate that c-Jun prevents apoptosis by antagonizing p53 activity, illustrating a mechanism that might contribute to the early stages of human HCC development.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Ricci, Romeo/K-3009-2013	Ricci, Romeo/0000-0002-9766-4369; Kenner, Lukas/0000-0003-2184-1338; Eferl, Robert/0000-0002-6074-7144; Wagner, Erwin F/0000-0001-7872-0196				Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BELLET DH, 1984, P NATL ACAD SCI-BIOL, V81, P3869, DOI 10.1073/pnas.81.12.3869; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Gillet R, 2000, ONCOGENE, V19, P3498, DOI 10.1038/sj.onc.1203671; HACKER HJ, 1991, CANCER RES, V51, P1952; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544; KATO M, 1993, FUND APPL TOXICOL, V20, P155, DOI 10.1006/faat.1993.1021; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LEIST M, 1994, J IMMUNOL, V153, P1778; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Masui T, 1997, CANCER LETT, V112, P33, DOI 10.1016/S0304-3835(96)04543-0; MURAKAMI Y, 1991, CANCER RES, V51, P5520; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Okuda K, 2000, J HEPATOL, V32, P225, DOI 10.1016/S0168-8278(00)80428-6; PINKUS R, 1993, BIOCHEM J, V290, P637, DOI 10.1042/bj2900637; PITOT HC, 1990, ANNU REV PHARMACOL, V30, P465; Preston GA, 1996, MOL CELL BIOL, V16, P211; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; SCHULTEHERMANN R, 1992, TOXICOL LETT, V64-5, P569, DOI 10.1016/0378-4274(92)90233-A; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; VESSELINOVITCH SD, 1984, J CANCER RES CLIN, V108, P60, DOI 10.1007/BF00390974; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; ZHANG XK, 1990, ONCOGENE, V5, P909	47	390	412	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					181	192		10.1016/S0092-8674(03)00042-4	http://dx.doi.org/10.1016/S0092-8674(03)00042-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553907	Bronze			2022-12-24	WOS:000181191600008
J	Geldner, N; Anders, N; Wolters, H; Keicher, J; Kornberger, W; Muller, P; Delbarre, A; Ueda, T; Nakano, A; Jurgens, G				Geldner, N; Anders, N; Wolters, H; Keicher, J; Kornberger, W; Muller, P; Delbarre, A; Ueda, T; Nakano, A; Jurgens, G			The Arabidopsis GNOM ARF-GEF mediates endosomal recycling, auxin transport, and auxin-dependent plant growth	CELL			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; ADP-RIBOSYLATION FACTOR-1; BREFELDIN-A; ENDOPLASMIC-RETICULUM; PATTERN-FORMATION; PLASMA-MEMBRANE; GOLGI NETWORK; RAB GTPASE; PROTEIN; EFFLUX	Exchange factors for ARF GTPases (ARF-GEFs) regulate vesicle trafficking in a variety of organisms. The Arabidopsis protein GNOM is a brefeldin A (BFA) sensitive ARF-GEF that is required for the proper polar localization of PIN1, a candidate transporter of the plant hormone auxin. Mutations in GNOM lead to developmental defects that resemble those caused by interfering with auxin transport. Both PIN1 localization and auxin transport are also sensitive to BFA. In this paper, we show that GNOM localizes to endosomes and is required for their structural integrity. We engineered a BFA-resistant version of GNOM. In plants harboring this fully functional GNOM variant, PIN1 localization and auxin transport are no longer sensitive to BFA, while trafficking of other proteins is still affected by the drug. Our results demonstrate that GNOM is required for the recycling of auxin transport components and suggest that ARF-GEFs regulate specific endosomal trafficking pathways.	Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; CNRS, Inst Sci Vegetales, F-91198 Gif Sur Yvette, France; RIKEN, Mol Membrane Biol lab, Wako, Saitama 3510198, Japan	Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; RIKEN	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de	Nakano, Akihiko/G-4942-2014; UEDA, TAKASHI/G-4939-2014; Nakano, Akihiko/C-6185-2009; Nakano, Akihiko/A-6420-2016; Geldner, Niko/Y-2481-2019; Ueda, Takashi/G-6984-2011	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; Ueda, Takashi/0000-0002-5190-892X; Anders, Nadine/0000-0001-9854-576X; Geldner, Niko/0000-0002-2300-9644				AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; BarPeled M, 1997, PLANT PHYSIOL, V114, P315, DOI 10.1104/pp.114.1.315; Bassham DC, 2000, MOL BIOL CELL, V11, P2251, DOI 10.1091/mbc.11.7.2251; Bednarek SY, 2002, TRAFFIC, V3, P621, DOI 10.1034/j.1600-0854.2002.30904.x; Boman AL, 2001, J CELL SCI, V114, P3413; Busch M, 1996, MOL GEN GENET, V250, P681, DOI 10.1007/BF02172979; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Delbarre A, 1998, PLANT PHYSIOL, V116, P833, DOI 10.1104/pp.116.2.833; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Grebe M, 2002, CURR BIOL, V12, P329, DOI 10.1016/S0960-9822(02)00654-1; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Hadfi K, 1998, DEVELOPMENT, V125, P879; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Heese M, 2001, J CELL BIOL, V155, P239, DOI 10.1083/jcb.200107126; Holstein SEH, 2002, TRAFFIC, V3, P614, DOI 10.1034/j.1600-0854.2002.30903.x; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Jurgens G, 2002, TRAFFIC, V3, P605, DOI 10.1034/j.1600-0854.2002.30902.x; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; MAYER U, 1993, DEVELOPMENT, V117, P149; Morris DA, 1998, PLANTA, V205, P606, DOI 10.1007/s004250050363; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; ORCI L, 1991, CELL, V64, P1183; Parry G, 2001, PLANT J, V25, P399, DOI 10.1046/j.1365-313x.2001.00970.x; Parton RM, 2001, J CELL SCI, V114, P2685; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 2001, J CELL SCI, V114, P2241; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sanderfoot AA, 2001, PLANT CELL, V13, P659, DOI 10.1105/tpc.13.3.659; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; SATIATJEUNEMAITRE B, 1992, J CELL SCI, V103, P1153; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Shevell DE, 2000, PLANT CELL, V12, P2047, DOI 10.1105/tpc.12.11.2047; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Takeuchi M, 2002, PLANT J, V31, P499, DOI 10.1046/j.1365-313X.2002.01372.x; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Ueda T, 2002, CURR OPIN PLANT BIOL, V5, P513, DOI 10.1016/S1369-5266(02)00299-6; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221; Yasuhara H, 2000, PLANT CELL PHYSIOL, V41, P300, DOI 10.1093/pcp/41.3.300; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	64	838	891	4	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					219	230		10.1016/S0092-8674(03)00003-5	http://dx.doi.org/10.1016/S0092-8674(03)00003-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553910	Bronze			2022-12-24	WOS:000181191600011
J	Nair, SK; Burley, SK				Nair, SK; Burley, SK			X-ray structures of Myc-Max and Mad-Max recognizing DNA: Molecular bases of regulation by proto-oncogenic transcription factors	CELL			English	Article							C-MYC; CRYSTAL-STRUCTURE; LEUCINE ZIPPER; INDUCED-DIFFERENTIATION; TRANSFORMING ACTIVITY; NUCLEOTIDE-SEQUENCE; BURKITT-LYMPHOMA; GENE-REGULATION; REPRESSOR SIN3; TARGET GENES	X-ray structures of the basic/helix-loop-helix/leucine zipper (bHLHZ) domains of Myc-Max and Mad-Max heterodimers bound to their common DNA target (Enhancer or E box hexanucleotide, 5'-CACGTG-3') have been determined at 1.9 Angstrom and 2.0 Angstrom resolution, respectively. E box recognition by these two structurally similar transcription factor pairs determines whether a cell will divide and proliferate (Myc-Max) or differentiate and become quiescent (Mad-Max). Deregulation of Myc has been implicated in the development of many human cancers, including Burkitt's lymphoma, neuroblastomas, and small cell lung cancers. Both quasi-symmetric heterodimers resemble the symmetric Max homodimer, albeit with marked structural differences in the coiled-coil leucine zipper regions that explain preferential homo- and heteromeric dimerization of these three evolutionarily related DNA-binding proteins. The Myc-Max heterodimer, but not its Mad-Max counterpart, dimerizes to form a bivalent heterotetramer, which explains how Myc can upregulate expression of genes with promoters bearing widely separated E boxes.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Burley, SK (corresponding author), Struct Genomix Inc, 10505 Roselle St, San Diego, CA 92121 USA.	stephen_burley@stromix.com	Nair, Satish/AAY-2510-2021	Burley, Stephen K./0000-0002-2487-9713				AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BACA M, 1995, J AM CHEM SOC, V117, P1881, DOI 10.1021/ja00112a003; Bao JX, 1996, ONCOGENE, V12, P2171; BENVENISTY N, 1992, ONCOGENE, V7, P2399; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eilers M, 1999, MOL CELLS, V9, P1; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FISHER DE, 1992, P NATL ACAD SCI USA, V89, P11779, DOI 10.1073/pnas.89.24.11779; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; HILL CP, 1993, P NATL ACAD SCI USA, V90, P5167, DOI 10.1073/pnas.90.11.5167; HURLIN PJ, 1994, COLD SPRING HARB SYM, V59, P109, DOI 10.1101/SQB.1994.059.01.014; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kretzner L, 1992, Curr Top Microbiol Immunol, V182, P435; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Larsson LG, 1997, ONCOGENE, V15, P737, DOI 10.1038/sj.onc.1201390; LARSSON LG, 1994, ONCOGENE, V9, P1247; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOORE JP, 1987, ONCOGENE RES, V2, P65; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEKLUDOVA L, 1994, P NATL ACAD SCI USA, V91, P6948, DOI 10.1073/pnas.91.15.6948; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; SHEINESS D, 1978, J VIROL, V28, P600, DOI 10.1128/JVI.28.2.600-610.1978; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; WATSON DK, 1983, P NATL ACAD SCI-BIOL, V80, P3642, DOI 10.1073/pnas.80.12.3642; WATT R, 1983, NATURE, V303, P725, DOI 10.1038/303725a0; Winston RL, 2000, CHEM BIOL, V7, P245, DOI 10.1016/S1074-5521(00)00099-5; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	69	367	399	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					193	205		10.1016/S0092-8674(02)01284-9	http://dx.doi.org/10.1016/S0092-8674(02)01284-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553908	Bronze			2022-12-24	WOS:000181191600009
J	Tulin, A; Spradling, A				Tulin, A; Spradling, A			Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci	SCIENCE			English	Article							EXPRESSION	Steroid response and stress-activated genes such as hsp70 undergo puffing in Drosophila larval salivary glands, a local loosening of polytene chromatin structure associated with gene induction. We find that puffs acquire elevated levels of adenosine diphosphate ( ADP)-ribose modified proteins and that poly( ADP) ribose polymerase ( PARP) is required to produce normal-sized puffs and normal amounts of Hsp70 after heat exposure. We propose that chromosomal PARP molecules become activated by developmental or environmental cues and strip nearby chromatin proteins off DNA to generate a puff. Such local loosening may facilitate transcription and may transiently make protein complexes more accessible to modi cation, promoting chromatin remodeling during development.	Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21210 USA	Carnegie Institution for Science	Tulin, A (corresponding author), Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Res Labs, 115 W Univ Pkwy, Baltimore, MD 21210 USA.				Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM27875] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027875, R37GM027875] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARTWRIGHT IL, 1986, MOL CELL BIOL, V6, P779, DOI 10.1128/MCB.6.3.779; Hagstrom K, 1997, CURR OPIN GENET DEV, V7, P814, DOI 10.1016/S0959-437X(97)80045-7; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MEYEROWITZ EM, 1985, COLD SPRING HARB SYM, V50, P347, DOI 10.1101/SQB.1985.050.01.044; SIMON JA, 1985, CHROMOSOMA, V93, P26, DOI 10.1007/BF01259442; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	10	370	381	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					560	562		10.1126/science.1078764	http://dx.doi.org/10.1126/science.1078764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543974				2022-12-24	WOS:000180559800048
J	Berg, L; Riise, GC; Cosman, D; Bergstrom, T; Olofsson, S; Karre, W; Carbone, E				Berg, L; Riise, GC; Cosman, D; Bergstrom, T; Olofsson, S; Karre, W; Carbone, E			LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients	LANCET			English	Article							INHIBITORY RECEPTOR; CELLS	Human cytomegalovirus infection is a major cause of morbidity after lung transplantation. LIR-1 (leucocyte immunoglobulin-like receptor-1) is an inhibitory cell surface receptor that has high affinity for an MHC class I homologue (UL18) encoded by human cytomegalovirus. We aimed to investigate whether reactivation of human cytomegalovirus affects the expression of LIR-1. We measured LIR-1 expression on peripheral blood lymphocytes from 13 lung-transplant recipients and established human cytomegalovirus load using PCR. Eight patients developed cytomegalovirus disease. The percentage of cells expressing LIR-1 increased in the patients who developed cytomegalovirus disease several weeks before viral DNA was detectable by PCR. Measurement of LIR-1 expression might allow early identification of cytomegalovirus disease in lung-transplant patients.	Karolinska Inst, Microbiol & Tumourbiol Ctr, S-17177 Stockholm, Sweden; Univ Gothenburg, Sahlgrens Univ Hosp, Dept Resp Med & Allergol, Gothenburg, Sweden; Univ Gothenburg, Sahlgrens Univ Hosp, Dept Clin Virol, Gothenburg, Sweden; Amgen Corp, Mol Biol, Seattle, WA USA; Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy	Karolinska Institutet; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Magna Graecia University of Catanzaro	Carbone, E (corresponding author), Karolinska Inst, Microbiol & Tumourbiol Ctr, Box 280, S-17177 Stockholm, Sweden.	ennio.carbone@mtc.ki.se		carbone, ennio/0000-0002-2275-8803; Berg, Louise/0000-0001-6538-2837; Bergstrom, Tomas/0000-0002-9257-6757				Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; LJUNGMAN P, 1993, BONE MARROW TRANSPL, V12, P399; Riise GC, 2000, CHEST, V118, P1653, DOI 10.1378/chest.118.6.1653; Wang LL, 2000, J IMMUNOL, V164, P5215, DOI 10.4049/jimmunol.164.10.5215	5	55	56	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2003	361	9363					1099	1101		10.1016/S0140-6736(03)12855-3	http://dx.doi.org/10.1016/S0140-6736(03)12855-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672315				2022-12-24	WOS:000181865200013
J	Takasugi, N; Tomita, T; Hayashi, I; Tsuruoka, M; Niimura, M; Takahashi, Y; Thinakaran, G; Iwatsubo, T				Takasugi, N; Tomita, T; Hayashi, I; Tsuruoka, M; Niimura, M; Takahashi, Y; Thinakaran, G; Iwatsubo, T			The role of presenilin cofactors in the gamma-secretase complex	NATURE			English	Article							AMYLOID-BETA-PROTEIN; INTRAMEMBRANE PROTEOLYSIS; PRECURSOR PROTEIN; NICASTRIN; NOTCH; CLEAVAGE; CELLS; APH-1; APP; STABILIZATION	Mutations in presenilin genes account for the majority of the cases of the familial form of Alzheimer's disease (FAD). Presenilin is essential for gamma-secretase activity, a proteolytic activity involved in intramembrane cleavage of Notch and beta-amyloid precursor protein (betaAPP)(1,2). Cleavage of betaAPP by FAD mutant presenilin results in the overproduction of highly amyloidogenic amyloid beta42 peptides(3-6). gamma-Secretase activity requires the formation of a stable, high-molecular-mass protein complex(7-11) that, in addition to the endoproteolysed fragmented form of presenilin, contains essential cofactors including nicastrin(12-14), APH-1 (refs 15-18) and PEN-2 ( refs 16, 19). However, the role of each protein in complex formation and the generation of enzymatic activity is unclear. Here we show that Drosophila APH-1 (Aph-1) increases the stability of Drosophila presenilin (Psn) holoprotein in the complex. Depletion of PEN-2 by RNA interference prevents endoproteolysis of presenilin and promotes stabilization of the holoprotein in both Drosophila and mammalian cells, including primary neurons. Co-expression of Drosophila Pen-2 with Aph-1 and nicastrin increases the formation of Psn fragments as well as gamma-secretase activity. Thus, APH-1 stabilizes the presenilin holoprotein in the complex, whereas PEN-2 is required for endoproteolytic processing of presenilin and conferring gamma-secretase activity to the complex.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Tokyo; University of Chicago	Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; TAKASUGI, NOBUMASA/0000-0002-6059-2082				Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takasugi N, 2002, J BIOL CHEM, V277, P50198, DOI 10.1074/jbc.M205352200; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	28	743	781	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					438	441		10.1038/nature01506	http://dx.doi.org/10.1038/nature01506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660785				2022-12-24	WOS:000181801200046
J	Fiorillo, CD; Tobler, PN; Schultz, W				Fiorillo, CD; Tobler, PN; Schultz, W			Discrete coding of reward probability and uncertainty by dopamine neurons	SCIENCE			English	Article							RESPONSES; STIMULI; SIGNAL	Uncertainty is critical in the measure of information and in assessing the accuracy of predictions. It is determined by probability P, being maximal. at P = 0.5 and decreasing at higher and lower probabilities. Using distinct stimuli to indicate the probability of reward, we found that the phasic activation of dopamine neurons varied monotonically across the full range of probabilities, supporting past claims that this response codes the discrepancy between predicted and actual reward. In contrast, a previously unobserved response co-varied with uncertainty and consisted of a gradual increase in activity until the potential time of reward. The coding of uncertainty suggests a possible role for dopamine signals in attention-based learning and risk-taking behavior.	Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Fribourg; University of Cambridge	Fiorillo, CD (corresponding author), Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland.	cdf28@cam.ac.uk	Fiorillo, Christopher Dante/C-1718-2011	Tobler, Philippe/0000-0002-4915-9448; Fiorillo, Christopher/0000-0002-7232-9505	Wellcome Trust [095495] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Dickinson A., 1980, CONT ANIMAL LEARNING; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIORILLO CD, UNPUB; Gallistel C. R., 1990, ORG LEARNING; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; KAYE H, 1984, J EXP PSYCHOL ANIM B, V10, P90, DOI 10.1037/0097-7403.10.1.90; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; PEARCE JM, 1987, INTRO ANIMAL COGNITI; Rao R. P., 2002, PROBABILISTIC MODELS; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	23	1315	1335	3	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2003	299	5614					1898	1902		10.1126/science.1077349	http://dx.doi.org/10.1126/science.1077349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649484	Green Submitted			2022-12-24	WOS:000181669700048
J	Rehling, P; Model, K; Brandner, K; Kovermann, P; Sickmann, A; Meyer, HE; Kuhlbrandt, W; Wagner, R; Truscott, KN; Pfanner, N				Rehling, P; Model, K; Brandner, K; Kovermann, P; Sickmann, A; Meyer, HE; Kuhlbrandt, W; Wagner, R; Truscott, KN; Pfanner, N			Protein insertion into the mitochondrial inner membrane by a twin-pore translocase	SCIENCE			English	Article							OUTER-MEMBRANE; INTERMEMBRANE SPACE; IMPORT RECEPTORS; ADP/ATP CARRIER; COMPLEX; CHANNEL; PREPROTEINS; BIOGENESIS; MACHINERY; FAMILY	The mitochondrial inner membrane imports numerous proteins that span it multiple times using the membrane potential Deltapsi as the only external energy source. We purified the protein insertion complex (TIM22 complex), a twin-pore translocase that mediated the insertion of precursor proteins in a three-step process. After the precursor is tethered to the translocase without losing energy from the Deltapsi, two energy-requiring steps were needed. First, Deltapsi acted on the precursor protein and promoted its docking in the translocase complex. Then, Deltapsi and an internal signal peptide together induced rapid gating transitions in one pore and closing of the other pore and drove membrane insertion to completion. Thus, protein insertion was driven by the coordinated action of a twin-pore complex in two voltage-dependent steps.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Max Planck Inst Biophys, Abt Strukturbiol, D-60528 Frankfurt, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Univ Osnabruck, Fachbereich Biol Chem, D-49034 Osnabruck, Germany; Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany	University of Freiburg; Max Planck Society; University of Freiburg; University Osnabruck; Ruhr University Bochum	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.		Sickmann, Albert/A-1010-2011; Kovermann, Peter/AAF-4411-2020; Pfanner, Nikolaus/AAV-7878-2021; Truscott, Kaye/D-3362-2012	Sickmann, Albert/0000-0002-2388-5265; Kovermann, Peter/0000-0001-5296-4918; Truscott, Kaye/0000-0002-5352-9835; Kuhlbrandt, Werner/0000-0002-2013-4810				Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Davis AJ, 1998, MOL BIOL CELL, V9, P2577, DOI 10.1091/mbc.9.9.2577; ElMoualij B, 1997, YEAST, V13, P573, DOI 10.1002/(SICI)1097-0061(199705)13:6<573::AID-YEA107>3.0.CO;2-I; Geissler A, 2000, MOL BIOL CELL, V11, P3977, DOI 10.1091/mbc.11.11.3977; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Kaldi K, 1998, EMBO J, V17, P1569, DOI 10.1093/emboj/17.6.1569; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; PFANNER N, 1985, EMBO J, V4, P2819, DOI 10.1002/j.1460-2075.1985.tb04009.x; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; Zara V, 2001, J MOL BIOL, V310, P965, DOI 10.1006/jmbi.2001.4833	23	232	244	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1747	1751		10.1126/science.1080945	http://dx.doi.org/10.1126/science.1080945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637749				2022-12-24	WOS:000181519500050
J	Aligne, CA; Moss, ME; Auinger, P; Weitzman, M				Aligne, CA; Moss, ME; Auinger, P; Weitzman, M			Association of pediatric dental caries with passive smoking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; ENVIRONMENTAL TOBACCO-SMOKE; 3RD NATIONAL-HEALTH; CHILDRENS ORAL HEALTH; BLOOD LEAD LEVELS; UNITED-STATES; PRESCHOOL-CHILDREN; PARENTAL SMOKING; COTININE LEVELS; US POPULATION	Context Dental decay is the most common chronic disease of children and it disproportionately affects those living in poverty, but the reasons for this are not clear. Passive smoking may be a modifiable, risk factor for dental caries. Objective To examine the relationship between dental caries and serum cotinine levels. Design, Setting, and Participants Cross-sectional data from the Third National Health and Nutrition Examination Survey (1988-1994) of 3531 children aged 4 to 11 years, who had had both dental examinations and a serum cotinine level measurement. Main Outcome Measures Passive smoking defined as serum cotinine levels of 0.2 to 10 ng/mL and caries defined as decayed (unfilled) or filled tooth surfaces. Results Twenty-five percent of the children had at least 1 unfilled decayed tooth surface and 33% had at least 1 filled surface. Fifty-three percent had cotinine levels consistent with passive smoking. Elevated cotinine level was significantly associated with both decayed (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.5-2.9) and filled (OR, 1.4; 95% CI, 1.1-1.8) tooth surfaces in deciduous but not in permanent teeth. This relationship persisted after adjusting forage, sex, race, family income, geographic region, frequency of dental visits, and blood lead level. For dental caries in deciduous teeth, the adjusted OR was 1.8 (95% CI, 1.2-2.7) for the risk of decayed surfaces and 1.4 (95% CI, 1.1-2.0) for filled surfaces. We estimated the population attributable risk-from passive smoking to be 27% for decayed and 14% for filled tooth surfaces. Conclusions There is an association between environmental tobacco smoke and risk of caries among children. Reduction of passive smoking is important not only for the prevention of many medical problems, but also for the promotion of children's dental health.	Pediathink, Rochester, NY USA; Eastman Sch Dent, Rochester, NY USA; Amer Acad Pediat, Ctr Child Hlth Res, Elk Grove Village, IL 60007 USA; Univ Rochester, Sch Med, Dept Community & Prevent Med, Rochester, NY USA; Univ Rochester, Sch Med, Dept Pediat, Rochester, NY 14642 USA	University of Rochester; American Academy of Pediatrics; University of Rochester; University of Rochester	Aligne, CA (corresponding author), 620 Pk Ave,Box 135, Rochester, NY 14607 USA.		Moss, Mark E/AAF-1697-2020; Moss, Mark E/Q-3014-2019	Moss, Mark E/0000-0003-0105-0416; 				ADAIR SM, 1999, PEDIAT DENT; Aligne CA, 1997, ARCH PEDIAT ADOL MED, V151, P648, DOI 10.1001/archpedi.1997.02170440010002; Arbes SJ, 2001, AM J PUBLIC HEALTH, V91, P253, DOI 10.2105/AJPH.91.2.253; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; Brown LJ, 2000, J AM DENT ASSOC, V131, P223, DOI 10.14219/jada.archive.2000.0151; Brunelle J A, 1990, J Dent Res, V69 Spec No, P723; BRUNELLE JA, 1982, J DENT RES, V61, P1346; *CDC, 1992, MMWR-MORBID MORTAL W, V41, P372; CDC (Centers for Disease Control and Prevention), 2001, NAT REP HUM EXP ENV; CHARLTON A, 1994, J FAM PRACTICE, V38, P267; DiFranza JR, 1996, PEDIATRICS, V97, P560; DOLL R, 1992, BMJ-BRIT MED J, V305, P1521, DOI 10.1136/bmj.305.6868.1521; Drury TF, 1996, J DENT RES, V75, P620, DOI 10.1177/002203459607502S02; EDELSTEIN BL, 1995, PUBLIC HEALTH REP, V110, P522; Edelstein BL, 2002, AMBUL PEDIATR, V2, P141, DOI 10.1367/1539-4409(2002)002<0141:DIOHAA>2.0.CO;2; Edwards K, 1999, HUM EXP TOXICOL, V18, P233, DOI 10.1191/096032799678839978; Ettinger R L, 1999, Dent Clin North Am, V43, P679; Hopper JA, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e47; Kaste LM, 1996, J DENT RES, V75, P631, DOI 10.1177/002203459607502S03; KIDD EAM, 1997, ESSENTIALS DENT CARI; LINDEMEYER RG, 1981, J AM DENT ASSOC, V103, P719, DOI 10.14219/jada.archive.1981.0372; MANDEL ID, 1987, J DENT RES, V66, P623, DOI 10.1177/00220345870660S203; Mannino DM, 2002, CHEST, V122, P409, DOI 10.1378/chest.122.2.409; Mannino DM, 2001, CHEST, V120, P718, DOI 10.1378/chest.120.3.718; Moss ME, 1999, JAMA-J AM MED ASSOC, V281, P2294, DOI 10.1001/jama.281.24.2294; Mouradian WE, 2000, JAMA-J AM MED ASSOC, V284, P2625, DOI 10.1001/jama.284.20.2625; Nelson E, 1999, HUM EXP TOXICOL, V18, P252, DOI 10.1191/096032799678840002; *NIH, 1999, SMOK TOB CONTR MON N, V10; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; RONCHETTI R, 1994, EUR RESPIR J, V7, P472, DOI 10.1183/09031936.94.07030472; Schafer TE, 2000, PEDIATR CLIN N AM, V47, P1021, DOI 10.1016/S0031-3955(05)70256-X; SCHYDLOWER M, 1994, PEDIATRICS, V93, P866; Seow WK, 1998, COMMUNITY DENT ORAL, V26, P8, DOI 10.1111/j.1600-0528.1998.tb02090.x; Shah BV, 1997, SOFTWARE STAT ANAL C; Stamm J. W., 1991, RISK MARKERS ORAL DI, V1, P132; Strauss RS, 2001, PEDIATRICS, V107, P540, DOI 10.1542/peds.107.3.540; Tinanoff N, 2000, J PUBLIC HEALTH DENT, V60, P197, DOI 10.1111/j.1752-7325.2000.tb03328.x; Tinanoff Norman, 1997, Pediatric Dentistry, V19, P12; VAANANEN MK, 1994, SCAND J DENT RES, V102, P103; Vargas CM, 1998, J AM DENT ASSOC, V129, P1229, DOI 10.14219/jada.archive.1998.0420; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Weaver VM, 1996, CANCER EPIDEM BIOMAR, V5, P135; Weitzman M, 2001, AMBUL PEDIATR, V1, P162, DOI 10.1367/1539-4409(2001)001<0162:ACSOHN>2.0.CO;2; Williams SA, 2000, CARIES RES, V34, P117, DOI 10.1159/000016578; Winn DM, 1996, J DENT RES, V75, P642, DOI 10.1177/002203459607502S04; WOOD RA, 2001, PRIMARY PEDIAT CARE, P1318; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; CENSUS 2000 SUPPLEME; ORAL HLTH AM REPORT; 1997, MMWR MORB MORTAL WKL, V46, P1038	50	154	159	2	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1258	1264		10.1001/jama.289.10.1258	http://dx.doi.org/10.1001/jama.289.10.1258			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633187	Bronze			2022-12-24	WOS:000181466500027
J	Chilcott, J; McCabe, C; Tappenden, P; O'Hagan, A; Cooper, NJ; Abrams, K; Claxton, K				Chilcott, J; McCabe, C; Tappenden, P; O'Hagan, A; Cooper, NJ; Abrams, K; Claxton, K		Cost Effectiveness Multiple Sclero	Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. Design Modelling cost effectiveness. Setting UK NHS. Participants Patients with relapsing remitting multiple sclerosis and secondary progressive multiple sclerosis. Main outcome measures Cost per quality adjusted life year gained. Results The base case cost per quality adjusted life year gained by using any of the four treatments ranged from pound42 000 ($66 469; (sic) 61 630) to pound98 000 based on efficacy information in the public domain. Uncertainty analysis suggests that the probability of any of these therapies having a cost effectiveness better than pound20 000 is below 20%. The key determinants of cost effectiveness were the time horizon, the progression of patients after stopping treatment, differential discount rates, and the price of the treatments. Conclusions Cost effectiveness varied markedly between the interventions. Uncertainty around point estimates was substantial. This uncertainty could be reduced by conducting research on the true magnitude of the effect of these drugs, the progression of patients after stopping treatment, the costs of care, and the quality of life of the patients. Price was the key modifiable determinant of the cost effectiveness of these treatments.	Univ Sheffield, Sch Hlth & Related Res Rapid Rev Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Dept Probabil & Stat, Ctr Bayesian Stat Hlth Econ, Sheffield S3 7RH, S Yorkshire, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ York, Dept Econ & Related Studies, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of Sheffield; University of Sheffield; University of Leicester; University of York - UK	McCabe, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res Rapid Rev Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.		Tappenden, Paul/B-4557-2009; McCabe, Christopher/E-2051-2016; O'Hagan, Anthony/B-2992-2016; Abrams, Keith/AAA-2557-2020; Chilcott, Jim/B-4474-2009	O'Hagan, Anthony/0000-0002-7994-0702; Abrams, Keith/0000-0002-7557-1567	Multiple Sclerosis Society [491] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		*ASS BRIT NEUR, 2001, GUID TREATM INT BET; *ASS BRIT NEUR, 2001, GUID US BET INT GLAT; *BRIT MED ASS, 2001, BRIT NAT FORM, P422; Brown MG, 2000, INT J TECHNOL ASSESS, V16, P751, DOI 10.1017/S026646230010203X; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EBERS G, 2001, LONDON ONTARIO COHOR; Forbes RB, 1999, BMJ-BRIT MED J, V319, P1529, DOI 10.1136/bmj.319.7224.1529; Kendrick M, 2000, PHARMACOECONOMICS, V18, P45, DOI 10.2165/00019053-200018010-00005; Kobelt G, 2000, SCANDINAVIAN WORKING; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; *MULT SCL RES TRUS, 2001, QUAL LIF PEOPL MULT; *NAT I CLIN EXC, 2002, BET INT GLAT AC TREA; *NAT I CLIN EXC, TECHN APPR COMM M 13; National Grid, 2002, FULL GUID US BET INT, P1; Noseworthy J, 2003, LANCET, V361, P350, DOI 10.1016/S0140-6736(03)12354-9; PARKIN D, 1998, HLTH TECHNOL ASSESS, V4, pR1; PATZOLD U, 1982, ACTA NEUROL SCAND, V65, P248, DOI 10.1111/j.1600-0404.1982.tb03084.x; PROSSER L, 2000, COST EFFECTIVENESS T; RICE GPA, 2001, COCHRANE LIB; RICHARDS RG, 2002, HLTH TECHNOL ASSESS, V6, pR1; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133	21	108	108	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					522	525		10.1136/bmj.326.7388.522	http://dx.doi.org/10.1136/bmj.326.7388.522			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623909	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000181548400014
J	Lim, LP; Glasner, ME; Yekta, S; Burge, CB; Bartel, DP				Lim, LP; Glasner, ME; Yekta, S; Burge, CB; Bartel, DP			Vertebrate MicroRNA genes	SCIENCE			English	Article							IDENTIFICATION; RNAS		MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Lim, LP (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Burge, Christopher B./AAH-2177-2020	Glasner, Margaret/0000-0003-1818-1965				Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LIM LP, IN PRESS GENES DEV; Moss EG, 2002, CURR BIOL, V12, pR688, DOI 10.1016/S0960-9822(02)01206-X	6	941	1238	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1540	1540		10.1126/science.1080372	http://dx.doi.org/10.1126/science.1080372			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624257				2022-12-24	WOS:000181367900027
J	Juengst, ET; Binstock, RH; Mehlman, MJ; Post, SG				Juengst, ET; Binstock, RH; Mehlman, MJ; Post, SG			Aging - Antiaging research and the need for public dialogue	SCIENCE			English	Editorial Material							POLICY		Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA	Case Western Reserve University	Juengst, ET (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.			Juengst, Eric/0000-0002-8374-5774	NATIONAL INSTITUTE ON AGING [R01AG020916] Funding Source: NIH RePORTER; NIA NIH HHS [1R01-AGHG20916-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], QUEST IMMORTALITY SC; [Anonymous], 2000, MORAL CHALLENGE ALZH; BINSTOCK RH, IN PRESS GERONTOLOGI; BONNICKSEN AL, 2002, CRAFTING CLONING POL; Butler R, 2001, GENERATIONS, V25, P63; Butler RN, 2002, J GERONTOL A-BIOL, V57, pB333, DOI 10.1093/gerona/57.9.B333; Cohen Gene., 2000, CREATIVE AGE AWAKENI; De Grey ADNJ, 2002, ANN NY ACAD SCI, V959, P452, DOI 10.1111/j.1749-6632.2002.tb02115.x; de Grey ADNJ, 2002, BIOESSAYS, V24, P667, DOI 10.1002/bies.10113; de Grey ADNJ, 2000, BIOGERONTOLOGY, V1, P369, DOI 10.1023/A:1026547023576; Fisher A, 2002, J GERONTOL A-BIOL, V57, pM636, DOI 10.1093/gerona/57.10.M636; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Garland MJ, 1999, PUBLIC UNDERST SCI, V8, P241, DOI 10.1088/0963-6625/8/3/308; GRUMAN G, 1966, T AM PHILOS SOC, V56; Hackler C, 2001, GENERATIONS, V25, P15; Hayflick L, 2001, GENERATIONS, V25, P20; Juengst ET, 2002, J ANTI-AGING MED, V5, P73, DOI 10.1089/109454502317629318; Kass L R, 2001, First Things, P17; Kirkland JL, 2002, CLIN GERIATR MED, V18, P383, DOI 10.1016/S0749-0690(02)00023-X; Lane MA, 2002, SCI AM, V287, P36, DOI 10.1038/scientificamerican0802-36; MASORO EJ, 2001, J GERONTOL A, V56; Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006; Moody H. R., 1995, WORLD GROWING OLD CO, P9; Moody HR, 2001, GENERATIONS, V25, P33; *NAT I AG, 2001, ACT PLAN AG RES STRA; Olshansky SJ, 2002, SCI AM, V286, P92, DOI 10.1038/scientificamerican0602-92; Olshansky SJ, 2002, J GERONTOL A-BIOL, V57, pB292, DOI 10.1093/gerona/57.8.B292; SELTZER M, 1995, IMPACT INCREASED LIF; WALTERS L, 1991, HUM GENE THER, V2, P115, DOI 10.1089/hum.1991.2.2-115; WATSON J, 1992, GENE MAPPING USING L, pR15	30	38	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1323	1323		10.1126/science.1083135	http://dx.doi.org/10.1126/science.1083135			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610284				2022-12-24	WOS:000181192300029
J	Krause, TG; Hviid, A; Koch, A; Friborg, J; Hjuler, T; Wohlfahrt, J; Olsen, OR; Kristensen, B; Melbye, M				Krause, TG; Hviid, A; Koch, A; Friborg, J; Hjuler, T; Wohlfahrt, J; Olsen, OR; Kristensen, B; Melbye, M			BCG vaccination and risk of atopy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN; SENSITIZATION; CHILDHOOD	Context It has been suggested that BCG vaccination may protect against development of allergic diseases, particularly when given just after birth. BCG vaccination was given routinely to all infants in Greenland until 1990, when it was withdrawn from the vaccination program.,Whether this resulted in an increased prevalence of atopy in children born after the stop of BCG vaccination is unknown. Objective To determine whether BCG vaccination and age at BCG vaccination are associated with development of atopy. Design, Setting, and Participants Cross-sectional study among schoolchildren aged 8 to 16 years in 4 towns on the northwest coast of Greenland. Participants had a blood sample drawn and information on BCG vaccination was obtained during 2 periods, November 1998 and November 2001. A total of 1686 children (79% of available children) participated, 1575 of whom had complete information on vaccination status. Atopy was defined as a positive test result in an assay that tests for IgE specific against the most common inhalant allergens in serum. Main Outcome Measures Odds ratio (OR) of atopy in BCG-vaccinated compared with unvaccinated children and OR according to age at vaccination. Results The risk of atopy was the same in BCG-vaccinated compared with unvaccinated children after adjustment for confounders (OR, 1.03; 95% confidence interval, 0.72-1.48). The risk of atopy in BCG-vaccinated children was not associated with age at vaccination (P=.17). Conclusions BCG vaccination administered to infants is not associated with reduced risk of development of atopy.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; Sisimiut Hosp, Sisimiut, Greenland; Pharmacia, Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Pfizer	Krause, TG (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	tgv@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127; Koch, Anders/0000-0001-9205-1048; melbye, mads/0000-0001-8264-6785; Friborg, Jeppe/0000-0001-5423-0627; Hjuler, Thomas/0000-0002-3860-0306				Aaby P, 2000, CLIN EXP ALLERGY, V30, P644, DOI 10.1046/j.1365-2222.2000.00803.x; Alm JS, 1997, LANCET, V350, P400, DOI 10.1016/S0140-6736(97)02207-1; Alm JS, 2002, GENES IMMUN, V3, P71, DOI 10.1038/sj.gene.6363834; *AT, 1991, STAT HLTH GREENL REP; Gruber C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e36; Gruber C, 2002, PEDIAT ALLERG IMM-UK, V13, P177, DOI 10.1034/j.1399-3038.2002.01006.x; Gruber C, 2001, PEDIAT ALLERG IMM-UK, V12, P296, DOI 10.1034/j.1399-3038.2001.1r046.x; Krause TG, 2002, CLIN EXP ALLERGY, V32, P367, DOI 10.1046/j.1365-2222.2002.01316.x; Marchant A, 1999, J IMMUNOL, V163, P2249; MARTINEZ FD, 1994, THORAX, V49, P1189, DOI 10.1136/thx.49.12.1189; Pershagen G, 2000, PEDIATR ALLERGY IMMU, V11, P26, DOI 10.1034/j.1399-3038.2000.00507.x; ROMANUS V, 1992, TUBERCLE LUNG DIS, V73, P150, DOI 10.1016/0962-8479(92)90149-E; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Strannegard IL, 1998, ALLERGY, V53, P249, DOI 10.1111/j.1398-9995.1998.tb03884.x	14	44	45	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1012	1015		10.1001/jama.289.8.1012	http://dx.doi.org/10.1001/jama.289.8.1012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597754	Bronze			2022-12-24	WOS:000181129800028
J	Bray, D				Bray, D			Molecular prodigality	SCIENCE			English	Editorial Material									Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Bray, D (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Nakada K, 2002, DIFFERENTIATION, V70, P92, DOI 10.1046/j.1432-0436.2002.700204.x; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Wolfram S., 2002, NEW KIND SCI	11	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1189	1190		10.1126/science.1080010	http://dx.doi.org/10.1126/science.1080010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595679				2022-12-24	WOS:000181065500025
J	Zheng, XY; Wang, J; Haerry, TE; Wu, AYH; Martin, J; O'Connor, MB; Lee, CHJ; Lee, T				Zheng, XY; Wang, J; Haerry, TE; Wu, AYH; Martin, J; O'Connor, MB; Lee, CHJ; Lee, T			TGF-beta signaling activates steroid hormone receptor expression during neuronal remodeling in the Drosophila brain	CELL			English	Article							REPRESSIBLE CELL MARKER; ECDYSONE RECEPTOR; MUSHROOM BODIES; CAENORHABDITIS-ELEGANS; LARVAL DEVELOPMENT; MOSAIC ANALYSIS; NERVOUS-SYSTEM; II RECEPTOR; C-ELEGANS; METAMORPHOSIS	Metamorphosis of the Drosophila brain involves pruning of many larval-specific dendrites and axons followed by outgrowth of adult-specific processes. From a genetic mosaic screen, we recovered two independent mutations that block neuronal remodeling in the mushroom bodies (MBs). These phenotypically indistinguishable mutations affect Baboon function, a Drosophila TGF-beta/activin type I receptor, and dSmad2, its downstream transcriptional effector. We also show that Punt and Wit, two type II receptors, act redundantly in this process. In addition, knocking out dActivin around the mid-third instar stage interferes with remodeling. Binding of the insect steroid hormone ecdysone to distinct ecdysone receptor isoforms induces different metamorphic responses in various larval tissues. Interestingly, expression of the ecdysone receptor B1 isoform (EcR-B1) is reduced in activin pathway mutants, and restoring EcR-B1 expression significantly rescues remodeling defects. We conclude that the Drosophila Activin signaling pathway mediates neuronal remodeling in part by regulating EcR-B1 expression.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Internal Med, Hematol Oncol Sect, Chicago, IL 60612 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Lee, T (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.		O'Connor, Michael B/C-9977-2014; Zheng, Xiaoyan/AAG-1251-2020	O'Connor, Michael B/0000-0002-3067-5506; Zheng, Xiaoyan/0000-0003-4983-5503	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42049] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Antebi A, 2000, GENE DEV, V14, P1512; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chen YJ, 1998, DEVELOPMENT, V125, P1759; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Das P, 1999, GENES CELLS, V4, P123, DOI 10.1046/j.1365-2443.1999.00244.x; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dockendorff TC, 2000, MOL GEN GENET, V263, P137, DOI 10.1007/s004380050040; Ebendal T, 1998, J NEUROSCI RES, V51, P139, DOI 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Henderson KD, 1998, BIOCHEM BIOPH RES CO, V252, P195, DOI 10.1006/bbrc.1998.9562; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; KONEV AY, 1994, GENETIKA+, V30, P201; Kutty G, 1998, BIOCHEM BIOPH RES CO, V246, P644, DOI 10.1006/bbrc.1998.8678; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEVINE RB, 1984, J EXP BIOL, V112, P27; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; Li H, 2001, NEUROSCIENCE, V106, P193, DOI 10.1016/S0306-4522(01)00263-9; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; MURAKAMI F, 1992, NEUROSCI RES, V15, P235, DOI 10.1016/0168-0102(92)90045-E; Newfeld SJ, 1999, GENETICS, V152, P783; Nguyen M, 2000, MECH DEVELOP, V95, P201, DOI 10.1016/S0925-4773(00)00338-5; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Osada SI, 1999, DEVELOPMENT, V126, P3229; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, GENETIC ENV REGULATI, P739, DOI DOI 10.1101/087969532.33.739; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Savage-Dunn C, 2001, CYTOKINE GROWTH F R, V12, P305, DOI 10.1016/S1359-6101(01)00015-6; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; YANG MY, 1995, NEURON, V15, P45; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F	55	173	177	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					303	315		10.1016/S0092-8674(03)00072-2	http://dx.doi.org/10.1016/S0092-8674(03)00072-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581521	Bronze			2022-12-24	WOS:000181252200003
J	Rona, PA				Rona, PA			Resources of the sea floor	SCIENCE			English	Editorial Material									Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Rona, PA (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA.	rona@imcs.rutgers.edu						BROARD WJ, 1997, NY TIMES        0127, pA1; GARNETT RHT, 2000, MAR SCI SER, P103; HEIN JR, COMMUNICATION; Herzig P.M., 2000, MAR SCI SER, P347; HUMPHRIS SE, 1995, NATURE, V377, P713, DOI 10.1038/377713a0; Iizasa K, 1999, SCIENCE, V283, P975, DOI 10.1126/science.283.5404.975; JANNASCH HW, 1995, J MAR BIOTECHNOL, V3, P5; Koschinsky A, 2000, MAR SCI SER, P239; LENOBLE JP, 1995, MARINE MINERAL OCCUR, P1; MEADE C, 1991, SCIENCE, V252, P68, DOI 10.1126/science.252.5002.68; Mero J.L., 1965, MINERAL RESOURCES SE, DOI DOI 10.1016/S0422-9894(08)70765-7; Nawab Z, 2001, PROPOSED TECHNOLOGIE, P26; Rona PA, 2002, EPISODES, V25, P2, DOI 10.18814/epiiugs/2002/v25i1/001; RONA PA, 1993, ECON GEOL, V8, P1989; Yang KH, 1996, NATURE, V383, P420, DOI 10.1038/383420a0	15	109	117	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					673	674		10.1126/science.1080679	http://dx.doi.org/10.1126/science.1080679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560541				2022-12-24	WOS:000180687700035
J	Lalloo, F; Varley, J; Ellis, D; Moran, A; O'Dair, L; Pharoah, P; Evans, DGR				Lalloo, F; Varley, J; Ellis, D; Moran, A; O'Dair, L; Pharoah, P; Evans, DGR		Early Onset Breast Canc Study Grp	Prediction of pathogenic mutations in patients with early-onset breast cancer by family history	LANCET			English	Article								We aimed to assess frequency and penetrance of BRCA1, BRCA2, and TP53 mutations in women diagnosed with breast cancer aged 30 years or younger, and then correlate this frequency with family history. 17 of 36 familial cases had a BRCA1, BRCA2, or TP53 mutation, compared with three of 63 non-familial cases. The calculated population frequency of TP53 mutations was one In 5000, substantially greater than previous estimates. This finding underlines the importance of accurate elucidation of a family history from young women diagnosed with breast cancer. Establishment of family history could help with development of patient-specific management and tumour surveillance protocols.	St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; Christie NHS Trust, Canc Res UK Paterson Inst Canc Res, Manchester, Lancs, England; Guys Hosp, London SE1 9RT, England; Univ Manchester, Ctr Canc Epidemiol, Manchester M13 9PL, Lancs, England; Univ Cambridge, Dept Oncol, Strangeways Res Lab, Cambridge CB2 1TN, England	University of Manchester; Cancer Research UK; Christie NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Manchester; University of Cambridge	Lalloo, F (corresponding author), St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England.	Fiona.Lalloo@cmmc.nhs.uk	Evans, D Gareth/AAB-4308-2022; Pharoah, Paul/V-6658-2019; Mathew, Christopher G/G-3434-2015	Evans, D Gareth/0000-0002-8482-5784; Pharoah, Paul/0000-0001-8494-732X; Mathew, Christopher G/0000-0003-4178-1838; Howell, Anthony/0000-0002-6233-719X				BIRCH JM, 1994, CANCER RES, V54, P1298; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301	4	130	132	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 29	2003	361	9363					1101	1102		10.1016/S0140-6736(03)12856-5	http://dx.doi.org/10.1016/S0140-6736(03)12856-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672316				2022-12-24	WOS:000181865200014
J	Nishida, H; Pigg, KB; Rigby, JF				Nishida, H; Pigg, KB; Rigby, JF			Swimming sperm in an extinct Gondwanan plant	NATURE			English	Article									Chuo Univ, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan; Queensland Univ Technol, Sch Nat Resource Sci, Brisbane, Qld, Australia; Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA	Chuo University; Queensland University of Technology (QUT); Arizona State University; Arizona State University-Tempe	Nishida, H (corresponding author), Chuo Univ, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.							BLERHORST DW, 1971, MORPHOLOGY VASCULAR; CASS D, 1970, AM J BOT, V57, P2; CHAMBERLAIN CJ, 1935, GYMNOSPERMS; Gifford EM, 1989, MORPHOLOGY EVOLUTION; Gould RE, 1977, ALCHERINGA, V1, P387, DOI 10.1080/03115517708527774; Hirase S., 1896, BOT MAG TOKYO, V10, P325; Ikeno, 1896, BOT MAG TOKYO, V10, P367, DOI 10.15281/jplantres1887.10.115_61; LI Y, 1989, PROTOPLASMA, V149, P57, DOI 10.1007/BF01623983; NORSTOG KJ, 1986, BOT GAZ, V147, P40, DOI 10.1086/337566; Pigg KB, 1997, REV PALAEOBOT PALYNO, V97, P339, DOI 10.1016/S0034-6667(97)00007-9; RETALIACK G, 1988, PALEOBIOLOGY, V7, P54; ROTHWELL GW, 2001, BOT 2001, P25; STEWART WN, 1951, AM MIDL NAT, V46, P717, DOI 10.2307/2421812	13	29	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					396	397		10.1038/422396a	http://dx.doi.org/10.1038/422396a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660772				2022-12-24	WOS:000181801200033
J	Hassall, O; Bedu-Addo, G; Adarkwa, M; Danso, K; Bates, I				Hassall, O; Bedu-Addo, G; Adarkwa, M; Danso, K; Bates, I			Umbilical-cord blood for transfusion in children with severe anaemia in under-resourced countries	LANCET			English	Article								Shortage of blood for transfusion contributes substantially to mortality of children with severe anaemia in sub-Saharan Africa. Umbilical-cord blood could be an additional and readily available source of blood. We aimed to show whether it is possible to gather cord blood in a busy Ghanaian labour ward. Mean volume of each blood sample obtained from the umbilical cord was 85 mL (SID 28.0). This amount of blood is sufficient to raise the haemoglobin concentrations of 28 (21%) of 131 children needing transfusions in the same hospital, by 30 g/L. Further work is needed to improve the sterility of cord blood and to establish the resource and logistical implications of scaling-up for sub-Saharan Africa transfusion services.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Komfo Anokye Teaching Hosp, Kumasi, Ghana	Liverpool School of Tropical Medicine; University of Liverpool; Kwame Nkrumah University Science & Technology	Bates, I (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.			bates, imelda/0000-0002-0862-8199				English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; INSLEY J, 1996, PAEDIAT VADE MECUM; Lackritz EM, 1997, AIDS, V11, P1487, DOI 10.1097/00002030-199712000-00013; *WHO, 1999, CLIN US BLOOD HDB	4	29	32	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					678	679		10.1016/S0140-6736(03)12565-2	http://dx.doi.org/10.1016/S0140-6736(03)12565-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606183				2022-12-24	WOS:000181129500021
J	Burgess, SA; Walker, ML; Sakakibara, H; Knight, PJ; Oiwa, K				Burgess, SA; Walker, ML; Sakakibara, H; Knight, PJ; Oiwa, K			Dynein structure and power stroke	NATURE			English	Article							HEAVY-CHAIN; ADENOSINE-TRIPHOSPHATASE; CYTOPLASMIC DYNEIN; NUCLEOTIDE-BINDING; MYOSIN; ATP; ACTIVATION; PROTEINS; FLAGELLA; FAMILY	Dynein ATPases are microtubule motors that are critical to diverse processes such as vesicle transport and the beating of sperm tails; however, their mechanism of force generation is unknown. Each dynein comprises a head, from which a stalk and a stem emerge. Here we use electron microscopy and image processing to reveal new structural details of dynein c, an isoform from Chlamydomonas reinhardtii flagella, at the start and end of its power stroke. Both stem and stalk are flexible, and the stem connects to the head by means of a linker approximately 10 nm long that we propose lies across the head. With both ADP and vanadate bound, the stem and stalk emerge from the head 10 nm apart. However, without nucleotide they emerge much closer together owing to a change in linker orientation, and the coiled-coil stalk becomes stiffer. The net result is a shortening of the molecule coupled to an approximately 15-nm displacement of the tip of the stalk. These changes indicate a mechanism for the dynein power stroke.	Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; Commun Res Labs, Kansai Adv Res Ctr, Kobe, Hyogo 6512492, Japan	University of Leeds; University of Leeds; National Institute of Information & Communications Technology (NICT) - Japan	Burgess, SA (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.a.burgess@leeds.ac.uk	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X				Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; BURGESS SA, 1995, J MOL BIOL, V250, P52, DOI 10.1006/jmbi.1995.0357; Burgess SA, 1997, J CELL BIOL, V139, P675, DOI 10.1083/jcb.139.3.675; DiBella LM, 2001, INT REV CYTOL, V210, P227; ELLIOTT A, 1976, PROC R SOC SER B-BIO, V193, P45, DOI 10.1098/rspb.1976.0030; Fan J, 2001, J MOL BIOL, V307, P1317, DOI 10.1006/jmbi.2001.4566; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Gee M, 1998, EUR BIOPHYS J BIOPHY, V27, P466, DOI 10.1007/s002490050157; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GIBBONS IR, 1991, METHOD ENZYMOL, V196, P428; GIBBONS IR, 1987, J BIOL CHEM, V262, P2780; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; GOODENOUGH U, 1984, J MOL BIOL, V180, P1083, DOI 10.1016/0022-2836(84)90272-9; Goodenough U.W., 1989, CELL MOVEMENT, V1, P121; GOODENOUGH UW, 1982, J CELL BIOL, V95, P798, DOI 10.1083/jcb.95.3.798; GOODENOUGH UW, 1987, J MOL BIOL, V194, P481, DOI 10.1016/0022-2836(87)90676-0; JOHNSON JG, 1988, CANADIAN SOC PETROLE, V14, P161; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 2000, J CELL SCI, V113, P2521; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Mocz G, 1996, BIOCHEMISTRY-US, V35, P9204, DOI 10.1021/bi960662u; Neuwald AF, 1999, GENOME RES, V9, P27; OGAWA K, 1991, NATURE, V352, P643, DOI 10.1038/352643a0; OKUNO M, 1980, J CELL BIOL, V85, P712, DOI 10.1083/jcb.85.3.712; OMOTO CK, 1986, BIOCHEMISTRY-US, V25, P419, DOI 10.1021/bi00350a022; Sakakibara H, 1999, NATURE, V400, P586, DOI 10.1038/23066; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Shiroguchi K, 2001, CELL MOTIL CYTOSKEL, V49, P189, DOI 10.1002/cm.1032; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Vallee RB, 1998, TRENDS CELL BIOL, V8, P490, DOI 10.1016/S0962-8924(98)01379-8; VERNON GG, 1995, EXP CELL RES, V220, P482, DOI 10.1006/excr.1995.1340; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Woolley D, 2000, Essays Biochem, V35, P103; Yagi T, 2000, CELL STRUCT FUNCT, V25, P263, DOI 10.1247/csf.25.263	41	390	395	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					715	718		10.1038/nature01377	http://dx.doi.org/10.1038/nature01377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610617	Green Accepted			2022-12-24	WOS:000180938000035
J	Mamdouh, Z; Chen, X; Pierini, LM; Maxfield, FR; Muller, WA				Mamdouh, Z; Chen, X; Pierini, LM; Maxfield, FR; Muller, WA			Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis	NATURE			English	Article							VESICULO-VACUOLAR ORGANELLES; TRANSENDOTHELIAL MIGRATION; CELL-ADHESION; TRANSMIGRATION; MONOCYTES; CADHERIN; LEUKOCYTES	Leukocytes enter sites of inflammation by squeezing through the borders between endothelial cells that line postcapillary venules at that site. This rapid process, called transendothelial migration (TEM) or diapedesis, is completed within 90 s after a leukocyte arrests on the endothelial surface(1-4). In this time, the leukocyte moves in ameboid fashion across the endothelial borders, which remain tightly apposed to it during transit. It is not known how the endothelial cell changes its borders rapidly and reversibly to accommodate the migrating leukocyte. Here we show that there is a membrane network just below the plasmalemma at the cell borders that is connected at intervals to the junctional surface. PECAM-1, an integral membrane protein with an essential role in TEM5-7, is found in this compartment and constitutively recycles evenly along endothelial cell borders. During TEM, however, recycling PECAM is targeted to segments of the junction across which monocytes are in the act of migration. In addition, blockade of TEM with antibodies against PECAM specifically blocks the recruitment of this membrane to the zones of leukocyte migration, without affecting the constitutive membrane trafficking.	Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University; Cornell University	Muller, WA (corresponding author), Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10021 USA.		Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866				Ali J, 1997, MICROCIRCULATION-LON, V4, P267, DOI 10.3109/10739689709146790; Allport JR, 2000, J CELL BIOL, V148, P203, DOI 10.1083/jcb.148.1.203; Bamforth SD, 1997, INVEST OPHTH VIS SCI, V38, P25; Berman ME, 1996, J IMMUNOL, V156, P1515; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Feng D, 1996, J EXP MED, V183, P1981, DOI 10.1084/jem.183.5.1981; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; HAMMERSEN F, 1987, PROG APPL MICROCIRC, V12, P1; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; MULLER WA, 1992, J EXP MED, V176, P819, DOI 10.1084/jem.176.3.819; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Muller WA, 1999, J LEUKOCYTE BIOL, V66, P698, DOI 10.1002/jlb.66.5.698; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Vasile E, 1999, J HISTOCHEM CYTOCHEM, V47, P159, DOI 10.1177/002215549904700205; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713	21	248	255	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					748	753		10.1038/nature01300	http://dx.doi.org/10.1038/nature01300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610627				2022-12-24	WOS:000180938000045
J	Hwang, JS; Druffel, ERM				Hwang, JS; Druffel, ERM			Lipid-like material as the source of the uncharacterized organic carbon in the ocean?	SCIENCE			English	Article							MACROMOLECULAR CONSTITUENTS; SELECTIVE PRESERVATION; ISOTOPE FRACTIONATION; COMPOUND CLASSES; MATTER; PACIFIC; RADIOCARBON; SEDIMENTS; ORIGIN; VARIABILITY	The composition and formation mechanisms of the uncharacterized fraction of oceanic particulate organic carbon (POC) are not well understood. We isolated biologically important compound classes and the acid-insoluble fraction, a proxy of the uncharacterized fraction, from sinking POC in the deep Northeast Pacific and measured carbon isotope ratios to constrain the source(s) of the uncharacterized fraction. Stable carbon and radiocarbon isotope signatures of the acid-insoluble fraction were similar to those of the lipid fraction, implying that the acid-insoluble fraction might be composed of selectively accumulated lipid-like macromolecules.	Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hwang, JS (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	jeomshik@uci.edu; edruffel@uci.edu						Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; De Leeuw J.W., 1993, ORG GEOCHEM, V11, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; DEGENS ET, 1968, DEEP-SEA RES, V15, P11, DOI 10.1016/0011-7471(68)90025-9; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; EGLINTON TI, 1994, ORG GEOCHEM, V21, P721, DOI 10.1016/0146-6380(94)90015-9; FLAVIANO C, 1994, ORG GEOCHEM, V22, P759, DOI 10.1016/0146-6380(94)90137-6; Garcette-Lepecq A, 2000, ORG GEOCHEM, V31, P1663, DOI 10.1016/S0146-6380(00)00100-5; Gelinas Y, 2001, SCIENCE, V294, P145, DOI 10.1126/science.1062363; HATCHER PG, 1983, NATURE, V305, P498, DOI 10.1038/305498a0; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HEDGES JI, 1978, GEOCHIM COSMOCHIM AC, V42, P69, DOI 10.1016/0016-7037(78)90218-1; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; HENRICHS SM, 1995, MAR CHEM, V49, P127, DOI 10.1016/0304-4203(95)00012-G; HWANG JH, UNPUB; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; Knicker H, 1996, ORG GEOCHEM, V24, P661, DOI 10.1016/0146-6380(96)00057-5; Largeau C, 1995, ADV MICROB ECOL, V14, P77; Masiello CA, 1998, DEEP-SEA RES PT II, V45, P617, DOI 10.1016/S0967-0645(97)00096-9; Masiello CA, 2001, GLOBAL BIOGEOCHEM CY, V15, P407, DOI 10.1029/2000GB001290; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; MINOR EC, UNPUB GEOCHIM COSMOC; Peulve S, 1996, GEOCHIM COSMOCHIM AC, V60, P1239, DOI 10.1016/0016-7037(95)00442-4; QIAN Y, 1992, CHEM GEOL, V101, P201, DOI 10.1016/0009-2541(92)90002-M; Sherrell RM, 1998, DEEP-SEA RES PT II, V45, P733, DOI 10.1016/S0967-0645(97)00100-8; Smith KL, 2001, LIMNOL OCEANOGR, V46, P543, DOI 10.4319/lo.2001.46.3.0543; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; TISSOT BP, 1984, PETROLEUM FORMATIO 2, pCH2; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Wang XC, 2001, MAR CHEM, V73, P65, DOI 10.1016/S0304-4203(00)00090-6; Wang XC, 1998, GEOCHIM COSMOCHIM AC, V62, P1365, DOI 10.1016/S0016-7037(98)00074-X	32	71	74	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					881	884		10.1126/science.1078508	http://dx.doi.org/10.1126/science.1078508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574627	Green Submitted			2022-12-24	WOS:000180830900049
J	Fledelius, HC				Fledelius, HC			High atmospheric pressure and myopic shift in caisson workers	LANCET			English	Editorial Material							HYPERBARIC-OXYGEN THERAPY		Rigshosp, Univ Eye Dept, DK-2100 Copenhagen O, Denmark	Rigshospitalet	Fledelius, HC (corresponding author), Rigshosp, Univ Eye Dept, DK-2100 Copenhagen O, Denmark.							Anderson B Jr, 1978, Trans Am Ophthalmol Soc, V76, P116; CURTIN BJ, 1985, MYOPIAS BASIC SCI CL, P3; Fledelius HC, 2002, ACTA OPHTHALMOL SCAN, V80, P188, DOI 10.1034/j.1600-0420.2002.800213.x; Kindwall EP, 1994, HYPERBARIC MED, pS45; LYNE AJ, 1978, T OPHTHAL SOC UK, V98, P66; Onoo A, 2002, BRIT J OPHTHALMOL, V86, P1274, DOI 10.1136/bjo.86.11.1274; PALMQUIST BM, 1984, BRIT J OPHTHALMOL, V68, P113, DOI 10.1136/bjo.68.2.113; Ross ME, 1996, OPTOMETRY VISION SCI, V73, P487, DOI 10.1097/00006324-199607000-00006	8	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					362	362		10.1016/S0140-6736(03)12443-9	http://dx.doi.org/10.1016/S0140-6736(03)12443-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573370				2022-12-24	WOS:000180787000006
J	Brown, BR				Brown, BR			Sensing temperature without ion channels	NATURE			English	Article							NEURONS		Univ San Francisco, Dept Phys, San Francisco, CA 94117 USA	University of San Francisco	Brown, BR (corresponding author), Univ San Francisco, Dept Phys, San Francisco, CA 94117 USA.							Brown BR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061903; CAREY FG, 1982, COPEIA, P254; GROSSO G, 2000, SOLID STATE PHYSICS; KALMIJN AJ, 1966, NATURE, V212, P1232, DOI 10.1038/2121232b0; MacDonald D. K. C, 1962, THERMOELECTRICITY IN; MONTGOMERY JC, 1984, COMP BIOCHEM PHYS A, V79, P189, DOI 10.1016/0300-9629(84)90731-X; MURRAY RW, 1960, NATURE, V187, P957, DOI 10.1038/187957a0; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Sand A, 1938, PROC R SOC SER B-BIO, V125, P524, DOI 10.1098/rspb.1938.0041; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Wilkens LA, 1997, P ROY SOC B-BIOL SCI, V264, P1723, DOI 10.1098/rspb.1997.0239; Wissing H, 1988, Prog Brain Res, V74, P99	13	40	40	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					495	495		10.1038/421495a	http://dx.doi.org/10.1038/421495a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556879	Bronze			2022-12-24	WOS:000180670600031
J	Verheyen, E; Salzburger, W; Snoeks, J; Meyer, A				Verheyen, E; Salzburger, W; Snoeks, J; Meyer, A			Origin of the superflock of cichlid fishes from Lake Victoria, East Africa	SCIENCE			English	Article							LATE PLEISTOCENE DESICCATION; HAPLOCHROMINE FISHES; SPECIES FLOCK; EVOLUTION; TANGANYIKA; PHYLOGENY; LINEAGE; HISTORY; AGE	Lake Victoria harbors a unique species-rich flock of more than 500 endemic haplochromine cichlid fishes. The origin, age, and mechanism of diversification of this extraordinary radiation are still debated. Geological evidence suggests that the lake dried out completely about 14,700 years ago. On the basis of phylogenetic analyses of almost 300 DNA sequences of the mitochondrial control region of East African cichlids, we find that the Lake Victoria cichlid flock is derived from the geologically older Lake Kivu. We suggest that the two seeding lineages may have already been lake-adapted when they colonized Lake Victoria. A haplotype analysis further shows that the most recent desiccation of Lake Victoria did not lead to a complete extinction of its endemic cichlid fauna and that the major lineage diversification took place about 100,000 years ago.	Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, D-78457 Constance, Germany; Royal Belgian Inst Nat Sci, Vertebrate Dept, B-1000 Brussels, Belgium; Royal Museum Cent Africa, Vertebrate Sect, B-3080 Tervuren, Belgium	University of Konstanz; Royal Belgian Institute of Natural Sciences; Royal Museum for Central Africa	Meyer, A (corresponding author), Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, Univ Str 10, D-78457 Constance, Germany.	axel.meyer@uni-konstanz.de	Meyer, Axel/C-9826-2009; VERHEYEN, ERIK K/E-5550-2013; Salzburger, Walter/G-1598-2011	Meyer, Axel/0000-0002-0888-8193; VERHEYEN, ERIK K/0000-0001-7157-1474; Salzburger, Walter/0000-0002-9988-1674				Beadle L.C., 1974, INLAND WATERS TROPIC, DOI [10.4319/lo.1977.22.5.0972b, DOI 10.4319/LO.1977.22.5.0972B]; Booton GC, 1999, MOL PHYLOGENET EVOL, V11, P273, DOI 10.1006/mpev.1998.0576; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; EBINGER CJ, 1989, GEOL SOC AM BULL, V101, P885, DOI 10.1130/0016-7606(1989)101<0885:TDOTWB>2.3.CO;2; Fryer G, 1997, HYDROBIOLOGIA, V354, P177, DOI 10.1023/A:1003183432203; Fryer G, 2001, P ROY SOC B-BIOL SCI, V268, P1147, DOI 10.1098/rspb.2001.1601; Greenwood P.H., 1980, Bulletin of the British Museum (Natural History) Zoology, V39, P1; GREENWOOD P H, 1973, Bulletin of the British Museum (Natural History) Zoology, V25, P139; Greenwood P. H., 1981, HAPLOCHROMINE FISHES; Johnson TC, 2000, AMBIO, V29, P2, DOI 10.1639/0044-7447(2000)029[0002:THHOLV]2.0.CO;2; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; Kaufman LS, 1997, ENDEAVOUR, V21, P23, DOI 10.1016/S0160-9327(96)10034-X; LEE WJ, 1995, J MOL EVOL, V41, P54; Lippitsch E, 1997, J FISH BIOL, V51, P284; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Meyer Axel, 1999, P141; MOEYERSONS J, 1979, MUS R AFR CENTR TERV, P127; Nagl S, 2000, P ROY SOC B-BIOL SCI, V267, P1049, DOI 10.1098/rspb.2000.1109; POUCLET A, 1978, MUS R AFR CENTR DEP, P145; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Schmidt U, 2001, PALAEOECO A, V27, P51; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Seehausen O, 2002, P ROY SOC B-BIOL SCI, V269, P491, DOI 10.1098/rspb.2001.1906; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; Snoeks J, 1997, S AFR J SCI, V93, P579; Snoeks Jos, 2001, Journal of Aquariculture & Aquatic Sciences, V9, P150; Stiassny Melanie L. J., 1994, V50, P235; Stiassny MLJ, 1999, SCI AM, V280, P64, DOI 10.1038/scientificamerican0299-64; STIASSNY MLJ, 1992, NETH J ZOOL, V42, P260, DOI 10.1163/156854291X00324; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; STURMBAUER C, 1994, MOL BIOL EVOL, V11, P691; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; STURMBAUER C, 1992, NATURE, V358, P578, DOI 10.1038/358578a0; SWOFFORD DL, 2000, PAUP STAR PHYLOGENET; 1953, ANN REPORT E AFRICAN, V41	35	311	331	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					325	329		10.1126/science.1080699	http://dx.doi.org/10.1126/science.1080699			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12649486	Green Submitted			2022-12-24	WOS:000182135400056
J	Kaplan, MJ; McCune, WJ				Kaplan, MJ; McCune, WJ			New evidence for vascular disease in patients with early rheumatoid arthritis	LANCET			English	Editorial Material							IMPROVES ENDOTHELIAL FUNCTION; ATHEROSCLEROSIS; MORTALITY; INFLAMMATION		Univ Michigan, Sch Med, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kaplan, MJ (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA.	makaplan@med.umich.edu						Bergholm R, 2002, ARTERIOSCL THROM VAS, V22, P1637, DOI 10.1161/01.ATV.0000033516.73864.4E; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Goodson NJ, 2002, ARTHRITIS RHEUM-US, V46, P2010, DOI 10.1002/art.10419; Greaves DR, 2002, TRENDS IMMUNOL, V23, P535, DOI 10.1016/S1471-4906(02)02331-1; Hurlimann D, 2002, CIRCULATION, V106, P2184, DOI 10.1161/01.CIR.0000037521.71373.44; Kumeda Y, 2002, ARTHRITIS RHEUM-US, V46, P1489, DOI 10.1002/art.10269; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; Martens PB, 1997, ARTHRITIS RHEUM, V40, P1106, DOI 10.1002/art.1780400615; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Park YB, 2002, ARTHRITIS RHEUM, V46, P1714, DOI 10.1002/art.10359; Pasceri V, 1999, CIRCULATION, V100, P2124, DOI 10.1161/01.CIR.100.21.2124; Sanada M, 2002, J CLIN ENDOCR METAB, V87, P4634, DOI 10.1210/jc.2001-011223; Symmons DPM, 1998, J RHEUMATOL, V25, P1072; Wallberg-Jonsson S, 2002, J RHEUMATOL, V29, P875; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Woo KS, 2002, AM J MED, V112, P535, DOI 10.1016/S0002-9343(02)01075-6	17	27	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2003	361	9363					1068	1069		10.1016/S0140-6736(03)12901-7	http://dx.doi.org/10.1016/S0140-6736(03)12901-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672306				2022-12-24	WOS:000181865200004
J	Zhang, HL; Yang, ZR; Shen, Y; Tong, L				Zhang, HL; Yang, ZR; Shen, Y; Tong, L			Crystal structure of the carboxyltransferase domain of acetyl-coenzyme a carboxylase	SCIENCE			English	Article							COA CARBOXYLASE; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; ARYLOXYPHENOXYPROPIONATE; INHIBITORS	Acetyl-coenzyme A carboxylases (ACCs) are required for the biosynthesis and oxidation of long-chain fatty acids. They are targets for therapeutics against obesity and diabetes, and several herbicides function by inhibiting their carboxyltransferase (CT) domain. We determined the crystal structure of the free enzyme and the coenzyme A complex of yeast CT at 2.7 angstrom resolution and found that it comprises two domains, both belonging to the crotonase/ClpP superfamily. The active site is at the interface of a dimer. Mutagenesis and kinetic studies reveal the functional roles of conserved residues here. The herbicides target the active site of CT, providing a lead for inhibitor development against human ACCs.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.			Tong, Liang/0000-0002-0563-6468				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; ALBERTS AW, 1972, ENZYMES, V6, P37; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Jelenska J, 2002, J BIOL CHEM, V277, P23208, DOI 10.1074/jbc.M200455200; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Lenhard JM, 2002, ADV DRUG DELIVER REV, V54, P1199, DOI 10.1016/S0169-409X(02)00092-3; Levert KL, 2002, J BIOL CHEM, V277, P16347, DOI 10.1074/jbc.C200113200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; POLAKIS SE, 1974, J BIOL CHEM, V249, P6657; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang JM, 1997, CELL, V91, P447, DOI 10.1016/S0092-8674(00)80431-6; Weaver LH, 2001, PROTEIN SCI, V10, P2618, DOI 10.1110/ps.ps.32701; Zagnitko O, 2001, P NATL ACAD SCI USA, V98, P6617, DOI 10.1073/pnas.121172798	22	149	169	4	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2064	2067		10.1126/science.1081366	http://dx.doi.org/10.1126/science.1081366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663926				2022-12-24	WOS:000181834200054
J	Pearson, H				Pearson, H			Mystery virus slow to yield its identity as patient numbers rise	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					364	364		10.1038/422364b	http://dx.doi.org/10.1038/422364b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660744	Green Published, Bronze			2022-12-24	WOS:000181801200009
J	Seiffert, ER; Simons, EL; Attia, Y				Seiffert, ER; Simons, EL; Attia, Y			Fossil evidence for an ancient divergence of lorises and galagos	NATURE			English	Article							OLIGOCENE; DISCOVERY; EVOLUTION; PRIMATES; AGE	Morphological, molecular, and biogeographic data bearing on early primate evolution suggest that the clade containing extant (or 'crown') strepsirrhine primates (lemurs, lorises and galagos) arose in Afro-Arabia during the early Palaeogene(1), but over a century of palaeontological exploration on that landmass has failed to uncover any conclusive support for that hypothesis(2). Here we describe the first demonstrable crown strepsirrhines from the Afro-Arabian Palaeogene-a galagid and a possible lorisid from the late middle Eocene of Egypt, the latter of which provides the earliest fossil evidence for the distinctive strepsirrhine toothcomb. These discoveries approximately double the previous temporal range of undoubted lorisiforms and lend the first strong palaeontological support to the hypothesis of an ancient Afro-Arabian origin for crown Strepsirrhini and an Eocene divergence of extant lorisiform families(1,3).	Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27705 USA; Duke Primate Ctr, Div Fossil Primates, Durham, NC 27705 USA; Egyptian Geol Museum, Cairo, Egypt	Duke University; Duke University	Seiffert, ER (corresponding author), Duke Univ, Dept Biol Anthropol & Anat, 1013 Broad St, Durham, NC 27705 USA.	erik.seiffert@duke.edu						Beadnell HJL, 1905, TOPOGRAPHY GEOLOGY F; Bown T.M., 1988, US GEOL SURV PROF PA, V1452, P1; CHARLESD.P, 1970, NATURE, V227, P257, DOI 10.1038/227257a0; CONROY GC, 1987, INT J PRIMATOL, V8, P115, DOI 10.1007/BF02735160; GHEERBRANT E, 1995, CR ACAD SCI II A, V321, P425; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Godinot Marc, 1994, P235; Holroyd Patricia A., 1996, Palaeovertebrata (Montpellier), V25, P175; KAPPELMAN J, 1992, J GEOL, V100, P647, DOI 10.1086/629619; MacLatchy L, 2002, AM J PHYS ANTHROPOL, P104; Maier W., 1980, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, P1; Marivaux L, 2001, SCIENCE, V294, P587, DOI 10.1126/science.1065257; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Phillips EM, 2002, CAM S BIO EVOL ANTHR, V33, P83; Porter CA, 1997, INT J PRIMATOL, V18, P261, DOI 10.1023/A:1026328804319; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rasmussen DT, 1998, FOLIA PRIMATOL, V69, P250; ROSE KD, 1981, NATURE, V289, P583, DOI 10.1038/289583a0; Rose Kenneth D., 1994, P1; Simons EL, 1997, P NATL ACAD SCI USA, V94, P180, DOI 10.1073/pnas.94.1.180; SIMONS EL, 1986, J HUM EVOL, V15, P431, DOI 10.1016/S0047-2484(86)80026-4; Simons Elwyn L., 1994, P179; SIMPSON G G, 1967, Bulletin of the Museum of Comparative Zoology, V136, P39; SWOFFORD D.L., 2003, PAUP PHYLOGENETIC AN; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Yoder AD, 1997, EVOL ANTHROPOL, V6, P11, DOI 10.1002/(SICI)1520-6505(1997)6:1<11::AID-EVAN6>3.0.CO;2-Z; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/106351501300318003; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122	30	131	138	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2003	422	6930					421	424		10.1038/nature01489	http://dx.doi.org/10.1038/nature01489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660781	Green Published			2022-12-24	WOS:000181801200042
J	Williams, PM; Fowler, SB; Best, RB; Toca-Herrera, JL; Scott, KA; Steward, A; Clarke, J				Williams, PM; Fowler, SB; Best, RB; Toca-Herrera, JL; Scott, KA; Steward, A; Clarke, J			Hidden complexity in the mechanical properties of titin	NATURE			English	Article							MOLECULAR-DYNAMICS SIMULATION; ATOMIC-FORCE MICROSCOPY; MUSCLE PROTEIN TITIN; IMMUNOGLOBULIN DOMAINS; I-BAND; ELASTICITY; MODULES; EXTENSIBILITY; PATHWAY; DETAIL	Individual molecules of the giant protein titin span the A-bands and I-bands that make up striated muscle. The I-band region of titin is responsible for passive elasticity in such muscle(1-4), and contains tandem arrays of immunoglobulin domains. One such domain (I27) has been investigated extensively, using dynamic force spectroscopy and simulation(5-12). However, the relevance of these studies to the behaviour of the protein under physiological conditions was not established. Force studies reveal a lengthening of I27 without complete unfolding, forming a stable intermediate that has been suggested to be an important component of titin elasticity(6). To develop a more complete picture of the forced unfolding pathway, we use mutant titins-certain mutations allow the role of the partly unfolded intermediate to be investigated in more depth. Here we show that, under physiological forces, the partly unfolded intermediate does not contribute to mechanical strength. We also propose a unified forced unfolding model of all I27 analogues studied, and conclude that I27 can withstand higher forces in muscle than was predicted previously.	Univ Cambridge, Chem Lab, MRC, Ctr Prot Engn, Cambridge CB2 1EW, England; Univ Nottingham, Sch Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England	University of Cambridge; University of Nottingham	Clarke, J (corresponding author), Univ Cambridge, Chem Lab, MRC, Ctr Prot Engn, Lensfield Rd, Cambridge CB2 1EW, England.		Best, Robert/H-7588-2016; Williams, Philip M/C-6947-2009; Toca-Herrera, Jose L./AAX-7366-2021	Best, Robert/0000-0002-7893-3543; Williams, Philip M/0000-0002-1822-2133; Toca-Herrera, Jose L./0000-0001-8951-2616; Scott, Kathryn/0000-0003-3395-9210				Best RB, 2002, P NATL ACAD SCI USA, V99, P12143, DOI 10.1073/pnas.192351899; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Brockwell DJ, 2002, BIOPHYS J, V83, P458, DOI 10.1016/S0006-3495(02)75182-5; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Gautel M, 1996, J MUSCLE RES CELL M, V17, P449, DOI 10.1007/BF00123361; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; LABEIT S, 1992, EMBO J, V11, P1711, DOI 10.1002/j.1460-2075.1992.tb05222.x; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 1998, J CELL SCI, V111, P1567; Linke WA, 1998, BIOPHYS J, V75, P2613, DOI 10.1016/S0006-3495(98)77706-9; Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Ma K, 2001, BIOCHEMISTRY-US, V40, P3427, DOI 10.1021/bi0022792; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Press WH., 1992, NUMERICAL RECIPES C; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Trinick J, 1996, CURR BIOL, V6, P258, DOI 10.1016/S0960-9822(02)00472-4; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Tskhovrebova L, 1997, J MOL BIOL, V265, P100, DOI 10.1006/jmbi.1996.0717; Tskhovrebova L, 2001, J MOL BIOL, V310, P755, DOI 10.1006/jmbi.2001.4700	30	225	230	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					446	449		10.1038/nature01517	http://dx.doi.org/10.1038/nature01517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660787				2022-12-24	WOS:000181801200048
J	Abbott, A				Abbott, A			Chicken flu races through Dutch poultry farms	NATURE			English	News Item																		2003, NATURE, V422, P6	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					247	247		10.1038/422247b	http://dx.doi.org/10.1038/422247b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646883	Bronze			2022-12-24	WOS:000181637300006
J	Branson, R; Potoczna, N; Kral, JG; Lentes, K; Hoehe, MR; Horber, FF				Branson, R; Potoczna, N; Kral, JG; Lentes, K; Hoehe, MR; Horber, FF			Binge eating as a major phenotype of melanocortin 4 receptor gene mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-FAT DISTRIBUTION; EARLY-ONSET OBESITY; MORBID-OBESITY; FRAMESHIFT MUTATION; MISSENSE MUTATION; LEPTIN RECEPTOR; WEIGHT-LOSS; DISORDER; HUMANS; MC4R	Background: Obesity, a multifactorial disease caused by the interaction of genetic factors with the environment, is largely polygenic. A few mutations in these genes, such as in the leptin receptor (LEPR) gene and melanocortin 4 receptor (MC4R) gene, have been identified as causes of monogenic obesity. Methods: We sequenced the complete MC4R coding region, the region of the proopiomelanocortin gene (POMC) encoding the alpha melanocyte-stimulating hormone, and the leptin-binding domain of LEPR in 469 severely obese white subjects (370 women and 99 men; mean [+/-SE] age, 41.0+/-0.5 years; body-mass index [the weight in kilograms divided by the square of the height in meters], 44.1+/-2.0). Fifteen women and 10 men without a history of dieting or a family history of obesity served as normal-weight controls (age, 47.7+/-2.0 years; body-mass index, 21.6+/-0.4). Detailed phenotypic data, including information on body fat, resting energy expenditure, diet-induced thermogenesis, serum concentrations of leptin, and eating behavior, were collected. Results: Twenty-four obese subjects (5.1 percent) and one control subject (4 percent) had MC4R mutations, including five novel variants. Twenty of the 24 obese subjects with an MC4R mutation were matched for age, sex, and body-mass index with 120 of the 445 obese subjects without an MC4R mutation. All mutation carriers reported binge eating, as compared with 14.2 percent of obese subjects without mutations (P<0.001) and 0 percent of the normal-weight subjects without mutations. The prevalence of binge eating was similar among carriers of mutations in the leptin-binding domain of LEPR and noncarriers. No mutations were found in the region of POMC encoding (alpha) melanocyte-stimulating hormone. Conclusions: Binge eating is a major phenotypic characteristic of subjects with a mutation in MC4R, a candidate gene for the control of eating behavior.	Klin Hirslanden, CH-8008 Zurich, Switzerland; SUNY Downstate Med Ctr, Brooklyn, NY 11203 USA; Bioscientia, Ingelheim, Germany; Max Planck Inst Mol Genet, Berlin, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Max Planck Society	Horber, FF (corresponding author), Klin Hirslanden, Witellikerstr 40, CH-8008 Zurich, Switzerland.		horber, Fritz/AAL-5419-2020	Lentes, Klaus-Ulrich/0000-0002-1605-4332				*AM PSYCH ASS, 1994, DSM 4 CRIT SETS AX P, P703; Chen DL, 1999, J LIPID RES, V40, P1735; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; DEVLIN MJ, 1992, INT J EAT DISORDER, V11, P333, DOI 10.1002/1098-108X(199205)11:4&lt;333::AID-EAT2260110407&gt;3.0.CO;2-K; Dubern B, 2001, J PEDIATR-US, V139, P204, DOI 10.1067/mpd.2001.116284; Eriksson J, 1999, HORM METAB RES, V31, P616, DOI 10.1055/s-2007-978807; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Guss JL, 2002, OBES RES, V10, P1021, DOI 10.1038/oby.2002.139; Hamilton BS, 2002, OBES RES, V10, P182, DOI 10.1038/oby.2002.28; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Horber FF, 1997, NUTRITION, V13, P524, DOI 10.1016/S0899-9007(97)00031-2; Hsu LKG, 2002, INT J OBESITY, V26, P1398, DOI 10.1038/sj.ijo.0802081; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JACOBSEN P, 2002, J CLIN ENDOCR METAB, V84, P4442; Kalarchian MA, 2002, OBES SURG, V12, P270, DOI 10.1381/096089202762552494; Kobayashi H, 2002, DIABETES, V51, P243, DOI 10.2337/diabetes.51.1.243; Kral JG, 2001, SURG CLIN N AM, V81, P1039, DOI 10.1016/S0039-6109(05)70183-3; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Laederach-Hofmann K, 1999, INT J EAT DISORDER, V26, P231, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;231::AID-EAT1&gt;3.0.CO;2-6; Lahlou N, 2000, DIABETES, V49, P1347, DOI 10.2337/diabetes.49.8.1347; Lahlou N, 2002, DIABETES, V51, P1980, DOI 10.2337/diabetes.51.6.1980; Mergen M, 2001, J CLIN ENDOCR METAB, V86, P3448, DOI 10.1210/jc.86.7.3448; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Rankinen T, 2002, OBES RES, V10, P196, DOI 10.1038/oby.2002.30; Rosmond R, 2001, DIABETOLOGIA, V44, P1335, DOI 10.1007/s001250100649; Sina M, 1999, AM J HUM GENET, V65, P1501, DOI 10.1086/302660; SPITZER RL, 1993, INT J EAT DISORDER, V13, P137, DOI 10.1002/1098-108X(199303)13:2&lt;161::AID-EAT2260130204&gt;3.0.CO;2-R; SPITZER RL, 1992, INT J EAT DISORDER, V11, P191, DOI 10.1002/1098-108X(199204)11:3&lt;191::AID-EAT2260110302&gt;3.0.CO;2-S; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; TATARANNI PA, 1995, AM J CLIN NUTR, V62, P730, DOI 10.1093/ajcn/62.4.730; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wauters M, 1998, Eat Weight Disord, V3, P124; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; 1999, WHO TECH REP SER, V894, P1	43	246	260	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1096	1103		10.1056/NEJMoa021971	http://dx.doi.org/10.1056/NEJMoa021971			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	656UY	12646666	Bronze			2022-12-24	WOS:000181628400005
J	Gillett, NP; Zwiers, FW; Weaver, AJ; Stott, PA				Gillett, NP; Zwiers, FW; Weaver, AJ; Stott, PA			Detection of human influence on sea-level pressure	NATURE			English	Article							ANTHROPOGENIC CLIMATE-CHANGE; MODEL	Greenhouse gases and tropospheric sulphate aerosols-the main human influences on climate-have been shown to have had a detectable effect on surface air temperature(1-3), the temperature of the free troposphere and stratosphere(2,4) and ocean temperature(5,6) Nevertheless, the question remains as to whether human influence is detectable in any variable other than temperature. Here we detect an influence of anthropogenic greenhouse gases and sulphate aerosols in observations of winter sea-level pressure (December to February), using combined simulations from four climate models. We find increases in sea-level pressure over the subtropical North Atlantic Ocean, southern Europe and North Africa, and decreases in the polar regions and the North Pacific Ocean, in response to human influence. Our analysis also indicates that the climate models substantially underestimate the magnitude of the sea-level pressure response. This discrepancy suggests that the upward trend in the North Atlantic Oscillation index(7) (corresponding to strengthened westerlies in the North Atlantic region), as simulated in a number of global warming scenarios(8-10), may be too small, leading to an underestimation of the impacts of anthropogenic climate change on European climate.	Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Meteorol Serv Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC V8W 2Y2, Canada; Hadley Ctr Climate Predict & Res, Met Off, Bracknell RG12 2SY, Berks, England	University of Victoria; Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); Meteorological Service of Canada; Met Office - UK; Hadley Centre	Gillett, NP (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, POB 3055, Victoria, BC V8W 3P6, Canada.		Weaver, Andrew J/E-7590-2011; Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016	Weaver, Andrew J/0000-0001-8919-3598; Stott, Peter/0000-0003-4853-7686				Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; ALLEN MR, IN PRESS SURV GEOPHY; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Fyfe JC, 1999, GEOPHYS RES LETT, V26, P1601, DOI 10.1029/1999GL900317; Gillett NP, 2000, GEOPHYS RES LETT, V27, P993, DOI 10.1029/1999GL010981; Gillett NP, 2002, GEOPHYS RES LETT; GILLETT NP, 2002, J GEOPHYS RES; GILLETT NP, 2003, N ATLANTIC OSCILLATI, pCH9; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Krishnamurti TN, 1999, SCIENCE, V285, P1548, DOI 10.1126/science.285.5433.1548; Lambert SJ, 2001, CLIM DYNAM, V17, P83, DOI 10.1007/PL00013736; MITCHELL JFB, 2001, CLIMATE CHANGE 2001, pCH12; Osborn TJ, 1999, CLIM DYNAM, V15, P685, DOI 10.1007/s003820050310; REICHERT BK, 2002, GEOPHYS RES LETT; Shindell DT, 1999, NATURE, V399, P452, DOI 10.1038/20905; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Tett SFB, 1996, SCIENCE, V274, P1170, DOI 10.1126/science.274.5290.1170; Thomas JM, 2000, TOP CATAL, V11, P1; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; TRENBERTH KE, 1980, MON WEATHER REV, V108, P855, DOI 10.1175/1520-0493(1980)108<0855:TNHSLP>2.0.CO;2; [No title captured]	21	168	174	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					292	294		10.1038/nature01487	http://dx.doi.org/10.1038/nature01487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646917				2022-12-24	WOS:000181637300035
J	Knight, EL; Stampfer, MJ; Hankinson, SE; Spiegelman, D; Curhan, GC				Knight, EL; Stampfer, MJ; Hankinson, SE; Spiegelman, D; Curhan, GC			The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; FOOD FREQUENCY QUESTIONNAIRE; CREATININE CLEARANCE; DIETARY-PROTEIN; MEASUREMENT ERROR; HEALTHY-SUBJECTS; CONFIDENCE-INTERVALS; PHOSPHORUS INTAKE; SERUM CREATININE; BLOOD-PRESSURE	Background: In individuals with moderate to severe renal insufficiency, low protein intake may slow renal function decline. However, the long-term impact of protein intake on renal function in persons with normal renal function or mild renal insufficiency is unknown. Objective: To determine whether protein intake influences the rate of renal function change in women over an 11-year period. Design: Prospective cohort study. Setting: Nurses' Health Study. Participants: 1624 women enrolled in the Nurses' Health Study who were 42 to 68 years of age in 1989 and gave blood samples in 1989 and 2000. Ninety-eight percent of women were white, and 1% were African American. Measurements: Protein intake was measured in 1990 and 1994 by using a semi-quantitative food-frequency questionnaire. Creatinine concentration was used to estimate glomerular filtration rate (GFR) and creatinine clearance. Results: In multivariate linear regression analyses, high protein intake was not significantly associated with change in estimated GFR in women with normal renal function (defined as an estimated GFR greater than or equal to 80 mL/min per 1.73 m(2)). Change in estimated GFR in this subgroup over the 11-year period was 0.25 mL/min per 1.73 m(2) (95% Cl, -0.78 to 1.28 mL/min per 1.73 m(2)) per 10-g increase in protein intake; the change in estimated GFR was 1.14 mL/min per 1.73 m(2) (Cl, -3.63 to 5.92 mL/min per 1.73 m(2)) after measurement-error adjustment for protein intake. In women with mild renal insufficiency (defined as an estimated GFR > 55 mL/min per 1.73 m(2) but <80 mL/min per 1.73 m(2)), protein intake was significantly associated with a change in estimated GFR of -1.69 mL/min per 1.73 m(2) (Cl, -2.93 to -0.45 mL/min per 1.73 m 2) per 10-g increase in protein intake. After measurement-error adjustment, the change in estimated GFR was -7.72 mL/min per 1.73 m(2) (Cl, -15.52 to 0.08 mL/min per 1.73 m(2)) per 10-g increase in protein intake, an association of borderline statistical significance. High intake of nondairy animal protein in women with mild renal insufficiency was associated with a significantly greater change in estimated GFR (-1.21 mL/min per 1.73 M2 [Cl, -2.34 to -0.33 mL/min per 1.73 m(2)] per 10-g increase in nondairy animal protein intake). Conclusions: High protein intake was not associated with renal function decline in women with normal renal function. However, high total protein intake, particularly high intake of nondairy animal protein, may accelerate renal function decline in women with mild renal insufficiency.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital	Knight, EL (corresponding author), Channing Labs, Nurses Hlth Study, 3rd Floor,181 Longwood Ave, Boston, MA 02115 USA.	elknight@partners.org			NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052866, T32DK007791] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMSTRONG BG, 1989, STAT MED, V8, P1151, DOI 10.1002/sim.4780080916; Barsotti G, 1996, NEPHRON, V74, P390, DOI 10.1159/000189341; BARSOTTI G, 1984, CLIN NEPHROL, V21, P54; Blackburn GL, 2001, CLEV CLIN J MED, V68, P761, DOI 10.3949/ccjm.68.9.761; Brandle E, 1996, EUR J CLIN NUTR, V50, P734; BROWN SA, 1991, J AM SOC NEPHROL, V1, P1169; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; DAMICO G, 1994, NEPHROL DIAL TRANSPL, V9, P1590; Dworkin LD, 2001, CURR OPIN NEPHROL HY, V10, P551, DOI 10.1097/00041552-200109000-00001; FOUQUE D, 2000, COCHRANE DATABASE SY; Fuiano G, 1996, NEPHRON, V73, P430; GENTILE MG, 1993, CLIN NEPHROL, V40, P315; Grimm M, 2001, EUR J CLIN NUTR, V55, P153, DOI 10.1038/sj.ejcn.1601131; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; IHLE BU, 1989, NEW ENGL J MED, V321, P1773, DOI 10.1056/NEJM198912283212601; JIBANI MM, 1991, DIABETIC MED, V8, P949, DOI 10.1111/j.1464-5491.1991.tb01535.x; JONES MG, 1987, CLIN NEPHROL, V27, P71; Kasiske BL, 1998, AM J KIDNEY DIS, V31, P954, DOI 10.1053/ajkd.1998.v31.pm9631839; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; KONTESSIS PS, 1995, DIABETES CARE, V18, P1233, DOI 10.2337/diacare.18.9.1233; Krauss RM, 2000, STROKE, V31, P2751, DOI 10.1161/01.STR.31.11.2751; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEW SQ, 1991, J AM SOC NEPHROL, V2, P856; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; LOCATELLI F, 1991, LANCET, V337, P1299, DOI 10.1016/0140-6736(91)92977-A; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; McDowell M A, 1994, Adv Data, P1; NICOLL SR, 1991, NEPHRON, V59, P621, DOI 10.1159/000186654; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Rodriguez-Porcel M, 2001, HYPERTENSION, V37, P774, DOI 10.1161/01.HYP.37.2.774; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; SALAZAR DE, 1988, AM J MED, V84, P1053, DOI 10.1016/0002-9343(88)90310-5; SOKOLL LJ, 1994, CLIN CHEM, V40, P2276; Soroka N, 1998, NEPHRON, V79, P173, DOI 10.1159/000045021; Spiegelman D, 1997, AM J CLIN NUTR, V65, P1179; Stein K, 2000, J AM DIET ASSOC, V100, P760, DOI 10.1016/S0002-8223(00)00219-4; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; 2002, AM J KIDNEY DIS S2, V39, pS1	44	258	269	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2003	138	6					460	467		10.7326/0003-4819-138-6-200303180-00009	http://dx.doi.org/10.7326/0003-4819-138-6-200303180-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655PV	12639078	Green Published			2022-12-24	WOS:000181562400003
J	Thrall, PH; Burdon, JJ				Thrall, PH; Burdon, JJ			Evolution of virulence in a plant host-pathogen metapopulation	SCIENCE			English	Article							MELAMPSORA-LINI; INFECTIOUS-DISEASES; LOCAL ADAPTATION; PARASITE COEVOLUTION; RACIAL STRUCTURE; RESISTANCE; MARGINALE; POPULATION; SELECTION; MIGRATION	In a wild plant-pathogen system, host resistance and pathogen virulence varied markedly among local populations. Broadly virulent pathogens occurred more frequently in highly resistant host populations, whereas avirulent pathogens dominated susceptible populations. Experimental inoculations indicated a negative trade-off between spore production and virulence. The nonrandom spatial distribution of pathogens, maintained through time despite high pathogen mobility, implies that selection favors virulent strains of Melampsora lini in resistant Linum marginale populations and avirulent strains in susceptible populations. These results are consistent with gene-for-gene models of host-pathogen coevolution that require trade-offs to prevent pathogen virulence increasing until host resistance becomes selectively neutral.	CSIRO Plant Ind, Ctr Plant Biodivers Res, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Thrall, PH (corresponding author), CSIRO Plant Ind, Ctr Plant Biodivers Res, Gen POB 1600, Canberra, ACT 2601, Australia.		Burdon, Jeremy J/B-9913-2009					BLACK FL, 1995, EXP CLIN IMMUNOGENET, V12, P206; BURDON JJ, 1994, EVOLUTION, V48, P1564, DOI 10.1111/j.1558-5646.1994.tb02196.x; BURDON JJ, 1992, PLANT PATHOL, V41, P165, DOI 10.1111/j.1365-3059.1992.tb02335.x; Burdon JJ, 1999, EVOLUTION, V53, P704, DOI [10.1111/j.1558-5646.1999.tb05365.x, 10.2307/2640711]; CHIN KM, 1984, PLANT PATHOL, V33, P535, DOI 10.1111/j.1365-3059.1984.tb02878.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Heyndrickx L, 2000, AIDS, V14, P1862, DOI 10.1097/00002030-200008180-00028; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; JAROSZ AM, 1991, EVOLUTION, V45, P1618, DOI [10.2307/2409783, 10.1111/j.1558-5646.1991.tb02667.x]; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; LIPSITCH M, 1995, EVOLUTION, V49, P743, DOI 10.1111/j.1558-5646.1995.tb02310.x; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Lively CM, 2002, EVOL ECOL RES, V4, P219; Meagher S, 1999, EVOLUTION, V53, P1318, DOI [10.2307/2640837, 10.1111/j.1558-5646.1999.tb04547.x]; Messenger SL, 1999, P ROY SOC B-BIOL SCI, V266, P397, DOI 10.1098/rspb.1999.0651; Musser JM, 1996, EMERG INFECT DIS, V2, P1, DOI 10.3201/eid0201.960101; Parrish CR, 1999, VET MICROBIOL, V69, P29, DOI 10.1016/S0378-1135(99)00084-X; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; Thrall PH, 2002, EVOLUTION, V56, P1340; Thrall PH, 2000, PLANT PATHOL, V49, P767, DOI 10.1046/j.1365-3059.2000.00523.x; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; THRALL PH, IN PRESS PLANT PATHO	27	311	322	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1735	1737		10.1126/science.1080070	http://dx.doi.org/10.1126/science.1080070			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637745				2022-12-24	WOS:000181519500046
J	Dalton, R				Dalton, R			Auction of DNA archive cancelled	NATURE			English	News Item																		KLUG A, 2003, NATURE, V421, P564	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					102	102		10.1038/422102b	http://dx.doi.org/10.1038/422102b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634743	Bronze			2022-12-24	WOS:000181488900006
J	Cramer, T; Yamanishi, Y; Clausen, BE; Forster, I; Pawlinski, R; Mackman, N; Haase, VH; Jaenisch, R; Corr, M; Nizet, V; Firestein, GS; Gerber, HP; Ferrara, N; Johnson, RS				Cramer, T; Yamanishi, Y; Clausen, BE; Forster, I; Pawlinski, R; Mackman, N; Haase, VH; Jaenisch, R; Corr, M; Nizet, V; Firestein, GS; Gerber, HP; Ferrara, N; Johnson, RS			HIF-1 alpha is essential for myeloid cell-mediated inflammation	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; CUTANEOUS INFLAMMATION; ALVEOLAR MACROPHAGES; OXYGEN HOMEOSTASIS; ENERGY-METABOLISM; HUMAN-NEUTROPHILS; OXIDATIVE STRESS; TUMOR HYPOXIA; T-CELL; EXPRESSION	Granulocytes and monocytes/macrophages of the myeloid lineage are the chief cellular agents of innate immunity. Here, we have examined the inflammatory response in mice with conditional knockouts of the hypoxia responsive transcription factor HIF-1alpha, its negative regulator VHL, and a known downstream target, VEGF. We find that activation of HIF-1alpha is essential for myeloid cell infiltration and activation in vivo through a mechanism independent of VEGF. Loss of VHL leads to a large increase in acute inflammatory responses. Our results show that HIF-1alpha is essential for the regulation of glycolytic capacity in myeloid cells: when HIF-1alpha is absent, the cellular ATP pool is drastically reduced. The metabolic defect results in profound impairment of myeloid cell aggregation, motility, invasiveness, and bacterial killing. This role for HIF-1alpha demonstrates its direct regulation of survival and function in the inflammatory microenvironment.	Univ Calif San Diego, Sch Med, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Div Rheumatol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; Univ Amsterdam, Dept Cell Biol & Histol, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; Scripps Res Inst, Dept Immunol, San Diego, CA 92037 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam; Technical University of Munich; Scripps Research Institute; University of Pennsylvania; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Roche Holding; Genentech	Johnson, RS (corresponding author), Univ Calif San Diego, Sch Med, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.		Förster, Irmgard/P-8545-2016; Johnson, Randall/AAM-1189-2021; PAwlinski, Rafal/AAD-6090-2022; Haase, Volker Hans/AAJ-5061-2021; CLAUSEN, Björn Erik/A-8229-2010; Cramer, Thorsten/S-2479-2016; Haase, Volker Hans/A-6758-2013; Nizet, Victor/AAF-3190-2019	Förster, Irmgard/0000-0002-7644-5642; Johnson, Randall/0000-0002-4084-6639; CLAUSEN, Björn Erik/0000-0002-2484-7842; Cramer, Thorsten/0000-0002-6462-239X; Haase, Volker Hans/0000-0002-7051-8994; Nizet, Victor/0000-0003-3847-0422	NATIONAL CANCER INSTITUTE [R01CA082515, R01CA100787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002668] Funding Source: NIH RePORTER; NCI NIH HHS [CA82515, R01 CA100787, R01 CA082515] Funding Source: Medline; NIDDK NIH HHS [K08 DK002668] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNOLD F, 1987, BRIT J EXP PATHOL, V68, P569; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; BAKKER A., 1927, KLIN WOCHENSCHR, V6, P252, DOI 10.1007/BF01710710; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; BOXER LA, 1977, J CELL PHYSIOL, V91, P89, DOI 10.1002/jcp.1040910110; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Buttgereit F, 2000, IMMUNOL TODAY, V21, P192; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Denko NC, 2001, CANCER RES, V61, P795; Dvorak HF, 2000, SEMIN PERINATOL, V24, P75, DOI 10.1016/S0146-0005(00)80061-0; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Fleischmann W, 1927, BIOCHEM Z, V181, P395; Grunstein J, 1999, CANCER RES, V59, P1592; Haji-Michael PG, 1999, METABOLISM, V48, P779, DOI 10.1016/S0026-0495(99)90179-8; Hempel SL, 1996, AM J RESP CELL MOL, V14, P170, DOI 10.1165/ajrcmb.14.2.8630267; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; KALBHEN DA, 1967, MED PHARMACOL EXP, V16, P425; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KAY NE, 1980, J RETICULOENDOTH SOC, V28, P367; KELLETT DN, 1965, J PHARM PHARMACOL, V18, P199; Kempner W, 1939, J CLIN INVEST, V18, P291, DOI 10.1172/JCI101045; KITTLICK PD, 1986, EXP PATHOL-JENA, V30, P1; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Korhonen K, 2000, ANN CHIR GYNAECOL, V89, P7; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Levene PA, 1912, J BIOL CHEM, V11, P361; Levene PA, 1912, J BIOL CHEM, V12, P265; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; MANJUNATH N, 1993, J IMMUNOL, V151, P1528; MANNS G, 1967, EXP INT J EXP MED, V17, P557; MAPP PI, 1995, BRIT MED BULL, V51, P419, DOI 10.1093/oxfordjournals.bmb.a072970; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MICHL J, 1976, J EXP MED, V144, P1484, DOI 10.1084/jem.144.6.1484; NAJAFIPOUR H, 1995, EXP PHYSIOL, V80, P209, DOI 10.1113/expphysiol.1995.sp003841; NAKADATE T, 1985, JPN J PHARMACOL, V38, P161, DOI 10.1254/jjp.38.161; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; OFLAHERTY JT, 1977, J IMMUNOL, V119, P1751; Ott A, 1987, Adv Exp Med Biol, V220, P79; RAICK AN, 1973, CANCER RES, V33, P269; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; Roos D, 1979, Adv Exp Med Biol, V121, P29; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saadi S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0690hyp; SAWYER RG, 1991, ANN SURG, V213, P253, DOI 10.1097/00000658-199103000-00013; SBARRA AJ, 1959, J BIOL CHEM, V234, P1355; Schor H, 2000, Dev Immunol, V7, P227, DOI 10.1155/2000/51902; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; SIMCHOWITZ L, 1979, ARTHRITIS RHEUM, V22, P755, DOI 10.1002/art.1780220711; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thepen T, 2000, NAT BIOTECHNOL, V18, P48, DOI 10.1038/71908; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; VANOTTEREN GM, 1995, AM J RESP CELL MOL, V13, P399, DOI 10.1165/ajrcmb.13.4.7546769; WEISDORF DJ, 1982, BLOOD, V60, P888; WEISDORF DJ, 1982, INFLAMMATION, V6, P245, DOI 10.1007/BF00916406	65	1522	1610	7	150	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					645	657		10.1016/S0092-8674(03)00154-5	http://dx.doi.org/10.1016/S0092-8674(03)00154-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628185	Green Accepted, Bronze			2022-12-24	WOS:000181443600008
J	Dalal, HM; Evans, PH				Dalal, HM; Evans, PH			Achieving national service framework standards for cardiac rehabilitation and secondary prevention	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PRIMARY-CARE	Problem Integrated care for patients who survive a myocardial infarction is lacking. Many patients are not offered cardiac rehabilitation, and secondary prevention is not optimal. Design 12 month audit of 106 patients who survived an acute myocardial infarction. Background and setting Carrick Primary Care Trust in Cornwall (population 98 500) and one district general hospital. Key measures for improvement Proportion of patients who complete a cardiac rehabilitation programme after a myocardial infarction. Proportion of patients with optimal secondary prevention, as measured by smoking status, body mass index, cholesterol < 5.0 mmol/l, and blood pressure < 140/85 mm Hg. Strategies for change We set up a novel, integrated, and seamless system for cardiac rehabilitation. We employed a cardiac liaison nurse to identify and assess in hospital all patients with suspected acute myocardial infarction. The nurse offered patients the choice of home based rehabilitation with the Heart Manual or hospital based rehabilitation. The nurse gave discharge details to the patient's general practice; these were to be included on a practice based register of coronary heart disease. Effects of change All 106 eligible patients were offered cardiac rehabilitation and were included in a practice based register of coronary heart disease to facilitate long term follow up in primary care. 47 (44%) patients chose home based rehabilitation with the Heart Manual, and 41 (87%) of these completed the programme; 35 (33%) patients chose hospital based rehabilitation, and 17 (49%) of these completed the programme. The numbers of patients achieving secondary prevention targets improved significantly: those with serum cholesterol < 5.0 mmol/l at discharge increased from 28% at baseline to 75% at 12 months. Optimal care (at least 80-90% uptake of an intervention) was seen with antiplatelet and statin treatments and with smoking cessation. Significantly more patients were prescribed statins at follow up than at baseline (77/106 v 80/91, P=0.005). Lessons learnt National service framework targets for cardiac rehabilitation and secondary prevention can be achieved in patients who survive a myocardial infarction by integrating rehabilitation services (home and hospital) with secondary prevention clinics in primary care. Nurse led clinics in primary care facilitate long term structured care and optimal secondary prevention.	Royal Cornwall Hosp, Truro TR1 3LJ, Cornwall, England; Postgrad Med Ctr, Peninsula Med Sch, Somerset & N & E Devon Primary Care Res Network, Exeter EX2 5DW, Devon, England	Royal Cornwall Hospital; University of Exeter	Dalal, HM (corresponding author), Lower Lemon St Surg, Truro TR1 2LZ, Cornwall, England.			Evans, Philip/0000-0002-5277-3545				Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Bethell H J, 2001, J Cardiopulm Rehabil, V21, P111, DOI 10.1097/00008483-200103000-00008; Campbell NC, 1998, HEART, V80, P447, DOI 10.1136/hrt.80.5.447; *CORNW ISL SCILL H, 1998, HLTH POP 1998 ANN RE; Dalal HM, 1999, BRIT MED J, V319, P853, DOI 10.1136/bmj.319.7213.853a; de Bono DP, 1998, BRIT MED J, V316, P1329, DOI 10.1136/bmj.316.7141.1329; *DEP HLTH, 2000, NAT SERV FRAM COR HE; JOLLIFFE JA, 2002, COCHRANE LIB, V2, DOI UNSP AB001800; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G; Lewin RJP, 1998, BRIT MED J, V316, P1354, DOI 10.1136/bmj.316.7141.1354; Mayou R, 1996, BRIT MED J, V313, P1498, DOI 10.1136/bmj.313.7071.1498; Scottish Intercollegiate Guidelines Network 57, 2002, CARD REH NAT CLIN GU; Wood D, 1998, HEART, V80, pS1; 1998, EFFECTIVE HLTH CARE, V4	15	51	51	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					481	484		10.1136/bmj.326.7387.481	http://dx.doi.org/10.1136/bmj.326.7387.481			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609946	Green Published			2022-12-24	WOS:000181421400020
J	Filippone, M; Sartor, M; Zacchello, F; Baraldi, E				Filippone, M; Sartor, M; Zacchello, F; Baraldi, E			Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age	LANCET			English	Article							SEQUELAE	Bronchopulmonary dysplasia is associated with abnormalities in lung function during infancy, yet many infants recover with no respiratory problems in the long term. We therefore did a longitudinal study of pulmonary function in 18 children with moderate to severe bronchopulmonary dysplasia. Forced expiratory volume in 1 s (FEV1) and forced mid-expiratory flow (FEF25-75) at school age were lower than normal in 15 of IS children, and both showed a significant positive correlation with the maximal flow at functional residual capacity (Vmax(FRC)) at 24 months of age (r=0.68 and 0.85, respectively). Our results suggest that assessment of respiratory function during infancy can help to identify children with bronchopulmonary dysplasia at risk of incomplete recovery of respiratory function during childhood.	Univ Padua, Sch Med, Dept Paediat, I-35128 Padua, Italy	University of Padua	Baraldi, E (corresponding author), Univ Padua, Sch Med, Dept Paediat, Via Giustiniani 3, I-35128 Padua, Italy.		baraldi, eugenio/AAC-5233-2022	BARALDI, EUGENIO/0000-0002-1829-3652				Baraldi E, 1997, AM J RESP CRIT CARE, V155, P149, DOI 10.1164/ajrccm.155.1.9001304; Eber E, 2001, THORAX, V56, P317, DOI 10.1136/thorax.56.4.317; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603	5	95	100	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 1	2003	361	9359					753	754		10.1016/S0140-6736(03)12633-5	http://dx.doi.org/10.1016/S0140-6736(03)12633-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620742				2022-12-24	WOS:000181232000013
J	Blumenschine, RJ; Peters, CR; Masao, FT; Clarke, RJ; Deino, AL; Hay, RL; Swisher, CC; Stanistreet, IG; Ashley, GM; McHenry, LJ; Sikes, NE; van der Merwe, NJ; Tactikos, JC; Cushing, AE; Deocampo, DM; Njau, JK; Ebert, JI				Blumenschine, RJ; Peters, CR; Masao, FT; Clarke, RJ; Deino, AL; Hay, RL; Swisher, CC; Stanistreet, IG; Ashley, GM; McHenry, LJ; Sikes, NE; van der Merwe, NJ; Tactikos, JC; Cushing, AE; Deocampo, DM; Njau, JK; Ebert, JI			Late pliocene Homo and hominid land use from western Olduvai Gorge, Tanzania	SCIENCE			English	Article							PLEISTOCENE HOMINIDS; ZINJANTHROPUS; BASIN	Excavation in the previously little-explored western portion of Olduvai Gorge indicates that hominid land use of the eastern pateobasin extended at least episodically to the west. Finds included a dentally complete Homo maxilla (OH 65) with lower face, Oldowan stone artifacts, and butchery-marked bones dated to be between 1.84 and 1.79 million years old. The hominid shows strong affinities to the KNM ER 1470 cranium from Kenya (Homo rudolfensis), a morphotype previously unrecognized at Olduvai. ER 1470 and OH 65 can be accommodated in the H. habilis holotype, casting doubt on H. rudolfensis as a biologically valid taxon.	Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, New Brunswick, NJ 08901 USA; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Paleocultural & Environm Res, Dar Es Salaam, Tanzania; Univ Witwatersrand, Sch Med, Sch Anat Sci, ZA-2193 Johannesburg, South Africa; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85718 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; Univ Liverpool, Dept Earth Sci, Liverpool L69 3BX, Merseyside, England; Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Univ Cape Town, Dept Archaeol, ZA-7700 Rondebosch, Cape Town, South Africa; Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, MRC 119, Washington, DC 20560 USA; Ebert & Associates, Albuquerque, NM 87107 USA	Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Witwatersrand; Berkeley Geochronolgy Center; University of Arizona; Rutgers State University New Brunswick; University of Liverpool; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Cape Town; Smithsonian Institution; Smithsonian National Museum of Natural History	Blumenschine, RJ (corresponding author), Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, 131 George St, New Brunswick, NJ 08901 USA.		McHenry, Lindsay Jean/ABP-7150-2022	McHenry, Lindsay Jean/0000-0003-1805-1941				Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 1998, J HUM EVOL, V34, P565, DOI 10.1006/jhev.1998.0216; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; CURTIS GH, 1972, CALIBRATION HOMINOID, P289; Groves C., 1989, THEORY HUMAN PRIMATE; Hay R. L., 1976, GEOLOGY OLDUVAI GORG; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Leakey L. S. B., 1965, OLDUVAI GORGE 1951 1; LEAKEY LSB, 1964, NATURE, V202, P5, DOI 10.1038/202005a0; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; LEETHORP JA, 1987, S AFR J SCI, V83, P712; McMahon R.F., 1983, P505; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; PETERS CR, 1996, 4000000 YEARS HOMINI, P175; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; Stringer C.B., 1986, P266; TOBIAS PV, 1966, NATURE, V209, P953, DOI 10.1038/209953a0; Tobias PV, 1991, OLDUVAI GORGE, V4; Walker A., 1981, HOMO ERECTUS PAPERS, P193; Walter R.C., 1992, QUATERN INT, V14, P37, DOI DOI 10.1016/1040-6182(92)90008-P; WALTER RC, 1991, NATURE, V354, P145, DOI 10.1038/354145a0; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood Bernard, 1993, P485; [No title captured]	29	174	178	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1217	1221		10.1126/science.1075374	http://dx.doi.org/10.1126/science.1075374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	646YY	12595689				2022-12-24	WOS:000181065500036
J	Quill, TE; Cassel, CK				Quill, TE; Cassel, CK			Professional organizations' position statements on physician-assisted suicide: A case for studied neutrality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VOLUNTARY ACTIVE EUTHANASIA; OF-LIFE CARE; TERMINALLY-ILL; WASHINGTON-STATE; UNITED-STATES; OREGON DEATH; DIGNITY ACT; ATTITUDES; EXPERIENCES; DEPRESSION	Position statements opposing legalization of physician-assisted suicide by organizations such as the American College of Physicians-American Society of Internal Medicine rightly emphasize that palliative care should be the standard of care for the dying, and that the inadequacies that exist in its delivery should be remedied. But such position statements generally understate the limitations of palliative care to alleviate some end-of-life suffering, and they do not provide adequate guidance about how physicians should approach patients with intractable suffering who are prepared to die. In this manuscript, we briefly present. data about severe suffering before death for terminally ill patients, including those enrolled in hospice programs. We also review some of what is known about requests and responses for physician-assisted suicide in Oregon and in the rest of the United States. Preliminary data from Oregon suggest that legally sanctioned access to physician-assisted suicide is used by a very small number of patients and seems to be associated with improved delivery of hospice and palliative care. Physicians of good will, deep religious convictions, and considerable palliative care experience exist on both sides of the debate about legalization of physician-assisted suicide. In an effort to respect this diversity, and to encourage out profession to continue to struggle with the genuine dilemmas faced by some patients toward the end of their lives and by their families, we argue in favor of medical organizations' taking a position of studied neutrality on this contentious issue.	Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA	University of Rochester; Oregon Health & Science University	Quill, TE (corresponding author), Univ Rochester, Med Ctr, 601 Elmwood Ave,Box 601, Rochester, NY 14642 USA.							[Anonymous], 1995, J Am Geriatr Soc, V43, P577; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BATTIN MP, 1995, ACAD MED, V70, P583; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; BROCK DW, 1992, HASTINGS CENT REP, V22, P10, DOI 10.2307/3562560; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; COHEN LM, 1995, ARCH INTERN MED, V155, P42, DOI 10.1001/archinte.155.1.42; Coyle N, 1990, J Pain Symptom Manage, V5, P83; DONNELLY S, 1995, SEMIN ONCOL, V22, P67; DUBERSEIN PR, 1995, J AM GERIATR SOC, V43, P395, DOI 10.1111/j.1532-5415.1995.tb05814.x; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; FOLEY KM, 1995, PAIN FORUM, V4, P163; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Ingham JM, 1996, HEMATOL ONCOL CLIN N, V10, P21, DOI 10.1016/S0889-8588(05)70325-7; JACOBSON JA, 1995, J CLIN ETHIC, V6, P149; KANE RL, 1985, JAMA-J AM MED ASSOC, V253, P2683, DOI 10.1001/jama.253.18.2683; KASTING GA, 1993, PHYSICIAN ASSISTED D, P25; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; Lee MA, 1996, NEW ENGL J MED, V334, P310, DOI 10.1056/NEJM199602013340507; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; *NAT AC, 1997, APPR DEATH IMPR CAR; NEU S, 1986, NEW ENGL J MED, V314, P14, DOI 10.1056/NEJM198601023140103; Orentlicher D, 1997, NEW ENGL J MED, V337, P1236, DOI 10.1056/NEJM199710233371713; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Quill TE, 1998, ANN INTERN MED, V128, P552, DOI 10.7326/0003-4819-128-7-199804010-00006; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Sachs GA, 2000, JAMA-J AM MED ASSOC, V284, P2423, DOI 10.1001/jama.284.19.2423; SHAPIRO RS, 1994, ARCH INTERN MED, V154, P575, DOI 10.1001/archinte.154.5.575; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Slome LR, 1997, NEW ENGL J MED, V336, P417, DOI 10.1056/NEJM199702063360606; Snyder L, 2001, ANN INTERN MED, V135, P209, DOI 10.7326/0003-4819-135-3-200108070-00015; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811; *TASK FORC IMPR CA, 2002, OR DEATH DIG ACT GUI; Tolle SW, 1999, ANN INTERN MED, V130, P681, DOI 10.7326/0003-4819-130-8-199904200-00015; Ventafridda V, 1990, J Palliat Care, V6, P7; Whitney SN, 2001, J GEN INTERN MED, V16, P290, DOI 10.1046/j.1525-1497.2001.04159.x; 1996, BRIEF AMICUS CURIAE	46	28	28	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					208	211		10.7326/0003-4819-138-3-200302040-00013	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558360				2022-12-24	WOS:000181018600007
J	Li, Z; Gindler, J; Wang, H; Berry, RJ; Li, S; Correa, A; Zheng, JC; Erickson, JD; Wang, Y				Li, Z; Gindler, J; Wang, H; Berry, RJ; Li, S; Correa, A; Zheng, JC; Erickson, JD; Wang, Y			Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study	LANCET			English	Article							NEURAL-TUBE DEFECTS; PERICONCEPTIONAL MULTIVITAMIN USE; CONOTRUNCAL HEART-DEFECTS; TWIN PREGNANCIES; RISK; CHINA; PREVENTION; GESTATIONS; SINGLETON	Background Folic acid supplements are recommended for women of childbearing age to prevent neural tube defects in their offspring. Results of some studies, however, suggest an increase in multiple births associated with use of vitamin supplements that contain folic acid during pregnancy. Our aim was to assess this association. Methods We used data from a population-based cohort study from which we assessed the occurrence of multiple births in women (n=242 015) who had participated in a campaign to prevent neural tube defects with folic acid supplements (400 mug per day) in China. Folic acid use was ascertained before pregnancy outcome was known. We studied the relation between multiple births and any use of folic acid pills before or during early pregnancy; additionally, we investigated mechanisms by which folic acid could potentially affect the occurrence of multiple births by examining pill-taking at three time periods: before ovulation, around the time of fertilisation, and after conception. Findings 1496 (0.62%) multiple births occurred in a cohort of 242 015 women who had registered with the study between October, 1993, and September, 1995, and who had a pregnancy not affected by a birth defect; the rate of multiple births in women who did and did not take folic acid before or during early pregnancy was 0.59% and 0.65%, respectively (rate ratio 0.91; 95% CI 0.82-1.00). Interpretation Our findings suggest that consumption of folic acid supplements during pregnancy is not associated with an increased occurrence of multiple births.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Peking Univ, Hlth Sci Ctr, Natl Ctr Maternal & Infant Hlth, Beijing, Peoples R China; Peking Univ, Hlth Sci Ctr, Dept Hlth Care Epidemiol, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University; Peking University	Berry, RJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,MS F-45, Atlanta, GA 30341 USA.			Berry, Robert/0000-0002-7162-5046				Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Berry RJ, 2002, EPIDEMIOLOGY, V13, P114, DOI 10.1097/00001648-200201000-00021; Botto LD, 1996, PEDIATRICS, V98, P911; CHEN CJ, 1987, ACTA GENET MED GEMEL, V36, P335, DOI 10.1017/S0001566000006085; Cornel MC, 1997, TERATOLOGY, V55, P134; Czeizel A. E., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P175; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Ericson A, 2001, Twin Res, V4, P63, DOI 10.1375/twin.4.2.63; Gindler J, 2001, LANCET, V358, P796, DOI 10.1016/S0140-6736(01)05969-4; Hasbargen U, 2000, HUM REPROD, V15, P2659, DOI 10.1093/humrep/15.12.2659; Kinzler WL, 2000, J SOC GYNECOL INVEST, V7, P321, DOI 10.1016/S1071-5576(00)00084-8; KIRKE PN, 1992, ARCH DIS CHILD, V67, P1442, DOI 10.1136/adc.67.12.1442; LI DK, 1995, EPIDEMIOLOGY, V6, P212, DOI 10.1097/00001648-199505000-00004; Little J., 1988, TWINNING TWINS, P37; LUKE B, 1990, Fetal Diagnosis and Therapy, V5, P61; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; Mastroiacovo P., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P57; Mathews F, 1998, BRIT J OBSTET GYNAEC, V105, P954, DOI 10.1111/j.1471-0528.1998.tb10257.x; Mathews F, 1999, LANCET, V353, P291, DOI 10.1016/S0140-6736(05)74937-0; Myers MF, 2001, AM J EPIDEMIOL, V154, P1051, DOI 10.1093/aje/154.11.1051; NYLANDER PPS, 1979, ACTA GENET MED GEMEL, V28, P261, DOI 10.1017/S0001566000008746; POLLARD R, 1995, HUM BIOL, V67, P921; Schwartz DB, 1999, AM J OBSTET GYNECOL, V181, P912, DOI 10.1016/S0002-9378(99)70324-8; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; TOLAROVA M, 1995, TERATOLOGY, V51, P71, DOI 10.1002/tera.1420510205; VOGEL F, 1997, HUMAN GENETICS PROBL, P230; WALD N, 1991, LANCET, V338, P131; Werler MM, 1997, AM J MED GENET, V71, P93; WHIPLEY PW, 1966, AM J EPIDEMIOL, V85, P147; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; 2001, FOLIC ACID PREVENTIO	32	54	61	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					380	384		10.1016/S0140-6736(03)12390-2	http://dx.doi.org/10.1016/S0140-6736(03)12390-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573374				2022-12-24	WOS:000180787000010
J	Bakkenist, CJ; Kastan, MB				Bakkenist, CJ; Kastan, MB			DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation	NATURE			English	Article							S-PHASE CHECKPOINT; ATAXIA-TELANGIECTASIA GENE; NIJMEGEN BREAKAGE SYNDROME; FIELD GEL-ELECTROPHORESIS; TOPOISOMERASE-II; MAMMALIAN-CELLS; IN-VIVO; METAPHASE CHROMOSOMES; IONIZING IRRADIATION; CHROMATIN STRUCTURE	The ATM protein kinase, mutations of which are associated with the human disease ataxia-telangiectasia, mediates responses to ionizing radiation in mammalian cells. Here we show that ATM is held inactive in unirradiated cells as a dimer or higher-order multimer, with the kinase domain bound to a region surrounding serine 1981 that is contained within the previously described 'FAT' domain. Cellular irradiation induces rapid intermolecular autophosphorylation of serine 1981 that causes dimer dissociation and initiates cellular ATM kinase activity. Most ATM molecules in the cell are rapidly phosphorylated on this site after doses of radiation as low as 0.5 Gy, and binding of a phosphospecific antibody is detectable after the introduction of only a few DNA double-strand breaks in the cell. Activation of the ATM kinase seems to be an initiating event in cellular responses to irradiation, and our data indicate that ATM activation is not dependent on direct binding to DNA strand breaks, but may result from changes in the structure of chromatin.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.kastan@stjude.org						Alligood KJ, 2000, HYBRIDOMA, V19, P317, DOI 10.1089/027245700429864; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CEDERVALL B, 1995, RADIAT RES, V143, P8, DOI 10.2307/3578920; Chehab NH, 2000, GENE DEV, V14, P278; DEALMODOVAR JMR, 1994, INT J RADIAT BIOL, V65, P641, DOI 10.1080/09553009414550751; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JABERABOANSARI A, 1988, RADIAT RES, V114, P94, DOI 10.2307/3577147; JENSEN PB, 1994, CANCER RES, V54, P2959; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; KRAJEWSKI WA, 1995, FEBS LETT, V361, P149, DOI 10.1016/0014-5793(95)00144-X; Krajewski WA, 1999, J BIOMOL STRUCT DYN, V16, P1097, DOI 10.1080/07391102.1999.10508318; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; Malyapa RS, 1996, INT J RADIAT ONCOL, V35, P963, DOI 10.1016/0360-3016(96)00211-8; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; MEISENHELDER J, 1999, CURRENT PROTOCOLS S, V48; Richardson C, 1999, METH MOL B, V113, P453; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROTI JLR, 1987, CYTOMETRY, V8, P461, DOI 10.1002/cyto.990080505; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Snyder RD, 2000, ENVIRON MOL MUTAGEN, V35, P13, DOI 10.1002/(SICI)1098-2280(2000)35:1<13::AID-EM3>3.0.CO;2-1; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; WARD WS, 1989, CHROMOSOMA, V98, P153, DOI 10.1007/BF00329678; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	51	2550	2656	3	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					499	506		10.1038/nature01368	http://dx.doi.org/10.1038/nature01368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556884				2022-12-24	WOS:000180670600036
J	Natesh, R; Schwager, SLU; Sturrock, ED; Acharya, KR				Natesh, R; Schwager, SLU; Sturrock, ED; Acharya, KR			Crystal structure of the human angiotensin-converting enzyme-lisinopril complex	NATURE			English	Article							ACTIVE-SITE; COMPETITIVE INHIBITORS; MOLECULAR-CLONING; IDENTIFICATION; HYDROLYSIS; ACTIVATION; DEPENDENCE; SUBSTRATE; RESIDUES; BINDING	Angiotensin-converting enzyme (ACE) has a critical role in cardiovascular function by cleaving the carboxy terminal His-Leu dipeptide from angiotensin I to produce a potent vasopressor octapeptide, angiotensin II. Inhibitors of ACE are a first line of therapy for hypertension, heart failure, myocardial infarction and diabetic nephropathy. Notably, these inhibitors were developed without knowledge of the structure of human ACE, but were instead designed on the basis of an assumed mechanistic homology with carboxypeptidase A(1). Here we present the X-ray structure of human testicular ACE and its complex with one of the most widely used inhibitors, lisinopril (N-2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; also known as Prinivil or Zestril), at 2.0 Angstrom resolution. Analysis of the three-dimensional structure of ACE shows that it bears little similarity to that of carboxypeptidase A, but instead resembles neurolysin(2) and Pyrococcus furiosus carboxypeptidase(3)-zinc metallopeptidases with no detectable sequence similarity to ACE. The structure provides an opportunity to design domain-selective ACE inhibitors that may exhibit new pharmacological profiles.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Cape Town, Sch Med, Div Med Biochem, ZA-7925 Observatory, South Africa; Univ Cape Town, Sch Med, MRC, UCT Liver Res Ctr, ZA-7925 Observatory, South Africa	University of Bath; University of Cape Town; University of Cape Town	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	sturrock@curie.uct.ac.za; bsskra@bath.ac.uk	NATESH, Ramanathan/C-4488-2008	NATESH, Ramanathan/0000-0002-1145-5962; Acharya, K. Ravi/0000-0002-3009-4058				ABRAHAMS JP, 1996, ACTA CRYSTALLOGR D, V52, P110; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arndt JW, 2002, STRUCTURE, V10, P215, DOI 10.1016/S0969-2126(02)00698-6; BERNSTEIN KE, 1990, BIOCHEM BIOPH RES CO, V167, P310, DOI 10.1016/0006-291X(90)91766-L; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNNING P, 1978, BIOCHEM BIOPH RES CO, V83, P1442, DOI 10.1016/0006-291X(78)91382-7; BUNNING P, 1983, BIOCHEMISTRY-US, V22, P110, DOI 10.1021/bi00270a016; Chubb AJ, 2002, BIOCHEM BIOPH RES CO, V297, P1225, DOI 10.1016/S0006-291X(02)02324-0; CORVOL P, 1998, HDB PROTEOLYTIC ENZY, P1066; CUSHMAN DW, 1977, BIOCHEMISTRY-US, V16, P5484, DOI 10.1021/bi00644a014; DELAFORTELLE E, 1997, METHOD ENZYMOL, V276, P272; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P7118, DOI 10.1021/bi00243a012; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Junot C, 2001, J PHARMACOL EXP THER, V297, P606; Liu XF, 2001, J BIOL CHEM, V276, P33518, DOI 10.1074/jbc.M101495200; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patchett A A, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P1; PATCHETT AA, 1980, NATURE, V288, P280, DOI 10.1038/288280a0; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P3850, DOI 10.1021/bi00285a021; SKIDGEL RA, 1984, PEPTIDES, V5, P769, DOI 10.1016/0196-9781(84)90020-2; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; WEI L, 1992, J BIOL CHEM, V267, P13398; WILLIAMS TA, 1994, J BIOL CHEM, V269, P29430; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	30	614	656	9	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					551	554		10.1038/nature01370	http://dx.doi.org/10.1038/nature01370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540854				2022-12-24	WOS:000180670600050
J	Check, E				Check, E			BSE in human tissue fires debate on patient disclosure	NATURE			English	News Item																		Hilton DA, 2002, BRIT MED J, V325, P633, DOI 10.1136/bmj.325.7365.633; 2000, NATURE, V405, P7	2	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					326	326		10.1038/419326a	http://dx.doi.org/10.1038/419326a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12645536	Bronze			2022-12-24	WOS:000178195400005
J	Gao, KQ; Shubin, NH				Gao, KQ; Shubin, NH			Earliest known crown-group salamanders	NATURE			English	Article								Salamanders are a model system for studying the rates and patterns of the evolution of new anatomical structures(1-4). Recent discoveries of abundant Late Jurassic and Early Cretaceous salamanders are helping to address these issues(5-8). Here we report the discovery of well-preserved Middle Jurassic salamanders from China, which constitutes the earliest known record of crown-group urodeles (living salamanders and their closest relatives). The new specimens are from the volcanic deposits of the Jiulongshan Formation (Bathonian)(9-13), Inner Mongolia, China, and represent basal members of the Cryptobranchidae, a family that includes the endangered Asian giant salamander (Andrias) and the North American hellbender (Cryptobranchus). These fossils document a Mesozoic record of the Cryptobranchidae, predating the previous record of the group by some 100 million years(14-17). This discovery provides evidence to support the hypothesis that the divergence of the Cryptobranchidae from the Hynobiidae had taken place in Asia before the Middle Jurassic period.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China	University of Chicago; Peking University	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1027 E 57th St, Chicago, IL 60637 USA.							Dong Zhiming, 1998, Vertebrata Palasiatica, V36, P159; Duellman W.E., 1986, BIOL AMPHIBIANS; Estes R., 1981, HDB PALAOHERPETOLO 2; Evans SE, 1996, PHILOS T R SOC B, V351, P627, DOI 10.1098/rstb.1996.0061; EVANS SE, 1988, GEOBIOS-LYON, V21, P539, DOI 10.1016/S0016-6995(88)80069-X; GAO K, 1998, GEOL CHINA, V248, P40; Gao KQ, 2001, NATURE, V410, P574, DOI 10.1038/35069051; GUBIN YM, 1991, PALEONTOLOG J, P91; HARLAND BW, 1990, GEOLOGIC TIME SCALE; Ivachnenko M, 1978, PALEONTOL J, V1978, P362; [季强 Ji Qiang], 2002, [地质论评, Geological Review], V48, P221; KRZEMISKI W, 2002, POL PIS ENTOMOL, V71, P127; Larson Allan, 1993, Herpetological Monographs, V7, P77, DOI 10.2307/1466953; Milner A. R., 1983, EVOLUTION TIME SPACE, P431; Milner Andrew R., 2000, Amphibian Biology, V4, P1412; NAYLOR BG, 1981, COPEIA, P76, DOI 10.2307/1444042; NESSOV L A, 1988, Acta Zoologica Cracoviensia, V31, P475; Nessov LA, 1996, VESTNIK SANKT PETERS, V7, P3; REN D, 2002, STUTTGART BEIT NAT B, V33, P1; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; SCOTESE C. R., 2001, ATLAS EARTH HIST, V1; SHUBIN N, 1995, EVOLUTION, V49, P874, DOI 10.1111/j.1558-5646.1995.tb02323.x; Shubin N, 1996, AM ZOOL, V36, P51; VENCZEL M, 1987, 3 WORLD C HERP, P218; WAKE DB, 1987, SCIENCE, V238, P42, DOI 10.1126/science.238.4823.42; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; WAKE DB, 1983, J THEOR BIOL, V101, P211, DOI 10.1016/0022-5193(83)90335-1; Wang S. E., 2000, STRATIGRAPHICAL LEXI; Wang Yuan, 2000, Vertebrata Palasiatica, V38, P100	29	237	276	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					424	428		10.1038/nature01491	http://dx.doi.org/10.1038/nature01491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660782	Green Published			2022-12-24	WOS:000181801200043
J	Oppo, DW; McManus, JF; Cullen, JL				Oppo, DW; McManus, JF; Cullen, JL			Palaeo-oceanography: Deepwater variability in the Holocene epoch	NATURE			English	Article							NORTH-ATLANTIC CLIMATE; CIRCULATION		Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02540 USA; Salem State Coll, Dept Geol Sci, Salem, MA 01970 USA	Woods Hole Oceanographic Institution; Massachusetts System of Public Higher Education; Salem State University	Oppo, DW (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02540 USA.	doppo@whoi.edu						Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Bianchi GG, 1999, NATURE, V397, P515, DOI 10.1038/17362; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Chapman MR, 2000, HOLOCENE, V10, P287, DOI 10.1191/095968300671253196; Curry WB, 1988, PALEOCEANOGRAPHY, V3, P317, DOI 10.1029/PA003i003p00317; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; Keigwin LD, 2000, P NATL ACAD SCI USA, V97, P1343, DOI 10.1073/pnas.97.4.1343; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; STUIVER M, 1993, RADIOCARBON, V35, P137	13	197	204	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					277	278		10.1038/422277b	http://dx.doi.org/10.1038/422277b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646912				2022-12-24	WOS:000181637300030
J	Igakura, T; Stinchcombe, JC; Goon, PKC; Taylor, GP; Weber, JN; Griffiths, GM; Tanaka, Y; Osame, M; Bangham, CRM				Igakura, T; Stinchcombe, JC; Goon, PKC; Taylor, GP; Weber, JN; Griffiths, GM; Tanaka, Y; Osame, M; Bangham, CRM			Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton	SCIENCE			English	Article							T-CELL LEUKEMIA; HUMAN-IMMUNODEFICIENCY-VIRUS; ADHESION MOLECULE-1; SYNCYTIUM FORMATION; TYPE-1 INFECTION; TRANSMISSION; ANTIBODIES; ACTIVATION; EXPRESSION; ADENOVIRUS	Cell contact is required for efficient transmission of human T cell leukemia virus-type 1 (HTLV-1) between cells and between individuals, because naturally infected lymphocytes produce virtually no cell-free infectious HTLV-I particles. However, the mechanism of cell-to-cell spread of HTLV-I is not understood. We show here that cell contact rapidly induces polarization of the cytoskeleton of the infected cell to the cell-cell junction. HTLV-I core (Gag protein) complexes and the HTLV-I genome accumulate at the cell-cell junction and are then transferred to the uninfected cell. Other lymphotropic viruses, such as HIV-1, may similarly subvert normal T cell physiology to allow efficient propagation between cells.	Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Dept Genitourinary Med & Communicable Dis, London W2 1PG, England; Kagoshima Univ, Fac Med, Dept Internal Med 3, Kagoshima 8908520, Japan; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Ryukyus, Fac Med, Okinawa Asia Res Ctr Med Sci, Dept Immunol & Infect Dis, Okinawa 9030215, Japan	Imperial College London; Imperial College London; Kagoshima University; University of Oxford; University of the Ryukyus	Bangham, CRM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, St Marys Campus,Norfolk Pl, London W2 1PG, England.		Goon, Peter/AAF-2508-2021	stinchcombe, jane/0000-0003-1459-9299; Bangham, Charles/0000-0003-2624-3599; Griffiths, Gillian/0000-0003-0434-5842				Cullen BR, 2001, CELL, V105, P697, DOI 10.1016/S0092-8674(01)00392-0; Daenke S, 1999, J GEN VIROL, V80, P1429, DOI 10.1099/0022-1317-80-6-1429; Delamarre L, 1997, J VIROL, V71, P259, DOI 10.1128/JVI.71.1.259-266.1997; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; FAN N, 1992, J CLIN MICROBIOL, V30, P905, DOI 10.1128/JCM.30.4.905-910.1992; GESSAIN A, 1985, LANCET, V2, P407; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; Hildreth JEK, 1997, J VIROL, V71, P1173, DOI 10.1128/JVI.71.2.1173-1180.1997; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; Jassal SR, 2001, VIRUS RES, V78, P17, DOI 10.1016/S0168-1702(01)00279-9; Le Blanc I, 2002, J VIROL, V76, P905, DOI 10.1128/JVI.76.2.905-911.2002; Mabit H, 2002, J VIROL, V76, P9962, DOI 10.1128/JVI.76.19.9962-9971.2002; MERIC C, 1986, J VIROL, V60, P450; MEULLER NE, 1997, VIRAL INFECT HUMANS, P785; NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310; NAGY K, 1984, HUMAN T CELL LEUKEMI, P121; OKOCHI K, 1984, VOX SANG, V46, P245, DOI 10.1111/j.1423-0410.1984.tb00083.x; OSAME M, 1986, LANCET, V1, P1031; PEARCEPRATT R, 1994, J VIROL, V68, P2898, DOI 10.1128/JVI.68.5.2898-2905.1994; POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; SOMMERFELT MA, 1988, SCIENCE, V242, P1557, DOI 10.1126/science.3201246; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Valentin H, 1997, J VIROL, V71, P8522, DOI 10.1128/JVI.71.11.8522-8530.1997; Yamamoto A, 1997, J NEUROL SCI, V151, P121, DOI 10.1016/S0022-510X(97)00121-4; YAMAMOTO N, 1982, SCIENCE, V217, P737, DOI 10.1126/science.6980467	29	526	539	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1713	1716		10.1126/science.1080115	http://dx.doi.org/10.1126/science.1080115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12589003				2022-12-24	WOS:000181519500039
J	Itoh, Y; Kawamata, Y; Harada, M; Kobayashi, M; Fujii, R; Fukusumi, S; Ogi, K; Hosoya, M; Tanaka, Y; Uejima, H; Tanaka, H; Maruyama, M; Satoh, R; Okubo, S; Kizawa, H; Komatsu, H; Matsumura, F; Noguchi, Y; Shinobara, T; Hinuma, S; Fujisawa, Y; Fujino, M				Itoh, Y; Kawamata, Y; Harada, M; Kobayashi, M; Fujii, R; Fukusumi, S; Ogi, K; Hosoya, M; Tanaka, Y; Uejima, H; Tanaka, H; Maruyama, M; Satoh, R; Okubo, S; Kizawa, H; Komatsu, H; Matsumura, F; Noguchi, Y; Shinobara, T; Hinuma, S; Fujisawa, Y; Fujino, M			Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40	NATURE			English	Article							SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; RECEPTOR; GLUCOSE; RAT; EXPRESSION; SUBTYPE	Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue(1,2). Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion(3). Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion(4,5). Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood(6). Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.	Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Tsukuba, Ibaraki 3004293, Japan	Takeda Chemical Industries	Hinuma, S (corresponding author), Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.			Komatsu, Hidetoshi/0000-0003-1630-0537; Maruyama, Minoru/0000-0002-1478-9415; Kawamata, Yuji/0000-0001-5652-4899				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; BRAUN T, 1987, BIOCHEM BIOPH RES CO, V149, P125, DOI 10.1016/0006-291X(87)91613-5; BRISCOE CP, 2002, J BIOL CHEM     1219; BRUNO JF, 1993, ENDOCRINOLOGY, V133, P2561, DOI 10.1210/en.133.6.2561; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Gadsby R, 2002, ADV DRUG DELIVER REV, V54, P1165, DOI 10.1016/S0169-409X(02)00094-7; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hinuma S, 1999, J MOL MED, V77, P495, DOI 10.1007/s001090050403; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Jovanovic L, 1999, ANN CLIN LAB SCI, V29, P33; KAWAMATA Y, 2003, J BIOL CHEM     0110; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LANKATBUTTGEREIT B, 1994, EXP CLIN ENDOCRINOL, V102, P341, DOI 10.1055/s-0029-1211301; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Nunez EA, 1997, PROSTAG LEUKOTR ESS, V57, P107, DOI 10.1016/S0952-3278(97)90500-7; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; SPECTOR AA, 1975, SCIENCE, V190, P490, DOI 10.1126/science.1166323; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; WANK SA, 1992, P NATL ACAD SCI USA, V89, P3125, DOI 10.1073/pnas.89.7.3125; WOLHEIM CB, 1986, ANN NY ACAD SCI, V488, P317	26	1180	1299	7	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					173	176		10.1038/nature01478	http://dx.doi.org/10.1038/nature01478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12629551				2022-12-24	WOS:000181488900047
J	Milner-Gulland, EJ; Bukreevea, OM; Coulson, T; Lushchekina, AA; Kholodova, MV; Bekenov, AB; Grachev, IA				Milner-Gulland, EJ; Bukreevea, OM; Coulson, T; Lushchekina, AA; Kholodova, MV; Bekenov, AB; Grachev, IA			Conservation - Reproductive collapse in saiga antelope harems	NATURE			English	Article							POPULATIONS; DYNAMICS		Univ London Imperial Coll Sci Technol & Med, Dept Environm Sci & Technol, London SW7 2AZ, England; Dept Hunting Management, Elista 358000, Republic Kalmyk, Russia; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; AN Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; Minist Educ, Inst Zool, Almaty 480032, Kazakhstan	Imperial College London; University of Cambridge; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Institute of Zoology in Kazakhstan	Milner-Gulland, EJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Environm Sci & Technol, S Kensington Campus, London SW7 2AZ, England.		Grachev, Yuriy/AAY-9102-2020; Kholodova, Marina/V-3628-2019; Coulson, Tim/AAL-8148-2021; Lushchekina, Anna/C-3945-2014	Coulson, Tim/0000-0001-9371-9003; Lushchekina, Anna/0000-0003-1915-7430; Milner-Gulland, E.J./0000-0003-0324-2710; grachev, yuriy/0000-0003-3311-2079				Bekenov AB, 1998, MAMMAL REV, V28, P1, DOI 10.1046/j.1365-2907.1998.281024.x; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Hudson RJ., 1993, FARMING WAPITI RED D; Milner-Gulland EJ, 2001, ORYX, V35, P340, DOI 10.1017/S0030605300032105; MILNERGULLAND EJ, 1995, NATURE, V377, P488, DOI 10.1038/377488a0; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Robinson Sarah., 2000, PASTORALISM LAND DEG; Sharp R, 2002, ORYX, V36, P323, DOI 10.1017/S0030605302000625; Sokolov V. E., 1998, SAIGA FILOGENY TAXON; [No title captured]	10	177	189	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					135	135		10.1038/422135a	http://dx.doi.org/10.1038/422135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634775				2022-12-24	WOS:000181488900034
J	Parish, WL; Laumann, EO; Cohen, MS; Pan, SM; Zheng, HY; Hoffman, I; Wang, TF; Ng, KH				Parish, WL; Laumann, EO; Cohen, MS; Pan, SM; Zheng, HY; Hoffman, I; Wang, TF; Ng, KH			Population-based study of chlamydial infection in China - A hidden epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED DISEASES; REPUBLIC-OF-CHINA; TRACHOMATIS INFECTIONS; UNITED-STATES; RISK-FACTORS; SEX WORKERS; PREVALENCE; HIV; AIDS; WOMEN	Context Sexually transmitted diseases are increasing rapidly in China. Surveillance data imperfectly indicate current prevalence and risk factors, Objectives To estimate the prevalence of genital chlamydial and gonococcal infections and to describe patterns of infection by subgroup and behavioral patterns. Design, Setting, and Participants A national stratified probability sample of 3426 Chinese individuals (1738 women and 1688 men) aged 20 to 64 years, who were interviewed between August 1999 and August 2000, completed a computer-administered survey, and provided a urine specimen (69% total participation rate). Main Outcome Measure Positive-test result for chlamydial or gonococcal infections. Results The overall prevalence per 100 population of chlamydial infection was 2.6 (95% confidence interval [CI], 1.6-4.1) for women and 2.1 (95% CI, 1.3-3.3) for men. For gonococcal infection, the overall prevalence per 100 population was 0.08 (95% CI, 0.02-0.4) for women and 0.02 (95% CI, 0.005-0.1) for men. Risk factors for chlamydial infection among men aged 20 to 44 years were unprotected sex with a commercial sex worker (odds ratio [OR], 8.24; 95% CI, 3.51-19.35), less education (OR, 7.20; 95% CI, 2.31-22.37), and recent sex with their spouse or other steady partner (OR, 7.73; 95% CI, 2.70-22.10). Among women aged 20 to 44 years, risk factors for chlamydial infection were having less education (OR, 2.82; 95% CI, 1.01-7.91) and living in a city (OR, 3.46; 95% CI, 1.67-7.18) or along the southern coast (OR, 2.16; 95% CI, 1.29-3.63) and having a spouse or other steady sexual partner who earned a high income (OR, 2.85; 95% CI, 1.11-7.29), who socialized often (OR, 2.79; 95% CI, 1.08-7.19), or who traveled less than 1 week per year (OR, 5.40; 95% CI, 1.44-20.3). Conclusions The prevalence of chlamydial infection in China is substantial. The patterns of infection suggest potential avenues for intervention.	Univ Chicago, Natl Opin Res Ctr, Populat Res Ctr, Chicago, IL 60637 USA; Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; Renmin Univ, Sociol Sexual Inst, Beijing, Peoples R China; Peking Union Med Coll, Dermatol Venerol Div, Beijing, Peoples R China	University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; Renmin University of China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Parish, WL (corresponding author), 1126 E 59th St, Chicago, IL 60637 USA.				FIC NIH HHS [D43 TW01039] Funding Source: Medline; NIAID NIH HHS [U19 AI31496, P30 AI50410] Funding Source: Medline; NICHD NIH HHS [P30 HD18288, R01 HD34157] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034157, P30HD018288] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031496, P30AI050410] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALI MM, 2001, AIDS BEHAV, V5, P343, DOI DOI 10.1023/A:1013186806939; Belsley D.A., 1980, REGRESSION DIAGNOSTI; CARAEL M, 1995, SEXUAL BEHAV AIDS DE; *CDCP, 2003, CHLM US; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Cheng YM, 2002, CONTRACEPTION, V66, P179, DOI 10.1016/S0010-7824(02)00350-5; *CHIN CTR DIS CONT, YEAR 2001 NAT SEX TR; *CHIN NAT CENS OFF, 1997, 1995 NAT 1 PERC POP; Chinese Population Census Office under the State Council and Department of Population Social Science and Technology Statistics of the National Bureau of Statistics of China, 2002, TAB 2000 POP CENS PE; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Cohen MS, 1996, J INFECT DIS, V174, pS223, DOI 10.1093/infdis/174.Supplement_2.S223; DOLCINI MM, 2000, AIDS BEHAV, V4, P297; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Fonck K, 2000, SEX TRANSM DIS, V27, P417, DOI 10.1097/00007435-200008000-00007; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Gielen A, 2001, AIDS BEHAV, V5, P193; Groseclose SL, 1999, SEX TRANSM DIS, V26, P339, DOI 10.1097/00007435-199907000-00006; Hanenberg R, 1998, AIDS CARE, V10, P69, DOI 10.1080/713612352; Hee Choi Kyung, 2000, AIDS BEHAV, V4, P111; Hershatter Gail, 1997, DANGEROUS PLEASURES; Howell MR, 1998, ANN INTERN MED, V128, P277, DOI 10.7326/0003-4819-128-4-199802150-00005; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; KISH L, 1974, J ROY STAT SOC B MET, V36, P1; Klouman E, 2002, INT J STD AIDS, V13, P234, DOI 10.1258/0956462021925027; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lim L. L., 1998, SEX SECTOR EC SOCIAL; Long JS, 1997, REGRESSION MODELS CA; Morre SA, 1999, J CLIN MICROBIOL, V37, P3092; PARISH WL, 2003, CHINESE HLTH FAMILY; Paxton LA, 1998, SEX TRANSM INFECT, V74, P421, DOI 10.1136/sti.74.6.421; Pierpoint T, 2000, SEX TRANSM INFECT, V76, P273, DOI 10.1136/sti.76.4.273; Plafker T, 2001, BRIT MED J, V323, P714, DOI 10.1136/bmj.323.7315.714; Pulerwitz J, 2001, AM J PUBLIC HEALTH, V91, P1650, DOI 10.2105/AJPH.91.10.1650; Radcliffe KW, 2001, SEX TRANSM INFECT, V77, P265, DOI 10.1136/sti.77.4.265; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; Solomon S, 1998, INT J STD AIDS, V9, P98, DOI 10.1258/0956462981921756; *STAT STAT BUR, 1999, CHIN POP STAT YB 199; *STATA CORP, 2001, STATA REF MAN REL 7, V4; SUN S, 2002, CHINA DAILY     0309; Tarantola DJM, 2001, AIDS PATIENT CARE ST, V15, P439, DOI 10.1089/108729101316914476; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; *UNAIDS CHIN OFF, OBS CHIN YEAR 2000 A; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Van Duynhoven YTHP, 1997, INT J EPIDEMIOL, V26, P1373, DOI 10.1093/ije/26.6.1373; van Valkengoed IGM, 2000, SEX TRANSM INFECT, V76, P375, DOI 10.1136/sti.76.5.375; Wang JC, 2001, SEX TRANSM DIS, V28, P171, DOI 10.1097/00007435-200103000-00009; WEN C, NO CONDOMS PLEASE CH; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; ZHANG L, 2000, REDRAWING BOUNDARIES, P171; [No title captured]	52	214	226	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1265	1273		10.1001/jama.289.10.1265	http://dx.doi.org/10.1001/jama.289.10.1265			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633188	Bronze			2022-12-24	WOS:000181466500028
J	Ford, N; Cantau, N; Jeanmart, H				Ford, N; Cantau, N; Jeanmart, H			Homelessness and hardship in Moscow	LANCET			English	Editorial Material									Med Sans Frontieres, London EC1R 5DJ, England; Med Sans Frontieres, Moscow 12310, Russia	Doctors Without Borders; Doctors Without Borders	Cantau, N (corresponding author), Med Sans Frontieres, Shmitovskij Proezd Dom 3, Moscow 12310, Russia.							WHO, 2002, GLOB TUB CONTR	1	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					875	875		10.1016/S0140-6736(03)12717-1	http://dx.doi.org/10.1016/S0140-6736(03)12717-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642069				2022-12-24	WOS:000181466600030
J	Tomasz, A				Tomasz, A			"Intelligence coup" for drug designers: crystal structure of Staphylococcus aureus beta-lactam resistance protein PBP2A	LANCET			English	Editorial Material							BINDING		Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Rockefeller University	Tomasz, A (corresponding author), Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA.	tomasz@mail.rockefeller.edu	Tomasz, Alexander/B-9939-2011	Tomasz, Alexander/0000-0003-1520-1983				Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; *PUBL HLTH DISP, 2002, MMWR-MORBID MORTAL W, V51, P902; Sieradzki K, 1999, NEW ENGL J MED, V340, P517, DOI 10.1056/NEJM199902183400704; Toney JH, 1998, ANAL BIOCHEM, V255, P113, DOI 10.1006/abio.1997.2458; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001	13	4	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2003	361	9360					795	796		10.1016/S0140-6736(03)12719-5	http://dx.doi.org/10.1016/S0140-6736(03)12719-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642041				2022-12-24	WOS:000181466600003
J	Foster, SE; Vaughan, RD; Foster, WH; Califano, JA				Foster, SE; Vaughan, RD; Foster, WH; Califano, JA			Alcohol consumption and expenditures for underage drinking and adult excessive drinking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RELATIVE RISK; DRIVER AGE; PREVALENCE; YOUTH; IMPACT	Context Although estimates of the amount and proportion of alcohol consumed by underage and adult drinkers have been reported, more accurate estimates are possible and the economic impact has not been explored. Objectives To provide accurate estimates of underage and adult excessive drinking and to describe consumer expenditures linked to underage and adult excessive drinking. Design and Setting Information was obtained from national data sets, including 1999 versions of the National Household Survey of Drug Abuse, the Youth Risk Behavior Survey (YRBS), the Behavior Risk Factor Surveillance System (BRFSS), 2000 US Census, and national data on consumption and consumer expenditures for alcohol, published by Adams Business Research. Participants A total of 217192 persons aged 12 years or older across 3 data sources. Main Outcome Measures Amount as a proportion of total alcohol consumed and proportion of consumer expenditures on alcohol among underage (12-20 years) and adult excessive (greater than or equal to21 years) drinkers. Results The proportion of 12- to 20-year-olds who drink was estimated to be 50.0% using data from the YRBS; the proportion of adults aged 21 or older who drink was estimated to be 52.8% using data from the BRFSS. The estimated total number of drinks consumed per month was 4.21 billion; underage drinkers consumed 19.7% of this total. The amount of adult drinking that was excessive (>2 drinks per day) was 30.4%. Consumer expenditure on alcohol in the United States in 1999 was $116.2 billion; of that, $22.5 billion was attributed to underage drinking and $34.4 billion was attributed to adult excessive drinking. Conclusion These data Suggest that underage drinkers and adult excessive drinkers are responsible for 50.1% of alcohol consumption and, 48.9% of consumer expenditure.	Columbia Univ, Natl Ctr Addict & Subst Abuse, New York, NY 10017 USA; Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY USA; Columbia Univ, Dept Biostat, New York, NY USA	Columbia University; Columbia University; Columbia University	Foster, SE (corresponding author), Columbia Univ, Natl Ctr Addict & Subst Abuse, 633 3rd Ave, New York, NY 10017 USA.							*AD BUS RES, 2001, AD BEER HDB; *AD BUS RES, 2001, AD LIQ HDB; *AD BUS RES, 2001, AD WIN HDB; [Anonymous], 2000, ALCOHOL RES HEALTH, V24, P5; *CDCP, 1999, BEH RISK FACT SURV S; *CDCP, 1993, MMWR-MORBID MORTAL W, V41, P969; Center for Disease Control and Prevention, 1999, YOUTH RISK BEH SURV; Center on Alcohol Marketing and Youth, 2002, OV YOUTH TARG ALC AD; COOK PJ, 1984, ALCOHOLISM RELATED P, P56; Cowan CD, 2001, J DRUG ISSUES, V31, P599, DOI 10.1177/002204260103100302; *CTR SCI PUBL INT, 1996, STAT ALC TAX HLTH CI; *CTR SCI PUBL INT, 1996, AD RESP TEL BEER ADV; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5; EIGEN LD, 1996, DRINK AG 21 PROBL SO; EMBREE BG, 1993, J STUD ALCOHOL, V54, P334, DOI 10.15288/jsa.1993.54.334; Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901; Fendrich M, 2001, J DRUG ISSUES, V31, P615, DOI 10.1177/002204260103100303; Fowler FJ, 2001, J DRUG ISSUES, V31, P643, DOI 10.1177/002204260103100304; Gerstein D, 1981, ALCOHOL PUBLIC POLIC, P182; Gfroerer J, 1997, DRUG ALCOHOL DEPEN, V47, P19, DOI 10.1016/S0376-8716(97)00063-X; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Greenfield TK, 1999, J STUD ALCOHOL, V60, P78, DOI 10.15288/jsa.1999.60.78; GRUNBAUM JA, 2002, MMWR-MORBID MORTAL W, V51, P62; Harrison LD, 2001, J DRUG ISSUES, V31, P665, DOI 10.1177/002204260103100305; Hingson RW, 1999, ALCOHOL RES HEALTH, V23, P31; Jacobson JL, 1999, ALCOHOL RES HEALTH, V23, P25; JOHNSTON LD, 2000, MONITORING FUTURE CO; LAIXUTHAI A, 1993, CONTEMP POLICY ISSUE, V11, P70, DOI 10.1111/j.1465-7287.1993.tb00402.x; LEVY DT, 1999, COSTS UNDERAGE DRINK; *NAT CTR ADD SUBST, 2002, TEEN TIPPL AM UND DR; *NAT CTR ADD SUBST, 1998, BARS SUBST AB AM PRI; *NAT I ALC AB ALC, 2002, FAQS ALC AB ALC; *NAT I ALC AB ALC, 2000, C ALC HLTH HIGHL CUR; *OFF APPL STUD, 2001, NAT HOUS SURV DRUG A; *PAC I RES EV, 1999, REG STRAT PREV YOUTH; *PAC I RES EV, 1999, STRAT RED UND ALC US; Rogers JD, 1999, J STUD ALCOHOL, V60, P732, DOI 10.15288/jsa.1999.60.732; Schuman H., 1981, QUESTIONS ANSWERS AT; *SUBST AB MENT HLT, 1999, NAT HOUS SURV DRUG A; *SUBST AB MENT HLT, 2002, STAT SUBST AB MENT H; *US DEP COMM, 2002, PROF GEN DEM CHAR; *US DEP HHS, 2002, RES 2001 NAT HOUS SU, V1; *USDA, 2000, NUTR YOUR HLTH DIET; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387; ZADOR PL, 1991, J STUD ALCOHOL, V52, P302, DOI 10.15288/jsa.1991.52.302	46	67	69	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					989	995		10.1001/jama.289.8.989	http://dx.doi.org/10.1001/jama.289.8.989			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597750	Bronze			2022-12-24	WOS:000181129800024
J	Kim, UK; Jorgenson, E; Coon, H; Leppert, M; Risch, N; Drayna, D				Kim, UK; Jorgenson, E; Coon, H; Leppert, M; Risch, N; Drayna, D			Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide	SCIENCE			English	Article							RECEPTOR; FAMILY; LOCALIZATION; PERCEPTION; GENES	The ability to taste the substance phenylthiocarbamide (PTC) has been widely used for genetic and anthropological studies, but genetic studies have produced conflicting results and demonstrated complex inheritance for this trait. We have identified a small region on chromosome 7q that shows strong linkage disequilibrium between single-nucleotide polymorphism (SNP) markers and PTC taste sensitivity in unrelated subjects. This region contains a single gene that encodes a member of the TAS2R bitter taste receptor family. We identified three coding SNPs giving rise to five haplotypes in this gene worldwide. These haplotypes completely explain the bimodal distribution of PTC taste sensitivity, thus accounting for the inheritance of the classically defined taste insensitivity and for 55 to 85% of the variance in PTC sensitivity. Distinct phenotypes were associated with specific haplotypes, which demonstrates that this gene has a direct influence on PTC taste sensitivity and that sequence variants at different sites interact with each other within the encoded gene product.	Natl Inst Deafness & Other Commun Disorders, NIH, Rockville, MD 20850 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Utah, Med Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Med Ctr, Red Butte Hlth Ctr, Dept Psychiat, Salt Lake City, UT 84112 USA; Kaiser Permanente, Div Res, Oakland, CA 94612 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Stanford University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Kaiser Permanente	Drayna, D (corresponding author), Natl Inst Deafness & Other Commun Disorders, NIH, 5 Res Court, Rockville, MD 20850 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000046, Z01DC000046] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [T32 HG00044] Funding Source: Medline; PHS HHS [Z01-000046-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Blakeslee AF, 1932, P NATL ACAD SCI USA, V18, P120, DOI 10.1073/pnas.18.1.120; Blakfslee AF, 1935, P NATL ACAD SCI USA, V21, P84, DOI 10.1073/pnas.21.2.84; BOYD WC, 1950, GENETICS RACES MAN I, P276; BRANDTZAEG MERTON B, 1958, Acta Genet Stat Med, V8, P114; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHAUTARD.EA, 1974, ANN HUM GENET, V38, P191, DOI 10.1111/j.1469-1809.1974.tb01950.x; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DRAYNA D, IN PRESS HUM GENET; Enoch MA, 2001, ADDICT BEHAV, V26, P399, DOI 10.1016/S0306-4603(00)00117-9; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FALCONER DS, 1946, ANN EUGEN, V13, P211; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guo SW, 2001, ANN HUM BIOL, V28, P111; GUYER M, 1992, SCIENCE, V258, P67; HARRIS H, 1950, ANN EUGENIC, V15, P24, DOI 10.1111/j.1469-1809.1949.tb02419.x; KALMUS H, 1958, ANN HUM GENET, V22, P222, DOI 10.1111/j.1469-1809.1958.tb01416.x; LEE B. F., 1934, OHIO JOUR SCI, V34, P337; Levit SG, 1935, J GENET, V30, P389, DOI 10.1007/BF02982247; NABHAN C, 1995, BIOCHEM BIOPH RES CO, V212, P1015, DOI 10.1006/bbrc.1995.2071; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; OLSON JM, 1989, GENET EPIDEMIOL, V6, P423, DOI 10.1002/gepi.1370060305; Prodi DA, 2002, AM J HUM GENET, V71, P464; REDDY BM, 1989, GENET EPIDEMIOL, V6, P413, DOI 10.1002/gepi.1370060304; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; SPENCE MA, 1984, HUM GENET, V67, P183; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; TILLS D, 1983, DISTRIBUTION HUMAN B; Ueda T, 2001, BIOCHEM BIOPH RES CO, V285, P147, DOI 10.1006/bbrc.2001.5136; 1931, SCIENCE S, V73, P14	33	626	649	2	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1221	1225		10.1126/science.1080190	http://dx.doi.org/10.1126/science.1080190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595690				2022-12-24	WOS:000181065500037
J	Smith, MM; Johanson, Z				Smith, MM; Johanson, Z			Separate evolutionary origins of teeth from evidence in fossil jawed vertebrates	SCIENCE			English	Article								Placoderms are extinct jawed fishes of the class Placodermi and are basal among jawed vertebrates. It is generally thought that teeth are absent in placoderms and that the phylogenetic origin of teeth occurred after the evolution of jaws. However, we now report the presence of tooth rows in more derived placoderms, the arthrodires. New teeth are composed of gnathostome-type dentine and develop at specific locations. Hence, it appears that these placoderm teeth develop and are regulated as in other jawed vertebrates. Because tooth development occurs only in derived forms of placoderms, we suggest that teeth evolved at least twice, through a mechanism of convergent evolution.	Kings Coll London, Inst Dent, London SE1 9RT, England; Australian Museum, Sydney, NSW 2010, Australia	University of London; King's College London; Australian Museum	Smith, MM (corresponding author), Kings Coll London, Inst Dent, Guys Campus,London Bridge, London SE1 9RT, England.	moya.smith@kcl.ac.uk	Self, Casey J/B-6871-2011	Meredith Smith, Moya/0000-0002-3397-873X; Johanson, Zerina/0000-0002-8444-6776				Denison R., 1978, HDB PALEOICHTHYOLOGY; DENNERLINE J, 1995, INT HIST REV, V17, P127; Goujet D, 2001, SYST ASSOC SPEC VOL, V61, P209; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; McCollum M, 2001, J ANAT, V199, P153, DOI 10.1046/j.1469-7580.2001.19910153.x; ORVIG T, 1980, ZOOL SCR, V9, P141, DOI 10.1111/j.1463-6409.1980.tb00660.x; REIF WE, 1982, EVOL BIOL, V15, P287; Reisz RR, 2001, NATURE, V411, P548, DOI 10.1038/35079187; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; SMITH MM, 1993, EVOL BIOL, V27, P387; Smith MM, 2001, J ANAT, V199, P161; SMITH MM, IN PRESS EVOL DEV; Williams ME, 2001, J VERTEBR PALEONTOL, V21, P214, DOI 10.1671/0272-4634(2001)021[0214:TRICSW]2.0.CO;2; Wilson Mark V. H., 1999, Journal of Vertebrate Paleontology, V19, p85A; Young GC, 2001, J VERTEBR PALEONTOL, V21, P670, DOI 10.1671/0272-4634(2001)021[0670:PJSIAA]2.0.CO;2	15	79	86	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1235	1236		10.1126/science.1079623	http://dx.doi.org/10.1126/science.1079623			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595693				2022-12-24	WOS:000181065500041
J	Zubieta, JK; Heitzeg, MM; Smith, YR; Bueller, JA; Xu, K; Xu, YJ; Koeppe, RA; Stohler, CS; Goldman, D				Zubieta, JK; Heitzeg, MM; Smith, YR; Bueller, JA; Xu, K; Xu, YJ; Koeppe, RA; Stohler, CS; Goldman, D			COMT val(158)met genotype affects mu-opioid neurotransmitter responses to a pain stressor	SCIENCE			English	Article							CATECHOL-O-METHYLTRANSFERASE; AFFECTIVE DIMENSIONS; ANTERIOR CINGULATE; NOREPINEPHRINE; MODULATION; RECEPTORS; STRIATUM; BEHAVIOR; AMYGDALA; ORGANIZATION	Responses to pain and other stressors are regulated by interactions between multiple brain areas and neurochemical systems. We examined the influence of a common functional genetic polymorphism affecting the metabolism of catecholamines on the modulation of responses to sustained pain in humans. Individuals homozygous for the met(158) allele of the catechol-O-methyttransferase (COMT) polymorphism (val(158)met) showed diminished regional mu-opioid system responses to pain compared with heterozygotes. These effects were accompanied by higher sensory and affective ratings of pain and a more negative internal affective state. Opposite effects were observed in val(158) homozygotes. The COMT val(158)met polymorphism thus influences the human experience of pain and may underlie interindividual differences in the adaptation and responses to pain and other stressful stimuli.	Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Natl Inst Alcohol & Alcoholism, Neurogenet Lab, Rockville, MD 20852 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Zubieta, JK (corresponding author), Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA.		Zubieta, Jon-Kar/AAB-5565-2022; Xu, Ke/V-5941-2019; Goldman, David/F-9772-2010; STOHLER, CHRISTIAN/AAQ-7539-2020; Majid, Salma/AAT-2616-2020; Heitzeg, Mary/M-7154-2017	Xu, Ke/0000-0002-6472-7052; Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Heitzeg, Mary/0000-0002-6737-2971; Stohler, Christian S/0000-0003-0443-6146	NIDCR NIH HHS [R01 DE 12059, R01 DE 12743] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012743, R01DE012059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000303, Z01AA000298, Z01AA000302] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; CUMMING P, 1992, J NEUROCHEM, V59, P1905, DOI 10.1111/j.1471-4159.1992.tb11026.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; ENOCH MA, IN PRESS PSYCHOL GEN; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; GEORGE SR, 1987, PEPTIDES, V8, P487, DOI 10.1016/0196-9781(87)90014-3; HELMSTETTER FJ, 1995, J PHARMACOL EXP THER, V275, P381; Johnson PI, 1997, NEUROSCIENCE, V77, P187, DOI 10.1016/S0306-4522(96)00482-4; KALIN NH, 1988, BRAIN RES, V440, P285, DOI 10.1016/0006-8993(88)90997-3; Kalivas PW, 1999, ANN NY ACAD SCI, V877, P64, DOI 10.1111/j.1749-6632.1999.tb09261.x; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; KOPIN IJ, 1985, PHARMACOL REV, V37, P333; LI PP, 1984, J NEUROCHEM, V43, P1425, DOI 10.1111/j.1471-4159.1984.tb05404.x; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; MCALONAN GM, 1993, NEUROSCIENCE, V52, P605, DOI 10.1016/0306-4522(93)90410-H; Melzack R, 2000, HDB PAIN ASSESSMENT, P152; MOGENSON GJ, 1991, ADV EXP MED BIOL, V295, P267; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Napier TC, 1999, ANN NY ACAD SCI, V877, P176, DOI 10.1111/j.1749-6632.1999.tb09268.x; Nestler EJ, 2001, J NEUROSCI, V21, P8324, DOI 10.1523/JNEUROSCI.21-21-08324.2001; Oke AF, 1997, BRAIN RES, V763, P69, DOI 10.1016/S0006-8993(97)00404-6; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; Stohler CS, 1999, PAIN, V79, P165, DOI 10.1016/S0304-3959(98)00171-7; Tiihonen J, 1999, MOL PSYCHIATR, V4, P286, DOI 10.1038/sj.mp.4000509; UNTERWALD EM, 1994, NEUROREPORT, V5, P1613, DOI 10.1097/00001756-199408150-00018; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; VOGT BA, 1995, EXP NEUROL, V135, P83, DOI 10.1006/exnr.1995.1069; WATKINS LR, 1982, SCIENCE, V216, P1185, DOI 10.1126/science.6281891; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Zubieta JK, 2002, J NEUROSCI, V22, P5100, DOI 10.1523/JNEUROSCI.22-12-05100.2002; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	39	842	872	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1240	1243		10.1126/science.1078546	http://dx.doi.org/10.1126/science.1078546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595695				2022-12-24	WOS:000181065500043
J	Yoder, AD; Burns, MM; Zehr, S; Delefosse, T; Veron, G; Goodman, SM; Flynn, JJ				Yoder, AD; Burns, MM; Zehr, S; Delefosse, T; Veron, G; Goodman, SM; Flynn, JJ			Single origin of Malagasy Carnivora from an African ancestor	NATURE			English	Article							MADAGASCAR; PHYLOGENY; RADIATION; DISPERSAL; ANCIENT; LEMURS; INDIA	The Carnivora are one of only four orders of terrestrial mammals living in Madagascar today. All four (carnivorans, primates, rodents and lipotyphlan insectivores) are placental mammals with limited means for dispersal, yet they occur on a large island that has been surrounded by a formidable oceanic barrier for at least(88) million years(1,2), predating the age of origin for any of these groups(3,4). Even so, as many as four colonizations of Madagascar have been proposed for the Carnivora alone(5). The mystery of the island's mammalian origins is confounded by its poor Tertiary fossil record, which leaves us with no direct means for estimating dates of initial diversification. Here we use a multi-gene phylogenetic analysis to show that Malagasy carnivorans are monophyletic and thus the product of a single colonization of Madagascar by an African ancestor. Furthermore, a bayesian analysis(6) of divergence ages for Malagasy carnivorans and lemuriforms indicates that their respective colonizations were temporally separated by tens of millions of years. We therefore conclude that a single event, such as vicariance or common dispersal, cannot explain the presence of both groups in Madagascar.	Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06551 USA; Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Museum Natl Hist Nat, Lab Zool Mammiferes & Oiseaux, F-75231 Paris, France; WWF, Antananarivo 101, Madagascar	Yale University; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Museum National d'Histoire Naturelle (MNHN); World Wildlife Fund	Yoder, AD (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06551 USA.	anne.yoder@yale.edu	Veron, Geraldine/P-8163-2019	Veron, Geraldine/0000-0003-4247-3976				ALBIGNAC R, 1973, FAUNE MADAGASCAR, V36, P206; Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x; COFFIN MF, 1992, AAPG MEMOIR, V53, P207; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; GOODMAN SM, IN PRESS NATURAL HIS; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Krause D.W., 1999, GSA TODAY, V9, P1; Krause David W., 1997, P3; Krause DW, 2001, NATURE, V412, P497, DOI 10.1038/35087649; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Novacek MJ, 2001, CURR BIOL, V11, pR573, DOI 10.1016/S0960-9822(01)00347-5; OLSON LE, 1999, THESIS U CHICAGO, P349; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; SCHMID J, IN PRESS NATURAL HIS; SIMPSON GG, 1952, B AM MUS NAT HIST, V99, P163; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Veron G, 1995, MAMMALIA, V59, P551, DOI 10.1515/mamm.1995.59.4.551; Veron Geraldine, 1993, Journal of Mammalian Evolution, V1, P169, DOI 10.1007/BF01024706; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder AD, 1996, COLLOQ SEMI, P245	30	224	257	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					734	737		10.1038/nature01303	http://dx.doi.org/10.1038/nature01303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610623				2022-12-24	WOS:000180938000041
J	Hsieh, JC; Lee, L; Zhang, LQ; Wefer, S; Brown, K; DeRossi, C; Wines, ME; Rosenquist, T; Holdener, BC				Hsieh, JC; Lee, L; Zhang, LQ; Wefer, S; Brown, K; DeRossi, C; Wines, ME; Rosenquist, T; Holdener, BC			Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity	CELL			English	Article							RECEPTOR-RELATED PROTEIN; SUBCELLULAR-LOCALIZATION; MESODERM INDUCTION; PRIMITIVE ENDODERM; NODAL EXPRESSION; BODY PLAN; AXIS; GASTRULATION; DISABLED-2; RETENTION	Specification of embryonic polarity and pattern formation in multicellular organisms requires inductive signals from neighboring cells. One approach toward understanding these interactions is to study mutations that disrupt development. Here, we demonstrate that mesd, a gene identified in the mesoderm development (mesd) deletion interval on mouse chromosome 7, is essential for specification of embryonic polarity and mesoderm induction. MESD functions in the endoplasmic reticulum as a specific chaperone for LRP5 and LRP6, which in conjunction with Frizzled, are coreceptors for canonical WNT signal transduction. Disruption of embryonic polarity and mesoderm differentiation in mesd-deficient embryos likely results from a primary defect in WNT signaling. However, phenotypic differences between mesd-deficient and wnt3(-/-) embryos suggest that MESD may function on related members of the low-density lipoprotein receptor (LDLR) family, whose members mediate diverse cellular processes ranging from cargo transport to signaling.	SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Holdener, BC (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA.	bernadette.holdener@stonybrook.edu			NICHD NIH HHS [HD53964] Funding Source: Medline; NIGMS NIH HHS [R01 GM053964] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053964] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANG SL, 1994, DEVELOPMENT, V120, P2979; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; HO SN, 1989, BIOTECHNIQUES, V16, P51; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HODGES RS, 1988, J BIOL CHEM, V263, P11768; HOGAN B, 1994, MANIPULATING MOUSE E, V1; HOLDENER BC, 1994, DEVELOPMENT, V120, P1335; HOLDENERKENNY B, 1992, BIOESSAYS, V14, P831, DOI 10.1002/bies.950141208; Jorgensen MM, 2000, J BIOL CHEM, V275, P33861, DOI 10.1074/jbc.M004663200; LAWSON KA, 1991, CIBA FOUND S, V165, P891; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; SCHEDL A, 1992, GENOMICS, V14, P288, DOI 10.1016/S0888-7543(05)80218-6; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tam PPL, 1999, DEVELOPMENT, V126, P5171; Tam PPL, 2001, BIOESSAYS, V23, P508, DOI 10.1002/bies.1070; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Varlet I, 1997, DEVELOPMENT, V124, P1033; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Wines ME, 2001, GENOMICS, V72, P88, DOI 10.1006/geno.2000.6466; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810	39	198	220	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					355	367		10.1016/S0092-8674(03)00045-X	http://dx.doi.org/10.1016/S0092-8674(03)00045-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581525	Bronze			2022-12-24	WOS:000181252200007
J	Bluher, M; Kahn, BB; Kahn, CR				Bluher, M; Kahn, BB; Kahn, CR			Extended longevity in mice lacking the insulin receptor in adipose tissue	SCIENCE			English	Article							LIFE-SPAN; FOOD RESTRICTION; CALORIC RESTRICTION; GENE; MUTATIONS; EXTENSION; ELEGANS; GROWTH; MUTANT; MUSCLE	Caloric restriction has been shown to increase longevity in organisms ranging from yeast to mammals. In some organisms, this has been associated with a decreased fat mass and alterations in insulin/insulin-like growth factor 1 (IGF-1) pathways. To further explore these associations with enhanced longevity, we studied mice with a fat-specific insulin receptor knockout (FIRKO). These animals have reduced fat mass and are protected against age-related obesity and its subsequent metabolic abnormalities, although their food intake is normal. Both male and female FIRKO mice were found to have an increase in mean life-span of similar to134 days (18%), with parallel increases in median and maximum life-spans. Thus, a reduction of fat mass without caloric restriction can be associated with increased longevity in mice, possibly through effects on insulin signaling.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Kahn, CR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NIDDK NIH HHS [DK 30136, DK 56116, R01 DK043051, DK 43051] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK043051, P01DK056116, R01DK043051] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x; HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIM H, 1992, DIABETOLOGIA, V35, P261, DOI 10.1007/BF00400927; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KROOK A, 1993, LANCET, V342, P277, DOI 10.1016/0140-6736(93)91820-C; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee SS, 2002, NATURE, V418, P287, DOI 10.1038/418287a; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239; MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Piantanelli L, 2001, MECH AGEING DEV, V122, P463, DOI 10.1016/S0047-6374(00)00256-6; Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381, DOI 10.1093/gerona/55.8.B381; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257; WEINDRUCH W, 1998, RETARDATION AGING DI; WERTHEIMER E, 1993, NAT GENET, V5, P71, DOI 10.1038/ng0993-71; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	33	985	1012	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					572	574		10.1126/science.1078223	http://dx.doi.org/10.1126/science.1078223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543978				2022-12-24	WOS:000180559800052
J	McCarthy, HD; Ellis, SM; Cole, TJ				McCarthy, HD; Ellis, SM; Cole, TJ			Central overweight and obesity in British youth aged 11-16 years: cross sectional surveys of waist circumference	BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; FAT DISTRIBUTION; CHILDREN; ADOLESCENTS; PREVALENCE	Objective To compare changes over time in waist circumference (a measure of central fatness) and body mass index (a measure of overall obesity) in British youth. Design Representative cross sectional surveys in 1977, 1987, and 1997. Setting Great Britain. Participants Young people aged 11-16 years Surveyed in 1977 (boys) and 1987 (girls) for the British Standards Institute (n=3784) and in 1997 (both sexes) for the national diet and nutrition survey (n=776). Main outcome measures Waist Circumference, expressed as a standard deviation score using the first survey as reference, and body mass index (weight(kg)/height(m)(2)), expressed as a standard deviation score against the British 1990 revised reference. Overweight and obesity were defined as the measurement exceeding the 91st and 98th centile, respectively. Results Waist circumference increased sharply over the period between surveys (mean increases for boys and girls, 6.9 and 6.2 cm, or 0.84 and 1.02 SD score units, P <0.0001). In centile terms, waist circumference increased more in girls than in boys. Increases in body mass index were smaller and similar by sex (means 1.5 and 1.6, or 0.47 and 0.53 SD score units, P < 0.0001). Waist circumference in 1997 exceeded the 91st centile in 28% (n=110) of boys and 38% (n=147) of girls (against 9% for both sexes in 1977-87, P < 0.0001), whereas 14% (n=54) and 17% (n=68), respectively, exceeded the 98th centile (3% in 1977-87, P < 0.0001). The corresponding rates for body mass index in 1997 were 21% (n=80) of boys and 17% (n=67) of girls exceeding the 91st centile (8% and 6% in 1977-87) and 10% (n=39) and 8% (n=32) exceeding the 98th centile (3% and 2% in 1977-87). Conclusions Trends in waist circumference during the past 10-20 years have greatly exceeded those in body mass index, particularly in girls, showing that body mass index is a poor proxy for central fatness. Body mass index has therefore systematically underestimated the prevalence of obesity in young people.	London Metropolitan Univ, Dept Hlth & Human Sci, London N7 8DB, England; Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	London Metropolitan University; University of London; University College London	McCarthy, HD (corresponding author), London Metropolitan Univ, Dept Hlth & Human Sci, London N7 8DB, England.	d.mccarthy@londonmet.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	Medical Research Council [G9827821(62595), G9827821] Funding Source: Medline; MRC [G9827821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bates CJ, 2000, NATL DIET NUTR SURVE; BRAMBILLA P, 1994, INT J OBESITY, V18, P795; *BRIT STAND I, 1990, BS7321; *BRIT STAND I, 1990, BOD MEAS BOYS GIRLS; Bundred P, 2001, BMJ-BRIT MED J, V322, P326, DOI 10.1136/bmj.322.7282.326; Caprio S, 1996, AM J CLIN NUTR, V64, P12, DOI 10.1093/ajcn/64.1.12; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2000, AM J EPIDEMIOL, V152, P1179, DOI 10.1093/aje/152.12.1179; FLODMARK CE, 1994, ACTA PAEDIATR, V83, P941, DOI 10.1111/j.1651-2227.1994.tb13177.x; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Gregory JR, 1995, NATL DIET NUTR SURVE; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Moreno LA, 1998, J PEDIATR GASTR NUTR, V27, P176, DOI 10.1097/00005176-199808000-00009; Moreno LA, 2001, INT J OBESITY, V25, P1656, DOI 10.1038/sj.ijo.0801803; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Wells JCK, 2002, INT J OBESITY, V26, P1323, DOI 10.1038/sj.ijo.0802077; World Health Organization, 1995, PHYS STAT US INT ANT	21	308	336	0	20	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2003	326	7390					624	626		10.1136/bmj.326.7390.624	http://dx.doi.org/10.1136/bmj.326.7390.624			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661BF	12649234	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000181870800014
J	Bloor, K; Freemantle, N; Khadjesari, Z; Maynard, A				Bloor, K; Freemantle, N; Khadjesari, Z; Maynard, A			Impact of NICE guidance on laparoscopic surgery for inguinal hernias: analysis of interrupted time series	BRITISH MEDICAL JOURNAL			English	Article									Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of York - UK; University of Birmingham	Bloor, K (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.			Khadjesari, Zarnie/0000-0002-2958-9555; Freemantle, Nick/0000-0001-5807-5740; Bloor, Karen/0000-0003-4852-9854				DEVLIN HB, 1998, MANAGEMENT ABDOMINAL; Motson RW, 2002, BRIT MED J, V324, P1092, DOI 10.1136/bmj.324.7345.1092; National Institute for Clinical Excellence, 2001, GUID US LAP SURG ING	3	36	36	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2003	326	7389					578	578		10.1136/bmj.326.7389.578	http://dx.doi.org/10.1136/bmj.326.7389.578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	657ZF	12637402	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000181696600018
J	Boelaert, K; Franklyn, JA				Boelaert, K; Franklyn, JA			Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers?	LANCET			English	Editorial Material							EXPRESSION; GENE; THERAPY; TRANSPORTER; CLONING		Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Franklyn, JA (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.							Boland A, 2000, CANCER RES, V60, P3484; Cho JY, 2000, GENE THER, V7, P740, DOI 10.1038/sj.gt.3301170; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; ESKIN BA, 1970, T NEW YORK ACAD SCI, V32, P911, DOI 10.1111/j.2164-0947.1970.tb02988.x; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Mandell RB, 1999, CANCER RES, V59, P661; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Spitzweg C, 2000, CANCER RES, V60, P6526; Spitzweg C, 1999, CANCER RES, V59, P2136; Spitzweg C, 2001, J CLIN ENDOCR METAB, V86, P3327, DOI 10.1210/jc.86.7.3327; SPITZWEG C, 2002, P 74 ANN M AM THYR A, P128; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630	12	28	33	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					796	797		10.1016/S0140-6736(03)12720-1	http://dx.doi.org/10.1016/S0140-6736(03)12720-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642042				2022-12-24	WOS:000181466600004
J	Mercer, JM; Roth, VL				Mercer, JM; Roth, VL			The effects of Cenozoic global change on squirrel phylogeny	SCIENCE			English	Article							FLYING SQUIRRELS; EVOLUTION	By modifying habitats and creating bridges and barriers between landmasses, climate change and tectonic events are believed to have important consequences for diversification of terrestrial organisms. Such consequences should be most evident in phylogenetic histories of groups that are ancient, widespread, and diverse. The squirrel family (Sciuridae) is one of very few mammalian families endemic to Eurasia, Africa, and North and South America and is idea[ for examining these issues. Through phylogenetic and molecular-clock analyses, we infer that arrival and diversification of squirrels in Africa, on Sunda Shelf islands, across Beringea, and across the Panamanian isthmus coincide in timing and location with multiple well-documented sea-level, tectonic, and paleontological events. These precise correspondences point to an important role for global change in the diversification of a major group of mammals.	Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Mercer, JM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.							Berggren WA, 1992, EOCENE OLIGOCENE CLI, P1; Butlin R. K., 1998, P355; Coates Anthony G., 1996, P21; Corbet G, 1992, MAMMALS INDOMALAYAN; de Bruijn Hans, 1999, P271; DEBRUIJN H, 1989, PAPERS FOSSIL RODENT, P139; DEGRACIANSKY PC, 1998, SOC EC PALEONTOL MIN, V60; Emry R.J., 1984, P23; Emry RJ, 1996, J VERTEBR PALEONTOL, V16, P775, DOI 10.1080/02724634.1996.10011366; Emry RJ, 2001, J VERTEBR PALEONTOL, V21, P400, DOI 10.1671/0272-4634(2001)021[0400:DNNFDE]2.0.CO;2; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hoffman Robert S., 1993, P419; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Lavocat R., 1978, P69; Marincovich L, 1999, NATURE, V397, P149, DOI 10.1038/16446; MARSHALL LG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P329; MERCER JL, UNPUB; MILLER JR. G. S., 1901, P BIOL SOC WASH, V14, P23; MOORE JOSEPH CURTIS, 1959, BULL AMER MUS NAT HIST, V118, P153; Moss Steve J., 1998, P133; Nowack R.M., 1999, WALKERS MAMMALS WORL; Sanders WJ, 2002, J VERTEBR PALEONTOL, V22, P388, DOI 10.1671/0272-4634(2002)022[0388:NPFTEM]2.0.CO;2; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; THORINGTON RW, 1984, SCIENCE, V225, P1048, DOI 10.1126/science.225.4666.1048; Thorington RW, 1996, J MAMMAL, V77, P69, DOI 10.2307/1382710; VIANEYLIAUD M, 1984, EVOLUTIONARY RELATIO, P277; Welcomme JL, 2001, GEOL MAG, V138, P397, DOI 10.1017/S0016756801005428; Wilson DE, 1993, MAMMAL SPECIES WORLD; Wing Scott L., 1998, P37	30	225	243	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1568	1572		10.1126/science.1079705	http://dx.doi.org/10.1126/science.1079705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12595609				2022-12-24	WOS:000181367900036
J	Min, JR; Feng, Q; Li, ZZ; Zhang, Y; Xu, RM				Min, JR; Feng, Q; Li, ZZ; Zhang, Y; Xu, RM			Structure of the catalytic domain of human DOT1L, a Non-SET domain nucleosomal histone methyltransferase	CELL			English	Article							CRYSTAL-STRUCTURE; LYSINE METHYLTRANSFERASE; SILENCING PROTEIN; DIFFRACTION DATA; CORE PARTICLE; METHYLATION; H3; CHROMATIN; UBIQUITINATION; YEAST	Dot1 is an evolutionarily conserved histone methyltransferase that methylates lysine-79 of histone H3 in the core domain. Unlike other histone methyltransferases, Dot1 does not contain a SET domain, and it specifically methylates nucleosomal histone H3. We have solved a 2.5 Angstrom resolution structure of the catalytic domain of human Dot1, hDOT1L, in complex with S-adenosyl-L-methionine (SAM). The structure reveals a unique organization of a mainly alpha-helical N-terminal domain and a central open alpha/beta structure, an active site consisting of a SAM binding pocket, and a potential lysine binding channel. We also show that a flexible, positively charged region at the C terminus of the catalytic domain is critical for nucleosome binding and enzymatic activity. These structural and biochemical analyses, combined with molecular modeling, provide mechanistic insights into the catalytic mechanism and nucleosomal specificity of Dot1 proteins.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Cold Spring Harbor Laboratory; University of North Carolina; University of North Carolina Chapel Hill	Xu, RM (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		xu, rui/GRX-5734-2022; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Zhang, Yi/0000-0002-2789-0811	NIGMS NIH HHS [GM63070, GM63716] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063716] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Dlakic M, 2001, TRENDS BIOCHEM SCI, V26, P405, DOI 10.1016/S0968-0004(01)01856-4; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Singer MS, 1998, GENETICS, V150, P613; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	45	290	311	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					711	723		10.1016/S0092-8674(03)00114-4	http://dx.doi.org/10.1016/S0092-8674(03)00114-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628190	Bronze			2022-12-24	WOS:000181443600013
J	Niemeier, M; Crawford, JD; Tweed, DB				Niemeier, M; Crawford, JD; Tweed, DB			Optimal transsaccadic integration explains distorted spatial perception	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; APPARENT POSITION; DISPLACEMENT; SUPPRESSION; MOTION; COMPRESSION; SIGNALS; VISION; SPACE	We scan our surroundings with quick eye movements called saccades, and from the resulting sequence of images we build a unified percept by a process known as transsaccadic integration. This integration is often said to be flawed, because around the time of saccades, our perception is distorted(1-6) and we show saccadic suppression of displacement (SSD): we fail to notice if objects change location during the eye movement(7,8). Here we show that transsaccadic integration works by optimal inference. We simulated a visuomotor system with realistic saccades, retinal acuity, motion detectors and eye-position sense, and programmed it to make optimal use of these imperfect data when interpreting scenes. This optimized model showed human-like SSD and distortions of spatial perception. It made new predictions, including tight correlations between perception and motor action (for example, more SSD in people with less-precise eye control) and a graded contraction of perceived jumps; we verified these predictions experimentally. Our results suggest that the brain constructs its evolving picture of the world by optimally integrating each new piece of sensory or motor information.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Canadian Inst Hlth Res, Grp Act & Percept, Ottawa, ON, Canada; York Univ, Ctr Vis Res, Toronto, ON M3J 1P3, Canada	University of Toronto; University of Toronto; Institute for Work & Health; York University - Canada	Tweed, DB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.			Crawford, Doug/0000-0003-2288-1286				BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; CARPENTER RHS, 1991, VISION VISUAL DYSFUN, P1; CHOUDHURY BP, 1981, PHYSIOL BEHAV, V26, P125, DOI 10.1016/0031-9384(81)90087-1; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Gysen V, 2002, VISION RES, V42, P379, DOI 10.1016/S0042-6989(01)00296-6; Honda H, 1997, EXP BRAIN RES, V113, P327, DOI 10.1007/BF02450330; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; ILG UJ, 1993, VISION RES, V33, P211, DOI 10.1016/0042-6989(93)90159-T; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; LI WX, 1990, PERCEPT PSYCHOPHYS, V48, P453, DOI 10.3758/BF03211589; Li WX, 1997, VISION RES, V37, P1779, DOI 10.1016/S0042-6989(96)00301-X; MACK A, 1970, PERCEPT PSYCHOPHYS, V8, P291, DOI 10.3758/BF03212596; MACKAY DM, 1973, HDB SENSORY PHYSIOLO, V7, P307; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Morrone MC, 1997, J NEUROSCI, V17, P7941; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; TYNAN PD, 1982, VISION RES, V22, P61, DOI 10.1016/0042-6989(82)90167-5; VANOPSTAL AJ, 1989, VISION RES, V29, P1183, DOI 10.1016/0042-6989(89)90064-3; vonHelmholtz HL, 1910, HDB PHYSL OPTIK; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WESTHEIMER G, 1984, ANNU REV PSYCHOL, V35, P201, DOI 10.1146/annurev.psych.35.1.201	30	134	135	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					76	80		10.1038/nature01439	http://dx.doi.org/10.1038/nature01439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621435				2022-12-24	WOS:000181343100040
J	Goldberg, M; Stucki, M; Falck, J; D'Amours, D; Rahman, D; Pappin, D; Bartek, J; Jackson, SP				Goldberg, M; Stucki, M; Falck, J; D'Amours, D; Rahman, D; Pappin, D; Bartek, J; Jackson, SP			MDC1 is required for the intra-S-phase DNA damage checkpoint	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; CELLULAR-RESPONSE; HISTONE H2AX; NUCLEAR FOCI; REPAIR; GENE; ATM; DISORDERS	MRE11, RAD50 and NBS1 form a highly conserved protein complex (the MRE11 complex) that is involved in the detection, signalling and repair of DNA damage(1). We identify MDC1 (KIAA0170/NFBD1), a protein that contains a forkhead-associated (FHA) domain and two BRCA1 carboxy-terminal (BRCT) domains, as a binding partner for the MRE11 complex. We show that, in response to ionizing radiation, MDC1 is hyperphosphorylated in an ATM-dependent manner, and rapidly relocalizes to nuclear foci that also contain the MRE11 complex, phosphorylated histone H2AX and 53BP1. Downregulation of MDC1 expression by small interfering RNA yields a radioresistant DNA synthesis (RDS) phenotype and prevents ionizing radiation-induced focus formation by the MRE11 complex. However, downregulation of MDC1 does not abolish the ionizing radiation-induced phosphorylation of NBS1, CHK2 and SMC1, or the degradation of CDC25A. Furthermore, we show that overexpression of the MDC1 FHA domain interferes with focus formation by MDC1 itself and by the MRE11 complex, and induces an RDS phenotype. These findings reveal that MDC1-mediated focus formation by the MRE11 complex at sites of DNA damage is crucial for the efficient activation of the intra-S-phase checkpoint.	Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Imperial Coll Sch Med, Dept Proteom, London W12 0NN, England	University of Cambridge; University of Cambridge; Danish Cancer Society; Imperial College London	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England.		Dry, Kate/I-2328-2014; Stucki, Manuel/H-4739-2017; Bartek, Jiri/G-5870-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Goldberg, Michal/0000-0001-9397-2383; Pappin, Darryl/0000-0002-8981-8401				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Michelson RJ, 2000, BIOESSAYS, V22, P966, DOI 10.1002/1521-1878(200011)22:11<966::AID-BIES2>3.3.CO;2-C; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	30	402	433	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					952	956		10.1038/nature01445	http://dx.doi.org/10.1038/nature01445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607003				2022-12-24	WOS:000181186900051
J	Mora, C; Chittaro, PM; Sale, PF; Kritzer, JP; Ludsin, SA				Mora, C; Chittaro, PM; Sale, PF; Kritzer, JP; Ludsin, SA			Patterns and processes in reef fish diversity	NATURE			English	Article							BIODIVERSITY HOTSPOTS; CORAL; CONSERVATION; DURATION; PACIFIC	A central aim of ecology is to explain the heterogeneous distribution of biodiversity on earth. As expectations of diversity loss grow(1-5), this understanding is also critical for effective management and conservation. Although explanations for biodiversity patterns are still a matter for intense debate(5), they have often been considered to be scale-dependent(6,7). At large geographical scales, biogeographers have suggested that variation in species richness results from factors such as area, temperature, environmental stability, and geological processes, among many others(5,7-14). From the species pools generated by these large-scale processes, community ecologists have suggested that local-scale assembly of communities is achieved through processes such as competition, predation, recruitment, disturbances and immigration(5-8,15,16). Here we analyse hypotheses on speciation and dispersal for reef fish from the Indian and Pacific oceans and show how dispersal from a major centre of origination can simultaneously account for both large-scale gradients in species richness and the structure of local communities.	Univ Windsor, Dept Biol, Windsor, ON N9B 3P4, Canada	University of Windsor	Mora, C (corresponding author), Univ Windsor, Dept Biol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	moracamilo@hotmail.com	Ludsin, Stuart/F-2925-2010	Ludsin, Stuart/0000-0002-3866-2216; Chittaro, Paul/0000-0001-9310-7314				Allen G.R., 1994, Atoll Research Bulletin, V412, P1; [Anonymous], 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237.001; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonhomme F, 2000, ENVIRON BIOL FISH, V59, P365, DOI 10.1023/A:1026508715631; Caley MJ, 1997, ECOLOGY, V78, P70; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Cornell HV, 2000, CORAL REEFS, V19, P37, DOI 10.1007/s003380050224; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Grove J.S., 1997, FISHES GALAPAGOS ISL; Harmelin-Vivien Mireille L., 2002, P265, DOI 10.1016/B978-012615185-5/50016-5; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; JEN Veron, 1995, CORALS SPACE TIME BI; Karlson RH, 1998, ECOL MONOGR, V68, P259, DOI 10.1890/0012-9615(1998)068[0259:SDVILV]2.0.CO;2; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SPRINGER VG, 1982, SMITHSON CONTRIB ZOO, V177, P1; THOMSON DA, 1999, REEF FISHES SEA CORT; Victor BC, 2000, MAR ECOL PROG SER, V205, P241, DOI 10.3354/meps205241; VICTOR BC, 1986, MAR BIOL, V90, P317, DOI 10.1007/BF00428555; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; ZAPATA F, 1998, P 8 INT COR REEF S, V1, P1029	27	248	259	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					933	936		10.1038/nature01393	http://dx.doi.org/10.1038/nature01393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606998				2022-12-24	WOS:000181186900046
J	Rees, WE				Rees, WE			A blot on the land	NATURE			English	Article									Univ British Columbia, Sch Community & Reg Planning, Vancouver, BC V6T 1Z2, Canada	University of British Columbia	Rees, WE (corresponding author), Univ British Columbia, Sch Community & Reg Planning, 6333 Mem Rd, Vancouver, BC V6T 1Z2, Canada.							Rees W.E, 1992, ENVIRON URBAN, V4, P120, DOI 10.1177/095624789200400212; Rees WE, 2002, B SCI TECHNOL SOC, V22, P249, DOI DOI 10.1177/0270467602022004001; TAINTER JA, 1995, FUTURES, V27, P397, DOI 10.1016/0016-3287(95)00016-P; *WORLDW FUND NAT, 2002, LIV PLAN REP 2002	4	24	26	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					898	898		10.1038/421898a	http://dx.doi.org/10.1038/421898a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649BK	12606978	Bronze			2022-12-24	WOS:000181186900023
J	Wu, LZ; de Bruin, A; Saavedra, HI; Starovic, M; Trimboli, A; Yang, Y; Opavska, J; Wilson, P; Thompson, JC; Ostrowski, MC; Rosol, TJ; Woollett, LA; Weinstein, M; Cross, JC; Robinson, ML; Leone, G				Wu, LZ; de Bruin, A; Saavedra, HI; Starovic, M; Trimboli, A; Yang, Y; Opavska, J; Wilson, P; Thompson, JC; Ostrowski, MC; Rosol, TJ; Woollett, LA; Weinstein, M; Cross, JC; Robinson, ML; Leone, G			Extra-embryonic function of Rb is essential for embryonic development and viability	NATURE			English	Article							RETINOBLASTOMA GENE; MOUSE PLACENTA; CHIMERIC MICE; CELLS; PROLIFERATION; MUTATION; PROTEIN; DIFFERENTIATION; EXPRESSION; APOPTOSIS	The retinoblastoma (Rb) gene was the first tumour suppressor identified(1). Inactivation of Rb in mice results in unscheduled cell proliferation, apoptosis and widespread developmental defects, leading to embryonic death by day 14.5 (refs 2-4). However, the actual cause of the embryonic lethality has not been fully investigated. Here we show that loss of Rb leads to excessive proliferation of trophoblast cells and a severe disruption of the normal labyrinth architecture in the placenta. This is accompanied by a decrease in vascularization and a reduction in placental transport function. We used two complementary techniques-tetraploid aggregation and conditional knockout strategies-to demonstrate that Rb-deficient embryos supplied with a wild-type placenta can be carried to term, but die soon after birth. Most of the neurological and erythroid abnormalities thought to be responsible for the embryonic lethality of Rb-null animals were virtually absent in rescued Rb-null pups. These findings identify and define a key function of Rb in extra-embryonic cell lineages that is required for embryonic development and viability, and provide a mechanism for the cell autonomous versus non-cell autonomous roles of Rb in development.	Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Childrens Res Inst, Div Mol & Human Genet, Columbus, OH 43205 USA; Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Calgary; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; University of Cincinnati	Leone, G (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA.		Cross, James/AAU-2973-2020; Wenzel, Pamela/AAJ-1944-2021; Thompson, Jessica/GXW-0323-2022; Wenzel, Pamela/A-2992-2010; de Bruin, Alain/AAL-9195-2020; Cross, James/F-4814-2011; Rosol, Thomas/G-9585-2011; Ostrowski, Michael/H-3108-2011	Cross, James/0000-0003-0956-9378; Wenzel, Pamela/0000-0002-4530-015X; Cross, James/0000-0003-0956-9378; Rosol, Thomas/0000-0003-3737-1190; de Bruin, Alain/0000-0001-8579-2649; Ostrowski, Michael/0000-0003-2948-6297				Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; FARIA TN, 1991, BIOL REPROD, V44, P327, DOI 10.1095/biolreprod44.2.327; Hogan B, 1994, MANIPULATING MOUSE E; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; Kurz H, 1999, ANAT EMBRYOL, V200, P335, DOI 10.1007/s004290050284; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; LINZER DIH, 1985, P NATL ACAD SCI USA, V82, P4356, DOI 10.1073/pnas.82.13.4356; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Marino S, 2000, GENE DEV, V14, P994; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	29	305	311	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					942	947		10.1038/nature01417	http://dx.doi.org/10.1038/nature01417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607001				2022-12-24	WOS:000181186900049
J	Smith, GCS; Pell, JP; Walsh, D				Smith, GCS; Pell, JP; Walsh, D			Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FACTOR-V-LEIDEN		Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh EH5 3SE, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Box 223, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Walsh, David/0000-0002-3390-5039; Pell, Jill/0000-0002-8898-7035				NESS RB, 1993, NEW ENGL J MED, V328, P1528, DOI 10.1056/NEJM199305273282104; Rosendaal FR, 1997, BLOOD, V89, P2817, DOI 10.1182/blood.V89.8.2817; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Souza SS, 1999, HUM REPROD, V14, P2448, DOI 10.1093/humrep/14.10.2448; Vaarala O, 1998, LUPUS, V7, pS132, DOI 10.1177/096120339800700229	5	45	45	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					423	424		10.1136/bmj.326.7386.423	http://dx.doi.org/10.1136/bmj.326.7386.423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595381	Bronze, Green Published			2022-12-24	WOS:000181318000018
J	Tanaka, K; Tengeiji, A; Kato, T; Toyama, N; Shionoya, M				Tanaka, K; Tengeiji, A; Kato, T; Toyama, N; Shionoya, M			A discrete self-assembled metal array in artificial DNA	SCIENCE			English	Article							BASE-PAIR; COMPLEXES	DNA has a structural basis to array functionalized building blocks. Here we report the synthesis of a series of artificial oligonucleotides, d(5'-GH(n)C-3') (n = 1 to 5), with hydroxypyridone nucleobases (H) as flat bidentate ligands. Right-handed double helices of the oligonucleotides, nCu(2+).d(5'-GHnC-3'), (n = 1 to 5), were quantitatively formed through copper ion (Cu2+)-mediated alternative base pairing (H-Cu2+-H), where the Cu2+ ions incorporated into each complex were aligned along the helix axes inside the duplexes with the Cu2+-Cu2+ distance of 3.7 +/- 0.1 angstroms. The Cu2+ ions were coupled ferromagnetically with one another through unpaired d electrons to form magnetic chains.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Inst Mol Sci, Okazaki, Aichi 4448585, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Shionoya, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.		Tanaka, Kentaro/I-7056-2014	Tanaka, Kentaro/0000-0002-6395-4536				Atwell S, 2001, J AM CHEM SOC, V123, P12364, DOI 10.1021/ja011822e; BERGSTROM DE, 2001, CURRENT PROTOCOLS NU; Finniss GM, 1996, ANGEW CHEM INT EDIT, V35, P2772, DOI 10.1002/anie.199627721; Kool ET, 2002, ACCOUNTS CHEM RES, V35, P936, DOI 10.1021/ar000183u; Lai SY, 1999, J AM CHEM SOC, V121, P250, DOI 10.1021/ja982065w; Meggers E, 2000, J AM CHEM SOC, V122, P10714, DOI 10.1021/ja0025806; Palmans R, 1996, J AM CHEM SOC, V118, P12647, DOI 10.1021/ja962491m; Tanaka K, 1999, J ORG CHEM, V64, P5002, DOI 10.1021/jo990326u; Tanaka K, 2002, J AM CHEM SOC, V124, P8802, DOI 10.1021/ja020510o; Tanaka K, 2002, J AM CHEM SOC, V124, P12494, DOI 10.1021/ja027175o; Weizman H, 2001, J AM CHEM SOC, V123, P3375, DOI 10.1021/ja005785n	11	453	457	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1212	1213		10.1126/science.1080587	http://dx.doi.org/10.1126/science.1080587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595687				2022-12-24	WOS:000181065500034
J	Butler, D				Butler, D			Ministers back gene-crop advisers	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					775	775		10.1038/421775b	http://dx.doi.org/10.1038/421775b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594469	Bronze			2022-12-24	WOS:000181044700009
J	Axtell, MJ; Staskawicz, BJ				Axtell, MJ; Staskawicz, BJ			Initiation of RPS2-specified disease resistance in Arabidopsis is coupled to the AvrRpt2-directed elimination of RIN4	CELL			English	Article							NUCLEOTIDE-BINDING SITE; AVIRULENCE GENE AVRRPT2; LEUCINE-RICH REPEATS; PSEUDOMONAS-SYRINGAE; PLASMA-MEMBRANE; PTO KINASE; BACTERIAL PATHOGENESIS; MUTATIONAL ANALYSIS; PLANT IMMUNITY; PROTEIN	Plants have evolved a sophisticated innate immune system to recognize invading pathogens and to induce a set of host defense mechanisms resulting in disease resistance. Pathogen recognition is often mediated by plant disease resistance (R) proteins that respond specifically to one or a few pathogen-derived molecules. This specificity has led to suggestions of a receptor-ligand mode of R protein function. Delivery of the bacterial effector protein AvrRpt2 by Pseudomonas syringae specifically induces disease resistance in Arabidopsis plants expressing the RPS2 R protein. We demonstrate that RPS2 physically interacts with Arabidopsis RIN4 and that AvrRpt2 causes the elimination of RIN4 during activation of the RPS2 pathway. AvrRpt2-mediated RIN4 elimination also occurs in the rps2, ndr1, and Atrar1 mutant backgrounds, demonstrating that this activity can be achieved independent of an RPS2-mediated signaling pathway. Therefore, we suggest that RPS2 initiates signaling based upon perception of RIN4 disappearance rather than direct recognition of AvrRpt2.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Staskawicz, BJ (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.							Ausubel FM, 1994, CURRENT PROTOCOLS MO; Axtell MJ, 2001, MOL PLANT MICROBE IN, V14, P181, DOI 10.1094/MPMI.2001.14.2.181; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Guttman DS, 2001, MOL PLANT MICROBE IN, V14, P145, DOI 10.1094/MPMI.2001.14.2.145; Harlow E, 1999, USING ANTIBODIES LAB; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Leister RT, 2000, PLANT J, V22, P345, DOI 10.1046/j.1365-313x.2000.00744.x; Leister RT, 1996, P NATL ACAD SCI USA, V93, P15497, DOI 10.1073/pnas.93.26.15497; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Muskett PR, 2002, PLANT CELL, V14, P979, DOI 10.1105/tpc.001040; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; Schneider DS, 2002, CELL, V109, P537, DOI 10.1016/S0092-8674(02)00764-X; Sedbrook JC, 2002, PLANT CELL, V14, P1635, DOI 10.1105/tpc.002360; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439	51	611	641	4	111	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					369	377		10.1016/S0092-8674(03)00036-9	http://dx.doi.org/10.1016/S0092-8674(03)00036-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581526	Bronze			2022-12-24	WOS:000181252200008
J	Bernhard, JM				Bernhard, JM			Potential symbionts in bathyal foraminifera	SCIENCE			English	Article									Univ S Carolina, Dept Environm Hlth Sci, Norman J Arnold Sch Publ Hlth, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bernhard, JM (corresponding author), Univ S Carolina, Dept Environm Hlth Sci, Norman J Arnold Sch Publ Hlth, Columbia, SC 29208 USA.		Bernhard, Joan/M-3260-2013	Bernhard, Joan/0000-0003-2121-625X				AHARON P, 2001, GEOL SOC AM ABSTR, V33, pA162; Bernhard JM, 1999, EARTH-SCI REV, V46, P149, DOI 10.1016/S0012-8252(99)00017-3; FENCHEL T, 1995, ECOLOGY EVOLUTION AN; Giere O, 1996, BIOSYST ECOL SER, P353; Grzymski J, 2002, LIMNOL OCEANOGR, V47, P1569, DOI 10.4319/lo.2002.47.6.1569; Van Dover C., 2000, ECOLOGY DEEP SEA HYD; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041	7	77	85	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					861	861		10.1126/science.1077314	http://dx.doi.org/10.1126/science.1077314			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574621				2022-12-24	WOS:000180830900042
J	Zalfa, F; Giorgi, M; Primerano, B; Moro, A; Di Penta, A; Reis, S; Oostra, B; Bagni, C				Zalfa, F; Giorgi, M; Primerano, B; Moro, A; Di Penta, A; Reis, S; Oostra, B; Bagni, C			The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at Synapses	CELL			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; BC200 RNA; RIBONUCLEOPROTEIN PARTICLE; CLINICAL PHENOTYPE; DENDRITIC LOCATION; KNOCKOUT MICE; CGG REPEAT; GENE; IDENTIFICATION	The Fragile X syndrome, which results from the absence of functional FMRP protein, is the most common heritable form of mental retardation. Here, we show that FMRP acts as a translational repressor of specific mRNAs at synapses. Interestingly, FMRP associates not only with these target mRNAs, but also with the dendritic, non-translatable RNA BC1. Blocking of BC1 inhibits the interaction of FMRP with its target mRNAs. Furthermore, BC1 binds directly to FMRP and can also associate, in the absence of any protein, with the mRNAs regulated by FMRP. This suggests a mechanism where BC1 could determine the specificity of FMRP function by linking the regulated mRNAs and FMRP. Thus, when FMRP is not present, loss of translational repression of specific mRNAs at synapses could result in synaptic dysfunction phenotype of Fragile X patients.	Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; IRCCS, Fdn Santa Lucia, Ist Neurosci Sperimentali, Rome, Italy; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	University of Rome Tor Vergata; IRCCS Santa Lucia; Erasmus University Rotterdam; Erasmus MC	Bagni, C (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Via Ric Sci, I-00133 Rome, Italy.	bagni@uniroma2.it	Zalfa, Francesca/J-7759-2018	Zalfa, Francesca/0000-0002-1922-9468; Bagni, Claudia/0000-0002-4419-210X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER; NICHD NIH HHS [5 R01 HD38038] Funding Source: Medline; Telethon [GGP02357] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BAKKER CE, 1994, CELL, V78, P23; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Cheng JG, 1997, NEUROSCI LETT, V224, P206, DOI 10.1016/S0304-3940(97)13471-1; Cheng JG, 1996, DNA CELL BIOL, V15, P549, DOI 10.1089/dna.1996.15.549; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Feng Y, 1997, J NEUROSCI, V17, P1539; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; HIRST M, 1995, AM J HUM GENET, V56, P67; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; MEIJER H, 1994, HUM MOL GENET, V3, P615; Mila M, 2000, MOL CELL PROBE, V14, P115, DOI 10.1006/mcpr.2000.0293; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Oostra BA, 2002, TRENDS MOL MED, V8, P102, DOI 10.1016/S1471-4914(02)02271-2; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Rozhdestvensky TS, 2001, RNA, V7, P722, DOI 10.1017/S1355838201002485; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang HD, 2002, J NEUROSCI, V22, P10232; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; WOHRLE D, 1992, AM J HUM GENET, V51, P299; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	62	518	541	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					317	327		10.1016/S0092-8674(03)00079-5	http://dx.doi.org/10.1016/S0092-8674(03)00079-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581522	Green Published, Bronze			2022-12-24	WOS:000181252200004
J	Westneat, MW; Betz, O; Blob, RW; Fezzaa, K; Cooper, WJ; Lee, WK				Westneat, MW; Betz, O; Blob, RW; Fezzaa, K; Cooper, WJ; Lee, WK			Tracheal respiration in insects visualized with synchrotron X-ray imaging	SCIENCE			English	Article							VENTILATION	Insects are known to exchange respiratory gases in their system of tracheal tubes by using either diffusion or changes in internal pressure that are produced through body motion or hemolymph circulation. However, the inability to see inside living insects has limited our understanding of their respiration mechanisms. We used a synchrotron beam to obtain x-ray videos of living, breathing insects. Beetles, crickets, and ants exhibited rapid cycles of tracheal compression and expansion in the head and thorax. Body movements and hemolymph circulation cannot account for these cycles; therefore, our observations demonstrate a previously unknown mechanism of respiration in insects analogous to the inflation and deflation of vertebrate lungs.	Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; Univ Kiel, Dept Zool, Kiel, Germany; Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; Argonne Natl Lab, Adv Photon Source, Expt Facilities Div, Argonne, IL 60439 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Field Museum of Natural History (Chicago); University of Kiel; Clemson University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Westneat, MW (corresponding author), Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA.	mwestneat@fieldmuseum.org	Lee, Wah-Keat/GRR-9734-2022	Cooper, W. James/0000-0003-4204-4266; Blob, Richard/0000-0001-5026-343X				BRAINERD EL, 1989, SCIENCE, V246, P1593, DOI 10.1126/science.246.4937.1593; Carrier DR, 1996, J EXP BIOL, V199, P1455; Chapman R.F., 2012, INSECTS STRUCTURE FU; Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023; HILL AV, 1948, J PHYSIOL-LONDON, V107, P518, DOI 10.1113/jphysiol.1948.sp004296; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Komai Y, 1998, J EXP BIOL, V201, P2359; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P95, DOI 10.1007/BF01722125; Mill P.J., 1985, P517; Miller P.L., 1981, P367; Schmidt-Nielsen K, 1979, ANIMAL PHYSL; Slama K, 1999, ANN ENTOMOL SOC AM, V92, P916, DOI 10.1093/aesa/92.6.916; SLAMA K, 1988, BIOL BULL-US, V175, P289, DOI 10.2307/1541570; Tartes U, 2000, PHYSIOL ENTOMOL, V25, P151, DOI 10.1046/j.1365-3032.2000.00180.x; WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747; Wasserthal LT, 1996, ADV INSECT PHYSIOL, V26, P297, DOI 10.1016/S0065-2806(08)60033-8; WEISFOGH T, 1964, J EXP BIOL, V41, P207; Westneat MW, 1998, J EXP BIOL, V201, P3041	18	180	189	3	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					558	560		10.1126/science.1078008	http://dx.doi.org/10.1126/science.1078008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543973				2022-12-24	WOS:000180559800047
J	Lee, BH; Amon, A				Lee, BH; Amon, A			Role of Polo-like kinase CDC5 in programming meiosis I chromosome segregation	SCIENCE			English	Article							SISTER-CHROMATID SEPARATION; SINGLE-DIVISION MEIOSIS; COHESIN SUBUNIT SCC1; SACCHAROMYCES-CEREVISIAE; PRECOCIOUS SEPARATION; BUDDING YEAST; CELL-CYCLE; ANAPHASE; CENTROMERES; CLEAVAGE	Meiosis is a specialized cell division in which two chromosome segregation phases follow a single DNA replication phase. The budding yeast Polo-like kinase Cdc5 was found to be instrumental in establishing the meiosis I chromosome segregation program. Cdc5 was required to phosphorylate and remove meiotic cohesin from chromosomes. Furthermore, in the absence of CDC5 kinetochores were bioriented during meiosis I, and Mam1, a protein essential for coorientation, failed to associate with kinetochores. Thus, sister-kinetochore coorientation and chromosome segregation during meiosis I are coupled through their dependence on CDC5.	MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, Howard Hughes Med Inst, E17-233,40 Ames St, Cambridge, MA 02139 USA.			Amon, Angelika/0000-0001-9837-0314; Lee, Brian/0000-0003-2497-5139	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BUONOMO SB, IN PRESS DEV CELL; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Goshima G, 2001, GENES CELLS, V6, P765, DOI 10.1046/j.1365-2443.2001.00464.x; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Herrmann S, 1998, CHROMOSOMA, V107, P440, DOI 10.1007/PL00013778; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee B, 2001, CURR OPIN CELL BIOL, V13, P770, DOI 10.1016/S0955-0674(00)00282-9; Lee B.H., UNPUB; Lee BH, 2002, GENE DEV, V16, P1672, DOI 10.1101/gad.989302; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; MARSTON A, IN PRESS DEV CELL; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; SHARON G, 1990, GENETICS, V125, P487; SHARON G, 1990, GENETICS, V125, P475; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831	32	186	192	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					482	486		10.1126/science.1081846	http://dx.doi.org/10.1126/science.1081846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12663816				2022-12-24	WOS:000182295900039
J	Scorrano, L; Oakes, SA; Opferman, JT; Cheng, EH; Sorcinelli, MD; Pozzan, T; Korsmeyer, SJ				Scorrano, L; Oakes, SA; Opferman, JT; Cheng, EH; Sorcinelli, MD; Pozzan, T; Korsmeyer, SJ			BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis	SCIENCE			English	Article							CYTOCHROME-C; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; PERMEABILITY TRANSITION; BCL-2; CALCIUM; EXPRESSION; ACTIVATION; MOLECULES; CHANNELS	BAX and BAK are "multidomain" proapoptotic proteins that initiate mitochondrial dysfunction but also localize to the endoplasmic reticulum (ER). Mouse embryonic. broblasts deficient for BAX and BAK (DKO cells) were found to have a reduced resting concentration of calcium in the ER ([Ca2+](er)) that results in decreased uptake of Ca2+ by mitochondria after Ca2+ release from the ER. Expression of SERCA (sarcoplasmic-endoplasmic reticulum Ca2+ adenosine triphosphatase) corrected [Ca2+](er) and mitochondrial Ca2+ uptake in DKO cells, restoring apoptotic death in response to agents that release Ca2+ from intracellular stores (such as arachidonic acid, C-2-ceramide, and oxidative stress). In contrast, targeting of BAX to mitochondria selectively restored apoptosis to "BH3-only" signals. A third set of stimuli, including many intrinsic signals, required both ER-released Ca2+ and the presence of mitochondrial BAX or BAK to fully restore apoptosis. Thus, BAX and BAK operate in both the ER and mitochondria as an essential gateway for selected apoptotic signals.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA; Venetian Inst Mol Med, I-35121 Padua, Italy; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Veneto Institute Molecular Medicine; University of Padua	Korsmeyer, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu	Scorrano, Luca/K-3967-2019; Opferman, Joseph T/M-5331-2018; Scorrano, Luca/A-6652-2008	Scorrano, Luca/0000-0002-8515-8928; Opferman, Joseph T/0000-0002-1147-5621; Scorrano, Luca/0000-0002-8515-8928	NATIONAL CANCER INSTITUTE [R37CA050239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NCI NIH HHS [R37CA50239] Funding Source: Medline; NHLBI NIH HHS [T32HL07627] Funding Source: Medline; Telethon [TCP02016] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Decaudin D, 1997, CANCER RES, V57, P62; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Gajkowska B, 2001, CELL BIOL INT, V25, P725, DOI 10.1006/cbir.2001.0768; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; OAKES SA, UNPUB; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2	31	1154	1208	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					135	139		10.1126/science.1081208	http://dx.doi.org/10.1126/science.1081208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12624178				2022-12-24	WOS:000181988900050
J	Li, YY; Cunin, F; Link, JR; Gao, T; Betts, RE; Reiver, SH; Chin, V; Bhatia, SN; Sailor, MJ				Li, YY; Cunin, F; Link, JR; Gao, T; Betts, RE; Reiver, SH; Chin, V; Bhatia, SN; Sailor, MJ			Polymer replicas of photonic porous silicon for sensing and drug delivery applications	SCIENCE			English	Article							OPTICAL-PROPERTIES; FILTERS	Elaborate one-dimensional photonic crystals are constructed from a variety of organic and biopolymers, which can be dissolved or melted, by templating the solution-cast or injection-molded materials in porous silicon or porous silicon dioxide multilayer (rugate dielectric mirror) structures. After the removal of the template by chemical dissolution, the polymer castings replicate the photonic features and the nanostructure of the master. We demonstrate that these castings can be used as vapor sensors, as deformable and tunable optical filters, and as self-reporting, bioresorbable materials.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Li, YY (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,Dept 0358, La Jolla, CA 92093 USA.		Sailor, Michael J/H-9044-2017; Li, Yang Yang/J-9243-2012	Sailor, Michael J/0000-0002-4809-9826; LI, Yang Yang/0000-0003-4153-9558				Allcock P, 2001, J APPL PHYS, V90, P5052, DOI 10.1063/1.1412268; Berger MG, 1997, THIN SOLID FILMS, V297, P237, DOI 10.1016/S0040-6090(96)09361-3; Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702; Gao J, 2002, LANGMUIR, V18, P2229, DOI 10.1021/la015568f; HALIMAOUI A, 1997, PROPERTIES POROUS SI, P12; Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m; Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h; Lehmann V, 2001, APPL PHYS LETT, V78, P589, DOI 10.1063/1.1334943; Matthias S, 2002, ADV MATER, V14, P1618, DOI 10.1002/1521-4095(20021118)14:22<1618::AID-ADMA1618>3.0.CO;2-A; Moller K, 1998, CHEM MATER, V10, P2950, DOI 10.1021/cm980243e; Pavesi L, 1997, SEMICOND SCI TECH, V12, P570, DOI 10.1088/0268-1242/12/5/009; Polarz S, 2002, CHEM COMMUN, P2593, DOI 10.1039/b205708p; Reese CE, 2001, ANAL CHEM, V73, P5038, DOI 10.1021/ac010667j; Schmedake TA, 2002, ADV MATER, V14, P1270, DOI 10.1002/1521-4095(20020916)14:18<1270::AID-ADMA1270>3.0.CO;2-R; Snow PA, 1999, J APPL PHYS, V86, P1781, DOI 10.1063/1.370968; Thonissen M., 1997, PROPERTIES POROUS SI, V18, P30; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; VINCENT G, 1994, APPL PHYS LETT, V64, P2367, DOI 10.1063/1.111982; Wirtz M, 2002, CHEM-EUR J, V8, P3573; Xu XL, 2002, J AM CHEM SOC, V124, P13864, DOI 10.1021/ja026901k; Zangooie S, 1997, SENSOR ACTUAT B-CHEM, V43, P168, DOI 10.1016/S0925-4005(97)00148-2	21	341	395	4	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2003	299	5615					2045	2047		10.1126/science.1081298	http://dx.doi.org/10.1126/science.1081298			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663921				2022-12-24	WOS:000181834200047
J	Iizuka, N; Oka, M; Yamada-Okabe, H; Nishida, M; Maeda, Y; Mori, N; Takao, T; Tamesa, T; Tangoku, A; Tabuchi, H; Hamada, K; Nakayama, H; Ishitsuka, H; Miyamoto, T; Hirabayashi, A; Uchimura, S; Hamamoto, Y				Iizuka, N; Oka, M; Yamada-Okabe, H; Nishida, M; Maeda, Y; Mori, N; Takao, T; Tamesa, T; Tangoku, A; Tabuchi, H; Hamada, K; Nakayama, H; Ishitsuka, H; Miyamoto, T; Hirabayashi, A; Uchimura, S; Hamamoto, Y			Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection	LANCET			English	Article							GENE-EXPRESSION PATTERNS; CDNA MICROARRAY; CANCER; CLASSIFICATION; IDENTIFICATION	Background Hepatocellular carcinoma has a poor prognosis because of the high intrahepatic recurrence rate. There are technological limitations to traditional methods such as TNM staging for accurate prediction of recurrence, suggesting that new techniques are needed. Methods We investigated mRNA expression profiles in tissue specimens from a training set, comprising 33 patients with hepatocellular carcinoma, with high-density oligonucleotide microarrays representing about 6000 genes. We used this training set in a supervised learning manner to construct a predictive system, consisting of 12 genes, with the Fisher linear classifier. We then compared the predictive performance of our system with that of a predictive system with a support vector machine (SVM-based system) on a blinded set of samples from 27 newly enrolled patients. Findings Early intrahepatic recurrence within 1 year after curative surgery occurred in 12 (36%) and eight (30%) patients in the training and blinded sets, respectively. Our system correctly predicted early intrahepatic recurrence or non-recurrence in 25 (93%) of 27 samples in the blinded set and had a positive predictive value of 88% and a negative predictive value of 95%. By contrast, the SVM-based system predicted early intrahepatic recurrence or non-recurrence correctly in only 16 (60%) individuals in the blinded set, and the result yielded a positive predictive value of only 38% and a negative predictive value of 79%. Interpretation Our system predicted early intrahepatic recurrence or non-recurrence for patients with hepatocellular carcinoma much more accurately than the SVM-based system, suggesting that our system could serve as a new method for characterising the metastatic potential of hepatocellular carcinoma.	Yamaguchi Univ, Sch Med, Dept Surg 2, Yamaguchi 7558505, Japan; Yamaguchi Univ, Sch Med, Dept Bioregulatory Funct, Yamaguchi 7558505, Japan; Yamaguchi Univ, Fac Engn, Dept Comp Sci & Syst Engn, Yamaguchi 7558505, Japan; Nippon Roche Res Ctr, Dept Oncol, Kanagawa, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; Roche Holding	Oka, M (corresponding author), Yamaguchi Univ, Sch Med, Dept Surg 2, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.							Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; CABRERA T, 1995, SCAND J IMMUNOL, V41, P398, DOI 10.1111/j.1365-3083.1995.tb03584.x; DeRisi J, 1996, NAT GENET, V14, P457; Duda R. O., 2001, PATTERN CLASSIFICATI, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evron E, 2001, CANCER RES, V61, P2782; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; HSU HC, 1993, CANCER RES, V53, P4691; IIZUKA N, 1995, CANCER RES, V55, P652; Iizuka N, 2002, CANCER RES, V62, P3939; IZUMI R, 1994, GASTROENTEROLOGY, V106, P720, DOI 10.1016/0016-5085(94)90707-2; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kell DB, 2000, TRENDS BIOTECHNOL, V18, P93, DOI 10.1016/S0167-7799(99)01407-9; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Luo J, 2001, CANCER RES, V61, P4683; Mathew J, 1996, J PATHOL, V179, P74; Okabe H, 2001, CANCER RES, V61, P2129; Okuda K, 2000, J HEPATOL, V32, P225, DOI 10.1016/S0168-8278(00)80428-6; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shirota Y, 2001, HEPATOLOGY, V33, P832, DOI 10.1053/jhep.2001.23003; Sobin L, 2002, TNM CLASSIFICATION M, P81; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Xu L, 2001, CANCER RES, V61, P3176	31	413	448	1	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 15	2003	361	9361					923	929		10.1016/S0140-6736(03)12775-4	http://dx.doi.org/10.1016/S0140-6736(03)12775-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648972				2022-12-24	WOS:000181741600011
J	Acharya, U; Patel, S; Koundakjian, E; Nagashima, K; Han, X; Acharya, JK				Acharya, U; Patel, S; Koundakjian, E; Nagashima, K; Han, X; Acharya, JK			Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration	SCIENCE			English	Article							VISUAL-SYSTEM; DROSOPHILA; ARRESTIN; PROTEIN; ENDOCYTOSIS; RHODOPSIN; TRANSDUCTION; APOPTOSIS; DYNAMIN; ROLES	Mutations in proteins of the Drosophila phototransduction cascade, a prototypic guanine nucleotide-binding protein-coupled receptor signaling system, lead to retinal degeneration and have been used as models to understand human degenerative disorders. Here, modulating the sphingolipid biosynthetic pathway rescued retinal degeneration in Drosophila mutants. Targeted expression of Drosophila neutral ceramidase rescued retinal degeneration in arrestin and phospholipase C mutants. Decreasing flux through the de novo sphingolipid biosynthetic pathway also suppressed degeneration in these mutants. Both genetic backgrounds modulated the endocytic machinery because they suppressed defects in a dynamin mutant. Suppression of degeneration in arrestin mutant flies expressing ceramidase correlated with a decrease in ceramide levels. Thus, enzymes of sphingolipid metabolism may be suitable targets in the therapeutic management of retinal degeneration.	NCI, Regulat Cell Growth Lab, Frederick, MD 21702 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Sci Applicat Int Corp, Electron Microscopy Facil Image Anal Lab, Frederick, MD 21702 USA; Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; University of California System; University of California San Diego; Science Applications International Corporation (SAIC); Washington University (WUSTL)	Acharya, JK (corresponding author), NCI, Regulat Cell Growth Lab, Frederick, MD 21702 USA.			Acharya, Jairaj/0000-0001-7366-4228	NATIONAL CANCER INSTITUTE [ZIABC010331, Z01BC010331] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Han XL, 2002, ANAL BIOCHEM, V302, P199, DOI 10.1006/abio.2001.5536; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Nikolova-Karakashian M, 2000, METHOD ENZYMOL, V311, P194; Orem NR, 2002, VISION RES, V42, P497, DOI 10.1016/S0042-6989(01)00229-2; OTOUSA JE, 1997, PROGR RETINAL EYE RE, P691; POODRY CA, 1990, DEV BIOL, V138, P464, DOI 10.1016/0012-1606(90)90212-2; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Wang Q, 2001, Ophthalmic Genet, V22, P133, DOI 10.1076/opge.22.3.133.2224; ZERR DM, 1990, J NEUROSCI, V10, P2749	23	110	112	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1740	1743		10.1126/science.1080549	http://dx.doi.org/10.1126/science.1080549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637747				2022-12-24	WOS:000181519500048
J	Gregg, EW; Gerzoff, RB; Thompson, TJ; Williamson, DF				Gregg, EW; Gerzoff, RB; Thompson, TJ; Williamson, DF			Intentional weight loss and death in overweight and obese US adults 35 years of age and older	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ALL-CAUSE MORTALITY; BODY-WEIGHT; LIFE-STYLE; WOMEN; DIET; MEN; INTERVENTION; VARIABILITY; TRIAL	Background: Although weight loss improves risk factors for cardiovascular and metabolic disease, it is unclear whether intentional weight loss reduces mortality rates. Objective: To examine the relationships among intention to lose weight, weight loss, and all-cause mortality. Design: Prospective cohort study using a probability sample of the U.S. population. Setting: Interviewer-administered survey. Participants: 6391 overweight and obese persons (body mass index greater than or equal to 25 kg/m(2)) who were at least 35 years of age. Measurements: Intention to lose weight and weight change during the past year were assessed by self-report in 1989. Vital status was followed for 9 years. Hazard rate ratios (HRRs) were adjusted for age, sex, ethnicity, education, smoking, health status, health care utilization, and initial body mass index. Results: Compared with persons not trying to lose weight and reporting no weight change, those reporting intentional weight loss had a 24% lower mortality rate (HRR, 0.76 [95% CI, 0.60 to 0.97]) and those with unintentional weight loss had a 31% higher mortality rate (HRR, 1.31 [CI, 1.01 to 1.70]). However, mortality rates were lower in persons who reported trying to lose weight than those in not trying to lose weight, independent of actual weight change. Compared with persons not trying to lose weight and reporting no weight change, persons trying to lose weight had the following HRRs: no weight change, 0.80 (CI, 0.65 to 0.99); gained weight, 0.94 (CI, 0.65 to 1.37); and lost weight, 0.76 (CI, 0.60 to 0.97). Conclusions: Attempted weight loss is associated with lower all-cause mortality, independent of weight change. Self-reported intentional weight loss is associated with lower mortality rates, and weight loss is associated with higher mortality rates only if it is unintentional.	Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov		Gregg, Edward/0000-0003-2381-6822				ANDRES R, 1993, ANN INTERN MED, V119, P737, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00022; BLAIR SN, 1993, ANN INTERN MED, V119, P749, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00024; Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; FRENCH SA, 1995, INT J OBESITY, V19, P22; French SA, 1999, AM J EPIDEMIOL, V149, P504, DOI 10.1093/oxfordjournals.aje.a009844; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Lee IM, 1996, NUTR REV, V54, pS116; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; MELTZER AA, 1995, AM J EPIDEMIOL, V142, P1039, DOI 10.1093/oxfordjournals.aje.a117557; Meltzer AA, 1996, OBES RES, V4, P479, DOI 10.1002/j.1550-8528.1996.tb00257.x; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; *NAT CTR HLTH STAT, 1993, NAT CTR HLTH STAT 10, V3; *NAT CTR HLTH STAT, 1999, NAT HLTH INT SURV MU; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; PISUNYER FX, 1993, ANN INTERN MED, V119, P722, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00019; SINGH RB, 1992, BRIT MED J, V304, P1015, DOI 10.1136/bmj.304.6833.1015; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Wannamethee SG, 2000, AM J EPIDEMIOL, V151, P667, DOI 10.1093/oxfordjournals.aje.a010261; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P731, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00021; Williamson DF, 1999, AM J EPIDEMIOL, V149, P491, DOI 10.1093/oxfordjournals.aje.a009843; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680	29	169	175	5	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					383	389		10.7326/0003-4819-138-5-200303040-00007	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614090				2022-12-24	WOS:000181257300003
J	Molinari, M; Calanca, V; Galli, C; Lucca, P; Paganetti, P				Molinari, M; Calanca, V; Galli, C; Lucca, P; Paganetti, P			Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle	SCIENCE			English	Article							MANNOSIDASE-LIKE PROTEIN; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; QUALITY-CONTROL; DEGRADATION; DEFICIENT; YEAST	The mechanisms that determine how folding attempts are interrupted to target folding-incompetent proteins for endoplasmic reticulum-associated degradation (ERAD) are poorly defined. Here the alpha-mannosidase I-like protein EDEM was shown to extract misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle. EDEM overexpression resulted in faster release of folding-incompetent proteins from the calnexin cycle and earlier onset of degradation, whereas EDEM down-regulation prolonged folding attempts and delayed ERAD. Up-regulation of EDEM during ER stress may promote cell recovery by clearing the calnexin cycle and by accelerating ERAD of terminally misfolded polypeptides.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Novartis Pharma AG, Nervous Syst, CH-4002 Basel, Switzerland	Universita della Svizzera Italiana; Novartis	Molinari, M (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.		Paganetti, Paolo/AAF-8039-2020; Molinari, Maurizio/N-2587-2019	Molinari, Maurizio/0000-0002-7636-5829; Paganetti, Paolo/0000-0003-1896-6324				Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 2001, EMBO REP, V2, P423; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; ORA A, 1995, J BIOL CHEM, V270, P26060, DOI 10.1074/jbc.270.44.26060; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; RAY MK, 1991, J BIOL CHEM, V266, P22818	13	359	380	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1397	1400		10.1126/science.1079474	http://dx.doi.org/10.1126/science.1079474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610306				2022-12-24	WOS:000181192300053
J	Horrobin, DF				Horrobin, DF			Are large clinical trials in rapidly lethal diseases usually unethical?	LANCET			English	Editorial Material							MANTLE CELL LYMPHOMA; TRANSLATION INITIATION; INHIBITION		Laxdale Ltd, Stirling FK7 9JQ, Scotland		Horrobin, DF (corresponding author), Laxdale Ltd, Kings Pk House,Laurethill Business Pk, Stirling FK7 9JQ, Scotland.							Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; Dreyling MH, 1997, CANCER RES, V57, P4608; Edwards SJL, 1997, LANCET, V350, P804, DOI 10.1016/S0140-6736(97)02290-3; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; HORROBIN DF, 2002, BRIT MED J, V325, pA491; HORROBIN DF, IN PRESS MED HYPOTH; Hughes JR, 2002, JAMA-J AM MED ASSOC, V288, P2118; Janosky JE, 2002, JAMA-J AM MED ASSOC, V288, P2118, DOI 10.1001/jama.288.17.2118; Lilford RJ, 2002, JAMA-J AM MED ASSOC, V288, P2118; Oka K, 1996, LEUKEMIA LYMPHOMA, V21, P37, DOI 10.3109/10428199609067577; Palakurthi SS, 2000, CANCER RES, V60, P2919; Palakurthi SS, 2001, CANCER RES, V61, P6213; RIMOKH R, 1994, BLOOD, V83, P3689	14	41	42	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					695	697		10.1016/S0140-6736(03)12571-8	http://dx.doi.org/10.1016/S0140-6736(03)12571-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12611394				2022-12-24	WOS:000181129500026
J	Karlsson, A; Parales, JV; Parales, RE; Gibson, DT; Eklund, H; Ramaswamy, S				Karlsson, A; Parales, JV; Parales, RE; Gibson, DT; Eklund, H; Ramaswamy, S			Crystal structure of naphthalene dioxygenase: Side-on binding of dioxygen to iron	SCIENCE			English	Article							SP STRAIN NCIB-9816; PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; SOLUBLE METHANE MONOOXYGENASE; 1,2-DIOXYGENASE; ACTIVATION; COMPONENT; OXIDATION; DIHYDROXYLATION; FERREDOXINNAP; PURIFICATION	Binding of oxygen to iron is exploited in several biological and chemical processes. Although computational and spectroscopic results have suggested side-on binding, only end-on binding of oxygen to iron has been observed in crystal structures. We have determined structures of naphthalene dioxygenase that show a molecular oxygen species bound to the mononuclear iron in a side-on fashion. In a complex with substrate and dioxygen, the dioxygen molecule is lined up for an attack on the double bond of the aromatic substrate. The structures reported here provide the basis for a reaction mechanism and for the high stereospecificity of the reaction catalyzed by naphthalene dioxygenase.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Swedish Univ Agr Sci, Ctr Biomed, Dept Mol Biol, S-75124 Uppsala, Sweden; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Ctr Biocatalysis & Bioproc, Iowa City, IA 52242 USA	University of Iowa; Swedish University of Agricultural Sciences; University of Iowa; University of Iowa	Ramaswamy, S (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.		Karlsson, Andreas/AAD-1984-2019; Subramanian, Ramaswamy/Q-8671-2019; ID, IMCACAT/D-5867-2014	Subramanian, Ramaswamy/0000-0002-6709-190X; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029909, R01GM062904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29909, GM62904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD S, 1988, INORG CHEM, V27, P2230, DOI 10.1021/ic00286a006; Boyd DR, 1998, NAT PROD REP, V15, P309; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Chen K, 1999, ANGEW CHEM INT EDIT, V38, P2227, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2227::AID-ANIE2227>3.0.CO;2-B; Chen K, 2002, J AM CHEM SOC, V124, P3026, DOI 10.1021/ja0120025; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; HAIGLER BE, 1990, J BACTERIOL, V172, P465, DOI 10.1128/JB.172.1.465-468.1990; Harris DL, 2001, CURR OPIN CHEM BIOL, V5, P724, DOI 10.1016/S1367-5931(01)00272-1; Hudlicky T, 1999, ALDRICHIM ACTA, V32, P35; JEFFREY AM, 1975, BIOCHEMISTRY-US, V14, P575, DOI 10.1021/bi00674a018; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; LIPSCOMB JD, 1994, ANNU REV MICROBIOL, V48, P371, DOI 10.1146/annurev.mi.48.100194.002103; MATHER F, 2002, J AM CHEM SOC, V124, P4966; Neese F, 1998, J AM CHEM SOC, V120, P12829, DOI 10.1021/ja981561h; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Poulos TL, 1995, CURR OPIN STRUC BIOL, V5, P767, DOI 10.1016/0959-440X(95)80009-3; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Resnick SM, 1996, J IND MICROBIOL BIOT, V17, P438, DOI 10.1007/BF01574775; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wolfe MD, 2003, J BIOL CHEM, V278, P829, DOI 10.1074/jbc.M209604200; Wolfe MD, 2002, BIOCHEMISTRY-US, V41, P9611, DOI 10.1021/bi025912n; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200	30	365	370	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1039	1042		10.1126/science.1078020	http://dx.doi.org/10.1126/science.1078020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586937				2022-12-24	WOS:000180960000039
J	Burke, JP				Burke, JP			Infection control - A problem for patient safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIBIOTIC-PROPHYLAXIS; EPIDEMIOLOGY		Latter Day St Hosp, Dept Clin Epidemiol & Infect Dis, Salt Lake City, UT 84143 USA; Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Burke, JP (corresponding author), Latter Day St Hosp, Dept Clin Epidemiol & Infect Dis, Salt Lake City, UT 84143 USA.							[Anonymous], 1996, Am J Infect Control, V24, P380; BURKE JP, 1971, NEW ENGL J MED, V284, P115, DOI 10.1056/NEJM197101212840301; BURKE JP, 1983, AM J INFECT CONTROL, V11, P165, DOI 10.1016/0196-6553(83)90076-7; BURKE JP, 1991, J HOSP INFECT, V18, P424, DOI 10.1016/0195-6701(91)90052-A; Burke JP, 2001, CLIN INFECT DIS, V33, pS78, DOI 10.1086/321861; Calfee DP, 2002, INFECT CONT HOSP EP, V23, P407, DOI 10.1086/502077; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; CLASSEN DC, 1992, JAMA-J AM MED ASSOC, V267, P1922; Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Farr BM, 2000, INFECT CONT HOSP EP, V21, P411, DOI 10.1086/501783; Fleming CA, 2000, LUNG BIOL HEALTH DIS, V150, P53; GARIBALDI RA, 1974, NEW ENGL J MED, V291, P215, DOI 10.1056/NEJM197408012910501; Gaynes R, 2001, EMERG INFECT DIS, V7, P295, DOI 10.3201/eid0702.010230; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HUNT TK, 1981, AM J MED, V70, P712, DOI 10.1016/0002-9343(81)90602-1; Jarvis WR, 2001, EMERG INFECT DIS, V7, P170, DOI 10.3201/eid0702.010202; JARVIS WR, 2001, SEMIN INFECT CONTROL, V1, P74; KRITCHEVSKY SB, 1995, INFECT CONT HOSP EP, V16, P33; LANGMUIR AD, 1980, PUBLIC HEALTH REP, V95, P470; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LEDERBERG J, 1992, EMERGING INFECT MICR, P121; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OLSEN MA, 2002, SEMIN INFECT CONTROL, V2, P26; Peterson LR, 2002, J CLIN MICROBIOL, V40, P1, DOI 10.1128/JCM.40.1.1-4.2002; Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217; Pittet D, 2000, LANCET, V356, P2196; Platt R, 2002, INFECT CONT HOSP EP, V23, P361, DOI 10.1086/502066; ROTHMAN KJ, 1985, NEW ENGL J MED, V313, P258, DOI 10.1056/NEJM198507253130409; Scheckler WE, 1998, INFECT CONT HOSP EP, V19, P114; SCHECKLER WE, 2002, SEMIN INFECT CONTROL, V2, P81; Silver A, 1996, AM J SURG, V171, P548, DOI 10.1016/S0002-9610(96)00036-0; Stone PW, 2002, AM J INFECT CONTROL, V30, P145, DOI 10.1067/mic.2002.121099; Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320; Weinstein RA, 2001, NEW ENGL J MED, V344, P1544, DOI 10.1056/NEJM200105173442009; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; 2001, EVID REP TECHNOL ASS, V43, P1; 2000, MMWR MORB MORTAL WKL, V49, P149; 1992, MMWR MORB MORTAL WKL, V41, P783; 2000, MMWR MORB MORTAL WKL, V49, P189	41	684	722	3	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					651	656		10.1056/NEJMhpr020557	http://dx.doi.org/10.1056/NEJMhpr020557			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584377				2022-12-24	WOS:000180912900013
J	Herz, J; Marschang, P				Herz, J; Marschang, P			Coaxing the LDL receptor family into the fold	CELL			English	Review							TYROSINE PHOSPHORYLATION; LIPOPROTEIN; PROTEIN; DOMAIN; HYPERCHOLESTEROLEMIA; CHAPERONE	Low-density-lipoprotein (LDL) receptor family members control diverse developmental and physiological pathways. In this issue of Cell, both Culi and Mann and Hsieh et al. report on Boca/MESD, a highly conserved chaperone required for transport of LDLR family proteins to the cell surface. Together with recent insights into the atomic structure of the LDL receptor, they shed new light on the synthesis and trafficking of this important class of multifunctional receptors.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Marschang, Peter/0000-0002-8239-3447	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Simmons T, 1997, J BIOL CHEM, V272, P25531, DOI 10.1074/jbc.272.41.25531; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Swertfeger DK, 2002, J BIOL CHEM, V277, P4141, DOI 10.1074/jbc.M109124200; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1	20	59	63	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					289	292		10.1016/S0092-8674(03)00073-4	http://dx.doi.org/10.1016/S0092-8674(03)00073-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581519	Bronze			2022-12-24	WOS:000181252200001
J	Nisoli, E; Clementi, E; Paolucci, C; Cozzi, V; Tonello, C; Sciorati, C; Bracale, R; Valerio, A; Francolini, M; Moncada, S; Carruba, MO				Nisoli, E; Clementi, E; Paolucci, C; Cozzi, V; Tonello, C; Sciorati, C; Bracale, R; Valerio, A; Francolini, M; Moncada, S; Carruba, MO			Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide	SCIENCE			English	Article							RECEPTOR-GAMMA COACTIVATOR-1; NECROSIS-FACTOR-ALPHA; SYNTHASE; GENE; DIFFERENTIATION; THERMOGENESIS; ADIPOCYTES; ACTIVATION; EXPRESSION; NUCLEAR	Nitric oxide was found to trigger mitochondrial biogenesis in cells as diverse as brown adipocytes and 3T3-L1, U937, and HeLa cells. This effect of nitric oxide was dependent on guanosine 3',5'-monophosphate (cGMP) and was mediated by the induction of peroxisome proliferator-activated receptor gamma coactivator 1alpha, a master regulator of mitochondrial biogenesis. Moreover, the mitochondrial biogenesis induced by exposure to cold was markedly reduced in brown adipose tissue of endothelial nitric oxide synthase null-mutant (eNOS(-/-)) mice, which had a reduced metabolic rate and accelerated weight gain as compared to wild-type mice. Thus, a nitric oxide-cGMP-dependent pathway controls mitochondrial biogenesis and body energy balance.	Univ Milan, L Sacco Hosp Vialba, Dept Preclin Sci, Ctr Study & Res Obes, I-20157 Milan, Italy; Ist Auxol Italiano, I-20149 Milan, Italy; Ist Sci San Raffaele, DIBIT H, I-20132 Milan, Italy; Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy; Univ Brescia, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; CNR, Inst Neurosci, Cellular & Mol Pharmacol Sect, I-20129 Milan, Italy; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of Milan; Luigi Sacco Hospital; IRCCS Istituto Auxologico Italiano; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Calabria; University of Brescia; Consiglio Nazionale delle Ricerche (CNR); University of London; University College London	Nisoli, E (corresponding author), Univ Milan, L Sacco Hosp Vialba, Dept Preclin Sci, Ctr Study & Res Obes, I-20157 Milan, Italy.	enzo.nisoli@unimi.it	Valerio, Alessandra/B-3413-2009; Nisoli, Enzo/D-6526-2014; sciorati, clara/K-4823-2016	Valerio, Alessandra/0000-0001-5844-2256; Nisoli, Enzo/0000-0002-6670-1630; Carruba, Michele/0000-0003-4589-387X; FRANCOLINI, MAURA/0000-0002-3126-1575; BRACALE, Renata/0000-0003-3650-7033; sciorati, clara/0000-0003-2030-9366				Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; De Nadai C, 2000, P NATL ACAD SCI USA, V97, P5480, DOI 10.1073/pnas.070062397; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Giordano A, 2002, FEBS LETT, V514, P135, DOI 10.1016/S0014-5793(02)02245-7; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HIMMSHAGEN J, 1995, P SOC EXP BIOL MED, V208, P159, DOI 10.3181/00379727-208-43847A; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; NECHAD M, 1983, EXP CELL RES, V149, P119, DOI 10.1016/0014-4827(83)90385-3; Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751; Nisoli E, 1998, BRIT J PHARMACOL, V125, P888, DOI 10.1038/sj.bjp.0702131; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	20	968	1024	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					896	899		10.1126/science.1079368	http://dx.doi.org/10.1126/science.1079368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574632				2022-12-24	WOS:000180830900054
J	Torchin, ME; Lafferty, KD; Dobson, AP; McKenzie, VJ; Kuris, AM				Torchin, ME; Lafferty, KD; Dobson, AP; McKenzie, VJ; Kuris, AM			Introduced species and their missing parasites	NATURE			English	Article							POPULATION INTERACTIONS; STABILITY	Damage caused by introduced species results from the high population densities and large body sizes that they attain in their new location(1-4). Escape from the effects of natural enemies is a frequent explanation given for the success of introduced species(5,6). Because some parasites can reduce host density(7-13) and decrease body size(14), an invader that leaves parasites behind and encounters few new parasites can experience a demographic release and become a pest(4,15). To test whether introduced species are less parasitized, we have compared the parasites of exotic species in their native and introduced ranges, using 26 host species of molluscs, crustaceans, fishes, birds, mammals, amphibians and reptiles. Here we report that the number of parasite species found in native populations is twice that found in exotic populations. In addition, introduced populations are less heavily parasitized (in terms of percentage infected) than are native populations. Reduced parasitization of introduced species has several causes, including reduced probability of the introduction of parasites with exotic species (or early extinction after host establishment), absence of other required hosts in the new location, and the host-specific limitations of native parasites adapting to new hosts.	Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Western Ecol Res Ctr, US Geol Survey, Santa Barbara, CA 93106 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; Princeton University	Torchin, ME (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.		Lafferty, Kevin D./B-3888-2009					ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Chapman F. M., 1966, HDB BIRDS E N AM; CROFTON HD, 1971, PARASITOLOGY, V63, P343, DOI 10.1017/S0031182000079890; Dobson A.P., 1986, Ecological Studies, P58; GREGORY RD, 1991, PARASITOL TODAY, V7, P316, DOI 10.1016/0169-4758(91)90269-T; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; HAIR JD, 1970, AM MIDL NAT, V83, P555, DOI 10.2307/2423962; HARADA M, 1989, Japanese Journal of Parasitology, V38, P388; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KURIS AM, 1992, CAN J FISH AQUAT SCI, V49, P327, DOI 10.1139/f92-037; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; RYBAKOV AV, 1988, TREMATODA ECHINOSTOM, V22, P224; SCOTT ME, 1987, PARASITOLOGY, V95, P111, DOI 10.1017/S0031182000057590; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SHIMURA S, 1980, Japanese Journal of Parasitology, V29, P369; Torchin ME, 2001, BIOL INVASIONS, V3, P333, DOI 10.1023/A:1015855019360; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	22	997	1054	3	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					628	630		10.1038/nature01346	http://dx.doi.org/10.1038/nature01346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571595				2022-12-24	WOS:000180803200041
J	Freed, GL; Davis, MM; Clark, SJ				Freed, GL; Davis, MM; Clark, SJ			Variation in public and private supply of pneumococcal conjugate vaccine during a shortage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context In late August 2001, a serious shortage of the heptavalent pneumococcal conjugate vaccine (PCV7) developed in 34 state immunization programs. In September 2001, the Centers for Disease Control and Prevention published revised recommendations advising physicians to prioritize PCV7 to specific groups of children. The effect of the shortage at the practice level is unknown. Objective To determine the variation between public and private markets in the supply of PCV7 and the nature and extent of the PCV7 shortage at the practice level. Design, Setting, and Participants Semistructured interviews with office staff responsible for ordering vaccines at private practices in 12 states were conducted between October 19 and November 2, 2001. Main Outcome Measures Variation in supply of PCV7 obtained from public sources and through purchase on,the private market. Supply was characterized into 3 categories: "no problem," "problem obtaining a consistent supply, " and "out of stock. Results Interviews were completed at 405 practices, representing a response rate of 74%. Overall, 51% of practices reported at least 1 episode of being out of stock of public PCV7 and 64% of private PCV7, with significant state-to-state variation. Only 2 of 12 study states had a substantially higher proportion of practices experiencing out-of-stock episodes for public compared with private PCV7, while in 6 states public PCV7 was less frequently out of stock than private PCV7. Only 23% of practices in this study altered their administration policy for private PCV7, while 27% altered their policy for public PCV7. Conclusions The distribution and supply of PCV7 varied between public and private supplies and between states during the shortage. Few practices changed their administration schedules in response to revised recommendations.	Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Freed, GL (corresponding author), Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, 300 N Ingalls 6E08, Ann Arbor, MI 48109 USA.							*CDC, 2001, JAMA-J AM MED ASSOC, V286, P2232; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P783; Clements DA, 2001, ARCH PEDIAT ADOL MED, V155, P455, DOI 10.1001/archpedi.155.4.455; Davis MM, 2001, AMBUL PEDIATR, V1, P302, DOI 10.1367/1539-4409(2001)001<0302:PECRTT>2.0.CO;2; Freed GL, 2000, AM J PREV MED, V19, P32, DOI 10.1016/S0749-3797(00)00219-1; *I MED, 2000, CALL SHOTS REP COMM; ORENSTEIN WA, 1999, VACCINES; Wood D, 1998, ARCH PEDIAT ADOL MED, V152, P238	8	21	22	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					575	578		10.1001/jama.289.5.575	http://dx.doi.org/10.1001/jama.289.5.575			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578490	Bronze			2022-12-24	WOS:000180787500028
J	He, L; Lu, XY; Jolly, AF; Eldridge, AG; Watson, SJ; Jackson, PK; Barsh, GS; Gunn, TM				He, L; Lu, XY; Jolly, AF; Eldridge, AG; Watson, SJ; Jackson, PK; Barsh, GS; Gunn, TM			Spongiform degeneration in mahoganoid mutant mice	SCIENCE			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; AGOUTI PROTEIN; PIGMENTATION; MUTATIONS; ATTRACTIN; SUBSTRATE; RECEPTOR; OBESITY; SYSTEM	mahoganoid is a mouse coat-color mutation whose pigmentary phenotype and genetic interactions resemble those of Attractin (Atrn). Atrn mutations also cause spongiform neurodegeneration. Here, we show that a null mutation for mahoganoid causes a similar age-dependent neuropathology that includes many features of prion diseases but without accumulation of protease-resistant prion protein. The gene mutated in mahoganoid encodes a RING-containing protein with E3 ubiquitin ligase activity in vitro. Similarities in phenotype, expression, and genetic interactions suggest that mahoganoid and Atrn genes are part of a conserved pathway for regulated protein turnover whose function is essential for neuronal viability.	Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pediat,Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA	Cornell University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Michigan System; University of Michigan	Barsh, GS (corresponding author), Cornell Univ, Dept Biomed Sci, T4 018 VRT, Ithaca, NY 14853 USA.		Lu, Xin-Yun/M-8657-2016	Jackson, Peter/0000-0002-1742-2539; Gunn, Teresa/0000-0003-2688-6420				Barsh G, 2000, PIGM CELL RES, V13, P48, DOI 10.1034/j.1600-0749.13.s8.10.x; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bronson RT, 2001, J NEUROPATH EXP NEUR, V60, P724, DOI 10.1093/jnen/60.7.724; GOMI H, 1994, BRAIN RES, V653, P66, DOI 10.1016/0006-8993(94)90373-5; Gunn TM, 2001, GENETICS, V158, P1683; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jackson IJ, 1999, TRENDS GENET, V15, P429, DOI 10.1016/S0168-9525(99)01824-7; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kuramoto T, 2002, MAMM GENOME, V13, P36, DOI 10.1007/s00335-001-2116-9; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; LANE PW, 1960, MOUSE NEWS LETT, V22, P35; LIBERSKI PP, 1993, LIGHT ELECT MICROSCO, P155; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Miller KA, 1997, GENETICS, V146, P1407; Mouradian MM, 2002, NEUROLOGY, V58, P179, DOI 10.1212/WNL.58.2.179; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Phillips R.J., 1963, MOUSE NEWS LETT, V29, P38; PHILLIPS RJS, 1979, MOUSE NEWS LETT, V60, P46; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PRUSINER SB, 1997, MOL GENETIC BASIS NE, P103; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627	26	115	121	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					710	712		10.1126/science.1079694	http://dx.doi.org/10.1126/science.1079694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560552				2022-12-24	WOS:000180687700048
J	Xiao, YP; Wang, Y; Felleman, DJ				Xiao, YP; Wang, Y; Felleman, DJ			A spatially organized representation of colour in macaque cortical area V2	NATURE			English	Article							FUNCTIONAL-ORGANIZATION; FORM; SEGREGATION; MECHANISMS; DISPARITY; CORTEX; MONKEY; V4	Neurons responding selectively to different colours have been found in various cortical areas in macaque monkeys(1); however, little is known about whether and how the representation of colour is spatially organized in any cortical area. Cortical area V2 contains modules that respond preferentially to chromatic modulation, which are located in thin cytochrome oxidase stripes(2-4). Here we show that within and beyond these modules, gratings of different colours produce activations that peak at different locations. Optical recording of intrinsic signals revealed that the peak regions of the responses to different colours were spatially organized in the same order as colour stimuli are arranged in the DIN (German standard colour chart) colour system. Nearby regions represented colours of a similar hue. We found that the set of colour-specific regions formed 0.07-0.32-mm-wide and approximately 1.3-mm long bands that varied in shape from linear to nearly circular. Our finding suggests that thin stripes in V2 contain functional maps where the colour of a stimulus is represented by the location of its response activation peak.	Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Xiao, YP (corresponding author), Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA.			Xiao, Youping/0000-0003-3954-3443				BURKHALTER A, 1986, J NEUROSCI, V6, P2327; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Kiper DC, 1997, VISUAL NEUROSCI, V14, P1061, DOI 10.1017/S0952523800011779; Komatsu H, 1998, CURR OPIN NEUROBIOL, V8, P503, DOI 10.1016/S0959-4388(98)80038-X; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Moutoussis K, 2002, J NEUROPHYSIOL, V87, P2104, DOI 10.1152/jn.00248.2001; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; ROE AW, 1995, J NEUROSCI, V15, P3689; TOOTELL RBH, 1989, J NEUROSCI, V9, P2620; Ts'o DY, 2001, VISION RES, V41, P1333, DOI 10.1016/S0042-6989(01)00076-1; Xiao YP, 1999, CEREB CORTEX, V9, P792, DOI 10.1093/cercor/9.8.792; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P51, DOI 10.1016/0166-4328(95)00183-2	15	169	172	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					535	539		10.1038/nature01372	http://dx.doi.org/10.1038/nature01372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556893				2022-12-24	WOS:000180670600046
J	Tang, Y; Katuri, V; Dillner, A; Mishra, B; Deng, CX; Mishra, L				Tang, Y; Katuri, V; Dillner, A; Mishra, B; Deng, CX; Mishra, L			Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice	SCIENCE			English	Article							TGF-BETA; LIVER DEVELOPMENT; EPITHELIAL-CELLS; SMAD PROTEINS; PATHWAY; CANCER	Disruption of the adaptor protein ELF, a beta-spectrin, leads to disruption of transforming growth factor-beta (TGF-beta) signaling by Smad proteins in mice. Elf(-/-) mice exhibit a phenotype similar to smad2(+/-)/smad3(+/-) mutant mice of midgestational death due to gastrointestinal, liver, neural, and heart defects. We show that TGF-beta triggers phosphorylation and association of ELF with Smad3 and Smad4, followed by nuclear translocation. ELF deficiency results in mislocalization of Smad3 and Smad4 and loss of the TGF-beta-dependent transcriptional response, which could be rescued by overexpression of the COOH-terminal region of ELF. This study reveals an unexpected molecular link between a major dynamic scaffolding protein and a key signaling pathway.	NIDDKD, Genet Dev & Dis Branch, NIH, US Dept HHS, Bethesda, MD 20878 USA; Georgetown Univ, Dept Med, Dev Biol Lab, Washington, DC 20007 USA; Dept Vet Affairs, Washington, DC 20422 USA; Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Mishra, B (corresponding author), NIDDKD, Genet Dev & Dis Branch, NIH, US Dept HHS, Bethesda, MD 20878 USA.	lm229@georgetown.edu	deng, chuxia/N-6713-2016	Mishra, Lopa/0000-0002-6850-0808	NIDDK NIH HHS [R01 DK56111, R03 DK53861, R01 DK58637] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001, R01DK056111, ZIADK056001, R03DK053861] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bhanumathy CD, 2002, DEV DYNAM, V223, P59, DOI 10.1002/dvdy.1235; De Matteis MA, 2000, J CELL SCI, V113, P2331; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Einstein M, 2001, MOL CELL BIOL, V21, P5122, DOI 10.1128/MCB.21.15.5122-5131.2001; Engel ME, 1998, J CELL BIOCHEM, P111; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Mishra L, 1999, ONCOGENE, V18, P353, DOI 10.1038/sj.onc.1202313; Mishra L, 1998, INT J DEV BIOL, V42, P221; Moustakas A, 2002, GENE DEV, V16, P1867, DOI 10.1101/gad.1016802; Moustakas A, 2001, J CELL SCI, V114, P4359; NELSON WJ, 1986, J CELL BIOL, V103, P1751, DOI 10.1083/jcb.103.5.1751; Piek E, 1999, J CELL SCI, V112, P4557; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	22	216	225	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					574	577		10.1126/science.1075994	http://dx.doi.org/10.1126/science.1075994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543979	Green Published			2022-12-24	WOS:000180559800053
J	Thiele, A; Stoner, G				Thiele, A; Stoner, G			Neuronal synchrony does not correlate with motion coherence in cortical area MT	NATURE			English	Article							VISUAL-CORTEX; CONNECTIVITY; TRANSPARENCY; PERCEPTION; RESPONSES; RULES; CUE	Natural visual scenes are cluttered with multiple objects whose individual features must somehow be selectively linked (or 'bound') if perception is to coincide with reality. Recent neurophysiological evidence(1,2) supports a 'binding-by-synchrony' hypothesis3 : neurons excited by features of the same object fire synchronously, while neurons excited by features of different objects do not. Moving plaid patterns offer a straightforward means to test this idea. By appropriate manipulations of apparent transparency, the component gratings of a plaid pattern can be seen as parts of a single coherently moving surface or as two non-coherently moving surfaces. We examined directional tuning and synchrony of area-MT neurons in awake, fixating primates in response to perceptually coherent and non-coherent plaid patterns. Here we show that directional tuning correlated highly with perceptual coherence, which is consistent with an earlier study(4). Although we found stimulus-dependent synchrony, coherent plaids elicited significantly less synchrony than did non-coherent plaids. Our data therefore do not support the binding-by-synchrony hypothesis as applied to this class of motion stimuli in area MT.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Stoner, G (corresponding author), Univ Newcastle Upon Tyne, Henry Wellcome Bldg Neuroecol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.			Thiele, Alexander/0000-0003-4894-0213				AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BATSCHELET E, 1972, ANIMAL ORIENTATION N, P61; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; deOliveira SC, 1997, J NEUROSCI, V17, P9248; Eggermont JJ, 1996, EXP BRAIN RES, V110, P379; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lindsey DT, 1996, VISION RES, V36, P207, DOI 10.1016/0042-6989(95)00096-I; Movshon JA, 1985, STUDY GROUP PATTERN, P117, DOI [DOI 10.1007/978-3-662-09224-8_7., DOI 10.1007/978-3-662-09224-8_]; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Stoner GR, 1998, VISION RES, V38, P387, DOI 10.1016/S0042-6989(97)00132-6; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Stoner GR, 1996, VISION RES, V36, P1291, DOI 10.1016/0042-6989(95)00195-6; STONER GR, 1992, VISION RES, V32, P465, DOI 10.1016/0042-6989(92)90238-E; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x	20	116	117	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					366	370		10.1038/nature01285	http://dx.doi.org/10.1038/nature01285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540900				2022-12-24	WOS:000180533000041
J	Ferguson, NM; Galvani, AP; Bush, RM				Ferguson, NM; Galvani, AP; Bush, RM			Ecological and immunological determinants of influenza evolution	NATURE			English	Article							A VIRUSES; CELLULAR-IMMUNITY; HEMAGGLUTININ; INFECTION; VACCINE; FLU	In pandemic and epidemic forms, influenza causes substantial, sometimes catastrophic, morbidity and mortality. Intense selection from the host immune system drives antigenic change in influenza A and B, resulting in continuous replacement of circulating strains with new variants able to re-infect hosts immune to earlier types. This 'antigenic drift'(1) often requires a new vaccine to be formulated before each annual epidemic. However, given the high transmissibility and mutation rate of influenza, the constancy of genetic diversity within lineages over time is paradoxical. Another enigma is the replacement of existing strains during a global pandemic caused by 'antigenic shift'-the introduction of a new avian influenza A subtype into the human population(1). Here we explore ecological and immunological factors underlying these patterns using a mathematical model capturing both realistic epidemiological dynamics and viral evolution at the sequence level. By matching model output to phylogenetic patterns seen in sequence data collected through global surveillance(2), we find that short-lived strain-transcending immunity is essential to restrict viral diversity in the host population and thus to explain key aspects of drift and shift dynamics.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	Imperial College London; University of California System; University of California Berkeley; University of California System; University of California Irvine	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.		Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093				Benenson A.S., 1975, CONTROL COMMUNICABLE; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; *CDCP, 1986, MORB MORT WEEKL REP; COX N, 1993, OPTIONS CONTROL INFL, V2, P223; COX NJ, 1996, OPTIONS CONTROL INFL, V3, P591; DALY JM, 1998, TXB INFLUENZA, P168; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; FRANK AL, 1987, AM J EPIDEMIOL, V125, P576, DOI 10.1093/oxfordjournals.aje.a114571; FRANK AL, 1983, J MED VIROL, V12, P17, DOI 10.1002/jmv.1890120103; GILL PW, 1977, MED J AUSTRALIA, V2, P761, DOI 10.5694/j.1326-5377.1977.tb99276.x; GLEZEN WP, 1997, VIRAL INFECT HUMANS, P473; HOSKINS TW, 1979, LANCET, V1, P33; Layne SP, 2001, SCIENCE, V293, P1729, DOI 10.1126/science.293.5536.1729; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; MCELHANEY JE, 1995, VACCINE, V13, P6, DOI 10.1016/0264-410X(95)80003-V; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Nicholson KG, 1998, TXB INFLUENZA, P219; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Skoner DP, 1996, CLIN IMMUNOL IMMUNOP, V79, P294, DOI 10.1006/clin.1996.0082; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.immunol.8.1.737; YETTER RA, 1980, INFECT IMMUN, V29, P654; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	29	489	524	4	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					428	433		10.1038/nature01509	http://dx.doi.org/10.1038/nature01509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660783				2022-12-24	WOS:000181801200044
J	Martin, M; Turco, JH; Zegans, ME; Facklam, RR; Sodha, S; Elliott, JA; Pryor, JH; Beall, B; Erdman, DD; Baumgartner, YY; Sanchez, PA; Schwartzman, JD; Montero, J; Schuchat, A; Whitney, CG				Martin, M; Turco, JH; Zegans, ME; Facklam, RR; Sodha, S; Elliott, JA; Pryor, JH; Beall, B; Erdman, DD; Baumgartner, YY; Sanchez, PA; Schwartzman, JD; Montero, J; Schuchat, A; Whitney, CG			An outbreak of conjunctivitis due to atypical streptococcus pneumoniae	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDEMIC KERATOCONJUNCTIVITIS; CARE; IDENTIFICATION; INFECTION; SEQUENCE	Background: In February 2002, clinicians at the Dartmouth College Health Service recognized an outbreak of conjunctivitis; cultures of conjunctival swabs implicated Streptococcus pneumoniae. An investigation was begun to determine the extent of the outbreak, confirm the cause, identify modes of transmission, and implement control measures. Methods: Investigators reviewed the health service's data base for diagnoses of conjunctivitis. Viral and bacterial cultures were obtained from ill students. Bile-soluble isolates that were susceptible to ethylhydrocupreine (optochin) and therefore were presumed to be pneumococci underwent serotyping, capsular staining, pulsed-field gel electrophoresis, a DNA probe, and multilocus sequence typing. A cohort study of risk factors was conducted with the use of the Internet. Control measures included distribution of alcohol-based hand gel and messages about prevention. Results: Among 5060 students, 698 (13.8 percent) received a diagnosis of conjunctivitis from January 1, 2002, through April 12, 2002, including 22 percent of first-year students. Presumed pneumococci were isolated from 43.3 percent of conjunctival swabs (110 of 254); viral cultures performed on 85 specimens were negative. DNA probes and multilocus sequence typing confirmed that the organisms were pneumococci, although the bacteria did not have the characteristic capsule. On pulsed-field gel electrophoresis, strains were found to be identical to pneumococci that caused outbreaks of conjunctivitis in other parts of the country in 1980. Analysis of survey data from 1832 students indicated that close contact with a student with conjunctivitis, wearing contact lenses, membership on a sports team, and attending parties at or living in a fraternity or sorority house were associated with conjunctivitis. The rate of diagnosis of conjunctivitis declined after the implementation of control measures and after spring break. Conclusions: This large outbreak of conjunctivitis on a college campus was caused by an atypical, unencapsulated strain of S. pneumoniae that was identical to strains that had caused outbreaks two decades earlier.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Dartmouth Coll, Hlth Serv, Hanover, NH 03755 USA; Dartmouth Hitchcock Med Ctr, Hanover, NH USA; Dartmouth Coll Sch Med, Hanover, NH 03756 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; New Hampshire Dept Hlth & Human Serv, Off Community & Publ Hlth, Concord, NH 03301 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Dartmouth College; Dartmouth College; Dartmouth College; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Whitney, CG (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,MS C23, Atlanta, GA 30333 USA.	cwhitney@cdc.gov			NATIONAL EYE INSTITUTE [K08EY013977] Funding Source: NIH RePORTER; NEI NIH HHS [1 K08 EY13977-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AUSTRIAN R, 1994, HARRISONS PRINCIPLES, V1, P607; Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017; BLUESTONE CD, 1992, PEDIATR INFECT DIS J, V11, pS7, DOI 10.1097/00006454-199208001-00002; BUEHLER JW, 1983, SOUTHERN MED J, V76, P587, DOI 10.1097/00007611-198305000-00014; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P553; Chapin Kimberle, 1995, P33; Elliott JA, 1998, J CLIN MICROBIOL, V36, P2115, DOI 10.1128/JCM.36.7.2115-2116.1998; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Ertugrul N, 1997, J INFECT DIS, V176, P1401, DOI 10.1086/517331; Geslin P, 1997, ADV EXP MED BIOL, V418, P383; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1209, DOI 10.1093/clinids/23.6.1209; *IMP COLL, 2003, MULT LOC SEQ TYP HOM; JERNIGAN JA, 1993, J INFECT DIS, V167, P1307, DOI 10.1093/infdis/167.6.1307; Leibowitz HM, 2000, NEW ENGL J MED, V343, P345, DOI 10.1056/NEJM200008033430507; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MCDANIEL LS, 1991, INFECT IMMUN, V59, P222, DOI 10.1128/IAI.59.1.222-228.1991; MCMINN PC, 1991, J INFECT DIS, V164, P1113, DOI 10.1093/infdis/164.6.1113; National Committee for Clinical Laboratory Standards NCCLS, 2000, M7A5 NCCLS; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; OBRIEN TP, 2000, MANDELL DOUGLAS BENN, V1, P1251; PAPARELLO SF, 1991, MIL MED, V156, P256, DOI 10.1093/milmed/156.5.256; Parienti JJ, 2002, JAMA-J AM MED ASSOC, V288, P722, DOI 10.1001/jama.288.6.722; Parienti JJ, 2002, JAMA-J AM MED ASSOC, V288, P2688, DOI 10.1001/jama.288.21.2688-JLT1204-5-2; Pryor JH, 2002, J AM COLL HEALTH, V50, P267, DOI 10.1080/07448480209603444; Sampson JS, 1997, INFECT IMMUN, V65, P1967, DOI 10.1128/IAI.65.5.1967-1971.1997; Schinsky MF, 2000, INT J SYST EVOL MICR, V50, P575, DOI 10.1099/00207713-50-2-575; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SCHWARTZ B, 1989, American Journal of Ophthalmology, V107, P341; SEAL DV, 1982, BRIT J OPHTHALMOL, V66, P357, DOI 10.1136/bjo.66.6.357; SHAYEGANI M, 1982, J CLIN MICROBIOL, V16, P8, DOI 10.1128/JCM.16.1.8-14.1982; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TROTTIER S, 1991, PEDIATR INFECT DIS J, V10, P578, DOI 10.1097/00006454-199108000-00006; 2002, MMWR MORB MORTAL WKL, V51, P205; 1990, MMWR MORB MORTAL WKL, V39, P598; 2000, 50 MOST WIRED U	37	105	107	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1112	1121		10.1056/NEJMoa022521	http://dx.doi.org/10.1056/NEJMoa022521			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646668	Bronze			2022-12-24	WOS:000181628400007
J	Mukamal, KJ; Kuller, LH; Fitzpatrick, AL; Longstreth, WT; Mittleman, MA; Siscovick, DS				Mukamal, KJ; Kuller, LH; Fitzpatrick, AL; Longstreth, WT; Mittleman, MA; Siscovick, DS			Prospective-study of alcohol consumption and risk of dementia in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; TOBACCO CONSUMPTION; VASCULAR DEMENTIA; SMOKING; DRINKING; PERFORMANCE; IMPAIRMENT; BRAIN; QUESTIONNAIRE	Context Alcohol consumption has been associated with complex changes in cerebral vasculature and structure in older adults. How alcohol consumption affects the incidence of dementia is less clear. Objective To determine the prospective relationship of alcohol consumption and risk of dementia among older adults. Design, Setting, and Participants Nested case-control study of 373 cases with incident dementia and 373 controls who were among 5888 adults aged 65 years and older who participated in the Cardiovascular Health Study, a prospective, population-based cohort study in 4 US communities. The controls were frequency-matched on age, death before 1999, and their attendance of a 1998-1999 clinic. Participants in this study underwent magnetic resonance imaging (MRI) of the brain and cognitive testing between 1992 and 1994 and were followed up until 1999. Main Outcome Measures Odds of incident dementia, ascertained by detailed neurological and neuropsychological examinations according to average alcohol consumption, assessed by self-reported intake of beer, wine, and liquor at 2 visits prior to the date of the MRI. Result's Compared with abstention, the adjusted odds for dementia among those whose weekly alcohol consumption was less than 1 drink were 0.65 (95% confidence interval [CI], 0.41-1.02); 1 to 6 drinks, 0.46 (95% CI, 0.27-0.77); 7 to 13 drinks, 0.69 (95% CI, 0.37-1.31); and 14 or more drinks, 1.22 (95% CI, 0.60-2.49; P for quadratic term=.001). A trend toward greater odds of dementia associated with heavier alcohol consumption was most apparent among men and participants with an apolipoprotein E epsilon4 allele. We found generally similar relationships of alcohol use with Alzheimer disease and vascular dementia. Conclusions Compared with abstention, consumption of 1 to 6 drinks weekly is associated with a lower risk of incident dementia among older adults.	Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,RO-114, Boston, MA 02215 USA.	kmukamal@caregroup.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Mittleman, Murray/0000-0001-9788-7274	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085086, N01HC085082, N01HC085085, N01HC015103, N01HC085084, N01HC085083, N01HC085080, N01HC085081, N01HC085079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA000299] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01HC85080, N01HC85081, N01HC15103, N01HC85079, N01HC85086, N01HC85085, N01HC85084, N01HC85083, N01HC85082] Funding Source: Medline; NIAAA NIH HHS [K23AA00299] Funding Source: Medline; NIA NIH HHS [R01AG015928] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams WL, 1996, J AM GERIATR SOC, V44, P1082, DOI 10.1111/j.1532-5415.1996.tb02943.x; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; BAUMBAICKER C, 1985, DRUG ALCOHOL DEPEN, V15, P305, DOI 10.1016/0376-8716(85)90008-0; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Bryan RN, 1997, RADIOLOGY, V202, P47, DOI 10.1148/radiology.202.1.8988191; Cervilla JA, 2000, J NEUROL NEUROSUR PS, V68, P622, DOI 10.1136/jnnp.68.5.622; Cervilla JA, 2000, BRIT J PSYCHIAT, V177, P66, DOI 10.1192/bjp.177.1.66; CHRISTIAN JC, 1995, J STUD ALCOHOL, V56, P414, DOI 10.15288/jsa.1995.56.414; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; Dufouil C, 1997, AM J EPIDEMIOL, V146, P405, DOI 10.1093/oxfordjournals.aje.a009293; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; Edelstein SL, 1998, J WOMENS HEALTH, V7, P1271, DOI 10.1089/jwh.1998.7.1271; Elias PK, 1999, AM J EPIDEMIOL, V150, P580; Elwood PC, 1999, J EPIDEMIOL COMMUN H, V53, P9, DOI 10.1136/jech.53.1.9; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Fitzpatrick AL, 2002, AM J EPIDEMIOL, V155, ps53; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GILL JS, 1991, AM J MED, V90, P489, DOI 10.1016/0002-9343(91)80090-9; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goodwin N, 2001, J SOUTHWEST, V43, P1; GRAVES AB, 1991, INT J EPIDEMIOL, V20, pS48, DOI 10.1093/ije/20.Supplement_2.S48; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; HEBERT LE, 1992, AM J EPIDEMIOL, V135, P347, DOI 10.1093/oxfordjournals.aje.a116296; HEBERT LE, 1993, AM J EPIDEMIOL, V137, P881, DOI 10.1093/oxfordjournals.aje.a116749; Hendrie HC, 1996, J AM GERIATR SOC, V44, P1158, DOI 10.1111/j.1532-5415.1996.tb01364.x; HERZOG AR, 1998, NIH PUBLICATION; Jagust W, 2001, LANCET, V358, P2097, DOI 10.1016/S0140-6736(01)07230-0; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Leibovici D, 1999, INT J EPIDEMIOL, V28, P77, DOI 10.1093/ije/28.1.77; Leon J, 1998, HEALTH AFFAIR, V17, P206, DOI 10.1377/hlthaff.17.6.206; LOOMIS TA, 1958, Q J STUD ALCOHOL, V19, P30; Lopez OL, 2003, NEUROEPIDEMIOLOGY, V22, P1, DOI 10.1159/000067110; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; McDowell I, 2000, NEUROLOGY, V55, P66; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mukamal KJ, 2001, STROKE, V32, P1939, DOI 10.1161/hs0901.095723; NIXON SJ, 1998, NIH PUBLICATION; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P94; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; SCHERR PA, 1992, J AM GERIATR SOC, V40, P651, DOI 10.1111/j.1532-5415.1992.tb01954.x; Stampfer MJ, 2001, AM J EPIDEMIOL, V153, pS28; Sturmer T, 2001, EPIDEMIOLOGY, V12, P101; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; WANNAMETHEE G, 1988, INT J EPIDEMIOL, V17, P307, DOI 10.1093/ije/17.2.307; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Yue NC, 1997, RADIOLOGY, V202, P33, DOI 10.1148/radiology.202.1.8988189	57	311	323	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1405	1413		10.1001/jama.289.11.1405	http://dx.doi.org/10.1001/jama.289.11.1405			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	656PM	12636463	Bronze			2022-12-24	WOS:000181616200032
J	Wald, NJ; Huttly, WJ; Hackshaw, AK				Wald, NJ; Huttly, WJ; Hackshaw, AK			Antenatal screening for Down's syndrome with the quadruple test	LANCET			English	Article								Second trimester screening for Down's syndrome is widely practised throughout the world. We assessed the performance of antenatal serum screening for Down's syndrome with the quadruple test In 46 193 pregnancies from 14 hospitals over 5 years. Women who screened positive (risk greater than or equal to1 in 300) were offered diagnostic amniocentesis or chorionic villus sampling. Of 88 observed Down's syndrome pregnancies, 71 (81%) had a positive screening result (81% detection rate, 95% CI 72-89), and of 46 105 unaffected pregnancies, 3200 tested positive (7% false-positive rate). These results show that the quadruple test is a better method of screening for Down's syndrome than use of maternal age alone (51% detection rate, 14% false-positive rate) and is more effective than other second trimester screening tests. Therefore, we conclude that the quadruple test should be the test of choice in second trimester screening for Down's syndrome.	Barts & London Queen Mary Sch Med & Dent, Wolfson Inst Prevent Med, Dept Environm & Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Wald, NJ (corresponding author), Barts & London Queen Mary Sch Med & Dent, Wolfson Inst Prevent Med, Dept Environm & Prevent Med, London EC1M 6BQ, England.		Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021					Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; Wald N J, 1997, J Med Screen, V4, P181; Wald NJ, 1996, PRENATAL DIAG, V16, P143, DOI 10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F; Wald NJ, 1997, PRENATAL DIAG, V17, P285, DOI 10.1002/(SICI)1097-0223(199703)17:3<285::AID-PD71>3.0.CO;2-A; Wellesley D, 2002, BRIT MED J, V325, P15, DOI 10.1136/bmj.325.7354.15	5	91	99	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					835	836		10.1016/S0140-6736(03)12680-3	http://dx.doi.org/10.1016/S0140-6736(03)12680-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642052				2022-12-24	WOS:000181466600014
J	Lee, HK; Takamiya, K; Han, JS; Man, HY; Kim, CH; Rumbaugh, G; Yu, S; Ding, L; He, C; Petralia, RS; Wenthold, RJ; Gallagher, M; Huganir, RL				Lee, HK; Takamiya, K; Han, JS; Man, HY; Kim, CH; Rumbaugh, G; Yu, S; Ding, L; He, C; Petralia, RS; Wenthold, RJ; Gallagher, M; Huganir, RL			Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory	CELL			English	Article							GLUTAMATE RECEPTORS; REGULATORY PHOSPHORYLATION; SITES; POTENTIATION; SYNAPSES; REDISTRIBUTION; IDENTIFICATION; TRANSMISSION; TRAFFICKING; CONDUCTANCE	Plasticity of the nervous system is dependent on mechanisms that regulate the strength of synaptic transmission. Excitatory synapses in the brain undergo long-term potentiation (LTP) and long-term depression (LTD), cellular models of learning and memory. Protein phosphorylation is required for the induction of many forms of synaptic plasticity, including LTP and LTD. However, the critical kinase substrates that mediate plasticity have not been identified. We previously reported that phosphorylation of the GluR1 subunit of AMPA receptors, which mediate rapid excitatory transmission in the brain, is modulated during LTP and LTD. To test if GluR1 phosphorylation is necessary for plasticity and learning and memory, we generated mice with knockin mutations in the GluR1 phosphorylation sites. The phosphomutant mice show deficits in LTD and LTP and have memory defects in spatial learning tasks. These results demonstrate that phosphorylation of GluR1 is critical for LTD and LTP expression and the retention of memories.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA; NIDCD, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Takamiya, Kogo/0000-0001-7240-6307; Lee, Hey-Kyoung/0000-0002-5554-983X; Man, Hengye/0000-0002-3530-3066; Han, Jung-Soo/0000-0001-8447-4518	NIMH NIH HHS [R01 MH61108-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, Z01DC000003] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carvalho AL, 1999, J NEUROSCI, V19, P4748; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Luscher C, 2001, TRENDS NEUROSCI, V24, P665, DOI 10.1016/S0166-2236(00)01959-7; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; McDonald BJ, 2001, NEUROPHARMACOLOGY, V41, P672, DOI 10.1016/S0028-3908(01)00129-0; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; PERTRALLA RS, 1999, METHODS MOL BIOL NMD, P73; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	48	589	621	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					631	643		10.1016/S0092-8674(03)00122-3	http://dx.doi.org/10.1016/S0092-8674(03)00122-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628184	Bronze			2022-12-24	WOS:000181443600007
J	Trombetta, ES; Ebersold, M; Garrett, W; Pypaert, M; Mellman, I				Trombetta, ES; Ebersold, M; Garrett, W; Pypaert, M; Mellman, I			Activation of lysosomal function during dendritic cell maturation	SCIENCE			English	Article							II ANTIGEN PRESENTATION; IN-VIVO; INFLAMMATORY STIMULI; PLASMA-MEMBRANE; ATPASE ACTIVITY; HLA-DM; PROTEOLYSIS; COMPLEXES; ACIDIFICATION; DISSOCIATION	In response to a variety of stimuli, dendritic cells (DCs) transform from immature cells specialized for antigen capture into mature cells specialized for T cell stimulation. During maturation, the DCs acquire an enhanced capacity to form and accumulate peptide-MHC (major histocompatibility complex) class II complexes. Here we show that a key mechanism responsible for this alteration was the generalized activation of lysosomal function. In immature DCs, internalized antigens were slowly degraded and inefficiently used for peptide loading. Maturation induced activation of the vacuolar proton pump that enhanced lysosomal acidification and antigen proteolysis, facilitating efficient formation of peptide-MHC class II complexes. Lysosomal function in DCs thus appears to be specialized for the developmentally regulated processing of internalized antigens.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.			Garrett, Wendy/0000-0002-5092-0150	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034098] Funding Source: NIH RePORTER; NIAID NIH HHS [R37-AI34098] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; COHN ZA, 1969, J EXP MED, V129, P201, DOI 10.1084/jem.129.1.201; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Drakesmith H, 1998, P NATL ACAD SCI USA, V95, P14903, DOI 10.1073/pnas.95.25.14903; EHRENREICH BA, 1969, J EXP MED, V129, P227, DOI 10.1084/jem.129.1.227; FAGOTTO F, 1994, J CELL SCI, V107, P3325; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; MALLYA SK, 1992, J CELL BIOL, V117, P1211, DOI 10.1083/jcb.117.6.1211; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Vogt AB, 1999, TRENDS BIOCHEM SCI, V24, P150, DOI 10.1016/S0968-0004(99)01364-X; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	39	545	558	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1400	1403		10.1126/science.1080106	http://dx.doi.org/10.1126/science.1080106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610307				2022-12-24	WOS:000181192300054
J	McCulloh, KA; Sperry, JS; Adler, FR				McCulloh, KA; Sperry, JS; Adler, FR			Water transport in plants obeys Murray's law	NATURE			English	Article							HYDRAULIC CONDUCTANCE; STOMATAL CONDUCTANCE; GENERAL-MODEL; TRANSPIRATION	The optimal water transport system in plants should maximize hydraulic conductance (which is proportional to photosynthesis(1-5)) for a given investment in transport tissue. To investigate how this optimum may be achieved, we have performed computer simulations of the hydraulic conductance of a branched transport system. Here we show that the optimum network is not achieved by the commonly assumed pipe model of plant form(6-8), or its antecedent, da Vinci's rule(9,10). In these representations, the number and area of xylem conduits is constant at every branch rank. Instead, the optimum network has a minimum number of wide conduits at the base that feed an increasing number of narrower conduits distally. This follows from the application of Murray's law, which predicts the optimal taper of blood vessels in the cardiovascular system(11). Our measurements of plant xylem indicate that these conduits conform to the Murray's law optimum as long as they do not function additionally as supports for the plant body.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	McCulloh, KA (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mcculloh@biology.utah.edu						CANNY MJ, 1993, PHILOS T R SOC B, V341, P87, DOI 10.1098/rstb.1993.0094; da Vinci Leonardo, 1970, COURIER CORPORATION, P2; Enquist BJ, 2000, SFI S SCI C, P167; Givnish T. J., 1986, EC PLANT FORM FUNCTI, P3; GOULD SJ, 1979, P ROY SOC LOND B BIO, V205, P581, DOI DOI 10.1098/RSPB.1979.0086; Grafen A., 2002, MODERN STAT LIFE SCI; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; HORN H S, 1971, P144; Horn HS, 2000, SFI S SCI C, P199; Hubbard RM, 2001, PLANT CELL ENVIRON, V24, P113, DOI 10.1046/j.1365-3040.2001.00660.x; KELLER JB, 1966, J MATH MECH, V16, P433; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Mark R, 1996, AM SCI, V84, P383; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MEINZER FC, 1995, OECOLOGIA, V101, P514, DOI 10.1007/BF00329432; MEINZER FC, 1990, PLANT CELL ENVIRON, V13, P383, DOI 10.1111/j.1365-3040.1990.tb02142.x; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Raven JA., 1977, ADV BOTANICAL RESEAR, V5, P153, DOI DOI 10.1016/S0065-2296(08)60361-4; SALIENDRA NZ, 1995, PLANTA, V196, P357, DOI 10.1007/BF00201396; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Sokal R. R., 2009, INTRO BASIC STAT, V2; SPERRY JS, 1993, J EXP BOT, V44, P1075, DOI 10.1093/jxb/44.6.1075; Vogel S., 1994, LIFE MOVING FLUIDS P, V2nd ed.; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; ZIMMERMANN MH, 1983, XYLEM STRUCTURE ASCE, P15	27	300	316	8	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					939	942		10.1038/nature01444	http://dx.doi.org/10.1038/nature01444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607000				2022-12-24	WOS:000181186900048
J	Lopansri, BK; Anstey, NM; Weinberg, JB; Stoddard, GJ; Hobbs, MR; Levesque, MC; Mwaikambo, ED; Granger, DL				Lopansri, BK; Anstey, NM; Weinberg, JB; Stoddard, GJ; Hobbs, MR; Levesque, MC; Mwaikambo, ED; Granger, DL			Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production	LANCET			English	Article								Nitric oxide (NO) production and mononuclear cell NO synthase 2 (NOS2) expression are high in healthy Tanzanian children but low in those with cerebral malaria. Factors that downregulate NOS2 also diminish factors involved in cellular uptake and biosynthesis of L-arginine, the substrate for NO synthesis. We therefore postulated that L-arginine concentrations would be low in individuals with cerebral malaria. We measured concentrations of L-arginine in cryopreserved plasma samples from Tanzanian children with and without malaria. L-arginine concentrations were low in individuals with cerebral malaria (mean 46 mumol/L, SD 14), intermediate in those with uncomplicated malaria (70 mumol/L, 20), and within the normal range in healthy controls (122 mumol/L, 22; p<0.0001). Analysis by logistic regression showed that hypoargininaemia was significantly associated with cerebral malaria case-fatality. Hypoargininaemia may contribute to limited NO production in children with cerebral malaria and to severe disease.	Vet Affairs Med Ctr, Div Infect Dis, Salt Lake City, UT 84132 USA; Univ Utah, Med Ctr, Salt Lake City, UT USA; Flinders Univ No Terr Clin Sch, Darwin, NT, Australia; Menzies Sch Hlth Res, Div Infect Dis, Darwin, NT, Australia; Duke Univ, Med Ctr, Durham, NC USA; Vet Affairs Med Ctr, Div Hematol, Durham, NC USA; Univ Utah, Sch Med, Div Clin Epidemiol, Salt Lake City, UT USA; Hubert Kairuki Mem Univ, Dept Paediat, Dar Es Salaam, Tanzania	US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; Flinders University South Australia; Charles Darwin University; Menzies School of Health Research; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Granger, DL (corresponding author), Vet Affairs Med Ctr, Div Infect Dis, 30 N 1900 E,Room 4B319, Salt Lake City, UT 84132 USA.				NIAID NIH HHS [R01 AI041764] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041764] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Kamada Y, 2001, J CLIN INVEST, V108, P717, DOI 10.1172/JCI11260; Meyer J, 1997, ANAL BIOCHEM, V247, P11, DOI 10.1006/abio.1997.2008; Planche T, 2002, QJM-INT J MED, V95, P89, DOI 10.1093/qjmed/95.2.89; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001	5	133	137	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					676	678		10.1016/S0140-6736(03)12564-0	http://dx.doi.org/10.1016/S0140-6736(03)12564-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606182				2022-12-24	WOS:000181129500020
J	Aas, PA; Otterlei, M; Falnes, PO; Vagbo, CB; Skorpen, F; Akbari, M; Sundheim, O; Bjoras, M; Slupphaug, G; Seeberg, E; Krokan, HE				Aas, PA; Otterlei, M; Falnes, PO; Vagbo, CB; Skorpen, F; Akbari, M; Sundheim, O; Bjoras, M; Slupphaug, G; Seeberg, E; Krokan, HE			Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA	NATURE			English	Article							ESCHERICHIA-COLI; CLONING; CONSTRUCTION; EXPRESSION; NUCLEOTIDE; VECTORS; GENE	Repair of DNA damage is essential for maintaining genome integrity, and repair deficiencies in mammals are associated with cancer, neurological disease and developmental defects(1). Alkylation damage in DNA is repaired by at least three different mechanisms, including damage reversal by oxidative demethylation of 1-methyladenine and 3-methylcytosine by Escherichia coli AlkB(2,3). By contrast, little is known about consequences and cellular handling of alkylation damage to RNA(4). Here we show that two human AlkB homologues, hABH2 and hABH3, also are oxidative DNA demethylases and that AlkB and hABH3, but not hABH2, also repair RNA. Whereas AlkB and hABH3 prefer single-stranded nucleic acids, hABH2 acts more efficiently on double-stranded DNA. In addition, AlkB and hABH3 expressed in E. coli reactivate methylated RNA bacteriophage MS2 in vivo, illustrating the biological relevance of this repair activity and establishing RNA repair as a potentially important defence mechanism in living cells. The different catalytic properties and the different subnuclear localization patterns shown by the human homologues indicate that hABH2 and hABH3 have distinct roles in the cellular response to alkylation damage.	Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, N-7489 Trondheim, Norway; Univ Oslo, Natl Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway; Univ Oslo, Natl Hosp, Inst Med Microbiol, N-0027 Oslo, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Krokan, HE (corresponding author), Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, N-7489 Trondheim, Norway.		Bjørås, Magnar/N-9286-2017; Vågbø, Cathrine Broberg/N-3226-2017; Falnes, Pål Ø./AAA-4581-2020; Slupphaug, Geir/AAN-3794-2020	Vågbø, Cathrine Broberg/0000-0003-3959-7409; Akbari, Mansour/0000-0002-6490-7766; Slupphaug, Geir/0000-0002-7498-3500; Skorpen, Frank/0000-0001-7093-8000; Falnes, Pal/0000-0001-8114-6025; Otterlei, Marit/0000-0002-5232-1186				Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; ARAVIND L, 2001, GENOME BIOL, V2; BJELLAND S, 1993, NUCLEIC ACIDS RES, V21, P2045, DOI 10.1093/nar/21.9.2045; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; BOITEUX S, 1982, BIOCHIMIE, V64, P637, DOI 10.1016/S0300-9084(82)80103-X; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Dinglay S, 2000, GENE DEV, V14, P2097; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haug T, 1996, GENOMICS, V36, P408, DOI 10.1006/geno.1996.0485; Huang X, 2001, FREE RADICAL BIO MED, V31, P1341, DOI 10.1016/S0891-5849(01)00681-5; KAASEN I, 1986, J BACTERIOL, V168, P642, DOI 10.1128/jb.168.2.642-647.1986; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Matsugi J, 2001, BBA-GENE STRUCT EXPR, V1521, P81, DOI 10.1016/S0167-4781(01)00293-7; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; SAFFHILL R, 1984, CARCINOGENESIS, V5, P691; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Singer B., 1983, MOL BIOL MUTAGENS CA; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	27	486	505	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					859	863		10.1038/nature01363	http://dx.doi.org/10.1038/nature01363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594517				2022-12-24	WOS:000181044700052
J	Langkjaer, RB; Cliften, PF; Johnston, M; Piskur, J				Langkjaer, RB; Cliften, PF; Johnston, M; Piskur, J			Yeast genome duplication was followed by asynchronous differentiation of duplicated genes	NATURE			English	Article							HEMIASCOMYCETOUS YEASTS; SACCHAROMYCES; EVOLUTION; EXPLORATION; CHROMOSOMES; REGIONS; GROWTH	Gene redundancy has been observed in yeast, plant and human genomes, and is thought to be a consequence of whole-genome duplications(1-3). Baker's yeast, Saccharomyces cerevisiae, contains several hundred duplicated genes(1). Duplication(s) could have occurred before or after a given speciation. To understand the evolution of the yeast genome, we analysed orthologues of some of these genes in several related yeast species. On the basis of the inferred phylogeny of each set of genes, we were able to deduce whether the gene duplicated and/or specialized before or after the divergence of two yeast lineages. Here we show that the gene duplications might have occurred as a single event, and that it probably took place before the Saccharomyces and Kluyveromyces lineages diverged from each other. Further evolution of each duplicated gene pair-such as specialization or differentiation of the two copies, or deletion of a single copy-has taken place independently throughout the evolution of these species.	Tech Univ Denmark, Bioctr DTU, DK-2800 Lyngby, Denmark; Washington Univ, Sch Med, Dept Genet & Genome Sequencing Ctr, St Louis, MO 63110 USA	Technical University of Denmark; Washington University (WUSTL)	Piskur, J (corresponding author), Tech Univ Denmark, Bioctr DTU, Bldg 301, DK-2800 Lyngby, Denmark.	jp@biocentrum.dtu.dk	Johnston, Mark/K-3543-2019; Johnston, Mark/R-6156-2019	Johnston, Mark/0000-0002-4932-7229; 	NIGMS NIH HHS [R01 GM063803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063803] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berbee ML, 2001, MYCOTA, V7, P229; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hall TA, 1999, NUCL ACIDS S SERIES, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Koonin EV, 1997, CURR OPIN GENET DEV, V7, P757, DOI 10.1016/S0959-437X(97)80037-8; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; LALO D, 1993, CR ACAD SCI III-VIE, V316, P367; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langkjaer RB, 2000, J MOL BIOL, V304, P271, DOI 10.1006/jmbi.2000.4209; LANGKJAER RB, 2002, THESIS DTU; Llorente B, 2000, FEBS LETT, V487, P122, DOI 10.1016/S0014-5793(00)02291-2; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; MELNICK L, 1993, J MOL BIOL, V233, P372, DOI 10.1006/jmbi.1993.1518; Moller K, 2002, BIOTECHNOL BIOENG, V77, P186, DOI 10.1002/bit.10122; Moller K, 2001, J BACTERIOL, V183, P2485, DOI 10.1128/JB.183.8.2485-2489.2001; Ohno S., 1970, EVOLUTION GENE DUPLI; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Piskur J, 2001, TRENDS GENET, V17, P302, DOI 10.1016/S0168-9525(01)02308-3; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vaughan-Martini Ann, 1998, P358, DOI 10.1016/B978-044481312-1/50048-4; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WESOLOWSKILOUVE.M, 1906, NONCONVENTIONAL YEAS, P139; WICKSTEED BL, 1994, YEAST, V10, P39, DOI 10.1002/yea.320100105; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099	30	114	155	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					848	852		10.1038/nature01419	http://dx.doi.org/10.1038/nature01419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594514				2022-12-24	WOS:000181044700049
J	Vinicor, F; Bowman, B; Engelgau, M				Vinicor, F; Bowman, B; Engelgau, M			Diabetes: prevention needed	LANCET			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; HEALTH; PREVALENCE; MELLITUS; OBESITY; CARE; RISK		Ctr Dis Control & Prevent, Div Diabet Translat K10, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Vinicor, F (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat K10, Atlanta, GA 30341 USA.	fxv1@cdc.gov						Bagust A, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.19.s4.2.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Gavin JR, 1997, DIABETES CARE, V20, P1183; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; NARAYAN V, 2002, BRIT MED J, V325, P403; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Wylie G, 2002, BMJ-BRIT MED J, V324, P1190, DOI 10.1136/bmj.324.7347.1190	16	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					544	544		10.1016/S0140-6736(03)12561-5	http://dx.doi.org/10.1016/S0140-6736(03)12561-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598137				2022-12-24	WOS:000181033400005
J	Courcelle, J; Donaldson, JR; Chow, KH; Courcelle, CT				Courcelle, J; Donaldson, JR; Chow, KH; Courcelle, CT			DNA damage-induced replication fork regression and processing in Escherichia coli	SCIENCE			English	Article							AGAROSE-GEL ELECTROPHORESIS; ILLEGITIMATE RECOMBINATION; EXCISION-REPAIR; RECR PROTEINS; HELICASE; RESUMPTION; FILAMENTS; STRAND	DNA lesions that block replication are a primary cause of rearrangements, mutations, and lethality in all cells. After ultraviolet (UV)-induced DNA damage in Escherichia coli, replication recovery requires RecA and several other recF pathway proteins. To characterize the mechanism by which lesion-blocked replication forks recover, we used two-dimensional agarose get electrophoresis to show that replication-blocking DNA lesions induce a transient reversal of the replication fork in vivo. The reversed replication fork intermediate is stabilized by RecA and RecF and is degraded by the RecQ-RecJ helicase-nuclease when these proteins are absent. We propose that fork regression allows repair enzymes to gain access to the replication-blocking lesion, allowing processive replication to resume once the blocking lesion is removed.	Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Mississippi State University	Courcelle, J (corresponding author), Mississippi State Univ, Dept Biol Sci, Box GY, Mississippi State, MS 39762 USA.							Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; Courcelle J, 2001, P NATL ACAD SCI USA, V98, P8196, DOI 10.1073/pnas.121008898; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GANESAN AK, 1971, MOL GEN GENET, V113, P285, DOI 10.1007/BF00272328; GANESAN AK, 1974, J MOL BIOL, V87, P103, DOI 10.1016/0022-2836(74)90563-4; Hanada K, 2000, P NATL ACAD SCI USA, V97, P5989, DOI 10.1073/pnas.100101297; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; HORII ZI, 1968, PHOTOCHEM PHOTOBIOL, V8, P93, DOI 10.1111/j.1751-1097.1968.tb05850.x; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Rangarajan S, 2002, MOL MICROBIOL, V43, P617, DOI 10.1046/j.1365-2958.2002.02747.x; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; TSUJIMURA T, 1990, P NATL ACAD SCI USA, V87, P1566, DOI 10.1073/pnas.87.4.1566; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3	28	186	192	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1064	1067		10.1126/science.1081328	http://dx.doi.org/10.1126/science.1081328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12543983				2022-12-24	WOS:000180960000047
J	Darby, S; McGale, P; Peto, R; Granath, F; Hall, P; Ekbom, A				Darby, S; McGale, P; Peto, R; Granath, F; Hall, P; Ekbom, A			Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women	BRITISH MEDICAL JOURNAL			English	Article							LATERALITY		Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, S-10401 Stockholm, Sweden	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Karolinska Institutet; Karolinska Institutet	Darby, S (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Paszat LF, 1998, J CLIN ONCOL, V16, P2625, DOI 10.1200/JCO.1998.16.8.2625; RUTQVIST LE, 1990, BRIT J CANCER, V61, P866, DOI 10.1038/bjc.1990.193; Shimizu Y, 1999, RADIAT RES, V152, P374, DOI 10.2307/3580222; Weiss HA, 1996, CANCER CAUSE CONTROL, V7, P539, DOI 10.1007/BF00051887	5	173	182	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					256	257		10.1136/bmj.326.7383.256	http://dx.doi.org/10.1136/bmj.326.7383.256			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560277	Green Published, Bronze			2022-12-24	WOS:000180908300020
J	de Jong-van den Berg, L; Tobi, H; Bijker, B; van den Berg, P				de Jong-van den Berg, L; Tobi, H; Bijker, B; van den Berg, P			Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study	BRITISH MEDICAL JOURNAL			English	Article							3RD-GENERATION		Univ Groningen, Inst Drug Explorat, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, NL-9713 AV Groningen, Netherlands	University of Groningen	de Jong-van den Berg, L (corresponding author), Univ Groningen, Inst Drug Explorat, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, Antonius Deusinglaan 2, NL-9713 AV Groningen, Netherlands.		Tobi, Hilde/A-1512-2013	Tobi, Hilde/0000-0002-8804-0298				de Vries CS, 1998, CONTRACEPTION, V57, P247, DOI 10.1016/S0010-7824(98)00021-3; Drife JO, 2001, BRIT MED J, V323, P119, DOI 10.1136/bmj.323.7305.119; GEIJER RMM, 1996, HUISARTS WET, V39, P110; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; POULTER NR, 1995, LANCET, V346, P1575	5	5	5	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					254	254		10.1136/bmj.326.7383.254	http://dx.doi.org/10.1136/bmj.326.7383.254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560275	Bronze, Green Published			2022-12-24	WOS:000180908300018
J	Knight, J				Knight, J			Meeting aims to find brain's benchmarks for beauty	NATURE			English	News Item																			0	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					305	305		10.1038/421305b	http://dx.doi.org/10.1038/421305b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540868	Bronze			2022-12-24	WOS:000180533000012
J	Spranger, J; Kroke, A; Mohlig, M; Bergmann, MM; Ristow, M; Boeing, H; Pfeiffer, AFH				Spranger, J; Kroke, A; Mohlig, M; Bergmann, MM; Ristow, M; Boeing, H; Pfeiffer, AFH			Adiponectin and protection against type 2 diabetes mellitus	LANCET			English	Article							PROTEIN	Adiponectin is an adipocyte-derived peptide, which has anti-inflammatory and insulin-sensitising properties. We designed a nested case-control study to assess whether baseline adiponectin concentrations in plasma are independently associated with risk of type 2 diabetes. We found that adiponectin concentrations in plasma were lower among individuals who later developed type 2 diabetes than among controls (mean 5.34 mug/mL [SD 3.49] vs 6.87 mug/mL [4.58], p<0.0001). High concentrations of adiponectin were associated with a substantially reduced relative risk of type 2 diabetes after adjustment for age, sex, waist-to-hip ratio, body-mass index, smoking, exercise, alcohol consumption, education, and glycosylated haernoglobin A(1c) (odds ratio 4th vs 1st quartile 0.3 [95% CI 0.2-0.7], p=0.0051). We conclude that adiponectin is independently associated with a reduced risk of type 2 diabetes in apparently healthy individuals.	German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, D-14558 Bergholz Rehbrucke, Germany; Free Univ Berlin, Benjamin Franklin Med Ctr, Dept Nut Endocrinol & Metab, D-1000 Berlin, Germany; Free Univ Berlin, Univ Clin Benjamin Franklin, Dept Epidemiol, D-1000 Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spranger, J (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Arthur Scheunert Allee 114-116, D-14558 Bergholz Rehbrucke, Germany.	spranger@mail.dife.de	Pfeiffer, Andreas F.H./AAJ-2311-2020; Ristow, Michael/O-9858-2014	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Ristow, Michael/0000-0003-2109-2453				Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; KUBOTA N, 2002, J BIOL CHEM, V24, P24; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746	5	837	885	0	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					226	228		10.1016/S0140-6736(03)12255-6	http://dx.doi.org/10.1016/S0140-6736(03)12255-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547549				2022-12-24	WOS:000180535400015
J	Poutanen, SM; Low, DE; Henry, B; Finkelstein, S; Rose, D; Green, K; Tellier, R; Draker, R; Adachi, D; Ayers, M; Chan, AK; Skowronski, DM; Salit, I; Simor, AE; Slutsky, AS; Doyle, PW; Krajden, M; Petric, M; Brunham, RC; McGeer, AJ				Poutanen, SM; Low, DE; Henry, B; Finkelstein, S; Rose, D; Green, K; Tellier, R; Draker, R; Adachi, D; Ayers, M; Chan, AK; Skowronski, DM; Salit, I; Simor, AE; Slutsky, AS; Doyle, PW; Krajden, M; Petric, M; Brunham, RC; McGeer, AJ		Natl Microbiology Lab Canada; Canadian Severe Acute Respiratory	Identification of severe acute respiratory syndrome in Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN METAPNEUMOVIRUS; MECHANICAL VENTILATION; CORONAVIRUS; INFECTIONS; RIBAVIRIN; CHILDREN; TRIAL	BACKGROUND Severe acute respiratory syndrome (SARS) is a condition of unknown cause that has recently been recognized in patients in Asia, North America, and Europe. This report summarizes the initial epidemiologic findings, clinical description, and diagnostic findings that followed the identification of SARS in Canada. METHODS SARS was first identified in Canada in early March 2003. We collected epidemiologic, clinical, and diagnostic data from each of the first 10 cases prospectively as they were identified. Specimens from all cases were sent to local, provincial, national, and international laboratories for studies to identify an etiologic agent. RESULTS The patients ranged from 24 to 78 years old; 60 percent were men. Transmission occurred only after close contact. The most common presenting symptoms were fever (in 100 percent of cases) and malaise (in 70 percent), followed by nonproductive cough (in 100 percent) and dyspnea (in 80 percent) associated with infiltrates on chest radiography (in 100 percent). Lymphopenia (in 89 percent of those for whom data were available), elevated lactate dehydrogenase levels (in 80 percent), elevated aspartate aminotransferase levels (in 78 percent), and elevated creatinine kinase levels (in 56 percent) were common. Empirical therapy most commonly included antibiotics, oseltamivir, and intravenous ribavirin. Mechanical ventilation was required in five patients. Three patients died, and five have had clinical improvement. The results of laboratory investigations were negative or not clinically significant except for the amplification of human metapneumovirus from respiratory specimens from five of nine patients and the isolation and amplification of a novel coronavirus from five of nine patients. In four cases both pathogens were isolated. CONCLUSIONS SARS is a condition associated with substantial morbidity and mortality. It appears to be of viral origin, with patterns suggesting droplet or contact transmission. The role of human metapneumovirus, a novel coronavirus, or both requires further investigation.	Toronto Med Labs, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; City Toronto Publ Hlth Dept, Toronto, ON, Canada; Scarborough Gen Hosp, Toronto, ON, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; British Columbia Ctr Dis Control, Epidemiol Serv, Vancouver, BC, Canada; British Columbia Ctr Dis Control, Lab Serv, Vancouver, BC, Canada; Univ Hlth Network, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Vancouver Hosp & Hlth Sci Ctr, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; Scarborough Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of British Columbia; University of British Columbia	McGeer, AJ (corresponding author), Toronto Med Labs, 600 Univ Ave,Rm 1460, Toronto, ON M5G 1X5, Canada.		Slutsky, Arthur/M-3325-2019; Low, Donald/B-1726-2012; Poutanen, Susan M./N-8066-2019; mcgeer, allison/H-7747-2014; McGeer, Allison/AAB-6885-2020; Poutanen, Susan M/F-9640-2012; Slutsky, Arthur S/A-6013-2008; Draker, Ryan/GQP-7335-2022	Poutanen, Susan M./0000-0003-4747-2550; mcgeer, allison/0000-0001-5647-6137; McGeer, Allison/0000-0001-5647-6137; Poutanen, Susan M/0000-0003-4747-2550; Slutsky, Arthur S/0000-0002-6063-3876; 				[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P81; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Crotty S, 2001, NAT MED, V7, P255; Falsey AR, 1997, J AM GERIATR SOC, V45, P706, DOI 10.1111/j.1532-5415.1997.tb01474.x; Farr BM, 2000, RESP MED, V94, P954, DOI 10.1053/rmed.2000.0865; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Nissen MD, 2002, MED J AUSTRALIA, V176, P188, DOI 10.5694/j.1326-5377.2002.tb04354.x; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; SIDWELL RW, 1987, ANTIMICROB AGENTS CH, V31, P1130, DOI 10.1128/AAC.31.7.1130; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; SMITH DW, 1991, NEW ENGL J MED, V325, P24, DOI 10.1056/NEJM199107043250105; Stockton J, 2002, EMERG INFECT DIS, V8, P897, DOI 10.3201/eid0809.020084; TRUYEN U, 1995, VET MICROBIOL, V43, P103, DOI 10.1016/0378-1135(95)92531-F; Vabret A, 1998, PRESSE MED, V27, P1813; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEISS RC, 1989, VET MICROBIOL, V20, P255, DOI 10.1016/0378-1135(89)90049-7; 2003, MMWR MORB MORTAL WKL, V52, P241	23	783	923	0	54	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1995	2005		10.1056/NEJMoa030634	http://dx.doi.org/10.1056/NEJMoa030634			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12671061	Bronze, Green Published			2022-12-24	WOS:000182823400008
J	Straight, AF; Cheung, A; Limouze, J; Chen, I; Westwood, NJ; Sellers, JR; Mitchison, TJ				Straight, AF; Cheung, A; Limouze, J; Chen, I; Westwood, NJ; Sellers, JR; Mitchison, TJ			Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor	SCIENCE			English	Article							CONTRACTILE RING; PROTEIN-KINASE; MAMMALIAN-CELLS; MITOTIC SPINDLE; CLEAVAGE; LOCALIZATION; MICROTUBULES; PROTEOLYSIS; ANTIBODY; MIDZONE	Completion of cell division during cytokinesis requires temporally and spatially regulated communication from the microtubule cytoskeleton to the actin cytoskeleton and the cell membrane. We identified a specific inhibitor of nonmuscle myosin II, blebbistatin, that inhibited contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly. Using blebbistatin and other drugs, we showed that exit from the cytokinetic phase of the cell cycle depends on ubiquitin-mediated proteolysis. Continuous signals from microtubules are required to maintain the position of the cleavage furrow, and these signals control the localization of myosin II independently of other furrow components.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA; NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ St Andrews, Sch Chem, St Andrews KY16 9AJ, Fife, Scotland	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; University of St Andrews	Straight, AF (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 250 Longwood Ave, Boston, MA 02115 USA.	aaron_straight@hms.harvard.edu		Westwood, Nicholas/0000-0003-0630-0138; Chen, Irene/0000-0001-6040-7927; Straight, Aaron/0000-0001-5885-7881	NIGMS NIH HHS [GM62566, GM23928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023928, P01GM062566] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Cimini D, 1998, CHROMOSOMA, V107, P479, DOI 10.1007/s004120050332; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Fabbro D, 1999, PHARMACOL THERAPEUT, V82, P293, DOI 10.1016/S0163-7258(99)00005-4; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; FUJIWARA K, 1976, J CELL BIOL, V71, P848, DOI 10.1083/jcb.71.3.848; Gatti M, 2000, MICROSC RES TECHNIQ, V49, P202, DOI 10.1002/(SICI)1097-0029(20000415)49:2<202::AID-JEMT13>3.0.CO;2-8; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; HENRI JF, 2001, Patent No. 0155116; HENRI JF, 2001, Patent No. 0121596; HIRANO A, 1974, EXP CELL RES, V89, P111, DOI 10.1016/0014-4827(74)90193-1; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; MARTINEAU SN, 1995, J CELL BIOL, V131, P191, DOI 10.1083/jcb.131.1.191; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Rappaport R., 1996, DEV CELL BIOL SERIES, V32; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Shuster CB, 2002, CURR BIOL, V12, P854, DOI 10.1016/S0960-9822(02)00838-2; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981	32	1084	1112	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2003	299	5613					1743	1747		10.1126/science.1081412	http://dx.doi.org/10.1126/science.1081412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637748				2022-12-24	WOS:000181519500049
J	Walsh, JME; Terdiman, JP				Walsh, JME; Terdiman, JP			Colorectal cancer screening - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS ANALYSIS; OCCULT BLOOD-TEST; COLON-CANCER; FLEXIBLE SIGMOIDOSCOPY; AVERAGE-RISK; CONTROLLED-TRIAL; COLONOSCOPY; PARTICIPATION; GUIDELINES; ADHERENCE	Screening for colorectal cancer reduces mortality in individuals aged 50 years or older. A number of screening tests, including fecal occult blood tests, sigmoidoscopy, double-contrast barium enema, and colonoscopy, are recommended by professional organizations for colorectal cancer screening, yet the rates of colorectal cancer screening remain low. Questions regarding the quality of evidence for each screening test, whether screening for individuals at higher risk should be modified, the availability of the tests, and cost-effectiveness are addressed. Many potential barriers to colorectal cancer screening exist for the patient and the physician. Strategies to increase compliance for colorectal cancer screening are proposed.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Womens Hlth Clin Res Ctr, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Walsh, JME (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Womens Hlth Clin Res Ctr, Campus Box 1793,1635 Divisadero Suite 600, San Francisco, CA 94115 USA.	Jwalsh@medicine.ucsf.edu						Anderson ML, 2000, AM J GASTROENTEROL, V95, P3418, DOI 10.1111/j.1572-0241.2000.03356.x; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2000, GASTROENTEROLOGY, V118, pA187, DOI 10.1016/S0016-5085(00)82822-X; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Beeker C, 2000, J COMMUN HEALTH, V25, P263, DOI 10.1023/A:1005104406934; Bejes C, 1992, Fam Pract Res J, V12, P83; Bell CM, 1998, JAMA-J AM MED ASSOC, V279, P1015, DOI 10.1001/jama.279.13.1015; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Bini EJ, 1999, ARCH INTERN MED, V159, P2022, DOI 10.1001/archinte.159.17.2022; Brenes GA, 2000, PREV MED, V31, P410, DOI 10.1006/pmed.2000.0729; Burke CA, 2001, AM J GASTROENTEROL, V96, P3175; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; DiPalma AM, 1998, SOUTHERN MED J, V91, P342, DOI 10.1097/00007611-199804000-00005; Dominitz JA, 1997, AM J GASTROENTEROL, V92, P2171; EISNER MS, 1991, ARCH INTERN MED, V151, P2180, DOI 10.1001/archinte.151.11.2180; Ellerbeck EF, 2001, J GEN INTERN MED, V16, P697, DOI 10.1111/j.1525-1497.2001.01224.x; ELWOOD TW, 1978, AM J PUBLIC HEALTH, V68, P135, DOI 10.2105/AJPH.68.2.135; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; HARDCASTLE JD, 1986, CANCER-AM CANCER SOC, V58, P397, DOI 10.1002/1097-0142(19860715)58:2<397::AID-CNCR2820580235>3.0.CO;2-X; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; HARDCASTLE JD, 1983, LANCET, V2, P1; HERRINTON LJ, 1995, AM J EPIDEMIOL, V142, P961, DOI 10.1093/oxfordjournals.aje.a117744; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; KELLY RB, 1992, MED CARE, V30, P1029, DOI 10.1097/00005650-199211000-00006; Khandker RK, 2000, INT J TECHNOL ASSESS, V16, P799, DOI 10.1017/S0266462300102077; KING J, 1992, AUST NZ J SURG, V62, P714, DOI 10.1111/j.1445-2197.1992.tb07068.x; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LALLEMAND RC, 1984, BRIT MED J, V288, P31, DOI 10.1136/bmj.288.6410.31; LEE C Y, 1991, Yonsei Medical Journal, V32, P131; LEE FI, 1983, BRIT J CANCER, V48, P843, DOI 10.1038/bjc.1983.275; Lemon S, 2001, AM J PUBLIC HEALTH, V91, P1264, DOI 10.2105/AJPH.91.8.1264; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Ling BS, 2001, J GEN INTERN MED, V16, P822, DOI 10.1046/j.1525-1497.2001.10337.x; Lipkus IM, 1996, J COMMUN HEALTH, V21, P409, DOI 10.1007/BF01702602; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANT D, 1992, BRIT J GEN PRACT, V42, P18; MYERS RE, 1994, PREV MED, V23, P142, DOI 10.1006/pmed.1994.1020; MYERS RE, 1991, MED CARE, V29, P1039, DOI 10.1097/00005650-199110000-00009; NEALE AV, 1989, J OCCUP ENVIRON MED, V31, P1007, DOI 10.1097/00043764-198912000-00015; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Ness RM, 2000, AM J GASTROENTEROL, V95, P1800; NICHOLS S, 1986, BRIT MED J, V293, P107, DOI 10.1136/bmj.293.6539.107; Olynyk JK, 1996, MED J AUSTRALIA, V165, P74, DOI 10.5694/j.1326-5377.1996.tb124851.x; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; PLASKON PP, 1995, SOC WORK HEALTH CARE, V21, P59, DOI 10.1300/J010v21n04_04; PYE G, 1988, J EPIDEMIOL COMMUN H, V42, P66, DOI 10.1136/jech.42.1.66; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; Ransohoff DF, 1997, ANN INTERN MED, V126, P808, DOI 10.7326/0003-4819-126-10-199705150-00014; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Schroy PC, 1999, GASTROENTEROLOGY, V117, P304, DOI 10.1053/gast.1999.0029900304; SLATER PE, 1985, J CLIN GASTROENTEROL, V7, P51, DOI 10.1097/00004836-198502000-00007; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; Sonnenberg A, 2002, ARCH INTERN MED, V162, P163, DOI 10.1001/archinte.162.2.163; SONTAG SJ, 1983, AM J SURG, V145, P89, DOI 10.1016/0002-9610(83)90172-1; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; STRUEWING JP, 1991, AM J PREV MED, V7, P75, DOI 10.1016/S0749-3797(18)30941-3; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; THOMPSON RS, 1986, MED CARE, V24, P904, DOI 10.1097/00005650-198610000-00004; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VERNON SW, 1990, J OCCUP ENVIRON MED, V32, P46, DOI 10.1097/00043764-199001000-00013; Vernon SW, 1992, HEALTH VALUES, V16, P3; Vijan S, 2001, AM J MED, V111, P593, DOI 10.1016/S0002-9343(01)00977-9; Wagner JL, 1996, PREVENTION EARLY DET, P321; Walsh JME, 2002, PREV MED, V35, P209, DOI 10.1006/pmed.2002.1059; WEINRICH SP, 1993, GERONTOLOGIST, V33, P491, DOI 10.1093/geront/33.4.491; Weitzman ER, 2001, PREV MED, V32, P502, DOI 10.1006/pmed.2001.0838; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yamamoto M, 2000, HEPATO-GASTROENTEROL, V47, P396; 2000, MMWR MORB MORTAL WKL, V50, P162	78	95	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1297	1302		10.1001/jama.289.10.1297	http://dx.doi.org/10.1001/jama.289.10.1297			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633192	Bronze			2022-12-24	WOS:000181466500032
J	Shen, K; Bargmann, CI				Shen, K; Bargmann, CI			The immunoglobulin superfamily protein SYG-1 determines the location of specific synapses in C-elegans	CELL			English	Article							EGG-LAYING SYSTEM; CAENORHABDITIS-ELEGANS; MYOBLAST FUSION; ADHESION MOLECULE; VULVAL INDUCTION; SEX MYOBLASTS; MOTOR NEURONS; CELL LINEAGE; GENE; DROSOPHILA	During nervous system development, neurons form reproducible synapses onto specific targets. Here, we analyze the development of stereotyped synapses of the C. elegans HSNL neuron in vivo. Postsynaptic neurons and muscles were not required for accurate synaptic vesicle clustering in HSNL. Instead, vulval epithelial cells that contact HSNL act as synaptic guidepost cells that direct HSNL presynaptic vesicles to adjacent regions. The mutant syg-1(ky652) has defects in synapse formation that resemble those in animals that lack vulval epithelial cells: HSNL synaptic vesicles fail to accumulate at normal synaptic locations and form ectopic anterior clusters. syg-1 encodes an immunoglobulin superfamily protein that acts in the presynaptic HSNL axon. SYG-1 protein is localized to the site of future synapses, where it initiates synapse formation and localizes synaptic connections in response to the epithelial signal. SYG-1 is related to Drosophila IrreC and vertebrate NEPH1 proteins, which mediate cell-cell recognition in diverse developmental contexts.	Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, Box 0452, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618				Artero RD, 2001, DEVELOPMENT, V128, P4251; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bour BA, 2000, GENE DEV, V14, P1498; BRENNER S, 1974, GENETICS, V77, P71; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; CASH S, 1992, J NEUROSCI, V12, P2051; CLARK SG, 1993, CELL, V74, P43, DOI 10.1016/0092-8674(93)90293-Y; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Fournier-Thibault C, 1999, J NEUROSCI, V19, P1382; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HENRIKSON CK, 1974, J NEUROCYTOL, V6, P659; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Hobert O, 1998, J NEUROSCI, V18, P2084; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; LI C, 1990, NEURON, V4, P681, DOI 10.1016/0896-6273(90)90195-L; Mello C, 1995, METHOD CELL BIOL, V48, P451; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; O'Connor TP, 1999, CELL MOL LIFE SCI, V55, P1358, DOI 10.1007/s000180050376; POURQUIE O, 1992, J NEUROSCI, V12, P1548; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Wang MQ, 2001, CURR TOP DEV BIOL, V51, P189, DOI 10.1016/S0070-2153(01)51006-6; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43889	56	218	224	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					619	630		10.1016/S0092-8674(03)00113-2	http://dx.doi.org/10.1016/S0092-8674(03)00113-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628183	Bronze			2022-12-24	WOS:000181443600006
J	Oda, Y; Hosokawa, N; Wada, I; Nagata, K				Oda, Y; Hosokawa, N; Wada, I; Nagata, K			EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin	SCIENCE			English	Article							MANNOSIDASE-LIKE PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; QUALITY-CONTROL; CALRETICULIN; YEAST	Terminally misfolded proteins in the endoplasmic reticulum (ER) are retro-translocated to the cytoplasm and degraded by proteasomes through a mechanism known as ER-associated degradation (ERAD). EDEM, a postulated Man8B-binding protein, accelerates the degradation of misfolded proteins in the ER. Here, EDEM was shown to interact with calnexin, but not with calreticulin, through its transmembrane region. Both binding of substrates to calnexin and their release from calnexin were required for ERAD to occur. Overexpression of EDEM accelerated ERAD by promoting the release of terminally misfolded proteins from calnexin. Thus, EDEM appeared to function in the ERAD pathway by accepting substrates from calnexin.	Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068397, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan; Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608556, Japan	Kyoto University; Japan Science & Technology Agency (JST); Sapporo Medical University	Nagata, K (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068397, Japan.			Wada, Ikuo/0000-0001-5668-6994				Braakman I, 2001, EMBO REP, V2, P666, DOI 10.1093/embo-reports/kve162; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; CARBRAL CM, 2002, MOL BIOL CELL, V13, P2639; CARBRAL CM, 2001, TRENDS BIOCHEM SCI, V26, P619; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Danilczyk UG, 2000, J BIOL CHEM, V275, P13089, DOI 10.1074/jbc.275.17.13089; ELLGARD L, 2001, CURR OPIN CELL BIOL, V11, P120; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; ODA Y, UNPUB; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; Wilson CM, 2000, J BIOL CHEM, V275, P21224, DOI 10.1074/jbc.M000567200; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	27	360	375	3	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1394	1397		10.1126/science.1079181	http://dx.doi.org/10.1126/science.1079181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610305				2022-12-24	WOS:000181192300052
J	Hill, JM; Zalos, G; Halcox, JPJ; Schenke, WH; Waclawiw, MA; Quyyumi, AA; Finkel, T				Hill, JM; Zalos, G; Halcox, JPJ; Schenke, WH; Waclawiw, MA; Quyyumi, AA; Finkel, T			Circulating endothelial progenitor cells, vascular function, and cardiovascular risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; POSTNATAL NEOVASCULARIZATION; ATHEROSCLEROSIS; DYSFUNCTION; INCREASE; THERAPY; BLOOD; VIVO	BACKGROUND: Cardiovascular risk factors contribute to atherogenesis by inducing endothelial-cell injury and dysfunction. We hypothesized that endothelial progenitor cells derived from bone marrow have a role in ongoing endothelial repair and that impaired mobilization or depletion of these cells contributes to endothelial dysfunction and cardiovascular disease progression. METHODS: We measured the number of colony-forming units of endothelial progenitor cells in peripheral-blood samples from 45 men (mean [+/-SE] age, 50+/-2 years). The subjects had various degrees of cardiovascular risk but no history of cardiovascular disease. Endothelium-dependent and endothelium-independent function was assessed by high-resolution ultrasonography of the brachial artery. RESULTS: We observed a strong correlation between the number of circulating endothelial progenitor cells and the subjects' combined Framingham risk factor score (r=-0.47, P=0.001). Measurement of flow-mediated brachial-artery reactivity also revealed a significant relation between endothelial function and the number of progenitor cells (r=0.59, P<0.001). Indeed, the levels of circulating endothelial progenitor cells were a better predictor of vascular reactivity than was the presence or absence of conventional risk factors. In addition, endothelial progenitor cells from subjects at high risk for cardiovascular events had higher rates of in vitro senescence than cells from subjects at low risk. CONCLUSIONS: In healthy men, levels of endothelial progenitor cells may be a surrogate biologic marker for vascular function and cumulative cardiovascular risk. These findings suggest that endothelial injury in the absence of sufficient circulating progenitor cells may affect the progression of cardiovascular disease.	NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA; Emory Univ Hosp, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University	Finkel, T (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10-6N-240,10 Ctr Dr, Bethesda, MD 20892 USA.	finkelt@nih.gov	Mordwinkin, Nicholas M/A-4347-2010	Halcox, Julian/0000-0001-6926-2947	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, Z01HL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Corretti M. C., 2002, J AM COLL CARDIOL, V39, P1082; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Ito H, 1999, CANCER RES, V59, P5875; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Luttun A, 2002, TRENDS CARDIOVAS MED, V12, P88, DOI 10.1016/S1050-1738(01)00152-9; Masuda H, 1999, CIRCULATION, V100, P691; Masuda H, 1999, CIRCULATION, V100, P475; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Prasad A, 2001, J AM COLL CARDIOL, V38, P1089, DOI 10.1016/S0735-1097(01)01511-X; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; SHI Q, 1994, J VASC SURG, V20, P546, DOI 10.1016/0741-5214(94)90279-8; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; WILSON PWF, 1987, AM J CARDIOL, V59, pG91, DOI 10.1016/0002-9149(87)90165-2; WILSON PWF, 1987, AM J CARDIOL, V60, pA11	38	2836	3151	1	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					593	600		10.1056/NEJMoa022287	http://dx.doi.org/10.1056/NEJMoa022287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584367	Bronze			2022-12-24	WOS:000180912900004
J	McCulloch, M; Fallon, S; Wyndham, T; Hendy, E; Lough, J; Barnes, D				McCulloch, M; Fallon, S; Wyndham, T; Hendy, E; Lough, J; Barnes, D			Coral record of increased sediment flux to the inner Great Barrier Reef since European settlement	NATURE			English	Article							PHASE-SHIFTS; MASSIVE CORALS; PERSPECTIVES; IMPACTS; ISSUES; BANDS; WATER	The effect of European settlement on water quality in the Great Barrier Reef of Australia is a long-standing and controversial issue(1-6). Erosion and sediment transport in river catchments in this region have increased substantially since European settlement(6-10), but the magnitude of these changes remains uncertain(1-10). Here we report analyses of Ba/Ca ratios in long-lived Porites coral from Havannah Reef-a site on the inner Great Barrier Reef that is influenced by flood plumes from the Burdekin river-to establish a record of sediment fluxes from about 1750 to 1998. We find that, in the early part of the record, suspended sediment from river floods reached the inner reef area only occasionally, whereas after about 1870-following the beginning of European settlement-a five- to tenfold increase in the delivery of sediments is recorded with the highest fluxes occurring during the drought-breaking floods. We conclude that, since European settlement, land-use practices such as clearing and overstocking have led to major degradation of the semi-arid river catchments, resulting in substantially increased sediment loads entering the inner Great Barrier Reef.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian National University; Australian Institute of Marine Science	McCulloch, M (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	Malcom.McCulloch@anu.edu.au	Lough, Janice M/L-1682-2013; McCulloch, Malcolm T/C-3651-2009; Hendy, Erica J/H-4488-2016; Fallon, Stewart J/G-6645-2011	Lough, Janice M/0000-0002-3789-1009; McCulloch, Malcolm T/0000-0003-1538-1558; Hendy, Erica J/0000-0001-5949-4349; Fallon, Stewart J/0000-0002-8064-5903				ALIBERT C, IN PRESS GEOCHIM COS; Ash A. J., 1997, Rangeland Journal, V19, P123, DOI 10.1071/RJ9970123; Barnes DJ, 2001, CORAL REEFS, V19, P221, DOI 10.1007/PL00006958; BELL PR, 1991, MAR POLLUT BULL, V23, P89, DOI 10.1016/0025-326X(91)90655-C; BELPERIO AP, 1983, BMR J AUST GEOL GEOP, V8, P179; Devlin M., 2001, GREAT BARRIER REEF M; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Fallon SJ, 2002, GEOCHIM COSMOCHIM AC, V66, P45, DOI 10.1016/S0016-7037(01)00715-3; Furnas M, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P37; Haynes D, 2000, MAR POLLUT BULL, V41, P428, DOI 10.1016/S0025-326X(00)00150-8; Hendy EJ, 2002, SCIENCE, V295, P1511, DOI 10.1126/science.1067693; HOLMES JM, 1963, AUSTR OPEN N; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; ISDALE P, 1984, NATURE, V310, P578, DOI 10.1038/310578a0; King B, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P145; Larcombe P, 1999, CORAL REEFS, V18, P163, DOI 10.1007/s003380050174; LEA DW, 1989, NATURE, V340, P373, DOI 10.1038/340373a0; LI YH, 1979, EARTH PLANET SC LETT, V43, P343, DOI 10.1016/0012-821X(79)90089-X; LOUGH JM, IN PRESS HOLOCENE RE; McCook LJ, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P113; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P2747, DOI 10.1016/0016-7037(94)90142-2; Moore WS, 1999, MAR CHEM, V65, P111, DOI 10.1016/S0304-4203(99)00014-6; Moss AJ, 1993, PRELIMINARY ASSESSME; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Prosser IP, 2001, MAR FRESHWATER RES, V52, P81, DOI 10.1071/MF00033; SHEN GT, 1990, GLOBAL ECOLOGICAL CO, P255, DOI DOI 10.1016/S0422-9894(08)70038-2; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; SMITH SV, 1981, PAC SCI, V35, P279; Tudhope AW, 1996, PALAIOS, V11, P347, DOI 10.2307/3515245	30	529	548	3	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					727	730		10.1038/nature01361	http://dx.doi.org/10.1038/nature01361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610621				2022-12-24	WOS:000180938000039
J	Cawthon, RM; Smith, KR; O'Brien, E; Sivatchenko, A; Kerber, RA				Cawthon, RM; Smith, KR; O'Brien, E; Sivatchenko, A; Kerber, RA			Association between telomere length in blood and mortality in people aged 60 years or older	LANCET			English	Article								During normal ageing, the gradual loss of telomeric DNA in dividing somatic cells can contribute to replicative senescence, apoptosis, or neoplastic transformation. In the genetic disorder dyskeratosis congenita, telomere shortening Is accelerated, and patients have premature onset of many age-related diseases and early death. We aimed to assess an association between telomere length and mortality In 143 normal unrelated individuals over the age of 60 years. Those with shorter telomeres in blood DNA had poorer survival, attributable In part to a 3.18-fold higher mortality rate from heart disease (95% CI 1.36-7.45, p=0.0079), and an 8.54-fold higher mortality rate from infectious disease (1.52-47.9, p=0.015). These results lend support to the hypothesis that telomere shortening in human beings contributes to mortality in many age-related diseases.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Family & Consumer Studies, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Cawthon, RM (corresponding author), Univ Utah, Dept Human Genet, 15 N 2030 E St,Room 2100, Salt Lake City, UT 84112 USA.		Kerber, Richard/B-8038-2009; Smith, Ken/B-6451-2011	Smith, Ken/0000-0003-0682-3705	NCI NIH HHS [R29CA69421] Funding Source: Medline; NIA NIH HHS [K01 AG00767, AG13478] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA069421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG000767, R01AG013478] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0	5	1260	1305	3	145	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					393	395		10.1016/S0140-6736(03)12384-7	http://dx.doi.org/10.1016/S0140-6736(03)12384-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573379				2022-12-24	WOS:000180787000015
J	Yanez-Mo, M; Lara-Pezzi, E; Selgas, R; Ramirez-Huesca, M; Dominguez-Jimenez, C; Jimenez-Heffernan, JA; Aguilera, A; Sanchez-Tomero, JA; Bajo, MA; Alvarez, V; Castro, MA; del Peso, G; Cirujeda, A; Gamallo, C; Sanchez-Madrid, F; Lopez-Cabrera, M				Yanez-Mo, M; Lara-Pezzi, E; Selgas, R; Ramirez-Huesca, M; Dominguez-Jimenez, C; Jimenez-Heffernan, JA; Aguilera, A; Sanchez-Tomero, JA; Bajo, MA; Alvarez, V; Castro, MA; del Peso, G; Cirujeda, A; Gamallo, C; Sanchez-Madrid, F; Lopez-Cabrera, M			Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSCRIPTION FACTOR SNAIL; EXTRACELLULAR-MATRIX; E-CADHERIN; TGF-BETA; GROWTH; ADHESION; EXPRESSION; MEMBRANE; GLUCOSE; JUNCTIONS	BACKGROUND: During continuous ambulatory peritoneal dialysis, the peritoneum is exposed to bioincompatible dialysis fluids that cause denudation of mesothelial cells and, ultimately, tissue fibrosis and failure of ultrafiltration. However, the mechanism of this process has yet to be elucidated. METHODS: Mesothelial cells isolated from effluents in dialysis fluid from patients undergoing continuous ambulatory peritoneal dialysis were phenotypically characterized by flow cytometry, confocal immunofluorescence, Western blotting, and reverse-transcriptase polymerase chain reaction. These cells were compared with mesothelial cells from omentum and treated with various stimuli in vitro to mimic the transdifferentiation observed during continuous ambulatory peritoneal dialysis. Results were confirmed in vivo by immunohistochemical analysis performed on peritoneal-biopsy specimens. RESULTS: Soon after dialysis is initiated, peritoneal mesothelial cells undergo a transition from an epithelial phenotype to a mesenchymal phenotype with a progressive loss of epithelial morphology and a decrease in the expression of cytokeratins and E-cadherin through an induction of the transcriptional repressor snail. Mesothelial cells also acquire a migratory phenotype with the up-regulation of expression of a(sub 2) integrin. In vitro analyses point to wound repair and profibrotic and inflammatory cytokines as factors that initiate mesothelial transdifferentiation. Immunohistochemical studies of peritoneal-biopsy specimens from patients undergoing continuous ambulatory peritoneal dialysis demonstrate the expression of the mesothelial markers intercellular adhesion molecule 1 and cytokeratins in fibroblast-like cells entrapped in the stroma, suggesting that these cells stemmed from local conversion of mesothelial cells. CONCLUSIONS: Our results suggest that mesothelial cells have an active role in the structural and functional alteration of the peritoneum during peritoneal dialysis. The findings suggest potential targets for the design of new dialysis solutions and markers for the monitoring of patients.	Univ Autonoma Madrid, Hosp Univ Princesa, Dept Biol Mol, Madrid 28006, Spain; Univ Autonoma Madrid, Hosp Univ Princesa, Serv Inmunol, Madrid 28006, Spain; Hosp Univ La Paz, Serv Nefrol, Madrid, Spain; Inst Reina Sofia Invest Nefrol, Madrid, Spain; Hosp Univ Guadalajara, Serv Anat Patol, Guadalajara, Spain	Autonomous University of Madrid; Hospital de La Princesa; Autonomous University of Madrid; Hospital de La Princesa; Hospital Universitario La Paz	Lopez-Cabrera, M (corresponding author), Univ Autonoma Madrid, Hosp Univ Princesa, Dept Biol Mol, C Diego de Leon 62, Madrid 28006, Spain.		Bajo, Maria A/ABF-6991-2020; YÃÃez-MÃ, Maria/AAI-4544-2020; Sanchez-Madrid, Francisco/M-7889-2016; Lara-Pezzi, Enrique/E-2350-2015; Cabrera, Manuel López/AAA-5463-2019; SANCHEZ TOMERO, JOSE ANTONIO/Q-9346-2017; Yáñez-Mó, María/K-8577-2014	Bajo, Maria A/0000-0001-7364-557X; YÃÃez-MÃ, Maria/0000-0001-7484-2866; Sanchez-Madrid, Francisco/0000-0001-5303-0762; Lara-Pezzi, Enrique/0000-0002-2743-1033; Yáñez-Mó, María/0000-0001-7484-2866; Lopez Cabrera, Manuel/0000-0002-0976-9719				Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Birchmeier C, 1996, ACTA ANAT, V156, P217; BRULEZ HFH, 1995, PERITON DIALYSIS INT, V15, pS24; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; CHAIMOVITZ C, 1994, KIDNEY INT, V45, P1226, DOI 10.1038/ki.1994.163; CHAIMOVITZ C, 1994, KIDNEY INT, V46, P285; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14; Fang CC, 2000, KIDNEY INT, V57, P2626, DOI 10.1046/j.1523-1755.2000.00123.x; Faull RJ, 2001, KIDNEY INT, V59, P614, DOI 10.1046/j.1523-1755.2001.059002614.x; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Hay ED, 1995, ACTA ANAT, V154, P8; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Ito T, 2000, J AM SOC NEPHROL, V11, P1969, DOI 10.1681/ASN.V11111969; Krediet RT, 1999, KIDNEY INT, V55, P341, DOI 10.1046/j.1523-1755.1999.00264.x; Lai KN, 2000, AM J KIDNEY DIS, V35, P644, DOI 10.1016/S0272-6386(00)70011-4; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; Leavesley DI, 1999, NEPHROL DIAL TRANSPL, V14, P1208, DOI 10.1093/ndt/14.5.1208; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Medcalf JF, 2001, NEPHROL DIAL TRANSPL, V16, P1885, DOI 10.1093/ndt/16.9.1885; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rampino T, 2001, AM J PATHOL, V159, P1275, DOI 10.1016/S0002-9440(10)62514-X; ROUSSELLE P, 1995, J BIOL CHEM, V270, P13766, DOI 10.1074/jbc.270.23.13766; SELGAS R, 1994, AM J KIDNEY DIS, V23, P64, DOI 10.1016/S0272-6386(12)80814-6; SUASSUNA JHR, 1994, KIDNEY INT, V46, P443, DOI 10.1038/ki.1994.292; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yanez-Mo M, 2001, J CELL SCI, V114, P577; Yang WS, 1999, PERITON DIALYSIS INT, V19, P211	31	582	615	0	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					403	413		10.1056/NEJMoa020809	http://dx.doi.org/10.1056/NEJMoa020809			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556543				2022-12-24	WOS:000180643800005
J	Lahiri, SD; Zhang, GF; Dunaway-Mariano, D; Allen, KN				Lahiri, SD; Zhang, GF; Dunaway-Mariano, D; Allen, KN			The pentacovalent phosphorus intermediate of a phosphoryl transfer reaction	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ENZYME; PHOSPHOGLUCOMUTASE; MECHANISM; PHOSPHATE; COVALENT; STATE; CATALYSIS; PATHWAY; LACTIS	Enzymes provide enormous rate enhancements, unmatched by any other type of catalyst. The stabilization of high-energy states along the reaction coordinate is the crux of the catalytic power of enzymes. We report the atomic-resolution structure of a high-energy reaction intermediate stabilized in the active site of an enzyme. Crystallization of phosphorylated beta-phosphoglucomutase in the presence of the Mg(II) cofactor and either of the substrates glucose 1-phosphate or glucose 6-phosphate produced crystals of the enzyme-Mg(II)-glucose 1,6(bis)phosphate complex, which diffracted x-rays to 1.2 and 1.4 angstroms, respectively. The structure reveals a stabilized pentacovatent phosphorane formed in the phosphoryl transfer from the C(1)O of glucose 1,6-(bis)phosphate to the nucleophilic Asp8 carboxylate.	Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	University of New Mexico; Boston University	Dunaway-Mariano, D (corresponding author), Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA.	dd39@unm.edu; allen@med-xtal.bu.edu	Allen, Karen N./J-7045-2019	Allen, Karen N./0000-0001-7296-0551	NCRR NIH HHS [RR07707] Funding Source: Medline; NIGMS NIH HHS [GM16099] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898; Allison RD, 2002, METHOD ENZYMOL, V354, P455; Brubaker MJ, 1996, BIOCHEMISTRY-US, V35, P2854, DOI 10.1021/bi951105v; Bruice TC, 2002, ACCOUNTS CHEM RES, V35, P139, DOI 10.1021/ar0001665; Bruice TC, 1999, ACCOUNTS CHEM RES, V32, P127, DOI 10.1021/ar960131y; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; CLELAND WW, 1995, METHOD ENZYMOL, V249, P341; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Corbridge D. E. C., 1974, STRUCTURAL CHEM PHOS; DAI JB, 1992, J BIOL CHEM, V267, P6322; Dunaway-Mariano D, 1999, METHOD ENZYMOL, V308, P149; Gross JW, 2002, METHOD ENZYMOL, V354, P27; Hanes RE, 2002, ORG LETT, V4, P201, DOI 10.1021/ol016941d; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hu QY, 2002, J AM CHEM SOC, V124, P14858, DOI 10.1021/ja027976r; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Kack H, 1998, P NATL ACAD SCI USA, V95, P5495, DOI 10.1073/pnas.95.10.5495; KEMP G, 1976, TETRAHEDRON LETT, P4381; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; Li YF, 1998, J BIOL CHEM, V273, P15035, DOI 10.1074/jbc.273.24.15035; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muller S, 2002, J MOL BIOL, V315, P141, DOI 10.1006/jmbi.2001.5168; Naught LE, 2001, ARCH BIOCHEM BIOPHYS, V396, P111, DOI 10.1006/abbi.2001.2618; Pauling L, 1960, NATURE CHEM BOND, V3rd, P255; Petsko GA, 2000, CURR OPIN CHEM BIOL, V4, P89, DOI 10.1016/S1367-5931(99)00057-5; Qian N, 1997, MICROBIOL-SGM, V143, P855, DOI 10.1099/00221287-143-3-855; QIAN N, 1994, J BACTERIOL, V176, P5304, DOI 10.1128/JB.176.17.5304-5311.1994; Rajagopalan PTR, 2002, CHEM REC, V2, P24, DOI 10.1002/tcr.10009; RAMIREZ F, 1979, J AM CHEM SOC, V101, P1460, DOI 10.1021/ja00500a016; Regni C, 2002, STRUCTURE, V10, P269, DOI 10.1016/S0969-2126(02)00705-0; Ridder IS, 1999, J BIOL CHEM, V274, P30672, DOI 10.1074/jbc.274.43.30672; RUDNICK G, 1975, BIOCHEMISTRY-US, V14, P4515, DOI 10.1021/bi00691a028; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Schramm VL, 2001, CURR OPIN CHEM BIOL, V5, P556, DOI 10.1016/S1367-5931(00)00246-5; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; WESTHEIMER FH, 1968, ACCOUNTS CHEM RES, V1, P70, DOI 10.1021/ar50003a002; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; [No title captured]	44	290	295	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2003	299	5615					2067	2071		10.1126/science.1082710	http://dx.doi.org/10.1126/science.1082710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12637673				2022-12-24	WOS:000181834200055
J	Gaffikin, L; Blumenthal, PD; Emerson, M; Limpaphayom, K; Lumbiganon, P; Ringers, P; Srisupundit, S; Warakamin, S; Lewis, R; Chumworathayee, B; Kanavacharakul, S				Gaffikin, L; Blumenthal, PD; Emerson, M; Limpaphayom, K; Lumbiganon, P; Ringers, P; Srisupundit, S; Warakamin, S; Lewis, R; Chumworathayee, B; Kanavacharakul, S		RTCOG; JHPIEGO Corp Cervical Canc Grp	Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project	LANCET			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; ACETIC-ACID; DEVELOPING-COUNTRIES; VISUAL INSPECTION; NEOPLASIA; MANAGEMENT; PRECURSORS; CARCINOMA; TRIAL	Background To increase screening and treatment coverage, innovative approaches to cervical-cancer prevention are being investigated in rural Thailand. We assessed the value of a single-visit approach combining visual inspection of the cervix with acetic acid wash (VIA) and cryotherapy. Methods 12 trained nurses provided services in mobile (village health centre-based) and static (hospital-based) teams in four districts of Roi-et Province, Thailand. Over 7 months, 5999 women were tested by VIA. If they tested positive, after counselling about the benefits, potential risks, and probable side-effects they were offered cryotherapy. Data measuring safety, acceptability, feasibility, and effort to implement the programme were gathered. Findings The VIA test-positive rate was 13.3% (798/5999), and 98.5% (609/618) of those eligible accepted immediate treatment. Overall, 756 women received cryotherapy, 629 (83.2%) of whom returned for their first follow-up visit. No major complications were recorded, and 33 (4.4%) of those treated returned for a perceived problem. Only 17 (2.2%) of the treated women needed clinical management other than reassurance about side-effects. Both VIA and cryotherapy were highly acceptable to the patients (over 95% expressed satisfaction with their experience). At their 1-year visit, the squamocolumnar junction was visible to the nurses, and the VIA test-negative rate was 94.3%. Interpretation A single-visit approach with VIA and cryotherapy seems to be safe, acceptable, and feasible in rural Thailand, and is a potentially efficient method of cervical-cancer prevention in such settings.	JHPIEGO Corp, Cerv Canc Prevent Programme, Baltimore, MD 21231 USA	Jhpiego	Gaffikin, L (corresponding author), JHPIEGO Corp, Cerv Canc Prevent Programme, 1615 Thames St,Suite 200, Baltimore, MD 21231 USA.		Chumworathayi, Bandit/J-9927-2019	Chumworathayi, Bandit/0000-0003-1214-1962				ABWAO S, 1998, P REG M NAIR KEN 199; ANDERSEN ES, 1992, GYNECOL ONCOL, V45, P240, DOI 10.1016/0090-8258(92)90297-V; Belinson JL, 2001, OBSTET GYNECOL, V98, P441, DOI 10.1016/S0029-7844(01)01454-5; Blumenthal P D, 2001, Medscape Womens Health, V6, P1; CECCHINI S, 1993, TUMORI, V79, P22, DOI 10.1177/030089169307900104; Cox JT, 1999, LANCET, V353, P857, DOI 10.1016/S0140-6736(98)00392-4; CULLINS VE, 1999, REPROD HEALTH MATTER, V1, P134; Gaffikin L, 1999, LANCET, V353, P869; GAFFIKIN L, 1997, WORKSH P ALT CERV CA; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Holschneider CH, 1999, CANCER-AM CANCER SOC, V86, P2659, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2659::AID-CNCR10>3.0.CO;2-S; Kitchener HC, 1999, LANCET, V353, P856, DOI 10.1016/S0140-6736(98)00417-6; LIMPAPHAYOM K, 1997, BRIT J OBSTET GYNAEC, V23, P3107; Londhe M., 1997, Indian Journal of Cancer, V34, P88; MANDELBLATT JS, 2002, J NATL CANCER I, V94, P1; Megevand E, 1996, OBSTET GYNECOL, V88, P383, DOI 10.1016/0029-7844(96)00189-5; Mitchell MF, 1998, OBSTET GYNECOL, V92, P737, DOI 10.1097/00006250-199811000-00001; MORRIS DL, 1996, NURSE PRACTITIONER, V23, P101; Nuovo J, 2000, INT J GYNECOL OBSTET, V68, P25, DOI 10.1016/S0020-7292(99)00162-9; *REPR HLTH OUTL, 2003, CERV CANC PREV; Sankaranarayanan R, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P411; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.3.CO;2-S; Sankaranarayanan R, 1999, INT J CANCER, V80, P161, DOI 10.1002/(SICI)1097-0215(19990105)80:1<161::AID-IJC28>3.3.CO;2-#; Santos C, 1996, GYNECOL ONCOL, V61, P11, DOI 10.1006/gyno.1996.0088; Soler, 2000, Prim Care Update Ob Gyns, V7, P118, DOI 10.1016/S1068-607X(00)00032-9; *UNFPA, UPD 1998 1999 MATERN; [No title captured]	28	181	185	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					814	820						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642047				2022-12-24	WOS:000181466600009
J	Fu, XD; Harberd, NP				Fu, XD; Harberd, NP			Auxin promotes Arabidopsis root growth by modulating gibberellin response	NATURE			English	Article							GAI; DEGRADATION; TRANSPORT; GENE; DEREPRESSION; EXPRESSION; REDUCTION; REGULATOR; DEFINES; PROTEIN	The growth of plant organs is influenced by a stream of the phytohormone auxin that flows from the shoot apex to the tip of the root(1). However, until now it has not been known how auxin regulates the cell proliferation and enlargement that characterizes organ growth. Here we show that auxin controls the growth of roots by modulating cellular responses to the phytohormone gibberellin (GA). GA promotes the growth of plants by opposing the effects of nuclear DELLA protein growth repressors(2-8), one of which is Arabidopsis RGA (for repressor of gal-3)(9,10). GA opposes the action of several DELLA proteins by destabilizing them, reducing both the concentration of detectable DELLA proteins and their growth-restraining effects(9-14). We also show that auxin is necessary for GA-mediated control of root growth, and that attenuation of auxin transport or signalling delays the GA-induced disappearance of RGA from root cell nuclei. Our observations indicate that the shoot apex exerts long-distance control on the growth of plant organs through the effect of auxin on GA-mediated DELLA protein destabilization.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Harberd, NP (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England.	nicholas.harberd@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council [BBS/E/J/00000583] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 1995, PLANT HORMONES PHYSL, DOI DOI 10.1007/978-94-011-0473-9; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BRIAN P. W., 1958, Annals of Botany, V22, P1; Chansang H., 1982, Proceedings of the International Coral Reef Symposium, P129; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2001, GENETICS, V159, P777; EVANS ML, 1994, PLANTA, V194, P215, DOI 10.1007/BF01101680; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Fu XD, 2001, PLANT CELL, V13, P1791, DOI 10.1105/tpc.13.8.1791; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; King KE, 2001, GENETICS, V159, P767; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Lomax Terri L., 1995, P509; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Rogg LE, 2001, DEV CELL, V1, P595, DOI 10.1016/S1534-5807(01)00077-6; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368	30	557	640	4	213	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					740	743		10.1038/nature01387	http://dx.doi.org/10.1038/nature01387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610625				2022-12-24	WOS:000180938000043
J	Colburn, KA; Johnson, PRS				Colburn, KA; Johnson, PRS			Air pollution concerns not changed by S-PLUS flaw	SCIENCE			English	Editorial Material									NESCAUM, Boston, MA 02114 USA		Johnson, PRS (corresponding author), NESCAUM, Boston, MA 02114 USA.	pjohnson@nescaum.org						[Anonymous], 2000, 94 HLTH EFF I; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; DEVLIN RB, IN PRESS EUR RESP J; DOCKERY DW, 1993, NEW ENGL J MED, V329, P24; DOMINICI F, 2002, REPORT HLTH EFFECTS; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Health Effects Institute, 2001, AIRB PART HLTH HEI E; *HLTH EFF I, 2002, IMP NEW FIND NMMAPS; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; KATSOUYANNI K, 1997, BMJ-BRIT MED J, V314, P7095; Krewski D., 2000, REANALYSIS HARVARD 6; Peters A, 2000, EPIDEMIOLOGY, V11, P11, DOI 10.1097/00001648-200001000-00005; Peters A, 2002, LANCET, V360, P1184, DOI 10.1016/S0140-6736(02)11289-X; Peters A, 2001, CIRCULATION, V103, P2810; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P3; SAMOLI E, 2001, ENV HLTH PERSPECT, V109, P4; Schwartz J, 2001, EPIDEMIOLOGY, V12, P55, DOI 10.1097/00001648-200101000-00010; SCHWARTZ J, 2000, ENV HLTH PERSPECT, V108, P6; SCHWARTZ J, 1996, J AIR WASTE MANAGE, V46, P10; SCHWARTZ J, 2002, ENV HLTH PERSPECT, V110, P10; SCHWARTZ J, 2002, CLEAN AIR SCI ADV CO; SCHWARTZ J, 2002, REANALYSIS NMMAPS MO; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; *US EPA, 2002, CLEAN AIR SCI ADV CO, P175; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015; [No title captured]	30	15	15	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					665	666		10.1126/science.1082105	http://dx.doi.org/10.1126/science.1082105			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560535				2022-12-24	WOS:000180687700029
J	Breman, JG; Arita, I; Fenner, F				Breman, JG; Arita, I; Fenner, F			Preventing the return of smallpox	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Fogarty Int Ctr, Bethesda, MD 20892 USA; Agcy Cooperat Int Hlth, Kumamoto, Japan; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Australian National University; John Curtin School of Medical Research	Breman, JG (corresponding author), Fogarty Int Ctr, Bldg 16,Rm 214,16 Ctr Dr, Bethesda, MD 20892 USA.							Alibek K, 1999, BIOHAZARD CHILLING T; Basu RN, 1979, ERADICATION SMALLPOX; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; *CBW ARM ARMS LIM, 2003, CONV PROH DEV PROD S; Centers for Disease Control and Prevention, 2002, SMALLP RESP PLAN GUI; CONNOLLY C, 2002, WASHINGTON POST 1224, pA5; Connolly C, 2002, WASH POST, pA1; Fenner F., 1989, SMALLPOX ITS ERADICA, VVolume 43; FOEGE WH, 1971, AM J EPIDEMIOL, V94, P311, DOI 10.1093/oxfordjournals.aje.a121325; Gellman B., 2002, WASHINGTON POST 0120, pA1; GELLMAN B, 2002, WASHINGTON POST 1104, pA4; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Preston R., 2002, DEMON FREEZER TRUE S; *UN, 2002, BIOL WEAP CONV; WHO, 2002, WHOCDSCSRGAR20024, P6; *WHO, 2002, WHA5516 WHO; World Health Organisation, 2002, WHOCDSCSREPH200216; 2002, MONTEREY I INT STUDI	18	15	19	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					463	466		10.1056/NEJMp025175	http://dx.doi.org/10.1056/NEJMp025175			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556549	Bronze			2022-12-24	WOS:000180643800015
J	Pantelis, C; Velakoulis, D; McGorry, PD; Wood, SJ; Suckling, J; Phillips, LJ; Yung, AR; Bullmore, ET; Brewer, W; Soulsby, B; Desmond, P; McGuire, PK				Pantelis, C; Velakoulis, D; McGorry, PD; Wood, SJ; Suckling, J; Phillips, LJ; Yung, AR; Bullmore, ET; Brewer, W; Soulsby, B; Desmond, P; McGuire, PK			Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison	LANCET			English	Article							HIPPOCAMPAL VOLUME; FUNCTIONAL-PSYCHOSIS; MATTER CHANGES; SCHIZOPHRENIA; BRAIN; DISORDER; RISK; ENLARGEMENT; ILLNESS; ATLAS	Background Psychotic disorders, such as schizophrenia, are associated with neuroanatomical abnormalities, but whether these predate the onset of symptoms or develop progressively over the course of illness is unclear. We investigated this issue with MRI to study people with prodromal symptoms who are at ultra high-risk for the development of psychosis. Methods We did two comparisons, cross-sectional and longitudinal. For the cross-sectional comparison, 75 people with prodromal signs of psychosis were scanned with MRI. After at least 12 months of follow-up, 23 (31%) had developed psychosis and 52 (69%) had not. Baseline MRI data from these two subgroups were compared. For the longitudinal comparison, 21 of the ultra high-risk individuals were scanned again with MRI after at least 12 months. Ten of these had developed psychosis and 11 had not. MRI data from baseline and follow-up were compared within each group of people. Findings In the cross-sectional comparison, compared with people who did not develop psychosis, those who did develop the disorder had less grey matter in the right medial temporal, lateral temporal, and inferior frontal cortex, and in the cingulate cortex bilaterally. In the longitudinal comparison, when re-scanned, individuals who had developed psychosis showed a reduction in grey matter in the left parahippocampal, fusiform, orbitofrontal and cerebellar cortices, and the cingulate gyri. In those who had not become psychotic, longitudinal changes were restricted to the cerebellum. Interpretation Some of the grey-matter abnormalities associated with psychotic disorders predate the onset of frank symptoms, whereas others appear in association with their first expression.	Univ Melbourne, Dept Psychiat, Mental Hlth Programme, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; Univ Melbourne, Cognit Neuropsychiat Res & Acad Unit, Melbourne, Vic, Australia; Sunshine Hosp, Melbourne, Vic, Australia; Mental Hlth Res Inst Victoria, Appl Schizophrenia Div, Melbourne, Vic, Australia; Univ Melbourne, Personal Assessment & Crisis Evaluat Clin, Early Psychosis Prevent & Intervent Ctr, Melbourne, Vic, Australia; Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia; Guys Kings & St Thomas Med Sch, Clin Age Res Unit, London, England; Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 1TN, England; Inst Psychiat, Sect Neuroimaging, London, England; S London & Maudsley NHS Trust, Outreach & Support S London, London, England	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of London; King's College London; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust	Pantelis, C (corresponding author), Sunshine Hosp, Cognit Neuropsychiat Res & Acad Unit, POB 294, St Albans, Vic 3021, Australia.	cpant@unimelb.edu.au	Bullmore, Ed/C-1706-2012; Pantelis, Christos/H-7722-2014; Suckling, John/ABD-7246-2021; Yung, Alison/N-6729-2019; McGorry, Patrick/O-4115-2019; Wood, Stephen/ABF-4086-2020; Wood, Stephen J/M-8652-2014; Velakoulis, Dennis/A-4778-2008; Desmond, Patricia/D-1966-2014	Bullmore, Ed/0000-0002-8955-8283; Pantelis, Christos/0000-0002-9565-0238; Suckling, John/0000-0002-5098-1527; Yung, Alison/0000-0002-0401-9791; Wood, Stephen/0000-0003-4186-5919; Wood, Stephen J/0000-0003-4186-5919; Velakoulis, Dennis/0000-0002-8842-8479; Phillips, Lisa/0000-0003-1060-6068; McGorry, Patrick/0000-0002-3789-6168; Desmond, Patricia/0000-0002-4803-6323; McGuire, Philip/0000-0003-4381-0532				AASLY J, 1993, ACTA NEUROL SCAND, V87, P210; Altshuler LL, 2000, BIOL PSYCHIAT, V48, P147, DOI 10.1016/S0006-3223(00)00836-2; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cannon TD, 2001, NEUROIMAGE, V13, pS1034; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Crespo-Facorro B, 1999, AM J PSYCHIAT, V156, P386; CROW TJ, 1990, ACTA PSYCHIAT SCAND, V81, P401, DOI 10.1111/j.1600-0447.1990.tb05471.x; Dickey CC, 1999, BIOL PSYCHIAT, V45, P1393, DOI 10.1016/S0006-3223(99)00030-X; ELKIS H, 1995, ARCH GEN PSYCHIAT, V52, P735; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; JOHNSTONE EC, 1992, PSYCHOL MED, V22, P331, DOI 10.1017/S0033291700030270; KESHAVAN MS, 1994, LANCET, V344, P1434, DOI 10.1016/S0140-6736(94)90599-1; Lawrie SM, 1999, LANCET, V353, P30, DOI 10.1016/S0140-6736(98)06244-8; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; MCGORRY PD, 1990, SCHIZOPHR RES, V3, P221, DOI 10.1016/0920-9964(90)90002-O; PANTELIS C, 2001, COGNITIVE DEFICITS B, P217; Phillips LJ, 2002, SCHIZOPHR RES, V58, P145, DOI 10.1016/S0920-9964(01)00392-9; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; Roy PD, 1998, BIOL PSYCHIAT, V44, P418, DOI 10.1016/S0006-3223(98)00105-X; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Suckling J, 1999, MAGN RESON IMAGING, V17, P1065, DOI 10.1016/S0730-725X(99)00055-7; Talairach J., 1988, COPLANAR STEREOTAXIC; van Os J, 1999, SEARCH FOR THE CAUSES OF SCHIZOPHRENIA, VOL IV, P59; Velakoulis D, 1999, ARCH GEN PSYCHIAT, V56, P133, DOI 10.1001/archpsyc.56.2.133; Videbech P, 1997, ACTA PSYCHIAT SCAND, V96, P157, DOI 10.1111/j.1600-0447.1997.tb10146.x; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553; Wood SJ, 2001, SCHIZOPHR RES, V52, P37, DOI 10.1016/S0920-9964(01)00175-X; Wright IC, 1999, SCHIZOPHR RES, V35, P1, DOI 10.1016/S0920-9964(98)00094-2; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; WYATT RJ, 1995, BIOL PSYCHIAT, V38, P1, DOI 10.1016/0006-3223(95)00191-I; Yung AR, 1998, BRIT J PSYCHIAT, V172, P14, DOI 10.1192/S0007125000297602	32	978	994	1	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					281	288		10.1016/S0140-6736(03)12323-9	http://dx.doi.org/10.1016/S0140-6736(03)12323-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559861	Green Submitted			2022-12-24	WOS:000180643900008
J	Sundareshwar, PV; Morris, JT; Koepfler, EK; Fornwalt, B				Sundareshwar, PV; Morris, JT; Koepfler, EK; Fornwalt, B			Phosphorus limitation of coastal ecosystem processes	SCIENCE			English	Article							NITROGEN-FIXATION; SPARTINA-ALTERNIFLORA; BACTERIA; GROWTH; BACTERIOPLANKTON	Primary production in coastal wetlands is conventionally thought to be limited by nitrogen. Although the plant community in a pristine salt marsh was found to be limited primarily by nitrogen availability, the bacterial community in the soil was limited by phosphorus. Hence, in coastal wetlands, and possibly in many ecosystems, individual trophic groups may respond differently to nitrogen and phosphorus loading. Phosphorus limitation of the growth of nitrogen-transforming bacteria will affect carbon fixation, storage, and release mediated by plants, a result that has important implications for ecosystem management.	Duke Univ, Wetland Ctr, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; Coastal Carolina Univ, Dept Marine Sci, Conway, SC 29526 USA	Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Coastal Carolina University	Sundareshwar, PV (corresponding author), Duke Univ, Wetland Ctr, Nicholas Sch Environm & Earth Sci, Box 90333, Durham, NC 27708 USA.	pvs@duke.edu	morris, james/ABC-8111-2020; morris, james t/A-7003-2009					Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Bonin P, 2002, WATER RES, V36, P722, DOI 10.1016/S0043-1354(01)00269-X; BOYLE CD, 1981, NEW PHYTOL, V89, P275, DOI 10.1111/j.1469-8137.1981.tb07488.x; BROOME SW, 1975, SOIL SCI SOC AM J, V39, P301, DOI 10.2136/sssaj1975.03615995003900020022x; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cotner JB, 1997, AQUAT MICROB ECOL, V13, P141, DOI 10.3354/ame013141; CREWS TE, 1993, BIOGEOCHEMISTRY, V21, P141, DOI 10.1007/BF00001115; deSouza MP, 1997, ESTUAR COAST SHELF S, V45, P547, DOI 10.1006/ecss.1996.0221; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; FINDLAY SEG, 1984, J MICROBIOL METH, V2, P57, DOI 10.1016/0167-7012(84)90031-9; GALLARDO A, 1994, SOIL BIOL BIOCHEM, V26, P1409, DOI 10.1016/0038-0717(94)90225-9; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; JANSSON M, 1988, HYDROBIOLOGIA, V170, P157, DOI 10.1007/BF00024903; KROER N, 1993, LIMNOL OCEANOGR, V38, P1282, DOI 10.4319/lo.1993.38.6.1282; Loreau M, 1998, P ROY SOC B-BIOL SCI, V265, P33, DOI 10.1098/rspb.1998.0260; Mallin MA, 2000, AM SCI, V88, P26, DOI 10.1511/2000.15.762; MORRIS JT, 1990, ECOLOGY, V71, P2209, DOI 10.2307/1938633; Morris JT, 1999, LIMNOL OCEANOGR, V44, P699, DOI 10.4319/lo.1999.44.3.0699; NOWICKI BL, 1994, ESTUAR COAST SHELF S, V38, P137, DOI 10.1006/ecss.1994.1009; OVIATT C, 1995, MAR ECOL PROG SER, V116, P171, DOI 10.3354/meps116171; POMEROY LR, 1995, MAR ECOL PROG SER, V117, P259, DOI 10.3354/meps117259; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; SEITZINGER SP, 1983, SCIENCE, V222, P1244, DOI 10.1126/science.222.4629.1244; SMITH VH, 1992, BIOGEOCHEMISTRY, V18, P19, DOI 10.1007/BF00000424; Ulanowicz RE, 1999, J MARINE SYST, V19, P159, DOI 10.1016/S0924-7963(98)90017-3; VALIELA I, 1974, ECOLOGY HALOPHYTES, P547, DOI DOI 10.1016/B978-0-12-586450-3.50025-1; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Welsh DT, 2000, ECOL LETT, V3, P58, DOI 10.1046/j.1461-0248.2000.00111.x; WHEELER PA, 1986, LIMNOL OCEANOGR, V31, P998, DOI 10.4319/lo.1986.31.5.0998	30	273	301	15	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					563	565		10.1126/science.1079100	http://dx.doi.org/10.1126/science.1079100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543975				2022-12-24	WOS:000180559800049
J	Martin, SG; St Johnston, D				Martin, SG; St Johnston, D			A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; TUMOR-SUPPRESSOR; RNA LOCALIZATION; PAR-1; LKB1/STK11; HOMOLOG; ENCODES; MOSAICS; PKA	The PAR-4 and PAR-1 kinases are necessary for the formation of the anterior-posterior (A-P) axis in Caenorhabditis elegans(1-3). PAR-1 is also required for A-P axis determination in Drosophila(4,5). Here we show that the Drosophila par-4 homologue, lkb1, is required for the early A-P polarity of the oocyte, and for the repolarization of the oocyte cytoskeleton that defines the embryonic A-P axis. LKB1 is phosphorylated by PAR-1 in vitro, and overexpression of LKB1 partially rescues the par-1 phenotype. These two kinases therefore function in a conserved pathway for axis formation in flies and worms. lkb1 mutant clones also disrupt apical-basal epithelial polarity, suggesting a general role in cell polarization. The human homologue, LKB1, is mutated in Peutz-Jeghers syndrome(6,7) and is regulated by prenylation and by phosphorylation by protein kinase A(8,9). We show that protein kinase A phosphorylates Drosophila LKB1 on a conserved site that is important for its activity. Thus, Drosophila and human LKB1 may be functional homologues, suggesting that loss of cell polarity may contribute to tumour formation in individuals with Peutz-Jeghers syndrome.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	ds139@mole.bio.cam.ac.uk	Martin, Sophie/AAE-3198-2019; St Johnston, Daniel/C-9568-2009	Martin, Sophie/0000-0002-5317-2557; St Johnston, Daniel/0000-0001-5582-3301				Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Chou TB, 1996, GENETICS, V144, P1673; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1999, CELL MOL LIFE SCI, V55, P735, DOI 10.1007/s000180050329; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; LANE ME, 1994, GENE DEV, V8, P2986, DOI 10.1101/gad.8.24.2986; Martin J, 2001, J TURBUL, V2, P1; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Spradling Allan C., 1993, P1; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Watts JL, 2000, DEVELOPMENT, V127, P1467; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843	30	239	248	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					379	384		10.1038/nature01296	http://dx.doi.org/10.1038/nature01296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540903				2022-12-24	WOS:000180533000044
J	Timms, JM; Bell, A; Flavell, JR; Murray, PG; Rickinson, AB; Traverse-Glehen, A; Berger, F; Delecluse, HJ				Timms, JM; Bell, A; Flavell, JR; Murray, PG; Rickinson, AB; Traverse-Glehen, A; Berger, F; Delecluse, HJ			Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma	LANCET			English	Article							REED-STERNBERG CELLS; INFECTED B-CELLS; V-H GENES; SOMATIC HYPERMUTATION; IN-VIVO; EXPRESSION; DISORDERS; HETEROGENEITY; STRATEGIES; MUTATIONS	Background Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) encompasses a histologically broad range of lesions, arising from the expanded pool of EBV-infected B cells in the immunocompromised host. Identification of the precise cellular origin of these tumours could clarify their pathogenesis. Methods Of 13 cases of EBV-positive cases of PTLD characterised by histological analysis, pattern of EBV gene expression, and clinical course, 11 had monoclonal or biclonal lesions in which we determined the progenitor B cell by immunoglobulin heavy chain (IgH) genotyping. Results Two tumours had a naive B cell genotype and two showed patterns of IgH somatic mutation typical of antigen-selected (post-germinal-centre) memory cells. All four arose early post-transplant and expressed the markers of EBV transformation-Epstein-Barr nuclear antigen (EBNA) 2 and latent membrane protein (LMP) 1. However, seven tumours, either of early or late onset and including some with downregulated EBNA 2 and LMP 1, arose from post-germinal cells with randomly mutated or sterile IgH genotypes usually incompatible with B-cell survival in vivo. Interpretation PTLD can arise from a broad range of target B cells and not only from the pool of antigen-selected memory cells that EBV generally colonises in immunocompetent individuals. Tumour development seems frequently associated with the EBV-induced rescue and expansion of B cells that have failed the physiological process of germinal centre selection into memory. This finding shows an unexpected connection between pathogenesis of PTLD and that of EBV-positive Hodgkin's lymphoma, another B-cell malignancy of atypical post-germinal-centre cell origin.	Univ Birmingham, Dept Pathol, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Ctr Hosp Lyon Sud, Serv Anat Pathol, F-69310 Pierre Benite, France	University of Birmingham; Cancer Research UK; University of Birmingham; CHU Lyon	Delecluse, HJ (corresponding author), Univ Birmingham, Dept Pathol, Birmingham B15 2TT, W Midlands, England.	H.Delecluse@bham.ac.uk		Bell, Andrew/0000-0001-9520-4417; Delecluse, Henri-Jacques/0000-0002-1744-6274				AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; AUBIN J, 1995, LEUKEMIA, V9, P471; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Bierman PJ, 1996, ANN ONCOL, V7, P265; Brauninger A, 2001, J EXP MED, V194, P927, DOI 10.1084/jem.194.7.927; Cesarman E, 1998, BLOOD, V92, P2294, DOI 10.1182/blood.V92.7.2294.2294_2294_2302; CHAPMAN CJ, 1995, BLOOD, V85, P2176, DOI 10.1182/blood.V85.8.2176.bloodjournal8582176; DELECLUSE HJ, 1995, AM J PATHOL, V146, P1113; Garnier JL, 1996, TRANSPLANTATION, V61, P71, DOI 10.1097/00007890-199601150-00015; HANTO DW, 1989, TRANSPLANTATION, V47, P458, DOI 10.1097/00007890-198903000-00012; HERBST H, 1991, P NATL ACAD SCI USA, V88, P4766, DOI 10.1073/pnas.88.11.4766; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Klein U, 1998, IMMUNOL REV, V162, P261; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; LEVY S, 1988, J EXP MED, V168, P475, DOI 10.1084/jem.168.2.475; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; NALESNIK MA, 1993, CANCER-AM CANCER SOC, V72, P2568, DOI 10.1002/1097-0142(19931101)72:9<2568::AID-CNCR2820720910>3.0.CO;2-D; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rowlings PA, 1999, J CLIN ONCOL, V17, P3122, DOI 10.1200/JCO.1999.17.10.3122; STARZL TE, 1984, LANCET, V1, P583; TAMARU J, 1995, AM J PATHOL, V147, P1398; THOMAS JA, 1990, TRANSPLANTATION, V49, P944, DOI 10.1097/00007890-199005000-00022; World Health Organization, 2001, PATH GEN TUM HAEM LY; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604	29	119	120	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					217	223		10.1016/S0140-6736(03)12271-4	http://dx.doi.org/10.1016/S0140-6736(03)12271-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547545				2022-12-24	WOS:000180535400011
